Citrus Sinensis ID: 022520

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290------
Protein Sequence
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKAA
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccEEEccccccEEEEEEEEEcccccccccEEEEEEEEEEEEccEEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEccEEEccccccccEEEEEEEEcccccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccccEEEccccccEEEEEcccccccccccccEEEEEEccccccHHccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccHHHccccccccccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccc
Coil and Loop (DISEMBL)
masvsvvpasgntvgvdrlpeemndmkirddkemeatvvdgngteAGHIIVTTiggkngqpkqTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQtmrlldhpnvvslkhcffstteKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTigvchrdikpqnllvnphthqlklcdfgsakvlvkgepnisyicsryyrapelifgateyTAAIDIWSAGCVLAELllgqplfpgesgvDQLVEIIKVILHTEISLSIKAA
Flexible Loop (DISEMBL)
masvsvvpasgntvgvdrlpeemNDMKIRDDKEMEATVVDGNGTEAGHIIVTtiggkngqpKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIkkvlqdkrykNRELQtmrlldhpnvvSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHhykmsqrmPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILhteislsikaa
Low Complexity Region (SEG)
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKAA
Disordered region (IsUnstruct)
*****************************************NGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL*****
Disordered Region (DISOPRED)
************************************************IIVTTIG*********ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE********
Disordered Region (DISEMBL)
********ASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKAA
Disordered Region (DISPRO)
************************************TVVD**GTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKAA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	296	2.2.26 [Sep-21-2011]
P51139	411	Glycogen synthase kinase-	N/A	no	0.959	0.690	0.900	1e-153
P43288	405	Shaggy-related protein ki	yes	no	0.959	0.701	0.902	1e-153
Q40518	409	Shaggy-related protein ki	N/A	no	0.959	0.694	0.872	1e-149
P51137	411	Glycogen synthase kinase-	N/A	no	0.959	0.690	0.876	1e-149
P43289	409	Shaggy-related protein ki	no	no	0.959	0.694	0.865	1e-149
P51138	411	Glycogen synthase kinase-	N/A	no	0.959	0.690	0.852	1e-147
Q8VZD5	410	Shaggy-related protein ki	no	no	0.959	0.692	0.848	1e-147
Q96287	472	Shaggy-related protein ki	no	no	0.959	0.601	0.756	1e-131
O04160	468	Shaggy-related protein ki	N/A	no	0.905	0.572	0.762	1e-128
Q39012	407	Shaggy-related protein ki	no	no	0.871	0.633	0.802	1e-125

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  542 bits (1397), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 262/291 (90%), Positives = 274/291 (94%), Gaps = 7/291 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVL 291

Medicago sativa (taxid: 3879)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  540 bits (1391), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 258/286 (90%), Positives = 271/286 (94%), Gaps = 2/286 (0%)

Query: 1   MASVSVVPASG--NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKN 58
           MASV + P  G  ++ GVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTIGG+N
Sbjct: 1   MASVGIAPNPGARDSTGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRN 60

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           GQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRLLDHP
Sbjct: 61  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHP 120

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQI RA
Sbjct: 121 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRA 180

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPEL
Sbjct: 181 LSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 240

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           IFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 IFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 286

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  528 bits (1361), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 253/290 (87%), Positives = 270/290 (93%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           M SV + P SG      ++VGVDRLPEEMNDM+IRDDKE+EA +VDGNGTE GHIIVTTI
Sbjct: 1   MTSVGLAPVSGLRESSSHSVGVDRLPEEMNDMRIRDDKEIEAAIVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG++GQPKQTISYMAER+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVV LKHCFFSTTEKDE+YLNLVLEYVPETVHRVIKH+ K++QRMPLI VKLY YQ
Sbjct: 121 LDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I RAL+YIH+TIGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  526 bits (1356), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 256/292 (87%), Positives = 268/292 (91%), Gaps = 8/292 (2%)

Query: 1   MASVSVVPASG-------NTVGVDR-LPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVT 52
           MASV V P SG         +GVD  LPEEM+DMKIRDD+EMEATVVDGNGTE GHIIVT
Sbjct: 1   MASVGVAPTSGFREVLGDGEIGVDDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVT 60

Query: 53  TIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM 112
           TIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTM
Sbjct: 61  TIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 120

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMP+IYVKLY 
Sbjct: 121 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYT 180

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRY
Sbjct: 181 YQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 240

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           YRAPELIFGATEYT AID+WS GCVLAELLLGQPLFPGE GVDQLVEIIKV+
Sbjct: 241 YRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVL 292

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  526 bits (1356), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 251/290 (86%), Positives = 268/290 (92%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPA------SGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASV + P+      +GN    DRLPEEM DMKI+DDKEMEAT+V+GN TE GHIIVTTI
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  521 bits (1342), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 248/291 (85%), Positives = 266/291 (91%), Gaps = 7/291 (2%)

Query: 1   MASVSVVPASG-------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
           MA+  V PASG       + + VD+LP+E+  M+I+DDKEMEA VVDGN TEAGH+IVTT
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKDDKEMEAHVVDGNSTEAGHVIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAER VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVV+LKHCFFSTTEKDELYLNLVLE+VPETVHRVI+H+ KM+QRMPLIYVKLY Y
Sbjct: 121 LLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICR+LAYIHN +GV HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPELIFGATEYT+AIDIWSAGCVL ELLLGQPLFPG SGVDQLVEIIKV+
Sbjct: 241 RAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVL 291

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  519 bits (1337), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 247/291 (84%), Positives = 265/291 (91%), Gaps = 7/291 (2%)

Query: 1   MASVSVVPASG-------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
           MASV  +PAS         ++  ++LPE +N+MKI+DDKEMEA VVDGNGTE GHIIVTT
Sbjct: 1   MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 291

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  467 bits (1201), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 220/291 (75%), Positives = 250/291 (85%), Gaps = 7/291 (2%)

Query: 1   MASVSVVPASGNTVGVDRLPEEMNDMKIRD-------DKEMEATVVDGNGTEAGHIIVTT 53
           +A  S VPA       D+LP+ M +MKIRD       DK+ME TVV+G+GTE G +I TT
Sbjct: 65  VAGTSNVPAVSEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTT 124

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           +GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MR
Sbjct: 125 VGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMR 184

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY Y
Sbjct: 185 LQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTY 244

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSRYY
Sbjct: 245 QICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYY 304

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK++
Sbjct: 305 RAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKIL 355

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2

 Score =  457 bits (1177), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 212/278 (76%), Positives = 243/278 (87%), Gaps = 10/278 (3%)

Query: 17  DRLPEEMNDMKIRDD----------KEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTIS 66
           D+LPE MNDM++R+D          K+ME  +V+G GTE G +I TT+GG++G+PKQTIS
Sbjct: 74  DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNGCGTETGQVITTTVGGRDGKPKQTIS 133

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           YMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H 
Sbjct: 134 YMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHS 193

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           FFSTT+KDELYLNLVLE+VPETV+R +KH+ KM+Q MP+I V+LY YQICRAL Y+H  +
Sbjct: 194 FFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQHMPIILVQLYTYQICRALNYLHRVV 253

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           GVCHRDIKPQNLLVN HTHQLK+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT
Sbjct: 254 GVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 313

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK++
Sbjct: 314 NAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKIL 351

May mediate extracellular signals to regulate transcription in differentiating cells.

Brassica napus (taxid: 3708)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1

 Score =  447 bits (1150), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 207/258 (80%), Positives = 233/258 (90%)

Query: 27  KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKC 86
           ++  DKEM A V++GN    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKC
Sbjct: 30  ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query: 87  LETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP 146
           LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct: 90  LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
           ET++RV++H+   +QRMP+ YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQ
Sbjct: 150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query: 207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           +KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA+IDIWSAGCVLAELLLGQP
Sbjct: 210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query: 267 LFPGESGVDQLVEIIKVI 284
           LFPGE+ VDQLVEIIKV+
Sbjct: 270 LFPGENSVDQLVEIIKVL 287

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	296
224068663	409	predicted protein [Populus trichocarpa]	0.959	0.694	0.934	1e-158
224128207	409	predicted protein [Populus trichocarpa]	0.959	0.694	0.931	1e-158
255548323	409	Glycogen synthase kinase-3 beta, putativ	0.959	0.694	0.934	1e-157
449461703	409	PREDICTED: glycogen synthase kinase-3 ho	0.959	0.694	0.917	1e-156
164521171	409	serine/threonine protein kinase [Adonis	0.959	0.694	0.917	1e-154
225437683	409	PREDICTED: glycogen synthase kinase-3 ho	0.959	0.694	0.920	1e-154
225450484	409	PREDICTED: shaggy-related protein kinase	0.959	0.694	0.903	1e-152
255543002	383	Glycogen synthase kinase-3 beta, putativ	0.959	0.741	0.913	1e-152
313148	412	protein kinase [Medicago sativa]	0.959	0.689	0.900	1e-152
11182434	411	RecName: Full=Glycogen synthase kinase-3	0.959	0.690	0.900	1e-152

>gi|224068663|ref|XP_002302794.1| predicted protein [Populus trichocarpa] gi|222844520|gb|EEE82067.1| predicted protein [Populus trichocarpa]

 Score =  565 bits (1455), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 271/290 (93%), Positives = 278/290 (95%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSVVPASG      NT GVD+LPEEMNDMKI DDKEMEA VVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVVPASGLRDTLGNTTGVDKLPEEMNDMKISDDKEMEAAVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGLVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+YKMSQRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYYKMSQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128207|ref|XP_002320270.1| predicted protein [Populus trichocarpa] gi|222861043|gb|EEE98585.1| predicted protein [Populus trichocarpa]

 Score =  564 bits (1453), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 270/290 (93%), Positives = 280/290 (96%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPA------SGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSVVPA      SGN+ GVD+LP+EMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVVPATGLRDRSGNSAGVDKLPDEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+ KMSQRMPLIYVKLYFY+
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYSKMSQRMPLIYVKLYFYE 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT+AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTSAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255548323|ref|XP_002515218.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223545698|gb|EEF47202.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  560 bits (1444), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 271/290 (93%), Positives = 275/290 (94%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSV P SG      N  GVDRLP+EMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVAPTSGIRDPGGNAAGVDRLPDEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM QRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMGQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKP NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPHNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461703|ref|XP_004148581.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus] gi|449511511|ref|XP_004163975.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus]

 Score =  556 bits (1432), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 266/290 (91%), Positives = 277/290 (95%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPAS------GNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           M SVSV PAS      G+T+GVDRLP+EMNDMKIRDDKE+EATVVDGNGTE GHIIVTTI
Sbjct: 1   MTSVSVAPASMIRDHGGSTIGVDRLPDEMNDMKIRDDKEIEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAER VGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERAVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM+QRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMNQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRAL+YIHN+IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV+GEPNI+YICSRYYR
Sbjct: 181 ICRALSYIHNSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVRGEPNIAYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|164521171|gb|ABY60447.1| serine/threonine protein kinase [Adonis aestivalis var. palaestina]

 Score =  551 bits (1420), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 266/290 (91%), Positives = 272/290 (93%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVS+ P SG      N  G DRLPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSMAPPSGLRDPTGNAGGADRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET HRVIKH+ KM+QRMPLIYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETAHRVIKHYNKMNQRMPLIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

Source: Adonis aestivalis var. palaestina

Species: Adonis aestivalis

Genus: Adonis

Family: Ranunculaceae

Order: Ranunculales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225437683|ref|XP_002279596.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3 [Vitis vinifera] gi|147767229|emb|CAN75652.1| hypothetical protein VITISV_017659 [Vitis vinifera]

 Score =  549 bits (1415), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 267/290 (92%), Positives = 274/290 (94%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVS+ PASG      NTVGVDRLP+EMNDMKIRDDKEME TVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSIAPASGLREPNGNTVGVDRLPDEMNDMKIRDDKEMEDTVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEK+ELYLNLVLEYVPETVHRVIKH+ KM+QRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKEELYLNLVLEYVPETVHRVIKHYNKMNQRMPMIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIH  IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE NISYICSRYYR
Sbjct: 181 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGELNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225450484|ref|XP_002280673.1| PREDICTED: shaggy-related protein kinase alpha [Vitis vinifera]

 Score =  545 bits (1404), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 262/290 (90%), Positives = 272/290 (93%), Gaps = 6/290 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASV + P SG      +  GVDRLPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVGIAPTSGLREPSGHNAGVDRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I RAL+YIH +IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVL 290

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255543002|ref|XP_002512564.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223548525|gb|EEF50016.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  544 bits (1401), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 264/289 (91%), Positives = 273/289 (94%), Gaps = 5/289 (1%)

Query: 1   MASVSVVP-----ASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIG 55
           MASV V P     ASG+ VGVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTIG
Sbjct: 1   MASVGVAPTGLREASGHNVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIG 60

Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           G+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRLL
Sbjct: 61  GRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 120

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQI
Sbjct: 121 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYAYQI 180

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRA
Sbjct: 181 FRALSYIHCAIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 240

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           PELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 PELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 289

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|313148|emb|CAA48472.1| protein kinase [Medicago sativa]

 Score =  542 bits (1397), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 262/291 (90%), Positives = 274/291 (94%), Gaps = 7/291 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 2   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 61

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 62  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 121

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 122 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 181

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 182 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 241

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 242 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVL 292

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|11182434|sp|P51139.2|MSK3_MEDSA RecName: Full=Glycogen synthase kinase-3 homolog MsK-3

 Score =  542 bits (1397), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 262/291 (90%), Positives = 274/291 (94%), Gaps = 7/291 (2%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKV+
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVL 291

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	296
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.959	0.701	0.902	1.2e-138
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.959	0.694	0.865	1.2e-134
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.959	0.692	0.852	3.4e-132
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.959	0.601	0.756	1.8e-117
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.935	0.672	0.764	2.5e-113
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.871	0.633	0.802	3.2e-113
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.861	0.671	0.811	1.4e-112
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.908	0.638	0.730	2.6e-109
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.905	0.611	0.723	9.2e-107
UNIPROTKB|Q91757	420	gsk3b "Glycogen synthase kinas	0.817	0.576	0.666	1.8e-87

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1357 (482.7 bits), Expect = 1.2e-138, P = 1.2e-138
 Identities = 258/286 (90%), Positives = 271/286 (94%)

Query:     1 MASVSVVPASG--NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKN 58
             MASV + P  G  ++ GVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTIGG+N
Sbjct:     1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRN 60

Query:    59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
             GQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRLLDHP
Sbjct:    61 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHP 120

Query:   119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQI RA
Sbjct:   121 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRA 180

Query:   179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
             L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPEL
Sbjct:   181 LSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 240

Query:   239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             IFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct:   241 IFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 286

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1319 (469.4 bits), Expect = 1.2e-134, P = 1.2e-134
 Identities = 251/290 (86%), Positives = 268/290 (92%)

Query:     1 MASVSVVPAS------GNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
             MASV + P++      GN    DRLPEEM DMKI+DDKEMEAT+V+GN TE GHIIVTTI
Sbjct:     1 MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query:    55 GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
             GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRL
Sbjct:    61 GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query:   115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY YQ
Sbjct:   121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query:   175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
             I R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct:   181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query:   235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             APELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct:   241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 290

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1296 (461.3 bits), Expect = 3.4e-132, P = 3.4e-132
 Identities = 248/291 (85%), Positives = 266/291 (91%)

Query:     1 MASVSVVPASG------N-TVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
             MASV  +PAS       N ++  ++LPE +N+MKI+DDKEMEA VVDGNGTE GHIIVTT
Sbjct:     1 MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query:    54 IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
             IGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct:    61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query:   114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY Y
Sbjct:   121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query:   174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
             QICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct:   181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query:   234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             RAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV+
Sbjct:   241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 291

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1157 (412.3 bits), Expect = 1.8e-117, P = 1.8e-117
 Identities = 220/291 (75%), Positives = 250/291 (85%)

Query:     1 MASVSVVPASGNTVGVDRLPEEMNDMKIRD-------DKEMEATVVDGNGTEAGHIIVTT 53
             +A  S VPA       D+LP+ M +MKIRD       DK+ME TVV+G+GTE G +I TT
Sbjct:    65 VAGTSNVPAVSEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTT 124

Query:    54 IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
             +GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MR
Sbjct:   125 VGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMR 184

Query:   114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             L DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY Y
Sbjct:   185 LQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTY 244

Query:   174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
             QICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSRYY
Sbjct:   245 QICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYY 304

Query:   234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             RAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK++
Sbjct:   305 RAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKIL 355

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 214/280 (76%), Positives = 240/280 (85%)

Query:     5 SVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQT 64
             S+ P   +  G D L    +   I +DKEM A V++GN    GHII TTIGGKNG+PKQT
Sbjct:    13 SLAPQPPHLHGGDSLKRRPD---IDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQT 69

Query:    65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 124
             ISYMAERVVG GSFG+VFQAKCLETGE+VAIKKVLQD+RYKNRELQ MRL+DHPNVVSLK
Sbjct:    70 ISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLK 129

Query:   125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             HCFFSTT +DEL+LNLV+EYVPET++RV+KH+   +QRMP+ YVKLY YQI R LAYIH 
Sbjct:   130 HCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHT 189

Query:   185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
               GVCHRD+KPQNLLV+P THQ KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATE
Sbjct:   190 APGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 249

Query:   245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             YT++IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKV+
Sbjct:   250 YTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVL 289

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
 Identities = 207/258 (80%), Positives = 233/258 (90%)

Query:    27 KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKC 86
             ++  DKEM A V++GN    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKC
Sbjct:    30 ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query:    87 LETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP 146
             LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct:    90 LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query:   147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
             ET++RV++H+   +QRMP+ YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQ
Sbjct:   150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query:   207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
             +KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA+IDIWSAGCVLAELLLGQP
Sbjct:   210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query:   267 LFPGESGVDQLVEIIKVI 284
             LFPGE+ VDQLVEIIKV+
Sbjct:   270 LFPGENSVDQLVEIIKVL 287

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
 Identities = 207/255 (81%), Positives = 230/255 (90%)

Query:    30 DDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 89
             DDKEM A VVDG+    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:    90 GEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 149
             GE VAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+EYVPE++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             +RV+KH+   +QRMPL+YVKLY YQI R LAYIHN  GVCHRD+KPQNLLV+P THQ+K+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182

Query:   210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
             CDFGSAK LVKGE NISYICSR+YRAPELIFGATEYT +IDIWSAGCVLAELLLGQPLFP
Sbjct:   183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242

Query:   270 GESGVDQLVEIIKVI 284
             GE+ VDQLVEIIKV+
Sbjct:   243 GENAVDQLVEIIKVL 257

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1080 (385.2 bits), Expect = 2.6e-109, P = 2.6e-109
 Identities = 201/275 (73%), Positives = 237/275 (86%)

Query:    16 VDRLPEEMNDMKIRD------DKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMA 69
             VD L  ++ + +IRD      +++ E  ++DG G E GH+I TT+ G+NGQ +QT+SY++
Sbjct:    26 VDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYIS 85

Query:    70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
             E VVG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPN V+LKH FFS
Sbjct:    86 EHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFS 145

Query:   130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
              T+ +E+YLNLVLE+VPETV+RV + + + +Q MPLIYVKLY YQICRALAYIHN+ G+C
Sbjct:   146 RTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLC 205

Query:   190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI 249
             HRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYT AI
Sbjct:   206 HRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAI 265

Query:   250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             DIWS GCV+AELLLGQPLFPGESGVDQLVEIIKV+
Sbjct:   266 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 300

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1056 (376.8 bits), Expect = 9.2e-107, P = 9.2e-107
 Identities = 194/268 (72%), Positives = 228/268 (85%)

Query:    17 DRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHG 76
             D LP+E+ ++ + DDK+M+  ++ GNGTE+G II T   G N Q  +TISY AE V+G G
Sbjct:    59 DHLPKEIREVGLGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTG 118

Query:    77 SFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL 136
             SFGVVFQAKCLET E VAIKKVLQDKRYKNRELQ MR+LDHPNVV LKH FFSTTEKDEL
Sbjct:   119 SFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDEL 178

Query:   137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ 196
             YLNLVLEYVPET++R  + + KM+Q MPLIY++LY YQICRA+ Y+H  +GVCHRDIKPQ
Sbjct:   179 YLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQ 238

Query:   197 NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGC 256
             NLLVN  TH++K+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGATEYT+AID+WS GC
Sbjct:   239 NLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGC 298

Query:   257 VLAELLLGQPLFPGESGVDQLVEIIKVI 284
             V+AEL LG PLFPGE+ VDQLVEIIK++
Sbjct:   299 VMAELFLGHPLFPGETSVDQLVEIIKIL 326

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)]

 Score = 874 (312.7 bits), Expect = 1.8e-87, P = 1.8e-87
 Identities = 164/246 (66%), Positives = 207/246 (84%)

Query:    40 DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
             D +G++   ++ T   G+    +Q ++Y   +V+G+GSFGVV+QAK  +TGE VAIKKVL
Sbjct:    31 DKDGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVL 88

Query:   100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
             QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct:    89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query:   159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               Q +P+IYVKLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   149 AKQALPIIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPETAVLKLCDFGSAKQL 207

Query:   219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
             V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct:   208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query:   279 EIIKVI 284
             EIIKV+
Sbjct:   268 EIIKVL 273

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IDA

GO:0060070 "canonical Wnt receptor signaling pathway" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9020	0.9594	0.7012	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6793	0.7939	0.6491	yes	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8724	0.9594	0.6943	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6315	0.8547	0.6023	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8767	0.9594	0.6909	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8522	0.9594	0.6909	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9003	0.9594	0.6909	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6315	0.8547	0.6023	yes	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6315	0.8547	0.6023	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_II0912 hypothetical protein (409 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	296
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-98
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-71
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-70
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-68
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-68
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-67
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-65
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-65
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-60
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-56
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-55
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-55
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-54
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-53
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-53
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-52
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-52
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-51
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-51
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-50
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-50
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-48
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-47
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-47
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-46
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-45
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-44
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-44
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-43
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-42
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-42
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-42
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-42
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-41
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-41
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-40
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-40
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-40
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-40
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-39
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-39
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-37
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-37
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-37
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-36
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-36
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-36
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-36
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-33
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-33
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-33
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-33
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-32
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-32
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-32
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-31
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-31
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-31
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-29
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-29
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-28
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-27
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-26
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-26
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-26
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-25
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-24
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-24
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-23
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-23
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-20
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-20
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-19
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-19
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-18
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-18
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-17
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-16
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-16
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-15
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-08
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-05
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.003
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.003

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  295 bits (755), Expect = 5e-98
 Identities = 126/222 (56%), Positives = 178/222 (80%), Gaps = 4/222 (1%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           SY    ++G+GSFGVV++A C++T E VAIKKVLQD +YKNREL  M+ L+H N++ LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 126 CFFSTT-EKDE--LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            +++   +K+E  ++LN+V+E++P+TVH+ +KH+ + +  +PL  VKLY YQ+CRALAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   +CHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           T YT  ID+WS GC++AE++LG P+F G+S VDQLV II+V+
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287

Length = 440

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  219 bits (561), Expect = 4e-71
 Identities = 85/226 (37%), Positives = 131/226 (57%), Gaps = 21/226 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 121
           Y     +G GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L   F    ++D+LYL  V+EY     +  ++K   ++S+       + Y  QI  AL 
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           Y+H+  G+ HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++ 
Sbjct: 112 YLHS-KGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH 286
           G   Y  A+DIWS G +L ELL G+P FPG+   DQL+E+ K I  
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGK 211

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  217 bits (555), Expect = 9e-70
 Identities = 94/221 (42%), Positives = 134/221 (60%), Gaps = 18/221 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 125
           VVG G++GVV + +   TGE VAIKK  +   D+  K    RE++ +R L H N+V+LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F     K  LYL  V EYV  T+  +++        +P   V+ Y +Q+ +A+AY H+ 
Sbjct: 68  AFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGAT 243
             + HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y   +D+W+ GC++AELL G+PLFPG+S +DQL  I K +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  215 bits (551), Expect = 1e-68
 Identities = 89/230 (38%), Positives = 132/230 (57%), Gaps = 20/230 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + +G G++GVV  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 121 VSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           + L       S  + +++Y+  V E +   +H+VIK      Q +   +++ + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYR 234
           L Y+H +  V HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++V+
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  211 bits (539), Expect = 9e-68
 Identities = 80/231 (34%), Positives = 123/231 (53%), Gaps = 18/231 (7%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F    +KD LYL  V+EY           +      +     K    QI R L Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 242
           +  G+ HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++ G 
Sbjct: 116 S-NGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSI 293
             Y   +D+WS G +L ELL G+P F GE+ +DQL ++I+ IL   +    
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL-QLIRRILGPPLEFDE 223

Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  211 bits (538), Expect = 3e-67
 Identities = 87/225 (38%), Positives = 133/225 (59%), Gaps = 17/225 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L   F     K +LYL  V E++   ++++IK   +    +P   +K Y YQ+ + LA
Sbjct: 61  IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+  G+ HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            G   Y+  +DIWS GC+ AELL  +PLFPG+S +DQL +I + +
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL 215

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  205 bits (525), Expect = 3e-65
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 25/223 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSLK 124
           +G G++GVV++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN+V L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               +   + +LYL  V EY    + + +    K    +    +K   YQ+ R LAY H 
Sbjct: 65  DVIHT---ERKLYL--VFEYCDMDLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
           +  + HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 116 SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +  Y+ A+DIWS GC+ AE++ G+PLFPG+S +DQL +I +++
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  205 bits (525), Expect = 3e-65
 Identities = 81/221 (36%), Positives = 126/221 (57%), Gaps = 18/221 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
             +G G+ G+VF+AK  ETGE VA+KKV   +          RE++ ++   HP VV L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F            LV+EY+P  +  V++      + +P   VK Y   + + +AY+H 
Sbjct: 66  DVF-----PHGSGFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGA 242
             G+ HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA
Sbjct: 118 N-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
            +Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + 
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  192 bits (490), Expect = 8e-60
 Identities = 85/226 (37%), Positives = 123/226 (54%), Gaps = 24/226 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 117
           Y   + +G G++ VV++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN++ L   F     K    +NLV E++   + +VIK     S  +    +K Y     R
Sbjct: 62  PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SRYYR 234
            L Y+H+   + HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  183 bits (468), Expect = 1e-56
 Identities = 86/222 (38%), Positives = 136/222 (61%), Gaps = 19/222 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVS 122
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+V 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           LK  F    E DELY   V EY+   +++++K      +      ++   YQI + LA+I
Sbjct: 63  LKEVF---RENDELYF--VFEYMEGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHI 115

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H   G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           T Y++ +DIW+ GC++AEL   +PLFPG S +DQL +I  V+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL 215

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  181 bits (461), Expect = 1e-55
 Identities = 77/221 (34%), Positives = 125/221 (56%), Gaps = 20/221 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +G G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+V LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIHN 184
                T K +  + +V EY+   +  ++     K ++      +K Y  Q+   L Y+H+
Sbjct: 66  I---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIKCYMKQLLEGLQYLHS 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGA 242
             G+ HRDIK  N+L+N     LKL DFG A+   K       + + + +YR PEL+ GA
Sbjct: 119 -NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           T Y   +D+WS GC+LAEL LG+P+F G + ++QL +I ++
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  181 bits (462), Expect = 4e-55
 Identities = 92/233 (39%), Positives = 139/233 (59%), Gaps = 27/233 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRE---LQTMRLLDH 117
           Y   + +G G++G+V++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L +   +  +KD +YL  V EY+   +H VI+    + + +   Y+    YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA--NILEDVHKRYI---MYQLLK 118

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------YICSR 231
           AL YIH +  V HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIH-SGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +YRAPE++ G+T YT  +D+WS GC+L E+LLG+PLFPG S ++QL +II+VI
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  178 bits (453), Expect = 2e-54
 Identities = 88/219 (40%), Positives = 134/219 (61%), Gaps = 21/219 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN+V+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 184
           F     + +  L+LV EY   TV   ++ +    + +P   +K   +Q  +A+ + H  N
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 243
            I   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G T
Sbjct: 121 CI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  178 bits (452), Expect = 8e-54
 Identities = 96/239 (40%), Positives = 143/239 (59%), Gaps = 20/239 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V +KH     + ++   + +V E +   +H+VIK +  ++      + + + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALK 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 236
           YIH T  V HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 237 ELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSI 293
           EL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL ++I  +L T    +I
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLITDLLGTPSPETI 232

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (440), Expect = 2e-53
 Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 29/223 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                +DE +L LV+EY    ++  ++K +     ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-N 111

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           G+ HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
           +   DIWS G +L EL              +L ++I+ +L  +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIRKMLQKD 201

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  176 bits (448), Expect = 3e-53
 Identities = 89/227 (39%), Positives = 137/227 (60%), Gaps = 17/227 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y+  + +G G++G+V  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 121 VSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++K        +  +++Y+  V E +   +H++I+     SQ +   + + + YQ+ R 
Sbjct: 67  IAIKDIMPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRG 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPE 237
           L YIH+   V HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPE
Sbjct: 121 LKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           L+   +EYT AID+WS GC+ AELL  +PLFPG+  V QL  I +++
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 4e-52
 Identities = 79/229 (34%), Positives = 130/229 (56%), Gaps = 20/229 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 122 SLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +       +    +++Y+  V E +   ++++IK     +Q +   +++ + YQI R L
Sbjct: 67  GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRA 235
            YIH+   V HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           PE++  +  YT AIDIWS GC+LAE+L  +PLFPG+  + QL  I+ V+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL 226

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  171 bits (436), Expect = 5e-52
 Identities = 92/223 (41%), Positives = 134/223 (60%), Gaps = 27/223 (12%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 125
           +VG GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALA 180
            F     K  LYL  V E+V  TV   ++ +         ++        Y +QI R + 
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESRVRK--------YLFQILRGIE 114

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELI 239
           + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+
Sbjct: 115 FCHSH-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            G T+Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  169 bits (431), Expect = 5e-51
 Identities = 84/216 (38%), Positives = 130/216 (60%), Gaps = 19/216 (8%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFFS 129
           G++GVV++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN+V++K     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
           +   D++Y+  V+EYV   +  +++    M Q      VK    Q+   +A++H+   + 
Sbjct: 76  SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN-WIL 128

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYT 246
           HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +YRAPEL+ GA EY+
Sbjct: 129 HRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            AID+WS GC+ AELL  +PLFPG+S +DQL +I K
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  170 bits (432), Expect = 9e-51
 Identities = 80/226 (35%), Positives = 124/226 (54%), Gaps = 20/226 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 119 NVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+ L   F   +  ++   + LV   +   ++ ++K      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L YIH+  G+ HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I+ +
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  168 bits (428), Expect = 3e-50
 Identities = 79/230 (34%), Positives = 122/230 (53%), Gaps = 18/230 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPN 119
            Y     +G G++GVV  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +++++         D   + +V++ +   +H +I       Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGL 120

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYR 234
            YIH+   V HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APEL+    EYT AID+WS GC+ AE+L  + LFPG++ V QL  I+ V+
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  167 bits (425), Expect = 7e-50
 Identities = 86/228 (37%), Positives = 138/228 (60%), Gaps = 21/228 (9%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDH 117
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N++SL   F S  E  ++Y   V E +   +HR++      S+ +   +++ + YQI R
Sbjct: 69  ENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 236
            L Y+H+  GV HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           E++    +Y   +DIWSAGC+ AE+L G+PLFPG+  V+Q   I  ++
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL 222

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  163 bits (414), Expect = 1e-48
 Identities = 79/221 (35%), Positives = 118/221 (53%), Gaps = 23/221 (10%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 125
           G G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIK--HHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F         L LV E +   ++ +IK        +R     VK Y YQ+ ++L ++H
Sbjct: 66  VLFDRKTGR---LALVFELMDMNLYELIKGRKRPLPEKR-----VKSYMYQLLKSLDHMH 117

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              G+ HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +    
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y   +DIW+ GCV  E+L   PLFPG + +DQ+ +I  V+
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVL 215

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  161 bits (409), Expect = 3e-48
 Identities = 74/208 (35%), Positives = 108/208 (51%), Gaps = 18/208 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 124
            ++G GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             + S  ++++  LN+ LEYV       +    K   ++P   ++ Y  QI   LAY+H+
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIFG 241
             G+ HRDIK  N+LV+     +KL DFG AK L   E        R   Y+ APE+I G
Sbjct: 120 N-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFP 269
             EY  A DIWS GC + E+  G+P + 
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWS 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 2e-47
 Identities = 79/221 (35%), Positives = 128/221 (57%), Gaps = 20/221 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +   LYL  V E++   + + +         +    +K Y YQ+ + +AY H + 
Sbjct: 67  VHSENK---LYL--VFEFLDLDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIAYCH-SH 118

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G+ 
Sbjct: 119 RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +Y+  +DIWS GC+ AE++  +PLFPG+S +DQL  I + +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  160 bits (407), Expect = 2e-47
 Identities = 80/218 (36%), Positives = 117/218 (53%), Gaps = 19/218 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G+V++A+   +GE VA+KKV  D           RE+  +  L HPN+V LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                  D ++L  V+EY  + +  ++     M        VK    Q+ R L Y+H   
Sbjct: 75  VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            + HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ G T
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            YT AID+W+ GC+LAELL  +PL PG+S ++QL  II
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  158 bits (401), Expect = 7e-47
 Identities = 95/221 (42%), Positives = 132/221 (59%), Gaps = 19/221 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 125
           VVG G++GVV + +  ET E VAIKK          K    REL+ +R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F     + +LYL  V EYV + +  +++        +P   V+ Y YQ+ +A+ + H  
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 243
             + HRDIKP+NLL++ H   LKLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA 
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y  A+D+WS GC+L EL  GQPLFPGES +DQL  I KV+
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  160 bits (404), Expect = 2e-46
 Identities = 77/238 (32%), Positives = 114/238 (47%), Gaps = 26/238 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHP 118
           SY   R +G GSFG V+ A+  +    VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 119 -NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V L   F     +DE  L LV+EYV       +         +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------SYICS 230
           AL Y+H + G+ HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 231 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH 286
             Y APE++ G +    +++ DIWS G  L ELL G P F GE       + +K+IL 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Length = 384

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  156 bits (395), Expect = 2e-45
 Identities = 85/227 (37%), Positives = 126/227 (55%), Gaps = 23/227 (10%)

Query: 73  VGHGSFGVVFQAKCLET--GEAVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 123
           +G G++G+V  A+  ET   E VAIKK   V   K    R L+ ++LL     H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 124 KHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                      +ELYL    E +   +H++I+      Q +   + + + YQI   L YI
Sbjct: 68  YDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI 121

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 237
           H+   V HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAPE
Sbjct: 122 HSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++     YT AID+WS GC+LAELL  +P+F G+  VDQL +I++V+
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  154 bits (390), Expect = 1e-44
 Identities = 79/240 (32%), Positives = 132/240 (55%), Gaps = 33/240 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 122
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 123 LKHCFFST-----------TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           +      +           TE + +Y+  V EY+   +  V++        +   + +L+
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQ-----GPLSEEHARLF 119

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---- 227
            YQ+ R L YIH+   V HRD+KP N+ +N     LK+ DFG A+++   +P+ S+    
Sbjct: 120 MYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYL 175

Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              + +++YR+P L+     YT AID+W+AGC+ AE+L G+PLF G   ++Q+  I++ +
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  152 bits (385), Expect = 1e-44
 Identities = 83/223 (37%), Positives = 132/223 (59%), Gaps = 24/223 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL  V E++    H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 68  IHT---ENKLYL--VFEFL----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 119 H-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  148 bits (375), Expect = 6e-43
 Identities = 78/226 (34%), Positives = 122/226 (53%), Gaps = 24/226 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 120 VVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +V L   C    T++ EL L LV E+V + +   +    K    +P   +K    Q+ R 
Sbjct: 63  IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRG 119

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + ++H +  + HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE+
Sbjct: 120 VDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +  ++ Y   +D+WS GC+ AEL   +PLF G S  DQL +I  VI
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  148 bits (374), Expect = 1e-42
 Identities = 80/227 (35%), Positives = 132/227 (58%), Gaps = 19/227 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+   T E +A+KK+  ++  +       RE+  ++ + H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L+    S     E  L LV EY+   + + +      ++   LI  K Y YQI R +A
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI--KTYLYQILRGIA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H+   V HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE
Sbjct: 117 YCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ G+  Y+  +DIWS GC+ AE++  +PLFPG+S +D+L +I +++
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  147 bits (373), Expect = 1e-42
 Identities = 83/222 (37%), Positives = 125/222 (56%), Gaps = 22/222 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV EY  + +    K+    +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHSDKK-----LTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVI 284
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I +++
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  148 bits (375), Expect = 1e-42
 Identities = 76/237 (32%), Positives = 112/237 (47%), Gaps = 40/237 (16%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 126
           G G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 127 FFSTTEKDELYLNLVLEYVPETVH---------RVIKHHYKMSQRMPLIYVKLYFYQICR 177
                +K +     V    P   H          V       SQ      +K Y  Q+  
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQ------IKCYMLQLLE 126

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---------- 227
            + Y+H    + HRDIK  N+L++ +   LK+ DFG A+      PN             
Sbjct: 127 GINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 228 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
             + +R+YR PEL+ G   YT A+DIW  GCV AE+   +P+  G+S +DQL  I K
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  146 bits (370), Expect = 3e-42
 Identities = 75/223 (33%), Positives = 123/223 (55%), Gaps = 14/223 (6%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A+   TG+ VA+KK   +   +       RE+  +++L     +     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 127 FFSTTEKD-ELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHN 184
                EK+ +  L LV EY+   + + +  + +   R +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
             GV HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +T Y+  +DIWS GC+ AE+   QPLFPG+S + QL+ I K++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  145 bits (368), Expect = 4e-42
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 16/201 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
             +G G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           +    +KDEL+  +V+E+    ++  ++K     +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 246 TAAIDIWSAGCVLAELLLGQP 266
               DIWS G    EL  G+P
Sbjct: 175 DYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  147 bits (373), Expect = 1e-41
 Identities = 89/232 (38%), Positives = 130/232 (56%), Gaps = 38/232 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 122
           +R +G+G+FGVV+       G+ VA+KK   V Q+    KR   REL+ +    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 123 --------LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
                       F      +E+Y+  V E +   +H++I       Q +   +VK++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQ 111

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-----IC 229
           I R L Y+H + G+ HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + 
Sbjct: 112 ILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           ++YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I 
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  143 bits (364), Expect = 2e-41
 Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 32/222 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + +G GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +     F    EK    L +V+EY     + + IK   K  +  P   +  +F Q+C AL
Sbjct: 62  IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 230
            Y+H +  + HRDIKPQN+ +      +KL DFG +KVL         V G P       
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            YY +PEL      Y    DIWS GCVL EL   +  F GE+
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  143 bits (363), Expect = 3e-41
 Identities = 78/220 (35%), Positives = 127/220 (57%), Gaps = 18/220 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
             T  K    L LV EY+ + + + +  H      +    VK + YQ+ + +A+ H    
Sbjct: 67  IHTENK----LMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN-R 120

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 244
           V HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G+  
Sbjct: 121 VLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           Y+ +IDIWS GC++AE++ G+PLFPG +  DQL++I +++
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM 217

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  143 bits (363), Expect = 1e-40
 Identities = 82/225 (36%), Positives = 123/225 (54%), Gaps = 19/225 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 120
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL    H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L   F S    DE     LV+ Y+   + +++ H     +      V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLCGL 130

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 238
            YIH+  G+ HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  143 bits (361), Expect = 2e-40
 Identities = 82/218 (37%), Positives = 119/218 (54%), Gaps = 16/218 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 126
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 127 FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D  +   LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIHAA 137

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     Y
Sbjct: 138 -GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           T  +DIWS GC++AE+L G+PLF G   +DQL+EI+KV
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV 231

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 5e-40
 Identities = 77/228 (33%), Positives = 129/228 (56%), Gaps = 21/228 (9%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 120
           +Y     +G GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T +     L LV EY+   + + +         + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLA 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVI 284
           ++ G+TEY+ ++D+W  GC+  E+  G+PLFPG + V DQL +I +V+
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  140 bits (354), Expect = 7e-40
 Identities = 75/225 (33%), Positives = 126/225 (56%), Gaps = 27/225 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 122
           +G G++GVV++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L+       ++  LYL  + E++   + + +       Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM---QESRLYL--IFEFLSMDLKKYLDS-LPKGQYMDAELVKSYLYQILQGILFC 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H+   V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            G+  Y+  +DIWS G + AE+   +PLF G+S +DQL  I +++
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRIL 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 3e-39
 Identities = 73/229 (31%), Positives = 115/229 (50%), Gaps = 27/229 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F     + E  L LVLEY P  E +   +    + S+       + Y  +I  AL Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
           + +G+ +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 S-LGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D WS G +L E+L G+P F  E       EI + IL   +  
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED----RKEIYEKILKDPLRF 212

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 6e-39
 Identities = 85/240 (35%), Positives = 118/240 (49%), Gaps = 36/240 (15%)

Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +G G++G V++AK      G+  AIKK   DK           RE+  +R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 182
              F    +K  +YL  + +Y    + ++IK H       +P   VK   +QI   + Y+
Sbjct: 68  VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 183 HNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNISYICSRY 232
           H+   V HRD+KP N+LV    P    +K+ D G A       K L   +P +  I   +
Sbjct: 125 HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 283
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  134 bits (340), Expect = 3e-37
 Identities = 75/246 (30%), Positives = 118/246 (47%), Gaps = 46/246 (18%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------------RELQTMR 113
           +G G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            + H N++ L   +    E D  ++NLV++ +   + +V+    ++++      VK    
Sbjct: 76  EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLTES----QVKCILL 126

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----VLVKGEPNISYI 228
           QI   L  +H    + HRD+ P N+ +N      K+ DFG A+                +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 229 CSR----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
             R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+PLFPGE+ +DQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 279 EIIKVI 284
            I +++
Sbjct: 245 RIFELL 250

Length = 335

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  132 bits (335), Expect = 3e-37
 Identities = 75/223 (33%), Positives = 119/223 (53%), Gaps = 28/223 (12%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHC 126
           V+G GS GVV++ +   TG+  A+KK+     ++ R +  REL+T+R  + P VV     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F+      E  +++VLEY+   ++  ++K   K+ + +    +     QI + L Y+H  
Sbjct: 68  FYK-----EGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIF 240
             + HRDIKP NLL+N    ++K+ DFG +KVL     N    C+ +     Y +PE I 
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQ-P-LFPGESGVDQLVEII 281
           G + Y+ A DIWS G  L E  LG+ P L PG+    +L++ I
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  133 bits (336), Expect = 9e-37
 Identities = 78/227 (34%), Positives = 122/227 (53%), Gaps = 20/227 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 121 VSLKHCFFSTT---EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L   F   T     +E+YL  V   +   ++ ++K      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLR 129

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L YIH+  G+ HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  132 bits (334), Expect = 3e-36
 Identities = 82/233 (35%), Positives = 124/233 (53%), Gaps = 32/233 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 119 NVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYF 172
           N++ L + F    S  E  ++YL  V+E +   + +VI+    H +MS          Y 
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIQMDLDHERMS----------YL 123

Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
            YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +R
Sbjct: 124 LYQMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           YYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  +II+ +
Sbjct: 182 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  131 bits (331), Expect = 5e-36
 Identities = 78/220 (35%), Positives = 121/220 (55%), Gaps = 18/220 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 126 CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F      +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 6e-36
 Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 20/203 (9%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 125
           ++G G+FGVV++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                  +    L ++LEY    ++ ++IK      + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 243
             GV HRDIK  N+L       +KL DFG A  L     +  S + + Y+ APE+I   +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 244 EYTAAIDIWSAGCVLAELLLGQP 266
             + A DIWS GC + ELL G P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  129 bits (327), Expect = 8e-36
 Identities = 74/228 (32%), Positives = 118/228 (51%), Gaps = 24/228 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 125
            +G G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 126 CFFSTTE-----KDELYLNLVLEYVPETVHRVIKH---HYKMSQRMPLIYVKLYFYQICR 177
                 +     KD+    LV EY+   +  +++    H+          +K +  Q+  
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------IKSFMKQLLE 127

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRA 235
            L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR 
Sbjct: 128 GLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           PEL+ G   Y  AID+WS GC+L EL   +P+F     + QL  I ++
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  129 bits (326), Expect = 9e-36
 Identities = 83/229 (36%), Positives = 128/229 (55%), Gaps = 23/229 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN 119
           SY+    +G GS+  V++      G+ VA+K V+  K  +       RE   ++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V L H    T E     L  V EY+   + + +  H      +    V+L+ +Q+ R L
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGL 116

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 236
           AYIH    + HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 AYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPP 172

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVI 284
           +++ GAT+Y++A+DIW AGC+  E+L GQP FPG S V +QL +I  V+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVL 221

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  124 bits (314), Expect = 3e-34
 Identities = 75/237 (31%), Positives = 117/237 (49%), Gaps = 23/237 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 121
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                 +  TE++E  L + LE VP  ++ ++     K     P   ++LY  QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKL----LKKYGSFPEPVIRLYTRQILLGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           Y+H+     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI--SLSIKA 295
               Y  A DIWS GC + E+  G+P +    GV  + +I +      I   LS +A
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  123 bits (310), Expect = 1e-33
 Identities = 68/212 (32%), Positives = 113/212 (53%), Gaps = 25/212 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 126
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           +     ++++Y+   +EY    T+  +++H   + + +    +++Y  Q+   LAY+H +
Sbjct: 65  YGVEVHREKVYI--FMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLH-S 117

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 240
            G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 241 GAT--EYTAAIDIWSAGCVLAELLLGQPLFPG 270
           G     +  A DIWS GCV+ E+  G+  +  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  123 bits (311), Expect = 2e-33
 Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 42/236 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 118
           +   +++G GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            ++ L + F     +DE  L  VLEY P   + + I+ +  + ++      + Y  +I  
Sbjct: 63  GIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRY- 232
           AL Y+H+  G+ HRD+KP+N+L++   H +K+ DFG+AKVL                   
Sbjct: 114 ALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 233 ----------------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
                           Y +PEL+        + D+W+ GC++ ++L G+P F G +
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  123 bits (309), Expect = 3e-33
 Identities = 73/227 (32%), Positives = 125/227 (55%), Gaps = 20/227 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T    E  L LV EY+   + + + +       M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ G+TEY+  ID+W  GC+L E+  G+P+FPG +  ++L  I +++
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  123 bits (310), Expect = 3e-33
 Identities = 76/227 (33%), Positives = 124/227 (54%), Gaps = 20/227 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T +     L LV EY+ + + + +         M +  VK++ YQI R LA
Sbjct: 67  VTL-HDIVHTDKS----LTLVFEYLDKDLKQYMD---DCGNIMSMHNVKIFLYQILRGLA 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ G++EY+  ID+W  GC+  E+  G+PLFPG +  D+L  I +++
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  121 bits (305), Expect = 1e-32
 Identities = 73/227 (32%), Positives = 123/227 (54%), Gaps = 20/227 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R L 
Sbjct: 67  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNSINMHNVKLFLFQLLRGLN 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I +++
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  119 bits (300), Expect = 5e-32
 Identities = 79/223 (35%), Positives = 123/223 (55%), Gaps = 17/223 (7%)

Query: 73  VGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 122
           +G G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 123 L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   C  S T++ E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDF 125

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  
Sbjct: 126 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ VI
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  118 bits (299), Expect = 6e-32
 Identities = 78/231 (33%), Positives = 125/231 (54%), Gaps = 33/231 (14%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKHCFF 128
           G++G VF AK   TG+  AIK +   D   KN+      E   +     P VV L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S   K  LYL  V+EY+P   +  ++++   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHS-NG 113

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISY--------ICSRYYRAPEL 238
           + HRD+KP N+L++ + H LKL DFG +KV LV+ + N++         + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           I G   ++  +D WS GC+L E L+G P F GE+  +   EI + IL+ +I
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGET-PE---EIFQNILNGKI 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  118 bits (297), Expect = 9e-32
 Identities = 74/214 (34%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 119
           +  E+ +G G F VV++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+     F    E     LN+VLE      + R+IKH  K  + +P   +  YF Q+C A
Sbjct: 64  VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 237
           L ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHSK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  119 bits (299), Expect = 1e-31
 Identities = 79/230 (34%), Positives = 124/230 (53%), Gaps = 20/230 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 120
           SY     +G GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L H    T E     L LV EYV   + + +  H      +    VKL+ +Q+ R L+
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           YIH    + HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT 287
           ++ G+TEY+  +D+W  GC+  E++ G   FPG   +   +E I ++L T
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  119 bits (299), Expect = 1e-31
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 23/225 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH- 125
           +G G+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 126 CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    T     K   YL  V E+    +  ++ +    + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYY 134

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I 
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  116 bits (292), Expect = 7e-31
 Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 14/221 (6%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 123
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                ++    E  + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
               + HRD+KP+N+LV     Q+KL DFG A++          + + +YRAPE++  +T
Sbjct: 126 -ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  +I
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  116 bits (292), Expect = 1e-30
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 26/208 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D+  L LV+EYVP  E     +  H + S R P    + Y  Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H+ + + +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I 
Sbjct: 117 LHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y  A+D W+ G ++ E+L G P F
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  114 bits (288), Expect = 3e-30
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 22/225 (9%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                + +    L +V+EY     + ++I+   K  + +   ++     Q+  AL   HN
Sbjct: 67  RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 185 TIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 237
                  V HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (280), Expect = 3e-29
 Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 47/237 (19%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYF-YQICR 177
           V L       TE++ LY  +V+EY+     +  + K+  K+S         L F  QI R
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYMEGGDLLSYLRKNRPKLSLSD-----LLSFALQIAR 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 114 GMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
                   APE +    ++T+  D+WS G +L E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  112 bits (281), Expect = 6e-29
 Identities = 73/215 (33%), Positives = 115/215 (53%), Gaps = 26/215 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEA--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +  +    A+K++          RE+  +R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 183
           S +++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 184 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 233
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (278), Expect = 6e-29
 Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 44/236 (18%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V L       TE++ L   +V+EY+P    +  + K+  K    + L  +  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMPGGDLLDYLRKNRPK---ELSLSDLLSFALQIARG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 235 -------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
                  APE +    ++T+  D+WS G +L E+  LG+  +PG S   +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  112 bits (280), Expect = 7e-29
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 26/215 (12%)

Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +       A+K++          RE+  +R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 183
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 184 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 233
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (272), Expect = 5e-28
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 16/221 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKH 125
             +G G+ GVV +     TG+ +A+K +    ++  +    REL  +   + P +V    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F++  +     +++ +EY+       I    ++  R+P   +      + + L Y+H  
Sbjct: 67  AFYNNGD-----ISICMEYMDGGSLDKILK--EVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176

Query: 246 TAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVIL 285
           +   DIWS G  L EL  G+ P  P     D + E+++ I+
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (271), Expect = 7e-28
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 126
           V+G G+  VV+ A CL   E VAIK++  +K   +     +E+Q M   +HPNVV   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS-QRMPLIYVKLYFYQICRALAYIHN 184
            F     DEL+  LV+ Y+   ++  ++K  Y        +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELI 239
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLF 268
                Y    DIWS G    EL  G   +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (268), Expect = 2e-27
 Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 30/218 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYK------NRELQTM 112
           ++   ++G G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLY 171
           + LDH N+V          E  E YL++ LEYVP  ++   ++ + +  +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNISYI 228
             Q+   LAY+H+  G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 229 CSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQ 265
            S ++ APE+I   ++ Y+A +DIWS GCV+ E+  G+
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  108 bits (271), Expect = 2e-27
 Identities = 71/225 (31%), Positives = 119/225 (52%), Gaps = 16/225 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 136

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ +
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (267), Expect = 4e-27
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 30/207 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
            +G G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+V     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84

Query: 129 STTEKDELYLNLVLEY--------VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                    L +V+EY        +      + ++  +M++   + YV     ++ + L 
Sbjct: 85  ----LVGDELWVVMEYMDGGSLTDI------ITQNFVRMNEPQ-IAYVCR---EVLQGLE 130

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELI 239
           Y+H+   V HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE+I
Sbjct: 131 YLHSQ-NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
               +Y   +DIWS G +  E+  G+P
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  105 bits (265), Expect = 5e-27
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           + +G G+FG V++      GE     VA+K + +    +       E   M+ L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALA 180
            L       T+ + LY  +V EY+P      +    +       +   L    QI + + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------ 234
           Y+ +     HRD+  +N LV      +K+ DFG ++ + + +         YYR      
Sbjct: 117 YLES-KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165

Query: 235 ------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 APE +    ++T+  D+WS G +L E+  LG+  +PG S  +
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  106 bits (265), Expect = 1e-26
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 23/208 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K C+       E    LV+EY   +   +++ H K  Q + +  +        + LAY+H
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GALQGLAYLH 132

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +     HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I    
Sbjct: 133 S-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILAMD 187

Query: 244 E--YTAAIDIWSAGCVLAELLLGQ-PLF 268
           E  Y   +D+WS G    EL   + PLF
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 2e-26
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 24/225 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 123
           ++G G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +          L +++EY      R +     ++++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 242
             +GV HRDIK  N+LV  +T  +KLCDFG A +L +      +++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT 287
             Y    DIWS G  + E+  G P +   S VD     + +I  +
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF-RAMMLIPKS 217

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  104 bits (260), Expect = 2e-26
 Identities = 74/240 (30%), Positives = 114/240 (47%), Gaps = 40/240 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-------QDKRYKN------RELQTMR 113
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L H N+V            D  +LN+ LEYVP      + ++Y          V+ +  
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVR 113

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------- 225
           QI + L Y+HN  G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N         
Sbjct: 114 QILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNGA 168

Query: 226 --SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K+
Sbjct: 169 RPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 3e-26
 Identities = 70/226 (30%), Positives = 106/226 (46%), Gaps = 34/226 (15%)

Query: 76  GSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +S   KD  YL LV+EY+      ++        K    +P  + K Y  ++   +  +H
Sbjct: 64  YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              G+ HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           +     D WS GCV+ E L G P F  E+  D    +   IL   I
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDA---VFDNILSRRI 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  103 bits (259), Expect = 3e-26
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 22/211 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           RV+G G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQICRALAY 181
            + F     +DE  + LV++ +     R     Y +SQ++      VK +  +I  AL Y
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLR-----YHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H+  G+ HRDIKP N+L++   H + + DF  A  +       S   +  Y APE++  
Sbjct: 116 LHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
              Y+ A+D WS G    E L G+  + G S
Sbjct: 174 QG-YSVAVDWWSLGVTAYECLRGKRPYRGHS 203

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  104 bits (261), Expect = 6e-26
 Identities = 72/226 (31%), Positives = 119/226 (52%), Gaps = 22/226 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 129

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  104 bits (260), Expect = 9e-26
 Identities = 71/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  100 bits (251), Expect = 4e-25
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =   99 bits (250), Expect = 6e-25
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 46/228 (20%)

Query: 71  RVVGHGSFGVVFQAKC---LETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 122
           + +G G+FG V++ K          VA+K + +D   + R     E + M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETV-------HRVIKHHYKMSQRMPLIYVKLYFYQI 175
           L       TE++ LY  LVLEY+            R           + L  +  +  QI
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRP-VFPSPEKSTLSLKDLLSFAIQI 114

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + Y+ +     HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 115 AKGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 235 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                      APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 8e-25
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 18/217 (8%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 127
           G GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 128 FSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 D   L +V+EY P   + + I    K  + +P   +   F Q+ R L  +H   
Sbjct: 69  L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 187 GVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            + HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +   DIWS GC+L E+    P F   S  D   ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 99.6 bits (249), Expect = 9e-25
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 22/221 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G FG V   K        A+K V          + +   E + +   +HP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 126 CFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    KD+ Y+ +++EY     +  +++      +       + Y   +  A  Y+HN
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
             G+ +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I     
Sbjct: 112 -RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL 285
           Y  ++D WS G +L ELL G+P F GE   D + EI   IL
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPM-EIYNDIL 207

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 98.0 bits (244), Expect = 4e-24
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 16/213 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 120
           Y   RVVG G+FG+V   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +     F          L +V+EY P  T+   I+   + +  +    +  +F QI  AL
Sbjct: 62  IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H  + + HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            G   Y    DIW+ GCVL EL   +  F   +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.8 bits (243), Expect = 6e-24
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + ++IK+  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           A+ ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 98.2 bits (244), Expect = 9e-24
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187

Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 72/261 (27%), Positives = 115/261 (44%), Gaps = 56/261 (21%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 124
           V+G G+FG V+  +  +TG+  A+K + +    K  ++  +R         D P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  F    +DE +L LV+EY+P  + ++ +I+         P    + Y  ++  AL  +
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSV 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 219
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 220 KGEPNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           +   +               Y APE++ G T Y    D WS G +L E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 273 GVDQLVEIIKVILHTEISLSI 293
               L E    I++ + SL  
Sbjct: 235 ----LQETYNKIINWKESLRF 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 95.7 bits (238), Expect = 3e-23
 Identities = 61/228 (26%), Positives = 114/228 (50%), Gaps = 25/228 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 120
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +       +T E    + NL +E++       +   Y   +   +I    Y  Q+ R L+
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN---YTEQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRA 235
           Y+H    + HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K+
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.3 bits (237), Expect = 4e-23
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 26/210 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 121
           +++G G+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C      +D+  L++ +EY+P  +V   +K +  +++ +     + Y  QI   + 
Sbjct: 68  QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           E+I G   Y    D+WS GC + E+L  +P
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.2 bits (237), Expect = 4e-23
 Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 34/212 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 120
           Y+  RV+G G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++  + F      D+  L + +EY    T++  I       Q      V  Y +QI  A+
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAV 114

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 230
           +YIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P       
Sbjct: 115 SYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
            YY +PEL  G  +Y    DIW+ GCVL ELL
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 96.3 bits (239), Expect = 4e-23
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLH 142

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SH-NMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 6e-23
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 34/214 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLL---DHPNVVSLKH 125
           VG G +G VF AK  +TGE VA+K     +L         L    +L       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 126 CFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            F     +D+ YL L +EYVP            V+   +           + Y  ++  A
Sbjct: 69  AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----------ARFYMAEMFEA 113

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +  +H  +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE+
Sbjct: 114 VDALHE-LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEV 169

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           + G   Y   +D WS GC+L E L G P F G +
Sbjct: 170 LRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 6e-23
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 129
            +G GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 130 TTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
            T+     L +V+EY    +V  ++K     ++ +    +    YQ  + L Y+H+    
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120

Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTA 247
            HRDIK  N+L+N    Q KL DFG +  L        + I + ++ APE+I     Y  
Sbjct: 121 IHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178

Query: 248 AIDIWSAGCVLAELLLGQP 266
             DIWS G    E+  G+P
Sbjct: 179 KADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 95.9 bits (238), Expect = 7e-23
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 22/203 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +GHGSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H+ 
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLHSH 140

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 244
             + HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE+I    E 
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195

Query: 245 -YTAAIDIWSAGCVLAELLLGQP 266
            Y   +D+WS G    EL   +P
Sbjct: 196 QYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 94.9 bits (236), Expect = 1e-22
 Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 121
           +V+G GSFG V  AK    G+  A+ KVLQ K    K  +   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F T +K  LY   VL+YV       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTADK--LY--FVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++ 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 125
           V+G G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 126 CFF---STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            F         D+L+  LV+E     +V  ++K   K  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I 
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 241 GATE------YTAAIDIWSAGCVLAELLLGQP 266
            A +      Y A  D+WS G    EL  G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 76/239 (31%), Positives = 118/239 (49%), Gaps = 28/239 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L H  F T  KD L+   V+EYV       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-HSCFQT--KDRLFF--VMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++  
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI----SLSIKAA 296
              Y  A+D W+ G +L E+L GQ  F G+   D+L +    IL  E+     LS +A 
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQ---SILEDEVRYPRWLSKEAK 224

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 92.5 bits (230), Expect = 1e-21
 Identities = 73/222 (32%), Positives = 115/222 (51%), Gaps = 21/222 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  C F T E    +L  V+EY+       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-FCTFQTKE----HLFFVMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G
Sbjct: 113 H-KKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +Y  ++D WS G +L E+L+GQ  F GE   D+L + I  
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.0 bits (226), Expect = 1e-21
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 126
           +G GSFGVVF+          A+K++ L   ++R +   +   R+L   D   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D+  LN+V+EY     +H+++K      + +P   V  +F QI   LA++H+ 
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 241
             + HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +PEL   
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              Y    D+W+ G VL E   G+  F   +    +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 4e-21
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 17/208 (8%)

Query: 70  ERVV-GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 124
           ERVV G G++G+V+ A+ L T   +AIK++  +D RY    + E+     L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 182
                 +E    +  + +E VP  ++  +++  +  +      I    Y  QI   L Y+
Sbjct: 72  GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI-F 240
           H+   + HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  
Sbjct: 125 HDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           G   Y A  DIWS GC + E+  G+P F
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 5e-21
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 32/213 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 121
           +     +G GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                F   ++     L +++EY    +   ++K       ++   Y+     ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLE 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 233
           Y+H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
            APE+I   + Y    DIWS G    EL  G+P
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 6e-21
 Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 35/221 (15%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKK-----VLQDKRYKNRELQ 110
            K+ + ++  + +G G FG V      +     TGE VA+K        Q +    RE++
Sbjct: 2   EKRHLKFI--KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE 58

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYV 168
            +R LDH N+V  K        +    L L++EY+P    R     Y  +   ++ L  +
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRS---LRLIMEYLPSGSLR----DYLQRHRDQINLKRL 111

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------- 221
            L+  QIC+ + Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        
Sbjct: 112 LLFSSQICKGMDYLGSQ-RYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVK 169

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           EP  S I   +Y APE +  +   +A+ D+WS G  L EL 
Sbjct: 170 EPGESPI--FWY-APECLRTSKFSSAS-DVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.5 bits (219), Expect = 1e-20
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 22/218 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           + +G GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F S  E   L++  V+EY    + + R+ +    +     ++    +F QI   L +I
Sbjct: 65  --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIF 240
           H+   + HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I 
Sbjct: 118 HDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
               Y    DIWS GCVL EL   +  F G + + QLV
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 76/231 (32%), Positives = 111/231 (48%), Gaps = 26/231 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 121
           +V+G GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F TTEK    L  VL++V       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H +I + +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I 
Sbjct: 112 LH-SINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI- 168

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
               Y   +D W  G VL E+L G P F        + E+   ILH  + L
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYDNILHKPLVL 215

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 71/222 (31%), Positives = 119/222 (53%), Gaps = 21/222 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+    GE  A+K + +D    + +++ TM   R+L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T  K+ L+   V+E++       +  H +   R  L     Y  +I   L ++
Sbjct: 61  L-YCTFQT--KEHLFF--VMEFLNGGD---LMFHIQDKGRFDLYRATFYAAEIVCGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G
Sbjct: 113 HSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +YT ++D WS G +L E+L+GQ  F G+   D+L E I+V
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 87.7 bits (217), Expect = 5e-20
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +++G GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T E     L  V+EY+       +  H +   +  L     Y  +I   L ++
Sbjct: 61  L-YCTFQTKE----NLFFVMEYLNGGD---LMFHIQSCHKFDLPRATFYAAEIICGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G
Sbjct: 113 HSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
             +Y  ++D WS G +L E+L+GQ  F G 
Sbjct: 171 -QKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 8e-20
 Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 38/227 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                TE D+ +L +++EYVP   +   +++  + S    L Y      +I  AL Y+H 
Sbjct: 68  ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS----EIVCALEYLH- 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRAPEL 238
           +  + +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE+
Sbjct: 119 SKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPEV 169

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL 285
           I  +  +  A+D W+ G ++ E+L+G P F      D    I + IL
Sbjct: 170 I-QSKGHNKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKIL 211

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 87.2 bits (216), Expect = 9e-20
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 24/209 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 125
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F    +++ +Y   +LE+V   V   +  H + + R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVYF--LLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYRAPELIFGAT 243
             + +RD+KP+NLL++   H +K+ DFG AK +    P+ ++ +C +  Y APE+I  + 
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            +  A+D W+ G +L E + G P F  ++
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219

Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.8 bits (212), Expect = 1e-19
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y   RVVG GSFG     + + + +  A+K++   K         +E   +  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + K  F     + + +L +V+EY    + + ++     K+    P   +  +F Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPEL 238
            +IH    V HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 239 IFGATEYTAAIDIWSAGCVLAEL 261
           I+    Y    DIWS GC+L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 85.6 bits (212), Expect = 2e-19
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 124
           +G G FG V   +   TG+  A KK L  KR K R+ + M L +           +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 182
           + F +   KD+L L + L    +     +K+H Y + +   P      Y  QI   L ++
Sbjct: 60  YAFET---KDDLCLVMTLMNGGD-----LKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    + +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ G 
Sbjct: 112 HQR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  ++D ++ GC L E++ G+  F
Sbjct: 170 -VYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 85.6 bits (212), Expect = 2e-19
 Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 21/207 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    TG  VA+KK+  D R + R      E+  MR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           + S    DEL++  V+E++       I  H +M++   +  V L    + +AL+++H   
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ-IATVCL---AVLKALSFLHAQ- 134

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 135 GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGES 272
              +DIWS G ++ E++ G+P +  E 
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEP 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 85.2 bits (211), Expect = 3e-19
 Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 34/208 (16%)

Query: 73  VGHGSFGVVFQAKCL------ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 122
           +G G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            K   +S   ++   L LV+EY+P    R  + KH  ++  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYY 233
           Y+ +   V HRD+  +N+LV      +K+ DFG  KVL          EP  S I   ++
Sbjct: 123 YLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAEL 261
            APE +   ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 4e-19
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 38/212 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 129 STTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALA 180
               +D+L+  +V+EY      + +++V +      Q   + YV       CR     LA
Sbjct: 71  R---RDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV-------CRETLKGLA 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPEL 238
           Y+H T G  HRDIK  N+L+      +KL DFG +  L     +   S+I + Y+ APE+
Sbjct: 116 YLHET-GKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEV 172

Query: 239 IFGATE----YTAAIDIWSAGCVLAELLLGQP 266
              A E    Y    DIW+ G    EL   QP
Sbjct: 173 A--AVERKGGYDGKCDIWALGITAIELAELQP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (210), Expect = 5e-19
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 125
           +G GSFG V Q +  +T    A+K + +       E+         +  ++ P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             FS    ++LYL L      E     + HH +   R  L   + Y  ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLH-K 111

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 244
             V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGES 272
           YT A+D W+ G +L E+L G P F  E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 84.5 bits (209), Expect = 6e-19
 Identities = 65/228 (28%), Positives = 113/228 (49%), Gaps = 40/228 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 121
           +++ +G++G V+  +  ET +  A+KK+ +          + +  R++ T    ++P VV
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           S+  C F T      +L +V+EYV       ++K+       +P+   ++YF +   AL 
Sbjct: 65  SM-FCSFETKR----HLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNI-------------- 225
           Y+HN  G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+              
Sbjct: 116 YLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             +C +  Y APE+I     Y   +D W+ G +L E L+G   F G++
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 84.9 bits (210), Expect = 7e-19
 Identities = 67/245 (27%), Positives = 124/245 (50%), Gaps = 31/245 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 121
           RV+G GS+  V   +  +T    A+ KV++ +   + E    +QT + +     +HP +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAM-KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L  CF + +      L  V+E+V       +  H +  +++P  + + Y  +I  AL +
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIF 240
           +H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFP---GESGVDQLVE--IIKVILHTEI----SL 291
           G  +Y  ++D W+ G ++ E++ G+  F         DQ  E  + +VIL  +I    SL
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 292 SIKAA 296
           S+KA+
Sbjct: 229 SVKAS 233

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 83.6 bits (207), Expect = 1e-18
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           G G++GVV + + + TG  +A+K++       + KR       +MR +D P  V+     
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           F   E D   + + +E +  ++ +  K  Y     +P   +      I +AL Y+H+ + 
Sbjct: 70  FR--EGD---VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 244
           V HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGES 272
           Y    D+WS G  + EL  G+  FP +S
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 65/277 (23%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 123
           +V+G G+FG V   +  +TG   A+KK+ + +  +  ++  +R    +L   D+P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +DE YL L++EY+P  + +  ++K     ++     Y+     +   A+  
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIA----ETILAIDS 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 229
           IH  +G  HRDIKP NLL++   H +KL DFG              ++L    P+     
Sbjct: 117 IH-KLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 230 SR--------------------Y-------YRAPELIFGATEYTAAIDIWSAGCVLAELL 262
                                 Y       Y APE +F  T Y    D WS G ++ E+L
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Query: 263 LGQPLFPGESGVDQLVEIIK----VILHTEISLSIKA 295
           +G P F  ++  +   +II     +    E+ LS +A
Sbjct: 234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEA 270

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 82.7 bits (204), Expect = 2e-18
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 31/213 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 121
           V+G G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                 +  T  D+  +++ +E+VP  ++  ++         +P      Y  QI   +A
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI-------CSRYY 233
           Y+HN   V HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.5 bits (204), Expect = 3e-18
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 30/205 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHC 126
            +G G+ GVV +     +G  +A K + L+ K   +N   REL+ +   + P +V     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 127 FFSTTE-------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           F+S  E        D   L+ VL               K + R+P   +      + R L
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVL---------------KKAGRIPENILGKISIAVLRGL 112

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE +
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLG 264
            G T YT   DIWS G  L E+ +G
Sbjct: 171 QG-THYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 5e-18
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 41/214 (19%)

Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           RV+G G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K C    +E+    L L++EYVP    R  + KH   ++Q +      L+  QIC  +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 237
           AY+H+   + HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 238 ---LIFGATE------YTAAIDIWSAGCVLAELL 262
              + + A E      ++ A D+WS G  L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.0 bits (202), Expect = 5e-18
 Identities = 70/220 (31%), Positives = 112/220 (50%), Gaps = 23/220 (10%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTM 112
           G P++ +    +  +G GS G+V  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R   H NVV +   + S    DEL++  V+E++       I  H +M++      +    
Sbjct: 74  RDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVC 124

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
             + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P   S + + 
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 81.9 bits (202), Expect = 7e-18
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 21/220 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           RV+G GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 61  L-YCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I  
Sbjct: 113 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQ 169

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y  ++D W+ G +L E+L G   F  E+  D L E I
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 81.4 bits (201), Expect = 7e-18
 Identities = 70/238 (29%), Positives = 117/238 (49%), Gaps = 35/238 (14%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRLLDH---------- 117
           RV+G G++G VF  + +   + G+  A+K VL+    K   +Q  +  +H          
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60

Query: 118 ----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
               P +V+L H  F T  K    L+L+L+YV      +  H Y+  +      V++Y  
Sbjct: 61  VRRCPFLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIA 112

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSR 231
           +I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E     S+  + 
Sbjct: 113 EIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTI 170

Query: 232 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            Y APE+I G +  +  A+D WS G +  ELL G   F  +   +   EI + IL ++
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK 228

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 81.6 bits (201), Expect = 9e-18
 Identities = 71/244 (29%), Positives = 122/244 (50%), Gaps = 29/244 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 61  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFP---GESGVDQLVE--IIKVILHTEI----SLS 292
             +Y  ++D W+ G ++ E++ G+  F         DQ  E  + +VIL  +I    SLS
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 293 IKAA 296
           +KAA
Sbjct: 230 VKAA 233

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 23/209 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R LAY+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L EL +G+ P+ P ++
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDA 207

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 121
           +++G G+FG V+     +TG  +A+K+V  D               E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C     E+    L++ +E++P  ++   +K +  +++ +     + Y  QI   ++
Sbjct: 68  QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           E+I G   Y    DIWS GC + E+L  +P
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 121
           +V+G GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F T EK    L  VL+YV       +  H +  +       + Y  ++  A+ Y
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGE---LFFHLQRERCFLEPRARFYAAEVASAIGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE + 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VL 168

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +V+G G+FG V   +   + +  A+K + + +  K         E   M   +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            H  F    +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL  IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFYTAEVVLALDAIH 159

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 238
           + +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE+
Sbjct: 160 S-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPEV 214

Query: 239 IF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +    G   Y    D WS G  L E+L+G   F  +S V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 79.5 bits (196), Expect = 5e-17
 Identities = 71/230 (30%), Positives = 119/230 (51%), Gaps = 28/230 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L HC F T ++    L  V+EYV   + + ++ +     S++      + Y  ++  AL 
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALM 110

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 239
           ++H   GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
               EY  ++D W+ G ++ E++ GQP F  ++  D L E    ILH ++
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFE---SILHDDV 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 7e-17
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 120
           Y+  + +G GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQR---MPLIYVKLYFYQIC 176
           V  +  F    E   LY+  V++Y     +++ I      +QR    P   +  +F QIC
Sbjct: 62  VQYQESF---EENGNLYI--VMDYCEGGDLYKKIN-----AQRGVLFPEDQILDWFVQIC 111

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 235
            AL ++H+   + HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I     Y    DIW+ GCVL E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 68/245 (27%), Positives = 120/245 (48%), Gaps = 33/245 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 122
           RV+G GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF +T+      L LV+EYV       +  H +  +++P  + + Y  +IC AL ++
Sbjct: 61  LHSCFQTTSR-----LFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  +      S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF------PGESGVDQLVEIIKVILHTEI----SL 291
             EY  ++D W+ G ++ E++ G+  F      P  +  D L    +VIL   I     L
Sbjct: 171 -EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL---FQVILEKPIRIPRFL 226

Query: 292 SIKAA 296
           S+KA+
Sbjct: 227 SVKAS 231

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (194), Expect = 8e-17
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 21/210 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 122
           +G G+FG V+Q +  +T    A+K + + +    +E          L    L + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           LK   FS     +LYL  V +Y+       +  H +   R      K Y  ++  AL ++
Sbjct: 61  LK---FSFQTDSDLYL--VTDYMSGGE---LFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H    + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++  
Sbjct: 113 HKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
              YT  +D WS G ++ E+  G   F  E
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 9e-17
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 67  HSCFQTV--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I    
Sbjct: 120 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 24/216 (11%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLL 115
           I++   +++G G+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            H  +V    C     EK    L + +EY+P  +V   +K +  +++ +   Y +    Q
Sbjct: 62  QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR----Q 114

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICS 230
           I   ++Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
            Y+ +PE+I G   Y    D+WS GC + E+L  +P
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 1e-16
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 30/228 (13%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 126
           ++GHG+ G V++A  L T   +A+K +  D     ++    EL+ +   D P ++     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 127 FFSTTEKDELYLNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           FF      E  +++  E++      V+R I  H  +  R+ +  VK         L Y+ 
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYRKIPEH--VLGRIAVAVVK--------GLTYLW 112

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  
Sbjct: 113 -SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-E 168

Query: 244 EYTAAIDIWSAGCVLAELLLGQ---PLFPGESGVDQLVEIIKVILHTE 288
           +Y    D+WS G    EL LG+   P      G    +++++ I+  +
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 61/209 (29%), Positives = 112/209 (53%), Gaps = 23/209 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K   ++ +++ L  V +    + + L Y+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI-LGKVSI---AVIKGLTYLRE 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTM 112
           G P+  +    +  +G GS G+V  A    +G+ VA+KK+  D R + R      E+  M
Sbjct: 16  GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIM 71

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R   H NVV + + +      DEL++  V+E++       I  H +M++      +    
Sbjct: 72  RDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVC 122

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
             + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P   S + + 
Sbjct: 123 LAVLKALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           Y+ APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 24/210 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 121
           +++G G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C     EK    L++ +EY+P  ++   +K +  +++ +     + Y  QI + ++
Sbjct: 68  QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           E+I G   Y    D+WS  C + E+L  +P
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 1e-16
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L L    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H    + +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               YT + D W  GC++ E++ G+  F
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 74/239 (30%), Positives = 120/239 (50%), Gaps = 32/239 (13%)

Query: 71  RVVGHGSFGVVF---QAKCLETGEAVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 117
           +V+G G++G VF   +    +TG+  A+K VLQ     ++ K  E  +T R +L+H    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPET---VHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           P +V+L H  F T  K    L+L+L+YV       H   + ++   +      V+ Y  +
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE------VRFYSGE 113

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY- 232
           I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    
Sbjct: 114 IILALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           Y APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+ + IL  +   
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 71/236 (30%), Positives = 116/236 (49%), Gaps = 23/236 (9%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 120
           +V+G GSFG VF  + +   + G+  A+ KVL+    K R+    ++       ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAM-KVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L H  F T  K  LYL L      +   R+ K      +      VK Y  ++  AL 
Sbjct: 61  VKL-HYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALD 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPELI 239
           ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 113 HLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
                +T + D WS G ++ E+L G   F G+   + +  I+K  L     LS +A
Sbjct: 171 -NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEA 225

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 126
           +G G+FG V +     +G  +A+K++    D++ + R L      MR  D P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 127 FFSTTEKD-----ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            F   E D     EL +++ L+   + V+ V+K        +P   +        +AL Y
Sbjct: 72  LF--REGDCWICMEL-MDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNY 122

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-- 239
           +   + + HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I  
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIK 282
                Y    D+WS G  L E+  G+  +P   S  DQL +++K
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK 225

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.8 bits (186), Expect = 4e-16
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y   RVVG GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V+ +  +    E   LY+ +      +  H++ +   K+   +P   V  +F QI  AL
Sbjct: 61  IVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAMAL 115

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 238
            Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 239 IFGATEYTAAIDIWSAGCVLAEL 261
            F    Y    D+W+ GC + E+
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 4e-16
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 45/226 (19%)

Query: 73  VGHGSFGVVFQAKCLETGE---AVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 124
           +GHG+FG V +   L        VA+K      +   K+   RE   M  LDHP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                  + + L   LV+E  P   + + +K      + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLE 112

Query: 184 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
           +   V HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 235 ----APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
               APE I     +++  D+WS G  L E    G   +    G +
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 26/210 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 121
           +V+G GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L H  F T +K    L  VL+Y+   E  + + +    +  R      + Y  +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
            Y+H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +     Y   +D W  G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.9 bits (187), Expect = 6e-16
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           G G+ G V + +   TG   A+K +  D     ++   REL+  +    P +V     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 129 STTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              ++    + + +EY     +     +V K   ++ ++   +  K+    + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK---VLGKIAE-SVLKGLSYLH 122

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELI 239
            +  + HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 -SRKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            G   Y+   D+WS G  L E+   +  FP E
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPE 206

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 75.7 bits (186), Expect = 6e-16
 Identities = 67/233 (28%), Positives = 113/233 (48%), Gaps = 28/233 (12%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 120
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 178
           V + + F  T +K    L+L+              HY +SQ       ++ FY  +I   
Sbjct: 60  VCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           +     Y ++ D +S GC+L +LL G   F      D+  EI ++ L   + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVEL 218

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 6e-16
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G+ G V + K + TG  +A K V    +        RELQ M     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
            +     E  + + +E++   ++ R+    YK    +P+  +      +   L Y++N  
Sbjct: 73  LN-----ENNICMCMEFMDCGSLDRI----YKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
            + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 247 AAIDIWSAGCVLAELLLGQPLFP 269
              D+WS G  + EL LG+  FP
Sbjct: 181 VKSDVWSLGISIIELALGK--FP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 75.8 bits (186), Expect = 6e-16
 Identities = 64/225 (28%), Positives = 114/225 (50%), Gaps = 16/225 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           ++  +V GH S G ++  K L+    V   K  +  R + + L+ +R    P +V+L + 
Sbjct: 17  FLVRKVSGHDS-GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYA 73

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  AL ++H  +
Sbjct: 74  FQTDTK-----LHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-L 124

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELIFGA-T 243
           G+ +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y AP+++ G   
Sbjct: 125 GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  A+D WS G ++ ELL G   F  +   +   EI + IL +E
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.8 bits (186), Expect = 7e-16
 Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 22/234 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 122
           RV+G G FG V   +   TG+  A K+ L+ KR K R+ ++M L     L+  N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L +    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H      +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIK 294
               YT + D W  GC++ E++ GQ  F G     +  E+ + +L TE   S K
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.8 bits (186), Expect = 7e-16
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ ++M L     L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L L    +     +K H Y M +          Y  +IC  L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++ 
Sbjct: 117 DLHQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               YT + D W+ GC+L E++ GQ  F
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 39/235 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 119
           Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  AL
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLAL 155

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 229
             IH ++G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+     
Sbjct: 156 DAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD----- 208

Query: 230 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 75.4 bits (185), Expect = 9e-16
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 28/233 (12%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 120
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 178
           V + + F +    D+L   L L    +        HY +SQ       ++ FY  +I   
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDL-------HYHLSQHGVFSEKEMRFYATEIILG 109

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           +   T Y ++ D +S GC+L +LL G   F      D+  EI ++ L   + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVEL 218

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM       L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   +    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            Y  ++D W+ G +L E+L GQP F GE
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 39/235 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 119
           Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLAL 155

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 229
             IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+     
Sbjct: 156 DAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD----- 208

Query: 230 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.5 bits (180), Expect = 3e-15
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
           S   +D+L++   +E+      + I H         + YV     +  + L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVS---RETLQGLYYLHSK-GK 127

Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 244
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 245 -YTAAIDIWSAGCVLAELL-LGQPLF 268
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 74.1 bits (182), Expect = 3e-15
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 29/227 (12%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHP 118
           +V+G G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L    F T  K    L L+LEY+   E    + +    M           Y  +I 
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEIS 110

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 235
            AL ++H   G+ +RD+KP+N+L++   H +KL DFG  K  +         C    Y A
Sbjct: 111 LALEHLH-QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE I   + +  A+D WS G ++ ++L G P F  E+    + +I+K
Sbjct: 169 PE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 48/240 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 123
           +++G G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F + T     YL LV++Y P   + R+++      + +     + Y  ++  AL Y+
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYL 119

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEP 223
           H  +G+ +RD+KP+N+L++   H + L DF                   GS +  V   P
Sbjct: 120 HL-LGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 224 NISYICS-----------RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           + ++                Y APE+I G   + +A+D W+ G +L E+L G   F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.5 bits (180), Expect = 4e-15
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 21/212 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           + S    +EL++  ++E++       I    ++++      +      + +AL Y+H+  
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHSQ- 136

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I   T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
              +DIWS G ++ E++ G+P +  +S V  +
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 73.2 bits (180), Expect = 5e-15
 Identities = 72/233 (30%), Positives = 102/233 (43%), Gaps = 37/233 (15%)

Query: 71  RVVGHGSFGVVFQAK-CLETGE--AVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 122
           R +G G FG V+Q        E  AVA+K          RE        MR  DHP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++  V+E  P    R      K    + L  + LY YQ+  ALAY+
Sbjct: 72  L----IGVITENPVWI--VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYL 123

Query: 183 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
            +   V HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + AP
Sbjct: 124 ESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177

Query: 237 ELIFGATEYTAAIDIWSAG-CVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
           E I     +T+A D+W  G C+   L+LG   F G       V+   VI   E
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQG-------VKNNDVIGRIE 222

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 121
           V+G G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +L  CF     +D +    V+EY         +H                    Y   + 
Sbjct: 66  NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHT---------DVFSEPRAVFYAACVV 111

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
             L Y+H    + +RD+K  NLL++     +K+ DFG  K  +      S  C +  + A
Sbjct: 112 LGLQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           PE++   T YT A+D W  G ++ E+L+G+  FPG+
Sbjct: 170 PEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGD 204

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.5 bits (180), Expect = 5e-15
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   +HP +V L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIH 183
           +   +     L +++E+ P      I          P I V      ICR    AL Y+H
Sbjct: 79  YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------ICRQMLEALQYLH 127

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
            ++ + HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   
Sbjct: 128 -SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 243 T----EYTAAIDIWSAGCVLAELLLGQP 266
           T     Y    DIWS G  L E+   +P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 74/286 (25%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 123
           +V+G G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D  YL L++E++P  + +  +IK+    S+ +     + Y  +   A+  
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDV----TRFYMAECVLAIEA 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 229
           +H  +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I 
Sbjct: 117 VHK-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 230 SRY------------------------------------YRAPELIFGATEYTAAIDIWS 253
           +R                                     Y APE IF    Y    D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233

Query: 254 AGCVLAELLLGQPLFPGESGVDQLVEIIK----VILHTEISLSIKA 295
            G ++ E L+G P F  E+  +   +II     +    +I LS++A
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEA 279

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 32/209 (15%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           G G+FG V++A+  ETG   A K +       L+D      E+  +    HPN+V L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 127 FFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +F    +++L+  +++E+      +++   ++      Q   +        Q+  AL ++
Sbjct: 71  YFY---ENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVC------RQMLEALNFL 119

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI-- 239
           H+   V HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++  
Sbjct: 120 HSHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 240 --FGATEYTAAIDIWSAGCVLAELLLGQP 266
             F    Y    DIWS G  L EL   +P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 71  RVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 122
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP  V+
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F     KDE YL LVLE+V   +        + ++R P      Y  QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
             ++ + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 Q-SLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF 268
                AA D W+ G  + E+L+G P F
Sbjct: 203 VGHGKAA-DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 39/232 (16%)

Query: 56  GKNGQPKQTISYMA-ERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNR 107
                P    S    ERV  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRM 163
           E++ +R ++HPNVV     F    E     + ++LE++     E  H  I     ++   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMDGGSLEGTH--IADEQFLAD-- 172

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-E 222
                     QI   +AY+H    + HRDIKP NLL+N     +K+ DFG +++L +  +
Sbjct: 173 -------VARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223

Query: 223 PNISYICSRYYRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
           P  S + +  Y +PE I      GA +  A  DIWS G  + E  LG+  FP
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.8 bits (176), Expect = 1e-14
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEA-VAIKKVL-------QDKRYKNRELQTM--------RLLD 116
           +G G+FG V++ +    G+  +A+K++        +DKR +++ +  +          L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVL-EYVPETVHRVI---KHHYKMSQRMPLIYVKLYF 172
           HPN+V     F    E D LY+ + L E  P   H      K      +R+  I+V    
Sbjct: 68  HPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV---- 120

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            Q+  AL Y+H    + HRD+ P N+++     ++ + DFG AK         S + +  
Sbjct: 121 -QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y  PE++     Y    D+W+ GC+L ++   QP F
Sbjct: 179 YSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 27/223 (12%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             HPN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 43/221 (19%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 124
           +VG G FG V   +   TG+  A+K     VL  +    +   E   + + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           + F    +KD LYL  V+EY P  + +  + ++  +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-------KVLVK---GEPNISYICSRY 232
           H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K   G P+        
Sbjct: 119 H-QMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168

Query: 233 YRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y APE++      G   Y    D WS G +  E++ G+  F
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 3e-14
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           +G G++G V++     TG  +A+K++   L + ++     EL  +     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           F      E  + + +EY+       +      ++ +P   ++   Y + + L ++     
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 242
           + HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             YT   D+WS G  + E+ LG+  +P E+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPET 211

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.1 bits (176), Expect = 5e-14
 Identities = 69/248 (27%), Positives = 115/248 (46%), Gaps = 37/248 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G+G FG VF  K   T E    K +      +R K++   E+  MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V     F +   + +LY+  ++E+     + R I+  YKM  ++    +     Q+  AL
Sbjct: 75  VRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 180 AYIHNTIG------VCHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKV 217
           AY HN         V HRD+KPQN+ ++     +                K+ DFG +K 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 218 LVKGEPNISYIC--SRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +  
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 275 DQLVEIIK 282
            QL+  +K
Sbjct: 250 SQLISELK 257

Length = 1021

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.8 bits (170), Expect = 9e-14
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 27/228 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRL 114
           G PK+   Y     +G G+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           L +PN+V+    F      DEL+  +V+EY+       +     M +             
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTETCMDEAQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H    V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 28/212 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 123
           +G G+ G V++ +  +TG  +A+K++   +R  N+E     L+D       H  P +V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFYQICRALAYI 182
              F + ++     + + +E +   + +++K   ++   +P  I  K+    I +AL Y+
Sbjct: 80  YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMT-VAIVKALHYL 130

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFG 241
               GV HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I  
Sbjct: 131 KEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDP 188

Query: 242 AT---EYTAAIDIWSAGCVLAELLLGQPLFPG 270
                +Y    D+WS G  L EL  GQ  +  
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 32/213 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M     R+L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKM------SQRMPLIYVKLYFYQI 175
           L + +     KD L L L +    +     +K H Y M       QR        Y  ++
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFDEQR-----AIFYAAEL 111

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           C  L  +     + +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y A
Sbjct: 112 CCGLEDLQRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMA 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           PE+I    +YT + D W  GC++ E++ GQ  F
Sbjct: 170 PEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 124
           +G G FG V   +   TG+  A KK L  KR K +  + M LL+         P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 182
           + F S T     +L LV+  +       +K+H Y + +R + +  V  Y  QI   + ++
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGD---LKYHIYNVGERGLEMERVIHYSAQITCGILHL 111

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H ++ + +RD+KP+N+L++      +L D G A  L  G+       +  Y APE I   
Sbjct: 112 H-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y+  +D ++ GC + E++ G+  F
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 69/236 (29%), Positives = 109/236 (46%), Gaps = 36/236 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 123
           +V+G G+FG V   K   TG+  A+K + + +  K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 124 KHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F     +DE  L LV++Y V   +  ++    K   R+P    + Y  ++  A+  +
Sbjct: 67  HYAF-----QDENNLYLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYICSRY 232
           H  +G  HRDIKP N+L++ + H ++L DFGS   L+           G P+  YI    
Sbjct: 119 HQ-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEI 174

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +A E   G   Y    D WS G  + E+L G+  F  ES    LVE    I++ +
Sbjct: 175 LQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHK 224

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 19/218 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +  +   R    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 70/228 (30%), Positives = 108/228 (47%), Gaps = 20/228 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 131 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           T     +DE YL LV++Y       ++    K   R+P    + Y  ++  A+  IH   
Sbjct: 65  TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 240
            V HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
           G  +Y    D WS G  + E+L G+  F  ES    LVE    I++ E
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHE 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.4 bits (164), Expect = 5e-13
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++A+ L TGE  A+K +      D     +E+  ++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHN 184
           S   +++L+  + +EY      + I H       + + YV       CR     LAY+H 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYV-------CRETLQGLAYLH- 123

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           + G  HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A 
Sbjct: 124 SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAV 180

Query: 244 E----YTAAIDIWSAGCVLAELLLGQP 266
           E    Y    DIW+ G    EL   QP
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 61/206 (29%), Positives = 86/206 (41%), Gaps = 34/206 (16%)

Query: 88  ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 139
            TG  VAIK +  D         R++ RE      L HPN+V+L      + E     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
            V EYVP    R ++        +P         Q+  ALA  HN  G+ HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 200 VN-----PHTHQLKLCDFGSAKVLVKGEPNI--------SYICSRYYRAPELIFGATEYT 246
           V+     PH    K+ DFG   +L                 + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGES 272
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.1 bits (163), Expect = 7e-13
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 27/228 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 73  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 21/217 (9%)

Query: 67  YMAERVVGHGSFGVVFQA-KCLETGEAVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 121
           Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +   DH  +V
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 122 SLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRA 178
             KH  F   + D+  L L++EY     +++ IK   ++ + +P     V L FYQI  A
Sbjct: 129 --KH--FDDFKSDDKLL-LIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 235
           L  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY A
Sbjct: 182 LDEVHSR-KMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL +    Y+   D+WS G +L ELL     F G S
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 29/224 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F      D   L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            +    +Y  A+D W  G V+ E++ G+  F
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 27/228 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 120

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 179 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 20/204 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ETG  +A  KV+  K  +       E+  +   DHPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    +     P I  ++   Q   AL Y+H    
Sbjct: 72  YY-----ENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQTLEALNYLHEN-K 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 245 --YTAAIDIWSAGCVLAELLLGQP 266
             Y    D+WS G  L E+   +P
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 76/288 (26%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E   +   D+  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   ++S  +KD LY   V++Y+P  + +  +I+      +  P +  + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG--------EP 223
            +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG        EP
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Query: 224 NI-------------------------------SYICSRYYRAPELIFGATEYTAAIDIW 252
           +                                S + +  Y APE++     YT   D W
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWW 232

Query: 253 SAGCVLAELLLGQPLFPGESGVDQLVEII--KVILH--TEISLSIKAA 296
           S G +L E+L+GQP F   +  +  +++I  +  LH   ++ LS +A 
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAV 280

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.6 bits (157), Expect = 5e-12
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 14/217 (6%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLL 115
           P  + ++     +G G++G VF+    + G   A+K +L      + E++        L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           DHPNVV     ++    K+   L LVLE     +V  ++K   K  +RM    +    ++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 233
               L ++H    + HRD+K  N+L+      +KL DFG SA++        + + + ++
Sbjct: 133 ALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 234 RAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQP 266
            APE+I       + Y A  D+WS G    EL  G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 16/219 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   RV+G G+ G V  AK +  GE  A+K V        DK     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 121 VSLKHCFFSTTEKDE---LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           V     F     ++    L + LVL+Y     + + IK   K ++        L F Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYY 233
            A+ ++H+   + HRDIK  N+L+  +   +KL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            APE I+    Y+   D++S G +L ELL  +  F GE+
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 32/205 (15%)

Query: 82  FQAKCLE--TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 139
           F   C++  T E V IK     +     E   +R ++HP+++ LK  F         Y  
Sbjct: 107 FAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--------TYNK 156

Query: 140 LVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
                +P   ++   + Y  ++R + +  +      + RA+ Y+H    + HRDIK +N+
Sbjct: 157 FTCLILPR--YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENI 213

Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYTAAID 250
            +N H   + L DFG+A   V    N      +YY         APEL+     Y  A+D
Sbjct: 214 FIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVD 265

Query: 251 IWSAGCVLAELLLGQPLFPGESGVD 275
           IWSAG VL E+         + G+D
Sbjct: 266 IWSAGIVLFEMATCHDSLFEKDGLD 290

Length = 391

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             K      TE     + L++E++P     E + R  K+   + Q++       Y  QIC
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLK------YAVQIC 119

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----- 231
           + + Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +     
Sbjct: 120 KGMDYLGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDS 174

Query: 232 --YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             ++ APE +  +  Y A+ D+WS G  L ELL
Sbjct: 175 PVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 25/203 (12%)

Query: 79  GVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHCFFSTTE 132
            +V  AK   T   VA+KK+  D   K        E+ T R L HPN++     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
             ELY  +V   +   +   ++K H+     +P + +      +  AL YIH+  G  HR
Sbjct: 71  DSELY--VVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSK-GFIHR 125

Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNISYICSRYYRAPELIFGAT 243
            +K  ++L++     + L     +  ++K         +   S + +  + +PE++    
Sbjct: 126 SVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 244 E-YTAAIDIWSAGCVLAELLLGQ 265
           + Y    DI+S G    EL  G 
Sbjct: 185 QGYNEKSDIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 127
           +G G++G V++    + G   A+K +L      + E++        L +HPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +   +     L LVLE     +V  ++K      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            + HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 246 T----AAIDIWSAGCVLAELLLGQP 266
                A  D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 22/224 (9%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 123
           +V+G G+FG V   K     +  A+K + + +  K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +DE  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 240
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 241 ---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              G  +Y    D WS G  + E+L G+  F  ES V+   +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 126
            VVG+G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 127 FFSTT---EKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           F   +     D+L+  LV+E+     V + V     +  K        ++     +I R 
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAP 236
           LA++H    V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ AP
Sbjct: 134 LAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 190

Query: 237 ELIF----GATEYTAAIDIWSAGCVLAELLLGQP 266
           E+I         Y    DIWS G    E+  G P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 52/244 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 126
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------------------------- 213
            +G  HRDIKP NLL++   H +KL DFG                               
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 214 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 269 PGES 272
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 30/224 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG          E +  K  +     ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 58  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 62.0 bits (150), Expect = 5e-11
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 56/271 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 126
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------------PN-------- 224
            +G  HRDIKP NLL++   H +KL DFG    L K              P+        
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 225 ----------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
                            S + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 269 PGESGVDQLVEIIK----VILHTEISLSIKA 295
             E+  +   +++     +I   E+ +S KA
Sbjct: 237 CSETPQETYKKVMNWKETLIFPPEVPISEKA 267

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 43/234 (18%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTM---RLLDHPNVVSLKH 125
           ++G G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 126 C--FFSTTEKDELYLNLVL-EYVPETVHRVIKH----HYKMSQRMPLIYVKLYFYQICRA 178
              +F   + +  ++ +V+ +Y P  +  ++KH    H  ++Q           +Q   A
Sbjct: 196 IQRYF---QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ---------IIFQTGVA 243

Query: 179 LAYIHNTIGVCHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEP 223
           L Y H  + + H D+KP+N+L       V+P T++        +++CD G      +   
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHS 301

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
             + + +R+YR+PE++ G   +  + D+WS GC++ EL  G+ L+     ++ L
Sbjct: 302 RTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354

Length = 467

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 61.4 bits (149), Expect = 9e-11
 Identities = 64/267 (23%), Positives = 100/267 (37%), Gaps = 86/267 (32%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           + +G G+FG V   + ++T    A+K  L+      R        E   +   D+  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   ++S  +KD LY   V++Y+P  + +  +I+              + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRLGI-----FEEDLARFYIAELTCAIE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPH----------------THQLKL--------------- 209
            +H  +G  HRDIKP N+L++                  TH  K                
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 210 --------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGATEYTAAI 249
                   C     +   K            G PN        Y APE++   T YT   
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLC 225

Query: 250 DIWSAGCVLAELLLGQPLF----PGES 272
           D WS G +L E+L+GQP F    P E+
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAET 252

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 57/248 (22%)

Query: 73  VGHGSFGVVFQAK-----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLL-DHPNVV 121
           +G G+FG V +A+            VA+K +  D   K+      E++ M+++  H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYF-- 172
           +L       T++  LY+  V+EY             R    +       P     L    
Sbjct: 80  NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE-TLTQKD 133

Query: 173 -----YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
                YQ+ R + ++ +   + HRD+  +N+LV    H +K+ DFG A+       +I +
Sbjct: 134 LVSFAYQVARGMEFLASKKCI-HRDLAARNVLVT-EDHVMKIADFGLAR-------DIHH 184

Query: 228 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
           I   YYR            APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 240

Query: 275 DQLVEIIK 282
           ++L +++K
Sbjct: 241 EELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
             +G G+FG V++   L+    VA+K          KR   +E + ++  DHPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-- 183
                 +K  +Y+  V+E VP     ++    K   R+ +  +          + Y+   
Sbjct: 58  -IGVCVQKQPIYI--VMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------AP 236
           N I   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 272
           E L +G   YT+  D+WS G +L E   LG   +PG S
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLGG------GSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 41/230 (17%)

Query: 73  VGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 124
           +G GSFGVV + +   +G     VA+K +  DK         +E   M  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 125 HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
               +        L +V E  P     + + +    H+       +  +  Y  QI   +
Sbjct: 63  GVVLTHP------LMMVTELAPLGSLLDRLRKDALGHF------LISTLCDYAVQIANGM 110

Query: 180 AYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     I   HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +   
Sbjct: 111 RYLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPF 164

Query: 235 ---APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 280
              APE +   T ++ A D+W  G  L E+   G+  + G SG   L +I
Sbjct: 165 AWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 127
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 128 FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 128

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 240
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185

Query: 241 ---GATEYTAAIDIWSAGCVLAELLLGQP 266
                  Y    D+WS G    E+  G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  P     +     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 58.6 bits (142), Expect = 5e-10
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 66/242 (27%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIK--------KVLQDKRYKNR 107
           P   + ++ E  +G G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ----- 161
           E + M  L HPN+V    C      K++    L  EY+    +H  +  +   S      
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 162 -----RMPLIYVKLY--FYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 212
                +  L          QI   + Y+  H+     HRD+  +N LV      +K+ DF
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISDF 168

Query: 213 GSAKVLVKGEPNISYICSRYYR------------APELI-FGATEYTAAIDIWSAGCVLA 259
           G ++ +   +         YYR             PE I +G  ++T   DIWS G VL 
Sbjct: 169 GLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLW 217

Query: 260 EL 261
           E+
Sbjct: 218 EI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 5e-10
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     S+       + L+ + +P    +  V  H   +  +  L +      QI + +
Sbjct: 73  RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV----QIAKGM 122

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
           +Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 SYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 58.3 bits (142), Expect = 5e-10
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 40/199 (20%)

Query: 95  IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----- 146
           ++K+++ K +   E    Q M+  D+PN + L +    TT K  +   L+++Y+      
Sbjct: 45  VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
           + +        K   ++    VK    Q+  AL  +H    + H DIK +N+L +    +
Sbjct: 98  DLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHNII-HNDIKLENVLYDRAKDR 148

Query: 207 LKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAEL 261
           + LCD+G  K  + G P      S Y     Y +PE I G   Y  + D W+ G +  EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199

Query: 262 LLGQPLFPGESGVDQLVEI 280
           L G+   P +   D+ +++
Sbjct: 200 LTGK--HPFKEDEDEELDL 216

Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.0 bits (140), Expect = 9e-10
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     T  K  +   +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 48/231 (20%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 117
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYV-----------PETVHRVIKHHYKMSQRMPLI 166
             +V L   +   +E++ +Y+  V EY+            E     +     M+      
Sbjct: 61  DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA----- 110

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI- 225
                  QI   +AY+ +     HRD+  +N+LV  +    K+ DFG A+++   E +  
Sbjct: 111 -------QIAEGMAYLESR-NYIHRDLAARNILVGEN-LVCKIADFGLARLI---EDDEY 158

Query: 226 -SYICSRY---YRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            +   +++   + APE   +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 159 TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 20/227 (8%)

Query: 67  YMAERVVGHGSFGVVF--QAKCLETGEAVAIKKVL-------QDKRYKNRELQTMRLLDH 117
           Y+ ++ +G GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           P +V     F    E+D   +  + EY     +   ++      + +    V  +F Q+ 
Sbjct: 62  PAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 235
             + Y+H    + HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE +     Y +  DIWS GC+L E+      F G++ +  ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG V++     T E VAIK + L++   +     +E+  +   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y    DIWS G    EL  G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 19/161 (11%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKHCFF 128
           G+FG V+  +     +  A+K V + D   KN   ++Q  R    L   P +V L   ++
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S    + +YL  V+EY+     + + H Y    + M + Y+     ++  AL Y+H   G
Sbjct: 72  SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-G 124

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           + HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 72  VVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
            +G G FG VF AK      E GE + + K LQ  + +N      REL   R L H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYV-KLYF-YQI 175
            L        E +  Y  ++LEY      +   R  K   +  +  PL    K+    QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
              + ++ N   V HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAEL 261
                     APE +    +++   D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 56.0 bits (135), Expect = 3e-09
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 32/229 (13%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 121
           +++M E  +G G FGVV   K       VAIK + +    +     E + M  L HP +V
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L   +   T++  LY+  V E++     ++ + +   K+S+ M L   +     +C  +
Sbjct: 63  QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YY 233
            Y+       HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII 281
             PE +F  ++Y++  D+WS G ++ E+   G+  F  +S   ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 40/232 (17%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE--- 132
           GS G VF A      + V +K  +  K     E   ++ ++HP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134

Query: 133 -----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                  +LY  L                   S+ +P+    +   QI   L Y+H    
Sbjct: 135 VLPHYSSDLYTYLTKR----------------SRPLPIDQALIIEKQILEGLRYLHAQ-R 177

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
           + HRD+K +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +
Sbjct: 178 IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235

Query: 248 AIDIWSAGCVLAELLL----------GQPLFPGESGVDQLVEIIKVI-LHTE 288
             DIWSAG VL E+L             P    +S    L++II  + +H E
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287

Length = 357

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 16/95 (16%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           Q+  A+ YIH   G+ HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 234 --------RAPELIFGATEYTAAIDIWSAGCVLAE 260
                    APE++ G   YT ++DIWSAG V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 60/235 (25%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRL---LDHPNVVSL 123
           R++G G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIK-----------HHYKMSQRMPLIYVKLY 171
              +   ++ D +Y    + Y+   T+  ++K              K S       V  +
Sbjct: 68  ---YSICSDGDPVYYT--MPYIEGYTLKSLLKSVWQKESLSKELAEKTS-------VGAF 115

Query: 172 ---FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV----------L 218
              F++IC  + Y+H+  GV HRD+KP N+L+      + L D+G+A            +
Sbjct: 116 LSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDI 173

Query: 219 VKGEPNISY---------ICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELL 262
              E NI Y         + +  Y APE + G  A+E T   DI++ G +L ++L
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.2 bits (133), Expect = 8e-09
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 23/234 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 124
           +G G FG V   +   TG+  A KK L  KR K R+     +   R+L   +   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFY--QICRALAY 181
           + F + T+     L LV+  +     R   H Y + +  P     +  FY  QI   L +
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 240
           +H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ 
Sbjct: 113 LHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIK 294
           G  EY  ++D ++ G  L E++  +  F       +  E+ + IL+  ++   K
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 56/247 (22%)

Query: 70  ERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 119
            R +G GSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR---------MPLIYVKL 170
           VV L      +T +  L   +V+E + +   +     Y  S+R          P    K 
Sbjct: 71  VVRLLG--VVSTGQPTL---VVMELMAKGDLK----SYLRSRRPEAENNPGLGPPTLQKF 121

Query: 171 YFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
                +I   +AY+       HRD+  +N +V      +K+ DFG  +       +I   
Sbjct: 122 IQMAAEIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE- 171

Query: 229 CSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
            + YYR            APE +     +T   D+WS G VL E+  L +  + G S  +
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-E 228

Query: 276 QLVEIIK 282
           ++++ + 
Sbjct: 229 EVLKFVI 235

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 38/227 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           R +G G FG V++     T   VA+K +            E Q M+ L HP ++ L   +
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---Y 67

Query: 128 FSTTEKDELYL-------NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
              T ++ +Y+         +LEY+     R +    K+ Q   LI +     Q+   +A
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL----KLPQ---LIDMAA---QVASGMA 117

Query: 181 YI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           Y+   N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + A
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
           PE       ++   D+WS G +L E++  G+  +PG +   V Q V+
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 56/244 (22%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC--LETGEA---VAIKKVLQD------KRYKNREL 109
            + TI     R +G G+FG VF  +C  LE       VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-------YKMSQ 161
           + +    H N+V         TE D     +V EY+    +++ ++ H            
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 162 RM-PLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            M  L   +L     QI   + Y+ +   V HRD+  +N LV  +   +K+ DFG ++ +
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG-YDLVVKIGDFGMSRDV 172

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELLL--G 264
                   Y    YYR             PE I     +T   D+WS G VL E+     
Sbjct: 173 --------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222

Query: 265 QPLF 268
           QP +
Sbjct: 223 QPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 36/217 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 125
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H +++SL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHY------KMSQRMPLIYVKLYFYQICRAL 179
            F   +  + +Y+      + E + +     +      ++     LI +     Q+   +
Sbjct: 68  -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMA---CQVAEGM 117

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSRYYR 234
           AY+       HRD+  +N+LV       K+ DFG A+++     +  +  I Y     + 
Sbjct: 118 AYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWT 171

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
           APE       ++   D+WS G +L E+   GQ  +PG
Sbjct: 172 APEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 27/71 (38%), Positives = 39/71 (54%), Gaps = 9/71 (12%)

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             QI  AL  +H+T G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   
Sbjct: 261 MRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKE 316

Query: 232 Y-----YRAPE 237
           +     Y APE
Sbjct: 317 FLLDPRYAAPE 327

Length = 566

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 54/242 (22%)

Query: 71  RVVGHGSFGVVFQAKCLE-----TGEA-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 119
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 120 VVS-LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF---Y 173
           +V  L  C       +  Y  +++E +   + +   ++         PL+ +K       
Sbjct: 61  IVKLLGVCL----LNEPQY--IIMELMEGGDLLS-YLRDARVERFGPPLLTLKELLDICL 113

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYIC 229
            + +   Y+     + HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 114 DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 230 SRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
           S YYR            APE L+ G   +T   D+WS G ++ E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 276 QL 277
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++V+G G FG VF+      G    AVAIK +      K R     E   M    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     T  K  +   ++ EY+    + + ++ H        L+ +      I   + 
Sbjct: 70  RLEGVV--TKFKPAM---IITEYMENGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMK 121

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 122 YLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTA 178

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 179 PEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)

Query: 76  GSFGVVFQAKCLETGEAV---AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           GS G VF   C + G+      I K +   +   RE+  ++ + H  +++L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 192
               + + V   +P+    +  +  +    +PL        ++  ALAY+H   G+ HRD
Sbjct: 156 ---RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGR-GIIHRD 210

Query: 193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTA 247
           +K +N+ ++   + + L DFG+A  L       +  C  +       +PEL+     Y A
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266

Query: 248 AIDIWSAGCVLAELLLGQ-PLFPGE--SGVDQLVEIIK 282
             DIWSAG VL E+ +    LF  +  S   QL  II+
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304

Length = 392

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 6e-08
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 29/208 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + ++ EY+   ++ + ++ +    +      V +    I   + 
Sbjct: 69  RLEGVVTKSRP-----VMIITEYMENGSLDKFLREN--DGKFTVGQLVGM-LRGIASGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 234
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+  
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-T 175

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 176 APEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E    +   +           +  +  QI + 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----------LLNWCVQIAKG 121

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+     V HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 122 MNYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 180 LESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.9 bits (124), Expect = 7e-08
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 126
           ++G G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+V L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 127 FFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               T++  +Y  +V+E VP     +  R  K   K  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAP 236
            +     HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + AP
Sbjct: 110 ESK-NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAP 163

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           E L +G   Y++  D+WS G +L E   LG   +PG
Sbjct: 164 EALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.1 bits (125), Expect = 9e-08
 Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 50/237 (21%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 110
           P+  I Y   R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 111 TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
            M   DHPN+V L          C    + +  + +E   +          H        
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 159 MSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
               +PL   +      Q+   +AY+     V HRD+  +N LV  +   +K+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178

Query: 217 VLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVLAEL 261
                  NI    + YY+A            PE IF    YT   D+W+ G VL E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 30/201 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FGVV   K     + VAIK + +    ++    E + M  L HPN+V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67

Query: 130 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            T++  ++  +V EY+         R  K        + +         +C A+ Y+ + 
Sbjct: 68  CTKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SDVCEAMEYLESN 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 240
            G  HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173

Query: 241 GATEYTAAIDIWSAGCVLAEL 261
             + +++  D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            L     S T      + LV + +P     + VH   +H   +  ++ L +      QI 
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWC----VQIA 119

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---Y 233
           + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    +
Sbjct: 120 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 266
            A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 178 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 119
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 178
           +V+L     + T    + +  + EY       ++    +  +    +   L F YQ+ + 
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           +A++ +   + HRD+  +N+L+  H   +K+CDFG A+ ++     +    +R    + A
Sbjct: 154 MAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           PE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 212 PESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 19/108 (17%)

Query: 173 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 223
            Q+ + + ++   N I   HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 219 SQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 26/199 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 130 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            T++  +Y  +V EY+         R     ++ SQ + +         +C  +AY+ + 
Sbjct: 68  CTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEMC------KDVCEGMAYLESK 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 242
               HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   
Sbjct: 120 -QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175

Query: 243 TEYTAAIDIWSAGCVLAEL 261
           +++++  D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 53/238 (22%), Positives = 105/238 (44%), Gaps = 49/238 (20%)

Query: 71  RVVGHGSFGVVFQAKCLE-TGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNV 120
           + +G G FG V +A      G A    VA+K + ++      R    E   ++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL---------- 170
           + L   + + ++   L L  ++EY     +  ++   + S+++   Y+            
Sbjct: 66  IKL---YGACSQDGPLLL--IVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 171 --------------YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
                         + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 217 VLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            + + +  +     R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 21/152 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 123
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E   +   D+  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              ++S  +KD LY   V++Y+P  + +  +I+         P    + Y  ++  A+  
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGI-----FPEDLARFYIAELTCAVES 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           +H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 15/151 (9%)

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L     S   +D ++L  VL++        +  H      +P   VK +  ++  
Sbjct: 45  PNMVCLHKYIVS---EDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAP 236
           AL  +H    VC RD+ P N+L++   H ++L  F       + E +         Y AP
Sbjct: 97  ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYCAP 151

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPL 267
           E + G +E T A D WS G +L ELL G+ L
Sbjct: 152 E-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 47/244 (19%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ L       +    VA+K +  D   K+      E++ M+++  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---------IKHHYKMSQ--RMPLIYV 168
           +++L     + T+   LY+  ++EY  +   R          +++ Y +++     + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 169 KLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFG----LARDVNNID 191

Query: 227 YICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 249

Query: 279 EIIK 282
           +++K
Sbjct: 250 KLLK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 5e-07
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 36/202 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 129
           +G G FG V        G+ VA+K +  D         E   M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 130 TTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             + + LY  +V EY+      + +    +    ++Q++       +   +C  + Y+  
Sbjct: 71  --QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQL------GFALDVCEGMEYLEE 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 239
                HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +
Sbjct: 121 K-NFVHRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171

Query: 240 FGATEYTAAIDIWSAGCVLAEL 261
               +++   D+WS G +L E+
Sbjct: 172 -REKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 45/222 (20%)

Query: 72  VVGHGSFGVVFQAKCLETG----EAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 122
           ++  G+FG +F    ++      E V +K V              E   +  L H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 123 LKHCFFSTTEKDELYL------NLVL-----EYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           + H      E   +        NL L             + +      S +  L+++ + 
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL------STQQ-LVHMAI- 124

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 229
             QI   ++Y+H   GV H+DI  +N +++    Q+K+ D   ++ L   +    Y C  
Sbjct: 125 --QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLG 176

Query: 230 ---SRYYR--APELIFGATEYTAAIDIWSAGCVLAELL-LGQ 265
              +R  +  A E +    EY++A D+WS G +L EL+ LGQ
Sbjct: 177 DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 31/217 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 122
           RV+G G FG V+    +++       A+K +     L++     +E   M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 181
           L           E    +VL Y+    H  +++  +     P +   + F  Q+ + + Y
Sbjct: 61  L----LGICLPSEGSPLVVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL--I 239
           + +   V HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L   
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167

Query: 240 FGATE------YTAAIDIWSAGCVLAELLL-GQPLFP 269
           + A E      +T   D+WS G +L EL+  G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 49.1 bits (117), Expect = 8e-07
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 33/213 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 123
           +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F+  TE    Y NL L+Y+ E             Q +  + +     QI  A+ Y+ 
Sbjct: 74  EPPFYIITEF-MTYGNL-LDYLREC----------NRQEVNAVVLLYMATQISSAMEYLE 121

Query: 184 --NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
             N I   HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + APE 
Sbjct: 122 KKNFI---HRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPES 176

Query: 239 IFGATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 270
           +    +++   D+W+ G +L E+   G   +PG
Sbjct: 177 L-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 44/229 (19%)

Query: 71  RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
           R++G G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV+
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ------RMPLIYVKLYFYQI 175
            L      +  K  L + +V+  +P   H  +     MS+       +PL  +  +   I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYY 233
              + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YY
Sbjct: 123 ASGMEYLSSK-NFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YY 169

Query: 234 R---APELIFG--ATE------YTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R   A +L     A E      YT   D+W+ G  + E++  GQ  + G
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 7/116 (6%)

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            S+ +  + +  + YQ+ R + ++ +   V HRD+  +N+L+      +K+CDFG A+ +
Sbjct: 230 GSEGLTTLDLLSFTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDI 287

Query: 219 VKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           +     +S         + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 9e-07
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 19/108 (17%)

Query: 173 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 223
           YQ+ + ++++   N I   HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 221 YQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 37/225 (16%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 117
           P++T+     + +G G FG V+          VAIK + Q          E   M+ L H
Sbjct: 4   PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQI 175
           P +V L    ++   ++ +Y+  + EY+    +  +    K  + + L   KL     QI
Sbjct: 61  PRLVRL----YAVVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQI 111

Query: 176 CRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
              +A+I   N I   HRD++  N+LV+  T   K+ DFG A+++   E    Y      
Sbjct: 112 AEGMAFIERKNYI---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGA 163

Query: 232 ----YYRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                + APE I +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 164 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 122
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 123 --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
             L  C  ST +       LV + +P     ++ +  +   R+    +  +  QI + ++
Sbjct: 73  RLLGICLTSTVQ-------LVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 237
           Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 124 YLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            I     +T   D+WS G  + EL+
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 73  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP----------LIYVK 169
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P          L   +
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLR----EYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 170 LYF-------YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L F       YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +  
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFG----LARDV 184

Query: 223 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
            NI Y            + APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 242

Query: 275 DQLVEIIK 282
           ++L +++K
Sbjct: 243 EELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 4e-06
 Identities = 59/273 (21%), Positives = 103/273 (37%), Gaps = 78/273 (28%)

Query: 70  ERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDKRY-KNRELQT-MRLL----DHP 118
            + +G G+FG V QA             VA+K + +     + + L T +++L     H 
Sbjct: 12  GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHL 71

Query: 119 NVV------------------------------SLKHCFFSTTEKDELYLNLVLEYVPE- 147
           NVV                              S + CF     K      +  +   + 
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131

Query: 148 ----------------TVHRVIKHHYKMSQ-----RMPLIYVKL--YFYQICRALAYIHN 184
                              + +    +  +     + PL    L  Y +Q+ R + ++ +
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS 191

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 238
              + HRD+  +N+L++   + +K+CDFG A+ + K +P+  Y+     R      APE 
Sbjct: 192 RKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK-DPD--YVRKGDARLPLKWMAPES 246

Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 247 IFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.8 bits (111), Expect = 5e-06
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E V+G G FG V + +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALA 180
            L+     T  +  + +   +E      +  +    + +  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + 
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 122
           + +G G FG V + +  +       AV   K+    R +      E   M+  DHPNV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-------MPLIYVKLYFYQI 175
           L      T E +     +V+  +P   H  + H + +  R       +P   +  +   I
Sbjct: 65  LIGVCLQTVESEGYPSPVVI--LPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              + Y+ ++    HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + 
Sbjct: 122 ASGMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKM 176

Query: 236 PELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPG 270
           P + + A E      YT   D+WS G  + E+   GQ  +PG
Sbjct: 177 P-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 65/253 (25%)

Query: 73  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------L 165
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P               
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLR----EYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 166 IYVKLYF---YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           +  K      YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG A+      
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR------ 188

Query: 223 PNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 269
            +I +I   YY+            APE +F    YT   D+WS G +L E+  LG   +P
Sbjct: 189 -DIHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP 244

Query: 270 GESGVDQLVEIIK 282
           G   V++L +++K
Sbjct: 245 GVP-VEELFKLLK 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLLD-HPN 119
           +G G FG V +A+         +    VA+K +  +   K+      E++ M+L+  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------- 164
           +++L       T++  LY+  ++EY  +   R     +  ++R P               
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLR----EFLRARRPPGPDYTFDITKVPEEQ 130

Query: 165 LIYVKLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L +  L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +G 
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGV 184

Query: 223 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
            +I Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-V 242

Query: 275 DQLVEIIK 282
           ++L ++++
Sbjct: 243 EELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 46/192 (23%)

Query: 94  AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EY 144
           A     +D     +E++ +  L  PN+  L               E  E   LN  L ++
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKH 113

Query: 145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNP 202
           V ET    +  + K      L+Y+     QI   + Y+   N +   HRD+  +N LV  
Sbjct: 114 VAETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK 165

Query: 203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTAAID 250
             + +K+ DFG ++ L        Y    YY    RAP        E +    ++T   D
Sbjct: 166 -NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSD 214

Query: 251 IWSAGCVLAELL 262
           +W+ G  L E+L
Sbjct: 215 VWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 43/196 (21%)

Query: 93  VAIKKVLQD--KRYKN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 147
           VA+K +  D  K  +N   +E++ M  L +PN++ L          D+  L ++ EY+  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101

Query: 148 ------TVHRVIKHHYKMSQRMPLIYVKLYFY---QICRALAYIHNTIGVCHRDIKPQNL 198
                    R I+  +  +  +P + +    Y   QI   + Y+  ++   HRD+  +N 
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNC 160

Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------------APELIFGATEYT 246
           LV  H + +K+ DFG ++ L  G+         YYR            A E I    ++T
Sbjct: 161 LVGNH-YTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMAWESIL-LGKFT 209

Query: 247 AAIDIWSAGCVLAELL 262
            A D+W+ G  L E+ 
Sbjct: 210 TASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 4e-05
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 158 KMSQRMP-----LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 212
           K+   MP     +  +K    Q+   L  +H  IG+ HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 213 GSAKVLVKG---EPNISYICSRYYRAPELI 239
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.7 bits (103), Expect = 4e-05
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 48/231 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 120
           +++G G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM-------PLIYVKLYFY 173
           + L    F  +   ++   +V+  +P   H  + H + +  R+       PL  +  +  
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVI--LPFMKHGDL-HSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSR 231
            I   + Y+ N     HRD+  +N ++      + +C  DFG +K +  G+         
Sbjct: 121 DIALGMEYLSNR-NFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD--------- 167

Query: 232 YYRAPELI-----FGATE------YTAAIDIWSAGCVLAELL-LGQPLFPG 270
           YYR   +      + A E      YT+  D+W+ G  + E+   GQ  +PG
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.4 bits (102), Expect = 6e-05
 Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 31/208 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +++G G FG V +   +  G+++ I    K +QD+  +         +  M  LDH  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ++       L LV +  P    +  V +H   +  +  L +      QI + 
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC----VQIAKG 121

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYR 234
           + Y+     + HR++  +N+L+      +++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
              ++FG   YT   D+WS G  + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 43.0 bits (101), Expect = 7e-05
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 129
           ++G G FG V Q +   TG+ VA+K +  D   +    E   M  L H N+V L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
                   L +V+E + +  + V     +    + +I +  +   +   + Y+ +   + 
Sbjct: 71  NG------LYIVMELMSKG-NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI 249
           HRD+  +N+LV+      K+ DFG A+V   G  N        + APE +    ++++  
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178

Query: 250 DIWSAGCVLAELL-LGQPLFP 269
           D+WS G +L E+   G+  +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 29/121 (23%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QI   + Y+ +++   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 234 R------------APELIFGATEYTAAIDIWSAGCVLAELLL---GQPLFPGESGVDQLV 278
           R            A E I    ++T A D+W+ G  L E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 279 E 279
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAV-AIKKVLQDKRYK-NRELQTMRLLDHPNVVSL 123
           +G G+FG VF A+C        +   AV A+K+  +  R    RE + + +L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH---------YKMSQRMPLIYVKLYFY 173
              F+    +    L +V EY+    ++R ++ H          +      L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 174 --QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             QI   + Y+  ++   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 232 YYRA------------PELIFGATEYTAAIDIWSAGCVLAELL 262
           YYR             PE I    ++T   DIWS G VL E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 36/205 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59

Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              T+K  +Y  +V+E V      T  R      K+ + + ++            + Y+ 
Sbjct: 60  GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQMV------ENAAAGMEYLE 111

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------AP 236
           +   + HRD+  +N LV    + LK+ DFG    + + E +  Y  +   +       AP
Sbjct: 112 SKHCI-HRDLAARNCLVT-EKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAP 165

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAE 260
           E L +G   Y++  D+WS G +L E
Sbjct: 166 EALNYG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 9/111 (8%)

Query: 165 LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L Y+ L  + YQ+   + ++ +   V HRD+  +N+L+      +K+CDFG A+ +++  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293

Query: 223 PNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 269
             IS         + APE IF    YT   D+WS G +L E+  LG   +P
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYP 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 43/230 (18%)

Query: 71  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +GHG+FG V++              VA+K + +    ++      E   M   +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V        + E+   +  ++LE +     +      +     P            R +A
Sbjct: 72  V---RLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 181 ----YIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYR 234
               Y+       HRDI  +N L+         K+ DFG A+ + +         + YYR
Sbjct: 127 KGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASYYR 176

Query: 235 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 272
                       P   F    +T+  D+WS G +L E+  LG   +PG +
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 5/113 (4%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSR 231
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              +PE++ G   Y    DIWS G +L ++L       G+ G     +++K+I
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384

Length = 501

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 34/207 (16%)

Query: 73  VGHGSFGVVFQA--KCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           +G G+FG V +   K  +    VAIK VL+++  K+      RE + M  LD+P +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                  E + L   LV+E      +++ +         + +  V    +Q+   + Y+ 
Sbjct: 61  ---IGVCEAEALM--LVMEMASGGPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLE 112

Query: 184 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-------YRA 235
               V HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + A
Sbjct: 113 GKNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYA 166

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++++  D+WS G  + E  
Sbjct: 167 PECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVS 122
           S    + +G+G FG V+        + VA+K +            E Q M+ L H  +V 
Sbjct: 7   SLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L    ++   ++ +Y+  V EY+ + ++   +K     + ++P + V +   Q+   +AY
Sbjct: 66  L----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMA-AQVAAGMAY 117

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
           I   +   HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE 
Sbjct: 118 IER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 174

Query: 239 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 37/214 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FG V+      T + VAIK +           +E Q M+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 130 TTEKDELYLNLVLEYVPE-TVHRVIKH----HYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              ++ +Y+  V E++ + ++   +K     + K+ Q + +        QI   +AYI  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA------QIADGMAYIER 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL 238
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +       + APE 
Sbjct: 121 -MNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 174

Query: 239 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 35/217 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHH------YKMSQRMPLIYV 168
           +L        E    YL L +EY P           RV++           +  +    +
Sbjct: 72  NL----LGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
             +   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 127 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 182

Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 183 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 44/249 (17%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMR 113
           T+ +M E  +G   FG V++         E  +AVAIK  L+DK     R + +    MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 114 L-LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHR--VIKHHYK----------- 158
             L HPN+V    C      K++  L+++  Y   + +H   V++  +            
Sbjct: 63  SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            S   P  +V +   QI   + ++ ++  V H+D+  +N+LV    + +K+ D G  + +
Sbjct: 118 KSTLEPADFVHI-VTQIAAGMEFL-SSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREV 174

Query: 219 VKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
              +       S +  R+     +++G  +++   DIWS G VL E+   G   + G S 
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232

Query: 274 VDQLVEIIK 282
            D ++E+I+
Sbjct: 233 QD-VIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 40.0 bits (93), Expect = 9e-04
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 51/225 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           E V+G G+FG V +A   + G  +  AIK + +     D R    EL+ + +L  HPN++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 122 SL-KHCFFSTTEKDELYLNLVLEYVP--------------ETVHRVIKHH---YKMSQRM 163
           +L   C      ++  YL + +EY P              ET     K H     ++ + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            L +       +   + Y+     + HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LLQFAS----DVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 224 NISYICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL 262
              Y+     R P + + A E      YT   D+WS G +L E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 50/237 (21%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQ 110
            ++ I+ + E  +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLI 166
            M+     +VV L         K +  L +V+E +     ++  R ++   + +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 167 YVKLYFY---QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLGQP 266
                   YYR            APE +     +T + D+WS G VL E+  L  QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 54/227 (23%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNV 120
           +R +G G+FG VF A+C     E  + +   K L+D     ++  +RE + +  L H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH----YKMSQRMP--------LIY 167
           V     +    E D L   +V EY+    +++ ++ H      M++           +++
Sbjct: 70  VKF---YGVCVEGDPLI--MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +     QI   + Y+ +   V HRD+  +N LV  +   +K+ DFG ++ +   +     
Sbjct: 125 IA---QQIAAGMVYLASQHFV-HRDLATRNCLVGENL-LVKIGDFGMSRDVYSTD----- 174

Query: 228 ICSRYYRA------------PELIFGATEYTAAIDIWSAGCVLAELL 262
               YYR             PE I    ++T   D+WS G VL E+ 
Sbjct: 175 ----YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	296
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.98
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.6
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG3087	229	consensus Serine/threonine protein kinase [General	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.3
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.23
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.08
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.04
PRK09902	216	hypothetical protein; Provisional	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.76
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.75
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.62
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.5
PF01636	239	APH: Phosphotransferase enzyme family This family	98.44
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.39
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.3
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.3
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.21
PLN02876	822	acyl-CoA dehydrogenase	98.15
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.05
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.99
KOG2270	520	consensus Serine/threonine protein kinase involved	97.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.83
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.76
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.74
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.7
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.68
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.55
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.49
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.48
PRK05231	319	homoserine kinase; Provisional	97.44
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.4
PRK10593	297	hypothetical protein; Provisional	97.38
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.36
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.2
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.12
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.12
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.1
PLN02236	344	choline kinase	97.06
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.05
PRK12396	409	5-methylribose kinase; Reviewed	96.83
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.65
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.58
PTZ00384	383	choline kinase; Provisional	96.48
COG2334	331	Putative homoserine kinase type II (protein kinase	96.32
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.3
PLN02756	418	S-methyl-5-thioribose kinase	96.11
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.05
PRK11768	325	serine/threonine protein kinase; Provisional	95.62
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.1
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.94
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.69
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.53
PTZ00296	442	choline kinase; Provisional	94.31
PRK10271	188	thiK thiamine kinase; Provisional	93.96

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-54  Score=360.89  Aligned_cols=242  Identities=71%  Similarity=1.121  Sum_probs=224.9

Q ss_pred             ceeEEEeecCCCCCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceeccee
Q 022520           47 GHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC  126 (296)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  126 (296)
                      .........+..+.+.....|.-.+++|.|+||.||.|....+++.||||+..++.+...+|+.+|+.++|||||++..+
T Consensus         6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~   85 (364)
T KOG0658|consen    6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF   85 (364)
T ss_pred             eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence            34455556666667777778999999999999999999999999999999999999888999999999999999999999


Q ss_pred             eeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc
Q 022520          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (296)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~  206 (296)
                      |....+.+..+..+||||++.+|.+.+++....+.+++...++.+..||++||+|||+. ||+||||||.|+|+|.+.+.
T Consensus        86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCe
Confidence            98877666678889999999999999998777788999999999999999999999998 99999999999999999889


Q ss_pred             EEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       207 ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      +||||||.|+.+..+.++.+..+|..|+|||.+++..+|+.+.||||.||++.||+-|++.|.+.+..+++.+|.+.++.
T Consensus       165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             CCc
Q 022520          287 TEI  289 (296)
Q Consensus       287 ~~~  289 (296)
                      |.-
T Consensus       245 Pt~  247 (364)
T KOG0658|consen  245 PTR  247 (364)
T ss_pred             CCH
Confidence            854

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-51  Score=347.12  Aligned_cols=208  Identities=34%  Similarity=0.606  Sum_probs=181.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .++|.+.+.||+|+||+||+|+++.++..||||.+...      .+....|+++|+.++|||||.++++.     ....+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence            35799999999999999999999999999999988544      23345799999999999999999998     45556


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC-C----CcEEEee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-T----HQLKLCD  211 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~-~----~~ikl~D  211 (296)
                      +|+|||||. |+|..++...    +.+++..++.++.||+.||.+||++ +||||||||+||||+.. .    ..+||+|
T Consensus        84 i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999 5777777763    6899999999999999999999999 99999999999999864 1    2589999


Q ss_pred             ecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ||+|+.+.++.-..+..|+|.|||||+++.. .|+.|+|+||+|+++|+|++|++||+..+..+.+..+.+
T Consensus       159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k  228 (429)
T KOG0595|consen  159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK  228 (429)
T ss_pred             cchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence            9999998877777788999999999999654 499999999999999999999999998887666554443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-50  Score=355.37  Aligned_cols=220  Identities=31%  Similarity=0.502  Sum_probs=197.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+|...+.||+|||+.||.+++..+|+.||+|++...       .....+|+++.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5799999999999999999999999999999988542       23345899999999999999999999     77778


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +|||+|+|. ++|..+++.    ..++++.+++.+++||+.||.|||++ +|+|||||..|+|++.+. ++||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcC-cEEecccceee
Confidence            999999999 677777774    47899999999999999999999999 999999999999999988 79999999998


Q ss_pred             eeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccccccc
Q 022520          217 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA  295 (296)
Q Consensus       217 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (296)
                      .+... ....+..|||.|.|||++.... ++..+||||+||+||.||.|++||...+-.+.+..|...-...|-.+|..|
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A  245 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEA  245 (592)
T ss_pred             eecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHH
Confidence            88644 5667889999999999997544 899999999999999999999999999988999999998888888888776


Q ss_pred             C
Q 022520          296 A  296 (296)
Q Consensus       296 ~  296 (296)
                      +
T Consensus       246 ~  246 (592)
T KOG0575|consen  246 K  246 (592)
T ss_pred             H
Confidence            4

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.8e-51  Score=332.48  Aligned_cols=213  Identities=41%  Similarity=0.742  Sum_probs=193.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .|+.+-++|+|+||.||+++++.+|+.||||++..+.+      ...+|+++|++++|+|+|.+.++|     ....-.+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence            58888899999999999999999999999999965433      234899999999999999999999     5555689


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|+|||+.+++..+..+   ...++...++.+++|++.|+.|+|++ ++|||||||+||||+.++ .+||||||+|+.+.
T Consensus        78 LVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNG-VVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence            99999999999888876   47799999999999999999999999 999999999999999988 89999999999887


Q ss_pred             -cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          220 -KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       220 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                       ++..-...+.|.||+|||.+.++..|+...||||+||++.||++|.+.|.+.++.+++..|.+.++...
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~  222 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI  222 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC
Confidence             444456678899999999999988899999999999999999999999999999999999999987653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-50  Score=337.03  Aligned_cols=221  Identities=32%  Similarity=0.518  Sum_probs=189.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.++||+|+||+||.++.+.+++.+|+|+++..       .+....|..+|..++||+||+++..|     ++.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence            345899999999999999999999999999999988532       23345799999999999999999888     666


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..+|+|++|+.| .|...+.+    .+.+++..++.++.+|+.||.|||++ |||||||||+|||+|.+| .++|+|||+
T Consensus        98 ~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~G-Hi~LtDFgL  171 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQG-HIKLTDFGL  171 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCC-cEEEecccc
Confidence            669999999996 55555554    58899999999999999999999998 999999999999999998 799999999


Q ss_pred             eeee-ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcc-cc
Q 022520          215 AKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS-LS  292 (296)
Q Consensus       215 ~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  292 (296)
                      ++.. ..+....+.+||+.|||||++.+.. |+..+|.||||+++|+|++|.+||.+.+..+....|.+.=...+.. +|
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls  250 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS  250 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC
Confidence            9854 3445566779999999999998765 9999999999999999999999999999888888888755333333 55


Q ss_pred             ccc
Q 022520          293 IKA  295 (296)
Q Consensus       293 ~~~  295 (296)
                      ..|
T Consensus       251 ~~a  253 (357)
T KOG0598|consen  251 EEA  253 (357)
T ss_pred             HHH
Confidence            444

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3e-49  Score=317.48  Aligned_cols=215  Identities=37%  Similarity=0.682  Sum_probs=193.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|...+.||+|.||.||+|++..+|+.||||+++....      ...+|++.|+.++|+||+.+.++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            468899999999999999999999999999999965432      234899999999999999999999     444458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      .+|+||++.+|...++..   ...++..+++.|+.++++||+|||++ .|+||||||.|+||++++ .+||+|||+++..
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            899999999999998876   47899999999999999999999999 999999999999999988 8999999999987


Q ss_pred             ccCCCcc-cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          219 VKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       219 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      ....... ..+.|.+|+|||.++|...|+...||||.|||+.||+.|.+.|.+.++.+++..|.+.++.|..
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~  223 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP  223 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence            6554433 3477999999999999999999999999999999999999999999999999999999998854

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=346.27  Aligned_cols=217  Identities=35%  Similarity=0.647  Sum_probs=199.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh-----HHHHHHHHhcC-CCCceecceeeeeccCCCceE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .++|.++++||.|.||.||+|+.+.+++.||||+++......     .+|++.|++|+ ||||+++.+++.+..    .+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence            358999999999999999999999999999999987654433     37999999998 999999999985332    16


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|||||+..|.++++..   +..|++..++.|++||+.||+|+|.+ |+.|||+||+|||+.... .+||+|||+|+.
T Consensus        85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~-~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGND-VIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccc-eeEecccccccc
Confidence            9999999999999999987   58899999999999999999999999 999999999999999655 799999999999


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      +....+-...+.|.||+|||++.....|+.+.||||+|||++|+++-++.|.+.+..+++..|+..++.|..
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            988888888999999999999999899999999999999999999999999999999999999999998854

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-49  Score=343.86  Aligned_cols=221  Identities=37%  Similarity=0.656  Sum_probs=195.7

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      +...+.|+.+++||+|.||.||+|++..+|+.||+|++.-+..      ...+|+.||++|+||||+++.+..+..   .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~  189 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L  189 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence            3445579999999999999999999999999999999864431      234899999999999999999988654   3


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...+|+|+|||+.+|..++...   .-.|++.+++.+++||+.||+|||++ ||+|||||.+|||||.++ .+||+|||+
T Consensus       190 ~~siYlVFeYMdhDL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G-~LKiaDFGL  264 (560)
T KOG0600|consen  190 SGSIYLVFEYMDHDLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNG-VLKIADFGL  264 (560)
T ss_pred             CceEEEEEecccchhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCC-CEEeccccc
Confidence            3458999999999988887763   35799999999999999999999999 999999999999999988 899999999


Q ss_pred             eeeeccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          215 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       215 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      |+++....  .....+.|.||+|||.+.|...|+.+.|+||+||||.||++|++.|.+.+..+++..|.+.++.|..
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            99765544  3456678999999999999999999999999999999999999999999999999999999988753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-50  Score=327.11  Aligned_cols=212  Identities=34%  Similarity=0.566  Sum_probs=180.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecce-eeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH-CFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~~~~~~  137 (296)
                      .+|++.++||+|.||+||++++..+|+.+|.|.+.-+      .+..-.|+.+|++|+|||||++++ .|.    ++...
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~----~~~ev   94 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI----EDNEV   94 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh----ccchh
Confidence            4799999999999999999999999999999988522      222347999999999999999988 442    22233


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc--cCC--ceeccCCCCceEEcCCCCcEEEeee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--TIG--VCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~--~~~--iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      ++||||+|. |+|.+.+++..+..+.+++..+++++.|+++||..+|+  . .  |+||||||.|||++.++ .+||+||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~g-vvKLGDf  172 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANG-VVKLGDF  172 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCC-ceeeccc
Confidence            789999999 78889998888888899999999999999999999999  3 4  99999999999999888 8999999


Q ss_pred             cceeeeccCCCc-ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          213 GSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       213 g~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |+++.+...... .+.+|||.||+||.+.+.+ |++++||||+||++|||+.-++||.+.+-.+.-.+|.+.
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg  243 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG  243 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence            999987665543 4678999999999997766 999999999999999999999999998543333445443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=320.51  Aligned_cols=195  Identities=32%  Similarity=0.575  Sum_probs=172.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+.+....||+|..|+||+++|+.+++.+|+|.+...     .++..+|+++++.++||+||.+|++|+....    .+.
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3677889999999999999999999999999998322     3344689999999999999999999976543    388


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |+||||++ +|...+..    .+++++..+.+++.++++||.|||+ + +||||||||+|||+...+ +|||||||.++.
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~-~IIHRDIKPsNlLvNskG-eVKicDFGVS~~  228 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER-KIIHRDIKPSNLLVNSKG-EVKICDFGVSGI  228 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc-CeeeccCCHHHeeeccCC-CEEeccccccHH
Confidence            99999995 66666665    3789999999999999999999996 6 999999999999999988 899999999988


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      +.+. ...+.+||..|||||.+.+.. |+.++||||||+.++|+++|++||...
T Consensus       229 lvnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  229 LVNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             hhhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCc
Confidence            7665 556889999999999997765 999999999999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-48  Score=329.44  Aligned_cols=214  Identities=34%  Similarity=0.485  Sum_probs=178.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------h--hhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------R--YKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~--~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ..+.|.+.+.||+|+||.|-+|..+.+++.||||++....         .  ...+|+++|++|+|||||+++++|.   
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~---  246 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE---  246 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee---
Confidence            3456999999999999999999999999999999884221         1  1248999999999999999999993   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEE
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLK  208 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ik  208 (296)
                        ...+.|+||||++| .|.+.+-.    ++.+.+..-+.+++|++.|+.|||++ ||+||||||+|||+..+.  -.+|
T Consensus       247 --~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  247 --VPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             --cCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEE
Confidence              34447999999995 66666655    47788888899999999999999999 999999999999997652  2689


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhc
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEIIKVIL  285 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  285 (296)
                      |+|||+|+.........+.+|||.|.|||++.+.  ..+..+.|+|||||+||-+++|.+||.+..... ...+|.+.-.
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y  399 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY  399 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence            9999999998877778889999999999999543  234558999999999999999999999876555 4556665444


Q ss_pred             C
Q 022520          286 H  286 (296)
Q Consensus       286 ~  286 (296)
                      .
T Consensus       400 ~  400 (475)
T KOG0615|consen  400 A  400 (475)
T ss_pred             c
Confidence            3

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=309.86  Aligned_cols=220  Identities=29%  Similarity=0.468  Sum_probs=194.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...++|++.+.||.|+||.|.+++.+.+|..+|+|++....       +...+|..+|+.+.||+++++++.|     .+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence            44468999999999999999999999999999999885332       2234799999999999999999888     66


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..++++||||++| .+..+++.    .++|++..++.++.||+.||+|||+. +|++|||||+|||+|.+| .+||+|||
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G-~iKitDFG  189 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNG-HIKITDFG  189 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCC-cEEEEecc
Confidence            7779999999996 56666655    48999999999999999999999998 999999999999999998 79999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccccc
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSI  293 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  293 (296)
                      .|+.+...  ..+.+|||.|+|||++...+ |+.++|.|||||++|||+.|.+||.+.+....+..|+..-...|.-+|.
T Consensus       190 FAK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~  266 (355)
T KOG0616|consen  190 FAKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSS  266 (355)
T ss_pred             ceEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCH
Confidence            99987554  56778999999999997655 8999999999999999999999999999999999999998888887776


Q ss_pred             cc
Q 022520          294 KA  295 (296)
Q Consensus       294 ~~  295 (296)
                      .|
T Consensus       267 ~~  268 (355)
T KOG0616|consen  267 DA  268 (355)
T ss_pred             HH
Confidence            54

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-47  Score=315.83  Aligned_cols=216  Identities=34%  Similarity=0.591  Sum_probs=192.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh------hHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..|+.+..|++|.||.||+|+++.+++.||+|+++-+...      ..+|+.+|.+++|||||.+..+.+...-.   -+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d---~i  152 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD---KI  152 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc---ee
Confidence            4699999999999999999999999999999998644321      24899999999999999999988655432   28


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      |+|||||+.+|..++...   .++|...+++.++.|+++|++|||.+ .|+||||||+|+|+...| .+||+|||+|+.+
T Consensus       153 y~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  153 YIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKG-ILKIADFGLAREY  227 (419)
T ss_pred             eeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCC-cEEecccchhhhh
Confidence            899999999999888865   47899999999999999999999998 999999999999999888 8999999999987


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .... +....+-|.+|+|||.+.+.+.|+++.|+||+|||+.||+++++.|.+.+..+++..|.+.++.|.
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS  298 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence            5543 344557799999999999999999999999999999999999999999999999999999998874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=332.71  Aligned_cols=221  Identities=31%  Similarity=0.538  Sum_probs=191.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee-------cchhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      -..+|.+.+.||+|+|++|++|+++.+++.||||++..       ..+....|-.+|.+| .||.|++|+..|     ++
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD  145 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD  145 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence            34579999999999999999999999999999998742       233445788999999 899999999888     56


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...+|+|+||++ |.|++++...    +.|.+..++.++.+|+.||+|||++ |||||||||+|||+|.++ +++|+|||
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dm-hikITDFG  219 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDG-HIKITDFG  219 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCC-cEEEeecc
Confidence            666999999998 6888888874    8899999999999999999999998 999999999999999998 79999999


Q ss_pred             ceeeeccCCCc--------------ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022520          214 SAKVLVKGEPN--------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (296)
Q Consensus       214 ~~~~~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  279 (296)
                      .|..+.+....              .+++||..|.+||++... ..++.+|+|+||||+|+|+.|.+||.+.+.--.++.
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk  298 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK  298 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            99876433211              458999999999999544 479999999999999999999999999998888899


Q ss_pred             HHHhhcCCCccccccc
Q 022520          280 IIKVILHTEISLSIKA  295 (296)
Q Consensus       280 ~~~~~~~~~~~~~~~~  295 (296)
                      |+..-...+-.++..|
T Consensus       299 I~~l~y~fp~~fp~~a  314 (604)
T KOG0592|consen  299 IQALDYEFPEGFPEDA  314 (604)
T ss_pred             HHHhcccCCCCCCHHH
Confidence            9988877776666544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.6e-46  Score=324.22  Aligned_cols=209  Identities=32%  Similarity=0.545  Sum_probs=178.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh-------hHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..++|.+++.||+|+||.||+|+-+.+|..+|+|+++.+.-.       ...|-.+|...+.+.||+++.+|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            446899999999999999999999999999999998654322       23577888888999999999999     778


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .++|+||||++| ++..+|..    .+.|++.+++.++.+++.|++.||+. |+|||||||+|+|||..| .+||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~G-HiKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKG-HIKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCC-CEeeccccc
Confidence            889999999996 55555554    58999999999999999999999998 999999999999999998 799999999


Q ss_pred             eeeeccC-----------------------CC-----c--------------------ccccccccccCCccccCCCCCC
Q 022520          215 AKVLVKG-----------------------EP-----N--------------------ISYICSRYYRAPELIFGATEYT  246 (296)
Q Consensus       215 ~~~~~~~-----------------------~~-----~--------------------~~~~~t~~y~aPE~~~~~~~~~  246 (296)
                      +..+...                       .+     .                    .+.+|||.|||||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            8543110                       00     0                    1356899999999998877 99


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       247 ~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ..+|+||||||+||||.|.+||.+.++.+...+|++-
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw  403 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNW  403 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999999999999999999999998887666543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=324.39  Aligned_cols=219  Identities=32%  Similarity=0.466  Sum_probs=187.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---------chhhHHHHHHHHhcC-CCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  132 (296)
                      ..+.|.+.+.||+|+||+|+.|.+..++..||+|++...         .....+|+.+++.++ ||||+++++++..   
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t---   91 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT---   91 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence            345799999999999999999999999999999966432         223347999999999 9999999999843   


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                        ...+++|||||.| .|.+.+..    .+++.+..++++++|+++|++|||++ ||+||||||+|||++.+...+||+|
T Consensus        92 --~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   92 --PTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             --CCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEec
Confidence              3338999999995 77777776    47899999999999999999999998 9999999999999999823899999


Q ss_pred             ecceeee-ccCCCcccccccccccCCccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          212 FGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       212 fg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      ||++... ..+....+..||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||+..+....+..|.+.-...+.
T Consensus       165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~  244 (370)
T KOG0583|consen  165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS  244 (370)
T ss_pred             cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC
Confidence            9999877 4556677889999999999998766 5579999999999999999999999998877777777666555554


Q ss_pred             cc
Q 022520          290 SL  291 (296)
Q Consensus       290 ~~  291 (296)
                      -+
T Consensus       245 ~~  246 (370)
T KOG0583|consen  245 YL  246 (370)
T ss_pred             Cc
Confidence            44

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=308.57  Aligned_cols=222  Identities=34%  Similarity=0.658  Sum_probs=193.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHHhcCCCC-ceecceeeeeccC-CCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPN-VVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~  136 (296)
                      ..|..+++||+|.||+||+|+++.+|+.||+|++....+      ...+|+.+|+.++|+| |+.+++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            458888899999999999999999999999999864433      2258999999999999 9999999865442 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++|+||++-++..++.........++...++.+++||++||+|||++ +|+||||||+||||++++ .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCC-cEeeeccchHH
Confidence            5889999999999999988653324677789999999999999999999 999999999999999977 89999999998


Q ss_pred             eec-cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          217 VLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       217 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ... +...-...+.|.+|+|||++.+...|++..||||+|||++||+++++.|.+.++.+++..|.+.++.|.
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            654 334455678899999999999998899999999999999999999999999999999999999998883

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-44  Score=328.17  Aligned_cols=223  Identities=56%  Similarity=1.033  Sum_probs=193.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccC---CCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~i  140 (296)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++........+|+.+++.++|+||++++++|+....   ....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            347999999999999999999999999999999987766666789999999999999999888754321   23356789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      ||||+++++...+.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++..+||+|||+++....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            999999998888876655567899999999999999999999998 9999999999999997765799999999987655


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            5555567889999999998776668999999999999999999999999998888888887766544

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=328.87  Aligned_cols=214  Identities=39%  Similarity=0.666  Sum_probs=189.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh---HHHHHHHHhcC-C-----CCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD-H-----PNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||+|.||.|.+|.+..+++.||||+++......   ..|+.+|..|+ |     -|+|+++++|+     ...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----ccc
Confidence            6899999999999999999999999999999997665544   36899999986 3     48999999994     445


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC-CCCcEEEeeecce
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~-~~~~ikl~Dfg~~  215 (296)
                      ++|||+|.+..+|.++++.+.  ...++...++.+++||+.||.+||+. +|||+|||||||||.. +...||++|||.+
T Consensus       262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccc
Confidence            599999999999999999876  46699999999999999999999998 9999999999999954 3447999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcc
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  290 (296)
                      +.....  ..+...+..|+|||++.|.+ |+.+.||||||||++||++|.+.|.+.+..+++..|+..++.|+-.
T Consensus       339 c~~~q~--vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~  410 (586)
T KOG0667|consen  339 CFESQR--VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK  410 (586)
T ss_pred             cccCCc--ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence            875443  33777899999999998877 9999999999999999999999999999999999999999987753

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=308.53  Aligned_cols=218  Identities=43%  Similarity=0.716  Sum_probs=192.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .|...+.||.|+||.|..+.+..+|+.||+|++...      .+...+|+++|+.++|+||+.+.+++.........-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            466689999999999999999999999999998522      33445899999999999999999998663334445589


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|+|+|+.+|.+.++.    ++.+++..+..+++|+++||.|+|+- +|+||||||+|+|++.+- .+||+|||+|+...
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCC-CEEeccccceeecc
Confidence            9999999999888887    35599999999999999999999998 999999999999999887 79999999999875


Q ss_pred             c---CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          220 K---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       220 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      .   ....+..+.|.+|+|||++.....|+...||||+||||.||++|++.|.+.+..+++..|...++.|+-
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            3   233356778999999999988888999999999999999999999999999999999999999998854

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-45  Score=327.18  Aligned_cols=220  Identities=32%  Similarity=0.502  Sum_probs=195.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      +-|++.+.||.|+-|.|-+|++..+|+..|||++...       ....++|+-+|+.+.|||++++|++|     .+..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence            3599999999999999999999999999999999654       44567899999999999999999999     55566


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +|+|.||++ |.|.+++..    .+++++.++.++++||+.|+.|+|.. +|+||||||+|+|+|... +|||+|||+|.
T Consensus        87 lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~-nIKIADFGMAs  160 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKN-NIKIADFGMAS  160 (786)
T ss_pred             EEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhccc-CEeeeccceee
Confidence            999999998 577777776    48999999999999999999999998 999999999999999988 59999999999


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccccccc
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA  295 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (296)
                      ...++.-..+.+|+|.|.|||+++|.++.+.++||||+|||||.|++|+.||++.+-...+..+.+.....|...|-+|
T Consensus       161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~ea  239 (786)
T KOG0588|consen  161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEA  239 (786)
T ss_pred             cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHH
Confidence            8777777778899999999999999998999999999999999999999999988776667777776666665555443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-45  Score=323.23  Aligned_cols=210  Identities=33%  Similarity=0.590  Sum_probs=180.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-h-----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-R-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. .     ...+|+++++.++||||+.++++|     +....+|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEE
Confidence            6888999999999999999999999999999885332 2     246899999999999999999999     5566699


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|.|||.|+|..++..    ++.++++.++.+..++++||.|||+. +|+|||+||.|||++.++ .+|+||||+++...
T Consensus        78 vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGG-TLKLCDFGLARAMS  151 (808)
T ss_pred             EEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCC-ceeechhhhhhhcc
Confidence            9999999999888887    58999999999999999999999998 999999999999999887 89999999998765


Q ss_pred             cCCCc-ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccc
Q 022520          220 KGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL  291 (296)
Q Consensus       220 ~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  291 (296)
                      ..... ....|||.|||||...+.+ |+..+|+|||||++||+++|++||...+    +.++++.+...+...
T Consensus       152 ~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~d~v~~  219 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVKSILKDPVKP  219 (808)
T ss_pred             cCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHHHHhcCCCCC
Confidence            54432 3457899999999997655 9999999999999999999999998764    444445554444433

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-45  Score=325.20  Aligned_cols=222  Identities=28%  Similarity=0.447  Sum_probs=193.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (296)
                      ...++|.+.++||+|.||+|+++..+.+++.+|||.++++.       .....|..|+... +||.++.++.+|     +
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q  439 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q  439 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence            34468999999999999999999999999999999886543       2334577777766 599999999999     6


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...++++||||+.|+.   +.. ....+.|++..++.|+..++.||.|||++ ||||||||.+|||+|.+| .+||+|||
T Consensus       440 T~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eG-h~kiADFG  513 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEG-HVKIADFG  513 (694)
T ss_pred             cCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccC-cEEecccc
Confidence            6667999999999874   222 22357899999999999999999999999 999999999999999999 79999999


Q ss_pred             ceeeec-cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          214 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       214 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      +++... .+....+..|||.|||||++.+.. |+...|.|||||+||||+.|.+||.+++..+....|+..-...|+-+|
T Consensus       514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls  592 (694)
T KOG0694|consen  514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS  592 (694)
T ss_pred             cccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence            998764 555677889999999999997655 999999999999999999999999999988888999998888888888


Q ss_pred             ccc
Q 022520          293 IKA  295 (296)
Q Consensus       293 ~~~  295 (296)
                      .+|
T Consensus       593 ~ea  595 (694)
T KOG0694|consen  593 KEA  595 (694)
T ss_pred             HHH
Confidence            766

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=310.47  Aligned_cols=217  Identities=30%  Similarity=0.454  Sum_probs=177.0

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------------hhhHHHHHHHHhcCCCCce
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------RYKNRELQTMRLLDHPNVV  121 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~~E~~~l~~l~h~niv  121 (296)
                      ..+...+|++.+.||+|.||.|-+|++..+++.||||++....                  ..-.+|+.+|++|.|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3345568999999999999999999999999999999884221                  1224799999999999999


Q ss_pred             ecceeeeeccCCCceEEEEEEeccccc-HHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceE
Q 022520          122 SLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (296)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIl  199 (296)
                      +++++.   +......+|+|+|||..+ +.+    ... ..+ +.+.+++.++++++.||+|||.+ |||||||||+|+|
T Consensus       172 ~LiEvL---DDP~s~~~YlVley~s~G~v~w----~p~-d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLL  242 (576)
T KOG0585|consen  172 KLIEVL---DDPESDKLYLVLEYCSKGEVKW----CPP-DKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLL  242 (576)
T ss_pred             EEEEee---cCcccCceEEEEEeccCCcccc----CCC-CcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheE
Confidence            999987   334445689999999843 221    111 244 89999999999999999999999 9999999999999


Q ss_pred             EcCCCCcEEEeeecceeeeccC------CCcccccccccccCCccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          200 VNPHTHQLKLCDFGSAKVLVKG------EPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       200 i~~~~~~ikl~Dfg~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ++.++ ++||+|||.+.....+      ......+|||.|+|||.+.+.   ...+.+.||||+||+||.|+.|+.||.+
T Consensus       243 l~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  243 LSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99987 8999999998765222      122457899999999998762   3357899999999999999999999999


Q ss_pred             CChHHHHHHHHHhhcC
Q 022520          271 ESGVDQLVEIIKVILH  286 (296)
Q Consensus       271 ~~~~~~~~~~~~~~~~  286 (296)
                      ....+....|++.-..
T Consensus       322 ~~~~~l~~KIvn~pL~  337 (576)
T KOG0585|consen  322 DFELELFDKIVNDPLE  337 (576)
T ss_pred             chHHHHHHHHhcCccc
Confidence            8877777777764433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=310.30  Aligned_cols=217  Identities=30%  Similarity=0.472  Sum_probs=181.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcE-EEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEA-VAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~-vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ...+.+.||.|+||+||+|.+  .|.. ||+|++...      ...+.+|+.+|.+++|||||++++++.....    ..
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence            455667799999999999998  4555 999988543      2367789999999999999999999854331    47


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC-ceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ++||||+++ +|.+++...  ....++...+..++.||++||.|||++ + ||||||||+|||++.+..++||+|||+++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            899999994 666666553  357899999999999999999999998 9 99999999999999875479999999998


Q ss_pred             eeccC-CCcccccccccccCCccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccc
Q 022520          217 VLVKG-EPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL  291 (296)
Q Consensus       217 ~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  291 (296)
                      ..... .......||+.|||||++.+ ...|+.++||||||+++|||+||+.||.+....+....++....+++++.
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            76554 23344789999999999974 34599999999999999999999999999998777778877788887765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=305.96  Aligned_cols=219  Identities=33%  Similarity=0.533  Sum_probs=179.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..+|...+.||+|+||.||++.+..+|...|+|.....    .+.+.+|+.+|++++|||||++++.......   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            34689999999999999999999988999999988654    3446899999999999999999886422211   4588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC-CCCcEEEeeecceee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~-~~~~ikl~Dfg~~~~  217 (296)
                      ++|||++ |+|.+++....   .++++..++++.+|++.||+|||++ ||+||||||+|||++. ++ .+||+|||++..
T Consensus        93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNG-DVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCC-eEEeccCccccc
Confidence            9999998 47777777642   2799999999999999999999999 9999999999999999 45 899999999887


Q ss_pred             ecc----CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhhcCCCcc
Q 022520          218 LVK----GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       218 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~  290 (296)
                      ...    ........||+.|||||++.......+++|||||||++.||+||++||.. ....+.+..+...-..|+++
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip  245 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIP  245 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCC
Confidence            653    22244678999999999996433334599999999999999999999998 55556666666555445443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=299.24  Aligned_cols=217  Identities=29%  Similarity=0.508  Sum_probs=184.5

Q ss_pred             CCCCCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeec
Q 022520           56 GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFST  130 (296)
Q Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~  130 (296)
                      .....+.....|++..+||.|..++||+|+++..++.||||++.-.     .+.+.+|+..++.++||||++++.+|...
T Consensus        17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            3455677778899999999999999999999999999999999532     34567899999999999999999999544


Q ss_pred             cCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEE
Q 022520          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                      .     .+|+||+||. |++.+.++..+.  ..+.+..+..+++++++||.|||.+ |-||||||+.||||+.+| .|||
T Consensus        97 ~-----~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG-~VkL  167 (516)
T KOG0582|consen   97 S-----ELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDG-TVKL  167 (516)
T ss_pred             c-----eeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCC-cEEE
Confidence            4     3999999998 688899988874  5599999999999999999999999 999999999999999998 8999


Q ss_pred             eeecceeeeccCCC-c----ccccccccccCCcccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          210 CDFGSAKVLVKGEP-N----ISYICSRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       210 ~Dfg~~~~~~~~~~-~----~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      +|||.+-.+..... .    ...+||++|||||+++ ....|+.|+||||||++..||++|..||....+...+..-+
T Consensus       168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL  245 (516)
T KOG0582|consen  168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL  245 (516)
T ss_pred             cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            99997654433221 1    4458999999999954 34459999999999999999999999999988766654433

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.2e-42  Score=296.35  Aligned_cols=213  Identities=32%  Similarity=0.631  Sum_probs=180.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|++.+.||.|+||.||+|++..++..||+|.+...     .....+|+.+++.++||||+++++++     ....+.+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            4699999999999999999999999999999988532     12345799999999999999999988     3444688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+++++.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        80 lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~  154 (288)
T cd07871          80 LVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAKS  154 (288)
T ss_pred             EEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence            99999999888877643   34678899999999999999999998 999999999999999887 89999999987643


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP  223 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            222 22345679999999998766668999999999999999999999999988888887777766544

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-42  Score=307.20  Aligned_cols=205  Identities=28%  Similarity=0.471  Sum_probs=172.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++|+||+++++.+     .+...+
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            6999999999999999999999999999999885421       2345789999999999999999888     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+.+..    ..++++..++.++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            999999985 66666654    36799999999999999999999998 999999999999999887 899999999865


Q ss_pred             eccCC------------------------------------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHH
Q 022520          218 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (296)
Q Consensus       218 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  261 (296)
                      .....                                    ......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHH
Confidence            42210                                    012346899999999986654 89999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHH
Q 022520          262 LLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       262 ~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++|+.||.+.+..+.+..+.+
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~  250 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMN  250 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHc
Confidence            999999998887776666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=308.05  Aligned_cols=213  Identities=28%  Similarity=0.480  Sum_probs=183.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .|...++||+|+.|.||.|+...+++.||+|++...    .....+|+.+|+..+|+|||.+++.|...+.     +|+|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWVV  348 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWVV  348 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEEE
Confidence            588899999999999999999999999999998533    3344589999999999999999999965533     8999


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||++| +|.+.+..     -.+++.++..++++++.||+|||.+ ||+|||||.+|||++.++ .+||+|||+|..+..
T Consensus       349 MEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCC-cEEEeeeeeeecccc
Confidence            999996 55555543     4589999999999999999999999 999999999999999988 799999999877766


Q ss_pred             CC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      .. ...+.+|||+|||||+.... .|+++.||||||++++||+-|.+||-.++....+..|.. .+.+++...
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~  492 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNP  492 (550)
T ss_pred             ccCccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCc
Confidence            55 45678999999999999554 499999999999999999999999999888888877766 556665443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.6e-42  Score=301.03  Aligned_cols=214  Identities=42%  Similarity=0.740  Sum_probs=177.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|++..++..||+|.+...      .....+|+++++.++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            589999999999999999999999999999988532      12345799999999999999999988655444445688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+++++...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999988887765    35789999999999999999999998 999999999999999887 89999999987543


Q ss_pred             cCCC----cccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          220 KGEP----NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       220 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ....    .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            2221    1234689999999998542 4588999999999999999999999998876665555444433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-43  Score=296.66  Aligned_cols=216  Identities=25%  Similarity=0.443  Sum_probs=192.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      +...+|++.+.||+|.||.|-+|+....|+.||||.+..+       .-...+|++||..|+||||+.+|++|     ++
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN  124 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN  124 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence            3445899999999999999999999899999999988543       22345899999999999999999999     44


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..-+.|||||.. |.|.+++...    +.+++.+++.+++||.+|+.|+|.+ +++|||||.+|||+|.++ .+||+|||
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~-NiKIADFG  198 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNN-NIKIADFG  198 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCC-Ceeeeccc
Confidence            445889999987 6888888874    7899999999999999999999999 999999999999999988 79999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ++..+..+....+++|+|.|.+||+..|.++-++..|-|||||+||.|+.|..||++.+-...+.+|.+.....|
T Consensus       199 LSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP  273 (668)
T KOG0611|consen  199 LSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP  273 (668)
T ss_pred             hhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC
Confidence            999888888888999999999999999988888999999999999999999999999987777788877666554

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=294.39  Aligned_cols=204  Identities=27%  Similarity=0.436  Sum_probs=172.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++.+     .+....
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            699999999999999999999999999999988532       12345799999999999999998877     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            999999984 67776654    36789999999999999999999998 999999999999999877 899999999876


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ....  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus       151 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~  213 (291)
T cd05612         151 LRDR--TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG  213 (291)
T ss_pred             ccCC--cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            5332  23456899999999986544 789999999999999999999999987766555555543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.2e-41  Score=292.86  Aligned_cols=210  Identities=34%  Similarity=0.606  Sum_probs=174.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+.+++.++||||+++++++.     +....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeEE
Confidence            57999999999999999999999999999999885321     23457999999999999999999883     344589


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+++++.+.+...   ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus        80 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  154 (303)
T cd07869          80 LVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTG-ELKLADFGLARAKS  154 (303)
T ss_pred             EEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECCCCcceecc
Confidence            99999999988877653   35688999999999999999999998 999999999999999877 79999999987543


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhh
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVI  284 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~  284 (296)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+..+ .+.+..+....
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL  221 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence            221 223456789999999987666688999999999999999999999987654 34445554433

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-42  Score=303.47  Aligned_cols=205  Identities=31%  Similarity=0.518  Sum_probs=171.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++|+||++++++|     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            6999999999999999999999999999999986421       2234799999999999999999988     445568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+.+..    ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            999999985 66666654    35799999999999999999999998 999999999999999887 899999999875


Q ss_pred             eccCCC---------------------------------------cccccccccccCCccccCCCCCCCchhHHHHHHHH
Q 022520          218 LVKGEP---------------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  258 (296)
Q Consensus       218 ~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il  258 (296)
                      ......                                       .....||+.|+|||++.+.. ++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHH
Confidence            422110                                       01235899999999986544 89999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHH
Q 022520          259 AELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       259 ~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      |+|++|.+||.+.+..+.+..+.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~  253 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIIN  253 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHc
Confidence            999999999998877666655554

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-41  Score=297.96  Aligned_cols=205  Identities=29%  Similarity=0.457  Sum_probs=173.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++.     +..
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence            457999999999999999999999999999999885321       23457999999999999999999883     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+.+ +|.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            58999999985 66666654    36789999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  229 (329)
T PTZ00263        166 KKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA  229 (329)
T ss_pred             eEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence            765332  23457899999999986554 78999999999999999999999988776555555544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.5e-41  Score=290.19  Aligned_cols=200  Identities=26%  Similarity=0.399  Sum_probs=167.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+++.+++     .+....
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            3888999999999999999999999999999875321       1234799999999999999998887     334458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|...+....  ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRG-HIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeCCCcEE
Confidence            899999985 5555554321  34689999999999999999999998 999999999999999877 799999999987


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+...
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~  208 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV  208 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcch
Confidence            6444444456789999999999654 48999999999999999999999998765433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-42  Score=305.17  Aligned_cols=205  Identities=30%  Similarity=0.505  Sum_probs=170.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|.+.+.||+|+||.||++++..+++.||+|++....       ....+|+++++.++||||++++++|     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            6999999999999999999999999999999885321       2345799999999999999999988     444568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||++ ++|.+.+..    ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .++|+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            99999997 467666654    36789999999999999999999998 999999999999999877 899999999863


Q ss_pred             eccCCC------------------------------------------------cccccccccccCCccccCCCCCCCch
Q 022520          218 LVKGEP------------------------------------------------NISYICSRYYRAPELIFGATEYTAAI  249 (296)
Q Consensus       218 ~~~~~~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~  249 (296)
                      ......                                                .....||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCce
Confidence            211000                                                01246899999999986544 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       250 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      |||||||++|||++|.+||.+.+..+.+..+..
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  262 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIIN  262 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence            999999999999999999998776666655554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4e-41  Score=290.29  Aligned_cols=216  Identities=36%  Similarity=0.612  Sum_probs=178.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcC-CCcEEEEEEEeecc------hhhHHHHHHHHhc---CCCCceecceeeeeccCCCc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~  135 (296)
                      +|++.+.||+|+||.||+|++.. ++..||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999864 56889999885321      1234677777665   69999999998754433344


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..+++||||+++++..++....  ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5688999999998888876542  34588999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      .............+|+.|+|||.+.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~  227 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  227 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            8665444444567899999999986544 889999999999999999999999999888888888776543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-42  Score=274.95  Aligned_cols=224  Identities=29%  Similarity=0.426  Sum_probs=191.7

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ....++|.+.+.||+|-||.||+|+.+.++..||+|++...       ..+..+|+++...|+||||+++|++|.+.   
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~---   94 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS---   94 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc---
Confidence            34456899999999999999999999999999999988533       34456899999999999999999999544   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                        ..+|+++||.+ |.+...+....  ..++.+.....+++|++.||.|+|.. ++|||||||+|+|++..+ .+||+||
T Consensus        95 --~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~-~lkiAdf  168 (281)
T KOG0580|consen   95 --KRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAG-ELKIADF  168 (281)
T ss_pred             --ceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCC-CeeccCC
Confidence              44899999988 67777777433  46788888999999999999999998 999999999999999988 8999999


Q ss_pred             cceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       213 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      |.+...+ .....+.+||..|.+||...+.. ++...|+|++|++.||++.|.+||...+..+.++.|.+.-...|...|
T Consensus       169 GwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is  246 (281)
T KOG0580|consen  169 GWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTIS  246 (281)
T ss_pred             CceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccC
Confidence            9986544 44566788999999999986555 899999999999999999999999999988888999888777775555


Q ss_pred             ccc
Q 022520          293 IKA  295 (296)
Q Consensus       293 ~~~  295 (296)
                      -.|
T Consensus       247 ~~a  249 (281)
T KOG0580|consen  247 GGA  249 (281)
T ss_pred             hhH
Confidence            444

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-41  Score=304.20  Aligned_cols=205  Identities=28%  Similarity=0.470  Sum_probs=170.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|++++.||+|+||.||+|++..+++.||+|++....       ....+|+++++.++|+||+++++++.     +...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            5899999999999999999999999999999885432       23457999999999999999999883     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++|||||++ +|...+..    ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            999999985 66666654    35789999999999999999999998 999999999999999887 899999999743


Q ss_pred             eccC------------------------------------------------CCcccccccccccCCccccCCCCCCCch
Q 022520          218 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAI  249 (296)
Q Consensus       218 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  249 (296)
                      ....                                                .......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCee
Confidence            2100                                                0011246899999999986554 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       250 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      |||||||++|||++|++||.+.+..+....+..
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~  262 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN  262 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            999999999999999999998877666655554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-41  Score=301.56  Aligned_cols=210  Identities=29%  Similarity=0.480  Sum_probs=175.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.+.||+|+||.||++++..+++.+|+|.+...       .....+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            345799999999999999999999999999999988531       22345799999999999999999988     444


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .++++||||+++ +|.+++..     ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~-~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEEeccc
Confidence            568999999985 67666643     4588999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCCC--cccccccccccCCccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          215 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       215 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      +........  .....||+.|+|||++.+..   .++.++|||||||++|+|++|+.||.+.+....+.++....
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~  263 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK  263 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            986533221  23456899999999985432   37889999999999999999999999888777777776543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-41  Score=297.49  Aligned_cols=208  Identities=30%  Similarity=0.455  Sum_probs=173.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCC-cEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|.+.+.||+|+||.||+|.+..++ ..||+|.+...       .....+|+.+++.++||||+++++++     .+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence            4457999999999999999999876554 68999988532       12334799999999999999999988     33


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEecCC
Confidence            4458999999974 67666654    36789999999999999999999998 999999999999999877 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+....
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~  244 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI  244 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence            9976532  234567899999999986544 7899999999999999999999999887766666665544

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.6e-41  Score=301.58  Aligned_cols=204  Identities=28%  Similarity=0.476  Sum_probs=168.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|.+++.||+|+||+||+|++..+++.||+|++....       ....+|+++++.++|+||+++++++.     +...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            5899999999999999999999999999999885421       23457999999999999999999883     44458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            999999985 66666654    36789999999999999999999998 999999999999999877 899999998753


Q ss_pred             eccCC------------------------------------------------CcccccccccccCCccccCCCCCCCch
Q 022520          218 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTAAI  249 (296)
Q Consensus       218 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  249 (296)
                      .....                                                ......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCcc
Confidence            21000                                                012346899999999986544 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       250 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      |||||||++|||++|+.||...+..+....+.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~  261 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVI  261 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            99999999999999999999877655555544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.6e-41  Score=296.09  Aligned_cols=199  Identities=26%  Similarity=0.421  Sum_probs=164.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     ......++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999886421       2234689999999999999998887     34445899999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-C
Q 022520          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  221 (296)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-~  221 (296)
                      |+++ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9985 55555544    46789999999999999999999998 999999999999999887 799999999875322 2


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~  208 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  208 (323)
T ss_pred             CcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            2233456899999999986544 8999999999999999999999998876554444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-40  Score=286.72  Aligned_cols=209  Identities=44%  Similarity=0.768  Sum_probs=175.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++|+||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            6999999999999999999999999999999885431      2345799999999999999999988     3444589


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||++++++..+...   ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            99999998877766543   35789999999999999999999998 999999999999999877 89999999987653


Q ss_pred             cCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       220 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ...  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+..+
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  218 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG  218 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhC
Confidence            322  122356899999999986655 89999999999999999999999998877776666655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-40  Score=295.77  Aligned_cols=215  Identities=31%  Similarity=0.555  Sum_probs=177.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      ..+|++.+.||+|+||.||++.+..++..||+|.+...      .....+|+.+++.++||||+++++++..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            35799999999999999999999999999999988532      2234479999999999999999998754332 1223


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++||||+++++...+.      ..++...+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++.
T Consensus       100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEecCCCcc
Confidence            478999999998777653      3478888999999999999999998 999999999999999887 89999999987


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            654433344567899999999986544 8999999999999999999999999887766666665554443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.4e-41  Score=302.29  Aligned_cols=204  Identities=27%  Similarity=0.463  Sum_probs=168.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+++++.++|+||+++++.|     .+...+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            599999999999999999999999999999988532       22345799999999999999999888     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            999999985 67776654    35688999999999999999999998 999999999999999887 899999999742


Q ss_pred             eccC--------------------------------------------CCcccccccccccCCccccCCCCCCCchhHHH
Q 022520          218 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWS  253 (296)
Q Consensus       218 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS  253 (296)
                      ....                                            .......||+.|+|||++.+.. ++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeee
Confidence            2100                                            0011246899999999986544 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          254 AGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       254 lG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      |||++|+|++|+.||.+.+..+....+.
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~  257 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVI  257 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHh
Confidence            9999999999999999887655554443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=279.63  Aligned_cols=216  Identities=30%  Similarity=0.433  Sum_probs=184.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEe------ecchhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..++|.+.++||+|.|+.|+++.+..+|+.+|+|++.      .+.+.+++|+.|-+.|+|||||++.+.+     ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence            4467999999999999999999999999999999773      2345567899999999999999999888     6667


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC--CCCcEEEeeec
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~--~~~~ikl~Dfg  213 (296)
                      +.++|+|++.| .+...+-..    .-+++..+-.+++||+.+|+|+|.+ +|+|||+||+|+++-+  ++.-+||+|||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccc
Confidence            78999999996 444333332    3467888999999999999999999 9999999999999944  33369999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      ++..+.++..-...+|||.|||||++...+ |+..+|||+.||+||-|+.|++||.+.+..+.+++|.+.-...+.
T Consensus       159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS  233 (355)
T ss_pred             eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC
Confidence            999887666566788999999999997666 999999999999999999999999999888888898887665544

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.6e-41  Score=298.20  Aligned_cols=210  Identities=29%  Similarity=0.475  Sum_probs=174.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....+|++.+.||+|+||.||+|++..+++.+|+|.+...       .....+|..+++.++||||+++++++     .+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD  114 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence            3446899999999999999999999999999999988532       12234789999999999999999888     34


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..+.++||||+++ +|..++..     ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .++|+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~-~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCC-CEEEEeCC
Confidence            4568999999985 66666543     4588999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCC--cccccccccccCCccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          214 SAKVLVKGEP--NISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       214 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ++........  .....||+.|+|||++.+.   ..++.++|||||||++|+|++|++||.+.+.......+...
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  262 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH  262 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            9986543221  2345689999999998543   23788999999999999999999999988876666666653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-42  Score=299.32  Aligned_cols=213  Identities=29%  Similarity=0.495  Sum_probs=186.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++|..++++|+|+||.+++++++.++..+++|.+.-.      +....+|+.+++++.|||||.+.++|+    .+..+.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            4799999999999999999999999999999988432      223357999999999999999999994    344458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +|||+||+| ++.+.+....  ..-|+++.+..|+.|++.|+.|||++ .|+|||||+.|||+..+. .|+|+|||+++.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999996 6666666654  56799999999999999999999988 999999999999999988 689999999998


Q ss_pred             eccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       218 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ..... ...+.+||+.||+||++.+.+ |+.|+|||||||++|||++-+++|.+.+....+.+|.+....
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~  224 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS  224 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC
Confidence            87776 567789999999999996655 999999999999999999999999999988888888887733

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-41  Score=293.79  Aligned_cols=202  Identities=32%  Similarity=0.539  Sum_probs=171.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+++++.++||||+++++++     .+..+.
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999885331       2334789999999999999999888     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            999999985 67666654    36789999999999999999999998 999999999999999887 899999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~  211 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK  211 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence            433  23455789999999998665 48999999999999999999999999877655554444

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-41  Score=284.95  Aligned_cols=218  Identities=27%  Similarity=0.432  Sum_probs=181.5

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ......|++++.||.|.-|+||+++...++..+|+|++....       ...+.|.+||+.++||.++.+|+.|     +
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----e  147 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----E  147 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----e
Confidence            334457999999999999999999999999999999985321       2234689999999999999999999     6


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...+.|++||||+|+-+..+.+. +.++.+++..++.++.+++.||+|||.. |||+|||||+||||.++| .|.|+||.
T Consensus       148 t~~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredG-HIMLsDFD  224 (459)
T KOG0610|consen  148 TDKYSCLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDG-HIMLSDFD  224 (459)
T ss_pred             ccceeEEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCC-cEEeeecc
Confidence            67779999999997544444333 3368899999999999999999999998 999999999999999998 69999999


Q ss_pred             ceeeecc---------------------------------C-C-----------------------CcccccccccccCC
Q 022520          214 SAKVLVK---------------------------------G-E-----------------------PNISYICSRYYRAP  236 (296)
Q Consensus       214 ~~~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aP  236 (296)
                      ++....-                                 . .                       .....+||-.|.||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            8644200                                 0 0                       01235678999999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       237 E~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      |++.|.. .+.+.|+|+||+++|||+.|.-||.+.+..+++.+|+..-...
T Consensus       305 EvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F  354 (459)
T KOG0610|consen  305 EVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF  354 (459)
T ss_pred             eeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC
Confidence            9998776 7999999999999999999999999999999999888755443

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-40  Score=297.06  Aligned_cols=208  Identities=27%  Similarity=0.462  Sum_probs=173.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            345899999999999999999999999999999988532       12245789999999999999999887     445


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .++++||||+++ +|..++..     ..+++.++..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~~kL~DfG~  188 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence            568999999985 66666543     4688999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCC--CcccccccccccCCccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      +.......  ......||+.|+|||++.+..   .++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  261 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD  261 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence            87654322  123456899999999985432   378899999999999999999999998877666666654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.2e-40  Score=284.26  Aligned_cols=215  Identities=33%  Similarity=0.572  Sum_probs=178.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhc---CCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999885321      1234677777665   799999999988654444456


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..+++|||+++++..++....  ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999998887776532  34589999999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ............+|..|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+...+.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  224 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence            664443344556799999999986544 89999999999999999999999998887777777766553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-40  Score=296.54  Aligned_cols=211  Identities=25%  Similarity=0.330  Sum_probs=173.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|...  .....+|+++++.++||||++++++|..     ....++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEe
Confidence            347999999999999999999999999999999653  3345689999999999999999998843     344789999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC-
Q 022520          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  222 (296)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~-  222 (296)
                      ++.+++...+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++....... 
T Consensus       164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence            999888877765    35688999999999999999999998 999999999999999877 79999999986532221 


Q ss_pred             -CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHhhcCCC
Q 022520          223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-------GVDQLVEIIKVILHTE  288 (296)
Q Consensus       223 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~  288 (296)
                       ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+       ....+..+.+..+.++
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             cccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence             223457899999999986544 8999999999999999999997765432       2345555655554433

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-40  Score=296.22  Aligned_cols=216  Identities=37%  Similarity=0.605  Sum_probs=179.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+++++.++|+||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            378899999999999999999999999999987532      12345799999999999999999988544322223578


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+.+++...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999888777654    46789999999999999999999998 999999999999999887 89999999987653


Q ss_pred             cCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       220 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ...  ......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~  224 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP  224 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            322  12234578899999998776668999999999999999999999999988877777776655544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-40  Score=291.26  Aligned_cols=200  Identities=26%  Similarity=0.401  Sum_probs=164.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +.||+|+||.||++++..++..||+|.+....       ....+|+.+++.++||||++++++|.     ....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46899999999999999999999999885421       12346899999999999999998883     3445899999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC-
Q 022520          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  221 (296)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~-  221 (296)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++...... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9985 55555543    46789999999999999999999998 999999999999999887 8999999998653222 


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~  209 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM  209 (323)
T ss_pred             CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            2223456899999999986544 89999999999999999999999988776555555543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.6e-41  Score=297.73  Aligned_cols=205  Identities=28%  Similarity=0.457  Sum_probs=171.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.++..++|+||+++++.+     .+...+
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            689999999999999999999999999999988532       12334689999999999999999888     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            999999985 66666654    36789999999999999999999998 999999999999999887 899999999864


Q ss_pred             eccCC------------------------------------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHH
Q 022520          218 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (296)
Q Consensus       218 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  261 (296)
                      .....                                    ......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeec
Confidence            42210                                    011346899999999986554 89999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHH
Q 022520          262 LLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       262 ~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++|++||.+.+..+.+..+..
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~  250 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMN  250 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHc
Confidence            999999998877666665554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5e-40  Score=286.15  Aligned_cols=213  Identities=33%  Similarity=0.634  Sum_probs=178.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||+++++++.     .....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            46999999999999999999999999999999885322     23457999999999999999999884     334488


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+++++...+...   ...++...+..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            99999999888776653   35578899999999999999999998 999999999999999877 89999999987543


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ... ......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  224 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP  224 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            322 22334678999999998766668999999999999999999999999988777777777665543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-40  Score=289.35  Aligned_cols=206  Identities=29%  Similarity=0.461  Sum_probs=167.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCC-CceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  137 (296)
                      +|++.+.||+|+||.||+|++..+++.||+|++....       .....|.+++..++|+ +|+++++++.     ....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            4899999999999999999999999999999885421       2234688888888765 5777877773     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8899999985 66666544    35788999999999999999999998 999999999999999887 79999999986


Q ss_pred             eec-cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          217 VLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       217 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            432 222233456899999999986654 789999999999999999999999988766666655543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=295.17  Aligned_cols=205  Identities=31%  Similarity=0.521  Sum_probs=174.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|++++..++|+||+++++++     .+..+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            699999999999999999999999999999998532       12345799999999999999999887     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+.+...    ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            999999974 777766653    6789999999999999999999998 999999999999999887 899999999876


Q ss_pred             eccCC------------------------------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022520          218 LVKGE------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  267 (296)
Q Consensus       218 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p  267 (296)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54332                              12345689999999998665 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHH
Q 022520          268 FPGESGVDQLVEIIK  282 (296)
Q Consensus       268 f~~~~~~~~~~~~~~  282 (296)
                      |...+..+....+..
T Consensus       230 f~~~~~~~~~~~i~~  244 (350)
T cd05573         230 FYSDTLQETYNKIIN  244 (350)
T ss_pred             CCCCCHHHHHHHHhc
Confidence            998876666666555

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-40  Score=289.69  Aligned_cols=207  Identities=29%  Similarity=0.437  Sum_probs=168.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHHHHHhc-CCCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      +|.+.+.||+|+||.||+|++..+++.||+|.+.....       ....|..++..+ .|++|+++++++     .....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            48899999999999999999999999999998864321       123466677666 578899998887     33445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++||||+++ +|...+..    ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8899999984 66655544    36789999999999999999999998 999999999999999887 89999999987


Q ss_pred             eecc-CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          217 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       217 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      .... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            5432 22233456899999999986544 8999999999999999999999999887766666655433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=289.63  Aligned_cols=198  Identities=30%  Similarity=0.525  Sum_probs=164.1

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999885321       2234689999999999999998887     3344588999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC-C
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-P  223 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~-~  223 (296)
                      ++ +|...+..    ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||++....... .
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 66666654    36789999999999999999999998 999999999999999887 89999999987532222 2


Q ss_pred             cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       224 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~  207 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ  207 (312)
T ss_pred             cccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence            23456899999999986544 89999999999999999999999998776555555444

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=288.99  Aligned_cols=207  Identities=28%  Similarity=0.448  Sum_probs=171.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||++++..+++.||+|++...       ...+.+|..+++.++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            699999999999999999999999999999988531       12345788999999999999999988     344568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||++ ++|..++...   ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            99999997 4777766542   35789999999999999999999998 999999999999999887 899999999876


Q ss_pred             eccCCCc--ccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .......  ....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence            5433221  22468999999999853    23478899999999999999999999988776665555543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.8e-40  Score=292.14  Aligned_cols=215  Identities=31%  Similarity=0.556  Sum_probs=179.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            35799999999999999999999999999999988532      1234479999999999999999988743322 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++||||+++++...+.      ..++...+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+++
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence            578999999998877664      2477888999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  244 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  244 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            654443344567899999999986544 8999999999999999999999999988877777776655543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-40  Score=290.52  Aligned_cols=198  Identities=25%  Similarity=0.412  Sum_probs=162.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +.||+|+||.||++++..+++.||+|++....       ....+|+.+++.++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            46899999999999999999999999885421       2334688999999999999998887     34445899999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC-
Q 022520          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  221 (296)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~-  221 (296)
                      |+++ ++...+..    ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9985 55555543    36789999999999999999999998 999999999999999877 8999999998753222 


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  280 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  280 (296)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~  207 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (328)
T ss_pred             cccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence            2223456899999999986544 899999999999999999999999887655444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=289.50  Aligned_cols=209  Identities=34%  Similarity=0.536  Sum_probs=181.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcC-CCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  135 (296)
                      ...|.+.+.||.|.||.||+++++.+|+.+|+|.+....       ....+|+.+|+.+. |||||.+++.|     +..
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence            347999999999999999999999999999999985432       24568999999998 99999999999     445


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC---CcEEEee
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCD  211 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~---~~ikl~D  211 (296)
                      ..+++|||+|.| .|.+.+...     .+++..+..+++|++.++.|||+. ||+||||||+|+|+....   ..++++|
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEee
Confidence            568999999995 666666654     399999999999999999999998 999999999999996542   2799999


Q ss_pred             ecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ||++.....+......+||+.|+|||++... .|+..+||||+||++|.|+.|.+||.+.+......++.+.-
T Consensus       183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~  254 (382)
T KOG0032|consen  183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD  254 (382)
T ss_pred             CCCceEccCCceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence            9999988775566778999999999999544 49999999999999999999999999998777777666653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=294.68  Aligned_cols=207  Identities=27%  Similarity=0.394  Sum_probs=173.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      .+++.+.||+|-||.||.|.+... ..||+|.++..   ...+.+|+++|++|+|+|||++++++....     -++|||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence            467788999999999999998433 37899988653   345568999999999999999999984433     388999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      |||+ |+|++++...  ....+.......++.|||+|++||+++ ++|||||...|||++.+. .+||+|||+++...++
T Consensus       281 E~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence            9999 7899999873  357788999999999999999999999 999999999999999888 8999999999954443


Q ss_pred             CCcccc--cccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          222 EPNISY--ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       222 ~~~~~~--~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ......  ..+..|.|||.+.... ++.+||||||||+||||+| |+.||.+.+..+.+..+.+.
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G  420 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG  420 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence            322222  2266799999996544 9999999999999999998 99999999988877776654

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5e-40  Score=291.57  Aligned_cols=214  Identities=31%  Similarity=0.547  Sum_probs=177.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      .++|.+.+.||+|+||.||++.+..+++.||+|.+....      ....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            357999999999999999999999999999999885321      233479999999999999999998754332 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++||||+++++...+.      ..++...+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+++
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~-~~kl~Dfg~~~  167 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  167 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence            578999999998777654      3478888999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            654443344567899999999986544 899999999999999999999999988876766666555443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.1e-40  Score=289.40  Aligned_cols=208  Identities=27%  Similarity=0.421  Sum_probs=172.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|.+.+.||+|+||.||++++..+++.||+|.+...       .....+|..++..++|+||+++++++     .+..+.
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            699999999999999999999999999999988532       12244688899999999999999888     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+.+ +|..++...   ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            999999984 677776543   35789999999999999999999998 999999999999999877 799999999876


Q ss_pred             eccCCCc--ccccccccccCCccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          218 LVKGEPN--ISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       218 ~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .......  ....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence            5433222  234689999999998542    34788999999999999999999999987766666666543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.9e-40  Score=288.12  Aligned_cols=204  Identities=27%  Similarity=0.443  Sum_probs=165.3

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHH---HhcCCCCceecceeeeeccCCCce
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|..++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            778999999999999999999999999999986331       1223455444   4668999999999883     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|...+.     ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            58999999996 4444332     35789999999999999999999998 999999999999999887 8999999998


Q ss_pred             eeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          216 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       216 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ...... .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~  216 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND  216 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            653222 223345689999999998654 4899999999999999999999999988766666555543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.8e-39  Score=295.69  Aligned_cols=215  Identities=23%  Similarity=0.403  Sum_probs=174.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCC------CceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~  134 (296)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.++|.      ++++++++|..    +
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            467999999999999999999999999999999885422   2334678888777554      47777776632    2


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC---------
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---------  205 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---------  205 (296)
                      ..++++||+++++++.+.+..    ...+++..+..++.||+.||+|||++.||+||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            345789999999888887765    3678999999999999999999997339999999999999986542         


Q ss_pred             ------cEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022520          206 ------QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (296)
Q Consensus       206 ------~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  279 (296)
                            .+||+|||.+...  ........||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  4999999987542  22234567899999999997654 89999999999999999999999999888888887


Q ss_pred             HHHhhcCCCc
Q 022520          280 IIKVILHTEI  289 (296)
Q Consensus       280 ~~~~~~~~~~  289 (296)
                      +.+.++..+.
T Consensus       357 i~~~~g~~p~  366 (467)
T PTZ00284        357 MEKTLGRLPS  366 (467)
T ss_pred             HHHHcCCCCH
Confidence            7777665543

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=278.71  Aligned_cols=206  Identities=25%  Similarity=0.370  Sum_probs=169.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++|+||+++++++     ......
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4889999999999999999999899999999885421       2234699999999999999998887     334458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|...+...  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            999999985 555555432  135689999999999999999999998 999999999999999877 799999999877


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ...........|++.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~  214 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE  214 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH
Confidence            54443334457899999999986544 8899999999999999999999999876544433333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-39  Score=285.02  Aligned_cols=200  Identities=32%  Similarity=0.517  Sum_probs=162.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHh-cCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|.+....       .....|..++.. .+||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999886432       112345566654 4899999999887     3344589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99985 66555544    36789999999999999999999998 999999999999999887 8999999998764332


Q ss_pred             C-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      . ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~  210 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN  210 (316)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            2 233456899999999986554 89999999999999999999999998876555555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-39  Score=286.98  Aligned_cols=208  Identities=26%  Similarity=0.425  Sum_probs=172.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||++++..+++.+|+|.+....       ....+|..++..++|+||+++++++     .+...+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            6999999999999999999999999999999885321       1245688899999999999998888     344458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||++ ++|.+++...   ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            99999997 5777777643   35789999999999999999999998 999999999999999877 799999999876


Q ss_pred             eccCCCc--ccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          218 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       218 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .......  ....||+.|+|||++..    ...++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence            5333221  23468999999999852    344789999999999999999999999988776766666543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=289.73  Aligned_cols=222  Identities=32%  Similarity=0.466  Sum_probs=194.3

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      .+..+-|.+.+.||+|.|+.|-+|++..+|+.||||++...      ...+.+|+..|+.++|||||++|++.     ..
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DT   88 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DT   88 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cc
Confidence            34455799999999999999999999999999999998432      23445899999999999999999987     33


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..-+|+|+|.-+ |+|.+++..+   ...+.++.+++++.||+.|+.|+|+. .++||||||+|+.+.+..+-+||+|||
T Consensus        89 QTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeecc
Confidence            344899999977 5888988877   47899999999999999999999997 999999999999888777789999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccc
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL  291 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  291 (296)
                      ++..+.++....+.+|+..|.|||++.|..+.-++.||||||||||.|+.|++||+..++-+.+-.|+.+-..-|...
T Consensus       165 FSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshv  242 (864)
T KOG4717|consen  165 FSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHV  242 (864)
T ss_pred             ccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhh
Confidence            999888888888899999999999999998778999999999999999999999999888888888877655444433

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=292.47  Aligned_cols=207  Identities=28%  Similarity=0.459  Sum_probs=176.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..|+..+.||+|.||.||+|.+..+++.||+|++.-..     ...++|+.+|..++++||.++|++|+....     ++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HH
Confidence            36888899999999999999999999999999985332     234589999999999999999999965544     89


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||.| ++.++++.    ...+.+..+..++++++.||.|||.+ +.+|||||+.|||+..++ .+||+|||.+...
T Consensus        88 iiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESG-DVKLADFGVAGQL  161 (467)
T ss_pred             HHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccC-cEEEEecceeeee
Confidence            99999995 66666664    34557888888999999999999999 999999999999999986 8999999998766


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ..... ..+++|||.|||||++.+ ..|+.++||||||++.+||++|.+||....+...+..|-+.
T Consensus       162 ~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~  226 (467)
T KOG0201|consen  162 TNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS  226 (467)
T ss_pred             echhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC
Confidence            44433 367899999999999974 45999999999999999999999999888776555555443

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-39  Score=285.44  Aligned_cols=200  Identities=31%  Similarity=0.516  Sum_probs=163.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|++....       .....|..++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            46899999999999999999999999885421       1223577777765 799999999988     3444589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-  220 (296)
                      ||+++ +|...+..    ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .++|+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99985 55555544    46789999999999999999999998 999999999999999887 899999999875322 


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~  210 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN  210 (320)
T ss_pred             CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence            2223345689999999998654 489999999999999999999999998877666655554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.3e-40  Score=288.61  Aligned_cols=207  Identities=26%  Similarity=0.455  Sum_probs=173.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|.+.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++|+||+++++++     .+....
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            6999999999999999999999999999999886432       2345789999999999999998887     334458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||++ ++|.+++...   ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            99999997 5777776653   35789999999999999999999998 999999999999999887 899999999976


Q ss_pred             eccCCCc--ccccccccccCCccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEPN--ISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .......  ....||+.|+|||++..     ...++.++|||||||++|+|++|+.||...+....+..+..
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~  223 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN  223 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence            5433322  23468999999999852     34478899999999999999999999998877666666554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8e-40  Score=286.41  Aligned_cols=201  Identities=30%  Similarity=0.493  Sum_probs=164.8

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|++....       .....|.+++..+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            46899999999999999999999999886431       1233577888765 7999999999883     344589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99985 56555544    36789999999999999999999998 999999999999999887 8999999998754322


Q ss_pred             -CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       222 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.+.
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~  211 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD  211 (321)
T ss_pred             CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence             223345689999999998654 4899999999999999999999999988876666666543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-39  Score=284.16  Aligned_cols=206  Identities=29%  Similarity=0.458  Sum_probs=166.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcC-CCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  137 (296)
                      +|.+.+.||+|+||.||+|++..+++.||+|++....       .....|..+++.+. |++|+++++++     .....
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            3788899999999999999999999999999886431       12345778888776 46777888777     33345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++||||+++ +|...+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8899999985 66665544    36799999999999999999999998 999999999999999887 79999999987


Q ss_pred             eeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       217 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            532222 233456899999999986544 899999999999999999999999988766555555543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-39  Score=285.51  Aligned_cols=201  Identities=28%  Similarity=0.480  Sum_probs=164.4

Q ss_pred             eeeeecCceEEEEEEEc---CCCcEEEEEEEeecc--------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           71 RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +.||+|+||.||++++.   .+++.||+|.+....        ....+|+.+++.++||||++++++|.     ....++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            68999999999999874   468899999885321        12347999999999999999998883     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ +|...+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999985 56555544    46788889999999999999999998 999999999999999887 8999999998754


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.+.
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~  215 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG  215 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            2222 233456899999999986544 789999999999999999999999988766666655543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-39  Score=287.07  Aligned_cols=213  Identities=35%  Similarity=0.619  Sum_probs=177.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            47999999999999999999999999999999885432      233479999999999999999988743321 22234


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .+++++++++++...+..     ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~~~~~~~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            789999998888766642     5699999999999999999999998 999999999999999887 899999999986


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ....  .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus       168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            5332  334578999999999876566899999999999999999999999988777777666655443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.9e-40  Score=288.22  Aligned_cols=198  Identities=26%  Similarity=0.410  Sum_probs=162.1

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +.||+|+||.||++++..+++.||+|.+....       ....+|+++++.++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46899999999999999999999999885421       2234688899999999999998887     33445899999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      |+++ +|...+..    ...+++..+..++.||+.||.|||+ . ||+||||||+|||++.++ .++|+|||++......
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD  149 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCC-CEEEecCCCCeecCCC
Confidence            9986 55554443    4678999999999999999999997 6 999999999999999887 8999999998753222


Q ss_pred             -CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022520          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  280 (296)
Q Consensus       222 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  280 (296)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i  208 (325)
T cd05594         150 GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  208 (325)
T ss_pred             CcccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence             2223456899999999986544 899999999999999999999999887654444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.7e-39  Score=285.63  Aligned_cols=195  Identities=30%  Similarity=0.480  Sum_probs=162.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeecc--------hhhHHHHHHHHhc-CCCCceecceeeeeccCC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (296)
                      +|++.+.||+|+||.||++++.   .+++.||+|++....        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999874   478999999885321        2234688999999 589999998887     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      ....+++||||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCC-CEEEeeC
Confidence            44458899999985 66666654    35789999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          213 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       213 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |++.......  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            9987643322  2234568999999999876555788999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-39  Score=285.83  Aligned_cols=200  Identities=27%  Similarity=0.459  Sum_probs=161.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHH-HHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRE-LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|++.....       ....| ..+++.++|+||+++++++.     .....++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            469999999999999999999999998854221       11123 33567889999999998883     344588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ ++...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99986 56555544    46788899999999999999999998 999999999999999877 8999999998754222


Q ss_pred             -CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  210 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN  210 (325)
T ss_pred             CCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence             2234456899999999986544 88999999999999999999999998877666655544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-39  Score=285.84  Aligned_cols=200  Identities=29%  Similarity=0.483  Sum_probs=161.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHH-HHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||+||+|++..+++.||+|++.....       ...+|.. +++.++||||+++++++.     +....++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            468999999999999999999999998853211       1123333 567899999999998883     344588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99985 56555544    46789999999999999999999998 999999999999999887 8999999998653222


Q ss_pred             -CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~  210 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN  210 (323)
T ss_pred             CCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence             2233456899999999986544 89999999999999999999999998776655555544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.6e-39  Score=295.55  Aligned_cols=209  Identities=30%  Similarity=0.425  Sum_probs=173.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCC-CcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .|.+.+.||+|+||.||+|.+..+ +..||+|.+....    ....+|+.+++.++||||+++++.+.     .....++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence            599999999999999999998877 7889999764332    23457999999999999999999883     3345899


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||++ ++|.+.+........++++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~  220 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS  220 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence            999998 577777766554456789999999999999999999998 999999999999999887 89999999998654


Q ss_pred             cCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          220 KGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       220 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ....   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~  285 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY  285 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            3321   2345689999999998654 489999999999999999999999998776665555544

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-39  Score=282.99  Aligned_cols=199  Identities=29%  Similarity=0.489  Sum_probs=162.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHh-cCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|.+....       .....|..++.. ++||||+++++++     ....++++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999886432       223356677765 4899999999988     3445689999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-  220 (296)
                      ||+.+ +|...+..    ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||++..... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 66666544    36789999999999999999999998 999999999999999887 899999999864322 


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~  209 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR  209 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            22233456899999999986554 8999999999999999999999999877655444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.2e-39  Score=295.21  Aligned_cols=215  Identities=28%  Similarity=0.392  Sum_probs=176.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC---CCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~  135 (296)
                      .+|.+.+.||+|+||+||+|++..+++.||+|.+....      ....+|+.++..++|+|++++++.+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            48999999999999999999999999999999885431      234578899999999999998877643322   122


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..+++||||++ ++|.+.+.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            34789999998 578888876655567899999999999999999999998 999999999999999877 799999999


Q ss_pred             eeeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~  259 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA  259 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            87653321   223456899999999986544 89999999999999999999999998776555554443

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.4e-39  Score=278.14  Aligned_cols=214  Identities=32%  Similarity=0.619  Sum_probs=178.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++++.     .....
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            357999999999999999999999999999999885322     23457999999999999999999883     34458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+++++...+...   ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++ .++|+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            899999999888777653   35688999999999999999999998 999999999999999887 8999999998654


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+...+..+
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~  224 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP  224 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            3222 12234568899999998766668899999999999999999999999888777766666655443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-39  Score=285.06  Aligned_cols=208  Identities=25%  Similarity=0.441  Sum_probs=163.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++....     ....+|+.+++.+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence            3457999999999999999999852     345789999885432     2345799999999 899999999877432 


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh----------------------------------------------------
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK----------------------------------------------------  158 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~----------------------------------------------------  158 (296)
                         ...+++||||++ |+|.+++.....                                                    
T Consensus        84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence               223789999998 577777654321                                                    


Q ss_pred             ------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC---cccccc
Q 022520          159 ------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYIC  229 (296)
Q Consensus       159 ------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~  229 (296)
                            ...++++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+++.......   .....+
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCC
Confidence                  123577888899999999999999998 999999999999999877 899999999876433221   112334


Q ss_pred             cccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022520          230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (296)
Q Consensus       230 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  277 (296)
                      ++.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+
T Consensus       239 ~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~  286 (338)
T cd05102         239 PLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF  286 (338)
T ss_pred             CccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence            67899999986544 8999999999999999997 99999876543333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=286.31  Aligned_cols=212  Identities=26%  Similarity=0.368  Sum_probs=174.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc--CCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ..+|.+.+.||+|+||.||++...  .++..||+|.+... ....+|+++++.++|+||+++++.+.     .....+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYR-----WKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEe-----eCCEEEEE
Confidence            347999999999999999999764  35678999977543 34568999999999999999998883     34458899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      |+++.+++..++..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus       165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            99999988887743    46799999999999999999999998 999999999999999887 7999999998765433


Q ss_pred             CC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhcCCC
Q 022520          222 EP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVILHTE  288 (296)
Q Consensus       222 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~  288 (296)
                      ..   .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..   ....+..+.+.+...+
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             cccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            22   23457899999999986544 8999999999999999999999997653   3455666666554433

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-39  Score=284.84  Aligned_cols=199  Identities=29%  Similarity=0.469  Sum_probs=159.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHH-HHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|.+....       ....+|. .+++.++||||+++++.+     .+....++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999885321       1112333 467889999999999887     3344588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-  220 (296)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99985 55555443    46788999999999999999999998 999999999999999887 899999999875322 


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL  209 (321)
T ss_pred             CCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence            22233456899999999986544 8899999999999999999999999877555444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=296.80  Aligned_cols=203  Identities=28%  Similarity=0.487  Sum_probs=168.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch----hhHHHHHHHHhcC-CCCceeccee-eeeccCCC-ceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLD-HPNVVSLKHC-FFSTTEKD-ELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~~  137 (296)
                      .++++.+.|.+|||+.||+|++...+..||+|++....+    ...+|+++|++|+ |+|||.+++. ........ ...
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            368899999999999999999988889999998854432    3358999999997 9999999994 33332333 466


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      +.|.||||. |+|.+++.....  .+|++.++++|+.|+++|+++||.. +  |||||||-|||||+.++ ..||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g-~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADG-NYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence            889999999 699999987664  4599999999999999999999996 6  99999999999999888 899999999


Q ss_pred             eeeeccCCCc----------ccccccccccCCcccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          215 AKVLVKGEPN----------ISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       215 ~~~~~~~~~~----------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ++........          .....|+.|+|||++.  .....+.|+|||+|||+||.|+....||+..
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            8654332211          1233599999999973  3344799999999999999999999999765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=294.95  Aligned_cols=188  Identities=27%  Similarity=0.485  Sum_probs=166.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEeccc-cc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ET  148 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~  148 (296)
                      ++.||.|+.|.||+|+.  .++.||||+++   ...+.+++-|++|+|+||+.+.+++     ....++|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~---elkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVR---ELKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHh---hhhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            57799999999999987  77899999773   3345688999999999999999998     66778999999998 67


Q ss_pred             HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCccccc
Q 022520          149 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI  228 (296)
Q Consensus       149 l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~  228 (296)
                      |...|+.    .++.....+..|.++|+.|+.|||.+ .|||||||.-||||.-+. .|||+|||-++..........+.
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            7777776    46788888999999999999999999 999999999999999877 79999999999887777777899


Q ss_pred             ccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022520          229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (296)
Q Consensus       229 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  274 (296)
                      ||..|||||++...+ -+.|.|||||||+||||+||..||.+-+..
T Consensus       273 GTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdss  317 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSS  317 (904)
T ss_pred             hhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchh
Confidence            999999999997655 799999999999999999999999775543

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.4e-39  Score=275.89  Aligned_cols=193  Identities=25%  Similarity=0.373  Sum_probs=159.8

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ||+|+||+||++.+..+++.||+|.+....       .....|+++++.++|+||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999885321       2234689999999999999998887     3344588999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC-
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  223 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~-  223 (296)
                      ++ +|...+.........+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 56555544333356789999999999999999999998 999999999999999877 799999999876544332 


Q ss_pred             cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       224 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~  202 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGE  202 (280)
T ss_pred             ccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence            23356899999999996654 88999999999999999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-39  Score=285.01  Aligned_cols=200  Identities=29%  Similarity=0.493  Sum_probs=161.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHH-HHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|++....       .....|.. +++.++||||+++++.+     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46899999999999999999999999885431       11123333 56779999999998887     3344588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-  220 (296)
                      ||+++ ++...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++..... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99986 55555443    46789999999999999999999998 999999999999999887 899999999875322 


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|++||...+..+....+..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~  210 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH  210 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc
Confidence            22234456899999999986544 78999999999999999999999998776555555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=287.27  Aligned_cols=201  Identities=28%  Similarity=0.401  Sum_probs=167.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ..+.+|.-...||+|+||.||+|.. .++..||||++...    ...+.+|++++.+++|||+|++++++.+...    .
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~  146 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H  146 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence            3556788889999999999999985 45589999988543    2457899999999999999999999954432    4


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .++|+||++ |+|.+.+......  +++|....+|+.++++||+|||..+.  ||||||||+|||+|.+. .+||+|||+
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGL  223 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGL  223 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccC
Confidence            789999999 6777776654211  88999999999999999999999753  99999999999999888 899999999


Q ss_pred             eeeecc-CCCcccc-cccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          215 AKVLVK-GEPNISY-ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       215 ~~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |+.... ....... .||..|+|||.... ...+.++|||||||+|+|+++|+.|.+..
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            976543 3333333 79999999999865 44899999999999999999999988854

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.6e-39  Score=306.07  Aligned_cols=218  Identities=30%  Similarity=0.454  Sum_probs=176.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ....+|.+.+.||+|+||+||+|++..++..+|+|.+...      ...+..|+.+++.++|||||+++++|+...   .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---N   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---C
Confidence            3445899999999999999999999999999999988532      223457999999999999999999886432   3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC------CceeccCCCCceEEcCC-----
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI------GVCHRDIKPQNLLVNPH-----  203 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~iiH~Dlkp~NIli~~~-----  203 (296)
                      ..+++||||++ ++|..++.........+++..++.|+.||+.||.|||+..      +|+||||||+||||+.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            35789999998 5888888766555578999999999999999999999841      49999999999999642     


Q ss_pred             -----------CCcEEEeeecceeeeccCCCcccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          204 -----------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       204 -----------~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                                 ...+||+|||++.............||+.|+|||++.+. ..++.++|||||||+||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       124899999999765444334455789999999998543 34789999999999999999999999877


Q ss_pred             ChHHHHHHHHH
Q 022520          272 SGVDQLVEIIK  282 (296)
Q Consensus       272 ~~~~~~~~~~~  282 (296)
                      +....+...+.
T Consensus       247 ~~~~qli~~lk  257 (1021)
T PTZ00266        247 NNFSQLISELK  257 (1021)
T ss_pred             CcHHHHHHHHh
Confidence            66555544443

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.6e-39  Score=280.96  Aligned_cols=199  Identities=30%  Similarity=0.516  Sum_probs=161.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHh-cCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|.+....       .....|..+++. ++||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46899999999999999999999999886431       123356777765 59999999998883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||++......
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99985 66666654    35788999999999999999999998 999999999999999887 7999999998753222


Q ss_pred             -CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       222 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~  209 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR  209 (316)
T ss_pred             CCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             2233456899999999986544 8999999999999999999999999877655544443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=250.84  Aligned_cols=213  Identities=36%  Similarity=0.633  Sum_probs=184.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .|.-.++||+|.||+||+|++..+++.||+|....+.      ....+|+-+|+.++|.|||+++++...     ..-..
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence            4667789999999999999999999999999885432      234589999999999999999988632     22378


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|+|||...|..+....   ++.+..+.++.++.|+++||.|+|++ ++.||||||.|.||..++ ++||+|||+++...
T Consensus        78 lvfe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            99999998888877764   58899999999999999999999999 999999999999999988 89999999998653


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      -.- -....+-|.+|++|.++++..-|++..|+||.|||+.|+.. |++.|.+.+..+++..|.+.++.+.
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~  223 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCc
Confidence            222 12334569999999999999889999999999999999995 8999999999999999999988763

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.6e-39  Score=284.07  Aligned_cols=188  Identities=27%  Similarity=0.530  Sum_probs=157.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|..+++.+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46899999999999999999999999986421       2234688888888 799999999988     3444589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec-c
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~-~  220 (296)
                      ||+++ +|...+..    ..++++..++.++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++.... .
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99985 56555543    36799999999999999999999998 999999999999999877 89999999986432 2


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCccc
Confidence            22334457899999999986544 88999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=296.49  Aligned_cols=208  Identities=28%  Similarity=0.409  Sum_probs=172.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee-----cchhhHHHHHHHHhcCCCCceecceeeeeccC-CCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  138 (296)
                      ..|...+.||+|+||.||+++++.+|+.||||.+..     .....-+|+++|++++|+|||+++++--.... --....
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            468889999999999999999999999999998853     33445589999999999999999775421110 002235


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--C-CcEEEeeecc
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--T-HQLKLCDFGS  214 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~-~~ikl~Dfg~  214 (296)
                      .+|||||.| +|...+. .......+++.++..++.++..||.|||++ ||+||||||.||++-..  + ...||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~-~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLN-SPENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhc-CcccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            689999996 5555554 444567899999999999999999999998 99999999999998432  2 2569999999


Q ss_pred             eeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022520          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (296)
Q Consensus       215 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  274 (296)
                      |+.+.++....+.+||..|.+||.+.....|+...|.|||||++|+.+||..||......
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            999988888889999999999999865567999999999999999999999999865544

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-38  Score=278.78  Aligned_cols=199  Identities=35%  Similarity=0.608  Sum_probs=161.3

Q ss_pred             eeeeeecCceEEEEEEEc--CCCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           70 ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      .++||+|+||.||+|++.  .+++.||+|.+....  ....+|+.+++.++||||+++++++...   ....++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            468999999999999975  467899999885432  3456899999999999999999887543   234578999999


Q ss_pred             cccHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC---CCCcEEEeeecceee
Q 022520          146 PETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  217 (296)
Q Consensus       146 ~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~---~~~~ikl~Dfg~~~~  217 (296)
                      ++++...+.....     ....+++..++.++.||+.||.|||++ ||+||||||+|||++.   ....+||+|||+++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9998887764321     123588999999999999999999998 9999999999999942   223799999999976


Q ss_pred             eccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ......    .....+|+.|+|||++.+...++.++||||+||++|+|++|++||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            543221    2245679999999998776668999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.5e-39  Score=279.88  Aligned_cols=200  Identities=31%  Similarity=0.505  Sum_probs=163.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..++..||+|.+....       ....+|.++++.+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999886431       2234678888877 7999999999883     344589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-  220 (296)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99985 55555543    35799999999999999999999998 999999999999999887 899999999865322 


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~  210 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE  210 (318)
T ss_pred             CCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence            22233456899999999986544 89999999999999999999999988776555554443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-39  Score=284.02  Aligned_cols=201  Identities=28%  Similarity=0.482  Sum_probs=165.6

Q ss_pred             eeeeecCceEEEEEEEc---CCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      +.||+|+||.||++++.   .+++.||+|++....      ....+|+++++.++||||+++++++.     ....+++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            67999999999999874   578999999886422      22346899999999999999998883     34458899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||++ ++|.+.+..    ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .++|+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            99998 466666544    35789999999999999999999998 999999999999999887 799999999876533


Q ss_pred             C-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          221 G-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       221 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      . .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+.+..+.+.
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~  213 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA  213 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence            3 2233456899999999986544 789999999999999999999999988766666655543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.9e-38  Score=271.22  Aligned_cols=207  Identities=25%  Similarity=0.375  Sum_probs=169.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.+....       ....+|+++++.++|+|++++.+.+.     .....
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence            3778899999999999999999999999999885321       22357999999999999999988873     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|||+.+ ++...+...  ...++++..+..++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYG-HIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCC-CEEEecCCccee
Confidence            899999986 555554432  134699999999999999999999998 999999999999999877 799999999876


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...........|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.........+..
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~  215 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR  215 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            54433334557899999999986544 89999999999999999999999988765544444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=271.69  Aligned_cols=219  Identities=26%  Similarity=0.389  Sum_probs=184.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+|..+++||+|.||.|.+++-+.+++.+|+|+++...-       ....|-.+|+..+||.+..+..+|     +....
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~dr  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQDR  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCce
Confidence            478999999999999999999999999999998754322       123577899999999999998877     44445


Q ss_pred             EEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +|+||||..|+ |...+.+    .+.+++...+.+..+|+.||.|||++ +|++||||.+|.|+|.++ .|||+|||+++
T Consensus       243 lCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDG-HIKitDFGLCK  316 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDG-HIKITDFGLCK  316 (516)
T ss_pred             EEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCC-ceEeeecccch
Confidence            89999999864 4433333    57899999999999999999999998 999999999999999999 79999999997


Q ss_pred             ee-ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccccccc
Q 022520          217 VL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA  295 (296)
Q Consensus       217 ~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (296)
                      .. ..+....+.+|||.|+|||++. ...|+...|.|.+||++|||+.|+.||.+.+.......|...-.+.|..+|.+|
T Consensus       317 E~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eA  395 (516)
T KOG0690|consen  317 EEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEA  395 (516)
T ss_pred             hcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHH
Confidence            64 3445567889999999999994 455999999999999999999999999998766666677777777777777665

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-38  Score=280.45  Aligned_cols=194  Identities=26%  Similarity=0.379  Sum_probs=164.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      ...|++.+.||+|+||.||+|++..++..||+|....  .....|+.+++.++|+||+++++++..     ....++||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--cccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEE
Confidence            3469999999999999999999999999999996532  233569999999999999999998843     334789999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC
Q 022520          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (296)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~  223 (296)
                      ++.+++...+...   ..++++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++........
T Consensus       138 ~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        138 HYSSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             ccCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEecCccccccccCcc
Confidence            9999888877653   46789999999999999999999998 999999999999999877 799999999875433333


Q ss_pred             cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCC
Q 022520          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPG  270 (296)
Q Consensus       224 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~  270 (296)
                      .....||+.|+|||++.+.. ++.++|||||||++|||+++. ++|..
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             cccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccC
Confidence            44567899999999986654 899999999999999999854 55554

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.7e-40  Score=266.30  Aligned_cols=207  Identities=25%  Similarity=0.452  Sum_probs=180.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------c------hhhHHHHHHHHhc-CCCCceecceeeeeccC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------K------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (296)
                      .|.-.+.||.|..++|.++.++.++..+|+|++...      .      ....+|+.||+++ .||+|+++.+.|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            577889999999999999999999999999988421      1      1113689999987 699999999998     


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                      +...++++|+|.|+ |.|.+++..    .-.+++...+++++|++.|+.|||.+ +|+||||||+|||++.+. +|+|+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~-~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNM-NIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeecccc-ceEEec
Confidence            66677899999998 788888887    36789999999999999999999998 999999999999999887 899999


Q ss_pred             ecceeeeccCCCcccccccccccCCcccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ||.++.+.++......+|||.|+|||.+.     +.+.|+...|+||+|||||.|+.|.+||......-.+..|+..
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG  243 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG  243 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence            99999998888888899999999999984     3455899999999999999999999999887666666666654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-38  Score=277.89  Aligned_cols=200  Identities=29%  Similarity=0.491  Sum_probs=168.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .++|++.+.||+|+||.||++++..++..+|+|.+....     ....+|+++++.++||||+++++++..     ....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence            357999999999999999999999999999999885431     235589999999999999999998843     3348


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccc
Confidence            899999985 67666654    356899999999999999999999852699999999999999887 799999999876


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      .... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+
T Consensus       154 ~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~  209 (331)
T cd06649         154 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKE  209 (331)
T ss_pred             cccc-ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5332 233456899999999986554 8999999999999999999999998776533

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.7e-39  Score=281.07  Aligned_cols=187  Identities=29%  Similarity=0.548  Sum_probs=155.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|..++..+ +||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            47999999999999999999999999886421       1234677777766 8999999999883     344589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-  220 (296)
                      ||+++ +|...+..    ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++..... 
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99985 55555443    46799999999999999999999998 999999999999999887 799999999875322 


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCc
Confidence            22233457899999999986554 8899999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-38  Score=279.81  Aligned_cols=188  Identities=28%  Similarity=0.539  Sum_probs=156.8

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|..++..+ +|+||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986431       2234688888777 699999999988     3344589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc-
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~-  220 (296)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99985 56555543    36799999999999999999999998 999999999999999887 799999999875322 


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             CCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCc
Confidence            22334567899999999986544 89999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=288.59  Aligned_cols=208  Identities=21%  Similarity=0.309  Sum_probs=163.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ......+...||+|.||+||+|++  .| .||||.+..+      .+.+++|+.++++-+|.||+-+.+++.     ...
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~w--hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~  461 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRW--HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPP  461 (678)
T ss_pred             CHHHhhccceeccccccceeeccc--cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCc
Confidence            334567889999999999999998  44 3999988532      345668999999999999999999883     333


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                       +.||+.+|+|+.+....+..  ...|....+..|++|++.|+.|||.+ +|||||||..|||+.+++ +|||+|||++.
T Consensus       462 -~AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~-kVkIgDFGLat  536 (678)
T KOG0193|consen  462 -LAIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDL-KVKIGDFGLAT  536 (678)
T ss_pred             -eeeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCC-cEEEeccccee
Confidence             38999999985444333333  36788889999999999999999999 999999999999999886 89999999986


Q ss_pred             ee---ccCCCcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          217 VL---VKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       217 ~~---~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ..   ..........|...|||||++...  ..|++.+||||||+++|||++|..||......+.+..+-+.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG  608 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG  608 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence            43   222233345667889999998532  23899999999999999999999999954433333343333

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.6e-38  Score=271.03  Aligned_cols=212  Identities=34%  Similarity=0.636  Sum_probs=175.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|++|.||+|++..++..||+|.+....      ....+|+.+++.++|||++++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            4889999999999999999999899999999875321      23457999999999999999999884     334588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+++++...+.... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988877765432 235789999999999999999999998 999999999999999887 89999999987543


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~  219 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG  219 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            221 122345688999999986666678999999999999999999999998877666665555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=277.82  Aligned_cols=221  Identities=29%  Similarity=0.442  Sum_probs=186.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|.++.+||+|+||.|.+|..+.+.+.+|||+++.+.-       -...|-++|... +-|.+++++.+|...+   
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD---  423 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD---  423 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh---
Confidence            33479999999999999999999999999999998865432       223567777766 4678899988884333   


Q ss_pred             ceEEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                        .+|+||||+.|+ |-..+.+    -+++.+..+..++.+|+-||-|||++ |||+||||.+||++|.++ .|||+|||
T Consensus       424 --RLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eG-HiKi~DFG  495 (683)
T KOG0696|consen  424 --RLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  495 (683)
T ss_pred             --heeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCC-ceEeeecc
Confidence              388999999965 4444433    47888999999999999999999999 999999999999999998 79999999


Q ss_pred             ceeee-ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          214 SAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       214 ~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      +++.- .++....+..|||.|+|||++.-.+ |+..+|.||+||+||||+.|++||++++..+..+.|.......|-++|
T Consensus       496 mcKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslS  574 (683)
T KOG0696|consen  496 MCKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLS  574 (683)
T ss_pred             cccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccccc
Confidence            99763 3444567789999999999986555 999999999999999999999999999988888999998888898988


Q ss_pred             ccc
Q 022520          293 IKA  295 (296)
Q Consensus       293 ~~~  295 (296)
                      .+|
T Consensus       575 kEA  577 (683)
T KOG0696|consen  575 KEA  577 (683)
T ss_pred             HHH
Confidence            876

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=308.76  Aligned_cols=211  Identities=29%  Similarity=0.485  Sum_probs=183.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee-------cchhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....+|.++++||+|+||.|.+++++.+++.||+|++..       ....+..|-++|..-+.+=|+.++..|     ++
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD  146 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QD  146 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cC
Confidence            345689999999999999999999999999999998743       234556788899988999999998888     88


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..++|+||||++| +|..++...    .++|+.+++.|+..|+.||+-||+. |+|||||||+|||||..| .|||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~G-HikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSG-HIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccC-cEeeccch
Confidence            8889999999985 666666553    4899999999999999999999997 999999999999999998 79999999


Q ss_pred             ceeeeccCCC--cccccccccccCCcccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          214 SAKVLVKGEP--NISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       214 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .|-.+..+..  ....+|||.|.+||++.    +...|++..|.||+||++|||+.|.-||...+-++++-.|++.
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h  296 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH  296 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence            9877754432  34578999999999984    2245899999999999999999999999999999999998876

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=259.76  Aligned_cols=221  Identities=26%  Similarity=0.420  Sum_probs=181.6

Q ss_pred             cCCCCCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh-----HHHHHHHH-hcCCCCceecceeee
Q 022520           55 GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMR-LLDHPNVVSLKHCFF  128 (296)
Q Consensus        55 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~E~~~l~-~l~h~niv~~~~~~~  128 (296)
                      ++....+....+...+..||+|..|.||+++.+.+|...|||.+.......     ...+.++- ..+.|+||+.+++|+
T Consensus        82 ~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   82 GGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             cCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            333444555556788889999999999999999999999999985433221     12333332 235799999999996


Q ss_pred             eccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                      ....     ++|.||.|......+++..+   +++|+..+-++...+.+||.||.++-+|+|||+||+|||+|..+ .||
T Consensus       162 ~n~d-----V~IcMelMs~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niK  232 (391)
T KOG0983|consen  162 TNTD-----VFICMELMSTCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIK  232 (391)
T ss_pred             eCch-----HHHHHHHHHHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEE
Confidence            5443     67899999888888887764   77999999999999999999999876999999999999999888 899


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhh
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVI  284 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~  284 (296)
                      |||||++.++.+...+....|.+.|||||.+.-  .+.|+.++||||||++++||.||+.||.+.+ +.+.+-.+++..
T Consensus       233 lCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e  311 (391)
T KOG0983|consen  233 LCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE  311 (391)
T ss_pred             eecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence            999999999988888888999999999999842  3568999999999999999999999999864 556677777633

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=250.93  Aligned_cols=218  Identities=22%  Similarity=0.394  Sum_probs=182.2

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHHHHHhc-CCCCceecceeeeeccCC
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (296)
                      .....+....+..||+|++|.|=+.++..+|...|+|.+.....     ...+|+.+.... ..|.+|.+|+.++.... 
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-
Confidence            44455567778899999999999999999999999998854322     223455554443 68999999998854443 


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                          .||.||.|..++..+..+..+.++..++..+-+|+..+..||.|||+++.+||||+||+||||+.++ ++|+||||
T Consensus       120 ----vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG  194 (282)
T KOG0984|consen  120 ----VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG  194 (282)
T ss_pred             ----EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence                8999999999999999999988999999999999999999999999999999999999999999988 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHh
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKV  283 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~~~~~  283 (296)
                      ++..+.+.-...-..|...|||||.+..   ...|+.++||||||+++.||.+++.||+. .++.+++.++++.
T Consensus       195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            9988766554444677888999999842   23589999999999999999999999986 4666777777763

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=256.77  Aligned_cols=203  Identities=30%  Similarity=0.431  Sum_probs=171.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .+|++.+.||+|||+.||+++...++..+|+|++.-..    +...+|++.-++++|||++++++..+..........|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            47999999999999999999999999999999885333    33458999999999999999988776555445667899


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|.. |++++.+......+..+++.++..|+.++++||.+||+. .  ++||||||.|||++..+ .++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence            999876 789999988877777899999999999999999999997 7  99999999999999866 899999999865


Q ss_pred             eccCCC----------cccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          218 LVKGEP----------NISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       218 ~~~~~~----------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      ..-.-.          -....+|..|+|||.+.-.  ...+.++|||||||+||+|+.|..||+
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            421111          1234579999999998432  236889999999999999999999994

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.3e-38  Score=270.52  Aligned_cols=210  Identities=36%  Similarity=0.606  Sum_probs=172.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|++..+|+.+|+|.+....      ....+|+++++.++|+||+++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            4889999999999999999999999999999885321      23457999999999999999999883     344589


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|+||+++++...+...   ...+++..++.++.||+.||.|||++ +|+|+||||+||+++.++ .++|+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            99999999888776643   35689999999999999999999998 999999999999999887 89999999987543


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhhc
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGESGVDQLVEIIKVIL  285 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~  285 (296)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.+.
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  218 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence            222 1223456889999999877666789999999999999999988774 55555555555555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.9e-38  Score=269.03  Aligned_cols=190  Identities=25%  Similarity=0.404  Sum_probs=158.4

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ||+|+||.||++++..+++.||+|.+....       .....|+++++.++||||+++++++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885321       1223589999999999999998887     3445589999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~  224 (296)
                      ++ +|...+....  ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            85 5655554322  34588888899999999999999998 999999999999999877 8999999998776544443


Q ss_pred             ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       225 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence            4456899999999986655 8999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=289.84  Aligned_cols=206  Identities=31%  Similarity=0.523  Sum_probs=180.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch----h---hHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----Y---KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~---~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|.-++.||+|+||.||.|++..+.+.||||++.-+-+    .   ..+|+..|+.++|||++.+.+||....     ..
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hH
Confidence            47788999999999999999999999999999853322    1   237999999999999999999996443     37


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      |+|||||-|+-.+++.-+.   .++.+..+..|+.+.+.||+|||++ +.||||||..|||+...+ .|||+|||.+...
T Consensus       102 WLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            8999999999888888874   7899999999999999999999999 999999999999999887 8999999998764


Q ss_pred             ccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                         .+..+++|||+|||||++..  ...|+-++||||||++..||.-.++|+.+.+....+.-|.+.-
T Consensus       177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe  241 (948)
T KOG0577|consen  177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE  241 (948)
T ss_pred             ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC
Confidence               34457899999999999853  3458999999999999999999999999988888888887743

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=278.15  Aligned_cols=223  Identities=25%  Similarity=0.361  Sum_probs=184.6

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      |.-...|+.-++||+||||.|+-++-..+|+.+|+|++...       .....+|-.+|.+++.+.||.+-..|     +
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----e  255 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----E  255 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----c
Confidence            34445688999999999999999999999999999977322       22234789999999999999997777     3


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....+|+||..|+|+-+.+-..+. .+..|++..++.++.+|+.||++||.. +|++|||||+|||+|..| .+.|+|+|
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~G-hvRISDLG  332 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHG-HVRISDLG  332 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCC-CeEeeccc
Confidence            333488999999976333222221 135799999999999999999999999 999999999999999988 79999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      +|..+..+.+....+||.+|||||++.+.. |+...|.|||||++|||+.|+.||........-.++-+.....+..+|
T Consensus       333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS  410 (591)
T ss_pred             eEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc
Confidence            999999998888889999999999997665 999999999999999999999999987766666666666655555444

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-38  Score=275.70  Aligned_cols=213  Identities=37%  Similarity=0.646  Sum_probs=175.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.++|+||+++++++...........+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            5799999999999999999999999999999988532     12234699999999999999999887554444445678


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +++||+++++.+.+..     ..+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        85 lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD  157 (336)
T ss_pred             EEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence            9999999887776643     5799999999999999999999998 999999999999999887 89999999987653


Q ss_pred             cCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          220 KGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       220 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      .....    ....+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+...+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~  226 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL  226 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            32211    224578899999987665558899999999999999999999998876655555554433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-37  Score=267.32  Aligned_cols=209  Identities=41%  Similarity=0.758  Sum_probs=174.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+|++++++++.     .....+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence            6999999999999999999999899999999885332      22357999999999999999999883     344588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||++++++..+...   ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++....
T Consensus        77 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQG-QIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCC-cEEECccccceecC
Confidence            99999998766655432   35689999999999999999999998 999999999999999887 89999999987664


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ... ......++..|+|||.+.+...++.++||||||+++|+|++|++||.+.+..+.+..+.+.+
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~  217 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL  217 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            433 22334568889999998765668899999999999999999999999888777766665543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-39  Score=281.73  Aligned_cols=198  Identities=26%  Similarity=0.464  Sum_probs=160.3

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHHHHHhc---CCCCceecceeeeeccCCCceEEEEEE
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ||+|+||+||+|++..+++.||+|++.....       ....|..++..+   +||||+++++++     ......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999999999999998853211       112455666554   699999999888     3344589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 66655544    46789999999999999999999998 999999999999999887 8999999998653222


Q ss_pred             -CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       222 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                       .......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+.
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~  210 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA  210 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence             223345689999999998766568999999999999999999999998877655555443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-37  Score=267.83  Aligned_cols=219  Identities=33%  Similarity=0.598  Sum_probs=179.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+. |+||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6999999999999999999999999999999875332      23457999999995 6999999988865444344557


Q ss_pred             EEEEecccccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++++.+.+...... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.+...++|+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999888887654432 35689999999999999999999998 9999999999999998444899999999875


Q ss_pred             eccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       218 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ..... ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+..+.+..+.+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  229 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG  229 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            43221 122335688899999986656678999999999999999999999999887777776666544

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=283.17  Aligned_cols=195  Identities=30%  Similarity=0.502  Sum_probs=170.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEee------cchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      .++||+|.||+||-|+++.+|+.||||++.+      ......+|++||+.+.||.||.+.-.| +.    ...+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-ET----~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-ET----PERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-cC----CceEEEEeh
Confidence            4789999999999999999999999998842      234556899999999999999985544 33    333889999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--CCcEEEeeecceeeeccC
Q 022520          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~~~ikl~Dfg~~~~~~~~  221 (296)
                      -+.|+.++.+....  .+++++...+.++.||+.||.|||-+ +|+|+||||+|||+...  ..++||||||.|+.+...
T Consensus       644 Kl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            99999998887654  58899999999999999999999998 99999999999999643  338999999999999888


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ....+.+|||.|+|||++.... |....|+||.|||+|--+.|..||....+
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd  771 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED  771 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc
Confidence            8888999999999999996554 89999999999999999999999987543

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.5e-39  Score=264.83  Aligned_cols=220  Identities=35%  Similarity=0.598  Sum_probs=183.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCC----cEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..|++...||+|.||.||+|....++    +.+|+|+++...      ...-+|+.+++.++|+|++.+..+|...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            36999999999999999999655432    378999886542      2234899999999999999999998643    


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC---CCcEEEe
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH---THQLKLC  210 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~---~~~ikl~  210 (296)
                      ...+++++||.+.+|+..+..+... ...++...++.++.||+.|+.|||++ -|+||||||+|||+..+   .+.|||+
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEee
Confidence            3458999999999999999877643 34688999999999999999999999 89999999999999765   2389999


Q ss_pred             eecceeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHH
Q 022520          211 DFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------GVDQL  277 (296)
Q Consensus       211 Dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---------~~~~~  277 (296)
                      |||+++.+.+.-..    -..+-|.+|+|||.+.|...||++.||||.|||+.||+|-.+.|.+..         ..+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999887554322    234569999999999999999999999999999999999999997632         24678


Q ss_pred             HHHHHhhcCCCc
Q 022520          278 VEIIKVILHTEI  289 (296)
Q Consensus       278 ~~~~~~~~~~~~  289 (296)
                      ..|.+.++.|..
T Consensus       259 ~rIf~vLG~Pt~  270 (438)
T KOG0666|consen  259 DRIFEVLGTPTD  270 (438)
T ss_pred             HHHHHHcCCCcc
Confidence            888888887743

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-37  Score=268.05  Aligned_cols=197  Identities=28%  Similarity=0.429  Sum_probs=164.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....       ....+|+.+++.++|+|++++++.+.     .....
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence            3788899999999999999999999999999875321       22346999999999999999988873     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+.+....  ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHG-HIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeccceee
Confidence            899999985 6666654322  34689999999999999999999998 999999999999999877 799999999876


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ...........|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||....
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            54433334457899999999986554 8999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.6e-39  Score=256.54  Aligned_cols=247  Identities=29%  Similarity=0.528  Sum_probs=210.9

Q ss_pred             CCCCCCCccccccccccccccceeeeecCCCCCcceeEEEeecCCCCCCccccceEEeeeeeecCceEEEEEEEcCCCcE
Q 022520           13 TVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEA   92 (296)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~   92 (296)
                      ..+..|+..+++..+.+..++.|..+.+...                    .++|++.+++|+|-++.||.|.+..+++.
T Consensus         6 v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~--------------------~ddYeivrk~GRGKYSEVFeg~~~~~~eK   65 (338)
T KOG0668|consen    6 VPSVARVYADVNEERPREYWDYESLVIDWGN--------------------QDDYEIVRKVGRGKYSEVFEGINITNNEK   65 (338)
T ss_pred             cchhhhhhhhccccCchhhcchhheeeeccc--------------------cchHHHHHHHcCccHhhHhcccccCCCce
Confidence            4678899999999999999999976655321                    24799999999999999999999999999


Q ss_pred             EEEEEEeec-chhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHH
Q 022520           93 VAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL  170 (296)
Q Consensus        93 vavK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~  170 (296)
                      ++||+++.- .+...+|+++|+.|. ||||+++.++..++..   ....+|+||+...-...+      .+.++...++.
T Consensus        66 ~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~l------y~tl~d~dIry  136 (338)
T KOG0668|consen   66 CVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQL------YPTLTDYDIRY  136 (338)
T ss_pred             EEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cCchhHhhhhccccHHHH------hhhhchhhHHH
Confidence            999988653 445679999999997 9999999998854433   346789999986522222      36688889999


Q ss_pred             HHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchh
Q 022520          171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAID  250 (296)
Q Consensus       171 i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  250 (296)
                      ++.+++.||+|+|+. ||+|||+||.|++||.....++|+|+|+|.+..++..-.-.+.+..|-.||.+.....|+...|
T Consensus       137 Y~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD  215 (338)
T KOG0668|consen  137 YIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLD  215 (338)
T ss_pred             HHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHH
Confidence            999999999999998 9999999999999998877899999999999888877777788899999999987788999999


Q ss_pred             HHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhcCCCc
Q 022520          251 IWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       251 iwSlG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      +|||||+|..|+..+-| |.+.++.+++..|.+.++..++
T Consensus       216 ~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  216 MWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             HHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            99999999999998755 5688999999999999887654

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=267.19  Aligned_cols=211  Identities=33%  Similarity=0.638  Sum_probs=172.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|++.+.||+|++|.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++++     ....+.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            57999999999999999999998899999999885332     2335799999999999999999987     3444688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||++++|.+.+...   ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++ .++|+|||++....
T Consensus        80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence            99999999888776653   34788999999999999999999998 999999999999999887 79999999986532


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhc
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVIL  285 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~  285 (296)
                      ... ......++..|+|||.+.+...++.++||||+|+++|+|++|+.||.+.+ ..+.+..+.+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~  222 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG  222 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcC
Confidence            211 11223457889999998765668899999999999999999999998765 4444555544433

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.2e-37  Score=276.05  Aligned_cols=215  Identities=33%  Similarity=0.588  Sum_probs=178.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||++++++|..... .+..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            35799999999999999999999999999999987532      1233479999999999999999998754322 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++||||+.+++.+.+..      .++...+..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus        95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCccce
Confidence            5789999999988877653      278888999999999999999998 999999999999999887 79999999998


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ............+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+.+..+.+.++.+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            764443334456788999999986644 8999999999999999999999999888777777776665554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-37  Score=263.96  Aligned_cols=199  Identities=36%  Similarity=0.614  Sum_probs=168.0

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh------HHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK------NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |++.+.||+|+||+||++.+..+++.||+|.+.......      .+|+.+++.++|+||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            889999999999999999999999999999986543221      248899999999999999998854     444789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee-
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  218 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~-  218 (296)
                      ||+++++ ++.+.+..    ...+++..+..++.|++.||++||++ +|+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             cccccccccccccccc----cccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccccc
Confidence            9999997 78877773    47789999999999999999999998 999999999999999777 8999999998753 


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ  276 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  276 (296)
                      ..........+++.|+|||++.....++.++||||||+++|+|++|..||......+.
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~  207 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ  207 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence            2222334456799999999986345589999999999999999999999998743333

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.2e-37  Score=268.46  Aligned_cols=215  Identities=36%  Similarity=0.609  Sum_probs=179.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+|++++++++...   .....
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~~   83 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDSI   83 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCeE
Confidence            47999999999999999999999999999999885332      1234799999999999999999987532   22347


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+++++..++...   ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        84 ~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~  158 (309)
T cd07845          84 FLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKG-CLKIADFGLARTY  158 (309)
T ss_pred             EEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccceeeec
Confidence            899999998888777653   26789999999999999999999998 999999999999999877 8999999998765


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP  228 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            4332 22233457889999998766668999999999999999999999999988888888777755443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=274.31  Aligned_cols=196  Identities=29%  Similarity=0.426  Sum_probs=159.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ....+|...+.||+|+||.||+|++..+++.||+|.+....     ..+.+|+++++.++|+||+++++++     ....
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  145 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG  145 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence            34457999999999999999999999999999999885432     2345899999999999999999988     3444


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++||||+.++.+.   .    .....+..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus       146 ~~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DfG~~~  216 (353)
T PLN00034        146 EIQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAK-NVKIADFGVSR  216 (353)
T ss_pred             eEEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEcccccce
Confidence            588999999965322   1    23456777888999999999999998 999999999999999887 89999999987


Q ss_pred             eeccCC-CcccccccccccCCccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          217 VLVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       217 ~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ...... ......||..|+|||++...    ...+.++|||||||++|+|++|+.||...
T Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  276 (353)
T PLN00034        217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG  276 (353)
T ss_pred             ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            653322 22345789999999987432    23456899999999999999999999743

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.3e-38  Score=278.65  Aligned_cols=212  Identities=23%  Similarity=0.357  Sum_probs=165.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ...+|.+.+.||+|+||.||+|++...     +..||+|.+....     ....+|+++++.+ +|+||+++++++.   
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---  112 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---  112 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence            345799999999999999999986443     3579999885432     2345799999999 8999999999883   


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh----------------------------------------------------
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK----------------------------------------------------  158 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~----------------------------------------------------  158 (296)
                        .....++|||||+ ++|.+.+.....                                                    
T Consensus       113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence              3344889999998 577777654321                                                    


Q ss_pred             --------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc
Q 022520          159 --------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (296)
Q Consensus       159 --------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~  224 (296)
                                    ...++++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+++........
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcce
Confidence                          113578888999999999999999998 999999999999999776 8999999998765333211


Q ss_pred             ---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          225 ---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       225 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                         ....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||........+....+
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~  329 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK  329 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH
Confidence               1123456799999986544 8999999999999999997 9999987655444444443

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-37  Score=270.36  Aligned_cols=198  Identities=35%  Similarity=0.618  Sum_probs=160.0

Q ss_pred             eeeeeecCceEEEEEEEcC--CCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           70 ERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ..+||+|+||.||+|++..  ++..||+|.+....  ....+|+++++.++||||+++++++...   .....++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            3689999999999999753  56889999885432  2456899999999999999999987543   234578999999


Q ss_pred             cccHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC---CCCcEEEeeecceee
Q 022520          146 PETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  217 (296)
Q Consensus       146 ~~~l~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~---~~~~ikl~Dfg~~~~  217 (296)
                      ++++...+.....     ....+++..++.++.|++.||.|||++ +|+||||||+|||+..   ..+.++|+|||+++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            9988887764321     123588899999999999999999998 9999999999999942   223799999999976


Q ss_pred             eccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          218 LVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       218 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ......    .....+|+.|+|||++.+...++.++|||||||++|+|++|++||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            543321    223467899999999876666899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=282.80  Aligned_cols=205  Identities=32%  Similarity=0.481  Sum_probs=180.4

Q ss_pred             CCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      +.+.....|.+.+.||+|.|+.|.+|++..++..||+|.+.+..      ....+|+++++.++|||||+++.+...   
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t---  126 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET---  126 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee---
Confidence            44555668999999999999999999999999999999885432      234689999999999999999998833   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                        ...+|+||||+. |.+.+++..+    ++..+..++.++.|+.++++|||++ +|+|||||++|||++.+. .+||+|
T Consensus       127 --~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~m-nikIaD  198 (596)
T KOG0586|consen  127 --EATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENM-NIKIAD  198 (596)
T ss_pred             --cceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhccccccc-ceeeec
Confidence              334899999987 5667777664    6677788999999999999999999 999999999999999987 699999


Q ss_pred             ecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  274 (296)
                      ||++.++..+....++.|++.|.|||++.+..+.+++.|+||+|+++|.|+.|.+||++.+-.
T Consensus       199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk  261 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK  261 (596)
T ss_pred             cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence            999999988777888999999999999998888899999999999999999999999986643

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.9e-37  Score=265.45  Aligned_cols=211  Identities=39%  Similarity=0.742  Sum_probs=178.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....      ....+|+.+++.++|+||+++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            4899999999999999999999899999999885432      23457999999999999999999883     345588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|+||++++|.+.+...   ..++++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            99999977888777653   26789999999999999999999998 999999999999999877 79999999987654


Q ss_pred             cCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          220 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       220 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ....  .....++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.++.+.+..+...+..
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT  219 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCC
Confidence            4321  234567889999999876666789999999999999999999999988877777766665543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5e-37  Score=264.92  Aligned_cols=209  Identities=36%  Similarity=0.634  Sum_probs=170.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|.+.+.||+|+||.||+|.+..++..||+|.+....     ....+|+.+++.++|+||+++++++.     .....+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            57999999999999999999999999999999885332     13457999999999999999999873     334588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+.+++...+...   ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            99999998887766543   35678888999999999999999998 999999999999999877 89999999986532


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHh
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKV  283 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~~~~~  283 (296)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|..||...+. .+.+.++...
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  220 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV  220 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence            221 123345688999999986655578899999999999999999999987653 3444444443

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-37  Score=295.51  Aligned_cols=201  Identities=26%  Similarity=0.414  Sum_probs=164.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...       ...+.+|+++++.++||||+++++++.     +...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            4799999999999999999999999999999988532       123457999999999999999998873     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEE
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYK-------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                      .+++|||++| +|.+.+.....       .....+...+..++.|++.||+|||++ ||+||||||+||+++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCC-CEEE
Confidence            8899999985 67666654321       123455677888999999999999998 999999999999999887 7999


Q ss_pred             eeecceeeeccCC-------------------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          210 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       210 ~Dfg~~~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      +|||++.......                   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999987651110                   011246899999999986654 79999999999999999999999987


Q ss_pred             CCh
Q 022520          271 ESG  273 (296)
Q Consensus       271 ~~~  273 (296)
                      .+.
T Consensus       234 ~~~  236 (932)
T PRK13184        234 KKG  236 (932)
T ss_pred             cch
Confidence            543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-37  Score=273.22  Aligned_cols=198  Identities=28%  Similarity=0.497  Sum_probs=166.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .++|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|+++++.++|+||+++++++..     ....
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence            357999999999999999999999999999999875432     235589999999999999999998843     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+|+||||+|||++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~  153 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchh
Confidence            899999985 77777654    356889999999999999999999743799999999999999877 799999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .... ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~  207 (333)
T cd06650         154 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDA  207 (333)
T ss_pred             hhhh-ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence            4332 223446789999999986544 88999999999999999999999987654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.4e-37  Score=266.83  Aligned_cols=211  Identities=38%  Similarity=0.689  Sum_probs=175.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch---------hhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+.....         ....|+++++.++|+||+++++++.     +..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            48889999999999999999998999999998854322         2346899999999999999999884     344


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +.++||||+.++|...+...   ...+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            58899999977887777653   13689999999999999999999998 999999999999999877 89999999997


Q ss_pred             eeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       217 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ....... .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+...+..
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~  221 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT  221 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC
Confidence            6644322 223456788999999866556789999999999999999999999988877777666655433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=260.83  Aligned_cols=206  Identities=29%  Similarity=0.514  Sum_probs=169.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||+|++|.||.|.+..+++.+|+|.+....         ....+|+++++.++||||+++++++.     +..
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence            5899999999999999999999999999999875321         23457999999999999999999883     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++|+||+++ ++.+.+..    ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~-~~~l~dfg~~  151 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  151 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            68999999985 66666654    35688999999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       216 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+....+...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  222 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ  222 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc
Confidence            765332211    2345678899999997654 889999999999999999999999887665555544443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=287.52  Aligned_cols=215  Identities=28%  Similarity=0.500  Sum_probs=177.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEeccc
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP  146 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~  146 (296)
                      -+||+|.||+||-|+|..++...|||.+...    .+.+.+|+.+-+.|+|.|||++.+++     .+..++-|.||-++
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP  655 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence            3799999999999999999999999988543    34556899999999999999999997     55557889999998


Q ss_pred             c-cHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC
Q 022520          147 E-TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (296)
Q Consensus       147 ~-~l~~~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~  223 (296)
                      | +|..+++...   +++  .+..+..+.+||+.||.|||++ .|+|||||-+|+|+....+.+||+|||-++++..-.+
T Consensus       656 GGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP  731 (1226)
T KOG4279|consen  656 GGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP  731 (1226)
T ss_pred             CCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence            5 6667776653   677  7888999999999999999999 9999999999999998777899999999988766555


Q ss_pred             c-ccccccccccCCcccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhhcCCCcccccc
Q 022520          224 N-ISYICSRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL-VEIIKVILHTEISLSIK  294 (296)
Q Consensus       224 ~-~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  294 (296)
                      . -++.||..|||||++. |.+.|+.++|||||||++.||.||++||......+.. .+.----.+|++|.+..
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeels  805 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELS  805 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHH
Confidence            4 3568999999999994 4456999999999999999999999999877654442 33322234566655543

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-37  Score=280.97  Aligned_cols=192  Identities=28%  Similarity=0.373  Sum_probs=162.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|...  .....+|+++|++++|+||+++++++..     ....++||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            346999999999999999999999999999999643  2345689999999999999999998743     334789999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC
Q 022520          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (296)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~  223 (296)
                      ++.+++...+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+++.......
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            9998888877653   35789999999999999999999998 999999999999999877 799999999876533221


Q ss_pred             ---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022520          224 ---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  268 (296)
Q Consensus       224 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  268 (296)
                         .....||+.|+|||++.+.. ++.++|||||||++|||++|..|+
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCc
Confidence               12346899999999996654 899999999999999999988554

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.5e-37  Score=264.87  Aligned_cols=213  Identities=36%  Similarity=0.673  Sum_probs=176.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||.|++|.||+|++..++..||+|.+....      ....+|+++++.++||||+++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            4889999999999999999999999999999885322      23557999999999999999999873     344588


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+.+++...+....  ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            999999888777765432  35689999999999999999999998 999999999999999887 89999999987543


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      .... .....+++.|+|||.+.+...++.++|||||||++|+|+||+.||...+..+.+.++.+.+..+
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP  220 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            3221 2233467889999998665657889999999999999999999999888777777766655543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.4e-37  Score=265.64  Aligned_cols=213  Identities=35%  Similarity=0.648  Sum_probs=175.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|++.+.||.|++|.||+|.+..+++.||+|.+....      ....+|+++++.++|+||+++++++.     +....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            36999999999999999999999899999999874321      23457999999999999999999883     34458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+++++...+....  ...+++..+..++.||+.||.|||++ +++|+||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            9999999988877765432  23467888889999999999999998 99999999999999876557999999998754


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+.++...+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~  221 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG  221 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            3222 122345688999999986655578999999999999999999999998887777776665443

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=268.55  Aligned_cols=203  Identities=37%  Similarity=0.640  Sum_probs=169.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcC--CCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            48899999999999999999988  89999999886522       2345799999999999999999988532   224


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC----CCCcEEEee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----HTHQLKLCD  211 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~----~~~~ikl~D  211 (296)
                      .+++||||+++++...+........ .+++..+..++.|++.||.|||+. +|+||||||+||+++.    ++ .++|+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            5889999999988888776554333 789999999999999999999998 9999999999999998    66 799999


Q ss_pred             ecceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          212 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       212 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ||++........    .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            999876533221    12335688899999987666688999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.6e-37  Score=263.68  Aligned_cols=211  Identities=37%  Similarity=0.646  Sum_probs=173.9

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |++.+.||+|+||.||+|.+..++..||+|.+.....     ...+|+.+++++. |+|++++++++...   .....++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            6789999999999999999999999999998854321     1235888888885 99999999988533   1134789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      ||||+++++.+.+...   ...+++..+..++.|++.||.|||+. +++|+||||+||+++. + .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999999888877653   25689999999999999999999998 9999999999999998 5 899999999987654


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ........++..|+|||.+.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~  217 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT  217 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCC
Confidence            444444567899999998755555789999999999999999999999988877766666654433

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.3e-37  Score=263.88  Aligned_cols=202  Identities=30%  Similarity=0.513  Sum_probs=170.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...       .....+|+++++.++||||+++++++.     +....
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            699999999999999999999999999999988532       123457999999999999999999883     34458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||++ ++|.+.+..    ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 677777655    36789999999999999999999998 999999999999999887 799999999876


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ....  .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+.
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  211 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL  211 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            5443  3344678999999998654 47889999999999999999999998877554444444

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.6e-37  Score=263.50  Aligned_cols=211  Identities=35%  Similarity=0.662  Sum_probs=175.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||.|++|.||+|++..++..||+|.+...     .....+|+.+++.++|+||+++++++..     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            489999999999999999999999999999988543     2234579999999999999999998843     334789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      ||||+++++.+++..... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999988887765432 34689999999999999999999998 999999999999999877 899999999865432


Q ss_pred             CC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      .. ......+++.|++||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+..+.+..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  217 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM  217 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            21 12234568899999998776667899999999999999999999999888777666665543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=260.40  Aligned_cols=229  Identities=28%  Similarity=0.470  Sum_probs=185.7

Q ss_pred             CCCCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHh-cCCCCceecceeee
Q 022520           57 KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFF  128 (296)
Q Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~  128 (296)
                      ...+.....+|.++++||+|+|++|.+++.+.+.+.+|+|+++...       ...+.|-.+... -+||.+|-++.|| 
T Consensus       242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-  320 (593)
T KOG0695|consen  242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-  320 (593)
T ss_pred             ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-
Confidence            3444455568999999999999999999999999999999885321       122345555544 4799999999988 


Q ss_pred             eccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                          +....+++|.||++|+   .+..+.+..+.+|++.++.+..+|+.||.|||++ |||+||||.+|+|+|..+ .+|
T Consensus       321 ----qtesrlffvieyv~gg---dlmfhmqrqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeg-hik  391 (593)
T KOG0695|consen  321 ----QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEG-HIK  391 (593)
T ss_pred             ----cccceEEEEEEEecCc---ceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCC-cee
Confidence                5555688999999976   2233333458899999999999999999999999 999999999999999998 799


Q ss_pred             Eeeecceeee-ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CChHHHH-HH
Q 022520          209 LCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-------ESGVDQL-VE  279 (296)
Q Consensus       209 l~Dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-------~~~~~~~-~~  279 (296)
                      |+|+|+++.- .++....+..|||.|.|||++.+.. |+...|.|+|||+++||+.|+.||+-       .+..+++ +-
T Consensus       392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv  470 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV  470 (593)
T ss_pred             ecccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence            9999998764 4555677889999999999997655 99999999999999999999999962       2344555 44


Q ss_pred             HHHhhcCCCcccccccC
Q 022520          280 IIKVILHTEISLSIKAA  296 (296)
Q Consensus       280 ~~~~~~~~~~~~~~~~~  296 (296)
                      |+..--+.|-++|++|+
T Consensus       471 ilekqiriprslsvkas  487 (593)
T KOG0695|consen  471 ILEKQIRIPRSLSVKAS  487 (593)
T ss_pred             HhhhcccccceeehhhH
Confidence            55666777889999884

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-37  Score=267.26  Aligned_cols=207  Identities=21%  Similarity=0.326  Sum_probs=162.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcC----------------CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceec
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  123 (296)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+....     ..+.+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            579999999999999999998632                34479999885432     234579999999999999999


Q ss_pred             ceeeeeccCCCceEEEEEEeccc-ccHHHHHHHhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHccCC
Q 022520          124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK---------------MSQRMPLIYVKLYFYQICRALAYIHNTIG  187 (296)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~  187 (296)
                      ++++...     ...++||||+. ++|.+++.....               ....+++..+..++.||+.||.|||+. |
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~  158 (304)
T cd05096          85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-N  158 (304)
T ss_pred             EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-C
Confidence            9988433     33789999998 477777654321               112467788899999999999999998 9


Q ss_pred             ceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-
Q 022520          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  263 (296)
Q Consensus       188 iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-  263 (296)
                      |+||||||+|||++.++ .+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHc
Confidence            99999999999999877 899999999876533321   11233477899999986544 8999999999999999986 


Q ss_pred             -CCCCCCCCChHHHHHH
Q 022520          264 -GQPLFPGESGVDQLVE  279 (296)
Q Consensus       264 -g~~pf~~~~~~~~~~~  279 (296)
                       +..||...+..+.+..
T Consensus       237 ~~~~p~~~~~~~~~~~~  253 (304)
T cd05096         237 CKEQPYGELTDEQVIEN  253 (304)
T ss_pred             cCCCCCCcCCHHHHHHH
Confidence             5688987765554443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.8e-37  Score=270.62  Aligned_cols=215  Identities=40%  Similarity=0.698  Sum_probs=177.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+...      .....+|+.+++.++|+||+++++++...........
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4699999999999999999999999999999987532      1233479999999999999999998754443333457


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++++||+++++...+..    ..++++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++...
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence            89999999888777764    36799999999999999999999998 999999999999999887 8999999998765


Q ss_pred             ccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       219 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ... .......++..|+|||.+.....++.++|||||||++|+|++|++||.+.+....+..+...+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  226 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG  226 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            333 1223446788999999986544588999999999999999999999988776555555554433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.3e-37  Score=265.61  Aligned_cols=213  Identities=38%  Similarity=0.647  Sum_probs=178.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|.++....      ...+|+.+++.++||||+++++++....   ....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            469999999999999999999998999999998854321      2347999999999999999999875432   2458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+++++...+....   ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            8999999998887776542   4689999999999999999999998 999999999999999887 8999999998766


Q ss_pred             ccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       219 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ... .......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+.+..+...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG  224 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            443 2223345688899999987655578999999999999999999999999887777776665544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4e-37  Score=270.79  Aligned_cols=217  Identities=36%  Similarity=0.646  Sum_probs=179.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||+++++++.... ......
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            57999999999999999999999999999999885431      23347999999999999999998774433 344568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+++++.+.+..    ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999999887776654    35689999999999999999999998 999999999999999887 8999999998765


Q ss_pred             ccCCCc-----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          219 VKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       219 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ......     ....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+...++.++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            332211     2346788999999986655588999999999999999999999998887777766666555543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.8e-37  Score=274.24  Aligned_cols=211  Identities=23%  Similarity=0.368  Sum_probs=164.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeeccC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (296)
                      ..+|++.+.||+|+||.||+|++     ..++..||+|++....     ....+|+.+++.+ +||||+++++++.    
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~----  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT----  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence            34799999999999999999974     3456789999885332     2345799999999 8999999999883    


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  158 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~-----------------------------------------------------  158 (296)
                       .....++|||||+ |+|.+++.....                                                     
T Consensus       110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence             3344789999998 577777654210                                                     


Q ss_pred             ------------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          159 ------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       159 ------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                                        ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .++|+|||++.....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                              012577888999999999999999998 999999999999999776 799999999876533


Q ss_pred             CCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          221 GEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ....   ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........+.+..+
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~  331 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK  331 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH
Confidence            2211   1123356799999986544 8999999999999999998 8899987654444444433

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.1e-37  Score=263.55  Aligned_cols=209  Identities=18%  Similarity=0.256  Sum_probs=168.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      ..||+|+++.||+|.+  +|+.||+|.+....       ..+.+|+.+|++++||||+++++++.... .+...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5789999999999998  78899999885431       23448999999999999999999885422 22345789999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC
Q 022520          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (296)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~  222 (296)
                      |+++ +|.+.+..    ...+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||++...... 
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc-
Confidence            9995 67776654    356888889999999999999999743899999999999999887 8999999998754322 


Q ss_pred             CcccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          223 PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       223 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                       .....++..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+.+....+++
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~  243 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL  243 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence             2345678999999998542 45899999999999999999999999988776666666554444443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.2e-37  Score=261.56  Aligned_cols=208  Identities=22%  Similarity=0.308  Sum_probs=164.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||.||+|.+.   ..+..||+|.+....     ..+.+|+..++.++||||+++++++..     .
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence            346999999999999999999875   346789999876432     234579999999999999999998743     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||+++ +|.+++...   ...+++..+..++.|++.||+|||++ +++||||||+|||++.++ .++++|||.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~-~~~l~dfg~  153 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDL-VCKISGFRR  153 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCC-cEEECCCcc
Confidence            347899999996 555555542   35789999999999999999999998 999999999999999877 899999998


Q ss_pred             eeeeccCCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      +.........  ....++..|+|||.+.+.. ++.++|||||||++|++++ |..||.+.+..+.+..+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~  223 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED  223 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence            7543222111  1223467899999986544 8999999999999999875 9999998776655555443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.4e-37  Score=262.27  Aligned_cols=210  Identities=28%  Similarity=0.457  Sum_probs=168.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHH-HHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.....     ....|.. .++.++|+|++++++++..     ....+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence            68999999999999999999999999999998854321     1223444 3667799999999998843     33488


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ++|||+++++.+++.........+++..+..++.|++.||.|||++.+++||||||+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence            99999999888888765544567999999999999999999999855899999999999999887 89999999987654


Q ss_pred             cCCCcccccccccccCCccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH
Q 022520          220 KGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEII  281 (296)
Q Consensus       220 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~-~~~~~~~~~~  281 (296)
                      .........++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||... ...+.+..+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  221 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV  221 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence            43333335678899999988542   33688999999999999999999999753 2334444433

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-38  Score=281.48  Aligned_cols=209  Identities=25%  Similarity=0.409  Sum_probs=175.4

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEEe------ecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~------~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +...+||+|+|-+||+|.|..+|..||.-.++      ...  ..+..|+++|+.|+|+||+++|++|.....   .++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            56789999999999999999999999865432      222  455689999999999999999999976654   4577


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC-CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +|+|.+. |+|..+++.+    ++.....++.|++||++||.|||++- .|||||||-+||||..+.+.|||+|+|+|+.
T Consensus       120 ~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            8999988 7888888885    66778899999999999999999963 5999999999999999888999999999986


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ..... .....|||.|||||++.  ..|....||||||++|+||+|+.+||....+..++..-+....+
T Consensus       196 ~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK  261 (632)
T KOG0584|consen  196 LRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK  261 (632)
T ss_pred             hhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence            54433 33479999999999983  56999999999999999999999999988776666554444433

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.9e-36  Score=263.30  Aligned_cols=218  Identities=30%  Similarity=0.544  Sum_probs=176.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC---C
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---K  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~  133 (296)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999885321      122469999999999999999988754332   2


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      .....++||||+++++...+...   ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDG-ILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCC-cEEECcCC
Confidence            23457899999999887776542   34689999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCc-----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          214 SAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       214 ~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ++.........     ....++..|+|||.+.+...++.++||||||+++|+|++|++||.+.+....+..+.+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            98765332211     2335678899999986665578899999999999999999999998876666555555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-36  Score=264.26  Aligned_cols=217  Identities=33%  Similarity=0.620  Sum_probs=178.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC---CC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  134 (296)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+++++.++|+||+++++.+.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999999999999999885321      234579999999999999999988754432   22


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...+++||+|+++++...+...   ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            4467899999998877766542   35799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCCCc------------ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGEPN------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      +.........            ....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8754332211            1234578899999986655588999999999999999999999998887777766665


Q ss_pred             hhc
Q 022520          283 VIL  285 (296)
Q Consensus       283 ~~~  285 (296)
                      ...
T Consensus       242 ~~~  244 (311)
T cd07866         242 LCG  244 (311)
T ss_pred             HhC
Confidence            544

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=262.44  Aligned_cols=230  Identities=28%  Similarity=0.446  Sum_probs=187.0

Q ss_pred             CCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh---HHHHHHHHhcC--------CCCceecceee
Q 022520           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD--------HPNVVSLKHCF  127 (296)
Q Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~E~~~l~~l~--------h~niv~~~~~~  127 (296)
                      |.+....+|.+.++||.|-|++||+|.|....+.||+|+.+......   ..|+++|++++        ..+||+|++.|
T Consensus        72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            34445578999999999999999999999999999999887665443   36999999883        24799999988


Q ss_pred             eeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc------
Q 022520          128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------  201 (296)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~------  201 (296)
                      -... ..+.++|+|+|+++..|+.++....  .+.++...++.|++|++.||+|||..+||||.||||+|||+.      
T Consensus       152 khsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  152 KHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             eecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence            6554 5677899999999999999998765  578999999999999999999999999999999999999983      


Q ss_pred             --------------------------------------------------------------------------------
Q 022520          202 --------------------------------------------------------------------------------  201 (296)
Q Consensus       202 --------------------------------------------------------------------------------  201 (296)
                                                                                                      
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------------CC--------------------------------------------------
Q 022520          202 ----------------------------PH--------------------------------------------------  203 (296)
Q Consensus       202 ----------------------------~~--------------------------------------------------  203 (296)
                                                  +.                                                  
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                        00                                                  


Q ss_pred             -CCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHH
Q 022520          204 -THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQ  276 (296)
Q Consensus       204 -~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~  276 (296)
                       ..++||+|||-|+....  .......|..|+|||++.+.. |++.+||||++|++|||+||...|+..+      +.+.
T Consensus       389 ~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             cceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence             00256667766654321  223345688999999998877 9999999999999999999999996432      5678


Q ss_pred             HHHHHHhhcCCCcccccc
Q 022520          277 LVEIIKVILHTEISLSIK  294 (296)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~  294 (296)
                      +..|+..++..|-.+-+.
T Consensus       466 iA~i~ELLG~iPr~ia~~  483 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALG  483 (590)
T ss_pred             HHHHHHHHhhccHHHHhc
Confidence            999999998887655443

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=268.35  Aligned_cols=201  Identities=27%  Similarity=0.438  Sum_probs=173.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      -|.++.+||+|+||.||+|.++.+|..+|+|++.-+.  +..-+|+.++++++.+++|++|++|+....     +|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            4889999999999999999999999999999885443  344589999999999999999999975544     899999


Q ss_pred             ccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC
Q 022520          144 YVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (296)
Q Consensus       144 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~  222 (296)
                      ||+ |+..+.++..   +.++++.++..+++..++||.|||.. .-||||||..|||+..++ ..||+|||.+..+.+.-
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            999 6777766654   58899999999999999999999997 889999999999999988 79999999987653322


Q ss_pred             -CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022520          223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  277 (296)
Q Consensus       223 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  277 (296)
                       ...+..|||.|||||++..-. |..++||||||++..||..|++||.+-.+...+
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI  238 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI  238 (502)
T ss_pred             HhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence             235678999999999996544 899999999999999999999999876554443

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-36  Score=261.28  Aligned_cols=217  Identities=26%  Similarity=0.404  Sum_probs=175.8

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhc-CCCCceecceeeeeccCCCce
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +....+|++.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++.+ +|+||+++++++.........
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            345568999999999999999999999999999999875322   3445788999998 799999999988665545556


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+.+.........+++..+..++.|++.||.|||++ +++||||||+||+++.++ .++|+|||++
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~  171 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEG-GVKLVDFGVS  171 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCC-CEEEccCCce
Confidence            78999999985 66666655444456788999999999999999999998 999999999999999887 7999999998


Q ss_pred             eeeccCC-CcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022520          216 KVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (296)
Q Consensus       216 ~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  279 (296)
                      ....... ......+++.|+|||.+..    ...++.++|||||||++|+|++|+.||...+....+..
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~  240 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK  240 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence            7654322 2233467899999998742    23378899999999999999999999987765444433

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.9e-36  Score=257.83  Aligned_cols=206  Identities=28%  Similarity=0.469  Sum_probs=166.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|++.+.||+|+||.||.|.+..++..||+|.+....         ....+|+.+++.++|+||+++++++...   ...
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---MER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CCc
Confidence            6999999999999999999999999999999874221         2345699999999999999999877332   234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .++++|||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~Dfg~~  153 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVG-NVKLGDFGAS  153 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCC-CEEECcCccc
Confidence            57899999985 67666654    25678888999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCC----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       216 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .......    ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....+.++.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~  222 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA  222 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence            7543211    11234578899999998654 47899999999999999999999998776555544433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-36  Score=261.47  Aligned_cols=208  Identities=42%  Similarity=0.767  Sum_probs=172.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++|+||+++++++     .+....+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            6999999999999999999998889999999874321      2345799999999999999999988     4445689


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|+||+++++++.+...   ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            99999998665544432   34689999999999999999999998 999999999999999877 89999999987653


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .... .....++..|+|||.+.+...++.++||||||+++|+|++|++||...+..+.+..+...
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  216 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC  216 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Confidence            3322 223457889999999876566788999999999999999999999887766665555543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-36  Score=258.67  Aligned_cols=200  Identities=33%  Similarity=0.550  Sum_probs=165.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+++++.++||||+++++++...     ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            46999999999999999999999999999999774311       1235799999999999999999988432     34


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++++||+++ ++..++.........+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999995 66666665443345688999999999999999999998 999999999999999877 79999999987


Q ss_pred             eeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       217 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ....... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~  210 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence            6543222 12345788999999986544 7899999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=260.29  Aligned_cols=209  Identities=44%  Similarity=0.775  Sum_probs=175.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            699999999999999999999989999999987432      2345689999999999999999999844     33488


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ++|||++++++..+...   ...++...+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            99999998877665443   35689999999999999999999998 999999999999999877 89999999987654


Q ss_pred             cCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       220 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ...  ......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+.+..+...+
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  218 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL  218 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            443  23345678899999999776468999999999999999999999999887777666655543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.1e-36  Score=260.02  Aligned_cols=218  Identities=27%  Similarity=0.396  Sum_probs=176.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +|+|++++++++...........
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            356799999999999999999999999999999988542   23445788899988 89999999999876544344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++..
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~-~~kl~dfg~~~~  177 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEeecccchh
Confidence            899999985 67676665444456789999999999999999999998 999999999999999877 799999999875


Q ss_pred             eccCCC-cccccccccccCCccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEP-NISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~-~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...... .....++..|+|||.+....    .++.++|||||||++|+|++|++||...+....+..+.+
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~  247 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR  247 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence            433221 22345788999999875332    267899999999999999999999988766555555443

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.6e-36  Score=267.87  Aligned_cols=213  Identities=33%  Similarity=0.613  Sum_probs=173.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCC-------
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-------  133 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-------  133 (296)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|.+....    ....+|+++++.++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57999999999999999999999999999999885432    2345799999999999999998876433211       


Q ss_pred             --CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          134 --DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       134 --~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                        +....++||||+++++...+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++..++|+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECC
Confidence              1235789999999887766643     5689999999999999999999998 9999999999999986665799999


Q ss_pred             ecceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          212 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       212 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ||++........    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999876532211    122356888999998765555889999999999999999999999988776666555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-36  Score=266.55  Aligned_cols=217  Identities=40%  Similarity=0.667  Sum_probs=182.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|.+.+.||.|+||.||+|++..+++.||+|.+....      ....+|+.+++.++|+||+++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999998889999999885422      3455799999999999999999988655433334578


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ++|+|+++++.+.+..    ..++++..+..++.|++.||++||++ ||+|+||||+||+++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999877777654    35789999999999999999999998 999999999999999886 89999999998765


Q ss_pred             cCC----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          220 KGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       220 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ...    ......+++.|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+.+..+....+.++
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS  227 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence            543    123446788999999997664689999999999999999999999999888777777777665443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=260.94  Aligned_cols=200  Identities=20%  Similarity=0.281  Sum_probs=154.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecchhhH---------------HHHHHHHhcCCCCceeccee
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC  126 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~---------------~E~~~l~~l~h~niv~~~~~  126 (296)
                      .+|.+.+.||+|+||.||+|.+..+   +..+|+|..........               .+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998777   66777775432221111               12234455689999999887


Q ss_pred             eeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc
Q 022520          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (296)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~  206 (296)
                      ...... ...+.+++++++..++...+...    ...++..+..++.|++.||.|||+. +|+||||||+|||++.++ .
T Consensus        92 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKRC-RMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEecC-CceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-c
Confidence            643332 23456788898877776665542    3467888899999999999999998 999999999999999877 7


Q ss_pred             EEEeeecceeeeccCC--------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          207 LKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       207 ikl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ++|+|||+++......        ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999997653221        112346899999999986544 8999999999999999999999998764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=263.56  Aligned_cols=218  Identities=27%  Similarity=0.496  Sum_probs=183.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh---hHHHHHHHHhcCC--C----CceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY---KNRELQTMRLLDH--P----NVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~E~~~l~~l~h--~----niv~~~~~~~~~~~~~  134 (296)
                      ..+|.+.+.+|+|.||.|-.+.+..++..||+|+++.-.+.   ..-|+++|+++.+  |    -+|.+.++|     ..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            45899999999999999999999999999999988654333   2358999999842  1    367777777     55


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC-----------
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-----------  203 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~-----------  203 (296)
                      ....|||+|.++-++.+++..+.  ..+++..+++.+.+|++.+++|||+. +++|.||||+|||+.+.           
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCc
Confidence            56689999999989999998865  57899999999999999999999998 99999999999998310           


Q ss_pred             --------CCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          204 --------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       204 --------~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                              .-.|+++|||.|+....  .....+.|..|+|||++.+-+ ++.++||||+||||+|++||...|+..++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    11589999999987543  346678899999999998866 9999999999999999999999999999999


Q ss_pred             HHHHHHHhhcCCCcccc
Q 022520          276 QLVEIIKVILHTEISLS  292 (296)
Q Consensus       276 ~~~~~~~~~~~~~~~~~  292 (296)
                      .+..+.+.+++.|....
T Consensus       317 HLaMMerIlGp~P~~mi  333 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMI  333 (415)
T ss_pred             HHHHHHHhhCCCcHHHh
Confidence            99888888886665443

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-36  Score=256.28  Aligned_cols=206  Identities=30%  Similarity=0.524  Sum_probs=170.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||.|+||.||++.+..++..+|+|.+...     .....+|+.+++.++|+|++++++.+     .+...+++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            488999999999999999999999999999987432     12345788999999999999999988     34445899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||+++ ++.+.+....  ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999985 6766665422  45688999999999999999999998 999999999999999877 89999999987653


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .... .....+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~  213 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC  213 (255)
T ss_pred             ccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh
Confidence            3222 23456788999999986544 8899999999999999999999999876555544443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=258.97  Aligned_cols=210  Identities=36%  Similarity=0.667  Sum_probs=173.9

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |++.+.||.|++|.||+|.+..+|..||+|++....      ....+|+++++.++|+|++++++++.     +....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            678899999999999999999999999999885332      23457999999999999999999883     3455889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      +|||+++++...+....  ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999888887776532  14689999999999999999999998 999999999999999876 899999999865432


Q ss_pred             CC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      .. ......+++.|+|||++.+...++.++|+||||+++|+|++|++||...+..+.+..+.+...
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG  217 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            21 122335688899999886655578899999999999999999999998887777766665543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-36  Score=259.55  Aligned_cols=201  Identities=27%  Similarity=0.413  Sum_probs=165.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++|+||+++++++..     ....++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            4799999999999999999999999999999988533    2234579999999999999999998843     334789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ +|.+.+..    ..++++..+..++.|++.||.|||+. +|+|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999985 66665543    35789999999999999999999998 999999999999999877 79999999987653


Q ss_pred             cCC-CcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022520          220 KGE-PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ  276 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  276 (296)
                      ... ......+++.|+|||.+.+  ...++.++|+|||||++|+|++|+.||...+..+.
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~  217 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA  217 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence            322 1234467889999998742  23367899999999999999999999976554333

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-36  Score=264.93  Aligned_cols=199  Identities=26%  Similarity=0.456  Sum_probs=160.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc----EEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|++.+.||+|+||.||+|++..+++    .||+|.+....     ....+|+.+++.++||||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            469999999999999999999866655    48999875322     2345789999999999999999987432     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                       ..+++++|+. |++.+.+...   ...++...+..++.|++.||+|||++ +|+||||||+|||++.++ .++|+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~-~~kl~DfG~  155 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCC-cEEEccccc
Confidence             1468999988 5777777653   34688888999999999999999998 999999999999999877 799999999


Q ss_pred             eeeeccCCCccc---ccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022520          215 AKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (296)
Q Consensus       215 ~~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~  275 (296)
                      ++..........   ..++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+....+
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~  219 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE  219 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            986644332211   22356799999986544 8999999999999999997 999998876433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.8e-36  Score=269.11  Aligned_cols=209  Identities=24%  Similarity=0.401  Sum_probs=163.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhcC-CCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  131 (296)
                      ...+|.+.+.||+|+||.||+|.+..     ++..||+|++....     ..+.+|+++++.+. ||||+++++++    
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence            34579999999999999999998743     23579999885432     23457999999996 99999999988    


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh----------------------------------------------------
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK----------------------------------------------------  158 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~----------------------------------------------------  158 (296)
                       .+....++|||||+ |+|.+++.....                                                    
T Consensus       111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence             33445899999998 577766654311                                                    


Q ss_pred             ----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCce
Q 022520          159 ----------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (296)
Q Consensus       159 ----------------------------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NI  198 (296)
                                                              ....+++..+..++.|++.||.|||+. +|+|+||||+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Ni  268 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhE
Confidence                                                    113477888899999999999999998 999999999999


Q ss_pred             EEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 022520          199 LVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  274 (296)
Q Consensus       199 li~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~  274 (296)
                      |++.++ .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......
T Consensus       269 ll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         269 LLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            999877 799999999876533322   12234567899999986544 8999999999999999997 99999876544


Q ss_pred             HHHHH
Q 022520          275 DQLVE  279 (296)
Q Consensus       275 ~~~~~  279 (296)
                      +.+..
T Consensus       347 ~~~~~  351 (400)
T cd05105         347 STFYN  351 (400)
T ss_pred             HHHHH
Confidence            44433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=256.62  Aligned_cols=220  Identities=30%  Similarity=0.468  Sum_probs=177.6

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhc-CCCCceecceeeeeccC-CCc
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDE  135 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~  135 (296)
                      +...++|++.+.||.|++|.||+|.+..+++.+++|.+....   ....+|+.+++.+ +|+||+++++++..... ...
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            345578999999999999999999998889999999886433   3456799999998 79999999999866543 345


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..+++||||+++ ++.+.+.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~-~~~l~d~~~  159 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNA-EVKLVDFGV  159 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCC-eEEECCCcc
Confidence            668899999995 66666655443456789999999999999999999998 999999999999999877 799999999


Q ss_pred             eeeeccCCC-cccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGEP-NISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      +........ .....++..|+|||.+..    ...++.++|||||||++|+|++|++||........+.++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  232 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR  232 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence            876533221 233457889999998743    23467899999999999999999999987665555544443

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.6e-36  Score=253.27  Aligned_cols=207  Identities=29%  Similarity=0.469  Sum_probs=170.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++|||++++++++.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            488999999999999999999999999999987532      223347899999999999999999883     334588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||++ ++|.+.+....  ...++...+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            9999997 47777766532  45788999999999999999999998 999999999999999877 7999999998765


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..... .....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...+..+....+.+
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  215 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR  215 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            43322 22345788999999986544 78999999999999999999999988775554444443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=258.19  Aligned_cols=211  Identities=36%  Similarity=0.652  Sum_probs=176.0

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |.+.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+++++.++|+|++++++.+....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678999999999999999999899999999986542      23457999999999999999999884321   245889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |+||+++++...+...   ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998877776543   25789999999999999999999998 999999999999999887 899999999887644


Q ss_pred             CC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          221 GE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       221 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ..  ......++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+.+...
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~  219 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG  219 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            33  123345688899999876655678999999999999999999999998887777776666543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-36  Score=259.88  Aligned_cols=204  Identities=27%  Similarity=0.457  Sum_probs=164.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||+|+||.||+|.+..++..||+|.+....     ....+|+.+++.++|+||+++++++.     .....++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            6889999999999999999999899999999885421     23457999999999999999999884     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ ++..++... .....+++..+..++.|++.||.|||+..+|+|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999996 555555432 12347899999999999999999999633999999999999999876 89999999987553


Q ss_pred             cCCCcccccccccccCCccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022520          220 KGEPNISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  277 (296)
Q Consensus       220 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  277 (296)
                      .. ......+++.|+|||.+.+..     .++.++|+|||||++|+|++|+.||...+.....
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  216 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF  216 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH
Confidence            22 223345788899999974332     2578999999999999999999999876544433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=253.51  Aligned_cols=207  Identities=28%  Similarity=0.433  Sum_probs=170.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ++|++.+.||.|+||.||+|.+..+++.+++|.+...    .....+|+++++.++||||+++++.+..     ...+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            4799999999999999999999889999999988643    2345689999999999999999988743     345889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||+++ ++.+.+...   ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++....
T Consensus        78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999996 555555442   25789999999999999999999998 999999999999999877 79999999987653


Q ss_pred             cCC-CcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          220 KGE-PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ... ......++..|+|||.+.+.  ..++.++|+||||+++|+|++|++||...+..+....+.
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~  217 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS  217 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            322 22334678889999998554  247889999999999999999999998876555544443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.2e-36  Score=256.47  Aligned_cols=211  Identities=26%  Similarity=0.432  Sum_probs=170.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhc-CCCCceecceeeeeccCCC-ceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD-ELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~~~~  138 (296)
                      .+.|++.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +|+|++++++.+......+ ...+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            35699999999999999999999999999999988543   23345788899888 7999999999886543322 3457


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|||+++ ++.+.+....  ...+++..+..++.|++.||+|||++ +|+|+||||+||+++.++ .++|+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCC-CEEEccCCCcee
Confidence            899999985 6666665432  35688999999999999999999998 999999999999999887 799999999876


Q ss_pred             eccCC-CcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          218 LVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       218 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      ..... ......+++.|+|||++.+    ...++.++|||||||++|+|++|+.||...+......
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~  226 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  226 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            53221 2234567889999999853    2347889999999999999999999997665444433

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-36  Score=264.22  Aligned_cols=212  Identities=36%  Similarity=0.616  Sum_probs=173.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            57999999999999999999998899999999885432      234479999999999999999988753322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .+++++++++++.+.+..     ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .++|+|||++..
T Consensus        97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  169 (345)
T ss_pred             EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence            678999988887766543     4689999999999999999999998 999999999999999887 799999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+.....
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            422  233456788999999986655578999999999999999999999988776666665555443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.9e-36  Score=259.94  Aligned_cols=218  Identities=33%  Similarity=0.556  Sum_probs=178.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-----
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-----  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  132 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++|||++++++++.....     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            357999999999999999999999999999999885432      223479999999999999999988754331     


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      .+...+++|+||+++++...+...   ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++ .++|+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-cEEeCcc
Confidence            122368899999999877776643   35789999999999999999999998 999999999999999877 8999999


Q ss_pred             cceeeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          213 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       213 g~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      |++........  .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99876543321  122345778999998865555789999999999999999999999988877777777665543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-36  Score=254.32  Aligned_cols=206  Identities=27%  Similarity=0.489  Sum_probs=167.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+...         .....+|+++++.++|+||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence            699999999999999999999999999999987421         12345799999999999999999887432   223


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+++++||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~  153 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECccccc
Confidence            47789999985 67666654    35688899999999999999999998 999999999999999877 7999999998


Q ss_pred             eeeccC----CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          216 KVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       216 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ......    .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..........++.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  222 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA  222 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence            754321    1112345788999999986544 7899999999999999999999998876555555444

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.5e-36  Score=255.25  Aligned_cols=207  Identities=21%  Similarity=0.342  Sum_probs=167.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+++++.++|+||+++++++.     ....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            46999999999999999999999899999999886443   23457999999999999999998873     33347899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||++ ++|.+.+....  ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            99997 56777665432  34688899999999999999999998 999999999999999877 899999999876544


Q ss_pred             CCCcc--cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .....  ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~  219 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE  219 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            32211  122356799999886544 8899999999999999998 999998876544444443

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.3e-36  Score=259.32  Aligned_cols=189  Identities=31%  Similarity=0.522  Sum_probs=159.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||+|+||.||+|.+..++..||+|.+....     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            5888999999999999999999999999999885431     234479999999999999999998843     334789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      ||||++++.+...       ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997544322       3577888999999999999999998 999999999999999887 899999999876533


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      . ......+|..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             c-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchh
Confidence            2 233457899999999986554 89999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.3e-36  Score=264.27  Aligned_cols=212  Identities=35%  Similarity=0.588  Sum_probs=175.1

Q ss_pred             cceE-EeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------------------hhHHHHHHHHhcCCCCceecce
Q 022520           65 ISYM-AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLKH  125 (296)
Q Consensus        65 ~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~E~~~l~~l~h~niv~~~~  125 (296)
                      .+|. +.+.||.|+||.||+|.+..+++.||+|.+.....                  ...+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4676 45779999999999999999999999998853211                  2347999999999999999999


Q ss_pred             eeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC
Q 022520          126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (296)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~  205 (296)
                      ++.     ...+.++||||+.+++...+..    ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ 
T Consensus        88 ~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~-  156 (335)
T PTZ00024         88 VYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKG-  156 (335)
T ss_pred             EEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCC-
Confidence            884     3345889999999988887764    35689999999999999999999998 999999999999999887 


Q ss_pred             cEEEeeecceeeeccC---------------CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          206 QLKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       206 ~ikl~Dfg~~~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      .++|+|||++......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            8999999998765411               1111234577899999987666578999999999999999999999999


Q ss_pred             CChHHHHHHHHHhhcCC
Q 022520          271 ESGVDQLVEIIKVILHT  287 (296)
Q Consensus       271 ~~~~~~~~~~~~~~~~~  287 (296)
                      .++.+.+..+...+..+
T Consensus       237 ~~~~~~~~~i~~~~~~~  253 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTP  253 (335)
T ss_pred             CCHHHHHHHHHHHhCCC
Confidence            88877777776655433

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5e-36  Score=259.49  Aligned_cols=203  Identities=27%  Similarity=0.450  Sum_probs=167.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..+|++.+.||+|+||.||+|.+..++..+++|.+....    ....+|+.+++.++|+|++++++.+..     ....+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            357999999999999999999999999999999885432    334578999999999999999998843     33588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ ++.+.+..     ..++...+..++.|++.||+|||+. ||+|+||||+||+++.++ .++|+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~  166 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (296)
T ss_pred             EeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEECccccchhc
Confidence            99999985 66666543     4578889999999999999999998 999999999999999877 8999999988654


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  279 (296)
                      ..... .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+....+..
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~  227 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL  227 (296)
T ss_pred             cccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence            33221 22346788999999986544 78999999999999999999999987765444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-36  Score=260.83  Aligned_cols=206  Identities=29%  Similarity=0.515  Sum_probs=169.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....       ....+|+++++.++|+||+++++.+     .+....
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            6999999999999999999999899999999885432       2345789999999999999999887     344558


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+.+ +|.+.+...  ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999985 676666532  245789999999999999999999998 999999999999999877 799999998765


Q ss_pred             eccCCC------------------------------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 022520          218 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  267 (296)
Q Consensus       218 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p  267 (296)
                      ......                              .....||..|+|||.+.+.. ++.++||||||+++|+|++|+.|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCC
Confidence            422111                              11235788899999986554 78999999999999999999999


Q ss_pred             CCCCChHHHHHHHH
Q 022520          268 FPGESGVDQLVEII  281 (296)
Q Consensus       268 f~~~~~~~~~~~~~  281 (296)
                      |.+.+....+..+.
T Consensus       232 f~~~~~~~~~~~~~  245 (316)
T cd05574         232 FKGSNRDETFSNIL  245 (316)
T ss_pred             CCCCchHHHHHHHh
Confidence            98877655555444

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-36  Score=257.75  Aligned_cols=202  Identities=25%  Similarity=0.397  Sum_probs=166.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ....++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            47999999999999999999999999999999885432    234578999999999999999998743     344889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||+++ +|.+++..    .+.+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999985 66666554    36789999999999999999999998 999999999999999877 79999999987653


Q ss_pred             cCC-CcccccccccccCCcccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022520          220 KGE-PNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  277 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  277 (296)
                      ... ......|+..|+|||.+.  ....++.++|+|||||++|+|++|..||........+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~  218 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL  218 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence            322 123456789999999874  2234788999999999999999999998765543333

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.8e-36  Score=257.95  Aligned_cols=204  Identities=29%  Similarity=0.476  Sum_probs=168.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .+|++.+.||.|++|.||+|.+..+++.|++|.+....    ....+|+++++.++|+|++++++.+.     .....++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            47999999999999999999999999999999885332    23457999999999999999999884     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |+||+++ ++...+..     ..+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~  166 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccchhcc
Confidence            9999986 55555432     4689999999999999999999998 999999999999999877 89999999887543


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+..+.+..+.
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~  228 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  228 (296)
T ss_pred             cccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3322 22346788999999986544 7899999999999999999999999877655544443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=279.29  Aligned_cols=214  Identities=24%  Similarity=0.373  Sum_probs=179.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-h---hHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-Y---KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~---~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+.|.|+-.||-|+||.||+|.++.++..-|.|++..... .   ..-|++||..++||+||++++.|+..+.     +|
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence            3468999999999999999999998888888888743321 1   2258999999999999999999976654     89


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |..|||+|+-.+.+.-..  +..+.+.++..+++|++.||.|||++ +|||||||..|||+..+| .|+|+|||.+-...
T Consensus       106 iliEFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~  181 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDG-DIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEeecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecC-cEeeecccccccch
Confidence            999999987555544432  68899999999999999999999999 999999999999999998 79999999864322


Q ss_pred             c-CCCcccccccccccCCcccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          220 K-GEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       220 ~-~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      . ....-++.|||+|||||+.+    .+..|+.++||||||++|.||..+.+|-...+....+..|.+.-.+
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP  253 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP  253 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC
Confidence            2 22334678999999999974    3445899999999999999999999999999998888888876543

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-35  Score=251.55  Aligned_cols=208  Identities=31%  Similarity=0.513  Sum_probs=173.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...      .....+|+++++.++|+|++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            489999999999999999999999999999988532      123457999999999999999998873     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ +|.+.+....  ...+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999985 7777776532  34588999999999999999999998 99999999999999876657899999999876


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..........++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+..
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~  215 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS  215 (256)
T ss_pred             CCCccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh
Confidence            5554444566788999999986544 78999999999999999999999988776555545443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6e-36  Score=254.91  Aligned_cols=206  Identities=29%  Similarity=0.495  Sum_probs=167.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|...+.||+|+||.||+|.+..++..|++|.+...         .....+|+.+++.++|+||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence            689999999999999999999999999999987432         12345799999999999999999877432   234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+++++||+++ +|.+.+..    ...+++.....++.|++.||+|||+. +|+|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~-~~~l~dfg~~  153 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence            57899999985 67666654    35688899999999999999999998 999999999999999877 7999999998


Q ss_pred             eeeccCC----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       216 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .......    ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~  222 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA  222 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence            7543211    11224578889999998654 48899999999999999999999998776555554443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.6e-36  Score=258.55  Aligned_cols=207  Identities=28%  Similarity=0.428  Sum_probs=166.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +.|++.+.||.|+||.||+|++..+++.+++|.+....    ....+|+.+++.++|+|++++++++..     ...+++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            46999999999999999999999999999999885432    234468999999999999999998843     335889


Q ss_pred             EEecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPETV-HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~~l-~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||++++. ...+...   ...+++..+..++.|++.+|.|||++ +++|+||||+||+++.++ .++|+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            999999654 4444332   35689999999999999999999998 999999999999999776 89999999886542


Q ss_pred             cCC-CcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          220 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ... ......+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||...+....+.++.
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~  228 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA  228 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh
Confidence            221 1234457889999999842    2336789999999999999999999998766544444443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-36  Score=256.87  Aligned_cols=212  Identities=39%  Similarity=0.696  Sum_probs=178.2

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |.+.+.||.|++|+||+|.+..+++.|++|.+.....     ...+|+..++.++ |+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            6788999999999999999988899999998754322     2346888999998 9999999998843     445889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      ||||+++++.+.+....  ...+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888888776542  34789999999999999999999998 999999999999999877 899999999987655


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ........++..|+|||.+.....++.++|+||||+++++|++|++||...+..+.+..+...+..+
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP  218 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCC
Confidence            4444456678899999998665668899999999999999999999999888777777766655443

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.4e-35  Score=251.04  Aligned_cols=207  Identities=32%  Similarity=0.524  Sum_probs=172.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||.|+||.||.+++..++..+++|.+....      ....+|+++++.++|+||+++++++..     ....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            5899999999999999999999999999999875321      234579999999999999999999843     34588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++|||++ ++|.+.+....  ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            9999998 47777776532  35688999999999999999999998 999999999999999877 7999999998765


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+..
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~  215 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ  215 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence            3333 223456789999999986544 78899999999999999999999988776665555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-35  Score=250.23  Aligned_cols=208  Identities=28%  Similarity=0.467  Sum_probs=169.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .|++.+.||+|++|.||++.+..+++.||+|.+....      ....+|+++++.++|+|++++++.+.    .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4899999999999999999999999999999885321      23457899999999999999987762    1233578


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++|||+++ ++.+.+....  ...+++.++..++.|++.||.+||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999985 6666665432  35689999999999999999999998 999999999999999877 8999999998765


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+..
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~  216 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE  216 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            3322 22334578899999998654 478999999999999999999999987765554444433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.4e-36  Score=262.18  Aligned_cols=215  Identities=38%  Similarity=0.632  Sum_probs=175.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCC--CcEEEEEEEeec------chhhHHHHHHHHhc-CCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||+|+||.||++++..+  +..||+|.+...      .....+|+.+++.+ +|+||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            488999999999999999999877  899999987532      12335799999998 5999999988654332 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++++++++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4788999999888877754    46789999999999999999999998 999999999999999887 79999999987


Q ss_pred             eeccCCC-----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          217 VLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       217 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      .......     .....+|+.|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+...++.+
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            6533221     1234678899999987665558999999999999999999999999887777676666655443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.2e-36  Score=258.02  Aligned_cols=209  Identities=24%  Similarity=0.355  Sum_probs=167.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCC-----cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ..+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            47999999999999999999976554     679999885432     23457999999999999999999873     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~  201 (296)
                      ....+++|||++ ++|.+++......            ...++...+..++.|++.||.|||++ +++|+||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEc
Confidence            334789999998 5777777654211            14578889999999999999999998 999999999999999


Q ss_pred             CCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022520          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (296)
Q Consensus       202 ~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  277 (296)
                      .++ .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            877 799999999876533221   22334578899999986544 8999999999999999998 99999987765554


Q ss_pred             HHHH
Q 022520          278 VEII  281 (296)
Q Consensus       278 ~~~~  281 (296)
                      ..+.
T Consensus       237 ~~i~  240 (283)
T cd05048         237 EMIR  240 (283)
T ss_pred             HHHH
Confidence            4444

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7e-36  Score=260.00  Aligned_cols=196  Identities=29%  Similarity=0.489  Sum_probs=164.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|+++++.++||||+++++++..     ....++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            5999999999999999999999999999999875431     234579999999999999999999843     345889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+..+++|+||||+|||++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 67666654    367899999999999999999999733899999999999999877 79999999987543


Q ss_pred             cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       220 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.
T Consensus       152 ~~~-~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~  203 (308)
T cd06615         152 DSM-ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDA  203 (308)
T ss_pred             ccc-cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence            322 23456788999999986544 88999999999999999999999986653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=257.12  Aligned_cols=204  Identities=27%  Similarity=0.450  Sum_probs=170.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+.+++.++|+|++++++++..     ....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence            6889999999999999999999999999999885432     234579999999999999999998843     345889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |+||+++ ++.+.+..     .++++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999985 66666543     3789999999999999999999998 999999999999999877 89999999998765


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.+
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~  212 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK  212 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh
Confidence            432 233456788899999986655 89999999999999999999999987665444444333

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-35  Score=251.65  Aligned_cols=206  Identities=33%  Similarity=0.556  Sum_probs=170.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|+..+.||+|+||.||+|.+..++..|++|.+....         ....+|+.+++.++|+||+++++.+     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4778899999999999999998899999999875432         2345799999999999999999877     3334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++++||+++ ++.+++..    ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            58899999985 66666654    35688999999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .............++..|+|||.+.....++.++|+||||+++|+|++|+.||......+....+..
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR  216 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence            7654443334556788999999985443478999999999999999999999988765555555444

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-36  Score=279.60  Aligned_cols=213  Identities=23%  Similarity=0.340  Sum_probs=158.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCC-CcEEEEE------------------EEeec---chhhHHHHHHHHhcCCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLET-GEAVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV  121 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK------------------~~~~~---~~~~~~E~~~l~~l~h~niv  121 (296)
                      ..+|++.+.||+|+||+||+|..... +...+.|                  .+...   ...+.+|+.+|+.++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            35799999999999999999876432 2212211                  11111   12345799999999999999


Q ss_pred             ecceeeeeccCCCceEEEEEEecccccHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE
Q 022520          122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (296)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli  200 (296)
                      ++++++..     ....++|++++.+++..++.... ..........++.++.||+.||.|||++ ||+||||||+|||+
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEE
Confidence            99998843     33478999999988877765432 1123344667788999999999999998 99999999999999


Q ss_pred             cCCCCcEEEeeecceeeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCC--ChHH
Q 022520          201 NPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP-LFPGE--SGVD  275 (296)
Q Consensus       201 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~-pf~~~--~~~~  275 (296)
                      +.++ .+||+|||++........  .....||..|+|||++.+.. ++.++|||||||++|||++|.. ||...  ....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9887 799999999986644322  23457899999999986654 8999999999999999999875 45432  2334


Q ss_pred             HHHHHHHhh
Q 022520          276 QLVEIIKVI  284 (296)
Q Consensus       276 ~~~~~~~~~  284 (296)
                      .+.++...+
T Consensus       379 ~~~~~~~~~  387 (501)
T PHA03210        379 QLLKIIDSL  387 (501)
T ss_pred             HHHHHHHhc
Confidence            444444433

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.5e-36  Score=264.95  Aligned_cols=206  Identities=25%  Similarity=0.420  Sum_probs=161.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeeccC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (296)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|++....     ....+|+.+++.+ +|+||+++++++...  
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence            3579999999999999999997543     45789999885322     2234689999999 899999999877432  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 022520          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (296)
                        ...++++|||+++ +|...+.....                                                     
T Consensus        84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence              2347889999985 66666653221                                                     


Q ss_pred             ----cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC---cccccccc
Q 022520          159 ----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSR  231 (296)
Q Consensus       159 ----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~  231 (296)
                          ...++++..+..++.|++.||+|||++ +|+||||||+||+++.++ .++|+|||++..+.....   .....++.
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCc
Confidence                023688899999999999999999998 999999999999999877 799999999976533221   12234467


Q ss_pred             cccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022520          232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  276 (296)
Q Consensus       232 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  276 (296)
                      .|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.
T Consensus       240 ~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~  284 (337)
T cd05054         240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE  284 (337)
T ss_pred             cccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence            899999986654 8999999999999999997 9999987543333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.2e-36  Score=261.59  Aligned_cols=209  Identities=23%  Similarity=0.358  Sum_probs=162.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcE--EEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||.||+|.+..++..  +++|.+....     ....+|++++.++ +|+||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            34799999999999999999998777654  5777664321     2345799999999 899999999987     334


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~  202 (296)
                      ...++||||++ ++|.+++.....            ....+++..+..++.|++.||+|||++ |++||||||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~  159 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  159 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecC
Confidence            45889999998 577777764321            123578999999999999999999998 9999999999999998


Q ss_pred             CCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       203 ~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      ++ .++|+|||++..............+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            77 89999999986432111111223356799999885544 8899999999999999998 99999876654444333

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-35  Score=260.44  Aligned_cols=209  Identities=39%  Similarity=0.749  Sum_probs=172.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .++|.+.+.||.|+||.||+|.+..+++.||+|.+...      .....+|+++++.++||||+++.++|...    ...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCc
Confidence            45799999999999999999999999999999987431      23445799999999999999999987432    223


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++++||+++++...+..     .+++...+..++.|++.||.|||+. +|+|+||+|+||+++.++ .++|+|||++..
T Consensus        85 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence            789999998887766653     5688888999999999999999998 999999999999999877 899999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+.......+.+.++
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  223 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG  223 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            422  223446688999999886645589999999999999999999999988776555555554443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.6e-36  Score=253.83  Aligned_cols=196  Identities=29%  Similarity=0.466  Sum_probs=167.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...       .....+|+++++.++||||+++++++     .+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            489999999999999999999889999999988532       23445799999999999999999887     445568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++|+||+.+ +|...+..    ..++++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            999999985 66666654    25789999999999999999999998 999999999999999887 899999999876


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            64443344556788999999986544 89999999999999999999999998764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.1e-36  Score=259.54  Aligned_cols=210  Identities=23%  Similarity=0.332  Sum_probs=163.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc--EEEEEEEeec-----chhhHHHHHHHHhc-CCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+|++.+.||+|+||.||+|.+..++.  .+++|.++..     .....+|+.++.++ +||||+++++++.     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            369999999999999999999876664  4688877532     12345799999888 7999999999873     334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~  203 (296)
                      ..++++||++ ++|.+.+.....            ....+++..+..++.|++.||+|||++ ||+||||||+|||++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCC
Confidence            4789999998 577777765321            123588899999999999999999998 99999999999999987


Q ss_pred             CCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       204 ~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      + .++|+|||++..............+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.+
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 79999999986432211111222355799999985544 8899999999999999997 9999988776555555443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4e-36  Score=264.73  Aligned_cols=213  Identities=40%  Similarity=0.725  Sum_probs=174.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhc-CCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++...      .....+|+.+++.+ +|+||+++++++..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            345799999999999999999999888999999987432      12344799999999 99999999998743   233


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ...++||||++++|...+..     ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~-~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDC-RVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccch
Confidence            45789999999887776654     3678888889999999999999998 999999999999999888 8999999998


Q ss_pred             eeeccCCC------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          216 KVLVKGEP------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       216 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ........      .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            76533321      12345788999999886666678999999999999999999999998877766666555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.2e-36  Score=252.94  Aligned_cols=209  Identities=26%  Similarity=0.370  Sum_probs=167.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..+|++.++||+|+||.||+|.+. ++..||+|.+....   ....+|+.+++.++|+||+++++++     .+....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            357999999999999999999864 55679999875432   3445799999999999999998887     33444789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||++ +++.+.+....  ...++...+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 57777775532  45688888999999999999999998 999999999999999877 89999999997654


Q ss_pred             cCCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       220 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .....  ....++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...+..+....+.+.
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG  220 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence            32211  1223466899999985544 7889999999999999998 99999887665555555443

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.9e-36  Score=257.70  Aligned_cols=210  Identities=24%  Similarity=0.364  Sum_probs=168.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ..+|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ..+.+|+++++.++|+||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            346999999999999999999874     346789999885432     3445799999999999999999988433   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh----------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHY----------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~  202 (296)
                        ...++||||++ ++|.+++....          .....+++..+..++.|++.||.+||++ +++|+||||+||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~  157 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGY  157 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcC
Confidence              44889999998 47777776532          1224578889999999999999999998 9999999999999998


Q ss_pred             CCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 022520          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (296)
Q Consensus       203 ~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  278 (296)
                      ++ .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+...
T Consensus       158 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         158 DL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CC-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            87 899999999875433221   12334577899999986554 8999999999999999998 999998877655555


Q ss_pred             HHH
Q 022520          279 EII  281 (296)
Q Consensus       279 ~~~  281 (296)
                      .+.
T Consensus       236 ~~~  238 (280)
T cd05049         236 CIT  238 (280)
T ss_pred             HHH
Confidence            544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.6e-36  Score=255.42  Aligned_cols=212  Identities=21%  Similarity=0.289  Sum_probs=164.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      ...+|++.+.||+|+||.||+|.+.     .++..||+|.+....     ..+.+|+.+++.++|+||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            4567999999999999999999864     245689999874322     1244789999999999999999887     


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~  205 (296)
                      ......++||||++ ++|.+++......      ...++...+..++.|++.||.|||+. +++|+||||+||+++.++ 
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~-  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCC-
Confidence            33344789999998 4777776543211      12356778888999999999999998 999999999999999877 


Q ss_pred             cEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          206 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       206 ~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            799999999875433221   11223467899999986544 8999999999999999998 789998876655444443


Q ss_pred             H
Q 022520          282 K  282 (296)
Q Consensus       282 ~  282 (296)
                      .
T Consensus       236 ~  236 (277)
T cd05062         236 E  236 (277)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=253.85  Aligned_cols=214  Identities=35%  Similarity=0.603  Sum_probs=176.7

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhc---CCCCceecceeeeeccCCCceE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      |++.+.||.|+||.||+|++..++..+|+|.+....      ....+|+.+++.+   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678999999999999999998889999999885321      1233577777665   6999999999987655444556


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .+++|||+++++...+....  ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999988877776532  23689999999999999999999998 999999999999999986 899999999877


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ...........++..|+|||.+.+.. ++.++|+|||||++|+|++|++||...+..+.+..+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG  223 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcC
Confidence            64443334455788899999986654 78999999999999999999999999888777777766443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-35  Score=251.42  Aligned_cols=199  Identities=35%  Similarity=0.589  Sum_probs=167.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+++++.++|+|++++++++..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            4799999999999999999999989999999987421       2234579999999999999999998843     344


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++||||+++ +|..++.........++...+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999984 77777765544456689999999999999999999998 999999999999999877 79999999987


Q ss_pred             eeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       217 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ...... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            653332 123346788999999986544 789999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9e-36  Score=252.38  Aligned_cols=206  Identities=22%  Similarity=0.362  Sum_probs=165.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.+.||+|+||.||++.+. ++..+|+|.+...   .....+|+.+++.++||||+++++++.     .....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence            46899999999999999999874 4567999987543   234567999999999999999998873     33447899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||++ ++|.+.+...   ...+++..+..++.|++.||+|||++ +|+|+||||+||+++.++ .++|+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            99998 5666665542   24688999999999999999999998 999999999999999877 899999999875433


Q ss_pred             CCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+.+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~  216 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR  216 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence            2211  122345679999998654 48899999999999999999 8999998877666666554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.7e-36  Score=263.25  Aligned_cols=200  Identities=24%  Similarity=0.394  Sum_probs=159.9

Q ss_pred             Eeeeeeec--CceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           69 AERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        69 ~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ++++||+|  +|++||++.+..+++.||+|.+....      ....+|+.+++.++||||+++++++..     ....++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            46789999  78999999999999999999885431      234579999999999999999998843     334789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ ++.+++..+.  ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999984 6667765543  34588999999999999999999998 999999999999999877 79999998654322


Q ss_pred             cCCC--------cccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022520          220 KGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  277 (296)
Q Consensus       220 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  277 (296)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  219 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML  219 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence            1111        1123456779999998653 34889999999999999999999999876554433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=257.62  Aligned_cols=209  Identities=26%  Similarity=0.402  Sum_probs=170.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .++|.+.+.||.|+||.||+|.+..++..+|+|.+.....    .+.+|+++++.++|+|++++++.+.     .....+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence            3579999999999999999999988999999998854322    3447999999999999999999884     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ ++.+.+...   ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++ .++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~  153 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDG-DVKLADFGVSAKN  153 (280)
T ss_pred             EEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCC-CEEEccCccchhh
Confidence            99999986 565555443   35689999999999999999999998 999999999999999877 8999999987654


Q ss_pred             ccCC-CcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .... ......+++.|+|||.+..    ...++.++|+||||+++|+|++|++||...+..+.+..+.+
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  222 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK  222 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc
Confidence            3222 2233467889999999742    23367899999999999999999999988776555555443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.6e-36  Score=255.01  Aligned_cols=200  Identities=35%  Similarity=0.580  Sum_probs=166.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+|++.+.||.|+||.||+|++..++..+|+|.+...       .....+|+.+++.++|+||+++++++..     ...
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            3689999999999999999999999999999977432       1233478999999999999999998843     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++|||+++ ++.+++.........+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence            7899999985 77777765444456789999999999999999999998 999999999999999877 89999999987


Q ss_pred             eeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       217 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            6533322 22346788999999986544 7899999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.9e-35  Score=250.91  Aligned_cols=204  Identities=28%  Similarity=0.482  Sum_probs=170.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||.|+||.||++.+..++..+|+|.+....      ....+|+.+++.++|+|++++++.+..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            4889999999999999999999999999999875321      223468999999999999999887743   2334578


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-----ccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ++|||++ ++|.+.+........++++..+..++.||+.||+|||     +. +++|+||||+||+++.++ .++|+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCC-CEEEeccc
Confidence            9999998 4777787765555678999999999999999999999     87 999999999999999877 89999999


Q ss_pred             ceeeeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          214 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       214 ~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      ++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  217 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQ  217 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHH
Confidence            9876644332 33456799999999986544 7899999999999999999999999876433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=254.93  Aligned_cols=210  Identities=40%  Similarity=0.751  Sum_probs=176.1

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+....      ....+|+.+++.++|+||+++++.+.     .....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            567889999999999999998899999999885432      23457999999999999999999873     3345889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |+||+++++...+...   ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999999888777653   25789999999999999999999998 999999999999999877 799999999876644


Q ss_pred             CC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+...+..
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~  217 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT  217 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            33 2233457888999999876646899999999999999999999999988877777666655443

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.5e-36  Score=255.80  Aligned_cols=208  Identities=27%  Similarity=0.421  Sum_probs=168.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .|++.+.||.|+||.||+|.+..++..+++|.+....    ....+|+++++.++|+|++++++.+..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            4788999999999999999999999999999885432    234578999999999999999998843     3457899


Q ss_pred             Eeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      +||++++ +...+...   ..++++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCC-CEEEccccccccccc
Confidence            9999864 44444331   35789999999999999999999998 999999999999999877 899999999865432


Q ss_pred             CC-CcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          221 GE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .. ......+++.|+|||.+..    ...++.++|||||||++|+|++|++||...+..+....+.+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~  223 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS  223 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc
Confidence            21 1233467889999999742    234678999999999999999999999987766665555543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=250.39  Aligned_cols=208  Identities=24%  Similarity=0.347  Sum_probs=167.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..+|++.+.||+|++|.||+|.+. +++.||+|.+....   ....+|+.+++.++|+|++++++++.     .....++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeee
Confidence            357999999999999999999864 45679999885432   34557999999999999999998773     2334789


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||++ ++|.+.+....  ...+++..+..++.|++.||.+||+. +++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENN-ICKVADFGLARVIK  154 (261)
T ss_pred             eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCC-CEEECCcceEEEcc
Confidence            999995 67777766532  35689999999999999999999998 999999999999999887 79999999998764


Q ss_pred             cCCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       220 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      .....  .....+..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+....+..+.+
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  219 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ  219 (261)
T ss_pred             CCcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            32211  111224579999988554 48999999999999999999 9999998776655555544

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-35  Score=252.99  Aligned_cols=196  Identities=27%  Similarity=0.531  Sum_probs=163.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      +|+..+.||+|++|.||++.+..+++.+|+|.+....          ....+|+++++.++|+||+++++++     .+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4788899999999999999999999999999885322          2345799999999999999999988     344


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++|+||+.+ +|.+.+..    ..++++..+..++.|++.||.|||++ |++|+||+|+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            458899999985 66666654    35788999999999999999999998 9999999999999987765799999999


Q ss_pred             eeeeccCCC-----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          215 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       215 ~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      +........     .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            876543211     1234568899999998654 47899999999999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=261.23  Aligned_cols=211  Identities=37%  Similarity=0.661  Sum_probs=173.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCC-Cce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~  136 (296)
                      .++|.+.+.||+|+||.||+|.+..++..||+|.+....      ....+|+++++.++|+||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            357999999999999999999999999999999874321      2345799999999999999999987433221 123


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++||+|+++++...+..     ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            4689999998777766643     5789999999999999999999998 999999999999999877 79999999987


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .....  .....+++.|+|||.+.+...++.++|+||||+++|++++|+.||.+.+....+..+.+.
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07880         167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV  231 (343)
T ss_pred             ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            54322  233456889999999865455789999999999999999999999988766666655553

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.5e-36  Score=258.50  Aligned_cols=197  Identities=27%  Similarity=0.457  Sum_probs=164.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+....    ....+|+.+++.++|+|++++++++.     .....+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence            357999999999999999999999999999999885322    23457899999999999999999883     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ ++.+.+..     ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEECcCccceEc
Confidence            99999985 66665543     4678889999999999999999998 999999999999999877 8999999998765


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~  220 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            33322 223467889999999865 4478999999999999999999999977554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=259.12  Aligned_cols=220  Identities=36%  Similarity=0.593  Sum_probs=184.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+.+-.+.||.|+||.||.+.|..+|+.||+|++..-      .+...+|+++|-.++|.|++...++.-.....-...+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3566678999999999999999999999999988532      2344589999999999999998876532222111225


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      |+++|.+..+|...+-.    .+.++.+.++-+++||++||.|||+- +|.||||||.|.|++++- .+||||||+++..
T Consensus       133 YV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNC-vLKICDFGLARve  206 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNC-ILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCc-eEEeccccccccc
Confidence            67888888877776665    57899999999999999999999998 999999999999999876 7999999999865


Q ss_pred             ccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcc
Q 022520          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       219 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  290 (296)
                      ..+.  .....+-|.+|+|||+++|.+.|+.+.||||.|||+.|++..+..|...++.+++..|...++.|..+
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            3332  22345669999999999999999999999999999999999999999999999999999999888654

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.2e-35  Score=256.01  Aligned_cols=211  Identities=23%  Similarity=0.366  Sum_probs=167.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|.+.+.||+|+||.||++.+.     .++..+|+|.+....    ....+|+++++.++|+||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            357999999999999999999852     345678999875432    23457999999999999999999873     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhh---------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYK---------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~  204 (296)
                      ....++||||++ ++|.+++.....         ....+++..+..++.|++.||+|||++ |++||||||+||+++.++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCC
Confidence            345889999998 577777764321         123589999999999999999999998 999999999999999887


Q ss_pred             CcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          205 HQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       205 ~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                       .++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.+..+
T Consensus       158 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         158 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             -cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             899999999875533221   112334678999999855 448899999999999999998 89999887665555555


Q ss_pred             HH
Q 022520          281 IK  282 (296)
Q Consensus       281 ~~  282 (296)
                      .+
T Consensus       236 ~~  237 (288)
T cd05093         236 TQ  237 (288)
T ss_pred             Hc
Confidence            44

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=265.58  Aligned_cols=229  Identities=25%  Similarity=0.398  Sum_probs=184.2

Q ss_pred             CCCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----------hhHHHHHHHHhcCCCCceeccee
Q 022520           58 NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----------YKNRELQTMRLLDHPNVVSLKHC  126 (296)
Q Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~E~~~l~~l~h~niv~~~~~  126 (296)
                      ...+...++|.++..||+|||+.||+|.+...++.||||+-.....           ..-+|..|-+.|+||.||++|++
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            3455667789999999999999999999999999999996632211           11268899999999999999999


Q ss_pred             eeeccCCCceEEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC-CceeccCCCCceEEcCC-
Q 022520          127 FFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-GVCHRDIKPQNLLVNPH-  203 (296)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~iiH~Dlkp~NIli~~~-  203 (296)
                      |.....    .+|-|+|||+|. |.-+++.    ..-+++.+++.|+.||+.||.||.+.. .|||-||||.|||+-.. 
T Consensus       536 fslDtd----sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  536 FSLDTD----SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             eeeccc----cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence            854332    278899999984 4445555    467899999999999999999998742 69999999999999543 


Q ss_pred             -CCcEEEeeecceeeeccCCC--------cccccccccccCCccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          204 -THQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       204 -~~~ikl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                       -+.|||+|||+++.+.++..        .....||.||++||.+.-   .+..+.+.||||+|||+|+.+.|+.||...
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence             22799999999988755432        234578999999999843   355788999999999999999999999988


Q ss_pred             ChHHHHHHHHHhhcCCCcccccc
Q 022520          272 SGVDQLVEIIKVILHTEISLSIK  294 (296)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~  294 (296)
                      -....+.+--..+...++.++.|
T Consensus       688 qsQQdILqeNTIlkAtEVqFP~K  710 (775)
T KOG1151|consen  688 QSQQDILQENTILKATEVQFPPK  710 (775)
T ss_pred             hhHHHHHhhhchhcceeccCCCC
Confidence            77677777777777778777665

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-35  Score=253.05  Aligned_cols=205  Identities=32%  Similarity=0.550  Sum_probs=167.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------------hhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      +|.+...||.|+||.||+|.+..++..+|+|.+....             ....+|+.+++.++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            4788899999999999999998899999999874321             224578999999999999999998743   


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                        ..+.+++|||+++ +|..++..    ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCC-CEEecc
Confidence              3457899999985 66666654    35688899999999999999999998 999999999999999877 899999


Q ss_pred             ecceeeeccCCC-------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          212 FGSAKVLVKGEP-------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       212 fg~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ||.+........       .....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  226 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE  226 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence            999876642211       11234678899999986544 78899999999999999999999998766555544433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-35  Score=251.18  Aligned_cols=206  Identities=21%  Similarity=0.358  Sum_probs=165.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|.+.+.||+|+||.||+|.+.. +..+|+|.+....   ..+.+|+.+++.++||||+++++++.     .....+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence            469999999999999999998753 4569999875432   34567999999999999999999873     23347899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+.+ ++.+.+...   ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999985 676666543   24689999999999999999999998 999999999999999877 899999999876543


Q ss_pred             CCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ....  ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.+
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~  216 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ  216 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc
Confidence            3211  1223456799999986544 8899999999999999998 9999987766555444444

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=253.91  Aligned_cols=210  Identities=22%  Similarity=0.283  Sum_probs=166.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ..+|.+.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            45799999999999999999998643     4789999875332     23457899999999999999999883     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~  206 (296)
                      .....++||||++ ++|.+.+......      ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCC-C
Confidence            3345789999997 5777777643311      23467888999999999999999998 999999999999999887 8


Q ss_pred             EEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          207 LKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       207 ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ++|+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|++++ |..||...+..+....+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  235 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI  235 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence            99999999875533221   12234577899999985544 8999999999999999998 999998877655544444

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-35  Score=252.34  Aligned_cols=208  Identities=29%  Similarity=0.479  Sum_probs=170.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||.|+||+||+|.+..++..+++|++....     ....+|+++++.++|+|++++++.+.     .....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEEE
Confidence            6999999999999999999998899999999885322     34457999999999999999988873     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||++++ ++.+.+..... ...+++..+..++.|++.||++||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999985 66666654321 24688999999999999999999998 999999999999999877 79999999986654


Q ss_pred             cCCCc-----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          220 KGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       220 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .....     ....++..|+|||.+.....++.++|+|||||++|+|++|+.||...+....+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~  220 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL  220 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh
Confidence            43222     234578899999998665458899999999999999999999998776554444433

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-35  Score=251.32  Aligned_cols=205  Identities=27%  Similarity=0.376  Sum_probs=164.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.++||+|+||.||+|.+..+ ..||+|.+....   ..+.+|+++++.++|+||+++++.+.     . ...++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence            4799999999999999999988655 459999886422   34567999999999999999987652     1 226799


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+++ ++.+++....  ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 7777776432  34578899999999999999999998 999999999999999877 799999999976543


Q ss_pred             CCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ....  ....++..|+|||...+.. ++.++|||||||++|+|++ |..||.+....+.+..+.
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~  217 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  217 (262)
T ss_pred             cccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh
Confidence            3221  1234567899999885444 8999999999999999999 889998876655544443

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=252.72  Aligned_cols=212  Identities=22%  Similarity=0.358  Sum_probs=165.3

Q ss_pred             eEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           67 YMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      |.+.+.||+|+||.||.|.+..+   +..||+|.+....      ....+|+..++.++|+||+++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56789999999999999987643   4789999886432      234578999999999999999987754332 2334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..++++||++ +++...+.....  ....+++..+..++.|++.||.|||+. +++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCC-eEEECCcc
Confidence            5789999998 466666644321  224688999999999999999999998 999999999999999877 89999999


Q ss_pred             ceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       214 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      +++........   .....+..|+|||.+.+. .++.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~  229 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR  229 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99865433211   112346689999998544 48999999999999999999 889998876655544443

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=254.87  Aligned_cols=211  Identities=27%  Similarity=0.430  Sum_probs=170.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHHH-HHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++.+-...||.|.||+|++..++..|+..|||++.....     .+..|.+. ++.-+.||||++|+..+....     .
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c  138 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C  138 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence            345556789999999999999999999999999965432     22345544 344578999999998865443     7


Q ss_pred             EEEEecccccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ||.||.|.-++..+.+..+. ....+++..+-.+.-..+.||+||...+.|||||+||+|||++..| .+||||||++..
T Consensus       139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHh
Confidence            89999999888877665543 2467888888888888999999999988999999999999999988 799999999987


Q ss_pred             eccCCCcccccccccccCCccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEII  281 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~~~  281 (296)
                      +.+.-......|...|||||.+..... |..++|+||||++|||+.||+.||.+-++ .+++.+++
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv  283 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV  283 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence            666555556678888999999965544 89999999999999999999999998654 34444443

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-38  Score=295.80  Aligned_cols=222  Identities=27%  Similarity=0.472  Sum_probs=180.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee------cchhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .-..+|.-...||.|.||.||-|.+..+|+..|+|-++.      ......+|..+|..++|||+|+++++-++-..   
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--- 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--- 1308 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH---
Confidence            344567888899999999999999999999999997742      12344589999999999999999987644332   


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                        .+|.||||.+ +|.+++.+    ++..++...+.+..|++.|++|||++ ||+||||||+|||++.++ .+|++|||.
T Consensus      1309 --v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g-~iK~~DFGs 1380 (1509)
T KOG4645|consen 1309 --VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNG-LIKYGDFGS 1380 (1509)
T ss_pred             --HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCC-cEEeecccc
Confidence              7789999995 55555554    46677778888999999999999999 999999999999999888 899999999


Q ss_pred             eeeeccCCCc-----ccccccccccCCccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          215 AKVLVKGEPN-----ISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       215 ~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      |..+.+....     ....||+.|||||++.+..  ...-++|||||||++.||+||+.||...+..=++---+....+|
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence            9887555322     3567999999999996543  35678999999999999999999999988765555556666677


Q ss_pred             Ccccccc
Q 022520          288 EISLSIK  294 (296)
Q Consensus       288 ~~~~~~~  294 (296)
                      ++|.++.
T Consensus      1461 q~P~~ls 1467 (1509)
T KOG4645|consen 1461 QIPERLS 1467 (1509)
T ss_pred             CCchhhh
Confidence            7766543

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-35  Score=260.69  Aligned_cols=210  Identities=37%  Similarity=0.647  Sum_probs=171.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4799999999999999999999989999999988532      1234579999999999999999998754322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|++|+...+....      ...+++..+..++.|++.||.|||++ +++||||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6899999987655433      24688999999999999999999998 999999999999999887 899999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~  231 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  231 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            422  22345678899999998665558899999999999999999999999887666665555533

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.4e-35  Score=254.72  Aligned_cols=214  Identities=27%  Similarity=0.422  Sum_probs=171.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhc-CCCCceecceeeeeccC-CCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~  138 (296)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|.+....   .....|+.+++.+ +|+|++++++++..... ....++
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            357999999999999999999999999999999875432   2345688888888 79999999998864332 234568


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|||+++ ++.+++....  ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~-~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCcchhh
Confidence            899999985 6767665432  35688888999999999999999998 999999999999999887 799999999865


Q ss_pred             eccC-CCcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          218 LVKG-EPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       218 ~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .... .......+++.|+|||.+..    ...++.++|+|||||++|+|++|+.||........+..+.
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~  239 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP  239 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence            4321 12234567889999998752    2347889999999999999999999998766555444433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.4e-36  Score=257.57  Aligned_cols=201  Identities=25%  Similarity=0.399  Sum_probs=164.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|...+.||+|+||.||++.+..+++.+|+|.+...     .....+|+.++.++. |+||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            567788999999999999999999999999988532     123457888888886 9999999998743     23377


Q ss_pred             EEEecccccHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++|||++.++..+..... .....+++..+..++.|++.||+|||+..+++||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            999999887666544322 12467999999999999999999999744999999999999999877 7999999998765


Q ss_pred             ccCCCcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          219 VKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ..........++..|+|||.+.+.  ..++.++|||||||++|+|++|++||....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            444334445678899999998655  358899999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-38  Score=253.13  Aligned_cols=217  Identities=33%  Similarity=0.577  Sum_probs=182.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee-cc-----hhhHHHHHHHHhcCCCCceecceeeeec---cCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DK-----RYKNRELQTMRLLDHPNVVSLKHCFFST---TEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~  135 (296)
                      ..|.-..++|+|.||.||+|+...+++.||+|+..- ..     ....+|+++|+.++|+|++.+++.+-..   ...+.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            358888899999999999999999999999986532 11     1124899999999999999988776322   22345


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..+++|+.+|+.+|..++...   ..+++..++.+++++++.||.|+|.. .|+|||+||+|+||+.++ .+||+|||++
T Consensus        97 ~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dg-ilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDG-ILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCc-eEEeeccccc
Confidence            568999999999888887764   46899999999999999999999998 999999999999999988 8999999999


Q ss_pred             eeeccCCC-----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          216 KVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       216 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      +.+.....     -...+-|.+|++||.+.|...|+++.|||..||++.||.|+.+-|++.+...++..|...++.
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            76533221     123455999999999999999999999999999999999999999999998888877776654

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-35  Score=250.18  Aligned_cols=199  Identities=23%  Similarity=0.340  Sum_probs=158.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      +.||+|+||.||+|++..+++.+|+|.+....     ....+|+++++.++|+||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            46899999999999999899999999875322     23567999999999999999999873     334478999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~  224 (296)
                      ++ ++.+.+...   ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            85 666665432   34688999999999999999999998 999999999999999877 7999999998754322111


Q ss_pred             c---cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          225 I---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       225 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      .   ....+..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~  209 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI  209 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence            1   112245699999986544 7899999999999999997 88999876654443333

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-35  Score=250.79  Aligned_cols=203  Identities=29%  Similarity=0.498  Sum_probs=164.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+....          ....+|+++++.++|+||+++++++.     +.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            488899999999999999986 478899999875332          23457999999999999999999883     34


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++++||+++ +|.+.+..    ..++++..+..++.|++.||+|||+. +|+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568999999985 66666654    35688999999999999999999998 999999999999999877 899999998


Q ss_pred             eeeeccC-------CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          215 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       215 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      +......       .......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  221 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG  221 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence            8654211       1112345788999999986544 7899999999999999999999998766555444443

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.7e-35  Score=252.58  Aligned_cols=199  Identities=25%  Similarity=0.409  Sum_probs=160.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc----EEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|++.+.||+|+||+||+|++..++.    .||+|.+....     ....+|..+++.++|+||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   81 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-----   81 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence            479999999999999999999876665    48999875322     2334788899999999999998877421     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                       ..+++++|++ |++.+.+...   ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||+
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~-~~kL~dfG~  155 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC-cEEECCCCc
Confidence             2568999998 5777776543   35689999999999999999999998 999999999999998777 799999999


Q ss_pred             eeeeccCCCcc---cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022520          215 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (296)
Q Consensus       215 ~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~  275 (296)
                      ++.........   ...+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  219 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPARE  219 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            98664332221   123467899999986544 8899999999999999998 899998765433

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.2e-35  Score=252.03  Aligned_cols=212  Identities=22%  Similarity=0.348  Sum_probs=162.7

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCc--EEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      +.+.+.||+|+||.||+|++..++.  .+|+|.++..      .....+|+++++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999876664  6899977532      1234578999999999999999987654322 12234


Q ss_pred             EEEEEeccc-ccHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          138 LNLVLEYVP-ETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .+++|||+. +++.+.+....  .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 56666654322  1224578999999999999999999998 999999999999999877 799999999


Q ss_pred             eeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          215 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       215 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      +........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  228 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR  228 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            876533221   1122346789999998554 48999999999999999999 889998876554444443

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-37  Score=267.25  Aligned_cols=197  Identities=26%  Similarity=0.429  Sum_probs=161.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee------cchhhHHHHHHHHhcC-CCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  135 (296)
                      ....|+++++||+||.+.||++... +...+|+|++..      ....+.+|++.|.+|+ |.+|++++++-     -..
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d  432 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTD  432 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccC
Confidence            3346999999999999999999864 445677776532      1234568999999994 89999999976     345


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .++|+||||-+.+|...+....   ...+..+++.+++||+.++.++|.+ ||||.||||.|+|+-. | .+||+|||+|
T Consensus       433 ~~lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlVk-G-~LKLIDFGIA  506 (677)
T KOG0596|consen  433 GYLYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLVK-G-RLKLIDFGIA  506 (677)
T ss_pred             ceEEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEEe-e-eEEeeeechh
Confidence            6799999998888888887753   4455558999999999999999999 9999999999999985 3 7999999999


Q ss_pred             eeeccCCCc---ccccccccccCCccccCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          216 KVLVKGEPN---ISYICSRYYRAPELIFGAT----------EYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       216 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ..+..+..+   -+.+||+.||+||.+....          ..++++||||||||||+|+.|+.||...
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            988776654   3568999999999984221          1467899999999999999999999764

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-35  Score=261.56  Aligned_cols=213  Identities=37%  Similarity=0.641  Sum_probs=176.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      .++|.+.+.||+|++|.||+|++..++..||+|.+....      ....+|+.+++.++|+|++++.+++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            347999999999999999999999999999999875321      223469999999999999999887744332 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++|++|++++|.+.+..     .++++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~-~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEccccccc
Confidence            4789999998888777764     5789999999999999999999998 999999999999999877 89999999987


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      .....  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+...
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~  233 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG  233 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence            65322  33446788999999986554578999999999999999999999998887777776666544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.6e-35  Score=256.25  Aligned_cols=201  Identities=30%  Similarity=0.516  Sum_probs=167.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+++++.++|||++++.+++...     ..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence            35999999999999999999998899999999885321       2345789999999999999999988533     33


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|+||+.+++.+.+...   ..++++..+..++.|++.||.|||+. +|+|+||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPG-TVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCC-CEEEeecCccee
Confidence            7899999999888777643   35689999999999999999999998 999999999999999887 899999999875


Q ss_pred             eccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      ...   .....+++.|+|||++.+  ...++.++||||||+++|+|++|++||.+.+....+.
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~  224 (307)
T cd06607         165 VSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY  224 (307)
T ss_pred             cCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH
Confidence            432   234567889999998742  3447889999999999999999999998766544433

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.3e-35  Score=253.60  Aligned_cols=205  Identities=29%  Similarity=0.523  Sum_probs=166.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +|.+.+.||+|+||.||++.+..+++.|++|.+....       ....+|+++++.++||||+++++.+     ......
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            6899999999999999999999999999999885432       2334789999999999999999887     334458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|...+..    ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            999999985 66666654    35789999999999999999999998 999999999999999877 899999998763


Q ss_pred             eccCC----------------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          218 LVKGE----------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       218 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .....                ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+.+..+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            11000                001234677899999986544 8999999999999999999999998876555455444


Q ss_pred             H
Q 022520          282 K  282 (296)
Q Consensus       282 ~  282 (296)
                      .
T Consensus       230 ~  230 (305)
T cd05609         230 S  230 (305)
T ss_pred             h
Confidence            3

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.8e-36  Score=252.98  Aligned_cols=208  Identities=24%  Similarity=0.362  Sum_probs=170.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..+|++.+.||.|+||.||+|.+.. +..+++|.+....    ....+|+.+++.++|+||+++++++.     +....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            3479999999999999999999877 8899999885433    24457999999999999999988873     334478


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ +|.+++....  ...++...+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999985 7777776532  35688999999999999999999998 999999999999999887 8999999998765


Q ss_pred             ccCCCc-ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...... ....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||...+..+.+..+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~  219 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA  219 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh
Confidence            333211 123346789999998554 48899999999999999998 8999988776666665554

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.4e-35  Score=253.39  Aligned_cols=203  Identities=21%  Similarity=0.340  Sum_probs=161.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEc----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|++.+.||+|+||.||+|.+.    .++..+++|.+....     ..+.+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            46899999999999999999853    456789999885322     234579999999999999999988733     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhh-------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYK-------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~  201 (296)
                      ...+++|||+++ +|.+++.....             ....+++..+..++.|++.||.|||++ +++|+||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEc
Confidence            347899999984 67766643210             123478888999999999999999998 999999999999999


Q ss_pred             CCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022520          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (296)
Q Consensus       202 ~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~  275 (296)
                      .++ .++|+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            877 799999999976533221   12234467799999986544 8999999999999999998 999998766533

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=250.32  Aligned_cols=205  Identities=22%  Similarity=0.362  Sum_probs=164.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+....   ....+|+++++.++|+||+++++++     ......++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            35889999999999999999875 46679999875432   2445799999999999999998887     333457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+++ +|.+.+...   ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||+++...+
T Consensus        78 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCC-cEEECCcccceeccc
Confidence            999975 677766543   24688999999999999999999998 999999999999999877 799999999876543


Q ss_pred             CCCcc--cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .....  ...++..|+|||.+.+.. ++.++||||||+++|+|++ |++||...+..+....+.
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  215 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS  215 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Confidence            22111  122345799999986544 8899999999999999998 899998876655554443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=267.85  Aligned_cols=215  Identities=26%  Similarity=0.380  Sum_probs=171.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCC----cEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      .+-.+.++||+|+||.||+|+....+    ..||+|..+.+.       ..+.+|.++++.++|||||++|++...... 
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P-  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP-  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence            34455689999999999999976432    238999876421       223479999999999999999998754443 


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                          +++|||+|.| +|.+++....   ..++..+...++.+.++||+|||++ ++|||||-..|+|++.+. .+||+||
T Consensus       236 ----l~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~-~vKISDF  306 (474)
T KOG0194|consen  236 ----LMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKG-VVKISDF  306 (474)
T ss_pred             ----cEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCC-eEEeCcc
Confidence                8899999995 7888887742   3699999999999999999999999 999999999999999876 6899999


Q ss_pred             cceeeeccCCCcc-cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCcc
Q 022520          213 GSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       213 g~~~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  290 (296)
                      |+++....-.... ...-+..|+|||.+... .|++++|||||||++||+++ |..||.+....+....+.....+.+.+
T Consensus       307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~  385 (474)
T KOG0194|consen  307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP  385 (474)
T ss_pred             ccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence            9987542111111 11235789999999655 59999999999999999997 889999999888888886656555544

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-35  Score=253.14  Aligned_cols=195  Identities=30%  Similarity=0.461  Sum_probs=156.9

Q ss_pred             ce-EEeeeeeecCceEEEEEEE----cCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           66 SY-MAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        66 ~y-~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      +| .+.+.||+|+||+||++..    ..++..||+|.+....     ..+.+|+++++.++||||+++++++...   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            45 8999999999999988753    3567899999886432     2345799999999999999998876432   23


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...+++|||+++ ++.+.+..     ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDR-LVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCC-cEEEeeccc
Confidence            457899999985 66666543     4589999999999999999999998 999999999999999876 899999999


Q ss_pred             eeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       215 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      +........    .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            876543221    1122346679999998654 4889999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5e-35  Score=253.96  Aligned_cols=211  Identities=24%  Similarity=0.386  Sum_probs=166.2

Q ss_pred             CccccceEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeee
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (296)
                      +....+|.+.+.||+|+||.||++.+     ..++..+|+|.+....     ....+|+++++++ +|+||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            34445799999999999999999985     2345689999875432     2345799999999 79999999998733


Q ss_pred             ccCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          130 TTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       130 ~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                           ....+++|||+. ++|..++....  ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++
T Consensus       111 -----~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~  181 (302)
T cd05055         111 -----GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGK-IVK  181 (302)
T ss_pred             -----CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCC-eEE
Confidence                 334789999998 57777765422  23489999999999999999999998 999999999999999776 899


Q ss_pred             EeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          209 LCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      |+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+......
T Consensus       182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~  257 (302)
T cd05055         182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI  257 (302)
T ss_pred             ECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH
Confidence            999999875533221   11233467899999986554 7899999999999999998 999998766555444443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.6e-35  Score=262.70  Aligned_cols=214  Identities=24%  Similarity=0.388  Sum_probs=166.5

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcC-CCCceecceeee
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFF  128 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~  128 (296)
                      ......+|.+.+.||+|+||.||+|++.     ..++.||+|++....     ....+|+++|..+. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344557899999999999999999863     345689999986432     23457999999997 999999999883


Q ss_pred             eccCCCceEEEEEEeccc-ccHHHHHHHhhh-------------------------------------------------
Q 022520          129 STTEKDELYLNLVLEYVP-ETVHRVIKHHYK-------------------------------------------------  158 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~-------------------------------------------------  158 (296)
                      .     ....++||||+. |+|.+++.....                                                 
T Consensus       112 ~-----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         112 K-----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             c-----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            3     334789999998 577777754321                                                 


Q ss_pred             ---------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccC
Q 022520          159 ---------------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI  193 (296)
Q Consensus       159 ---------------------------------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dl  193 (296)
                                                                   ....+++..+..++.|++.||.|||+. +++||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdl  265 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDL  265 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccC
Confidence                                                         112356777888999999999999998 9999999


Q ss_pred             CCCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 022520          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  269 (296)
Q Consensus       194 kp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  269 (296)
                      ||+|||++.++ .++|+|||+++.......   .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus       266 kp~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         266 AARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             CcceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999876 899999999876532221   12334678899999986544 7899999999999999998 899998


Q ss_pred             CCChHHHHHHHH
Q 022520          270 GESGVDQLVEII  281 (296)
Q Consensus       270 ~~~~~~~~~~~~  281 (296)
                      .....+.+....
T Consensus       344 ~~~~~~~~~~~~  355 (401)
T cd05107         344 ELPMNEQFYNAI  355 (401)
T ss_pred             CCCchHHHHHHH
Confidence            766555544433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.9e-36  Score=256.06  Aligned_cols=210  Identities=22%  Similarity=0.327  Sum_probs=163.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      .+|++.+.||+|+||.||+|.+..     ++..||+|.+....     ..+.+|+.++..++||||+++++.+..     
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence            468899999999999999998754     35789999886432     234578899999999999999998733     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~  201 (296)
                      ....+++++|+.+ ++..++....            .....++...+..++.|++.||.|||++ ||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVF  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEec
Confidence            3337899999984 6666654211            1123578888999999999999999998 999999999999999


Q ss_pred             CCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022520          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (296)
Q Consensus       202 ~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  277 (296)
                      .++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+.+
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            876 799999999875533221   12234467899999986544 8899999999999999998 88999887665554


Q ss_pred             HHHHH
Q 022520          278 VEIIK  282 (296)
Q Consensus       278 ~~~~~  282 (296)
                      ..+.+
T Consensus       237 ~~i~~  241 (283)
T cd05091         237 EMIRN  241 (283)
T ss_pred             HHHHc
Confidence            44443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.1e-35  Score=247.27  Aligned_cols=202  Identities=23%  Similarity=0.350  Sum_probs=162.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      .+|.+.+.||+|+||.||++..  .+..+|+|.+....  ..+.+|+.+++.++|+|+++++++++..    ....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            4799999999999999999987  57789999885443  2345899999999999999999876432    23378999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ +|.+.+....  ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99984 7777766532  23578899999999999999999998 999999999999999877 8999999998754332


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~  279 (296)
                      .  ....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...+..+....
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  211 (256)
T ss_pred             C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            2  223345679999998554 48899999999999999997 9999987665443333

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=250.40  Aligned_cols=204  Identities=30%  Similarity=0.460  Sum_probs=167.5

Q ss_pred             ccceEEe-eeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHh-cCCCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      +++|++. ++||-|-.|.|..+.++.+|+.+|+|++.. .....+|+++--. -.|+|||.++++|-... .+..++.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEee
Confidence            3467765 579999999999999999999999997743 4444567776443 36999999999984443 556788899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeecceeee
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  218 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg~~~~~  218 (296)
                      ||+++| .|...+..+.  ...+++.++..|++||..|+.|||+. +|.||||||+|+|.....  -.+||+|||+|+..
T Consensus       138 mE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             eecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEeccccccccc
Confidence            999996 5555555543  56799999999999999999999998 999999999999996532  26899999999876


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .......+...||.|.|||++ +...|+...|+||+||++|-|+.|.+||.....
T Consensus       215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg  268 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_pred             CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence            544445566779999999998 556699999999999999999999999987654

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.8e-35  Score=255.20  Aligned_cols=205  Identities=23%  Similarity=0.411  Sum_probs=161.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcC-------CCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeee
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (296)
                      ..++|.+.+.||+|+||.||+|++..       +...+|+|.+....     ....+|+++++.+ +|+||+++++++. 
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-   94 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   94 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence            34679999999999999999998743       23569999886432     1234689999999 7999999999883 


Q ss_pred             ccCCCceEEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCC
Q 022520          130 TTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (296)
Q Consensus       130 ~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~  196 (296)
                          .....++||||++ ++|.+++.....            ....++...+..++.|++.||+|||++ |++|+||||+
T Consensus        95 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~  169 (307)
T cd05098          95 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAAR  169 (307)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHH
Confidence                3334789999998 578777765421            123588889999999999999999998 9999999999


Q ss_pred             ceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022520          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (296)
Q Consensus       197 NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~  272 (296)
                      ||+++.++ .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+
T Consensus       170 Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         170 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             heEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            99999887 899999999875532211   11122356899999986544 8999999999999999998 889998765


Q ss_pred             hHH
Q 022520          273 GVD  275 (296)
Q Consensus       273 ~~~  275 (296)
                      ..+
T Consensus       248 ~~~  250 (307)
T cd05098         248 VEE  250 (307)
T ss_pred             HHH
Confidence            433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-34  Score=250.13  Aligned_cols=199  Identities=28%  Similarity=0.462  Sum_probs=165.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|...+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+++++.++|+||++++++|...   ....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            6899999999999999999999999999999886432     2345899999999999999999887433   2334789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ +|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999985 77666665444456789999999999999999999998 999999999999999877 79999999986543


Q ss_pred             cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       220 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...
T Consensus       157 ~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         157 NSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            322 1234568889999998554 4889999999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.8e-35  Score=249.67  Aligned_cols=205  Identities=25%  Similarity=0.413  Sum_probs=163.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc---EEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..|++.+.||+|+||.||+|.+..+++   .||+|.+...     ...+..|+.+++.++||||+++++++.     +..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence            369999999999999999999876654   6999987543     123457999999999999999998873     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+++...   ...++...+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCC-cEEECCCccc
Confidence            47899999985 666666543   35688999999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCCCccc---cc---ccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          216 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       216 ~~~~~~~~~~~---~~---~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      ...........   ..   .+..|+|||.+.+.. ++.++|||||||++|||++ |..||...+..+....+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i  224 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI  224 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            76533222111   11   135799999986544 7999999999999999986 99999887665544444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.5e-35  Score=250.31  Aligned_cols=207  Identities=28%  Similarity=0.412  Sum_probs=164.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCC---cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+|++.+.||+|+||.||+|++..++   ..+|+|.+....     ....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            47999999999999999999986444   379999875322     23457899999999999999998873     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+.+...   ...++...+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            47899999985 666666543   35688999999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCCCcc----cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..........    ...++..|+|||.+.+.. ++.++|+|||||++|++++ |..||...+..+....+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~  224 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE  224 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC
Confidence            7654332111    112256799999986544 8999999999999999886 9999988766555554443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5e-35  Score=249.20  Aligned_cols=206  Identities=24%  Similarity=0.364  Sum_probs=164.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+|++.+.||+|+||.||+|.+..+   ...||+|.+....     ..+.+|+.+++.++|+||+++++.+.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            4699999999999999999998643   4689999875332     22346899999999999999999873     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..+++|||+++ +|.+++...   ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999985 677666543   24789999999999999999999998 999999999999999877 7999999999


Q ss_pred             eeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          216 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       216 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .........   ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE  222 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            876422211   122335689999998654 48899999999999999997 999998776555444443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-36  Score=278.49  Aligned_cols=210  Identities=24%  Similarity=0.376  Sum_probs=174.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      +.+..+.||+|.||+||+|+..     .+...||||.++...     ..+++|++++..++|||||++++++...+.   
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P---  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP---  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe---
Confidence            4677889999999999999863     345689999886543     346799999999999999999999954443   


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh------c----CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYK------M----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~------~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~  204 (296)
                        +++|+|||. |+|.++|..+..      .    ..+++..+...|+.||+.|++||-++ .++||||...|+||..+.
T Consensus       564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccce
Confidence              889999998 899999875541      1    23488889999999999999999998 999999999999999887


Q ss_pred             CcEEEeeecceeeeccCCCcc---cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          205 HQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       205 ~~ikl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                       .|||+|||+++.+.......   ...-+.+|||||.++.++ +++++||||+||+|||+++ |+.||.+.++.+.+..+
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             89999999998764433211   223377899999997555 9999999999999999996 99999999988887766


Q ss_pred             HHh
Q 022520          281 IKV  283 (296)
Q Consensus       281 ~~~  283 (296)
                      .+.
T Consensus       719 ~~g  721 (774)
T KOG1026|consen  719 RAG  721 (774)
T ss_pred             HcC
Confidence            654

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.1e-35  Score=258.89  Aligned_cols=207  Identities=25%  Similarity=0.414  Sum_probs=160.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeeccC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (296)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|.+....     ....+|+.++..+ +|+||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            357999999999999999999853     467899999885432     2244799999999 689999999877432  


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  158 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~-----------------------------------------------------  158 (296)
                        ...++++|||++ ++|.+++.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              234789999998 467666654210                                                     


Q ss_pred             ----------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc---c
Q 022520          159 ----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---I  225 (296)
Q Consensus       159 ----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~---~  225 (296)
                                ....++...+..++.|++.||+|||++ +|+||||||+||+++.++ .++|+|||++.........   .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcC
Confidence                      012467788889999999999999998 999999999999999877 8999999998765332211   1


Q ss_pred             cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022520          226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (296)
Q Consensus       226 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  277 (296)
                      ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........+
T Consensus       240 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  291 (343)
T cd05103         240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  291 (343)
T ss_pred             CCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH
Confidence            223456799999986544 8999999999999999996 99999876543333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-35  Score=247.80  Aligned_cols=210  Identities=26%  Similarity=0.369  Sum_probs=169.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..++|.+.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+.+++.++|+||+++++++.     .....+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence            3457999999999999999999975 4577999988643   234568999999999999999988873     333478


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ +|.+.+....  ...++...+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++...
T Consensus        78 ~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~  153 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENL-VCKIADFGLARLI  153 (261)
T ss_pred             EEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCC-CEEECccccceec
Confidence            99999985 7777765532  35688999999999999999999998 999999999999999887 8999999998765


Q ss_pred             ccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       219 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .....  ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.+....+..+...
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG  220 (261)
T ss_pred             cchhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            43211  11223356799999986544 8999999999999999998 99999887766666665543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.7e-35  Score=252.70  Aligned_cols=208  Identities=24%  Similarity=0.367  Sum_probs=166.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....    ....+|+.+++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            46999999999999999999864     345678899875432    34568999999999999999999873     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~  202 (296)
                      ...++||||++ ++|.+++..+..            ....+++..+..++.||+.||+|||++ +|+||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEcc
Confidence            44789999997 577777765321            123578899999999999999999998 9999999999999998


Q ss_pred             CCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 022520          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (296)
Q Consensus       203 ~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  278 (296)
                      ++ .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...+..+.+.
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 899999999875433211   12334578899999986544 8899999999999999998 999998776655444


Q ss_pred             HH
Q 022520          279 EI  280 (296)
Q Consensus       279 ~~  280 (296)
                      .+
T Consensus       237 ~~  238 (291)
T cd05094         237 CI  238 (291)
T ss_pred             HH
Confidence            43

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=268.44  Aligned_cols=215  Identities=27%  Similarity=0.402  Sum_probs=187.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----c---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----K---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+.+++..||-||||.|=++........+|+|+++..    .   .....|-.+|..++.|.||++|..|     .+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            3577888999999999999987666556888877432    1   1223688899999999999999988     78888


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +|+.||-|- |.++..+..    .+.|....++.++..++.|++|||++ |||+|||||+|.+++.++ -+||.|||.|+
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~G-y~KLVDFGFAK  568 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRG-YLKLVDFGFAK  568 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCC-ceEEeehhhHH
Confidence            999999876 577777766    37888999999999999999999999 999999999999999988 79999999999


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccc
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL  291 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  291 (296)
                      .+..+..+-+++|||.|.|||++.... .+.++|.||||+++|||++|.+||.+.++...+..|++.+-..++|.
T Consensus       569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr  642 (732)
T KOG0614|consen  569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR  642 (732)
T ss_pred             HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence            998888888899999999999997655 78999999999999999999999999999999999999987776653

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.5e-35  Score=248.31  Aligned_cols=197  Identities=30%  Similarity=0.522  Sum_probs=163.1

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ||.|+||.||+|++..+++.+|+|.+....       ....+|+.+++.++|+||+++++.+.     +....++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            689999999999998889999999885322       23457999999999999999999873     334588999999


Q ss_pred             c-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc
Q 022520          146 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (296)
Q Consensus       146 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~  224 (296)
                      + ++|.+.+..    ...++...+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            8 477666654    35688999999999999999999998 999999999999999887 8999999998876544333


Q ss_pred             ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH
Q 022520          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQLVEII  281 (296)
Q Consensus       225 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--~~~~~~~~~  281 (296)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+  ..+.+..+.
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  207 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL  207 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence            445678899999998554 47899999999999999999999998766  444444444

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.6e-35  Score=253.33  Aligned_cols=211  Identities=23%  Similarity=0.396  Sum_probs=165.3

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEc-------CCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceee
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCF  127 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~  127 (296)
                      .....+|.+.+.||+|+||.||+|++.       .++..||+|.+....     ....+|+.+++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            344568999999999999999999753       234579999875321     2345799999999 899999999988


Q ss_pred             eeccCCCceEEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC
Q 022520          128 FSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (296)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk  194 (296)
                      .     .....++||||++ ++|.+++.....            ....++...+..++.|++.||.|||++ |++|||||
T Consensus        91 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlk  164 (304)
T cd05101          91 T-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLA  164 (304)
T ss_pred             e-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeecccc
Confidence            3     3344789999998 477777765321            123577888999999999999999998 99999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  270 (296)
                      |+||+++.++ .++|+|||+++.......   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+
T Consensus       165 p~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         165 ARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             cceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999877 899999999876543221   12233467899999986544 8899999999999999998 8899987


Q ss_pred             CChHHHHHH
Q 022520          271 ESGVDQLVE  279 (296)
Q Consensus       271 ~~~~~~~~~  279 (296)
                      .+..+....
T Consensus       243 ~~~~~~~~~  251 (304)
T cd05101         243 IPVEELFKL  251 (304)
T ss_pred             CCHHHHHHH
Confidence            765444333

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4e-35  Score=251.38  Aligned_cols=197  Identities=26%  Similarity=0.435  Sum_probs=164.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .|+..+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.++|+||+++++++.     +....++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            5888999999999999999998899999999875332     23457999999999999999999884     3445899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ +|.+.+..     .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999985 66665542     5688899999999999999999998 999999999999999877 79999999987654


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      .... .....++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||...+...
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~  208 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMR  208 (277)
T ss_pred             CCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence            3332 22345688899999986544 7899999999999999999999998765443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-35  Score=255.62  Aligned_cols=203  Identities=31%  Similarity=0.477  Sum_probs=165.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .|.....||+|+||.||++.+..++..||+|.+....    ....+|+.+++.++|+|++++++.+.     .....++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence            4666788999999999999998899999999875322    23457999999999999999999884     33458899


Q ss_pred             Eeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||++++ +...+.     ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .++|+|||++.....
T Consensus        98 ~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~  170 (292)
T cd06658          98 MEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSK  170 (292)
T ss_pred             EeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccCcchhhccc
Confidence            9999864 444443     24688999999999999999999998 999999999999999887 899999999865432


Q ss_pred             CCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          221 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+.+..+.
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~  231 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR  231 (292)
T ss_pred             ccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            222 23346788999999985544 7899999999999999999999998876655544443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.6e-35  Score=248.45  Aligned_cols=205  Identities=32%  Similarity=0.567  Sum_probs=166.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--------------hhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      +|.+.+.||.|+||.||+|.+..+++.+|+|.+....              +...+|+.+++.++|+|++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            5889999999999999999998899999999874211              1234689999999999999999887    


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                       ......++||||+++ +|.+.+...    ..++...+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCC-eEEEe
Confidence             334458899999985 666666542    5788999999999999999999998 999999999999999877 89999


Q ss_pred             eecceeeeccCCC---cccccccccccCCccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          211 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       211 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      |||++........   .....++..|+|||.+.... .++.++|+||||+++|++++|..||...+..+.+..+.
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  225 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG  225 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh
Confidence            9999875432211   22345688999999985543 47889999999999999999999998766555444433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6e-35  Score=247.87  Aligned_cols=207  Identities=25%  Similarity=0.371  Sum_probs=165.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+.+++.++|+|++++++.+.     . ...++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEE
Confidence            357999999999999999999865 5567999988543   234568999999999999999987652     1 12679


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||+++ +|.+.+....  ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGL-VCKIADFGLARLIE  153 (260)
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCc-eEEeCCceeeeecc
Confidence            9999985 7777665432  35688999999999999999999998 999999999999999877 89999999997653


Q ss_pred             cCCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       220 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      .....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+.+
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~  218 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER  218 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            32211  122345679999988554 48899999999999999999 8999988776665555544

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-35  Score=251.15  Aligned_cols=191  Identities=26%  Similarity=0.401  Sum_probs=159.1

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ||+|+||+||+|.+..+++.||+|.+...       .....+|+++++.++|||++++++.+     ......++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            68999999999999999999999988532       11234699999999999999998887     3344588999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~  224 (296)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 6766665432  24689999999999999999999998 999999999999999887 8999999998765443333


Q ss_pred             ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       225 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.....
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            4456788999999986655 88999999999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.8e-35  Score=250.33  Aligned_cols=208  Identities=22%  Similarity=0.342  Sum_probs=163.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ..+|.+.+.||+|+||.||+|.+..     .+..||+|.+....     ..+.+|+.+++.++|+||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            3579999999999999999999976     67889999775322     2345789999999999999999987433   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcE
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQL  207 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~i  207 (296)
                        ...++||||++ ++|.+++.....   ....+++..+..++.||+.||.|||++ +++|+||||+||+++.++  ..+
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcce
Confidence              23679999997 577777765431   113588899999999999999999998 999999999999998643  258


Q ss_pred             EEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 022520          208 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (296)
Q Consensus       208 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  278 (296)
                      +|+|||++........   ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~  232 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME  232 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999876532211   11222356799999986554 8999999999999999996 999999876554433

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.3e-35  Score=252.28  Aligned_cols=211  Identities=20%  Similarity=0.287  Sum_probs=166.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCC----------------cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCcee
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETG----------------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVS  122 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~  122 (296)
                      ..+|++.+.||+|+||.||+|.+...+                ..||+|.+....     ....+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999876433                568999885432     23457999999999999999


Q ss_pred             cceeeeeccCCCceEEEEEEeccc-ccHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC
Q 022520          123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK-------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (296)
Q Consensus       123 ~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk  194 (296)
                      +++++..     ....+++||++. ++|..++.....       ....+++..+..++.|++.||+|||++ +++|+|||
T Consensus        84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlk  157 (296)
T cd05051          84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLA  157 (296)
T ss_pred             EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccc
Confidence            9988733     344789999998 477777765421       112689999999999999999999998 99999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFP  269 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~--g~~pf~  269 (296)
                      |+||+++.++ .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++  |..||.
T Consensus       158 p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         158 TRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             hhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999886 899999999876533321   12334567899999986544 8999999999999999998  778998


Q ss_pred             CCChHHHHHHHHH
Q 022520          270 GESGVDQLVEIIK  282 (296)
Q Consensus       270 ~~~~~~~~~~~~~  282 (296)
                      ..+..+.+.....
T Consensus       236 ~~~~~~~~~~~~~  248 (296)
T cd05051         236 HLTDQQVIENAGH  248 (296)
T ss_pred             CcChHHHHHHHHh
Confidence            7766555554443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.7e-35  Score=247.63  Aligned_cols=200  Identities=30%  Similarity=0.472  Sum_probs=167.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ++|++.+.||.|+||.||+|.+..++..+++|.+....  ....+|+++++.++|+||+++++++..     ....++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            47999999999999999999998889999999886443  445689999999999999999998843     34588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ +|.+.+...   ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99995 666665432   36789999999999999999999998 999999999999999887 7999999998765443


Q ss_pred             C-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       222 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      . ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~  206 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR  206 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            3 22234568899999998655 48899999999999999999999998765433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-34  Score=245.58  Aligned_cols=195  Identities=35%  Similarity=0.552  Sum_probs=167.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||.|++|.||+|++..+++.|++|++....     ....+|+..++.++|+|++++++++..     ....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence            5889999999999999999999999999999885442     345578999999999999999998843     345889


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ||||++ ++|.+.+...    ..+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~  150 (264)
T cd06623          77 VLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKG-EVKIADFGISKVL  150 (264)
T ss_pred             EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence            999999 5777776653    678999999999999999999999 8 999999999999999877 8999999998766


Q ss_pred             ccCCCcc-cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          219 VKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       219 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            4443332 45678899999998654 58899999999999999999999998774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-35  Score=250.09  Aligned_cols=205  Identities=22%  Similarity=0.335  Sum_probs=156.4

Q ss_pred             eeeeecCceEEEEEEEcC--CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +.||+|+||.||+|....  ....+++|.+....     ..+.+|+.+++.++|+||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            368999999999997532  34578888764321     23357899999999999999999873     3344889999


Q ss_pred             ccc-ccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          144 YVP-ETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       144 ~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      |++ ++|.+.+...... ....++..+..++.||+.||.|||++ +|+||||||+|||++.++ .++|+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCC-cEEEeccccccccccc
Confidence            998 4777777654321 23356778889999999999999998 999999999999999887 8999999998643222


Q ss_pred             CC---cccccccccccCCccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          222 EP---NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..   .....++..|+|||++..      ...++.++|||||||++|+|++ |..||....+.+.+.....
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  224 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR  224 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh
Confidence            11   122344677999998742      2346889999999999999998 7899988776665555444

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.5e-35  Score=246.94  Aligned_cols=206  Identities=25%  Similarity=0.367  Sum_probs=165.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..+|++.++||+|+||.||+|.+ .+++.||+|.+....   ....+|+.+++.++|+|++++++.+.     . ...++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence            45799999999999999999985 466789999886433   34567999999999999999987652     1 12689


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||+. +++.+.+....  ...++...+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05067          78 ITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETL-CCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCC-CEEEccCcceeecC
Confidence            999997 57777665432  35688899999999999999999998 999999999999999877 89999999987654


Q ss_pred             cCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          220 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       220 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ....  .....++..|+|||.+.+.. ++.++||||||+++|++++ |++||.+.+..+....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  217 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE  217 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Confidence            2221  12234467899999985544 7899999999999999998 999998877655544443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.4e-35  Score=247.99  Aligned_cols=207  Identities=25%  Similarity=0.370  Sum_probs=164.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc---EEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+|...+.||+|+||.||+|.+..++.   .+|+|.+....     ....+|+++++.++|+|++++.+++.     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            468899999999999999999876554   79999875432     23457899999999999999998883     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|...+...   ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCC-cEEECCCccc
Confidence            47899999985 666665442   35789999999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCCCcc----cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..........    ....+..|+|||.+.+. .++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~  225 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND  225 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc
Confidence            7653322111    11224579999998654 47899999999999999997 9999988776555555544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.9e-35  Score=245.83  Aligned_cols=207  Identities=29%  Similarity=0.517  Sum_probs=170.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.+|++++..+++.||+|.+...      .....+|+.+++.++|+||+++.+++     ......+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            489999999999999999999999999999988532      12345799999999999999999987     4445688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|+||+.+ ++.+.+....  ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999975 7766665422  34678899999999999999999998 999999999999999877 7999999998765


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+..+....+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~  215 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR  215 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc
Confidence            33221 12345788899999986554 78899999999999999999999988776665555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-35  Score=247.10  Aligned_cols=203  Identities=27%  Similarity=0.429  Sum_probs=166.3

Q ss_pred             eeeeecCceEEEEEEEcCC---CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|.+...   +..+++|.+....     ....+|++.++.++|+|++++++++..     ....+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999999866   8899999885432     344579999999999999999998843     44588999


Q ss_pred             eccc-ccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          143 EYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ||++ ++|.+.+......     ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCC-cEEEccccccc
Confidence            9995 6777777664211     36789999999999999999999998 999999999999999887 89999999998


Q ss_pred             eeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       217 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ......   ......++..|+|||.+... .++.++||||||+++|+|++ |..||...+..+....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  221 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR  221 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            764432   12334568889999998655 48999999999999999998 699999886655544444

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-34  Score=245.22  Aligned_cols=197  Identities=31%  Similarity=0.549  Sum_probs=163.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|.+.+.||+|+||.||+|.+..++..|++|.+.....      ...+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            58999999999999999999988999999998854322      345799999999999999999876     3344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|+||+++ ++.+.+..    ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 66665554    34578889999999999999999998 999999999999999876 8999999998766


Q ss_pred             ccCCCcc-----cccccccccCCccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          219 VKGEPNI-----SYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       219 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .......     ...+++.|+|||.+.+..  .++.++||||||+++|++++|+.||...+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~  211 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN  211 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence            4433221     235688999999986443  378899999999999999999999986643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5e-35  Score=252.61  Aligned_cols=211  Identities=23%  Similarity=0.393  Sum_probs=165.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeec
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~  130 (296)
                      ....+|++.+.||+|+||.||++.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++++.  
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--
Confidence            3445799999999999999999987643     3789999875432     1244789999999 8999999998873  


Q ss_pred             cCCCceEEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCc
Q 022520          131 TEKDELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~N  197 (296)
                         ....++++|||++ +++..++....            .....+++..+..++.|++.||.|||+. +|+|+||||+|
T Consensus        87 ---~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~N  162 (293)
T cd05053          87 ---QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARN  162 (293)
T ss_pred             ---CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-Cccccccceee
Confidence               3334789999997 57777765421            2345788999999999999999999998 99999999999


Q ss_pred             eEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022520          198 LLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (296)
Q Consensus       198 Ili~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~  273 (296)
                      ||++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+...
T Consensus       163 il~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         163 VLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             EEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            9999877 899999999876543321   1112335679999988554 48899999999999999997 9999988765


Q ss_pred             HHHHHHH
Q 022520          274 VDQLVEI  280 (296)
Q Consensus       274 ~~~~~~~  280 (296)
                      .+....+
T Consensus       241 ~~~~~~~  247 (293)
T cd05053         241 EELFKLL  247 (293)
T ss_pred             HHHHHHH
Confidence            4444433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-35  Score=249.30  Aligned_cols=205  Identities=27%  Similarity=0.433  Sum_probs=164.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc----EEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|++.+.||+|+||.||+|.+..++.    .+|+|.+....     ....+|+.+++.++|+||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            579999999999999999999876654    58899775432     234579999999999999999998753      


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||++ +++.+.+...   ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kL~dfg~  155 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCC-eEEECCCcc
Confidence            23789999997 5777776653   34689999999999999999999998 999999999999999877 799999999


Q ss_pred             eeeeccCCCccc---ccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          215 AKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       215 ~~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      +...........   ..++..|+|||.+... .++.++|+||||+++|++++ |+.||.+....+....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  225 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE  225 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence            976543322211   1225679999988544 47899999999999999998 999999876544433333

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-34  Score=245.91  Aligned_cols=206  Identities=26%  Similarity=0.373  Sum_probs=164.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ++|.+.+.||+|++|.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.     + ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence            4699999999999999999987554 458999775432   23457999999999999999987762     1 126799


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 7777776532  34578889999999999999999998 999999999999999877 799999999976533


Q ss_pred             CCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ....  ....++..|+|||...+.. ++.++||||||+++|+|++ |..||.+....+....+..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  218 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER  218 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            2211  1234467799999885544 8899999999999999999 8999998776665555544

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=246.89  Aligned_cols=195  Identities=27%  Similarity=0.469  Sum_probs=159.1

Q ss_pred             ceEE-eeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMA-ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      -|++ .+.||+|+|+.|--+....++..+|||++...    +....+|++++..+ .|+||+.++++|     ++...+|
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY  152 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY  152 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence            3554 36799999999999999999999999988432    33445899999998 599999999998     6666699


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC--cEEEeeeccee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAK  216 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~--~ikl~Dfg~~~  216 (296)
                      +|||-|.| +++..+..+    .-|++.++.++.++|+.||+|||.+ ||.||||||+|||-.....  -||||||.+..
T Consensus       153 LVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             EEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeecccccc
Confidence            99999985 677666654    5688999999999999999999999 9999999999999754321  58999999875


Q ss_pred             eeccCC--------CcccccccccccCCcccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          217 VLVKGE--------PNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       217 ~~~~~~--------~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      -..-..        ...+.+|+..|||||+..    ....|+.+.|.||||||+|-|+.|.+||.+
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence            432211        123567788899999952    234589999999999999999999999976

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-34  Score=252.35  Aligned_cols=206  Identities=31%  Similarity=0.515  Sum_probs=170.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|...+.||+|+||.||+|++..++..+|+|.+....       ....+|+++++.++|+|++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            4888999999999999999999899999999885321       134478999999999999999998843     3347


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+.+++.+.+...   ..++++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            899999999887776543   35689999999999999999999998 999999999999999877 7999999988654


Q ss_pred             ccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ..   .....+++.|+|||.+.+  ...++.++|||||||++|+|++|+.||...+....+..+....
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~  240 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE  240 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcc
Confidence            22   234567889999999742  2347889999999999999999999998876656565555443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-34  Score=249.46  Aligned_cols=196  Identities=28%  Similarity=0.491  Sum_probs=160.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeec--------chhhHHHHHHHHhc-CCCCceecceeeeeccCC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (296)
                      +|++.+.||.|+||.||+|++.   .+|..||+|.+...        .....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4889999999999999999875   47899999988532        12345789999999 589999998887     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      ....+++||||+++ ++.+.+..    ...+++..+..++.|++.||.|||+. +++||||+|+|||++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCC-CEEEeeC
Confidence            34458899999985 66666654    35788999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCC--CcccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          213 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       213 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      |++.......  ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||....
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  212 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG  212 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence            9987653322  12234578899999998543 236789999999999999999999997544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.7e-35  Score=249.51  Aligned_cols=189  Identities=25%  Similarity=0.418  Sum_probs=152.3

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHH---HHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQ---TMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .||+|+||.||+|.+..+++.||+|.+.....       ....|..   .++...||||+++++.+     ......++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            47999999999999988999999998753211       1123333   34445799999998887     334458899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+.+ +|...+..    ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999986 55555543    36799999999999999999999998 999999999999999877 899999999875433


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      . ......|+..|+|||.+.+...++.++||||+|+++|+|++|+.||....
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~  200 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence            2 22345689999999998655558899999999999999999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.2e-35  Score=246.69  Aligned_cols=197  Identities=24%  Similarity=0.358  Sum_probs=156.1

Q ss_pred             eeeecCceEEEEEEE--cCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           72 VVGHGSFGVVFQAKC--LETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.++|+||+++++.+.     +. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence            589999999999965  4567899999875332      23457899999999999999988752     11 2578999


Q ss_pred             cccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC
Q 022520          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (296)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~  222 (296)
                      |+++ +|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9985 67666654    35688999999999999999999998 999999999999999877 79999999987654332


Q ss_pred             Cc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          223 PN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       223 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ..    ....++..|+|||.+... .++.++|+|||||++|||++ |++||...+..+....+.
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~  212 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE  212 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            21    112235789999988543 47889999999999999998 999998876544444443

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1e-34  Score=253.28  Aligned_cols=212  Identities=23%  Similarity=0.387  Sum_probs=164.6

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEc-------CCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceee
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCF  127 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~  127 (296)
                      .....+|.+.+.||+|+||.||+|++.       .....+|+|.+....     ....+|+.+++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            344568999999999999999999863       234578999875322     1234789999999 699999999987


Q ss_pred             eeccCCCceEEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC
Q 022520          128 FSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (296)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk  194 (296)
                      .     .....+++|||++ ++|.+++.....            ....++...+..++.|++.||.|||++ |++|+|||
T Consensus        88 ~-----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlk  161 (314)
T cd05099          88 T-----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLA  161 (314)
T ss_pred             c-----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-Ceeecccc
Confidence            3     3344789999998 577777765321            124588889999999999999999998 99999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  270 (296)
                      |+|||++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus       162 p~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         162 ARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             ceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            9999999877 899999999976533211   1112234679999998654 48999999999999999998 8899987


Q ss_pred             CChHHHHHHH
Q 022520          271 ESGVDQLVEI  280 (296)
Q Consensus       271 ~~~~~~~~~~  280 (296)
                      .+..+.+..+
T Consensus       240 ~~~~~~~~~~  249 (314)
T cd05099         240 IPVEELFKLL  249 (314)
T ss_pred             CCHHHHHHHH
Confidence            7654444433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-34  Score=249.61  Aligned_cols=211  Identities=21%  Similarity=0.284  Sum_probs=163.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecch-----hhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      ..++|++.+.||+|+||.||+|.+..     .+..||+|.+.....     ...+|+.+++.++|+||+++++++.    
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            44689999999999999999997642     355899998753321     2346888999999999999999873    


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~  205 (296)
                       .....++||||++ ++|.+.+......      ...++...+..++.|++.||.|||++ +|+||||||+||+++.++ 
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~-  156 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDF-  156 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCC-
Confidence             2334789999998 5777777653211      13345677888999999999999998 999999999999999877 


Q ss_pred             cEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          206 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       206 ~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .++|+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999875432221   11223466799999986544 7999999999999999998 789998876555444433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-35  Score=254.81  Aligned_cols=202  Identities=27%  Similarity=0.453  Sum_probs=164.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .|.....||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|||++++++++..     ....+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEE
Confidence            355666899999999999999889999999988532    2234578999999999999999998843     3458899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      +||+++ ++...+.     ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~  169 (297)
T cd06659          97 MEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  169 (297)
T ss_pred             EecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCC-cEEEeechhHhhccc
Confidence            999986 5544443     25688999999999999999999998 999999999999999887 899999999865433


Q ss_pred             CC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022520          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  280 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  280 (296)
                      .. ......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  229 (297)
T cd06659         170 DVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  229 (297)
T ss_pred             ccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            22 123456789999999986544 899999999999999999999999877655544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-34  Score=254.65  Aligned_cols=214  Identities=22%  Similarity=0.387  Sum_probs=165.5

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCC-------CcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceee
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCF  127 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~  127 (296)
                      .....+|++.+.||+|+||.||+|++...       +..+|+|.+....     ....+|+++++.+ +|+||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            33445799999999999999999986432       2368999775322     2345799999999 899999999988


Q ss_pred             eeccCCCceEEEEEEecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC
Q 022520          128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (296)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk  194 (296)
                      .     .....++++||+++ +|.+++.....            ....++...+..++.|++.||.|||++ |++|||||
T Consensus        88 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlk  161 (334)
T cd05100          88 T-----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLA  161 (334)
T ss_pred             c-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceeccccc
Confidence            3     33347899999984 77777765321            123577888899999999999999998 99999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  270 (296)
                      |+|||++.++ .++|+|||+++........   ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+
T Consensus       162 p~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         162 ARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             cceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            9999999877 8999999998765332211   1222356799999986544 8899999999999999998 8899988


Q ss_pred             CChHHHHHHHHH
Q 022520          271 ESGVDQLVEIIK  282 (296)
Q Consensus       271 ~~~~~~~~~~~~  282 (296)
                      .+..+....+..
T Consensus       240 ~~~~~~~~~~~~  251 (334)
T cd05100         240 IPVEELFKLLKE  251 (334)
T ss_pred             CCHHHHHHHHHc
Confidence            765554444433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9e-35  Score=246.57  Aligned_cols=197  Identities=24%  Similarity=0.340  Sum_probs=155.3

Q ss_pred             eeeecCceEEEEEEEc--CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEec
Q 022520           72 VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  144 (296)
                      .||+|+||.||+|.+.  .++..||+|.+....     ....+|+.+++.++|+||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            4899999999999875  445679999885432     23457999999999999999988762     1 236899999


Q ss_pred             ccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC
Q 022520          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (296)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~  223 (296)
                      +++ +|.+.+...   ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++........
T Consensus        76 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            985 666665532   35789999999999999999999998 999999999999999877 899999999875533321


Q ss_pred             c----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          224 N----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       224 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      .    ....++..|+|||.+.+.. ++.++|||||||++|++++ |..||......+....+
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  211 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI  211 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            1    1122356899999985544 7899999999999999996 99999887765544333

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-35  Score=249.05  Aligned_cols=209  Identities=38%  Similarity=0.699  Sum_probs=175.2

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |++.+.||+|++|.||+|++..+++.+|+|.+....      ....+|+.+++.++|+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            677889999999999999999999999999885431      233468999999999999999998843     345889


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |+||+++++.+.+....   ..+++..+..++.|++.||.+||++ +|+|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999998888887642   5689999999999999999999998 999999999999999877 899999999876533


Q ss_pred             CC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      .. .......+..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+.+.
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  216 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG  216 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhC
Confidence            32 222344577899999987665689999999999999999999999999887777777666544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.1e-35  Score=249.57  Aligned_cols=211  Identities=24%  Similarity=0.364  Sum_probs=165.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|.+.++||+|+||.||++...     .++..+|+|.+....    ....+|+++++.++|+||+++++++..     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   78 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----   78 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----
Confidence            346889999999999999999753     356789999875332    345579999999999999999887733     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~  202 (296)
                      ....+++|||++ ++|.+++.....           ....+++..+..++.|++.||+|||+. +++|+||||+|||++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~  157 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQ  157 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcC
Confidence            334789999998 577777664321           113578899999999999999999998 9999999999999998


Q ss_pred             CCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 022520          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (296)
Q Consensus       203 ~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  278 (296)
                      ++ .++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+.+.
T Consensus       158 ~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         158 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             CC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            76 899999999875432221   12233467899999886544 8999999999999999998 899998776655555


Q ss_pred             HHHH
Q 022520          279 EIIK  282 (296)
Q Consensus       279 ~~~~  282 (296)
                      .+.+
T Consensus       236 ~~~~  239 (280)
T cd05092         236 CITQ  239 (280)
T ss_pred             HHHc
Confidence            4443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.7e-35  Score=249.64  Aligned_cols=189  Identities=26%  Similarity=0.437  Sum_probs=151.3

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHh---cCCCCceecceeeeeccCCCceEEEEE
Q 022520           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL---LDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .||+|+||.||++.+..+++.+|+|.+....       ....+|..+++.   .+|+|++.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999875321       112234433333   479999999888733     3347899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+++ +|...+..    ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999985 56555543    36799999999999999999999998 999999999999999877 899999999865433


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .. .....+++.|+|||.+.+...++.++||||+||++|+|++|..||....
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence            22 2345689999999998654557899999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-34  Score=248.50  Aligned_cols=199  Identities=23%  Similarity=0.385  Sum_probs=158.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc----EEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|++.+.||+|+||.||+|.+..++.    .+++|.+....     .....|+..++.++||||+++++++.     +.
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence            479999999999999999999877766    46777664221     12335677888999999999998762     11


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                       ..++++||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||+
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEEcCCcc
Confidence             2567899988 6777777643   35688999999999999999999998 999999999999999877 899999999


Q ss_pred             eeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022520          215 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (296)
Q Consensus       215 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~  275 (296)
                      ++.......   .....++..|+|||.+.+.. ++.++|||||||++||+++ |+.||.+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~  219 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE  219 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            976543322   12234567899999986544 8999999999999999998 999998876533

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.4e-35  Score=250.99  Aligned_cols=202  Identities=24%  Similarity=0.424  Sum_probs=158.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47889999999999999998753     23568888775332     23457999999999999999998873     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk  194 (296)
                      ...++++||+. ++|.+++.....                    ....+++..+..++.|++.||.|||+. +++|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-Ceehhhhh
Confidence            34788999998 577776654221                    124578889999999999999999998 99999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  270 (296)
                      |+|||++.++ .++|+|||+++.......   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999877 899999999875433221   11223466899999885544 8999999999999999998 9999987


Q ss_pred             CChHH
Q 022520          271 ESGVD  275 (296)
Q Consensus       271 ~~~~~  275 (296)
                      ....+
T Consensus       233 ~~~~~  237 (290)
T cd05045         233 IAPER  237 (290)
T ss_pred             CCHHH
Confidence            66443

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-35  Score=252.01  Aligned_cols=197  Identities=26%  Similarity=0.443  Sum_probs=162.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .|+..+.||+|+||.||+|.+..++..||+|.+....     ....+|+++++.++|+||+++++++.     .....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            5788899999999999999998899999999875322     23457999999999999999999884     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ ++.+.+.     ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            9999986 5555543     25688999999999999999999998 999999999999999877 89999999987653


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.......
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~  208 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMR  208 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence            3221 1233568889999998654 47899999999999999999999997655433

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-34  Score=244.19  Aligned_cols=208  Identities=29%  Similarity=0.465  Sum_probs=169.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|.+.+.||+|+||.||+|.+..++..+|+|.+...      .....+|+.+++.++|+|++++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            488999999999999999999999999999988532      23445799999999999999999987     3344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|+||+++ ++.+.+....  ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 7777665432  23578999999999999999999998 99999999999999987656799999998765


Q ss_pred             ccCCCc-ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+...++..
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  216 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ  216 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence            433221 2335788999999885544 78999999999999999999999987765555544443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.8e-35  Score=250.44  Aligned_cols=197  Identities=31%  Similarity=0.473  Sum_probs=163.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|++.+.||+|+||+||++.+..+++.||+|++....     ....+|+++++.++|+||+++++++.     .....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            47999999999999999999999899999999875432     23457999999999999999999884     334589


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ ++...+..    .+++++..+..++.+++.+|.|||+..+++|+||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999986 55555443    357899999999999999999999733899999999999999877 8999999998654


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .... .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||.....
T Consensus       155 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         155 INSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             hhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence            2222 2234678999999998654 488999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.9e-35  Score=251.62  Aligned_cols=200  Identities=28%  Similarity=0.461  Sum_probs=165.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+....    ....+|+.+++.++|||++++++.+..     ....+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            468999999999999999999998889999999874322    234578999999999999999998843     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|+||+++ ++.+.+..     ..++...+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 66666543     4578889999999999999999998 999999999999999877 8999999987654


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ  276 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  276 (296)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|++++|+.||...+..+.
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~  223 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (293)
T ss_pred             cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence            33222 2234578889999998654 478999999999999999999999987655433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-35  Score=248.72  Aligned_cols=202  Identities=24%  Similarity=0.374  Sum_probs=156.2

Q ss_pred             eeeeecCceEEEEEEEcCCCc--EEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|++..++.  .+++|.+....     ....+|+++++++ +||||+++++++.     .....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            368999999999999887765  46888775321     2344799999999 8999999999883     334478999


Q ss_pred             eccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEE
Q 022520          143 EYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                      ||++ ++|.+++.....            ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~-~~kl  153 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENY-VAKI  153 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCC-eEEE
Confidence            9998 577777765321            123578899999999999999999998 999999999999999887 8999


Q ss_pred             eeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       210 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      +|||++..............+..|+|||++... .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  224 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  224 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence            999998532211111112235679999998544 48899999999999999997 99999876654444444

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-34  Score=243.44  Aligned_cols=197  Identities=26%  Similarity=0.398  Sum_probs=162.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch---hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.+.||.|+||.||+|..  .++.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            4699999999999999999987  578899999865543   45579999999999999999998843     3347899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||++ +++.+.+....  ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            99998 57777766532  23689999999999999999999998 999999999999999877 799999999876533


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~  275 (296)
                      ...  ....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  207 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD  207 (256)
T ss_pred             ccc--cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            222  233456799999986544 7889999999999999997 999998776443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.2e-35  Score=247.52  Aligned_cols=205  Identities=28%  Similarity=0.448  Sum_probs=163.1

Q ss_pred             EEeeeeeecCceEEEEEEEc----CCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           68 MAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++.+.||.|.||.||+|.+.    ..+..|+||.+...     ...+.+|++.+++++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    34678999998532     2345579999999999999999999863222     7


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++|+||++ ++|.+.+....  ...++...+..++.|++.||.|||++ +++|+||+++|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             cccccccccccccccccccc--cccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccc
Confidence            89999998 68888888752  35789999999999999999999998 999999999999999887 899999999876


Q ss_pred             eccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ......   .........|+|||.+.... ++.++||||||+++||+++ |+.||...+..+....+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~  220 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ  220 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            522211   12234577899999986554 8999999999999999999 7899998877665666633

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-34  Score=244.62  Aligned_cols=201  Identities=28%  Similarity=0.408  Sum_probs=162.0

Q ss_pred             eeeeecCceEEEEEEEcC-CC--cEEEEEEEeecch-----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLE-TG--EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|++|.||+|.+.. .+  ..||+|.+.....     ...+|+.+++.++|+||+++++.+..      ...+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 33  3689998864433     44579999999999999999988743      4478999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||++ ++|.+.+.....  ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 577777765421  4688999999999999999999998 999999999999999887 8999999998765432


Q ss_pred             CCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          222 EPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...    ....++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...+..+.+..+..
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  215 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK  215 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            211    1234567899999885444 8999999999999999998 9999988776665555543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=248.32  Aligned_cols=198  Identities=30%  Similarity=0.563  Sum_probs=164.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcC---CCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+...     .....+|+.+++.++   |+|++++++++.     +...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            478889999999999999999999999999987532     123457888999886   999999999874     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++||||+++ +|.+++..     ..+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            8899999986 56555543     4788999999999999999999998 999999999999999876 89999999987


Q ss_pred             eeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       217 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      ....... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+...
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~  209 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR  209 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence            6644322 2334678899999998665557899999999999999999999998765433

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.3e-34  Score=242.22  Aligned_cols=208  Identities=32%  Similarity=0.535  Sum_probs=172.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|.+.+.||.|+||.||++.+..++..|++|.+....      ....+|+++++.++|+|++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            4889999999999999999998889999999885432      234579999999999999999998843     35588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|+|++++ ++.+.+.........+++..+..++.+++.||.+||++ |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 77777776544457899999999999999999999998 999999999999999876 8999999998765


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .... ......+++.|+|||.+.+.. ++.++|+||+|+++++|++|+.||...+..+....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  216 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL  216 (258)
T ss_pred             ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh
Confidence            4432 223346788999999886544 7899999999999999999999998876544444433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.1e-34  Score=247.10  Aligned_cols=207  Identities=20%  Similarity=0.278  Sum_probs=164.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcC----CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLE----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|.+.+.||+|+||.||+|.+..    .+..|++|.+....     ....+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3579999999999999999999875    25789999875432     2234789999999999999999876533    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEE
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMS----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                      ....+++++|++ +++..++.......    ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCC-cEEE
Confidence            223678999988 57777766543211    4688999999999999999999998 999999999999999877 8999


Q ss_pred             eeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022520          210 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (296)
Q Consensus       210 ~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  277 (296)
                      +|||+++........   ....++..|+|||.+.+.. ++.++|||||||++|++++ |+.||...+..+..
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  229 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA  229 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH
Confidence            999998755333211   1223466799999986544 8999999999999999998 99999877654433

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.5e-34  Score=247.84  Aligned_cols=201  Identities=26%  Similarity=0.410  Sum_probs=162.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHHHHHhc-CCCCceecceeeeeccCCCc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+.....     ...+|+.++... +|+||+++++++.     ..
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~   86 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TD   86 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cC
Confidence            344679999999999999999999988899999998854321     223466555555 5999999999884     34


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ...+++|||+++.+..++...   ...+++..+..++.|++.||.|||+..+|+||||+|+||+++.++ .++|+|||++
T Consensus        87 ~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~  162 (296)
T cd06618          87 SDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGIS  162 (296)
T ss_pred             CeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccc
Confidence            458999999988777766553   357899999999999999999999733999999999999999877 8999999998


Q ss_pred             eeeccCCCcccccccccccCCccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      .............++..|+|||.+.+.   ..++.++||||||+++|+|++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence            765444333444578889999998543   23688999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=250.92  Aligned_cols=208  Identities=22%  Similarity=0.320  Sum_probs=161.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCC--------------cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETG--------------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKH  125 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~  125 (296)
                      .+|++.+.||+|+||.||++++...+              ..||+|.+....     ..+.+|+++++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            47999999999999999999875432              358999875432     23457999999999999999999


Q ss_pred             eeeeccCCCceEEEEEEecccc-cHHHHHHHhhh--------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCC
Q 022520          126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK--------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (296)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~  196 (296)
                      ++.     .....++||||+.+ ++.+++.....        ....+++..+..++.|++.||.|||++ +++|+||||+
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~  158 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATR  158 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChh
Confidence            883     33347899999985 67666644211        112467888899999999999999998 9999999999


Q ss_pred             ceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 022520          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGE  271 (296)
Q Consensus       197 NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~--g~~pf~~~  271 (296)
                      ||+++.++ .++|+|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++  |..||...
T Consensus       159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999877 799999999875433221   11223467899999986544 8999999999999999998  66899887


Q ss_pred             ChHHHHHHH
Q 022520          272 SGVDQLVEI  280 (296)
Q Consensus       272 ~~~~~~~~~  280 (296)
                      +..+.+..+
T Consensus       237 ~~~~~~~~~  245 (295)
T cd05097         237 SDEQVIENT  245 (295)
T ss_pred             ChHHHHHHH
Confidence            655544443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-35  Score=279.88  Aligned_cols=219  Identities=29%  Similarity=0.454  Sum_probs=168.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeecc-------
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT-------  131 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  131 (296)
                      ..+|+..+.||+||||.||+++++-+|..||||++....     ....+|++.|.+|+|||+|+++..|++..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            346788899999999999999999999999999996542     22347999999999999999987776310       


Q ss_pred             ----------------------------------------------C---------------------------------
Q 022520          132 ----------------------------------------------E---------------------------------  132 (296)
Q Consensus       132 ----------------------------------------------~---------------------------------  132 (296)
                                                                    .                                 
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                          0                                 


Q ss_pred             ---------------------C-------CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc
Q 022520          133 ---------------------K-------DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN  184 (296)
Q Consensus       133 ---------------------~-------~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~  184 (296)
                                           .       ...++||=||||+.++++.+.+......  .....++++++|+.||+|+|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence                                 0       0146889999999877776665432111  466788999999999999999


Q ss_pred             cCCceeccCCCCceEEcCCCCcEEEeeecceeeec-------------------cCCCcccccccccccCCccccCCC--
Q 022520          185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT--  243 (296)
Q Consensus       185 ~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--  243 (296)
                      + |||||||||.|||++++. .|||+|||+++...                   +....+..+||.-|+|||++.+..  
T Consensus       716 ~-giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  716 Q-GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             C-ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            9 999999999999999877 89999999998721                   001234568899999999996655  


Q ss_pred             CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       244 ~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      .|+.|+|+||||++|+||+   .||...-  +. ..+++.+..+.+|.+
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~---yPF~TsM--ER-a~iL~~LR~g~iP~~  836 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEML---YPFGTSM--ER-ASILTNLRKGSIPEP  836 (1351)
T ss_pred             cccchhhhHHHHHHHHHHh---ccCCchH--HH-HHHHHhcccCCCCCC
Confidence            5999999999999999998   4565432  22 233333445555444

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-34  Score=246.51  Aligned_cols=200  Identities=27%  Similarity=0.448  Sum_probs=164.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      -|++.+.||+|+||.||+|.+..+++.+|+|.+....     ....+|+.+++.++|+||+++++++.     +....++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence            4888999999999999999998899999999875322     23457999999999999999999883     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ ++...+.     ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999986 5555554     25688999999999999999999998 999999999999999877 79999999987653


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  211 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF  211 (277)
T ss_pred             cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence            3221 1234568889999998654 47889999999999999999999998765444333

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.6e-34  Score=245.12  Aligned_cols=211  Identities=23%  Similarity=0.424  Sum_probs=168.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcC-CCcEEEEEEEeecc--------------hhhHHHHHHHHh-cCCCCceecceeeee
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK--------------RYKNRELQTMRL-LDHPNVVSLKHCFFS  129 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~--------------~~~~~E~~~l~~-l~h~niv~~~~~~~~  129 (296)
                      .|++.+.||+|+||.||+|.+.. .++.+|+|.+....              ....+|+.++.. ++|+||+++++.+. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            37889999999999999999987 68899999874211              112356776654 79999999999883 


Q ss_pred             ccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                          .....+++|||+++ ++.+.+.........+++..++.++.|++.||.|||+..+++|+||+|+||+++.++ .++
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence                34458999999985 777776654444567999999999999999999999632899999999999999887 899


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|++||...+.......+...
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~  228 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA  228 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc
Confidence            99999997654443334456788999999986544 799999999999999999999999876655444444443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.6e-34  Score=249.10  Aligned_cols=203  Identities=31%  Similarity=0.526  Sum_probs=167.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|...+.||+|+||.||+|++..++..|++|.+....       ....+|+++++.++|+|++++++++..     ....
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            4777889999999999999999999999999885321       123478999999999999999998843     3447


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+.+++...+...   ..++++..+..++.|++.+|.|||++ |++|+||+|+||+++.++ .++|+|||++...
T Consensus        97 ~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCC-CEEEeecCCCccc
Confidence            899999999888776643   35688999999999999999999998 999999999999999877 7999999988643


Q ss_pred             ccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      .   ......++..|+|||.+..  ...++.++|||||||++|+|++|.+||...+....+..+.
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~  233 (313)
T cd06633         172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  233 (313)
T ss_pred             C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            2   2234567889999999742  2347889999999999999999999998876555554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-34  Score=246.18  Aligned_cols=200  Identities=22%  Similarity=0.261  Sum_probs=154.4

Q ss_pred             eeeeecCceEEEEEEEc--CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +.||+|+||.||+|.+.  .++..+|+|.+....     ....+|+.+++.++||||+++++++.     +....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            36899999999999864  345679999875332     23457999999999999999998873     3334789999


Q ss_pred             ccc-ccHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          144 YVP-ETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       144 ~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      |++ ++|.+.+...... ....+...+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 5777776543321 23456677888999999999999998 999999999999999877 8999999998654322


Q ss_pred             CC---cccccccccccCCccccCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022520          222 EP---NISYICSRYYRAPELIFGAT------EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (296)
Q Consensus       222 ~~---~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  277 (296)
                      ..   .....++..|+|||++.+..      .++.++||||||+++|+|++ |+.||...+..+..
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  219 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL  219 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            11   11234577899999985321      35789999999999999996 99999877655443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.6e-34  Score=242.98  Aligned_cols=202  Identities=31%  Similarity=0.491  Sum_probs=169.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|+||.||++.+..+++.+++|.+....      ....+|+++++.++|+||+++++++..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            4889999999999999999999999999999885321      123468899999999999999988843     34588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|+||+++ ++...+.........+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999975 77777766554456789999999999999999999998 999999999999999876 7999999998766


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ  276 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  276 (296)
                      ... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+.
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~  209 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDL  209 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            444 333456788999999986544 78899999999999999999999988775443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=243.73  Aligned_cols=197  Identities=28%  Similarity=0.419  Sum_probs=157.5

Q ss_pred             eeeeecCceEEEEEEEcCCC---cEEEEEEEeecch-----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ++||+|+||.||+|.+...+   ..+|+|.+.....     ...+|+.+++.++|+|++++++++.     . ...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence            47899999999999876544   7899998864432     3457899999999999999988652     1 1268999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      +|++ ++|.+.+...    ..+++..+..++.|++.+|+|||.. +++|+||||+||+++.++ .++|+|||++......
T Consensus        75 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            9987 5777777653    4789999999999999999999998 999999999999999877 7999999998765433


Q ss_pred             CCcc----cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          222 EPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       222 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      ....    ...++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||...+..+....+
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~  211 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML  211 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            3211    112245799999985544 8999999999999999998 99999887765444443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-34  Score=250.47  Aligned_cols=206  Identities=22%  Similarity=0.330  Sum_probs=160.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcC----------------CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceec
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  123 (296)
                      .+|++.+.||+|+||.||++.+..                ++..+|+|.+....     ....+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986532                34578999885432     234579999999999999999


Q ss_pred             ceeeeeccCCCceEEEEEEeccc-ccHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCC
Q 022520          124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (296)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp  195 (296)
                      ++++..     ....+++|||++ ++|.+++......       ...+++..+..++.|++.||+|||+. |++|+||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCh
Confidence            998743     233789999998 5777777653211       12467788999999999999999998 999999999


Q ss_pred             CceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 022520          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPG  270 (296)
Q Consensus       196 ~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~--g~~pf~~  270 (296)
                      +|||++.++ .++|+|||++........   ......+..|+|||...+.. ++.++|||||||++|||++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 899999999876533221   11123357899999876544 8999999999999999998  7799987


Q ss_pred             CChHHHHH
Q 022520          271 ESGVDQLV  278 (296)
Q Consensus       271 ~~~~~~~~  278 (296)
                      .+..+.+.
T Consensus       237 ~~~~~~~~  244 (296)
T cd05095         237 LSDEQVIE  244 (296)
T ss_pred             cChHHHHH
Confidence            66554443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4e-34  Score=244.03  Aligned_cols=192  Identities=25%  Similarity=0.377  Sum_probs=156.2

Q ss_pred             ceEEeeee--eecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           66 SYMAERVV--GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        66 ~y~~~~~l--G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      .|.+.+.+  |+|+||.||++++..++..+|+|.+..... ...|......+ +|+|+++++++|..     ....++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence            46666665  999999999999999999999998754321 12244433333 79999999998843     33589999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||++ ++|.+++...    ..+++..+..++.|+++||.|||+. +++||||||+||+++.++..++|+|||++......
T Consensus        89 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9997 5777777652    4789999999999999999999998 99999999999999987757999999998765322


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                         ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence               2346788999999986544 7899999999999999999999998654

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3e-34  Score=243.64  Aligned_cols=206  Identities=26%  Similarity=0.383  Sum_probs=164.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .++|++.+.||+|+||.||++.+. .+..+|+|.+....   ....+|+.+++.++|+||+++++.+..      ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            357999999999999999999854 55679999875432   344579999999999999999887732      23689


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|||++ +++.+++....  ...++...+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence            999998 57777776532  35678888999999999999999998 999999999999999877 89999999987653


Q ss_pred             cCCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       220 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .....  ....++..|+|||.+... .++.++|+|||||++|++++ |+.||.+.+..+....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~  217 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE  217 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            32211  122345679999998654 48899999999999999998 999998876554444433

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-34  Score=247.99  Aligned_cols=196  Identities=31%  Similarity=0.500  Sum_probs=157.9

Q ss_pred             cceEEeeeeeecCceEEEEEEE----cCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+|++.+.||+|+||.||++..    ..++..||+|.+....    ..+.+|+++++.++||||+++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            4799999999999999999974    4578899999885432    2345799999999999999998876432   223


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||++ ++|.+++...   ...+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESEN-RVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCC-eEEECCCccc
Confidence            4789999997 5777776543   24588999999999999999999998 999999999999999877 7999999998


Q ss_pred             eeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       216 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      .........    ....++..|+|||.+.+.. ++.++|||||||++|||++|..|+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCC
Confidence            865433221    1112345699999986544 8899999999999999999876654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.7e-34  Score=242.19  Aligned_cols=205  Identities=28%  Similarity=0.438  Sum_probs=165.3

Q ss_pred             EEeeeeeecCceEEEEEEEcCCC----cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           68 MAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++.+.||.|+||.||++.+...+    ..||+|.+....     ....+|+.+++.++|+||+++++.+..     ....
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence            56789999999999999998766    899999885443     244579999999999999999998843     3458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|||+++ ++.+.+....  ...+++..+..++.|++.||.+||+. +++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENL-VVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCC-eEEEcccCCcee
Confidence            899999985 7777766532  12289999999999999999999998 999999999999999887 899999999876


Q ss_pred             eccCCCcc--cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ........  ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |++||...+..+....+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~  219 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK  219 (258)
T ss_pred             cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence            64442221  1235788999998844 458999999999999999998 8899988766555444443

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.9e-34  Score=250.40  Aligned_cols=197  Identities=26%  Similarity=0.415  Sum_probs=158.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc----EEEEEEEeecch-----hhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|+..+.||+|+||.||+|.+..++.    .+|+|.+.....     ...+|+.+++.++|+||+++++.+...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            468999999999999999999877775    468887754322     345788999999999999999987421     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                       ..+++++|++ +++.+.+...   ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~-~~kL~Dfg~  155 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCC-ceEEccccc
Confidence             1468999998 5777766543   34688889999999999999999998 999999999999998877 799999999


Q ss_pred             eeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022520          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (296)
Q Consensus       215 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~  273 (296)
                      +.........   ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~  217 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPT  217 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9765433221   1223467899999985544 8999999999999999997 9999987654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=242.75  Aligned_cols=197  Identities=33%  Similarity=0.525  Sum_probs=158.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHHH-HHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||.|+||.||+|.+..+++.||+|.+.....       ....|..+ ....+|+|++++++++.     .....++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999998999999998853211       11233333 34458999999999883     344589999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ +|..++..    ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99985 66666654    35789999999999999999999998 999999999999999877 899999999875432 


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                        .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+..
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  207 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS  207 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence              22345788899999986655 78999999999999999999999988776555554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-34  Score=246.23  Aligned_cols=194  Identities=30%  Similarity=0.533  Sum_probs=164.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+....     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            5888899999999999999999999999999885432     234578999999999999999998843     355889


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||++ ++|.+++....   ..+++..+..++.|++.+|+|||+ . +++|+||||+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~  151 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRG-QIKLCDFGVSGQL  151 (265)
T ss_pred             EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCC-CEEEeecccchhh
Confidence            999999 57777766532   678999999999999999999999 7 999999999999999877 8999999998655


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ...... ...++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            333222 26678899999998655 4899999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.1e-34  Score=241.46  Aligned_cols=205  Identities=22%  Similarity=0.395  Sum_probs=163.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.+.||.|+||.||+|.+. .+..+|+|.+...   .....+|+++++.++|||++++++++.     .....+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence            36899999999999999999875 4678999987543   234568999999999999999988873     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+++ +|.+.+...   ...+++..+..++.|++.+|++||+. +++|+||||+||+++.++ .++|+|||++.....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999985 555555432   24688899999999999999999998 999999999999999776 799999999876533


Q ss_pred             CCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ....  ....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+.+..+.
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  215 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN  215 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh
Confidence            2211  1223456899999986544 8899999999999999998 999998776555444443

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.1e-34  Score=238.80  Aligned_cols=202  Identities=28%  Similarity=0.502  Sum_probs=169.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      +|.+.+.||+|++|.||++.+..+++.+++|.+....    ....+|+++++.++|+|++++++++...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            4888999999999999999998889999999885543    3456899999999999999999988433     447899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      +||++ ++|.+.+...   ...+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 5766666553   25789999999999999999999998 999999999999999876 899999999877655


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+.+.
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  207 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALF  207 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence            43334556788999999986554 7899999999999999999999998875444443

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.4e-34  Score=243.33  Aligned_cols=205  Identities=29%  Similarity=0.410  Sum_probs=162.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+|.+.+.||+|+||.||+|.+...   ...|++|......     ....+|+.+++.++|+||+++++++..     . 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~-   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N-   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C-
Confidence            4699999999999999999987543   4578999875432     234579999999999999999987632     1 


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||++ ++|.+++...   ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~  154 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPD-CVKLGDFGLS  154 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCC-CeEEccCcee
Confidence            2578999998 5777776543   24689999999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCCCcc--cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          216 KVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       216 ~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ..........  ...++..|+|||.+... .++.++||||||+++|++++ |..||...+..+....+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~  222 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE  222 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            7654432211  12234679999988544 48899999999999999996 999998877655554443

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.4e-34  Score=242.23  Aligned_cols=197  Identities=29%  Similarity=0.513  Sum_probs=159.3

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ......||+|+||.||+|.+..++..|++|.+....    ....+|+.+++.++|+||+++++++.     .....++|+
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEE
Confidence            334468999999999999998899999999875432    24558999999999999999999873     345588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||+++ +|...+....   .++  ++..+..++.|++.||+|||+. +|+|+||||+||+++.+...++|+|||++....
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          85 EQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             ecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99985 6766665432   334  7788889999999999999998 999999999999998755589999999987653


Q ss_pred             cCCC-cccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          220 KGEP-NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .... .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            3222 2234578899999998543 337889999999999999999999997643

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.4e-34  Score=241.71  Aligned_cols=202  Identities=24%  Similarity=0.388  Sum_probs=163.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      .+|++.+.||+|+||.||++..  +++.||+|.+...  .....+|+.+++.++|+|++++++++..    +  ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~--~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH----N--GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC----C--CcEEEE
Confidence            4699999999999999999874  7788999988543  2345679999999999999999888732    1  157999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+. ++|...+....  ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            9998 57777776532  34678889999999999999999998 999999999999999877 8999999998754322


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                        ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |++||...+..+....+.
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  211 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE  211 (254)
T ss_pred             --CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence              12233456799999885544 8899999999999999997 999998876554444433

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.5e-34  Score=243.86  Aligned_cols=208  Identities=24%  Similarity=0.327  Sum_probs=163.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      .+|++.+.||.|+||.||+|++..     +.+.+++|.+....     ....+|+++++.++|+||+++++.+     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            479999999999999999999753     35678999774332     2356799999999999999999877     33


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                      ....++||||++ ++|.+++......     ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCC-cEE
Confidence            445789999998 5777777654311     12689999999999999999999998 999999999999999877 799


Q ss_pred             EeeecceeeeccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          209 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       209 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      ++|||++.......  ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........+..+
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            99999986432211  112334577899999886544 7899999999999999998 78999776554444433

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-35  Score=261.61  Aligned_cols=198  Identities=28%  Similarity=0.478  Sum_probs=165.3

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh-------hHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      |..++.||-|+||+|-++....+...+|+|.+....-.       -+.|-+||..-+++=||+||.+|     ++..++|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnLY  705 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNLY  705 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCceE
Confidence            77889999999999999998889999999977443222       23588899999999999999998     6666699


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||+|++| ++-.+|..    .+.|++..++.++.++.+|+++.|.. |+|||||||+|||||.+| .|||+|||+|+-+
T Consensus       706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdG-HIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCC-ceeeeeccccccc
Confidence            99999995 55566555    37899999999999999999999997 999999999999999999 7999999998654


Q ss_pred             cc---------CCC----------------------------------cccccccccccCCccccCCCCCCCchhHHHHH
Q 022520          219 VK---------GEP----------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAG  255 (296)
Q Consensus       219 ~~---------~~~----------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG  255 (296)
                      .-         +..                                  ....+||+.|+|||++.... |+.-.|.||.|
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~g  858 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVG  858 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhh
Confidence            10         000                                  01246899999999996544 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHH
Q 022520          256 CVLAELLLGQPLFPGESGVDQ  276 (296)
Q Consensus       256 ~il~~l~~g~~pf~~~~~~~~  276 (296)
                      ||||||+.|++||...+..+.
T Consensus       859 vil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcc
Confidence            999999999999987765444

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.5e-34  Score=246.81  Aligned_cols=208  Identities=25%  Similarity=0.361  Sum_probs=163.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ..+|++.+.||+|+||.||+|.+..     ++..+|+|.+....     ..+.+|+.+++.++||||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            3579999999999999999998743     67899999875432     23457999999999999999998873     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhh------------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYK------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk  194 (296)
                      .....+++|||+++ +|.+++.....                  ....+++..+..++.|++.||.|||++ +++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-Ceeccccc
Confidence            33347899999984 77777764321                  113467888899999999999999998 99999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  270 (296)
                      |+||+++.++ .++|+|||++........   ......+..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+
T Consensus       158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999887 899999999875433221   11223466799999986544 8999999999999999997 8889977


Q ss_pred             CChHHHHHH
Q 022520          271 ESGVDQLVE  279 (296)
Q Consensus       271 ~~~~~~~~~  279 (296)
                      .+..+.+..
T Consensus       236 ~~~~~~~~~  244 (288)
T cd05050         236 MAHEEVIYY  244 (288)
T ss_pred             CCHHHHHHH
Confidence            665444433

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.1e-34  Score=248.30  Aligned_cols=204  Identities=29%  Similarity=0.518  Sum_probs=167.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .|...+.||+|+||.||+|++..++..+|+|.+....       ....+|+++++.++|+|++++.+++..     ....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence            5888899999999999999999999999999875321       123468999999999999999998843     3347


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+.+++.+.+...   ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence            899999998877766543   35688999999999999999999998 999999999999999876 8999999998765


Q ss_pred             ccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..   .....+++.|+|||.+.+  ...++.++|||||||++|+|++|+.||...+..+.+..+.+
T Consensus       166 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  228 (308)
T cd06634         166 AP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ  228 (308)
T ss_pred             cC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh
Confidence            32   234467889999999742  23478899999999999999999999987665544444433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.1e-34  Score=240.15  Aligned_cols=199  Identities=24%  Similarity=0.389  Sum_probs=156.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      +.||+|+||.||+|.. .++..+|+|.+....     ....+|+.+++.++||||+++++++..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            3689999999999985 467889999875432     134579999999999999999998733     33478999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~  224 (296)
                      ++ ++.+.+...   ...+++..+..++.|++.+|.|||++ |++|+||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            84 666665432   34678999999999999999999998 999999999999999877 8999999998754332211


Q ss_pred             c--cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          225 I--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       225 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .  ...++..|+|||.+.+. .++.++||||||+++|++++ |..||...........+.
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~  208 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE  208 (250)
T ss_pred             cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            1  12335679999998554 47899999999999999998 999998776554444443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.2e-34  Score=242.12  Aligned_cols=204  Identities=20%  Similarity=0.304  Sum_probs=155.2

Q ss_pred             eeeecCceEEEEEEEcCC--CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEec
Q 022520           72 VVGHGSFGVVFQAKCLET--GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  144 (296)
                      .||+|+||.||++.....  ...+++|.+....     ....+|+.+++.++||||+++++.+.     .....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            689999999999975433  3456677654322     23457888999999999999999884     33447899999


Q ss_pred             cc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC-
Q 022520          145 VP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  222 (296)
Q Consensus       145 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~-  222 (296)
                      ++ ++|.+.+..........+...+..++.|++.||.|||+. +++|+||||+|||++.++ .++|+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            98 477777765433334567778889999999999999998 999999999999999877 79999999875321111 


Q ss_pred             --CcccccccccccCCccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          223 --PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       223 --~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                        ......++..|+|||++...      ..++.++|||||||++|+|++ |..||...+..+.+..+.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  223 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK  223 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence              12234568889999987421      235789999999999999997 5789988776666555443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-34  Score=243.39  Aligned_cols=191  Identities=19%  Similarity=0.210  Sum_probs=148.1

Q ss_pred             eeeeecCceEEEEEEEcC------------CCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           71 RVVGHGSFGVVFQAKCLE------------TGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~------------~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      +.||+|+||.||+|+...            ....+++|.+....    ..+.+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            468999999999998532            22358888764332    2344688899999999999999987432    


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC------cEE
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QLK  208 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~------~ik  208 (296)
                       ...++||||++++.++.+....  ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.      .++
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeE
Confidence             3367999999965444333221  35689999999999999999999998 9999999999999976542      289


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCC
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES  272 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~  272 (296)
                      ++|||++.....   .....++..|+|||.+.....++.++|||||||++|+|+ +|..||....
T Consensus       153 l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         153 LSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             eCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            999998865422   223456788999998865556899999999999999998 5889987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-34  Score=246.07  Aligned_cols=192  Identities=20%  Similarity=0.273  Sum_probs=152.0

Q ss_pred             eeeeecCceEEEEEEEcCCCc-------EEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGE-------AVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~-------~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +.||+|+||.||+|.+...+.       .+++|.+....    ....+|..+++.++|||++++++.+...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            468999999999999865443       48888774332    2345788999999999999999988543     2368


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc-------EEEee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-------LKLCD  211 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~-------ikl~D  211 (296)
                      +||||+++ +|..++...   ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 666666543   24678899999999999999999998 99999999999999876532       79999


Q ss_pred             ecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChH
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGV  274 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~  274 (296)
                      ||++.....   .....++..|+|||++.+...++.++|||||||++|+|++|. +||...+..
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~  212 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ  212 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence            998865422   223456888999999876555789999999999999999985 777665543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-34  Score=245.01  Aligned_cols=192  Identities=18%  Similarity=0.237  Sum_probs=149.2

Q ss_pred             eeeecCceEEEEEEEcC------------------------CCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceec
Q 022520           72 VVGHGSFGVVFQAKCLE------------------------TGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSL  123 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~  123 (296)
                      .||+|+||.||+|....                        ....|++|.+....    ..+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997532                        12468888774332    234468889999999999999


Q ss_pred             ceeeeeccCCCceEEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC
Q 022520          124 KHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (296)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~  202 (296)
                      ++++...     ...++||||++++ |...+...   ...+++.++..++.|++.||+|||++ +|+||||||+|||++.
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEec
Confidence            9988433     3478999999964 44444332   35789999999999999999999998 9999999999999975


Q ss_pred             CC------CcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHH
Q 022520          203 HT------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD  275 (296)
Q Consensus       203 ~~------~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~  275 (296)
                      .+      ..++++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||...+..+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            42      13899999987543222   22356778999999866556899999999999999995 6999998765433

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.6e-34  Score=251.37  Aligned_cols=202  Identities=20%  Similarity=0.346  Sum_probs=157.9

Q ss_pred             eeeeec--CceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ..||.|  +||+||++++..+++.||+|.+....      +...+|+.+++.++||||++++++|.     .....++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            456666  89999999999999999999875322      33457888899999999999999984     344588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+.+ ++..++....  ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99985 6766666543  34688999999999999999999998 999999999999999877 8999999864322111


Q ss_pred             CCc--------ccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          222 EPN--------ISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       222 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ...        ....++..|+|||++.+. ..++.++|||||||++|+|++|++||......+.+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  223 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL  223 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh
Confidence            111        011235669999998654 347899999999999999999999999876555544443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7e-34  Score=241.27  Aligned_cols=198  Identities=33%  Similarity=0.577  Sum_probs=162.2

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ||.|+||.||++++..+++.+++|.+....       ....+|+++++.++|+||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999998889999999885432       2345788999999999999998887     3445588999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC--
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  222 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~--  222 (296)
                      ++ +|...+...    ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            85 676666542    4789999999999999999999998 999999999999999887 89999999986543321  


Q ss_pred             -------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          223 -------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       223 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                             ......++..|+|||.+.... ++.++|+||||+++|++++|..||...+..+....+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  215 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN  215 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence                   112345678899999986554 78999999999999999999999987775554444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-33  Score=243.27  Aligned_cols=203  Identities=30%  Similarity=0.482  Sum_probs=165.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .|...+.||+|++|.||++.+..+++.+++|.+....    ....+|+.+++.++|+|++++++.+..     ....+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            4666789999999999999998899999999875322    234578999999999999999998743     3447899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      +||+++ +|.+.+..     .+++...+..++.|++.||+|||++ |++||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999975 66655543     4688899999999999999999998 999999999999999877 899999998765433


Q ss_pred             CCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          221 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       221 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ... .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+....+..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~  228 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR  228 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            222 22345788999999986554 8899999999999999999999998766554444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.9e-34  Score=241.12  Aligned_cols=199  Identities=25%  Similarity=0.393  Sum_probs=152.2

Q ss_pred             eeeeecCceEEEEEEEcC---CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +.||+|+||.||+|.+..   .+..+|+|.+....     ....+|+.+++.++|||++++++.+...    ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998753   34679999874321     2344788999999999999998866422    22367899


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+. +++.+++...   ....+...+..++.|++.||.|||+. +++||||||+|||++.++ .++|+|||++......
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            9988 5777776543   24466777888999999999999998 999999999999999877 7999999998754322


Q ss_pred             C-----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022520          222 E-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (296)
Q Consensus       222 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~  279 (296)
                      .     ......++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~  214 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY  214 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            1     11123346789999988654 48899999999999999999 5677876655443333

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=247.58  Aligned_cols=204  Identities=25%  Similarity=0.347  Sum_probs=164.3

Q ss_pred             EEeecCCCCCCccc-----cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee-cchhhHHHHHHHH--hcCCCCcee
Q 022520           51 VTTIGGKNGQPKQT-----ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQTMR--LLDHPNVVS  122 (296)
Q Consensus        51 ~~~~~~~~~~~~~~-----~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~--~l~h~niv~  122 (296)
                      ..++++..|.|...     .+..+.+.||+|.||.||+|.+  .|+.||||++.. +.....+|.++.+  .|+|+||+.
T Consensus       192 ~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  192 LETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             hccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhh
Confidence            34555556666543     3588999999999999999999  788999999964 3455667888776  469999999


Q ss_pred             cceeeeeccCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC-------CceeccCC
Q 022520          123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-------GVCHRDIK  194 (296)
Q Consensus       123 ~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------~iiH~Dlk  194 (296)
                      +++.-...+ .....+|+|++|-+ |+|.++|..     ..++.+...+++..+++||++||..+       .|.|||||
T Consensus       270 FIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK  343 (513)
T KOG2052|consen  270 FIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK  343 (513)
T ss_pred             hhhccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence            987754333 23456899999998 899999987     56888999999999999999999843       59999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCC-----CcccccccccccCCccccCCCC-----CCCchhHHHHHHHHHHHHh
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLL  263 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~l~~  263 (296)
                      ..|||+.+++ .+.|+|+|+|.......     .....+||.+|||||++.....     .-..+||||||+++||++-
T Consensus       344 SKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  344 SKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             cccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            9999999988 89999999998765553     3456789999999999843321     1235999999999999874

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7e-34  Score=243.43  Aligned_cols=204  Identities=32%  Similarity=0.579  Sum_probs=168.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcC-CCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  137 (296)
                      +|.+.+.||.|+||.||+|.+..++..||+|.+...       .....+|.++++.++ |+||+++++++     .+...
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            699999999999999999999999999999988532       123457889999998 99999999887     34445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++|||++. ++|.+.+..    ...+++..+..++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            889999995 677777765    35799999999999999999999998 999999999999999877 79999999987


Q ss_pred             eeccCCC---------------------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          217 VLVKGEP---------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       217 ~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      .......                     .....++..|+|||.+.+.. ++.++|+||||++++++++|+.||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            6533221                     12234678899999886544 7889999999999999999999999877544


Q ss_pred             HHHHHH
Q 022520          276 QLVEII  281 (296)
Q Consensus       276 ~~~~~~  281 (296)
                      .+..+.
T Consensus       230 ~~~~~~  235 (280)
T cd05581         230 TFQKIL  235 (280)
T ss_pred             HHHHHH
Confidence            444443

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=258.10  Aligned_cols=210  Identities=30%  Similarity=0.434  Sum_probs=170.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ....|.+...+|.|+|+.|-.+.+..+++..++|++........+|+.++... +|+||+++.+.+     .+....|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            45679999999999999999999999999999999977655666788776655 799999999998     667779999


Q ss_pred             Eeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc-CCCCcEEEeeecceeeec
Q 022520          142 LEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       142 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~-~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||.+.|. +++.+..     .+.....+..|+++|+.++.|||++ |++||||||+|||++ ..+ +++|+|||.++...
T Consensus       395 ~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCC-cEEEEEechhhhCc
Confidence            9999974 3333332     2233367778999999999999999 999999999999995 555 79999999998654


Q ss_pred             cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcc
Q 022520          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       220 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  290 (296)
                      +.  ..+..-|..|.|||++. ...|+.++|+||||++||+|++|+.||......   .++.+.+..++.+
T Consensus       468 ~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s  532 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS  532 (612)
T ss_pred             hh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc
Confidence            43  22334478899999996 455999999999999999999999999987654   5666666666544

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-33  Score=243.17  Aligned_cols=206  Identities=31%  Similarity=0.485  Sum_probs=170.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ...|++.+.||+|++|.||+|.+..++..+++|.+....   ....+|++.++.++|+|++++++++...     ...++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   92 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV   92 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence            346999999999999999999998889999999886443   3455799999999999999999988443     44889


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ++||++ ++|.+.+....   ..++...+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDG-SVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCC-CEEECccchhhhhc
Confidence            999999 57777776642   3789999999999999999999998 999999999999999877 79999999876543


Q ss_pred             cCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022520          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  280 (296)
Q Consensus       220 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  280 (296)
                      .... .....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~  228 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI  228 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            3221 12335678899999986544 789999999999999999999999887655444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-33  Score=239.40  Aligned_cols=190  Identities=22%  Similarity=0.249  Sum_probs=152.8

Q ss_pred             eeeeecCceEEEEEEEcCCC----------cEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           71 RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~----------~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ..+.+|+.+++.++|+||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            46899999999999997666          357888765432   345678999999999999999998754      22


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC------cEEEe
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QLKLC  210 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~------~ikl~  210 (296)
                      .++||||+++ +|..++...   ...++...+..++.||+.||.|||++ +|+|+||||+||+++.++.      .++|+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeC
Confidence            5799999985 566666543   23688999999999999999999998 9999999999999987652      49999


Q ss_pred             eecceeeeccCCCcccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 022520          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (296)
Q Consensus       211 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~  273 (296)
                      |||++.....   .....++..|+|||.+.+. ..++.++|||||||++|+|++ |..||...+.
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence            9999876433   2234567789999998655 358899999999999999999 5788877653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.8e-33  Score=267.27  Aligned_cols=141  Identities=26%  Similarity=0.441  Sum_probs=122.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++|+||+++++++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            47999999999999999999999999999999886432       3456789999999999999998877     33445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++||||+. ++|..++..    ...+++..++.++.||+.||.|||.+ +|+||||||+|||++.++ .++|+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            899999997 467766654    35688899999999999999999998 999999999999999877 89999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=235.23  Aligned_cols=202  Identities=36%  Similarity=0.600  Sum_probs=168.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|++.+.||+|++|.||++.+..+++.|++|.+....      ....+|+++++.++|+|++++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4889999999999999999999899999999885443      23457999999999999999988873     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++|+|+++ +|.+.+..    ...+++..+..++.|++.+|.+||+. ||+|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 66666554    36789999999999999999999998 999999999999999876 8999999998876


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  279 (296)
                      ..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~  210 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR  210 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            44432 23346788999999986554 78999999999999999999999987665444433

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-34  Score=261.15  Aligned_cols=218  Identities=28%  Similarity=0.451  Sum_probs=184.5

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhc-CCCCceecceeeeeccCCCce
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +...+.|++.++||.|.+|.||+++++.+++..|+|+...+.   ...+.|.++|+.. .|||++.++++|+........
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            344557999999999999999999999999999999875433   3445677888876 699999999999888777778


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+|+|||||++ +..++++...  +.++.++++..|++.++.||.+||.+ .++|||||-.|||+..++ .+||+|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~-~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENA-EVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccC-cEEEeeeeee
Confidence            89999999994 6667776655  78999999999999999999999998 999999999999999988 7999999987


Q ss_pred             eeeccCC-CcccccccccccCCccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGE-PNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .-+.... ...+..|||.|||||++....    .|+.++|+||||++..||..|.+|+-+..+...+..|-+
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR  242 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  242 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence            6553332 345678999999999986543    367789999999999999999999998887777766544

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=271.87  Aligned_cols=212  Identities=22%  Similarity=0.398  Sum_probs=170.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCC-C----cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLET-G----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~-~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      .+-.+.+.||+|.||.||.|..... +    ..||+|.+....     ..+.+|..+|+.++|||||+++++.+....  
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~--  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP--  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence            4578899999999999999997643 3    348999885442     334589999999999999999999976333  


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                         .+|++|||. |+|+.+++....   ....++..++..++.|+++|+.||+++ ++|||||...|+|++... .+||+
T Consensus       770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccC-cEEEc
Confidence               689999998 588888886521   135688899999999999999999998 999999999999999886 89999


Q ss_pred             eecceeeeccCCCccc---ccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 022520          211 DFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       211 Dfg~~~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      |||+|+-+.+......   ..-...|||||.+.. ..++.++|||||||++||+++ |..||.+.++.+.+.-..+..
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG  921 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence            9999984433321111   122567999999965 459999999999999999997 999999999877776555443

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4e-33  Score=235.54  Aligned_cols=197  Identities=36%  Similarity=0.575  Sum_probs=166.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+....      ....+|+++++.++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4888999999999999999998899999999885433      24457999999999999999988874321   24588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +++||++ +++.+.+...    ..+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999996 5666666542    4889999999999999999999998 999999999999999876 8999999998876


Q ss_pred             ccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          219 VKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       219 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .....   .....++..|+|||.+.+.. .+.++||||||+++|+|++|..||...+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            55543   34456788999999986544 7899999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.1e-34  Score=245.20  Aligned_cols=201  Identities=30%  Similarity=0.458  Sum_probs=162.9

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      |.....||+|+||.||++.+..+++.||+|++....    ....+|+.+++.++|+|++++++.+.     .....+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence            444578999999999999999999999999874322    23457899999999999999999884     334588999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||+++ ++.+.+.     ..++++..+..++.|++.+|+|||+. |++|+||+|+||+++.++ .++|+|||++......
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence            99986 4444432     24688999999999999999999998 999999999999999887 7999999988765433


Q ss_pred             CC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022520          222 EP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  280 (296)
Q Consensus       222 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  280 (296)
                      .. .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+..+.+..+
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~  228 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  228 (292)
T ss_pred             cccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            22 2334678899999988544 4789999999999999999999999877655444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.4e-34  Score=245.76  Aligned_cols=195  Identities=27%  Similarity=0.416  Sum_probs=156.7

Q ss_pred             cceEEeeeeeecCceEEEEEEE----cCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..|++.+.||+|+||.||++++    ..++..||+|.+....     ....+|+.+++.++|+|++++++++...   +.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            3588999999999999999984    4568899999875321     2345799999999999999998877432   23


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||++ ++|...+...   ...+++..+..++.|++.||+|||++ |++||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~-~~~l~dfg~  155 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGL  155 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCC-CEEECCCcc
Confidence            44789999997 4676666543   24688999999999999999999998 999999999999999877 799999999


Q ss_pred             eeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022520          215 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  268 (296)
Q Consensus       215 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  268 (296)
                      +.........    ....++..|+|||.+.+.. ++.++|||||||++|+|++++.|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCC
Confidence            8765433211    1234566799999986544 889999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-33  Score=241.16  Aligned_cols=209  Identities=23%  Similarity=0.384  Sum_probs=160.2

Q ss_pred             eEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc-e
Q 022520           67 YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE-L  136 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~  136 (296)
                      |.+.+.||+|+||.||+|.+.   .++..||+|.+....      ....+|+.+++.++||||+++++.+......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            667889999999999999864   357899999885432      124478999999999999999998755433222 2


Q ss_pred             EEEEEEeccc-ccHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..+++++|+. +++..++....  .....++...+..++.|++.||+|||+. +|+|+||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCC-CEEECccc
Confidence            3568889987 46555554322  1123578889999999999999999998 999999999999999877 79999999


Q ss_pred             ceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 022520          214 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (296)
Q Consensus       214 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  278 (296)
                      +++.......   .....+++.|++||.+.... ++.++|||||||++|+|++ |++||.+.+..+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~  226 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN  226 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH
Confidence            9876533221   12233467899999985544 7889999999999999998 889998776544333

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=237.03  Aligned_cols=198  Identities=25%  Similarity=0.411  Sum_probs=157.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      +.||.|+||.||++.+.. ++.||+|.+....     ....+|+++++.++|+||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            468999999999999877 8999999875432     23457999999999999999998874     333478999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCc
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~  224 (296)
                      .+ ++.+.+...   ...++...+..++.+++.+|.|||++ +++||||||+||+++.++ .++|+|||.+.........
T Consensus        75 ~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            74 666666542   34678889999999999999999998 999999999999999877 8999999998754322211


Q ss_pred             c---cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          225 I---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       225 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      .   ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~  208 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI  208 (251)
T ss_pred             eccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence            1   122356699999986554 8999999999999999998 88999877654433333

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=234.82  Aligned_cols=198  Identities=34%  Similarity=0.566  Sum_probs=163.4

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ||.|+||.||++.+..+++.+|+|.+....       ....+|+.+++.++|+|++++++.+     ......++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            689999999999998889999999885432       2445789999999999999999887     4455689999999


Q ss_pred             c-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC-C
Q 022520          146 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-P  223 (296)
Q Consensus       146 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~-~  223 (296)
                      + ++|.+.+...    ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++....... .
T Consensus        76 ~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 6777777653    4689999999999999999999998 999999999999999877 89999999987654431 2


Q ss_pred             cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       224 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .....++..|+|||...+.. .+.++|+||||+++|++++|..||...+..+....+..
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  207 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK  207 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            33456688899999986544 78899999999999999999999987765444444433

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=255.10  Aligned_cols=200  Identities=29%  Similarity=0.450  Sum_probs=172.8

Q ss_pred             CCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh------------HHHHHHHHhcC---CCCceec
Q 022520           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK------------NRELQTMRLLD---HPNVVSL  123 (296)
Q Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~E~~~l~~l~---h~niv~~  123 (296)
                      ..+.+..+|...+.+|.|+||.|++|.++.+...|++|.+.+.+-..            --|+.||..++   |+||+++
T Consensus       555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            34455567999999999999999999999999999999885432111            15999999997   9999999


Q ss_pred             ceeeeeccCCCceEEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc
Q 022520          124 KHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (296)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~  201 (296)
                      +++|     ++..++|++||.-+.  +|.+++..    ...+.+.++..|++|++.|+++||++ ||+|||||-+|+.++
T Consensus       635 LdfF-----Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd  704 (772)
T KOG1152|consen  635 LDFF-----EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVD  704 (772)
T ss_pred             hhee-----ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEe
Confidence            9999     777889999998774  56666665    57889999999999999999999999 999999999999999


Q ss_pred             CCCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          202 PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       202 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      .+| -+||+|||.+.....+ +.-.++||..|.|||++.|.++.+..-|||+||++||.++....||.+
T Consensus       705 ~~g-~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  705 SNG-FVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cCC-eEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            998 8999999998765444 455788999999999998888788999999999999999999988864

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.2e-34  Score=241.61  Aligned_cols=202  Identities=22%  Similarity=0.365  Sum_probs=157.8

Q ss_pred             eeeeecCceEEEEEEEcCCC------cEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           71 RVVGHGSFGVVFQAKCLETG------EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +.||+|+||.||+|++....      ..+|+|.+...     .....+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36899999999999976433      68999977432     2234579999999999999999988743     33478


Q ss_pred             EEEeccc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC----CcEEEee
Q 022520          140 LVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCD  211 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~----~~ikl~D  211 (296)
                      +||||++ ++|.+.+.....   ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999998 577777765432   124478888999999999999999998 999999999999998754    2699999


Q ss_pred             ecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022520          212 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (296)
Q Consensus       212 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~  279 (296)
                      ||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...+..+....
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~  225 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH  225 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence            999875533221   11234467899999986544 8999999999999999998 9999987765554443

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.9e-33  Score=243.23  Aligned_cols=192  Identities=24%  Similarity=0.384  Sum_probs=152.3

Q ss_pred             CceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecccc-cH
Q 022520           77 SFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TV  149 (296)
Q Consensus        77 ~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l  149 (296)
                      ++|.||++++..+++.||+|++...      .....+|+++++.++|+||+++++++.     .....+++|||+++ ++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence            4455666666779999999988543      124558999999999999999999884     33447899999984 66


Q ss_pred             HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC------
Q 022520          150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP------  223 (296)
Q Consensus       150 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~------  223 (296)
                      .+++....  ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||.+........      
T Consensus        87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCC-ceEEecCccceeeccccccccccc
Confidence            66666543  34688999999999999999999998 999999999999999877 899999998865532211      


Q ss_pred             --cccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022520          224 --NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  277 (296)
Q Consensus       224 --~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  277 (296)
                        .....++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||........+
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~  219 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML  219 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence              1223457789999998553 34789999999999999999999999987654444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.6e-33  Score=237.72  Aligned_cols=206  Identities=25%  Similarity=0.461  Sum_probs=163.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||+|+||.||++.+...+..+++|..+..         ......|+.+++.++|||++++++.+..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            589999999999999999999877766666655321         1123468889999999999999988743     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++|+||+++ ++...+.........+++..+..++.|++.||.|||+. |++|+||||+||+++.+  .++|+|||.+
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~~--~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKNN--LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeecC--CEeecccCce
Confidence            47899999985 66666665444456799999999999999999999998 99999999999999753  6999999998


Q ss_pred             eeeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022520          216 KVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  280 (296)
Q Consensus       216 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  280 (296)
                      ........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~  217 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI  217 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            76543322 2234578899999988544 3788999999999999999999999876544444333

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.9e-33  Score=238.07  Aligned_cols=195  Identities=29%  Similarity=0.490  Sum_probs=157.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeecc--------hhhHHHHHHHHhc-CCCCceecceeeeeccCC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (296)
                      +|++.+.||+|++|.||++++.   .+++.||+|.+....        ....+|++++..+ +|+||+++++++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4889999999999999999864   467899999885321        2234789999999 599999999887     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      .....++||||+.+ ++...+..    ...+++..+..++.|++.+|.|||+. +++|+||||+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEEEC
Confidence            34457899999985 66666543    35688999999999999999999998 999999999999999877 7999999


Q ss_pred             cceeeeccCCC--cccccccccccCCccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          213 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       213 g~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  211 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD  211 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence            99876533321  12245788999999975432 3678999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=249.82  Aligned_cols=210  Identities=22%  Similarity=0.325  Sum_probs=170.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ....+.++||+|-||.|.++.- ..+..||+|.++..     ...+.+|+++|.+|+||||+.+++++.....     ++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence            4578899999999999999984 44689999988543     2456689999999999999999999865443     78


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|+||++ |+|.+++..+....  .......+++.||++||+||.+. +++||||.+.|+|++.+. ++||+|||+++.+
T Consensus       612 mI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEF-TIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcc-cEEecCccccccc
Confidence            9999998 78889988874222  34445667999999999999986 999999999999999998 8999999999866


Q ss_pred             ccCCCcc---cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhhc
Q 022520          219 VKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       219 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ..+....   ..+-+.+|||+|.+.-.+ +++++|+|+||+++||+++  ...||...++.+...+....+.
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~  758 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFR  758 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcC
Confidence            5544321   234478999999986555 8999999999999999986  6799999887666666555443

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-33  Score=239.83  Aligned_cols=198  Identities=29%  Similarity=0.459  Sum_probs=160.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEc----CCCcEEEEEEEeecch-----hhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..|.+.+.||+|+||.||+|...    .+++.+|+|.+.....     .+.+|+++++.++|+||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            46888999999999999999864    3478999998864432     45689999999999999999887633   224


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .+.+++|||++ +++.+++...   ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESED-LVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEccccc
Confidence            45789999997 4777776543   23688999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          215 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       215 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      +.........    ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccc
Confidence            9876432221    112335669999988654 4789999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=253.30  Aligned_cols=208  Identities=30%  Similarity=0.480  Sum_probs=168.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCC----CcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLET----GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ......+.++||.|.||.||.|.....    .-.||||.-+.+     ...+..|.-+++.++||||+++++++.+..  
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P--  464 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP--  464 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc--
Confidence            333456677899999999999987532    345888877543     344557999999999999999999984332  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                          .|||||.++ |.|..++..+   ...++...+..++.||+.+|+|||+. .++||||...|||+.+.. .+||+||
T Consensus       465 ----~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~-CVKLaDF  535 (974)
T KOG4257|consen  465 ----MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQ-CVKLADF  535 (974)
T ss_pred             ----eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcc-eeeeccc
Confidence                799999999 7888888876   36789999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCCCcccccc--cccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          213 GSAKVLVKGEPNISYIC--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       213 g~~~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      |+++.+.+...-....|  +.-|||||.+. .+.++.++|||.|||++||++. |..||.+-.+.+.+-.|.+
T Consensus       536 GLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn  607 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN  607 (974)
T ss_pred             chhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC
Confidence            99998766543333333  56799999984 4558999999999999999995 9999998776665544443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=246.07  Aligned_cols=193  Identities=27%  Similarity=0.395  Sum_probs=157.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee-cchhhHHHHHHHHh--cCCCCceecceeeeeccCCCceEEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ...+.+.+|+|+||.||+|+.  +++.||||++.. ....+.+|-+|...  ++|+||++++..--.... +...+++|+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEEe
Confidence            467889999999999999987  678999999953 44556677777664  689999998765432221 234589999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC--------CceeccCCCCceEEcCCCCcEEEeeec
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      +|.+ |+|.++++.     ...++....+++..+++||+|||+..        .|+|||||..|||+..|. +..|+|||
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG  361 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG  361 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence            9988 899999987     46899999999999999999999842        699999999999999988 89999999


Q ss_pred             ceeeeccCCC---cccccccccccCCccccCCCCCC-----CchhHHHHHHHHHHHHhCCCC
Q 022520          214 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYT-----AAIDIWSAGCVLAELLLGQPL  267 (296)
Q Consensus       214 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwSlG~il~~l~~g~~p  267 (296)
                      +|..+..+.+   ....+||.+|||||++.+.-...     .+.||||+|.+||||++....
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~  423 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTD  423 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccc
Confidence            9988865543   34578999999999996654443     468999999999999985533

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.4e-34  Score=248.18  Aligned_cols=217  Identities=35%  Similarity=0.539  Sum_probs=183.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh---hHHHHHHHHhcC------CCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY---KNRELQTMRLLD------HPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|.+.-..|+|-||+|.+|.+...|..||||+|......   -.+|+++|++|+      --++++++..|     ..
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~h  505 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KH  505 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hh
Confidence            34789999999999999999999999999999999655332   347999999995      24789988888     44


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..++|+|+|.+.-.|.+.++..- .+-.|....++.+++|++.||..|... ||+|.||||.|||+......+||||||.
T Consensus       506 knHLClVFE~LslNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  506 KNHLCLVFEPLSLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             cceeEEEehhhhchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCcc
Confidence            55599999999999998888653 345688889999999999999999875 9999999999999998877899999999


Q ss_pred             eeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       215 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      |..+.... -..+.-+..|.|||++.|-+ |+...|+||.||+||||+||+..|.+.++-+++...+..=++.|-
T Consensus       584 A~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  584 ASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             cccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            98764432 33455577899999998877 899999999999999999999999999998888887776665553

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=257.32  Aligned_cols=212  Identities=25%  Similarity=0.395  Sum_probs=178.1

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCC---cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .-.|.++||.|.||.|++|+.+..+   ..||||.++...     ..+..|..||-+++||||++|.++...     ..-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence            3578899999999999999987555   579999997543     234469999999999999999998843     333


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..||+|||+ |+|..+|+.+   .+.|...++..+++.|+.|+.||-+. +++||||...|||++.+. .+|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeeccce-EEEecccccee
Confidence            889999999 6888888876   47799999999999999999999998 999999999999999988 89999999999


Q ss_pred             eeccCC-Ccccccc---cccccCCccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          217 VLVKGE-PNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       217 ~~~~~~-~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .+.++. ...+..|   +.+|.|||.+. .++++.++||||+|++|||.+ .|..||.+.++.+.+..|.+....|+
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp  855 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP  855 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence            775544 2223333   56899999995 455999999999999999988 59999999999999998888665543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.9e-32  Score=229.57  Aligned_cols=180  Identities=26%  Similarity=0.305  Sum_probs=147.6

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecccc-cHHHHHH
Q 022520           76 GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIK  154 (296)
Q Consensus        76 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~  154 (296)
                      |.+|.||++++..+++.||+|.+.... ...+|...+....||||+++++++.     +....++||||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            889999999999999999999986543 2334555556667999999999883     34458899999985 7777765


Q ss_pred             HhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCccccccccccc
Q 022520          155 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR  234 (296)
Q Consensus       155 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~  234 (296)
                      ..    .++++..+..++.|++.||.|||+. +|+||||||+||+++.++ .++++|||.+......  .....++..|+
T Consensus        78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 KF----LNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             Hh----cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            53    4689999999999999999999998 999999999999999887 7999999987654322  22344577899


Q ss_pred             CCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       235 aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      |||.+.+.. ++.++|+||+|+++|+|++|+.||..
T Consensus       150 aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         150 APEVGGISE-ETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             CCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhc
Confidence            999885444 78999999999999999999988754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=251.76  Aligned_cols=206  Identities=25%  Similarity=0.398  Sum_probs=171.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ..++.++||+|.||.|++|.|...   -..||||.+..+.     ..+.+|+.+|.+|+|+|++++|++..+..      
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp------  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP------  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch------
Confidence            466778999999999999999743   3579999886443     34568999999999999999999986422      


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..+|||.++ |+|++.|...  ....|....+..++.||+.||.||.++ ++|||||...|+|+-... .|||+|||+++
T Consensus       185 ~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllaspr-tVKI~DFGLmR  260 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPR-TVKICDFGLMR  260 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccc-eeeeeccccee
Confidence            568999999 7888888762  356788889999999999999999999 999999999999998755 89999999999


Q ss_pred             eeccCCCcccccc----cccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          217 VLVKGEPNISYIC----SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       217 ~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      .+...........    ...|.|||.+... .++.++|||++||++|||++ |..||.+....+.++.|-+
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~  330 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA  330 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc
Confidence            8866655443222    5579999999654 48999999999999999997 8899999998877776653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.2e-32  Score=250.84  Aligned_cols=203  Identities=24%  Similarity=0.331  Sum_probs=141.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCC----CcEEEEEEEeecchhhHHHHHH---HHhcCCCCceecceeeeeccC-CC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLET----GEAVAIKKVLQDKRYKNRELQT---MRLLDHPNVVSLKHCFFSTTE-KD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~-~~  134 (296)
                      ..++|.+.+.||+|+||.||+|++..+    +..||+|++.....   .|...   ++...+.++..+...+..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456899999999999999999999888    89999998753221   22222   222233344444333322221 33


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhh----------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCc
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYK----------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~N  197 (296)
                      ....++|++|+++ +|.+++.....                .........+..++.|++.||.|||++ +|+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHH
Confidence            4457899999985 66666653210                001112345677999999999999998 99999999999


Q ss_pred             eEEcCCCCcEEEeeecceeeeccCC--CcccccccccccCCccccCCC---------------------CCCCchhHHHH
Q 022520          198 LLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTAAIDIWSA  254 (296)
Q Consensus       198 Ili~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwSl  254 (296)
                      ||++.+...+||+|||++.......  ......+|+.|+|||.+....                     .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9998754489999999997543322  223457799999999763221                     13446799999


Q ss_pred             HHHHHHHHhCCCCCC
Q 022520          255 GCVLAELLLGQPLFP  269 (296)
Q Consensus       255 G~il~~l~~g~~pf~  269 (296)
                      ||+||||+++..|+.
T Consensus       366 GviL~el~~~~~~~~  380 (566)
T PLN03225        366 GLIFLQMAFPNLRSD  380 (566)
T ss_pred             HHHHHHHHhCcCCCc
Confidence            999999999776654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-33  Score=230.31  Aligned_cols=216  Identities=34%  Similarity=0.595  Sum_probs=182.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCceEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYL  138 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  138 (296)
                      +|.-++.+|.|.- .|-.+-|.-.+++||+|+....      .+...+|..++..++|+||++++.+|..... .....+
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            6888899999998 7777888888999999987433      2344589999999999999999998854432 112337


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      |+|||+|..++...+.      ..+.-..+..++.|++.|+.|||+. ||+||||||+||++..+. .+||.|||+++..
T Consensus        97 y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   97 YLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDC-TLKILDFGLARTE  168 (369)
T ss_pred             HHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchh-heeeccchhhccc
Confidence            8999999998888776      2356677899999999999999998 999999999999999877 8999999999876


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCccc
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL  291 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  291 (296)
                      ...--.+..+.|..|.|||++.+.. +...+||||+||++.||++|+..|.+.+-.+++.++...++.+..++
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence            5553455677899999999998777 89999999999999999999999999999999999999988886654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.2e-32  Score=269.41  Aligned_cols=186  Identities=23%  Similarity=0.367  Sum_probs=152.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      .|...+.||+|+||.||+|++..++..||+|.+........+|++.+++++||||+++++++...     ...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            45667789999999999999988999999998865555556789999999999999999998433     3378999999


Q ss_pred             cc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---ccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH---NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH---~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ++ +|.+.+.       .+++..+..++.|++.||+|||   +. +|+||||||+||+++.+. ..++. ||....... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            84 6666653       3778889999999999999999   66 999999999999999776 56654 665443211 


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                        .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||+.
T Consensus       835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCc
Confidence              1233678999999998654 489999999999999999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-31  Score=218.71  Aligned_cols=197  Identities=34%  Similarity=0.579  Sum_probs=164.0

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      |.+.+.||.|++|.||++.+..+++.+++|.+...     .....+|++.++.++|+|++++++.+..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            56789999999999999999888899999988543     3345679999999999999999988733     2347899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +|++++ +|.+.+...    .. +++..+..++.+++.++.+||+. +++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999997 777776653    23 78889999999999999999998 999999999999999876 89999999988765


Q ss_pred             cCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChH
Q 022520          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGV  274 (296)
Q Consensus       220 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~  274 (296)
                      ...  ......++..|++||.+.....++.++|+|+||+++++|++|+.||.. .++.
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            543  234456788899999874334477899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-32  Score=242.55  Aligned_cols=209  Identities=21%  Similarity=0.373  Sum_probs=173.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ...+..+..+||-|.||.||.|.|+...-.||||.++.+.   ..+..|..+|+.++|||+|++++++....     -+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFY  339 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFY  339 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeE
Confidence            3445667789999999999999999989999999998764   34568999999999999999999995443     389


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ||+|||. |.|++++++..+  ..++...+..++.||.+|++||..+ ++|||||...|+|+.++. .+|++|||+++++
T Consensus       340 IiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnh-iVKvADFGLsRlM  415 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-IVKVADFGLSRLM  415 (1157)
T ss_pred             EEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccc-eEEeeccchhhhh
Confidence            9999987 899999988653  4567777888999999999999998 999999999999999877 8999999999988


Q ss_pred             ccCCCcc--cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..+....  ..-...-|.|||.+.-+ .++.++|||+|||+|||+.| |-.||.+-+- .++..++.
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLE  480 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLE  480 (1157)
T ss_pred             cCCceecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHh
Confidence            6665432  22336679999998544 48999999999999999997 8899999764 34444433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.1e-32  Score=234.99  Aligned_cols=216  Identities=31%  Similarity=0.491  Sum_probs=178.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcC---CCcEEEEEEEe--ecchhhHHHHHHHHhc-CCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVL--QDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ....|.++.+||+|.|++||++.+..   .++.||+|.+.  +......+|+++|..+ .+.||+++.+++     ....
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence            33469999999999999999999887   78999999884  4456677999999998 588999999988     4555


Q ss_pred             EEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ...+|+||++.. ..++..       .++..+++.+++.++.||.++|.+ |||||||||+|+|.+....+-.|+|||++
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhH
Confidence            588999999964 333333       366888999999999999999998 99999999999999998878999999998


Q ss_pred             eeeccC---------------------------------------------CCcccccccccccCCccccCCCCCCCchh
Q 022520          216 KVLVKG---------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAID  250 (296)
Q Consensus       216 ~~~~~~---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  250 (296)
                      ......                                             .......||++|+|||+++..+..+++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            721000                                             00123458999999999998888999999


Q ss_pred             HHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhhcCCCccc
Q 022520          251 IWSAGCVLAELLLGQPLFP-GESGVDQLVEIIKVILHTEISL  291 (296)
Q Consensus       251 iwSlG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~  291 (296)
                      |||.|||++.+++++.||. ..++.+.+.+|+..++..++..
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk  302 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRK  302 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHH
Confidence            9999999999999998865 5678889999999988776643

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=9.5e-30  Score=231.69  Aligned_cols=207  Identities=23%  Similarity=0.323  Sum_probs=146.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEc----------------CCCcEEEEEEEeecch------------------hhHH
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCL----------------ETGEAVAIKKVLQDKR------------------YKNR  107 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~------------------~~~~  107 (296)
                      ...++|.+.++||+|+||+||+|.+.                ..++.||||++.....                  ....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34568999999999999999999752                2456799998853321                  1113


Q ss_pred             HHHHHHhcCCCCc-----eecceeeeeccC---CCceEEEEEEecccc-cHHHHHHHhhh--------------------
Q 022520          108 ELQTMRLLDHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYVPE-TVHRVIKHHYK--------------------  158 (296)
Q Consensus       108 E~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~iv~e~~~~-~l~~~l~~~~~--------------------  158 (296)
                      |+.++.+++|.++     +++++++.....   ......++|+||+++ +|.+.+.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            5666677766554     566665533211   112347899999984 66666643210                    


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCccc--ccccccccCC
Q 022520          159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAP  236 (296)
Q Consensus       159 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~--~~~t~~y~aP  236 (296)
                      ....+++..++.++.|++.+|.|||+. +|+||||||+|||++.++ .++|+|||++...........  ..+|+.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            012345677889999999999999998 999999999999999887 899999999865433322222  2347899999


Q ss_pred             ccccCCCC-------------------C--CCchhHHHHHHHHHHHHhCCC-CCCC
Q 022520          237 ELIFGATE-------------------Y--TAAIDIWSAGCVLAELLLGQP-LFPG  270 (296)
Q Consensus       237 E~~~~~~~-------------------~--~~~~DiwSlG~il~~l~~g~~-pf~~  270 (296)
                      |.+.....                   +  ..+.||||+||++|+|++|.. ||.+
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99743210                   1  124699999999999999884 7754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=240.43  Aligned_cols=199  Identities=29%  Similarity=0.448  Sum_probs=164.6

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCC----cEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+..++||+|+||+||+|.+.-.+    -+||+|++...     ...+.+|+-+|..++|||+++++++.....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            3556789999999999999987555    46888877432     334557899999999999999999884332     


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                       ..||++|++ |.|+++++.+.   .++.......|+.||++||.|||++ +++||||-..|||+.+.. .+|+.|||++
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~-hvkitdfgla  845 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPN-HVKITDFGLA  845 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCC-eEEEEecchh
Confidence             568999999 78999998874   6788889999999999999999999 999999999999999876 7999999999


Q ss_pred             eeeccCCCcccccc---cccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022520          216 KVLVKGEPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  276 (296)
Q Consensus       216 ~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  276 (296)
                      +....+.......+   .+-|||-|.+.. +.|+.++||||+||++||++| |..|+++....+.
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI  909 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI  909 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence            88766554444333   556899998854 459999999999999999997 9999999765443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=247.11  Aligned_cols=197  Identities=29%  Similarity=0.453  Sum_probs=159.1

Q ss_pred             eEEeeeeeecCceE-EEEEEEcCCCcEEEEEEEeecc-hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEEe
Q 022520           67 YMAERVVGHGSFGV-VFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        67 y~~~~~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      |.-.+.+|.|+.|+ ||+|..  .++.||||.+.... ...++|+..|+.. +||||++++..-     .+..+.||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence            55567899999985 799987  88899999886544 3567999999988 599999986543     67778999999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC---CC-CcEEEeeecceeeec
Q 022520          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVLV  219 (296)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~---~~-~~ikl~Dfg~~~~~~  219 (296)
                      .|..+|.+++...............+..+.|+++||++||+. +|+||||||.||||+.   ++ .+++|+|||+++.+.
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            999999999987421112222245667889999999999996 9999999999999976   22 378999999999987


Q ss_pred             cCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC
Q 022520          220 KGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGES  272 (296)
Q Consensus       220 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~  272 (296)
                      .+...    .+..||-+|+|||++.... .+.++|||||||++|+.++| ..||...-
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~  719 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL  719 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH
Confidence            76543    3457899999999997655 57799999999999999985 79997643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.9e-29  Score=210.65  Aligned_cols=191  Identities=38%  Similarity=0.658  Sum_probs=158.9

Q ss_pred             CceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecccc-cHH
Q 022520           77 SFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVH  150 (296)
Q Consensus        77 ~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~  150 (296)
                      +||.||+|.+..+++.+++|++...     .....+|++.+++++|+|++++++++..     ....++++|++++ ++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999888999999988543     3455689999999999999999998843     2447899999997 777


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCccccccc
Q 022520          151 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS  230 (296)
Q Consensus       151 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t  230 (296)
                      ..+...    ..++...+..++.+++.++.+||+. +++|+||+|.||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKKR----GRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            776552    3388899999999999999999998 999999999999999886 8999999999876555444556678


Q ss_pred             ccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022520          231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (296)
Q Consensus       231 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  279 (296)
                      ..|++||.+.+.. ++.++||||||++++++++|..||......+.+.+
T Consensus       150 ~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~  197 (244)
T smart00220      150 PEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK  197 (244)
T ss_pred             cCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            8999999986444 78899999999999999999999988444444333

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=214.09  Aligned_cols=198  Identities=23%  Similarity=0.370  Sum_probs=151.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..+.|.+.+.||+|.||.+-+++++.++..+++|.+....   ..+.+|..---.| .|.||+.-|++-+..    ..++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc----CceE
Confidence            3457999999999999999999999999999999875443   3344555443333 589999887765433    3357


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE-cCCCCcEEEeeeccee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAK  216 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli-~~~~~~ikl~Dfg~~~  216 (296)
                      .+++||++ |+|...+..     ..+.+...++++.|+++|++|||++ +++|||||.+|||| +.+.-+|||||||+.+
T Consensus        98 vF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeeccccc
Confidence            78999999 666555443     5677888999999999999999999 99999999999998 4455589999999986


Q ss_pred             eeccCCCcccccccccccCCccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ....-  -....-+..|.+||.+....    ...+.+|+|.||+++|.++||++||+...
T Consensus       172 k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~  229 (378)
T KOG1345|consen  172 KVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS  229 (378)
T ss_pred             ccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence            53111  11112255689999874322    24677999999999999999999998643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=208.90  Aligned_cols=198  Identities=24%  Similarity=0.347  Sum_probs=169.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEE--eecchhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ..|++.++||+|+||.++.|.+..++++||||.-  ++....+..|....+.|. .++|...|.+.     +++.+..+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhh
Confidence            3799999999999999999999999999999955  344556678999999885 57887765433     566677899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC----CCCcEEEeeecceee
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----HTHQLKLCDFGSAKV  217 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~----~~~~ikl~Dfg~~~~  217 (296)
                      +|.++.+|.+++...   +++|+..++..++.|++.-++++|++ .+|+|||||+|+||..    +.+.|.++|||+|+.
T Consensus       103 idLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            999999999988876   58899999999999999999999999 9999999999999964    333699999999988


Q ss_pred             eccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ..+..+        ..+..||.+||+-...++.+ .+.+.|+-|||-++++++-|.+||.+..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            755543        34567899999988877655 7999999999999999999999999865

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-29  Score=233.87  Aligned_cols=216  Identities=25%  Similarity=0.414  Sum_probs=167.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEc----C---CCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeeccC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCL----E---TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~----~---~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (296)
                      +..+.+.||+|.||.||+|.-.    .   ....||||..+...     ..+..|+++++.+ .|+||+.+.+++..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            4567779999999999999743    1   14679999876433     3445799999988 59999999998844   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhh---hc-------C--CCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceE
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHY---KM-------S--QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~---~~-------~--~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIl  199 (296)
                        ....++|+||+. |+|+.+++...   ..       .  ..++..++..++.||+.|++||++. +++||||-..|||
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVL  450 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEE
Confidence              334789999998 78888888765   11       1  1388899999999999999999998 9999999999999


Q ss_pred             EcCCCCcEEEeeecceeeeccCCCcc--ccc--ccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 022520          200 VNPHTHQLKLCDFGSAKVLVKGEPNI--SYI--CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  274 (296)
Q Consensus       200 i~~~~~~ikl~Dfg~~~~~~~~~~~~--~~~--~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~  274 (296)
                      +..+. .+||+|||+++.........  ...  -...|||||.+.. ..|+.++||||+|++|||+++ |..||.+-...
T Consensus       451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99886 89999999998644433221  111  2446999999965 569999999999999999997 88999986533


Q ss_pred             HHHHHHHHhhcCCCc
Q 022520          275 DQLVEIIKVILHTEI  289 (296)
Q Consensus       275 ~~~~~~~~~~~~~~~  289 (296)
                      ..+.+.++...+.+.
T Consensus       529 ~~l~~~l~~G~r~~~  543 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQ  543 (609)
T ss_pred             HHHHHHHhcCCCCCC
Confidence            444555555544433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=199.68  Aligned_cols=204  Identities=25%  Similarity=0.332  Sum_probs=168.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch--hhHHHHHHHHhcCC-CCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--YKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      +.|+++++||+|+||.+|.|....+|+.||||.-.+...  .+..|.++.+.|++ ..|..+.+++     .+..+..+|
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceee
Confidence            479999999999999999999999999999997755433  44579999999875 5666666655     455567899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeecceeeec
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV  219 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg~~~~~~  219 (296)
                      |+.++.+|.+++...   ++.++..++.-++.|++.-++|+|.+ ++|||||||+|+|+.-+.  +++.|+|||+++...
T Consensus        90 MdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999999999888765   47899999999999999999999999 999999999999996543  378999999998774


Q ss_pred             cCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          220 KGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       220 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      +...        .....||.+|.+-....+.. .+.+.|+-|+|.+|.++--|..||++.......+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence            4432        34578899999887765444 7889999999999999999999999876544433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=230.16  Aligned_cols=215  Identities=27%  Similarity=0.399  Sum_probs=178.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee----cchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .++|.++..+|.|.||.||+++++.+++..|+|.++-    +....++|+-+++.++|+||+.+++.|..-..     .|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cE
Confidence            4579999999999999999999999999999998863    23456789999999999999999999954333     89


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |+||||+++.++.+   +...+++++.++...+++.+.||+|||+. |-+|||||-.|||+...+ .+|++|||.+..+.
T Consensus        89 icMEycgggslQdi---y~~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~g-DvklaDfgvsaqit  163 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDI---YHVTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEG-DVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEecCCCcccce---eeecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccC-ceeecccCchhhhh
Confidence            99999997644433   34478999999999999999999999998 999999999999999888 79999999875432


Q ss_pred             cC-CCcccccccccccCCcccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          220 KG-EPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       220 ~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .. .....+.||+.|||||+..  ....|...+|||++|+...|+.--++|.....+...+..+-+....++
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp  235 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP  235 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence            21 2345678999999999962  223488999999999999999888888777777777777777766554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-27  Score=207.26  Aligned_cols=200  Identities=24%  Similarity=0.266  Sum_probs=162.4

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCC-cEEEEEEEeecc----hhhHHHHHHHHhcCC----CCceecceeeeeccCCCce
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK----RYKNRELQTMRLLDH----PNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~----~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~  136 (296)
                      +|.+.+.||+|+||.||.|.+..++ +.+|+|......    .....|..++..+..    +++..+++.+.    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987764 678888765421    146679999998873    57777766552    2445


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC----CcEEEeee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCDF  212 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~----~~ikl~Df  212 (296)
                      +.++||+.++.+|.++.....  .+.++..++..++.|++.+|.+||+. |++||||||+|+.+....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999999776654  58899999999999999999999998 999999999999998653    47999999


Q ss_pred             ccee--eeccCC--------C-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          213 GSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       213 g~~~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      |+++  ......        . .....||..|.++....+.. .+.+.|+||++.++.+++.|..||.+...
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            9998  321111        1 22355899999999876554 89999999999999999999999987664

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.3e-26  Score=188.98  Aligned_cols=179  Identities=35%  Similarity=0.608  Sum_probs=149.5

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEeccc-
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-  146 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-  146 (296)
                      ||+|.+|.||++.+..+++.+++|.+....     ....+|+..++.++|++++++++++..     ....++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            689999999999998779999999986554     346789999999999999999988843     345889999999 


Q ss_pred             ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC-CCCcEEEeeecceeeeccCC-Cc
Q 022520          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  224 (296)
Q Consensus       147 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~-~~~~ikl~Dfg~~~~~~~~~-~~  224 (296)
                      +++...+....   ..++...+..++.+++++|.+||+. +++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            67777766531   4688899999999999999999998 9999999999999998 55 89999999987654332 12


Q ss_pred             ccccccccccCCccccCCCCCCCchhHHHHHHHHHHH
Q 022520          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (296)
Q Consensus       225 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  261 (296)
                      ....+...|++||.+.....++.++|+|++|++++++
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            3355688899999985543578999999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.3e-26  Score=202.91  Aligned_cols=158  Identities=20%  Similarity=0.299  Sum_probs=119.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcC-CCcEEEEEEEeec---------chhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      ....|.+.+.||+|+||+||+|++.. +++.+|||++...         ...+.+|+++|+.++|+|+++.+..+   . 
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~-   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G-   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C-
Confidence            44579999999999999999999876 6788899976422         22356899999999999998632211   1 


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccC-CCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dl-kp~NIli~~~~~~ikl~D  211 (296)
                          ..++||||++|..+....       ...   ...++.|++.+|.|||++ ||+|||| ||+|||++.++ .++|+|
T Consensus        92 ----~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~-~ikLiD  155 (365)
T PRK09188         92 ----KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDG-EAAVID  155 (365)
T ss_pred             ----CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCC-CEEEEE
Confidence                268999999975443211       111   135788999999999998 9999999 99999998776 799999


Q ss_pred             ecceeeeccCCCc---------ccccccccccCCcccc
Q 022520          212 FGSAKVLVKGEPN---------ISYICSRYYRAPELIF  240 (296)
Q Consensus       212 fg~~~~~~~~~~~---------~~~~~t~~y~aPE~~~  240 (296)
                      ||+++........         ....+++.|+|||.+.
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999876443211         2334677899999873

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3.8e-26  Score=221.93  Aligned_cols=152  Identities=18%  Similarity=0.205  Sum_probs=113.3

Q ss_pred             hcCC-CCceecceeeeecc--CCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCcee
Q 022520          114 LLDH-PNVVSLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (296)
Q Consensus       114 ~l~h-~niv~~~~~~~~~~--~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH  190 (296)
                      .++| +||+.+++.|-...  ......++.++|+++++|.+.+...   ...+++..++.+++||+.||+|||++ ||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ-GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            3445 57777777651111  1122346788999999999888643   35699999999999999999999998 9999


Q ss_pred             ccCCCCceEEcCCC------------------CcEEEeeecceeeeccCC-----------------CcccccccccccC
Q 022520          191 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNISYICSRYYRA  235 (296)
Q Consensus       191 ~Dlkp~NIli~~~~------------------~~ikl~Dfg~~~~~~~~~-----------------~~~~~~~t~~y~a  235 (296)
                      |||||+||||+..+                  ..+|++|||+++......                 ......+|++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999995422                  256777777765421100                 0012357889999


Q ss_pred             CccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       236 PE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ||++.+.. ++.++|||||||+||||++|.+||..
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhh
Confidence            99987655 89999999999999999999998764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-25  Score=190.28  Aligned_cols=211  Identities=21%  Similarity=0.271  Sum_probs=159.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCC-----cEEEEEEEeecchhh-----HHHHHHHHhcCCCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~-----~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      +..++++.-.+-+|.||.||.|.++..+     +.|-+|..++.....     ..|.-.|.-+.|||++++.++..+.. 
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-  360 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-  360 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-
Confidence            3456778888999999999999776433     345556554443332     25666677778999999988876433 


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcE
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHY----KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~i  207 (296)
                         ...++++.+++ |+|..++....    ...+.++-.++..++.|++.|++|||++ ++||.||...|.+||... ++
T Consensus       361 ---~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~L-qV  435 (563)
T KOG1024|consen  361 ---ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQL-QV  435 (563)
T ss_pred             ---CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-Ccccchhhhhcceehhhe-eE
Confidence               23567888888 67777777322    1234566778888999999999999999 999999999999999876 89


Q ss_pred             EEeeecceeeeccCCCcc---cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          208 KLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       208 kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      ||+|=.+++-+.+...+-   ....+..||+||.+.... |+.++|+|||||+||||+| |+.||..-++.+...-+
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            999999988765543321   122266799999996544 9999999999999999997 99999888776554433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=9.1e-23  Score=177.09  Aligned_cols=197  Identities=37%  Similarity=0.548  Sum_probs=158.0

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCC-CceecceeeeeccCCCceEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  138 (296)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+...       .....+|..++..+.|+ +++++.+.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            788999999999999999986   77888877432       23345788899999988 7999988882     22226


Q ss_pred             EEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++++++.+. +.+.+...... ..++......++.|++.++.++|+. +++|||+||+||+++.....++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            8999999964 44333332110 2688999999999999999999998 9999999999999998764599999999875


Q ss_pred             eccCC-------CcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          218 LVKGE-------PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       218 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .....       ......++..|+|||.+.+.  ..+....|+||+|++++++++|..||.....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            54433       23566789999999998663  4578999999999999999999999887764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=6.1e-24  Score=171.46  Aligned_cols=134  Identities=16%  Similarity=0.220  Sum_probs=102.7

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------------h-----------------hHHHHHHHHhcCCCC
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------------Y-----------------KNRELQTMRLLDHPN  119 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~-----------------~~~E~~~l~~l~h~n  119 (296)
                      ...||+|+||.||+|.+. +|+.||+|++.....             .                 ..+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 899999998854321             1                 124889999998877


Q ss_pred             ceecceeeeeccCCCceEEEEEEecccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HccCCceeccCCCCc
Q 022520          120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVCHRDIKPQN  197 (296)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~iiH~Dlkp~N  197 (296)
                      +.......  ..   .  .++||||++++.+ .....    ..+++...+..++.|++.+|.+| |+. ||+||||||+|
T Consensus        81 v~~p~~~~--~~---~--~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~N  148 (190)
T cd05147          81 IPCPEPIL--LK---S--HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYN  148 (190)
T ss_pred             CCCCcEEE--ec---C--CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHH
Confidence            64332211  11   1  3699999997533 22222    35788999999999999999999 787 99999999999


Q ss_pred             eEEcCCCCcEEEeeecceeee
Q 022520          198 LLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       198 Ili~~~~~~ikl~Dfg~~~~~  218 (296)
                      ||++. + .++|+|||++...
T Consensus       149 Ili~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEEC-C-cEEEEEccccccC
Confidence            99984 4 7999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.8e-24  Score=172.64  Aligned_cols=169  Identities=13%  Similarity=0.153  Sum_probs=122.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chh---------hHHHHHHHHhcCCCCceecceeeeec
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRY---------KNRELQTMRLLDHPNVVSLKHCFFST  130 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~  130 (296)
                      ..+|++.+.||.|+||.||++..  ++..+|+|.+...    ...         ..+|+..+.++.|++|..+.+.+...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            45899999999999999999765  4668999988422    111         35788899999999999998876543


Q ss_pred             cCCC---ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc
Q 022520          131 TEKD---ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (296)
Q Consensus       131 ~~~~---~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~  206 (296)
                      ....   ....+++|||++| ++.+..        .+++    ....+++.+|..||.. |++|||+||+||++++++  
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g--  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG--  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC--
Confidence            2111   2236799999997 444431        1222    2455899999999998 999999999999999766  


Q ss_pred             EEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHH
Q 022520          207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (296)
Q Consensus       207 ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  261 (296)
                      ++|+|||...........            +.+.-...+..++|+||||+++..+
T Consensus       173 i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHH
Confidence            999999987643221110            1121222366899999999998654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=8e-23  Score=163.29  Aligned_cols=109  Identities=27%  Similarity=0.301  Sum_probs=91.7

Q ss_pred             ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCccc
Q 022520          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS  226 (296)
Q Consensus       147 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~  226 (296)
                      |+|.+.+...   ..++++..++.++.|++.||.|||++ +      ||+|||++.++ .+++  ||++......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            4666777653   35799999999999999999999998 7      99999999877 7888  9998765332    2


Q ss_pred             ccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       227 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ..||+.|||||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus        64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~  109 (176)
T smart00750       64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERE  109 (176)
T ss_pred             CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccch
Confidence            36789999999996654 89999999999999999999999976543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.1e-22  Score=164.56  Aligned_cols=134  Identities=17%  Similarity=0.250  Sum_probs=104.1

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------------------------------hhHHHHHHHHhcCCCC
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  119 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~n  119 (296)
                      ...||+|+||.||+|.+. +|+.||+|++.....                              ....|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999986 899999998864311                              1136788899999988


Q ss_pred             ceecceeeeeccCCCceEEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCc
Q 022520          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQN  197 (296)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~N  197 (296)
                      +........  . .    .++||||++|. +......    ..+++...+..++.|++.+|.+||. . ||+||||||+|
T Consensus        81 i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILL--K-K----NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEe--c-C----CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhh
Confidence            754333221  1 1    36899999975 3222222    2467788899999999999999999 8 99999999999


Q ss_pred             eEEcCCCCcEEEeeecceeee
Q 022520          198 LLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       198 Ili~~~~~~ikl~Dfg~~~~~  218 (296)
                      |+++ ++ .++|+|||++...
T Consensus       149 Ill~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CC-CEEEEEcccceec
Confidence            9998 54 7999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.5e-22  Score=162.48  Aligned_cols=181  Identities=18%  Similarity=0.133  Sum_probs=130.8

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch--------hhHHHHHHHHhcC-CCCceecceeeeeccCCCceEE
Q 022520           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      -+...|++|+||+|+.+..  .+.+++.+.+.....        ...+|+++|++|. |+++++++++.     .    .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence            3567899999999998865  777888776654332        3568999999995 47788876631     1    5


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccC-CCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dl-kp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|+|+.|..+....         +.. ...++.|++.+|.++|++ ||+|||| ||+|||++.++ .++|+|||++..
T Consensus        74 ~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDG-SPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCC-CEEEEECCCcee
Confidence            7999999975432111         011 134678999999999998 9999999 79999999877 799999999985


Q ss_pred             eccCCCc--------------ccccccccccCCccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          218 LVKGEPN--------------ISYICSRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       218 ~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ......-              .....++.|++|+.-.--...+ ...+.++.|+-+|.++|++.|+.+.
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            4332210              0112367777777642221223 5678999999999999999887654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=3.9e-22  Score=167.98  Aligned_cols=202  Identities=24%  Similarity=0.320  Sum_probs=126.7

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHH-------HhcC----------CCCceecceeee
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLD----------HPNVVSLKHCFF  128 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-------~~l~----------h~niv~~~~~~~  128 (296)
                      .+...+.||.|+++.||.+++..+++.+|+|++....+...++++.+       ..+.          |-.++.-.+...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            57788999999999999999999999999998865443332222222       2221          111221112211


Q ss_pred             ecc-------CCCce-----EEEEEEecccccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHccCCceeccC
Q 022520          129 STT-------EKDEL-----YLNLVLEYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDI  193 (296)
Q Consensus       129 ~~~-------~~~~~-----~~~iv~e~~~~~l~~~l~~~~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dl  193 (296)
                      ...       ..+..     ..+++|+-+.++|..++.........   +.......+..|+++.+++||.+ |++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEeccc
Confidence            110       01111     24678888888888776644332222   22222233457999999999998 9999999


Q ss_pred             CCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCccccCC-------CCCCCchhHHHHHHHHHHHHhCCC
Q 022520          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQP  266 (296)
Q Consensus       194 kp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~l~~g~~  266 (296)
                      +|+|+|++.+| .+.|+||+.........  .....+..|.+||.....       -.++.+.|.|+||+++|.|..|..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999988 89999999876542221  113446779999976321       237889999999999999999999


Q ss_pred             CCCCC
Q 022520          267 LFPGE  271 (296)
Q Consensus       267 pf~~~  271 (296)
                      ||...
T Consensus       249 Pf~~~  253 (288)
T PF14531_consen  249 PFGLS  253 (288)
T ss_dssp             STCCC
T ss_pred             CCCCC
Confidence            99743

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.7e-22  Score=188.11  Aligned_cols=194  Identities=26%  Similarity=0.413  Sum_probs=149.8

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEEee----cchh------hHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----DKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .....+|.|++|.|+.+......+.++.|.+..    ....      ...|+-+-..+.|+|++.....+.....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            456789999999999998877777677665431    1111      1124444456789999887666543322     


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ..-+||||+++|..++...    ..+....+..+++|++.|+.|||+. ||.|||+||+|+++..++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCC-ceEEeecCccee
Confidence            2234999999777777652    4788888999999999999999998 999999999999999988 899999999866


Q ss_pred             eccCCC-----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ..-+..     .....|+..|+|||++.+........||||.|+++..|.+|+.||....
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~  529 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK  529 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence            533322     3456789999999999777766678999999999999999999997543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=1.3e-20  Score=153.69  Aligned_cols=137  Identities=18%  Similarity=0.258  Sum_probs=101.5

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhc-----CCCCceecceeeeeccCCCceEE
Q 022520           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .-.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     +||||+++++++..... ....+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEE
Confidence            3457899999999995  6666665 68987543    34456899999999     67999999998844321 12234


Q ss_pred             EEEEeccc---ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHccCCceeccCCCCceEEcCC---CCcEEEee
Q 022520          139 NLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL-AYIHNTIGVCHRDIKPQNLLVNPH---THQLKLCD  211 (296)
Q Consensus       139 ~iv~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~iiH~Dlkp~NIli~~~---~~~ikl~D  211 (296)
                      .+|+||++   ++|.+++..     ..+++.  ..++.|++.++ +|||++ +|+||||||+|||++..   ..+++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            58999954   588888854     235555  35577888777 899999 99999999999999742   22799999


Q ss_pred             -eccee
Q 022520          212 -FGSAK  216 (296)
Q Consensus       212 -fg~~~  216 (296)
                       ||...
T Consensus       153 g~G~~~  158 (210)
T PRK10345        153 NIGEST  158 (210)
T ss_pred             CCCCcc
Confidence             55443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-22  Score=181.71  Aligned_cols=191  Identities=30%  Similarity=0.455  Sum_probs=148.8

Q ss_pred             eeeecCceEEEEEEEc---CCCcEEEEEEEeec------chhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEEE
Q 022520           72 VVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ++|.|.||.|++++-.   ..+..+|+|.....      ......|-.++..++ ||.+|++...|     +...-.+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence            3799999999988632   35667788765321      123345778888886 99999998877     333337889


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      +++..++   .+..+......+.+.....+...++-+++++|+. +|+|||+|++||+++.+| .+++.|||+++.....
T Consensus        76 ld~~rgg---~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~G-hi~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGG---DLFTRLSKEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccc---hhhhccccCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccC-ccccCCchhhhHhHhh
Confidence            9998875   2222222346677888888999999999999998 999999999999999998 6999999999876554


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...   .||..|||||++.   .....+|.||+|+++++|+||..||..    +....|.+
T Consensus       151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~  201 (612)
T KOG0603|consen  151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK  201 (612)
T ss_pred             hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence            433   7899999999985   257889999999999999999999998    44455554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=6.8e-21  Score=181.44  Aligned_cols=192  Identities=26%  Similarity=0.400  Sum_probs=147.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh-hHHHHHHHHhcC---CCCceecceeeeeccCCCceEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-KNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ....|.|.+.||+|+||.||+|.... |+.||+|+-+..... +.-=.+++.+|+   -+.|.++..+++..+.     -
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S  769 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----S  769 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----c
Confidence            44579999999999999999999866 999999966443221 111123344444   3456666555544333     4


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc------CCCCcEEEee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------PHTHQLKLCD  211 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~------~~~~~ikl~D  211 (296)
                      .+|++|.+ |+|++++..    ++..++..+..+..|+++-++.||.. +|||+||||+|++|.      .+...++|+|
T Consensus       770 ~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            68999998 899888873    57788888999999999999999998 999999999999993      2223599999


Q ss_pred             ecce---eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022520          212 FGSA---KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  266 (296)
Q Consensus       212 fg~~---~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  266 (296)
                      ||.+   +...++.......+|-.+-.+|+..|.+ |+..+|.|.|+.+++-|+.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            9986   3334444455667788999999987666 9999999999999999999873

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=8.4e-21  Score=161.72  Aligned_cols=149  Identities=23%  Similarity=0.353  Sum_probs=114.0

Q ss_pred             CCCCceecceeeeeccC----------------------CCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHH
Q 022520          116 DHPNVVSLKHCFFSTTE----------------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY  173 (296)
Q Consensus       116 ~h~niv~~~~~~~~~~~----------------------~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~  173 (296)
                      +|||||++...|.+...                      .....+|+||...+.+|..++..     +..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            59999999888865321                      22345889999999999998876     4466667777899


Q ss_pred             HHHHHHHHHHccCCceeccCCCCceEEcCCCC---cEEEeeecceeeeccCC-------CcccccccccccCCccccCCC
Q 022520          174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKLCDFGSAKVLVKGE-------PNISYICSRYYRAPELIFGAT  243 (296)
Q Consensus       174 ~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---~ikl~Dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~  243 (296)
                      |+++|+.|||.+ ||.|||+|.+|||+.-+.+   .+.++|||++-.-....       ......|...-||||+....+
T Consensus       349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999999 9999999999999943322   57899999885422211       112345677899999985443


Q ss_pred             CC-----CCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          244 EY-----TAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       244 ~~-----~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ..     -.++|.|+.|.+.||+++...||.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            21     2479999999999999999999976

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.7e-20  Score=155.21  Aligned_cols=138  Identities=14%  Similarity=0.140  Sum_probs=104.1

Q ss_pred             ceEEeeeeeecCceEEEEEE-EcCCCcEEEEEEEeecc----------------------------hhhHHHHHHHHhcC
Q 022520           66 SYMAERVVGHGSFGVVFQAK-CLETGEAVAIKKVLQDK----------------------------RYKNRELQTMRLLD  116 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~----------------------------~~~~~E~~~l~~l~  116 (296)
                      .|.+.+.||+|+||.||+|. +..+|+.||+|.+....                            ....+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 66789999999885331                            01246899999997


Q ss_pred             CCCceecceeeeeccCCCceEEEEEEecccccH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC-ceeccCC
Q 022520          117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV-HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIK  194 (296)
Q Consensus       117 h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~l-~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-iiH~Dlk  194 (296)
                      +. .+.+...+.. . .    .++||||+++.. ......    ...+....+..++.|++.+|.+||++ | ++|+|||
T Consensus       109 ~~-~i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dik  176 (237)
T smart00090      109 EA-GVPVPKPIAW-R-R----NVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLS  176 (237)
T ss_pred             hc-CCCCCeeeEe-c-C----ceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCC
Confidence            53 3333233311 1 1    469999999843 322211    23455666788999999999999998 9 9999999


Q ss_pred             CCceEEcCCCCcEEEeeecceee
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 44 799999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.82  E-value=1.2e-20  Score=177.30  Aligned_cols=175  Identities=26%  Similarity=0.491  Sum_probs=128.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEec
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  144 (296)
                      .+|..++.+-.|+||.||.++|+.+.+++|+| +.+..-.       ++     ||+.+.+.           .++|   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lR-----nilt~a~n-----------pfvv---  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LR-----NILTFAGN-----------PFVV---  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hh-----ccccccCC-----------ccee---
Confidence            47999999999999999999999999999995 5333222       22     23333211           1122   


Q ss_pred             ccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC-
Q 022520          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  223 (296)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~-  223 (296)
                        |+-...++.    .++++..        ++.+++|||+. ||+|||+||+|.+|..-+ .+|++|||+++....... 
T Consensus       136 --gDc~tllk~----~g~lPvd--------mvla~Eylh~y-givhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --GDCATLLKN----IGPLPVD--------MVLAVEYLHSY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --chhhhhccc----CCCCcch--------hhHHhHhhccC-CeecCCCCCCcceeeecc-cccccchhhhhhhhhhccc
Confidence              222223322    2455543        36689999997 999999999999999887 799999999765321111 


Q ss_pred             ---------------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          224 ---------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       224 ---------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                                     .....|||.|.|||++.... |+...|+|++|+|+|+++-|+.||.+.+..+.+.+.+..
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence                           12346899999999996555 999999999999999999999999999887766655543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-20  Score=177.87  Aligned_cols=190  Identities=33%  Similarity=0.503  Sum_probs=138.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhH---HHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      +|...+.||.+.|=+|.+|++. .| .|++|++....     ..+.   +|++ ...+++||++++.-.-     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            5788899999999999999873 33 48999884332     1222   3444 5667999999975543     22233


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .|+|-+|...+|.+.+...    .-+...+.+.|+.|++.||..+|.. ||+|||||.+||||.+=. -+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeec-hhhhhcccccCC
Confidence            5678888888888877652    3355666777889999999999998 999999999999999866 589999986432


Q ss_pred             --eccCCCc-cc-c----cccccccCCccccCC----------CCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 022520          218 --LVKGEPN-IS-Y----ICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLL-GQPLFP  269 (296)
Q Consensus       218 --~~~~~~~-~~-~----~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~l~~-g~~pf~  269 (296)
                        +..+.+. .+ +    ..-.+|.|||.+...          +..+++.||||+||+++|+++ |++||.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence              2222221 11 1    113469999998431          125788999999999999997 899983

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.1e-18  Score=142.26  Aligned_cols=132  Identities=17%  Similarity=0.159  Sum_probs=98.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--------------------------hhhHHHHHHHHhcCCCC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN  119 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~~l~~l~h~n  119 (296)
                      .|.+.+.||.|+||.||++.+. +|+.||+|++..+.                          .....|+.++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888899999999999999864 79999999864321                          01346788888887774


Q ss_pred             c--eecceeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCc
Q 022520          120 V--VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (296)
Q Consensus       120 i--v~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~N  197 (296)
                      +  ...++    .     ...++||||++|..+..+..         ......++.+++.++.++|+. ||+|+||||+|
T Consensus        95 i~v~~~~~----~-----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPID----W-----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFN  155 (198)
T ss_pred             CCCCceee----c-----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCccc
Confidence            3  22221    1     11478999999753332211         023456888999999999998 99999999999


Q ss_pred             eEEcCCCCcEEEeeecceeee
Q 022520          198 LLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       198 Ili~~~~~~ikl~Dfg~~~~~  218 (296)
                      |+++.++ .++|+|||++...
T Consensus       156 ill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCC-cEEEEECCccccC
Confidence            9999866 8999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.3e-18  Score=140.69  Aligned_cols=129  Identities=19%  Similarity=0.334  Sum_probs=100.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +.||+|++|.||+|.+  .+..+++|+.....            ....+|++++..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5789999999999987  67789999764221            12346899999999998876655543322     25


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|||++| ++.+.+...    .   . ....++.+++.+|.+||+. +++|+|++|.|||++ ++ .++|+|||++..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            789999986 565555431    1   1 6778899999999999998 999999999999999 44 799999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=5.8e-18  Score=137.98  Aligned_cols=125  Identities=20%  Similarity=0.351  Sum_probs=93.6

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .||+|+||.||+|.+  ++..+++|......            ....+|++++..+.|+++....-.+....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            379999999999985  67789999764321            22346999999998887554433332221     257


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +||||++| ++.+.+...    ..       .++.+++.+|.+||+. |++|+|++|+||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999986 555444321    10       6788999999999998 999999999999999 44 799999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.1e-17  Score=155.90  Aligned_cols=131  Identities=18%  Similarity=0.287  Sum_probs=98.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      .|...+.||+|+||+||++.+...  .+++|+....            .....+|+++++.++|++++.....+....  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--  409 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--  409 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence            456789999999999999987433  3444432111            123457999999999999887655443221  


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                         ..++||||+++ +|.+.+.            ....++.+++.+|.+||+. +++||||||+|||++ ++ .++|+||
T Consensus       410 ---~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl~-~~-~~~liDF  471 (535)
T PRK09605        410 ---EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIVR-DD-RLYLIDF  471 (535)
T ss_pred             ---CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEEE-CC-cEEEEeC
Confidence               25799999986 5555443            2356888999999999998 999999999999994 34 7999999


Q ss_pred             cceeee
Q 022520          213 GSAKVL  218 (296)
Q Consensus       213 g~~~~~  218 (296)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            999753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=1.2e-18  Score=153.72  Aligned_cols=121  Identities=31%  Similarity=0.550  Sum_probs=101.8

Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .+++|.|++|.. +|.+.+. +.......+......++.|+..|++|   + +.+|+|+||.||+...+. ++||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~-rr~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~-q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLR-RRRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDD-QLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhh-CCCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccch-hhhhhhhhh
Confidence            468899999995 5555554 33445667788899999999999999   6 999999999999998776 899999999


Q ss_pred             eeeeccCC-------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh
Q 022520          215 AKVLVKGE-------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  263 (296)
Q Consensus       215 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~  263 (296)
                      ........       .....+||.+||+||.+.+.. |+.++||||||++|+|++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHH
Confidence            87765554       345678999999999997766 9999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2.7e-17  Score=132.63  Aligned_cols=130  Identities=21%  Similarity=0.243  Sum_probs=89.3

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh----------------------------HHHHHHHHhcCCCC--
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--  119 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~E~~~l~~l~h~n--  119 (296)
                      .+.||+|+||.||+|.+. +++.||+|++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999976 78999999875432111                            12344444443322  


Q ss_pred             ceecceeeeeccCCCceEEEEEEeccccc-HH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCC
Q 022520          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQ  196 (296)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~  196 (296)
                      +.+.+.+         ...++||||++++ +. ..+....     . ...+..++.+++.++.++|. . +|+|+||||+
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~  144 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREA-GLVHGDLSEY  144 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhcc-CcCcCCCChh
Confidence            2222111         1147999999972 11 1111111     0 14577889999999999999 7 9999999999


Q ss_pred             ceEEcCCCCcEEEeeecceeee
Q 022520          197 NLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       197 NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ||+++ ++ .++|+|||.+...
T Consensus       145 Nili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         145 NILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             hEEEE-CC-cEEEEECcccccc
Confidence            99999 54 7999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.72  E-value=3.9e-18  Score=138.96  Aligned_cols=206  Identities=17%  Similarity=0.246  Sum_probs=147.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee------cchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +..+.-+|.+...|..|+|++..+  -+++|++.-      -.+.+++|.-.|+.+.||||+++++.+     .......
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence            455667889999999999999544  455665531      133456788899999999999999988     4445578


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceec-cCCCCceEEcCCCCcEEE--eeecce
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR-DIKPQNLLVNPHTHQLKL--CDFGSA  215 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~-Dlkp~NIli~~~~~~ikl--~Dfg~~  215 (296)
                      +|..||+ |+|...+-..-  +--..-.++.+++.++++|++|||+.-.++-| -|....++||++. +.+|  +|--++
T Consensus       264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence            9999999 66666665422  23345667888999999999999995344444 5888899998875 4443  342222


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEY--TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      -      ......-.|.||+||.+...+..  -.++|+|||++++||+-|...||...++.+.=-++.-..++.
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv  408 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV  408 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc
Confidence            1      12233448899999999765543  346999999999999999999999988776644444434333

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=2.6e-16  Score=131.48  Aligned_cols=134  Identities=16%  Similarity=0.269  Sum_probs=97.1

Q ss_pred             eeeee-ecCceEEEEEEEcCCCcEEEEEEEeec-----------------chhhHHHHHHHHhcCCCCc--eecceeeee
Q 022520           70 ERVVG-HGSFGVVFQAKCLETGEAVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNV--VSLKHCFFS  129 (296)
Q Consensus        70 ~~~lG-~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~E~~~l~~l~h~ni--v~~~~~~~~  129 (296)
                      ...|| .||.|+||.+..  .+..+++|.+...                 .....+|++++..++|+++  +..++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 899999999986  4778999977421                 1223469999999998885  444443222


Q ss_pred             ccCCCceEEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcE
Q 022520          130 TTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (296)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~i  207 (296)
                      .. ......++|||+++|  ++.+.+..     .+++...    +.+++.+|.+||+. ||+|+||||+|||++.++ .+
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~-~v  181 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHDA-GVYHADLNAHNILLDPDG-KF  181 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCC-CE
Confidence            11 111123599999986  56555542     3455543    56899999999998 999999999999999876 79


Q ss_pred             EEeeecceee
Q 022520          208 KLCDFGSAKV  217 (296)
Q Consensus       208 kl~Dfg~~~~  217 (296)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999999864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.3e-16  Score=123.58  Aligned_cols=131  Identities=19%  Similarity=0.230  Sum_probs=100.6

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--hhhHHHHHHHHhcCC--CCceecceeeeeccCCCceEEEEEEec
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDELYLNLVLEY  144 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~iv~e~  144 (296)
                      +.+.||.|.++.||++.+.  +..+++|......  ....+|..+++.+++  .++.+++..+.     .....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence            4578999999999999973  4789999885543  256789999999976  47777766552     22447899999


Q ss_pred             ccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcc--CCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++.....+          +......++.+++.+|+.||..  .+++|+|++|+||++++.+ .++++|||.+..
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            987522211          3445567788999999999984  1699999999999999855 799999998863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.60  E-value=2.1e-15  Score=135.30  Aligned_cols=150  Identities=27%  Similarity=0.429  Sum_probs=118.0

Q ss_pred             HHhcCCCCceecceeeeeccCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCc-e
Q 022520          112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-C  189 (296)
Q Consensus       112 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i-i  189 (296)
                      |+.+.|.|+.++++..+..     ...++|.+||. |+|.+.+...   ...++......++++++.||.|||.. .| .
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS-PIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence            4568999999999998655     33789999998 7888877763   45677777888999999999999997 66 9


Q ss_pred             eccCCCCceEEcCCCCcEEEeeecceeeeccC---CCcccccccccccCCccccCCC--C----CCCchhHHHHHHHHHH
Q 022520          190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGAT--E----YTAAIDIWSAGCVLAE  260 (296)
Q Consensus       190 H~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~--~----~~~~~DiwSlG~il~~  260 (296)
                      |+.+++.|.+++..- .+||+|||+.......   .......-...|.|||.+....  .    .+.+.||||+|++++|
T Consensus        72 hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            999999999999876 8999999998654320   1111112245699999985531  1    4677999999999999


Q ss_pred             HHhCCCCCCCC
Q 022520          261 LLLGQPLFPGE  271 (296)
Q Consensus       261 l~~g~~pf~~~  271 (296)
                      +++...||...
T Consensus       151 i~~r~~~~~~~  161 (484)
T KOG1023|consen  151 ILFRSGPFDLR  161 (484)
T ss_pred             HHhccCccccc
Confidence            99999999863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=7e-17  Score=150.66  Aligned_cols=200  Identities=27%  Similarity=0.347  Sum_probs=152.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcC-CCcEEEEEEEeecc------hhhHHHHHHHHhcC-CCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..|.+.+.||+|+|+.|-...... ....+|.|.+....      .....|..+-+.+. |+|++.+++..     .+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            358899999999999998887743 34556666553322      11224777777776 99999998877     5555


Q ss_pred             EEEEEEeccccc-HHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHH-ccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          137 YLNLVLEYVPET-VHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~~~-l~~~l~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH-~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      +.++++++..|+ +...+.   .... ..+......++.|+..++.|+| .. ++.|+|+||+|.+++..+..+++.|||
T Consensus        95 ~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             ccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCch
Confidence            578999997753 333331   1122 5666678889999999999999 77 999999999999998766469999999


Q ss_pred             ceeeecc-CCC---cccccc-cccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          214 SAKVLVK-GEP---NISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       214 ~~~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ++..... ...   .....| ++.|+|||...+.....+..|+||+|+++..+++|..|+.....
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            9987755 221   233466 99999999997755578899999999999999999999876543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=4e-14  Score=127.29  Aligned_cols=199  Identities=26%  Similarity=0.298  Sum_probs=154.9

Q ss_pred             CccccceEEeeeeee--cCceEEEEEEE--cCCCcEEEEEEEee------cchhhHHHHHHHHhc-CCCCceecceeeee
Q 022520           61 PKQTISYMAERVVGH--GSFGVVFQAKC--LETGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vavK~~~~------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (296)
                      ......+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.      ......+|+...+.+ .|+|.++.+..+  
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--  187 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--  187 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--
Confidence            334446778889999  99999999998  78899999996321      222334677777766 489999976666  


Q ss_pred             ccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHccCCceeccCCCCceEEcCCCC
Q 022520          130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (296)
Q Consensus       130 ~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~iiH~Dlkp~NIli~~~~~  205 (296)
                         .+....++-+|+|+.++..+....   ..-++...++..+.+...    ||.++|+. +++|-|+||+||++..+..
T Consensus       188 ---e~~~~lfiqtE~~~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  188 ---EGSGILFIQTELCGESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             ---ccCCcceeeeccccchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccc
Confidence               555568889999997776665543   344778888888888888    99999998 9999999999999998834


Q ss_pred             cEEEeeecceeeeccCCCcc------cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          206 QLKLCDFGSAKVLVKGEPNI------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       206 ~ikl~Dfg~~~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ..+++|||+...+.+.....      ...+...|++||.+.  .-++...|++++|.++.+-.++..++..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccC
Confidence            89999999998876655222      125677899999873  3479999999999999999988765543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=3.3e-13  Score=106.93  Aligned_cols=125  Identities=15%  Similarity=0.221  Sum_probs=90.1

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEeccc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP  146 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~  146 (296)
                      ++.|+.|.++.||+++.  .+..+++|......   ....+|+.+++.+.+.++++-.-.+ .   ...  .++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~---~~~--~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-D---PET--GVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-e---CCC--CeEEEEecC
Confidence            46788999999999986  47789999875443   3356899999998766655433222 1   111  358999999


Q ss_pred             ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCc-----eeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       147 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i-----iH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      |......        ..   ....++.+++.+|+.||.. ++     +|+|++|.||+++ ++ .++++||+.+.
T Consensus        75 G~~l~~~--------~~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DF---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cc---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            7422111        01   1124567899999999987 75     9999999999999 44 79999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=5.2e-13  Score=121.03  Aligned_cols=137  Identities=20%  Similarity=0.269  Sum_probs=88.1

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-hhhH-------------------------------------------
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKN-------------------------------------------  106 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~-------------------------------------------  106 (296)
                      +.||.|++|.||+|+. .+|+.||||+..... ....                                           
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999985 578999999874321 1111                                           


Q ss_pred             HHHHHHHhc----CCCCceecceeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHH-HHH
Q 022520          107 RELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR-ALA  180 (296)
Q Consensus       107 ~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~-~l~  180 (296)
                      +|...+.++    +|.+-+.+-.++.....    ..++||||++| ++.+......   ....   ...++.+++. .+.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHH
Confidence            233333333    23333443344422111    25799999997 4444332211   1122   2345555555 467


Q ss_pred             HHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       181 ~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      .+|.. |++|+|+||.||+++.++ +++++|||++..+.+
T Consensus       272 ql~~~-g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~~  309 (437)
T TIGR01982       272 QVLRD-GFFHADLHPGNIFVLKDG-KIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHhC-CceeCCCCcccEEECCCC-cEEEEeCCCeeECCH
Confidence            88988 999999999999998877 899999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=6.1e-13  Score=106.82  Aligned_cols=131  Identities=17%  Similarity=0.219  Sum_probs=91.6

Q ss_pred             eeeeecCceEEEEEEEcC------CCcEEEEEEEeec--------------ch------------hh----HHHHHHHHh
Q 022520           71 RVVGHGSFGVVFQAKCLE------TGEAVAIKKVLQD--------------KR------------YK----NRELQTMRL  114 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~--------------~~------------~~----~~E~~~l~~  114 (296)
                      -.||.|--+.||.|....      .+..+|+|+++..              ..            ..    ++|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543      3578999977311              00            01    168888888


Q ss_pred             cCC--CCceecceeeeeccCCCceEEEEEEeccccc-HH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HccCCce
Q 022520          115 LDH--PNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVC  189 (296)
Q Consensus       115 l~h--~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~ii  189 (296)
                      +..  -++...+++.     .    .++||||++++ +. ..+..     ..++...+..++.+++.+|..| |.. |++
T Consensus        83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~-glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC-NLV  147 (197)
T ss_pred             HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC-Cee
Confidence            853  3444443321     2    57899999863 21 12221     2345556677889999999998 887 999


Q ss_pred             eccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       190 H~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      |+||++.||+++. + .+.|+|||.+...
T Consensus       148 HGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            9999999999974 3 6999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=1.5e-13  Score=126.29  Aligned_cols=141  Identities=20%  Similarity=0.267  Sum_probs=87.5

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh--------------------------------------h--
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY--------------------------------------K--  105 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------------------~--  105 (296)
                      .|.. +.||+|++|.||+|+...+|+.||||+.......                                      .  
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 7899999999999998877999999988533100                                      0  


Q ss_pred             ----HHHHHHHHhc----CCCCceecceeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcC---CCCCHHHHHHHHH
Q 022520          106 ----NRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS---QRMPLIYVKLYFY  173 (296)
Q Consensus       106 ----~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~---~~~~~~~~~~i~~  173 (296)
                          .+|...+.++    .+.+.+.+-.+|.+-.    ...++||||+.| .+.+. ......+   ..+....+..++.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~-~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDV-AALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhH-HHHHhcCCCHHHHHHHHHHHHHH
Confidence                1222222222    2333344333332211    125699999997 44332 1111101   1233444444555


Q ss_pred             HHHHHHHHHHccCCceeccCCCCceEEcCCC---CcEEEeeecceeeecc
Q 022520          174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLVK  220 (296)
Q Consensus       174 ~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~---~~ikl~Dfg~~~~~~~  220 (296)
                      |++       .. |++|+|+||.||+++.++   .+++++|||++..+..
T Consensus       275 Qif-------~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF-------RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            554       46 999999999999998765   3799999999987644

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.45  E-value=1.4e-12  Score=101.21  Aligned_cols=139  Identities=19%  Similarity=0.279  Sum_probs=100.9

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ....+-+|+-+.|+++.+  .|+...||.-...            .....+|+++|.++.--.|.--.-+|.+...    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            466788999999999987  7888888854221            2223479999988865444433223333222    


Q ss_pred             EEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcE--EEeee
Q 022520          137 YLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDF  212 (296)
Q Consensus       137 ~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~i--kl~Df  212 (296)
                       -.|+|||++|  ++.+++.....  ..........++++|=..+.-||.. +|||+||..+||++.+++.++  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEee
Confidence             4689999998  77777776542  2233333467888999999999998 999999999999998877655  89999


Q ss_pred             cceee
Q 022520          213 GSAKV  217 (296)
Q Consensus       213 g~~~~  217 (296)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99854

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=1.7e-12  Score=118.32  Aligned_cols=180  Identities=23%  Similarity=0.300  Sum_probs=126.4

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      |.+ ....-++.+..-.|..+.++.+|.+..++....    ...+-++-|+.++||||+++++.+     ......|+|+
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence            555 333334433333466677888999988865443    234678889999999999999988     4444689999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC
Q 022520          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (296)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~  222 (296)
                      |.+.. +...++.       +....+...+.||+.||.|||..++++|++|.-+.|+++..| ..||++|.++.....-.
T Consensus        89 ErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   89 ERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN  159 (690)
T ss_pred             ecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence            98763 2233333       225556677889999999999777999999999999999988 89999999987543322


Q ss_pred             Ccc-cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhC
Q 022520          223 PNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  264 (296)
Q Consensus       223 ~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g  264 (296)
                      ... ...--..|..|+.+..   -+...|.|-|||++++++.|
T Consensus       160 ~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  160 APAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            111 1111223556654421   12457999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=6.1e-12  Score=105.65  Aligned_cols=171  Identities=18%  Similarity=0.213  Sum_probs=122.3

Q ss_pred             HHHHhcCCCCceecceeeeeccCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC-C
Q 022520          110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-G  187 (296)
Q Consensus       110 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~  187 (296)
                      .-|-++.|.|||+++.++.+....+.....++.+|+. +++..+|++..+....+....+.+|+.||++||.|||+.- .
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3455567999999998887666656667888999998 7888999888887888999999999999999999999841 5


Q ss_pred             ceeccCCCCceEEcCCCCcEEEeeecceeeeccC-----CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHH
Q 022520          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  262 (296)
Q Consensus       188 iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~  262 (296)
                      |+|+++....|++..++ -||+.--.-.......     .......+-++|.+||.= .....+.++|||++|.+..+|.
T Consensus       199 iihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             cccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHH
Confidence            99999999999999776 4554322111100000     011122346789999863 2233577899999999999999


Q ss_pred             hCCC-CCCCCChHHHHHHHHH
Q 022520          263 LGQP-LFPGESGVDQLVEIIK  282 (296)
Q Consensus       263 ~g~~-pf~~~~~~~~~~~~~~  282 (296)
                      .+.. |-.+.+..+.-..+.+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~  297 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIAN  297 (458)
T ss_pred             HheeccCCCcceeehhhhhhh
Confidence            8874 4444444333334433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=3.3e-11  Score=94.00  Aligned_cols=126  Identities=14%  Similarity=0.305  Sum_probs=86.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeec------------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..+++|+-+.++.+.+  -|..+++|.-...            .....+|..++.++..-.+..-.-+++++..     .
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence            3578899999999976  4445777744221            1122368888888754433322222222222     4


Q ss_pred             EEEEecccccHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~~l~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .|+|||++|.+.. .+...           ...+++.+=.-+.-||.. ||+|+||.++||++..+  .+.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            6899999986554 55442           124566777788899998 99999999999999865  499999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.23  E-value=2.8e-10  Score=101.23  Aligned_cols=170  Identities=22%  Similarity=0.327  Sum_probs=129.5

Q ss_pred             CceEEEEEEEcCCCcEEEEEEEeecch----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecccc--cHH
Q 022520           77 SFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVH  150 (296)
Q Consensus        77 ~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~--~l~  150 (296)
                      .-.+.|++....+|..|++|++..++.    ....-+++++++.|.|+|++.++|.... -+...+++|++|.++  +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            346889999999999999998832221    2234688999999999999999986333 445568899999884  666


Q ss_pred             HHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          151 RVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       151 ~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +.......           .+...++..++.++.|+..||.++|+. |+..+-|.|.+||++.+. +++|+-+|+...+.
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence            65543321           234567899999999999999999998 999999999999999776 79999998876554


Q ss_pred             cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022520          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  266 (296)
Q Consensus       220 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  266 (296)
                      .+.           .+|  +.    --.+-|.=.||.+++.|.||..
T Consensus       445 ~d~-----------~~~--le----~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDP-----------TEP--LE----SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCC-----------Ccc--hh----HHhhhhHHHHHHHHHHHhhccc
Confidence            332           011  21    1235799999999999999964

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.23  E-value=7.6e-11  Score=94.34  Aligned_cols=121  Identities=22%  Similarity=0.307  Sum_probs=75.4

Q ss_pred             EEEEEEEcCCCcEEEEEEEeecc------------------------------hhhHHHHHHHHhcCCCC--ceecceee
Q 022520           80 VVFQAKCLETGEAVAIKKVLQDK------------------------------RYKNRELQTMRLLDHPN--VVSLKHCF  127 (296)
Q Consensus        80 ~V~~~~~~~~~~~vavK~~~~~~------------------------------~~~~~E~~~l~~l~h~n--iv~~~~~~  127 (296)
                      .||.|.. .++..+|+|+.....                              ....+|.+.|.++...+  +.+.+++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888885 567799999774210                              01126999999997664  34443322


Q ss_pred             eeccCCCceEEEEEEeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHccCCceeccCCCCceEEcCCC
Q 022520          128 FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY-IHNTIGVCHRDIKPQNLLVNPHT  204 (296)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~iiH~Dlkp~NIli~~~~  204 (296)
                           .    ..+||||++  |.....+....     +.......++.+++..+.. +|.. ||+|+||.+.||+++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-
Confidence                 2    368999999  64333333321     1123355677788885555 5777 99999999999999976 


Q ss_pred             CcEEEeeecceeee
Q 022520          205 HQLKLCDFGSAKVL  218 (296)
Q Consensus       205 ~~ikl~Dfg~~~~~  218 (296)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             6999999998643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=5.2e-12  Score=113.80  Aligned_cols=193  Identities=22%  Similarity=0.207  Sum_probs=138.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEc-CCCcEEEEEEEeecchhhH------HHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDKRYKN------RELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|..+..||.|.|+.|+.+... .++..+++|...+......      .|+.+...+ .|.+++.++..|.....  
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--
Confidence            3457889999999999999988755 6788899987654433222      355554444 58888887777744332  


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                         .++=.|||.+....+-...   ...+.+...+++..|++.++.++|+. .++|+|+||+||++..++..-++.|||+
T Consensus       341 ---~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 ---GYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ---ccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhcccccc
Confidence               4578889975433332221   24566667788899999999999998 9999999999999988644688999999


Q ss_pred             eeeeccCCCccccccccccc-CCccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022520          215 AKVLVKGEPNISYICSRYYR-APELIFGATEYTAAIDIWSAGCVLAELLLGQP  266 (296)
Q Consensus       215 ~~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  266 (296)
                      ...+ . ........+.+++ .+|.+.....+..+.|++|||..+.+.++|..
T Consensus       414 ~t~~-~-~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  414 WTRL-A-FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cccc-c-eecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            8642 1 1112223344455 36666666668899999999999999998873

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=9.9e-10  Score=93.03  Aligned_cols=110  Identities=13%  Similarity=0.154  Sum_probs=76.6

Q ss_pred             hHHHHHHHHhcCCCCceec--ceeeeeccCCCceEEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 022520          105 KNRELQTMRLLDHPNVVSL--KHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA  180 (296)
Q Consensus       105 ~~~E~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~  180 (296)
                      ..+|+..+..|...+|...  +.++...........++|||++++  ++.+++....  ..+.+......++.+++..+.
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence            4588888888754444332  222211111112235689999997  5666664322  244556677789999999999


Q ss_pred             HHHccCCceeccCCCCceEEcCC------CCcEEEeeecceee
Q 022520          181 YIHNTIGVCHRDIKPQNLLVNPH------THQLKLCDFGSAKV  217 (296)
Q Consensus       181 ~LH~~~~iiH~Dlkp~NIli~~~------~~~ikl~Dfg~~~~  217 (296)
                      -||.. ||+|+|++++|||++.+      ...+.|+||+.+..
T Consensus       153 ~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        153 DMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99998 99999999999999852      33799999998853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=8.1e-10  Score=96.19  Aligned_cols=196  Identities=15%  Similarity=0.227  Sum_probs=130.8

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-hhHHHHHHHHhc-CCCCceecceee----eeccCCCceEEEEE
Q 022520           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRELQTMRLL-DHPNVVSLKHCF----FSTTEKDELYLNLV  141 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l-~h~niv~~~~~~----~~~~~~~~~~~~iv  141 (296)
                      ...+.||+|+-+.+|-.-.  -+. .+.|++..... ...+-.+.|... .||-+-. .-.+    .... .+...+.+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~-rvaWPqa~L~G~-~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNY-RVAWPQATLHGG-RRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecch--hhc-hhheeecCCCchHHHHHHHHhccCCCCcchhh-hhcccHHHhhCC-CccceeEEe
Confidence            3567899999999995543  222 34477744322 222334444443 3443222 0011    0111 223336678


Q ss_pred             Eecccc--cHHHHHH--HhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          142 LEYVPE--TVHRVIK--HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       142 ~e~~~~--~l~~~l~--~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |+.+.+  ....++.  ...+......+..+.+..+.++.+.+.||.+ |-.-+|+.++|+|++.++ .+.|+|=..-..
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDS-KVVLVDSDSFQI  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCc-eEEEEcccceee
Confidence            888875  3332222  1111234466888999999999999999999 999999999999999877 799998554444


Q ss_pred             eccCCCcccccccccccCCcccc----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLG-QPLFPG  270 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~  270 (296)
                      -.++....+.+|.+.|.+||...    .....+..+|.|.||+++++++.| +.||.+
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            45666677889999999999853    222357789999999999999986 899976

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=1.1e-09  Score=90.38  Aligned_cols=139  Identities=17%  Similarity=0.177  Sum_probs=88.1

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCC--ceecceeeeeccCCCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +.|+.|..+.||++... +|+.+++|.....     .....+|.++++.+.+.+  +.+++......  ......++||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence            56899999999999863 3578999977543     235568999999997644  34444333111  10123578999


Q ss_pred             cccccHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc--------------------------------------
Q 022520          144 YVPETVH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--------------------------------------  184 (296)
Q Consensus       144 ~~~~~l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~--------------------------------------  184 (296)
                      |++|... ..+.     ...++......++.+++..|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            9987422 2110     0123334444444455555544442                                      


Q ss_pred             -----------------cCCceeccCCCCceEEcCC-CCcEEEeeecceee
Q 022520          185 -----------------TIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  217 (296)
Q Consensus       185 -----------------~~~iiH~Dlkp~NIli~~~-~~~ikl~Dfg~~~~  217 (296)
                                       ...++|+|++|.||+++.+ ...+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             1257999999999999983 22578999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.08  E-value=3.5e-11  Score=114.48  Aligned_cols=207  Identities=22%  Similarity=0.272  Sum_probs=141.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhH-------HHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+.+.+.+-+-+|.++.++.+.-...+...+.|..........       .+-.++-...+|-++.....+     ....
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs  877 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS  877 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence            3467788889999999999988767776666664433222211       222222223345555433322     2233


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      -.+++++|+++ ++...+..    .+..+.+-++.++..+..++++||.. .+.|+|++|.|+|+..++ ..++.|||..
T Consensus       878 P~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~g-h~~l~~~~t~  951 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDG-HRPLTDFGTL  951 (1205)
T ss_pred             CcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccC-CcccCccccc
Confidence            36789999975 43333332    34566666777788889999999987 799999999999999887 6899999843


Q ss_pred             eeeccC--------------------------------CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh
Q 022520          216 KVLVKG--------------------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  263 (296)
Q Consensus       216 ~~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~  263 (296)
                      ....-.                                .......+|+.|.+||.+.+.. .+..+|+|+.|+++++.++
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhc
Confidence            221000                                0012245699999999997766 6889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHH
Q 022520          264 GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       264 g~~pf~~~~~~~~~~~~~~  282 (296)
                      |.+||......+...+|.+
T Consensus      1031 g~pp~na~tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILN 1049 (1205)
T ss_pred             CCCCCCCcchhhhhhcccc
Confidence            9999999887666655544

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.04  E-value=1.5e-09  Score=89.73  Aligned_cols=130  Identities=19%  Similarity=0.183  Sum_probs=90.6

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--------------------------hhhHHHHHHHHhcCCC--
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------------RYKNRELQTMRLLDHP--  118 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~~l~~l~h~--  118 (296)
                      +.+...||-|--|.||.|.+. .|.++|+|.-....                          ...++|.++|++|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567889999999999999864 68899999542111                          1123788999988544  


Q ss_pred             CceecceeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCce
Q 022520          119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (296)
Q Consensus       119 niv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NI  198 (296)
                      .+.+.++         ....++|||+++|-.+.-+        ++..+....++..|+.-+..+-.. ||+|+|+++=||
T Consensus       172 ~VP~P~~---------~nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIA---------WNRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNI  233 (304)
T ss_pred             CCCCccc---------cccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHc-CccccCCchheE
Confidence            4444322         2226799999998432211        112334445556666666655555 999999999999


Q ss_pred             EEcCCCCcEEEeeeccee
Q 022520          199 LVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       199 li~~~~~~ikl~Dfg~~~  216 (296)
                      ++++++ .+.++||-.+.
T Consensus       234 lV~~dg-~~~vIDwPQ~v  250 (304)
T COG0478         234 LVTEDG-DIVVIDWPQAV  250 (304)
T ss_pred             EEecCC-CEEEEeCcccc
Confidence            999987 79999997664

>PRK09902 hypothetical protein; Provisional

Probab=98.95  E-value=4.2e-08  Score=79.22  Aligned_cols=137  Identities=13%  Similarity=0.127  Sum_probs=95.4

Q ss_pred             eecCceEEEEEEEcCCCcEEEEEEEe----------ecchhhHHHHHHHHhcCCCCc--eecceeeee-ccCCCceEEEE
Q 022520           74 GHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLLDHPNV--VSLKHCFFS-TTEKDELYLNL  140 (296)
Q Consensus        74 G~G~~g~V~~~~~~~~~~~vavK~~~----------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~-~~~~~~~~~~i  140 (296)
                      |.||.|.|+....  .|..+-+|+-.          .....+.+|+..|+.|...++  .+..  |.. .........+|
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv--f~~~~k~~~~~rA~L  102 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV--FGEAVKIEGEWRALL  102 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc--eeeeeccCCceEEEE
Confidence            5688888988765  44467777542          123445689999998854333  3332  222 11223445678


Q ss_pred             EEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC-cEEEeeecceee
Q 022520          141 VLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (296)
Q Consensus       141 v~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~-~ikl~Dfg~~~~  217 (296)
                      |+|-+++  +|.+.+....  ..+.+......++.+++..+.-||.. |+.|+|+-+.||+++.++. .+.++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9998884  7766664421  23456666778999999999999998 9999999999999986552 499999997754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=5.5e-08  Score=79.58  Aligned_cols=108  Identities=18%  Similarity=0.307  Sum_probs=75.8

Q ss_pred             hhHHHHHHHHhcCCCCce--ecceeeeeccCCCceEEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 022520          104 YKNRELQTMRLLDHPNVV--SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL  179 (296)
Q Consensus       104 ~~~~E~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  179 (296)
                      ...+|...+..|...+|.  +.+.+..... ......++|+|++++  +|.+.+....    ..+......++.+++..+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            345788887777543333  2222222211 112345789999986  5666665532    255566778899999999


Q ss_pred             HHHHccCCceeccCCCCceEEcCCC--CcEEEeeecceee
Q 022520          180 AYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  217 (296)
Q Consensus       180 ~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg~~~~  217 (296)
                      +-||.. ||+|+|+++.|||++.+.  ..+.|+||+.++.
T Consensus       132 ~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999 999999999999998764  3689999998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.76  E-value=2.5e-07  Score=75.07  Aligned_cols=136  Identities=15%  Similarity=0.235  Sum_probs=85.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhH-------------HHHHHHHhcCCCCceecceeeee-
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------RELQTMRLLDHPNVVSLKHCFFS-  129 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~E~~~l~~l~h~niv~~~~~~~~-  129 (296)
                      ..+|.+.+++-......|.+..-  ++..+++|.........+             +.+..+..+...++.-+.+.++. 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34688888888888777777654  778899997754332222             23333333333222222221111 


Q ss_pred             --ccCCCceEEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc
Q 022520          130 --TTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (296)
Q Consensus       130 --~~~~~~~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~  206 (296)
                        ....-....+++|||++|- +.+..        .+++    .+...+..++.-||+. |+.|+|.+|.|+++..+  .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~--~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN--G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC--c
Confidence              1112223456899999984 22221        1222    2334677789999998 99999999999999965  4


Q ss_pred             EEEeeeccee
Q 022520          207 LKLCDFGSAK  216 (296)
Q Consensus       207 ikl~Dfg~~~  216 (296)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.75  E-value=1.4e-07  Score=77.50  Aligned_cols=130  Identities=17%  Similarity=0.228  Sum_probs=87.2

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEEeecchhh----------------------------HHHHHHHHhcCCCC--ce
Q 022520           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--VV  121 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~E~~~l~~l~h~n--iv  121 (296)
                      .|..|--+.||+|.. .++..+|+|++......+                            .+|..-|+++...+  +.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            677788889999974 578899999885322111                            14666666664332  22


Q ss_pred             ecceeeeeccCCCceEEEEEEeccccc-HH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceE
Q 022520          122 SLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (296)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIl  199 (296)
                      +-+.+.     .    ..+||||++.. .. -.|+     .-++...++..+..+++..+.-|-...+++|+||+.=|||
T Consensus       134 ~Pi~~~-----~----nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         134 EPIAFR-----N----NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             Cceeec-----C----CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence            322222     1    45899999853 11 1111     1223333677788889999888877459999999999999


Q ss_pred             EcCCCCcEEEeeecceeee
Q 022520          200 VNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       200 i~~~~~~ikl~Dfg~~~~~  218 (296)
                      +. ++ .+.++|||.+...
T Consensus       200 ~~-~~-~p~iID~~QaV~~  216 (268)
T COG1718         200 VH-DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             EE-CC-eEEEEECcccccc
Confidence            99 44 6999999988643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.68  E-value=7.5e-09  Score=95.21  Aligned_cols=98  Identities=24%  Similarity=0.438  Sum_probs=74.8

Q ss_pred             HHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC--------c--ccccccccccCCccccCCC
Q 022520          174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------N--ISYICSRYYRAPELIFGAT  243 (296)
Q Consensus       174 ~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~--------~--~~~~~t~~y~aPE~~~~~~  243 (296)
                      +.+.||.|+|.+-++||++|.|++|.++..+ .+||+.|+.+....+...        .  ....-...|.|||.+.+ .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3448999999988999999999999999887 799999998754433111        0  01112446999999866 4


Q ss_pred             CCCCchhHHHHHHHHHHHH-hCCCCCCCCCh
Q 022520          244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESG  273 (296)
Q Consensus       244 ~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~  273 (296)
                      .-++++|+||+||++|.+. .|+.-+...+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~  215 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG  215 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCC
Confidence            4789999999999999999 56666665543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=1.5e-07  Score=86.38  Aligned_cols=138  Identities=22%  Similarity=0.290  Sum_probs=81.6

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh--------------------------------------------H
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--------------------------------------------N  106 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------------------------~  106 (296)
                      ..|+.++-|.||+|+. .+|+.||||+...+-...                                            .
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5688999999999996 459999999774321100                                            0


Q ss_pred             HHHHHHHhc----CCCCceecceeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHH-HH
Q 022520          107 RELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA-LA  180 (296)
Q Consensus       107 ~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~-l~  180 (296)
                      +|...+.++    ++..-+.+-.+|.+-..+    -.++|||++| .+.+.....   ...++...   ++..++.+ +.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~---ia~~~~~~f~~  279 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALK---SAGIDRKE---LAELLVRAFLR  279 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHH---hcCCCHHH---HHHHHHHHHHH
Confidence            233333332    233333333444322222    4689999998 333332111   12333222   22222222 11


Q ss_pred             HHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       181 ~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      .+=.. |+.|.|.+|.||+++.++ ++.+.|||+...+.+.
T Consensus       280 q~~~d-gffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~~  318 (517)
T COG0661         280 QLLRD-GFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHhc-CccccCCCccceEEecCC-cEEEEcCcceecCCHH
Confidence            22225 999999999999999987 8999999999876443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.50  E-value=1.6e-08  Score=92.35  Aligned_cols=185  Identities=18%  Similarity=0.125  Sum_probs=132.7

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCC-ceecceeeeeccCCCceEEEEEEecc
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      |.....+++|+.+.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++.+     +.+.+.++.++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhhh
Confidence            566777999999999999876555444 5655443 34445899999999999 44444333     5667788999999


Q ss_pred             ccc--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC
Q 022520          146 PET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (296)
Q Consensus       146 ~~~--l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~  223 (296)
                      .++  ....+..   ..-.+.......+++.-++++++||+. .-+|+|    ||+..+.  ..+..||+....+.+.-.
T Consensus       317 s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  317 STGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             cCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc-cccCcc----ccccccc--ccccccccCCcccCcccc
Confidence            854  1111110   012233445556777788899999986 568998    8888764  589999999876655555


Q ss_pred             cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       224 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      .....+|+.++|||+...+. +....|.|++++-..+|.-|-+|-.
T Consensus       387 ~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCC
Confidence            66778899999999886655 7888999999987667777776653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.44  E-value=3.9e-06  Score=69.56  Aligned_cols=75  Identities=17%  Similarity=0.194  Sum_probs=49.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCc--eecceeeeeccCCCceEEEEEEecc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....+  .+++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4678999999999998743  58999987544  3455678889888864444  3333322  1112233478899999


Q ss_pred             ccc
Q 022520          146 PET  148 (296)
Q Consensus       146 ~~~  148 (296)
                      +|.
T Consensus        78 ~g~   80 (239)
T PF01636_consen   78 PGR   80 (239)
T ss_dssp             SSE
T ss_pred             ccc
Confidence            974

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.39  E-value=2e-06  Score=67.04  Aligned_cols=128  Identities=17%  Similarity=0.260  Sum_probs=84.0

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEec
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  144 (296)
                      -...+.|++|.+|.||++.+  .+..+|+|+-..+  ...++.|.++|..++..++.+=.-.| .   .    .++.|||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~   93 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEY   93 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhh
Confidence            34567899999999999998  6668999976543  45667899999999887776632222 1   1    2356999


Q ss_pred             ccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC-CCceEEcCCCCcEEEeeecceee
Q 022520          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK-PQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk-p~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +.| .|......       ....++.    .++..---|-.. ||-|+.|. |..+++-.+. .+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~-------~~rk~l~----~vlE~a~~LD~~-GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIG-------GDRKHLL----RVLEKAYKLDRL-GIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhc-------ccHHHHH----HHHHHHHHHHHh-ccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            998 44333221       1222233    344443334444 99999986 4444444444 699999999874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.30  E-value=1e-05  Score=65.04  Aligned_cols=126  Identities=26%  Similarity=0.354  Sum_probs=89.0

Q ss_pred             cceEEeeeeeecCc-eEEEEEEEcCCCcEEEEEEEee-----------c--------------chhhHHHHHHHHhc---
Q 022520           65 ISYMAERVVGHGSF-GVVFQAKCLETGEAVAIKKVLQ-----------D--------------KRYKNRELQTMRLL---  115 (296)
Q Consensus        65 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vavK~~~~-----------~--------------~~~~~~E~~~l~~l---  115 (296)
                      .+++.++.||.|.- |.||+++.  +|+.+|+|.+..           .              ...+..|.....+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57999999999999 99999987  788999998421           0              11233577666655   


Q ss_pred             CCCCc--eecceeeeeccC-------------CCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 022520          116 DHPNV--VSLKHCFFSTTE-------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA  180 (296)
Q Consensus       116 ~h~ni--v~~~~~~~~~~~-------------~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~  180 (296)
                      .+.++  |+++++..-...             .......||.||+...-            .+....    +.+|++-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            45566  888888754421             12234568888877542            222222    457888889


Q ss_pred             HHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       181 ~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+|.. ||+-+|+++.|..   +   -+|+|||.+
T Consensus       179 ~~~k~-gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL-GIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             HHHHC-CeeeccCcccccc---C---CEEEecccC
Confidence            99987 9999999999985   2   389999965

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=1.2e-05  Score=73.89  Aligned_cols=135  Identities=21%  Similarity=0.265  Sum_probs=80.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeecchhh-----------------------------------H------HHH
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----------------------------------N------REL  109 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------------------~------~E~  109 (296)
                      +.||..+.|.||+|+-. +|+.||||+-..+-+..                                   .      +|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            57999999999999864 59999999653221100                                   0      122


Q ss_pred             H----HHHhcCCCC---ceecceeeeeccCCCceEEEEEEecccc---cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 022520          110 Q----TMRLLDHPN---VVSLKHCFFSTTEKDELYLNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL  179 (296)
Q Consensus       110 ~----~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~iv~e~~~~---~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  179 (296)
                      +    +.+.+.|-+   -|.+-.+|.+-..+    ..++||||+|   +-.+.+..     ..++...+..-+-+...-+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~----RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~q  316 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTK----RVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLEQ  316 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcc----eEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHHH
Confidence            2    223334545   22233334322222    5689999997   22333433     3344444333222322222


Q ss_pred             HHHHccCCceeccCCCCceEEcC---CCCcEEEeeecceeee
Q 022520          180 AYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  218 (296)
Q Consensus       180 ~~LH~~~~iiH~Dlkp~NIli~~---~~~~ikl~Dfg~~~~~  218 (296)
                      -+.  + |++|+|=+|.||++.+   .+.++.+-|||+...+
T Consensus       317 If~--~-GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  317 IFK--T-GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHh--c-CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            222  4 8999999999999984   3458999999998765

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.21  E-value=2.2e-05  Score=65.11  Aligned_cols=69  Identities=17%  Similarity=0.143  Sum_probs=44.0

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCc--eecceeeeeccCCCceEEEEEEeccc
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYVP  146 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~iv~e~~~  146 (296)
                      ..||+|..+.||+.    .+..+++|.....  .....+|.++++.+..-++  .+.+++.     .......+||++++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            56899999999973    2446778876432  2345689999988864444  2222222     11222567999999


Q ss_pred             cc
Q 022520          147 ET  148 (296)
Q Consensus       147 ~~  148 (296)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            84

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=3.1e-05  Score=76.30  Aligned_cols=77  Identities=19%  Similarity=0.211  Sum_probs=48.7

Q ss_pred             eeeeeecCceEEEEEEEcCCC--cEEEEEEEeec-----chhhHHHHHHHHhcC-CCCc--eecceeeeeccCCCceEEE
Q 022520           70 ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQD-----KRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~--~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~  139 (296)
                      .+.++.|.+..+|+......+  ..+++|+....     .....+|.++++.+. |.++  .+++..+.+.  ......+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            567788999999998764332  46777765321     234568999999995 6664  3333332111  1112356


Q ss_pred             EEEeccccc
Q 022520          140 LVLEYVPET  148 (296)
Q Consensus       140 iv~e~~~~~  148 (296)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            899999874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.05  E-value=6.2e-05  Score=63.15  Aligned_cols=29  Identities=28%  Similarity=0.351  Sum_probs=25.3

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++|+|+.|.||+++.+. .+.|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGK-FSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCc-EEEEEEccccc
Confidence            589999999999999854 57899999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.99  E-value=0.00014  Score=60.63  Aligned_cols=70  Identities=17%  Similarity=0.248  Sum_probs=44.2

Q ss_pred             eeeeeecCceEEEEEEEcC-CCcEEEEEEEeecch---hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecc
Q 022520           70 ERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      ++.|..|-...+|++.... ++..|++|+......   ...+|..+++.+...++++-.-.+  .  .+    .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~--~--~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYAT--F--QN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEE--e--CC----cEEEEee
Confidence            4567778888999987533 356788897643321   224789999988655554432111  1  11    3699998


Q ss_pred             cc
Q 022520          146 PE  147 (296)
Q Consensus       146 ~~  147 (296)
                      +|
T Consensus        75 ~G   76 (235)
T cd05157          75 PG   76 (235)
T ss_pred             CC
Confidence            86

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.93  E-value=7.3e-05  Score=65.08  Aligned_cols=134  Identities=17%  Similarity=0.256  Sum_probs=92.9

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------ch------------------------hhHHHHHHHHhcCCC
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KR------------------------YKNRELQTMRLLDHP  118 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~------------------------~~~~E~~~l~~l~h~  118 (296)
                      +.-+|..|--+.||.|. ..+|..+|||+++.+      +.                        ..++|+.-|+++...
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            45567888899999997 568888999987422      00                        012577778887665


Q ss_pred             CceecceeeeeccCCCceEEEEEEecccccHH--HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCC
Q 022520          119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVH--RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (296)
Q Consensus       119 niv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~--~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~  196 (296)
                      .|.-- ...+.      ....+||++++.+-+  -.|+     .-.++...+..+-.+++.-+.-|...++++|.||.-=
T Consensus       227 GIP~P-ePIlL------k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf  294 (520)
T KOG2270|consen  227 GIPCP-EPILL------KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF  294 (520)
T ss_pred             CCCCC-Cceee------ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence            53321 11111      114689999984311  1122     3456666788888888888888888789999999999


Q ss_pred             ceEEcCCCCcEEEeeecceee
Q 022520          197 NLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       197 NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |+|+..+  .+.++|.+.+..
T Consensus       295 N~LyhdG--~lyiIDVSQSVE  313 (520)
T KOG2270|consen  295 NLLYHDG--KLYIIDVSQSVE  313 (520)
T ss_pred             hheEECC--EEEEEEcccccc
Confidence            9999853  699999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.83  E-value=0.00022  Score=59.48  Aligned_cols=29  Identities=34%  Similarity=0.441  Sum_probs=24.1

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++|+|+.|.||+++.+. ..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            589999999999998543 34699999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.76  E-value=0.00021  Score=60.42  Aligned_cols=133  Identities=19%  Similarity=0.246  Sum_probs=72.9

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEEeecch----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEeccccc
Q 022520           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET  148 (296)
Q Consensus        73 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~  148 (296)
                      +..|-.+.+|+...  ++..+++|.......    ...+|.++++.+...++++-.-.+   . .    -++|++|++|.
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~---~-~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV---N-E----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE---e-C----CEEEEEeccCc
Confidence            45577788898863  566788886543222    246799999998755554321111   1 1    24799999873


Q ss_pred             HHH-----------HH----HHhhhc---CCCCCH-HHHHHHHHHH---------HHHHHHHHc-------cCCceeccC
Q 022520          149 VHR-----------VI----KHHYKM---SQRMPL-IYVKLYFYQI---------CRALAYIHN-------TIGVCHRDI  193 (296)
Q Consensus       149 l~~-----------~l----~~~~~~---~~~~~~-~~~~~i~~~i---------~~~l~~LH~-------~~~iiH~Dl  193 (296)
                      ...           .+    ......   ..++.. ..+..+..++         ...+..+-.       ...++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            211           11    111111   111111 1112222111         111111111       114899999


Q ss_pred             CCCceEEcCCCCcEEEeeecceee
Q 022520          194 KPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       194 kp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .|.||+++.++  +.|+||..+..
T Consensus       154 ~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC--CEEEeccccCc
Confidence            99999998765  78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.74  E-value=0.00082  Score=54.38  Aligned_cols=128  Identities=21%  Similarity=0.338  Sum_probs=80.1

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--------------------hhhHHHHHHHHhcC------CCCceec
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSL  123 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------~~~~~E~~~l~~l~------h~niv~~  123 (296)
                      ...||+|+.=.||.  |..+ ...+||+.....                    ....+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35789999999984  3333 345778775444                    33346766665555      6788888


Q ss_pred             ceeeeeccCCCceEEEEEEeccc---c----cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCC
Q 022520          124 KHCFFSTTEKDELYLNLVLEYVP---E----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (296)
Q Consensus       124 ~~~~~~~~~~~~~~~~iv~e~~~---~----~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~  196 (296)
                      ++.....     .-..+|+|.+.   |    +|.+++..     ..++. .+...   +-.-..+|-++ +|+.+|++|.
T Consensus        83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~---L~~f~~~l~~~-~Iv~~dl~~~  147 (199)
T PF10707_consen   83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQA---LDEFKRYLLDH-HIVIRDLNPH  147 (199)
T ss_pred             eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHH---HHHHHHHHHHc-CCeecCCCcc
Confidence            8866222     22566777653   2    45555543     44555 33333   33444567777 9999999999


Q ss_pred             ceEEcCCC--C-cEEEee-ecce
Q 022520          197 NLLVNPHT--H-QLKLCD-FGSA  215 (296)
Q Consensus       197 NIli~~~~--~-~ikl~D-fg~~  215 (296)
                      ||++....  . .+.|+| ||..
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCCc
Confidence            99996432  2 577887 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.70  E-value=0.00014  Score=58.51  Aligned_cols=101  Identities=22%  Similarity=0.172  Sum_probs=75.2

Q ss_pred             HHHHHHHHhcCC-CCceecceeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022520          106 NRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH  183 (296)
Q Consensus       106 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH  183 (296)
                      .+|.-+++.+++ +++.++++++     .    ..++.||.+. +++.. ..........++....+++.+++..+.+|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            458888999976 5888888876     2    3568899884 33311 000001134678889999999999999998


Q ss_pred             c---cCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          184 N---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       184 ~---~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      .   . .+.-.|++|+|+-++.++ ++|++|...+...
T Consensus        77 ~~~~~-~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   77 HGPLG-FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             cCCCC-cEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            7   4 588899999999999877 7999999976543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.68  E-value=3.8e-05  Score=65.79  Aligned_cols=130  Identities=18%  Similarity=0.225  Sum_probs=85.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----------ch----------------hhHHHHHHHHhcC-CC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KR----------------YKNRELQTMRLLD-HP  118 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~----------------~~~~E~~~l~~l~-h~  118 (296)
                      -|.+...||-|--+.||.+-+ ..|.+.++|.-...          +.                ...+|...|+.|. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            377889999999999999986 56788888843111          10                0125777777774 33


Q ss_pred             CceecceeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCc
Q 022520          119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (296)
Q Consensus       119 niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~N  197 (296)
                      .-|+-  .      -+....++||+++.| .+.+. .+         ...+..+...+..-+--|..+ |+||+|..-=|
T Consensus       172 fpVPk--p------iD~~RH~Vvmelv~g~Pl~~v-~~---------v~d~~~ly~~lm~~Iv~la~~-GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPK--P------IDHNRHCVVMELVDGYPLRQV-RH---------VEDPPTLYDDLMGLIVRLANH-GLIHGDFNEFN  232 (465)
T ss_pred             CCCCC--c------ccccceeeHHHhhcccceeee-ee---------cCChHHHHHHHHHHHHHHHHc-Cceecccchhe
Confidence            32321  1      122236789999886 33322 11         111223444555566677788 99999999999


Q ss_pred             eEEcCCCCcEEEeeeccee
Q 022520          198 LLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       198 Ili~~~~~~ikl~Dfg~~~  216 (296)
                      |+++.+. .++++||-.+-
T Consensus       233 imv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  233 IMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             eEEecCC-CEEEeechHhh
Confidence            9999766 79999998653

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.55  E-value=0.0026  Score=57.04  Aligned_cols=71  Identities=21%  Similarity=0.309  Sum_probs=46.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEee-----------cchhhHHHHHHHHhcC---CCCceecceeeeeccCCCc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~  135 (296)
                      .+.||.|.+..||++.+...++.++||.-..           .......|.+.|+.+.   ...+.+++++.     .  
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~--  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E--  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence            4678999999999999754335899997421           1223356888888763   23445554432     1  


Q ss_pred             eEEEEEEecccc
Q 022520          136 LYLNLVLEYVPE  147 (296)
Q Consensus       136 ~~~~iv~e~~~~  147 (296)
                      ...++|||++++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            114689999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.49  E-value=0.0015  Score=56.79  Aligned_cols=146  Identities=12%  Similarity=0.054  Sum_probs=76.0

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCc--eecceeeeec-cCCCceEEEEEEe
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFST-TEKDELYLNLVLE  143 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~-~~~~~~~~~iv~e  143 (296)
                      ..+.++.|....+|++.. .++ .+++|+....  ......|.+++..|...++  .+++..--.. ........+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            355677777789998864 333 5778876442  2344567788877743332  2222110000 0011223578999


Q ss_pred             cccccH-----HH-------HHHHhhhcCCCC--------C-HHHHH--------------HHHHHHHHHHHHHHc----
Q 022520          144 YVPETV-----HR-------VIKHHYKMSQRM--------P-LIYVK--------------LYFYQICRALAYIHN----  184 (296)
Q Consensus       144 ~~~~~l-----~~-------~l~~~~~~~~~~--------~-~~~~~--------------~i~~~i~~~l~~LH~----  184 (296)
                      |++|..     ..       .+.........+        . ..+..              .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            988621     11       111000000000        0 00000              001122334444432    


Q ss_pred             --cCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          185 --TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       185 --~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                        ..+++|+|+.+.||+++.++ ...|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence              13899999999999998765 468999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.48  E-value=0.0012  Score=57.12  Aligned_cols=142  Identities=13%  Similarity=0.029  Sum_probs=76.4

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEee-cchhhHHHHHHHHhcCCCC--ceecceeeeeccC----CCceEEEEEE
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE----KDELYLNLVL  142 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~----~~~~~~~iv~  142 (296)
                      .+.+..|....+|+...  ++..+++|.... .......|++++..+.+.+  +.+++..   ...    ......++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~---~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIAD---RDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccC---CCCcEeeeeCCceEEEE
Confidence            45677787789998864  444688897753 2334557888888885433  2232221   000    0112356899


Q ss_pred             ecccccHH------------HHHHHhhhcCCCC--------CHHHHHH------------HHHHHHHHHHHHHc------
Q 022520          143 EYVPETVH------------RVIKHHYKMSQRM--------PLIYVKL------------YFYQICRALAYIHN------  184 (296)
Q Consensus       143 e~~~~~l~------------~~l~~~~~~~~~~--------~~~~~~~------------i~~~i~~~l~~LH~------  184 (296)
                      ++++|...            +.+.........+        ...+...            ....+..++.++..      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            99986321            1111000000000        0010000            01112233344332      


Q ss_pred             cCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       185 ~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ..+++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDE-LSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence            12799999999999999754 467999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.44  E-value=0.0038  Score=54.53  Aligned_cols=30  Identities=30%  Similarity=0.292  Sum_probs=25.2

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||+|+.|.||+++.+. ..-++||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~  217 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDR-LSGFIDFYFACN  217 (319)
T ss_pred             ccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence            899999999999998543 347999998753

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.40  E-value=0.002  Score=55.85  Aligned_cols=31  Identities=35%  Similarity=0.535  Sum_probs=26.6

Q ss_pred             CceeccCCCCceEEcCC---CCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~---~~~ikl~Dfg~~~~  217 (296)
                      .++|+|+.|.||+++.+   .+.+.++||..+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            68999999999999874   23799999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=97.38  E-value=0.0044  Score=53.63  Aligned_cols=76  Identities=8%  Similarity=0.036  Sum_probs=48.6

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEee--cchhhHHHHHHHHhcCCC---CceecceeeeeccCCCceEEEEEEe
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDHP---NVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      -.+.||.|..+.||.... .++ .+.+|..+.  .......|.+.|+.+...   .+.++++.+....  .....++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEe
Confidence            456899999999998864 233 466676543  234667899999988543   3445544332111  1122578999


Q ss_pred             ccccc
Q 022520          144 YVPET  148 (296)
Q Consensus       144 ~~~~~  148 (296)
                      +++|.
T Consensus        94 ~i~G~   98 (297)
T PRK10593         94 RLRGV   98 (297)
T ss_pred             ccCCE
Confidence            99863

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.36  E-value=0.00036  Score=68.75  Aligned_cols=153  Identities=20%  Similarity=0.310  Sum_probs=101.7

Q ss_pred             HHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcc
Q 022520          107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT  185 (296)
Q Consensus       107 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~  185 (296)
                      .|.+.+.++.|+|++.++.+-+.....+ ....+..++|.. ++...+.+    -...+....+.+..+++.||+++|+.
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            4677788899999999877654433222 112233445553 44444444    36788899999999999999999997


Q ss_pred             CCceeccCCCC---ceEEcCCCCcEEEe--eecceeeeccCCCcccccccccccCCccccCCCCCC--CchhHHHHHHHH
Q 022520          186 IGVCHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT--AAIDIWSAGCVL  258 (296)
Q Consensus       186 ~~iiH~Dlkp~---NIli~~~~~~ikl~--Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~~DiwSlG~il  258 (296)
                       ...|.-|..+   +--.+..+ .+.++  ||+.+..............+..+-+||...... +.  ...|+|.+|..+
T Consensus       306 -~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 -SLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -ccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHHH
Confidence             6666555444   33334333 35555  888887766655555555666777888764332 33  346999999999


Q ss_pred             HHHHhCCCC
Q 022520          259 AELLLGQPL  267 (296)
Q Consensus       259 ~~l~~g~~p  267 (296)
                      ..+..|..+
T Consensus       383 ~~~~~~~~i  391 (1351)
T KOG1035|consen  383 LQLSQGEDI  391 (1351)
T ss_pred             hhhhhcCcc
Confidence            999876643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.20  E-value=0.0059  Score=53.84  Aligned_cols=29  Identities=24%  Similarity=0.309  Sum_probs=25.0

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|||+.+.||++.++  .++++|+..+..
T Consensus       193 ~llHGDl~~gNi~~~~~--~~~~iD~e~~~~  221 (370)
T TIGR01767       193 TLLHGDLHSGSIFVSEH--ETKVIDPEFAFY  221 (370)
T ss_pred             eeeeccCCcccEEEcCC--CCEEEcCccccc
Confidence            68999999999999865  488999997754

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.12  E-value=7.4e-05  Score=75.30  Aligned_cols=156  Identities=15%  Similarity=0.018  Sum_probs=103.0

Q ss_pred             HHHHHHhcCCCCceecceeeeeccCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC
Q 022520          108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI  186 (296)
Q Consensus       108 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~  186 (296)
                      |...++...|+++...+.-..   ......-++.++|+. |.+...+.........+...-+....++.+....-+|+.-
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~---ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIP---PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCC---CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            334455567888877644332   122222456888887 5666666655443444444444444444355555555531


Q ss_pred             ----CceeccCCCCceEEcCCCCcEEEeeecceeeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHH
Q 022520          187 ----GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (296)
Q Consensus       187 ----~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  261 (296)
                          --+|+++|+-|.+|..+. .++++++|+.+...+. .......+++.|++|++... -.++.++|+|+.|+-+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence                268999999999999887 7999999999832222 22334567889999998743 3478889999999999999


Q ss_pred             HhCCCCC
Q 022520          262 LLGQPLF  268 (296)
Q Consensus       262 ~~g~~pf  268 (296)
                      ..|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8888876

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.12  E-value=0.011  Score=51.33  Aligned_cols=28  Identities=29%  Similarity=0.631  Sum_probs=24.7

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            7899999999999987 3 68999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.10  E-value=0.009  Score=52.57  Aligned_cols=30  Identities=27%  Similarity=0.435  Sum_probs=26.2

Q ss_pred             ceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       188 iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++|+|+.+.||+++++++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999986544799999998864

>PLN02236 choline kinase

Probab=97.06  E-value=0.0074  Score=53.41  Aligned_cols=31  Identities=26%  Similarity=0.645  Sum_probs=26.9

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|+|+++.||+++.+...+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986544799999998864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.05  E-value=0.01  Score=52.04  Aligned_cols=75  Identities=17%  Similarity=0.309  Sum_probs=59.3

Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      .+..+.|++|++-++++...        ..-..+++..++.+.+..++-+..+...-|||+...||||+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            45677889999877654332        12234567788889998888888877899999999999999 56 7999999


Q ss_pred             cceee
Q 022520          213 GSAKV  217 (296)
Q Consensus       213 g~~~~  217 (296)
                      -+++.
T Consensus       366 klsRl  370 (488)
T COG5072         366 KLSRL  370 (488)
T ss_pred             eeeec
Confidence            99984

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.83  E-value=0.009  Score=53.36  Aligned_cols=71  Identities=17%  Similarity=0.212  Sum_probs=44.4

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEee----------cchhhHHHHHHHHhcC--CCCce-ecceeeeeccCCCce
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----------DKRYKNRELQTMRLLD--HPNVV-SLKHCFFSTTEKDEL  136 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~E~~~l~~l~--h~niv-~~~~~~~~~~~~~~~  136 (296)
                      .+.||.|.-..||++.+...+..|+||.-..          +..+..-|.++|+...  -|..| +++++-       ..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence            6778999999999999844456799996521          1122235788887663  34434 443321       11


Q ss_pred             EEEEEEecccc
Q 022520          137 YLNLVLEYVPE  147 (296)
Q Consensus       137 ~~~iv~e~~~~  147 (296)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            14578998864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.65  E-value=0.032  Score=48.53  Aligned_cols=30  Identities=13%  Similarity=0.186  Sum_probs=26.7

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|+|+.+.|++++.++ .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            799999999999998776 689999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.58  E-value=0.053  Score=46.41  Aligned_cols=31  Identities=29%  Similarity=0.517  Sum_probs=25.3

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|+|++|.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997542346999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PTZ00384 choline kinase; Provisional

Probab=96.48  E-value=0.089  Score=47.22  Aligned_cols=29  Identities=28%  Similarity=0.344  Sum_probs=24.8

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ..+|.|+-+.||+.+.+  .+.++||..|..
T Consensus       228 VfCHNDL~~gNIL~~~~--~l~lID~EYA~~  256 (383)
T PTZ00384        228 LFCHNDLFFTNILDFNQ--GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeccCCcccEEecCC--CEEEEEeccccC
Confidence            68999999999998654  599999998764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.32  E-value=0.078  Score=46.52  Aligned_cols=30  Identities=30%  Similarity=0.521  Sum_probs=25.6

Q ss_pred             ceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       188 iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +||+|+.|.||+++.++.-+-++||+-+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            999999999999998762378999998753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.30  E-value=0.059  Score=46.90  Aligned_cols=30  Identities=27%  Similarity=0.513  Sum_probs=26.9

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|+|+.+.|+++++++ .+=+.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999887 488999999875

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.11  E-value=0.19  Score=45.31  Aligned_cols=70  Identities=19%  Similarity=0.241  Sum_probs=44.3

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEee-----------cchhhHHHHHHHHhcC---CCCceecceeeeeccCCC
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~  134 (296)
                      ..+.||.|....||+..+  .+..++||+-..           +......|.+.|+.+.   ...+.+++.+.     .+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            367789999999999986  345688996541           2222335677776653   23455554443     21


Q ss_pred             ceEEEEEEecccc
Q 022520          135 ELYLNLVLEYVPE  147 (296)
Q Consensus       135 ~~~~~iv~e~~~~  147 (296)
                      .  ..++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            1  4578999976

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.05  E-value=0.011  Score=54.10  Aligned_cols=117  Identities=21%  Similarity=0.282  Sum_probs=73.0

Q ss_pred             HHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC
Q 022520          107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI  186 (296)
Q Consensus       107 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~  186 (296)
                      -...+++.+.|+|...+.+.--...    ....+|||+++.++.+.+..+.     +...       +++       .+ 
T Consensus        31 gr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~~-   86 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------AH-   86 (725)
T ss_pred             hhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------cc-
Confidence            3566788889999999877552222    2267899999999998887642     1111       111       22 


Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  266 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  266 (296)
                      ++.|-     |        .++.+| -++..               |  |-.      .++|+||||+|.++.++..|..
T Consensus        87 ~~~~~-----~--------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   87 GVLHL-----N--------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             cccee-----h--------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhH
Confidence            33332     1        233333 11100               0  111      2259999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHhh
Q 022520          267 LFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       267 pf~~~~~~~~~~~~~~~~  284 (296)
                      .+...+.-+++..+.+..
T Consensus       130 l~~~~~~s~~l~~i~k~~  147 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYY  147 (725)
T ss_pred             HHHHHHHHHHHHHHHHhc
Confidence            998877767766666543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.62  E-value=0.36  Score=42.40  Aligned_cols=28  Identities=25%  Similarity=0.357  Sum_probs=23.9

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||+|+.+.|||++ +  .+.|+||+-+..
T Consensus       197 ~liHgD~h~~NvL~~-d--~~~iIDFDd~~~  224 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D--GPHFVDLDDARM  224 (325)
T ss_pred             cceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence            789999999999995 3  478999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.10  E-value=0.025  Score=46.24  Aligned_cols=31  Identities=39%  Similarity=0.689  Sum_probs=20.1

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      -++|+|+.|.||+++...+.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            6999999999999933334899999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.94  E-value=0.2  Score=43.10  Aligned_cols=73  Identities=16%  Similarity=0.210  Sum_probs=41.6

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-chhhHHHHHHHHhcC--CC-CceecceeeeeccCCCceEEEEEEe
Q 022520           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      +-.+.++.|....+|+..  .++..+.+|.-... ...+..|.+-|+.|.  .+ .+.+.+.+....   +.  .++|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~---~~--~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD---DD--AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S---SC--CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec---CC--ceEEEE
Confidence            345678889999999887  57778889976532 345678999898884  22 344444443221   11  378999


Q ss_pred             cccc
Q 022520          144 YVPE  147 (296)
Q Consensus       144 ~~~~  147 (296)
                      |++.
T Consensus        93 ~l~~   96 (288)
T PF03881_consen   93 FLEM   96 (288)
T ss_dssp             ----
T ss_pred             eecC
Confidence            9873

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.69  E-value=0.06  Score=45.88  Aligned_cols=49  Identities=29%  Similarity=0.466  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHHHHHHcc-CCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          168 VKLYFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       168 ~~~i~~~i~~~l~~LH~~-~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +...+..+-..+.-.+.. .-++|+|+.|+|++.++.+ .++|+||.-|..
T Consensus       134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            333444555555555532 2499999999999999856 799999998864

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.53  E-value=0.057  Score=47.06  Aligned_cols=79  Identities=22%  Similarity=0.276  Sum_probs=42.8

Q ss_pred             EEEEecccccHHHHHHHhhhcCCCC-CHHHHHHHHHHHHHHHH---HHHccCCceeccCCCCceEEcCCCC---------
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRM-PLIYVKLYFYQICRALA---YIHNTIGVCHRDIKPQNLLVNPHTH---------  205 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~-~~~~~~~i~~~i~~~l~---~LH~~~~iiH~Dlkp~NIli~~~~~---------  205 (296)
                      .||++....+....-.......+-. -.+-++.++.|++.-.-   .|-.....+|-||||+|||+-+...         
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~  326 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR  326 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence            3788876654333222222112211 22335666777765431   1221126999999999999843321         


Q ss_pred             --------cEEEeeecceee
Q 022520          206 --------QLKLCDFGSAKV  217 (296)
Q Consensus       206 --------~ikl~Dfg~~~~  217 (296)
                              ..+|-||.+++.
T Consensus       327 ~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  327 NYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             EEEecccceeeecccCHHHh
Confidence                    356777777653

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PTZ00296 choline kinase; Provisional

Probab=94.31  E-value=1.1  Score=41.22  Aligned_cols=70  Identities=13%  Similarity=0.145  Sum_probs=43.1

Q ss_pred             EeeeeeecCceEEEEEEEcCC--------CcEEEEEEEeecch---hhHHHHHHHHhcCCCCcee-cceeeeeccCCCce
Q 022520           69 AERVVGHGSFGVVFQAKCLET--------GEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS-LKHCFFSTTEKDEL  136 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~---~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~~  136 (296)
                      -++.|..|-.-.+|++.....        ++.|.+++.-....   ...+|..+++.+...+|-+ +++.+     .+  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----SG--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----CC--
Confidence            455666777888998875421        46788887643332   2346888888886655553 33333     21  


Q ss_pred             EEEEEEecccc
Q 022520          137 YLNLVLEYVPE  147 (296)
Q Consensus       137 ~~~iv~e~~~~  147 (296)
                        +.|.+|++|
T Consensus       182 --g~I~efi~g  190 (442)
T PTZ00296        182 --GRIEEWLYG  190 (442)
T ss_pred             --CEEEEeeCC
Confidence              246777775

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.96  E-value=0.048  Score=43.57  Aligned_cols=29  Identities=28%  Similarity=0.350  Sum_probs=24.9

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      -.+|+|+.|.||++..++  ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            479999999999998654  89999998864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	296
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-97
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-97
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-97
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-97
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-97
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-96
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-96
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-96
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-95
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-95
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-95
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-95
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-95
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-95
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-94
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-94
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-94
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-94
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-94
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-93
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-92
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-90
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-66
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-65
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-35
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-35
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-35
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-34
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-34
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-34
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-34
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-34
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-34
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-34
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-34
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-34
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-34
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-34
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-34
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-34
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-34
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-34
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-34
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-34
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-34
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-34
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-34
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-34
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-34
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-34
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-34
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-34
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-33
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-33
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-33
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-33
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-33
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-33
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-33
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-33
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-33
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-33
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-33
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-33
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-33
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-32
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-32
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-31
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-31
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-30
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-30
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-30
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-30
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-30
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-30
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-30
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-30
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-30
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-30
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-30
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-30
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-30
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-30
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-30
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-30
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-30
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-30
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-30
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-30
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-30
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-30
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-30
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-30
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-30
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-30
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-30
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-30
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-30
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-30
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-30
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-30
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-30
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-30
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-30
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-30
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-30
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-30
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-30
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-30
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-30
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-30
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-30
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-30
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-30
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-30
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-30
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-30
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-30
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-30
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-30
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-30
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-30
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-30
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-30
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-30
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-30
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-30
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-30
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-30
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-30
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-30
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-30
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-30
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-30
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-30
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-30
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-30
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-30
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-30
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-30
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-30
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-30
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-29
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-29
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-29
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-29
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-29
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-29
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-29
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-29
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-29
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-29
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-29
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-29
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-29
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-29
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-29
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-29
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-29
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-29
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-29
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-29
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-29
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-29
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-29
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-28
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-28
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-28
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-28
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-28
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-28
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-25
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-25
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-25
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-24
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-24
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-24
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-24
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-24
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-24
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-24
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-24
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-24
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-24
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-24
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-23
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-23
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-23
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-23
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-23
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-23
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-23
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-23
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-23
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-23
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-23
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-23
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-23
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-23
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-23
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-23
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-23
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-23
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-23
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-23
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-23
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-23
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-23
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-22
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-22
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-22
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-22
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-22
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-22
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-22
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-22
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-21
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-21
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-21
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-21
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-21
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-21
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-21
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-21
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-21
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-21
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-21
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-21
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-21
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-21
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-21
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-21
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-21
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-21
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-21
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-21
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-20
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-20
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-20
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-20
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-20
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-20
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-20
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-20
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-20
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-20
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-20
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-20
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-20
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-20
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-20
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-20
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-19
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-19
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-19
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-19
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-17
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-17
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-17
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-17
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-17
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-17
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-17
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-17
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-17
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-17
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-17
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-16
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-16
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-16
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-16
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-15
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-15
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-15
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		9e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-12
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		7e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-11
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-11
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-11
3soa_A	444	Full-Length Human Camkii Length = 444		3e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-09
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		4e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		8e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-04

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  351 bits (900), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 168/266 (63%), Positives = 211/266 (79%), Gaps = 13/266 (4%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 24  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 72
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 73  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 132
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 191
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 192 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 251
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVI 284
           AELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 252 AELLLGQPIFPGDSGVDQLVEIIKVL 277

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  351 bits (900), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 168/266 (63%), Positives = 211/266 (79%), Gaps = 13/266 (4%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 14  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 62
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 63  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 122
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 181
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 182 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 241
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVI 284
           AELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 242 AELLLGQPIFPGDSGVDQLVEIIKVL 267

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  351 bits (900), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 168/266 (63%), Positives = 211/266 (79%), Gaps = 13/266 (4%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 20  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVI 284
           AELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVL 273

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  350 bits (899), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 168/266 (63%), Positives = 211/266 (79%), Gaps = 13/266 (4%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 22  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 70
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 71  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 130
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 189
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 190 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 249
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVI 284
           AELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 250 AELLLGQPIFPGDSGVDQLVEIIKVL 275

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  350 bits (899), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 168/266 (63%), Positives = 211/266 (79%), Gaps = 13/266 (4%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 65  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 113
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 114 VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 173
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 232
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 233 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 292
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVI 284
           AELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 293 AELLLGQPIFPGDSGVDQLVEIIKVL 318

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  348 bits (893), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 164/246 (66%), Positives = 206/246 (83%), Gaps = 4/246 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 279 EIIKVI 284
           EIIKV+
Sbjct: 247 EIIKVL 252

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  347 bits (891), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 167/266 (62%), Positives = 210/266 (78%), Gaps = 13/266 (4%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 20  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVI 284
           AELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVL 273

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  347 bits (891), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 164/236 (69%), Positives = 202/236 (85%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 11  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 69
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 70  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 129
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 130 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 188
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 244

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  345 bits (886), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 164/236 (69%), Positives = 202/236 (85%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  345 bits (886), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 163/246 (66%), Positives = 205/246 (83%), Gaps = 4/246 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 279 EIIKVI 284
           EIIKV+
Sbjct: 246 EIIKVL 251

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  345 bits (885), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 163/246 (66%), Positives = 205/246 (83%), Gaps = 4/246 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 279 EIIKVI 284
           EIIKV+
Sbjct: 253 EIIKVL 258

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  345 bits (885), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 163/246 (66%), Positives = 205/246 (83%), Gaps = 4/246 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 279 EIIKVI 284
           EIIKV+
Sbjct: 242 EIIKVL 247

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  345 bits (885), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 163/246 (66%), Positives = 205/246 (83%), Gaps = 4/246 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 279 EIIKVI 284
           EIIKV+
Sbjct: 246 EIIKVL 251

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  343 bits (879), Expect = 9e-95,   Method: Compositional matrix adjust.
 Identities = 163/236 (69%), Positives = 201/236 (85%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  343 bits (879), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 163/236 (69%), Positives = 201/236 (85%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  343 bits (879), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 163/236 (69%), Positives = 201/236 (85%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 7   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 65
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 66  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 125
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 126 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 184
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  342 bits (878), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 163/236 (69%), Positives = 201/236 (85%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 10  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 68
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 69  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 128
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 129 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 187
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 243

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  340 bits (872), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 162/236 (68%), Positives = 200/236 (84%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  339 bits (870), Expect = 9e-94,   Method: Compositional matrix adjust.
 Identities = 162/236 (68%), Positives = 200/236 (84%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  339 bits (870), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 162/236 (68%), Positives = 200/236 (84%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK D +YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  334 bits (857), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 160/236 (67%), Positives = 198/236 (83%), Gaps = 3/236 (1%)
Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVP TV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYV 124
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  327 bits (839), Expect = 4e-90,   Method: Compositional matrix adjust.
 Identities = 158/237 (66%), Positives = 195/237 (82%), Gaps = 4/237 (1%)
Query: 49  IIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE 108
           I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
           LQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV+R  +H+ K+ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKV+
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  248 bits (632), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 115/229 (50%), Positives = 164/229 (71%), Gaps = 6/229 (2%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LLDHP 118
           K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 119 NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L+  F++  E+D  ++YLN+V+EYVP+T+HR  +++Y+     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 177 RALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           PELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL EI++V+
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 115/251 (45%), Positives = 167/251 (66%), Gaps = 34/251 (13%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH N++ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 127 FFSTTEKD---------------------------------ELYLNLVLEYVPETVHRVI 153
           F++T +++                                   YLN+++EYVP+T+H+V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 154 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   + LKLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
           SAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 274 VDQLVEIIKVI 284
           +DQLV II+++
Sbjct: 248 IDQLVRIIQIM 258

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/222 (40%), Positives = 132/222 (59%), Gaps = 23/222 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNT 185
           F     + +  L+LV EY   TV     H     QR +P   VK   +Q  +A+ + H  
Sbjct: 71  F-----RRKRRLHLVFEYCDHTV----LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
               HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G 
Sbjct: 122 -NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGD 177
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  144 bits (363), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 86/240 (35%), Positives = 137/240 (57%), Gaps = 24/240 (10%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 109
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIY 167
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 86/240 (35%), Positives = 137/240 (57%), Gaps = 24/240 (10%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 109
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIY 167
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 84/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E VH+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 82/221 (37%), Positives = 131/221 (59%), Gaps = 20/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E+V + + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 181
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 224

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 181
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 224

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 86/236 (36%), Positives = 136/236 (57%), Gaps = 19/236 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 126 CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 239
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 177 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
               EYT AID+WS GC+  E+L  + LFPG++ V QL ++I ++L T     I+A
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL-QLIMMVLGTPSPAVIQA 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/223 (37%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 86/236 (36%), Positives = 136/236 (57%), Gaps = 19/236 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 126 CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 239
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 178 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
               EYT AID+WS GC+  E+L  + LFPG++ V QL ++I ++L T     I+A
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL-QLIMMVLGTPSPAVIQA 290

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/223 (36%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + L++ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/223 (36%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/223 (36%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/223 (36%), Positives = 131/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/223 (36%), Positives = 130/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/223 (36%), Positives = 130/223 (58%), Gaps = 24/223 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/221 (36%), Positives = 129/221 (58%), Gaps = 20/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 124
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/221 (36%), Positives = 130/221 (58%), Gaps = 20/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 123
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/221 (36%), Positives = 130/221 (58%), Gaps = 20/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/221 (36%), Positives = 129/221 (58%), Gaps = 20/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/227 (36%), Positives = 130/227 (57%), Gaps = 22/227 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLLRGVA 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           + H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLIN-SDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  ++
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/227 (36%), Positives = 130/227 (57%), Gaps = 22/227 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLLRGVA 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           + H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLIN-SDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  ++
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/217 (36%), Positives = 126/217 (58%), Gaps = 17/217 (7%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 125
           +VG GS+G+V + +  +TG  VAIKK L+       K+   RE++ ++ L H N+V+L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
                 +K   YL  V E+V    H ++         +    V+ Y +QI   + + H+ 
Sbjct: 92  V---CKKKKRWYL--VFEFVD---HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATE 244
             + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 144 -NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 138/247 (55%), Gaps = 39/247 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTM-RLLDHPN 119
           Y   + +G G++G+V+++    TGE VA+KK+        D +   RE+  +  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V+L +   +  ++D   + LV +Y+   +H VI+     +  +  ++ +   YQ+ + +
Sbjct: 71  IVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIKVI 122
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------------------- 220
            Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V                    
Sbjct: 123 KYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 221 --GEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
              +P ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++QL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 278 VEIIKVI 284
             II VI
Sbjct: 241 ERIIGVI 247

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  134 bits (338), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 79/224 (35%), Positives = 123/224 (54%), Gaps = 24/224 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F   +      ++LV +++   +  +IK +   S  +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 240
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QHW-ILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + +
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/221 (36%), Positives = 122/221 (55%), Gaps = 16/221 (7%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 125 HCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F   T  +D   + LV   +   ++ ++K     SQ +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKYIH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 245

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 79/221 (35%), Positives = 121/221 (54%), Gaps = 16/221 (7%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 125 HCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F   T  +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 245

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 135/236 (57%), Gaps = 17/236 (7%)
Query: 59  GQPKQT-ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL 115
           GQP      Y   + +G G++G+V  A        VAIKK+   + + Y  R L+ +++L
Sbjct: 36  GQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQIL 95
Query: 116 ---DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
               H NV+ ++    ++T +    + +V + +   +++++K     SQ++   ++  + 
Sbjct: 96  LRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFL 150
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----I 228
           YQI R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A++      +  +    +
Sbjct: 151 YQILRGLKYIHSA-NVLHRDLKPSNLLIN-TTCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/222 (36%), Positives = 125/222 (56%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNA 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 125/222 (56%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 125/222 (56%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K     SQ++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 125/222 (56%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 79/221 (35%), Positives = 120/221 (54%), Gaps = 16/221 (7%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 125 HCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F   T  +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 140
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 141 SA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 196
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVV 237

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 99  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 151
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 152 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 249

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 77/224 (34%), Positives = 128/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + LV   +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 134/235 (57%), Gaps = 23/235 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKN----RELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------ISYIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +      EP       + ++ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  +I
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 133/235 (56%), Gaps = 23/235 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------ISYIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +      EP         Y+ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  +I
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 79/218 (36%), Positives = 116/218 (53%), Gaps = 16/218 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 126
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 127 FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D+     LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQMLKGLRYIH-A 146
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRD+KP NL VN    +LK+ DFG A+           + +R+YRAPE+I     Y
Sbjct: 147 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           T  +DIWS GC++AE++ G+ LF G   +DQL EI+KV
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 251

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 220
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 250

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 258

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 245

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNW 220
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 262

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 87  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 139
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 140 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 195
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 237

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 252

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 244

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 88  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 140
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 141 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 196
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 238

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 241

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 236

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 250

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 241

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 77/226 (34%), Positives = 125/226 (55%), Gaps = 19/226 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 119
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 120 VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+ L   F   +     Y   LV+ ++   + +++   +   +      ++   YQ+ + 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK------IQYLVYQMLKG 156
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 237
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 157 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 211
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  127 bits (318), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 133/242 (54%), Gaps = 37/242 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVV- 121
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 122 ----------SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
                      L     S TE + +Y+  V EY+   +  V+       ++ PL+  + +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVL-------EQGPLLEEHAR 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 227
           L+ YQ+ R L YIH+   V HRD+KP NL +N     LK+ DFG A+++   +P+ S+  
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKG 179
Query: 228 -----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
                + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+  I++
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 283 VI 284
            I
Sbjct: 240 SI 241

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 129/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVI 284
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I +++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 75/219 (34%), Positives = 123/219 (56%), Gaps = 18/219 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 126 CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F   T  +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           Y   +DIWS GC++AELL G+ LFPG   ++QL +I+++
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRL 267

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/226 (34%), Positives = 125/226 (55%), Gaps = 19/226 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 119
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 120 VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+ L   F   +     Y   LV+ ++   + +++   +   +      ++   YQ+ + 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK------IQYLVYQMLKG 138
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 237
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 139 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 128/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/222 (36%), Positives = 122/222 (54%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVI 284
            Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I +++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLL 219

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 124/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K       ++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CAKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 259

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 123/221 (55%), Gaps = 22/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I +++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 132/235 (56%), Gaps = 23/235 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------ISYIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +      EP          + 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  +I
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 127/221 (57%), Gaps = 16/221 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 243
           V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 127/221 (57%), Gaps = 16/221 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 243
           V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 123/221 (55%), Gaps = 22/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I +++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRIL 217

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 128/224 (57%), Gaps = 22/224 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 123/221 (55%), Gaps = 22/221 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I +++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  124 bits (310), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 79/222 (35%), Positives = 123/222 (55%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/222 (33%), Positives = 122/222 (54%), Gaps = 19/222 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G+G++  V++     TG  VA+K+V  D          RE+  M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +  +     L LV E++   + + +         + + L  VK + +Q+ + LA+ H  
Sbjct: 73  HTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP+++ G+
Sbjct: 128 -KILHRDLKPQNLLINKRG-QLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 124/227 (54%), Gaps = 20/227 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNIINMHNVKLFLFQLLRGLA 114
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I +++
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 129/239 (53%), Gaps = 17/239 (7%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ VI
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 129/239 (53%), Gaps = 17/239 (7%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ VI
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 129/239 (53%), Gaps = 17/239 (7%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    +    +P 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALT 177
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ VI
Sbjct: 178 SVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 122/225 (54%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                      L+L+ EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 IHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151
Query: 187 GVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
              HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +V+
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 116/222 (52%), Gaps = 13/222 (5%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMR-LLDHPNVVSL 123
            Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 244 EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
            Y  ++D+WS GC+LA ++   +P F G    DQLV I KV+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 130/233 (55%), Gaps = 17/233 (7%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I+++
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 130/233 (55%), Gaps = 17/233 (7%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I+++
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 22/239 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++V+
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 22/239 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++V+
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 22/239 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 139
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++V+
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 255

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 128/233 (54%), Gaps = 17/233 (7%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I+++
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 117/235 (49%), Gaps = 25/235 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------------LQDKRYKNRELQTMRL 114
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 115 LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 117/235 (49%), Gaps = 25/235 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------------LQDKRYKNRELQTMRL 114
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 115 LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 64/174 (36%), Positives = 97/174 (55%), Gaps = 16/174 (9%)
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQ 161
           RE+  +R L HPNV+SL+  F S  ++    + L+ +Y    +  +IK H      K   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL 218
           ++P   VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 219 ---VKGEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
              +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 117/226 (51%), Gaps = 24/226 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 120 VVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           VV L   C  S T++ E+ + LV E+V + +   +         +P   +K    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRG 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE+
Sbjct: 125 LDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  +I
Sbjct: 183 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 XGIKHLHSA-GIIHRDLKPSNIVVK-SDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 117/226 (51%), Gaps = 24/226 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 120 VVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           VV L   C  S T++ E+ + LV E+V + +   +         +P   +K    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRG 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE+
Sbjct: 125 LDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  +I
Sbjct: 183 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 XGIKHLHSA-GIIHRDLKPSNIVVK-SDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 129
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 XGIKHLHSA-GIIHRDLKPSNIVVK-SDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 117/226 (51%), Gaps = 24/226 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 120 VVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           VV L   C  S T++ E+ + LV E+V + +   +         +P   +K    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRG 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE+
Sbjct: 125 LDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  +I
Sbjct: 183 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 117/229 (51%), Gaps = 27/229 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------RELQTMRLLD--- 116
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 117 HPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           HPNVV L   C  S T++ E+ + LV E+V + +   +         +P   +K    Q 
Sbjct: 73  HPNVVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQF 129
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 130 LRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           PE++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  +I
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 116/224 (51%), Gaps = 17/224 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E VA+K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N+L++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KV+
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 174
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 175 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 233 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 119/223 (53%), Gaps = 16/223 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            G   Y A +DIWS GC++ EL+ G  +F G   +DQ  ++I+
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIE 239

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 130
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 131 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 189 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 240

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 135
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 136 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 193
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 194 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 238

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 130
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 131 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 189 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 129
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQML 174
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 175 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 233 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 138
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+        + ++ +RYYRAP
Sbjct: 139 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAP 196
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 197 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 241

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 137
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 138 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 16/223 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 137
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 138 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 237

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 148 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 117/227 (51%), Gaps = 23/227 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL-KH 125
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L + 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 126 CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    +     K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 44/118 (37%), Positives = 73/118 (61%), Gaps = 2/118 (1%)
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           ++ Y Y+I +AL Y H ++G+ HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           + SRY++ PEL+     Y  ++D+WS GC+LA ++   +P F G    DQLV I KV+
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 23/224 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 110 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 162
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVL 248

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 109 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 161
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVL 247

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 141
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 142 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 199
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 200 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 244

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 84/146 (57%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 110 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 162
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G    DQLV I KV+
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVL 248

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 130
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 131 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 189 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 233

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 115/224 (51%), Gaps = 23/224 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL-KH 125
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L + 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 126 CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    +     K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKASIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 115/224 (51%), Gaps = 17/224 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 100
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 101 TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 151
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 152 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 210
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KV+
Sbjct: 211 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 254

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 116/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 115/224 (51%), Gaps = 23/224 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL-KH 125
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L + 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 126 CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    +     K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 139
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 140 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 115/224 (51%), Gaps = 17/224 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KV+
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/249 (31%), Positives = 120/249 (48%), Gaps = 50/249 (20%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y+ + ++G GS+G V+ A    T + VAIKKV      L D +   RE+  +  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 120 VVSLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L          + DELY+  VLE     + ++ K    +++     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNI----------- 225
              +IH + G+ HRD+KP N L+N     +K+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 226 -----------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQ-------- 265
                      S++ +R+YRAPELI     YT +IDIWS GC+ AELL + Q        
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 266 --PLFPGES 272
             PLFPG S
Sbjct: 259 RFPLFPGSS 267

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 83/146 (56%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 112 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 164
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G+   DQLV I KV+
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVL 250

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 83/146 (56%), Gaps = 8/146 (5%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 117 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 169
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVI 284
            ++   +P F G+   DQLV I KV+
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVL 255

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 116/253 (45%), Gaps = 55/253 (21%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y  + ++G GS+G V+ A      + VAIKKV      L D +   RE+  +  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 120 VVSLKHCFF--STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L          + DELY+  VLE     + ++ K    ++++    +VK   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI------------ 225
              +IH + G+ HRD+KP N L+N     +K+CDFG A+  +  + +I            
Sbjct: 143 GEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEEN 199
Query: 226 ---------------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ----- 265
                          S++ +R+YRAPELI     YT +IDIWS GC+ AELL        
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 266 ------PLFPGES 272
                 PLFPG S
Sbjct: 260 NPTNRFPLFPGSS 272

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 116/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 239

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 13/228 (5%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L+  
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 243

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 13/228 (5%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 107 PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 157
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 158 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 216
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 264

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 22/226 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+
Sbjct: 195 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 239

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 75  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 13/228 (5%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 244

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 13/228 (5%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 243

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 74  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 13/228 (5%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 243

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 13/228 (5%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 243

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 69  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK---NRELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     +    RE+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 65  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 244

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 116/253 (45%), Gaps = 55/253 (21%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 120
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 121 VS-LKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  L        EK DELY+  VLE       ++ +    +++    +++K   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVG 168
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------------ 226
           + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S            
Sbjct: 169 VKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 227 ----------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL------- 263
                           ++ +R+YRAPELI     YT AID+WS GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 264 ----GQPLFPGES 272
                 PLFPG S
Sbjct: 287 YHADRGPLFPGSS 299

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 88  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 138
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 139 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 245

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 13/228 (5%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 243

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 11/168 (6%)
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVI 284
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KV+
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 243

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/233 (33%), Positives = 116/233 (49%), Gaps = 17/233 (7%)
Query: 55  GGKNGQ-PKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 107
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 108 -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 164
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 222
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGV 274
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P    V
Sbjct: 179 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/233 (33%), Positives = 116/233 (49%), Gaps = 17/233 (7%)
Query: 55  GGKNGQ-PKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 107
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 108 -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 164
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 222
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 121 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 179
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGV 274
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P    V
Sbjct: 180 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 231

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 161
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 265

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 160
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 264

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 121/251 (48%), Gaps = 31/251 (12%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 119 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 164
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTH-QLKLCDFGSAKVLV 219
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+    +P    Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 273
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 274 VDQLVEIIKVI 284
            D + +II+++
Sbjct: 247 DDHIAQIIELL 257

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 121/251 (48%), Gaps = 31/251 (12%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 119 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 164
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTH-QLKLCDFGSAKVLV 219
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+    +P    Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 273
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 274 VDQLVEIIKVI 284
            D + +II+++
Sbjct: 247 DDHIAQIIELL 257

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 24/227 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +  L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 143
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 247

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 120/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+
Sbjct: 150 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 208 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 250

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 120/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 145
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+
Sbjct: 146 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 204 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 246

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 118/228 (51%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 101
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF    + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 102 LYFCF---QDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 154 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 212 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 254

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 121/235 (51%), Gaps = 45/235 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 123 LKHCFFSTTEKDELYLNL-------VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           L   +F+  + ++LY  L       +L+Y+     R I    +   R        Y  +I
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGCLLKYI-----RKIGSFDETCTR-------FYTAEI 141
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRY 232
             AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  
Sbjct: 142 VSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 233 YRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
           Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 200 YVSPELL---TEKSASKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 249

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 171
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 120/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 205 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 247

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 149 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 207 ---TEKSAXKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL 249

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 244 E--YTAAIDIWSAGCVLAELLLGQP 266
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 149 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 207 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL 249

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 149 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 207 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 249

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 99
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 100 L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 151
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 152 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 210 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 252

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 205 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 247

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 205 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 247

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 149 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 207 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 249

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 149 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 207 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 249

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 15/232 (6%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 127
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 142
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELI-FGATEY 245
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQ--LVEIIKVILHTEISLSIKA 295
             A DIWS GC + E+  G+P F  E G  Q  + ++    +H EI  S+ A
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF-YELGEPQAAMFKVGMFKVHPEIPESMSA 253

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 150 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 208 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 250

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 15/232 (6%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 127
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 128
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELI-FGATEY 245
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQ--LVEIIKVILHTEISLSIKA 295
             A DIWS GC + E+  G+P F  E G  Q  + ++    +H EI  S+ A
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFY-ELGEPQAAMFKVGMFKVHPEIPESMSA 239

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 79  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 131 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 189 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 145
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 146 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 204 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 246

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 72  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 123
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 124 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 182 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 224

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 73  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 125 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 183 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 225

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 74  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 126 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 184 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 226

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 75  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 127 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 185 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 227

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y  ++ +G G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 123
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 124 VSAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 118/228 (51%), Gaps = 31/228 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 122
           +++G GSF     A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYL 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELI 239
           H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 240 FGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKV 283
              TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+
Sbjct: 205 ---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL 247

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/240 (33%), Positives = 124/240 (51%), Gaps = 25/240 (10%)
Query: 58  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMR 113
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLY 171
            L HPN++ LK  F + TE     ++LVLE V   E   R+++  Y  S+R     VK  
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGY-YSERDAADAVK-- 155
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNISYIC 229
             QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C
Sbjct: 156 --QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC 211
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ   + + IL+ E
Sbjct: 212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQF--MFRRILNCE 267

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 25/227 (11%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------R 107
           G + QP    +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E++ M++L+HPN+V L    F   E ++  L L++EY    E    ++ H      RM  
Sbjct: 61  EVRIMKILNHPNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHG-----RMKE 110
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              +  F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    
Sbjct: 111 KEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLD 168
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           ++  S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H +   +       +  F QI
Sbjct: 66  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGWMKEKE-----ARAKFRQI 115
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 116 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 173
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +++ L     + T+       +V+EYV   E    + KH      R+  +  +  F QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE   +   S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E+I G       +DIWS G +L  LL G   F  E
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +++ L     + T+       +V+EYV   E    + KH      R+  +  +  F QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRDSCGSPNYAAP 179
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E+I G       +DIWS G +L  LL G   F  E
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L L++EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQI 123
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 124 VSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           Y+    +G GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L     + T+     + +V+EY    +   I    +M++       + +F QI  A+
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELFDYIVEKKRMTEDEG----RRFFQQIICAI 121
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y H    + HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            G       +D+WS G VL  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 21/241 (8%)
Query: 48  HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKR 103
           H IVT    K G      +     ++G G FG V + +   TG  +A K    + ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 104 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQ 161
               E+  M  LDH N++ L   F S  +     + LV+EYV   E   R+I   Y +++
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVK 220
              ++++K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+    
Sbjct: 187 LDTILFMK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            E       +  + APE++      +   D+WS G +   LL G   F G++  + L  I
Sbjct: 242 REKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 281 I 281
           +
Sbjct: 301 L 301

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 115/221 (52%), Gaps = 32/221 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 184
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE++   G   Y  A+D WS G +L   L G P F
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 115/221 (52%), Gaps = 32/221 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE++   G   Y  A+D WS G +L   L G P F
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 115/221 (52%), Gaps = 32/221 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE++   G   Y  A+D WS G +L   L G P F
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 115/221 (52%), Gaps = 32/221 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE++   G   Y  A+D WS G +L   L G P F
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 115/221 (52%), Gaps = 32/221 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE++   G   Y  A+D WS G +L   L G P F
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 114/214 (53%), Gaps = 25/214 (11%)
Query: 70  ERV--VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 120
           ER+  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 76
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V     F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R L
Sbjct: 77  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 127
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE +
Sbjct: 128 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
            G T Y+   DIWS G  L EL +G+ P+ P ++
Sbjct: 186 QG-THYSVQSDIWSMGLSLVELAVGRYPIPPPDA 218

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 255
Query: 289 ISL 291
           +  
Sbjct: 256 VRF 258

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 124/242 (51%), Gaps = 28/242 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCG 201
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKV 256
Query: 290 SL 291
Sbjct: 257 RF 258

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 122/243 (50%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 122/243 (50%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    R +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           +  + ++ P +V L+  F     KD   L +VLEY P      +  H +   R    + +
Sbjct: 94  RIQQAVNFPFLVKLEFSF-----KDNSNLYMVLEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 200
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 255
Query: 289 ISL 291
           +  
Sbjct: 256 VRF 258

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 255
Query: 289 ISL 291
           +  
Sbjct: 256 VRF 258

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 125/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 118/240 (49%), Gaps = 24/240 (10%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SR 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C + 
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 258

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 116/228 (50%), Gaps = 24/228 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           RV+G GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 89  L-FCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I  
Sbjct: 141 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQ 197
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
              Y  A+D W+ G +L E+L G   F  E+  D    + + IL+ E+
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEV 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 118/240 (49%), Gaps = 24/240 (10%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SR 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C + 
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 258

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 124/242 (51%), Gaps = 28/242 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 79  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 130
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   
Sbjct: 131 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCG 186
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++
Sbjct: 187 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKV 241
Query: 290 SL 291
Sbjct: 242 RF 243

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 118/240 (49%), Gaps = 24/240 (10%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFXEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SR 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C + 
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 258

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 20/216 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DH 117
            ++  +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           P +  +  C F T E     L  V+EY+       + +H +   +  L     Y  +I  
Sbjct: 78  PFLTHM-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 236
            L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C +  Y AP
Sbjct: 130 GLQFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           E++ G  +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 188 EILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 19/226 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 86  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 134
Query: 188 VCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYD 193
Query: 247 AAI-DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             + D+WS G  L  +L+G   F          + I  IL+ + ++
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 239

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 19/226 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYD 194
Query: 247 AAI-DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             + D+WS G  L  +L+G   F          + I  IL+ + ++
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 113/222 (50%), Gaps = 22/222 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 90
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 91  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 142 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 198
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH 286
           Y+   DIWS G  L E+ +G+      SG   + E++  I++
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVN 240

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+   +   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F  +T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-KVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  D    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV 221

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 122/243 (50%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 115/221 (52%), Gaps = 32/221 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 317
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE++   G   Y  A+D WS G +L   L G P F
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 115/221 (52%), Gaps = 32/221 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYIC- 229
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 303
Query: 230 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE++   G   Y  A+D WS G +L   L G P F
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 114 RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 165
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 166 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 220
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 221 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 275
Query: 289 ISL 291
           +  
Sbjct: 276 VRF 278

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 255
Query: 289 ISL 291
           +  
Sbjct: 256 VRF 258

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 116/230 (50%), Gaps = 25/230 (10%)
Query: 59  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 111
           G P++   Y+A  + +G GS G+V  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           MR   H NVV +   + S    DEL++  V+E++       I  H +M++      +   
Sbjct: 96  MRDYHHDNVVDM---YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
              + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P    +  +
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E  +  +  I
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 255
Query: 289 ISL 291
           +  
Sbjct: 256 VRF 258

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 255
Query: 289 ISL 291
           +  
Sbjct: 256 VRF 258

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 121/244 (49%), Gaps = 29/244 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVA---IKKVLQDKRYKNRELQTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A   +KK L +       +QT + +     +HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ G
Sbjct: 170 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFP---GESGVDQLVE--IIKVILHTEI----SLS 292
             +Y  ++D W+ G ++ E++ G+  F         DQ  E  + +VIL  +I    SLS
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 293 IKAA 296
           +KAA
Sbjct: 287 VKAA 290

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 247
Query: 289 ISL 291
           +  
Sbjct: 248 VRF 250

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 122/244 (50%), Gaps = 29/244 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 123 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFP---GESGVDQLVE--IIKVILHTEI----SLS 292
             +Y  ++D W+ G ++ E++ G+  F         DQ  E  + +VIL  +I    SLS
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 239
Query: 293 IKAA 296
           +KAA
Sbjct: 240 VKAA 243

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 36/227 (15%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRLLD-HPNVVSLKH 125
           RV+  G F  V++A+ + +G   A+K++L ++  KNR    E+  M+ L  HPN+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF-- 91
Query: 126 CFFSTTEKDE-----LYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQICRA 178
           C  ++  K+E         L+ E     +   +K   KM  R PL    V   FYQ CRA
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK---KMESRGPLSCDTVLKIFYQTCRA 148
Query: 179 LAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------ 231
           + ++H     + HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R      
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEE 206
Query: 232 --------YYRAPELI--FGATEYTAAIDIWSAGCVLAELLLGQPLF 268
                    YR PE+I  +         DIW+ GC+L  L   Q  F
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
             Y    D+WSAG +L  LL G P F G++  D L
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F   T   ++YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 88  LYETFEDNT---DIYLVMELCTGGELFERVVHKRVFRESDAARIM------KDVLSAVAY 138
Query: 182 IHNTIGVCHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            H  + V HRD+KP+N   L +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 139 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            G   Y    D WSAG ++  LL G P F   +  + +++I
Sbjct: 198 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI 236

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 122/244 (50%), Gaps = 29/244 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 127 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFP---GESGVDQLVE--IIKVILHTEI----SLS 292
             +Y  ++D W+ G ++ E++ G+  F         DQ  E  + +VIL  +I    SLS
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 293 IKAA 296
           +KAA
Sbjct: 244 VKAA 247

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 23/212 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVD 275
           Y+   DIWS G  L E+ +G+ P+ P ++  D
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKED 211

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F   T   ++YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 71  LYETFEDNT---DIYLVMELCTGGELFERVVHKRVFRESDAARIM------KDVLSAVAY 121
Query: 182 IHNTIGVCHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            H  + V HRD+KP+N   L +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 122 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            G   Y    D WSAG ++  LL G P F   +  + +++I
Sbjct: 181 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI 219

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 122/244 (50%), Gaps = 29/244 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 138 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFP---GESGVDQLVE--IIKVILHTEI----SLS 292
             +Y  ++D W+ G ++ E++ G+  F         DQ  E  + +VIL  +I    S+S
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMS 254
Query: 293 IKAA 296
           +KAA
Sbjct: 255 VKAA 258

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 247
Query: 289 ISL 291
           +  
Sbjct: 248 VRF 250

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 20/211 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  C F T E     L  V+EY+       + +H +   +  L     Y  +I   L ++
Sbjct: 84  M-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C +  Y APE++ G
Sbjct: 136 HSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 194 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 28/209 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D   + ++++Y+   E    + K     SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYRAPELI 239
           +H+   + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C +  Y APE++
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV 175
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLF 268
                Y  +ID WS G ++ E+L G   F
Sbjct: 176 -STKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 123/243 (50%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 200
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 255
Query: 289 ISL 291
           +  
Sbjct: 256 VRF 258

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 185 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 241
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 238

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 29/211 (13%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH---HYKMSQRMPLIYVKLYFY 173
           +++ L     + ++     + +V+EYV   E    + K+     K S+R+        F 
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQ 123
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QI   + Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y
Sbjct: 124 QILSGVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNY 181
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            APE+I G       +DIWS+G +L  LL G
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  L     LS +A
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 225

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
             Y    D+WSAG +L  LL G P F G++  D L  +
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
             Y    D+WSAG +L  LL G P F G++  D L  +
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 91  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 141 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  L     LS +A
Sbjct: 199 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 254

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 98
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 99  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 150 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 206
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
           Y+   DIWS G  L E+ +G+ P+ P ++
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  L     LS +A
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 220

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 124/243 (51%), Gaps = 30/243 (12%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYV       +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
            +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  +
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGK 254
Query: 289 ISL 291
           +  
Sbjct: 255 VRF 257

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV EY    E    ++ H     +       +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVXEYASGGEVFDYLVAHGRXKEKE-----ARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 129 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 274
Query: 187 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-- 243
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            YT   D+WS G +   LL G   F GE+  + L  +
Sbjct: 335 YYT---DMWSVGVLSYILLSGLSPFGGENDDETLRNV 368

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 129 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 168
Query: 187 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-- 243
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            YT   D+WS G +   LL G   F GE+  + L  +
Sbjct: 229 YYT---DMWSVGVLSYILLSGLSPFGGENDDETLRNV 262

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 64  TISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQ 110
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMPLIYVK 169
               L+HP +V++     + T    L   +V+EYV     R I H    M+ +  +  + 
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---- 225
                 C+AL + H   G+ HRD+KP N+L++  T+ +K+ DFG A+ +     ++    
Sbjct: 124 ----DACQALNFSHQN-GIIHRDVKPANILIS-ATNAVKVVDFGIARAIADSGNSVXQTA 177
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           + I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G P F   +  +    I +V
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 66  SYMAERVVGHGSFGVVF--QAKCLETGEAVA-IKKVLQDK-RYKN-------------RE 108
           SY   R +G G++G V   + K   + +A+  IKK   DK RY +              E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLI 166
           +  ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I  H K  +     
Sbjct: 97  ISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAAN 150
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN 224
            +K    QI   + Y+H    + HRDIKP+N+L+        +K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  D
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 247

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 218

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 19/226 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++    EY 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYD 194
Query: 247 AAI-DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             + D+WS G  L  +L+G   F          + I  IL+ + ++
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 117/239 (48%), Gaps = 27/239 (11%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 119
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAP 236
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K  L+    L+ +A
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 118/271 (43%), Gaps = 65/271 (23%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 116
           Y  +  +G GS+GVV  A   +T    AIK + ++K          R K  E++ M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYV------------------------------- 145
           HPN+  L   +     +DE Y+ LV+E                                 
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 146 -PETVHRVIK---HHYKMS----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 197
            PE     I    H ++ S    QR  LI       QI  AL Y+HN  G+CHRDIKP+N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLI--SNIMRQIFSALHYLHNQ-GICHRDIKPEN 198
Query: 198 LLVNPH-THQLKLCDFGSAKVLVKGEPNISY-----ICSRYYRAPELIFGATE-YTAAID 250
            L + + + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 251 IWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            WSAG +L  LL+G   FPG +  D + +++
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 64  TISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQ 110
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMPLIYVK 169
               L+HP +V++     + T    L   +V+EYV     R I H    M+ +  +  + 
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 227
                 C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++   
Sbjct: 124 ----DACQALNFSHQN-GIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 228 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
             I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 27/239 (11%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 119
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAP 236
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +         C    Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K  L+    L+ +A
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 122
           R +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            K   +S   ++   L L++E++P    R  ++  K  +R+  I +  Y  QIC+ + Y+
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLR--EYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRA 235
             T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ A
Sbjct: 134 -GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYA 188
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +   ++++ A D+WS G VL EL 
Sbjct: 189 PESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 162
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 163 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 218
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 219 SL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 35/228 (15%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNISYICSRYYRA 235
           H+   V HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  
Sbjct: 126 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G P F   +  +    I +V
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV 225

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 139 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 194
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 195 SL-TESKFSVASDVWSFGVVLYELF 218

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 28/248 (11%)
Query: 53  TIGGKNGQPKQTISYMAERV---------VGHGSFGVVFQAKCLETGEAVAIK----KVL 99
           ++  +NG+   +    AE +         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 100 QDKRYK-NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHY 157
           + K      E+  +R + H N+V+L+  + S    + LYL + L    E   R++ K  Y
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 158 KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL--CDFGSA 215
                  LI       Q+  A+ Y+H  +G+ HRD+KP+NLL      + K+   DFG +
Sbjct: 118 TEKDASTLIR------QVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLS 170
Query: 216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           K+  KG+   +   +  Y APE +     Y+ A+D WS G +   LL G P F  E+   
Sbjct: 171 KMEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSK 229
Query: 276 QLVEIIKV 283
              +I+K 
Sbjct: 230 LFEQILKA 237

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 120/233 (51%), Gaps = 25/233 (10%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK-----KVLQDKRYKNRELQTMRLLDH----P 118
           +V+G G++G VF  + +   +TG+  A+K      ++Q  +         ++L+H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +V+L + F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  A
Sbjct: 120 FLVTLHYAFQTETK-----LHLILDYINGGE---LFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAP 236
           L ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y AP
Sbjct: 172 LEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 237 ELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
           +++ G  + +  A+D WS G ++ ELL G   F  +   +   EI + IL +E
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 137
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 193
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 194 SL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVV 121
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +   F     +D   + +V+E     E + R++    +  + +   YV     Q+  AL
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNAL 137
Query: 180 AYIHNTIGVCHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           AY H+   V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y AP
Sbjct: 138 AYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           E+     + T   DIWSAG V+  LL G   F G S
Sbjct: 196 EVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 134
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 136
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 137 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 192
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 193 SL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 19/226 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +   T E VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +++EY    E   R+       + R      + +F Q+   ++Y H ++ 
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCH-SMQ 136
Query: 188 VCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 247 AAI-DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             I D+WS G  L  +L+G   F          + I+ IL  + S+
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 64  TISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQ 110
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMPLIYVK 169
               L+HP +V++     + T    L   +V+EYV     R I H    M+ +  +  + 
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 227
                 C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++   
Sbjct: 124 ----DACQALNFSHQN-GIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 228 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
             I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 130
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 131 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 187 SL-TESKFSVASDVWSFGVVLYELF 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 130 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 185
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 186 SL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 135
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 191
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 192 SL-TESKFSVASDVWSFGVVLYELF 215

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           R +G GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +DE  + +V++ +   +   +++H + +       VKL+  ++  AL Y+ 
Sbjct: 81  WYSF-----QDEEDMFMVVDLL---LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-- 241
           N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+     
Sbjct: 133 NQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQ 265
              Y+ A+D WS G    ELL G+
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 112/227 (49%), Gaps = 27/227 (11%)
Query: 64  TISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQ 110
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMPLIYVK 169
               L+HP +V++     + T    L   +V+EYV     R I H    M+ +  +  + 
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 227
                 C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++   
Sbjct: 124 ----DACQALNFSHQN-GIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 228 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 136 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 189
Query: 225 ISY----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 64  TISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYKNRELQ 110
           T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE Q
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQ 64
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMPLIYVK 169
               L+HP +V++     + T    L   +V+EYV     R I H    M+ +  +  + 
Sbjct: 65  NAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 227
                 C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++   
Sbjct: 124 ----DACQALNFSHQN-GIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 228 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
             I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 178 AVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 125 HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +S   ++   L L++EY+P  ++   ++ H   ++R+  I +  Y  QIC+ + Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQAH---AERIDHIKLLQYTSQICKGMEYL- 133
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAP 236
            T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ AP
Sbjct: 134 GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAP 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E +   ++++ A D+WS G VL EL 
Sbjct: 190 ESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM------- 112
            P+    YM  R +G G F   ++   ++T E  A K V +    K  + + M       
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE   +   + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE +     ++  +DIWS GC+L  LL+G+P F
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 19/226 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+C FG +K  V        + +  Y APE++    EY 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL-KKEYD 194
Query: 247 AAI-DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             + D+WS G  L  +L+G   F          + I  IL+ + ++
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +G G    V+ A+       VAIK +    R K        RE+     L H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 126 CFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                 E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI   + + H+
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QILDGIKHAHD 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIF 240
            + + HRDIKPQN+L++ +   LK+ DFG AK L   E +++     + +  Y +PE   
Sbjct: 130 -MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAK 185
Query: 241 G-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           G AT+     DI+S G VL E+L+G+P F GE+ V
Sbjct: 186 GEATD--ECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y APE++     Y ++ D +S GC+L +LL G   F
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 126
           +G G++GVV + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
            F   +     + + +E +  ++ +  K      Q +P   +      I +AL ++H+ +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGAT 243
            V HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            Y+   DIWS G  + EL + +  FP +S
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDS 259

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 72  VVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 129 STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                +      ++ +V E +  + +  IK +  +  R  L +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFR--LDHIRKMAYQICKSVNFLHS 136
Query: 185 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 223
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + + + +R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 284 I 284
           +
Sbjct: 250 L 250

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 20/224 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y+  + +G GSFG     K  E G    IK++       +++    RE+  +  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +  F    E   LY+  V++Y    +   R+      + Q   ++    +F QIC A
Sbjct: 86  VQYRESF---EENGSLYI--VMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLA 137
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPE 237
           L ++H+   + HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            I     Y    DIW+ GCVL EL   +  F   S  + +++II
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 248 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 297
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 298 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 354
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y APE++     Y ++ D +S GC+L +LL G   F
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 180
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 181 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 234
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 235 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 74
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 75  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T 
Sbjct: 126 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-TH 182
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGR 203

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM------- 112
            P+    YM  R +G G F   ++   ++T E  A K V +    K  + + M       
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE +     ++  +DIWS GC+L  LL+G+P F
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  A
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLA 186
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+    
Sbjct: 187 LDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPD---- 240
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 241 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM------- 112
            P+    YM  R +G G F   ++   ++T E  A K V +    K  + + M       
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 132
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE +     ++  +DIWS GC+L  LL+G+P F
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 61  PKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMR 113
           P    SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 15  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 72
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              H NVV + + +      DEL++  V+E++       I  H +M++      +     
Sbjct: 73  DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 232
            + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y
Sbjct: 124 AVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 181
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           + APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 182 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 116/228 (50%), Gaps = 24/228 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  + 
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SK 234
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
            Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 278

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y APE++     Y ++ D +S GC+L +LL G   F
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL---------- 115
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 116 -DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
            D P +V + + F  T +K    L+L+              HY +SQ        + FY 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y APE++     Y ++ D +S GC+L +LL G   F
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 115/228 (50%), Gaps = 22/228 (9%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT----MRLLDH 117
           ++T  +M   V+G G+F  VF  K   TG+  A+K + +   +++  L+     ++ + H
Sbjct: 8   RKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V+L+  + STT     YL + L    E   R+++      +   L+       Q+  
Sbjct: 66  ENIVTLEDIYESTTH---YYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS 117
Query: 178 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           A+ Y+H   G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C +  Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK 220

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 61  PKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMR 113
           P    SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 19  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 76
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              H NVV + + +      DEL++  V+E++       I  H +M++      +     
Sbjct: 77  DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 127
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 232
            + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y
Sbjct: 128 AVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 185
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           + APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 186 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 118/237 (49%), Gaps = 25/237 (10%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVV 121
           +V+G GSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 144 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
           +     ++ + D WS G ++ E+L G   F G+   + +  I+K  L     LS +A
Sbjct: 202 V-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEA 257

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 61  PKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMR 113
           P    SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 26  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 83
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              H NVV + + +      DEL++  V+E++       I  H +M++      +     
Sbjct: 84  DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 134
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 232
            + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y
Sbjct: 135 AVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 192
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           + APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 193 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 230

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 126
           +G G++GVV + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
            F   +     + + +E +  ++ +  K      Q +P   +      I +AL ++H+ +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGA 242
            V HRD+KP N+L+N    Q+K+CDFG +  LV     +I   C + Y APE I      
Sbjct: 130 SVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQ 187
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             Y+   DIWS G  + EL + +  FP +S
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR--FPYDS 215

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM------- 112
            P+    YM  R +G G F   ++   ++T E  A K V +    K  + + M       
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE +     ++  +DIWS GC+L  LL+G+P F
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 26/240 (10%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD-HPNVVSL 123
           + ++ +G GSF +  +    ++ +A A+K +   KR +    +E+  ++L + HPN+V L
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F      D+L+  LV+E +   E   R+ K  +        I  KL       A+++
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL-----VSAVSH 121
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
           +H+ +GV HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVILHTEISLSIKA 295
           +     Y  + D+WS G +L  +L GQ  F            VEI+K I   + S   +A
Sbjct: 181 L-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 233
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 278

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 61  PKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMR 113
           P    SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 24  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 81
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              H NVV + + +      DEL++  V+E++       I  H +M++      +     
Sbjct: 82  DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 132
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 232
            + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y
Sbjct: 133 AVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 190
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           + APELI     Y   +DIWS G ++ E++ G+P +  E
Sbjct: 191 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 228

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 108 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 213
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 258

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 61  PKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMR 113
           P    SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 69  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 126
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              H NVV + + +      DEL++  V+E++       I  H +M++      +     
Sbjct: 127 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 177
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 232
            + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y
Sbjct: 178 AVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 235
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           + APELI     Y   +DIWS G ++ E++ G+P +
Sbjct: 236 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 24/228 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SK 213
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
            Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 24/228 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SK 213
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
            Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 61  PKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMR 113
           P    SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 146 PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 203
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              H NVV + + +      DEL++  V+E++       I  H +M++      +     
Sbjct: 204 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 254
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 232
            + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y
Sbjct: 255 AVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 312
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           + APELI     Y   +DIWS G ++ E++ G+P +
Sbjct: 313 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 39/241 (16%)
Query: 72  VVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 129 STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                +      ++ +V E +  + +  IK +  +  R  L +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFR--LDHIRKMAYQICKSVNFLHS 136
Query: 185 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 223
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + + +  R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 284 I 284
           +
Sbjct: 250 L 250

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 132
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 TKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 189 SL-TESKFSVASDVWSFGVVLYELF 212

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
                Y+ A+D WS G +   LL G P F  E+      +I+K 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 233

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 21/230 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 81  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           T +   +D+W AG +  E L+G P F   S  +    I+ V L     LS
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 23/229 (10%)
Query: 65  ISYMAERV--VGHGSFGVVF--QAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLD 116
           +S M +RV  +G G++G V   + K      A+ I +        N     E+  ++LLD
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLE-YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           HPN++ L + FF    +D+    LV+E Y    +   I H  K ++    + +K    Q+
Sbjct: 95  HPNIMKL-YDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK----QV 145
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYY 233
              + Y+H    + HRD+KP+NLL+        +K+ DFG + V    +     + + YY
Sbjct: 146 LSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYY 204
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            APE++    +Y    D+WS G +L  LL G P F G++  + L ++ K
Sbjct: 205 IAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 29/240 (12%)
Query: 42  NGTEAGHIIVTTIGGKNGQPK-QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ 100
           +G + G++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 101 DKRYKNRELQTMRLLDHPNVVSLKH-------CFFSTTEKDELYLNLVLEYVPETVHRVI 153
            +R  N+E +  R+L   +VV   H       CF +     ++++   +E +     ++ 
Sbjct: 59  -RRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLK 114
Query: 154 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           K   +M   +P   +      I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG
Sbjct: 115 K---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFG 170
Query: 214 SAKVLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFP 269
            +  LV  +          Y APE I        +Y    D+WS G  L EL  GQ  FP
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 94  EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 146 -SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 200 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 244

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 102 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 154 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 252

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 21/230 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 80  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           T +   +D+W AG +  E L+G P F   S  +    I+ V L     LS
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 117/233 (50%), Gaps = 20/233 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------LLDHPNVVSLK 124
           ++G GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + F     +D  Y+ LVLE      ++R +K+  K          + + +QI   + Y+H
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGA 242
           +  G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   
Sbjct: 130 SH-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
           + +    D+WS GC+   LL+G+P F  ++  + L +++         LSI+A
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA 239

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 18/232 (7%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  A    T E  AIK + +D   ++ +++        + LLD P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T ++    L  V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 86  HSCFQTVDR----LYFVMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISIGLFFLHK 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I    
Sbjct: 139 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AYQ 195
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
            Y  ++D W+ G +L E+L GQP F GE   +    I++  +    SLS +A
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 247

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 118/234 (50%), Gaps = 24/234 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII--KVILHTEISLSIK 294
             Y  A+D W+ G ++ E+  G P F  +  +    +I+  KV   +  S  +K
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLK 266

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 19/226 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  +  E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYAH-AMQ 135
Query: 188 VCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           V HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++    EY 
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL-KKEYD 194
Query: 247 AAI-DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             + D+WS G  L  +L+G   F          + I  IL+ + ++
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ ++  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYQMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 37/214 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           V+G G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 128 FSTTEKDELYLNLVLEYVP-ETVHRVIK---HHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                KD+  LN + EY+   T+  +IK     Y  SQR+       +   I   +AY+H
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS------FAKDIASGMAYLH 125
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEP-------------NISYI 228
            ++ + HRD+   N LV      + + DFG A+++V  K +P               + +
Sbjct: 126 -SMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
            + Y+ APE+I G + Y   +D++S G VL E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
                Y+ A+D WS G +   LL G P F  E+      +I+K 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 233

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
                Y+ A+D WS G +   LL G P F  E+      +I+K 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 233

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 24/235 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 119
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L   F    +K   YL + +    E    +I     + Q+   +   +   Q+    
Sbjct: 66  IMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGT 117
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE
Sbjct: 118 TYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           ++    +Y    D+WS G +L  LL G P F G++  DQ  EI+K +   + S  
Sbjct: 177 VL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRVEKGKFSFD 225

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
                Y+ A+D WS G +   LL G P F  E+      +I+K 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 233

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 116/229 (50%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +  Y AP +I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 26/241 (10%)
Query: 63  QTISYMAERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMR 113
           Q +S   +RV  +G G++G V   K   TG   AIK + +              E+  ++
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            LDHPN++ L   F    +K   YL + +    E    +I     + Q+   +   +   
Sbjct: 77  QLDHPNIMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMK 128
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSR 231
           Q+     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + 
Sbjct: 129 QVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 187
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           YY APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI+K +   + S 
Sbjct: 188 YYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRVEKGKFSF 241
Query: 292 S 292
Sbjct: 242 D 242

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVV--SLKHCF- 127
           +V+G GSFG V  A+  +  E     KVLQ K    ++ +   ++   NV+  ++KH F 
Sbjct: 44  KVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFL 101
Query: 128 ----FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
               FS    D+LY   VL+Y+   E  + + +    +  R      + Y  +I  AL Y
Sbjct: 102 VGLHFSFQTADKLYF--VLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALGY 154
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE + 
Sbjct: 155 LH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 32/223 (14%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--------NRELQTMRLLDHPNVV 121
           E ++G G FG V++A     G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 122 SLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L+          E  L LV+E+     ++RV+       +R+P   +  +  QI R + 
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 181 YIHN--TIGVCHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
           Y+H+   + + HRD+K  N+L+       +     LK+ DFG A+   +    +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAY 178
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
            + APE+I  A+ ++   D+WS G +L ELL G+  F G  G+
Sbjct: 179 AWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH 117
           QP++    + +  +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           P+VV     +F  T+     L +V+EY    +V  +I+   K      +  +        
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI---LQSTL 135
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRYYRA 235
           + L Y+H    + HRDIK  N+L+N   H  KL DFG A  L       +  I + ++ A
Sbjct: 136 KGLEYLHFMRKI-HRDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           PE+I     Y    DIWS G    E+  G+P +
Sbjct: 194 PEVI-QEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 116/229 (50%), Gaps = 26/229 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K+ ++   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C +    APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVRF 257

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ 265
                +   +D+WS G VL  +L G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ 265
                +   +D+WS G VL  +L G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ 265
                +   +D+WS G VL  +L G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ 265
                +   +D+WS G VL  +L G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ 265
                +   +D+WS G VL  +L G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           Y+  + +G G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 123 L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L  +C      K E +L L   +   T+   I+        +    +      ICR L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKG-------EPNISYICSR 231
           IH   G  HRD+KP N+L+     Q  L D GS   A + V+G       +   +  C+ 
Sbjct: 150 IHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 232 YYRAPELIFGATEYTA---AIDIWSAGCVLAELLLGQ 265
            YRAPEL F    +       D+WS GCVL  ++ G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 122
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           LK  +      D  Y+ +V E +   E + ++++  +  S+R          + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKF-FSERE----ASAVLFTITKTVE 130
Query: 181 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           APE +     Y AA DIWS G +L  +L G   F      D   EI+  I   + SLS
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLS 243

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 67
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 68  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 120 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 215

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 22/238 (9%)
Query: 61  PKQTISYMAERV-----VGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQ--- 110
           P+Q   + AE +     +G G++G V +     +G+ +A+K++    D++ + + L    
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLD 72
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYV 168
             MR  D P +V      F   +       + +E +  +  +  K+ Y  +   +P   +
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
                   +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  LV         
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 229 CSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK 282
             R Y APE I  +     Y    D+WS G  L EL  G+  +P  + V DQL +++K
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 109/238 (45%), Gaps = 24/238 (10%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 122
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           LK  +      D  Y+ +V E     E + ++++  +  S+R          + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKF-FSERE----ASAVLFTITKTVE 130
Query: 181 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           APE +     Y AA DIWS G +L   L G   F      D   EI+  I   + SLS
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTGYTPF-ANGPDDTPEEILARIGSGKFSLS 243

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 19  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 78  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 129
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 242
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 243 TEYTAAIDIWSAGCVLAELLLGQP 266
           T Y    DIWS G  L E+   +P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 27  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 86  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 137
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 242
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 243 TEYTAAIDIWSAGCVLAELLLGQP 266
           T Y    DIWS G  L E+   +P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      N   + ++      Y APE
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 177
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQ 265
           L+     +   +D+WS G VL  +L G+
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQ 265
           L+     +   +D+WS G VL  +L G+
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF--- 128
           ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 129 ---STTEKDELY-----LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
               T+ K+        L + +E+  + T+ + I+   +  +++  +     F QI + +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGV 135
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE I
Sbjct: 136 DYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 240 FGATEYTAAIDIWSAGCVLAELL 262
             + +Y   +D+++ G +LAELL
Sbjct: 194 -SSQDYGKEVDLYALGLILAELL 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+    +L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINAMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G+ G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKNRELQTMRLLDHPNVV 121
           YM    +G G FG+V   +C+ET       A  +K    D+    +E+  + +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L   F S  E     L ++ E++   +   R+    +++++R  + YV    +Q+C AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 180 AYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
            ++H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           +      + A D+WS G ++  LL G   F  E+   Q++E I
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI 215

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           L+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE 216

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           L+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++     LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           L+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----- 112
           N   K + +Y  +  +G G+F VV +     TG   A K ++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREAR 80
Query: 113 --RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVK 169
             R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I   
Sbjct: 81  ICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 135
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 227
               QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +
Sbjct: 136 ----QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
             +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E
Sbjct: 191 AGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 129
           ++G G FG VF+AK    G+   I++V  +     RE++ +  LDH N+V    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 130 ---TTEKDELYLNLVLEYVPETVHRVIKHHYK---------------------MSQRMPL 165
               T  D L  +   +Y PE      +   K                       +++  
Sbjct: 79  YDPETSDDSLESS---DYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           +     F QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L       
Sbjct: 136 VLALELFEQITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRT 193
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               +  Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 194 RSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +    E     L +++E++       I    ++++      +      + +ALAY+H   
Sbjct: 111 YLVGEE-----LWVLMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHAQ- 160
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P    +  + Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
              +DIWS G ++ E++ G+P +  +S V  +
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 130/278 (46%), Gaps = 44/278 (15%)
Query: 24  NDMKIRDDKEME---ATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAE----RVVGHG 76
           + +K ++++EM+    +  D +G E   + +        +PK  ++ M E    +++G G
Sbjct: 111 DGLKKQEEEEMDFRSGSPSDNSGAEEMEVSL-------AKPKHRVT-MNEFEYLKLLGKG 162
Query: 77  SFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +FG V   K   TG   A+K + ++             +NR LQ  R   HP + +LK+ 
Sbjct: 163 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYS 219
Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F  T ++    L  V+EY    E    + +       R      + Y  +I  AL Y+H+
Sbjct: 220 F-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALDYLHS 269
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
              V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +    
Sbjct: 270 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 327
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 364

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G G++GVV + + + +G+  A+K++   +   N + Q   L D         C F+ T 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI---RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 133 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              L+    + +  E    ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATE 244
            HRD+KP N+L+N    Q+K CDFG +  LV     +I   C + Y APE I        
Sbjct: 159 IHRDVKPSNVLIN-ALGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQKG 216
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGES 272
           Y+   DIWS G    EL + +  FP +S
Sbjct: 217 YSVKSDIWSLGITXIELAILR--FPYDS 242

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG   A+K + ++             +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 120
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 180 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG   A+K + ++             +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 121
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG   A+K + ++             +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 122
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 182 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 223

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 27/228 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 22/234 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    +   +YL   L    E + ++++  +  S+R          + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKF-FSERE----ASFVLHTIGKTVEYLHSQ 140
Query: 186 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVILHTEISLS 292
                Y    DIWS G +L  +L G  P   G S  D   EI+  I   + +LS
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSGKFTLS 248

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 22/234 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    +   +YL   L    E + ++++  +  S+R          + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKF-FSERE----ASFVLHTIGKTVEYLHSQ 140
Query: 186 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVILHTEISLS 292
                Y    DIWS G +L  +L G  P   G S  D   EI+  I   + +LS
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSGKFTLS 248

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--ELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--T 185
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 72  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 181
Query: 246 TAAIDIWSAGCVLAELLLGQPLF 268
           +   D++S G +L E++  +  F
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPF 204

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQICR 177
           S    + S   KDEL+L + L     +V  +IKH     +    +     +     ++  
Sbjct: 72  SY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSR 231
            L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ + 
Sbjct: 128 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            + APE++     Y    DIWS G    EL  G
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQICR 177
           S    + S   KDEL+L + L     +V  +IKH     +    +     +     ++  
Sbjct: 77  SY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSR 231
            L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ + 
Sbjct: 133 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            + APE++     Y    DIWS G    EL  G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--ELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--T 185
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 71  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 180
Query: 246 TAAIDIWSAGCVLAELLLGQPLF 268
           +   D++S G +L E++  +  F
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPF 203

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVS 122
           IS+  + V+GHG+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                +  TEKD  +  + +E    T+   ++   K    + L  + L   Q    LA++
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQ--KDFAHLGLEPITL-LQQTTSGLAHL 134
Query: 183 HNTIGVCHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNISYIC----SRYYR 234
           H ++ + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  + 
Sbjct: 135 H-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 235 APELIFGATEY--TAAIDIWSAGCVL 258
           APE++    +   T  +DI+SAGCV 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVF 219

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG   A+K + ++             +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 260
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 361

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 27/228 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 27/228 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 226

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 115/224 (51%), Gaps = 41/224 (18%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 123 LKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
             +C  S T    LY+     NL L+ + E+ + V   + K+ +    I +     QI  
Sbjct: 92  Y-YC--SETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL---LRQIAS 144
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 226 SYICSRY-----YRAPELIFGATE--YTAAIDIWSAGCVLAELL 262
               +       +RAPEL+  +T+   T +IDI+S GCV   +L
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 27/228 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 115/224 (51%), Gaps = 41/224 (18%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 123 LKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
             +C  S T    LY+     NL L+ + E+ + V   + K+ +    I +     QI  
Sbjct: 92  Y-YC--SETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL---LRQIAS 144
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 226 SYICSRY-----YRAPELIFGATE--YTAAIDIWSAGCVLAELL 262
               +       +RAPEL+  +T+   T +IDI+S GCV   +L
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E 
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 61  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 111
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 112 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 170
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E 
Sbjct: 171 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E 
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+F VV +   +  G+  A K +       +D +   RE +  RLL HPN+V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             S +E+   YL   L    E    ++ + +Y  +     I       QI  A+ + H  
Sbjct: 89  --SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ- 139
Query: 186 IGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 241
           +GV HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +  
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLR 197
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
              Y   +D+W+ G +L  LL+G P F  E 
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDED 228

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 27/228 (11%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 226

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +  K C     EK    L LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H+   + HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLHSQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 185 FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  
Sbjct: 114 ESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E
Sbjct: 172 YLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDE 209

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 107 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 160
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 161 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 218
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 94  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 147
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 148 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 205
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
             +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
             +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  
Sbjct: 114 ESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E 
Sbjct: 172 YLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDED 210

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
             +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
             +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 33/210 (15%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           R +G G FG V    +      TGE VA+K +  D   ++R     E+  +R L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K C     +     L LV+EYVP    R  + +H   ++Q +      L+  QIC  +
Sbjct: 97  KYKGC---CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEGM 147
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRY 232
           AY+H    + HRD+  +N+L++ +   +K+ DFG AK + +G       E   S +   +
Sbjct: 148 AYLHAQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---F 202
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           + APE +     Y A+ D+WS G  L ELL
Sbjct: 203 WYAPECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 52/302 (17%)
Query: 13  TVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERV 72
           + GVD   E +    ++  K    +V D    + GH+ V  IG           ++ ER 
Sbjct: 8   SSGVDLGTENLYFQSMQSSKRSSRSVEDD---KEGHL-VCRIG----------DWLQERY 53
Query: 73  -----VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 124
                +G G+FG V   +CL+       VA+K +    +Y+      + +L        +
Sbjct: 54  EIVGNLGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKE 111
Query: 125 HCFFSTTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + F      D      ++ +  E + +     +K +    Q  PL +V+   YQ+C AL 
Sbjct: 112 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALR 169
Query: 181 YIHNTIGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGE 222
           ++H    + H D+KP+N+L          N H            +++ DFGSA      E
Sbjct: 170 FLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHE 226
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K
Sbjct: 227 HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 283 VI 284
           ++
Sbjct: 286 IL 287

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ----DKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+FGVV   +C+E  TG     K +      DK     E+  M  L HP +++L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 185 TIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              + H DIKP+N++        +K+ DFG A  L   E       +  + APE++    
Sbjct: 168 H-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DRE 225
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
                 D+W+ G +   LL G   F GE  ++ L  +
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +  K C     EK    L LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H    + HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 185 FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
            N+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  SNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            A+ + H  +GV HRD+KP+NLL+        +KL DFG A + V+G+      +  +  
Sbjct: 114 EAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           Y +PE +     Y   +DIW+ G +L  LL+G P F  E 
Sbjct: 172 YLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 44/250 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 282 KVILHTEISL 291
           K +    I  
Sbjct: 239 KKLRSVSIEF 248

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 132
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 133 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +     +   L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 130 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---------NPHTH------ 205
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 206 ---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC+L E  
Sbjct: 186 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYY 242
Query: 263 LGQPLFPGESGVDQLVEIIKVI 284
            G  LF      + LV + K++
Sbjct: 243 RGFTLFQTHENREHLVMMEKIL 264

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 44/250 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 282 KVILHTEISL 291
           K +    I  
Sbjct: 239 KKLRSVSIEF 248

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 145
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 146 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 133
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 134 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---------NPHTH------ 205
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 206 ---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC+L E  
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYY 233
Query: 263 LGQPLFPGESGVDQLVEIIKVI 284
            G  LF      + LV + K++
Sbjct: 234 RGFTLFQTHENREHLVMMEKIL 255

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 88  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 141 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 197
Query: 245 YTAAIDIWSAGCVLAELLLGQPLF 268
           ++  +D+WS GC++  LL+G+P F
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 235
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +  +  Y A+ D+WS G  L ELL
Sbjct: 198 PECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 245 YTAAIDIWSAGCVLAELLLGQPLF 268
           ++  +D+WS GC++  LL+G+P F
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 24/236 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 123
           +V+G G+F  V   K  +TG+  A+K + +    K  E+   R         D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F     +DE YL LV+EY       ++    K  +R+P    + Y  +I  A+  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFG 241
             +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 R-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 242 ATEYTAAI------DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
                         D W+ G    E+  GQ  F  +S  +   +I+    H  + L
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 245 YTAAIDIWSAGCVLAELLLGQPLF 268
           ++  +D+WS GC++  LL+G+P F
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 114/228 (50%), Gaps = 45/228 (19%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 123 LKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
             +C  S T    LY+     NL L+ + E+ + V   + K+ +    I +     QI  
Sbjct: 74  Y-YC--SETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL---LRQIAS 126
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ + 
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 226 SYICSRY-----YRAPELIFGAT------EYTAAIDIWSAGCVLAELL 262
               +       +RAPEL+  +         T +IDI+S GCV   +L
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 127
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 235
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 128 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +  +  Y A+ D+WS G  L ELL
Sbjct: 186 PECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 23/234 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F+     D   + L+LEY P  E    + K      QR   I       ++  AL Y
Sbjct: 89  YNYFY-----DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATI-----MEELADALMY 138
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H    V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CHGK-KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIKA 295
              +   +D+W  G +  ELL+G P F   S  +    I+KV L    S+   A
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGA 248

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T ++    L  V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I    
Sbjct: 140 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 196
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 48/259 (18%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC-LETG--EAVAIKKVLQDKR--YKNRELQTMRLL 115
           P+ +  +  E  +G G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 116 D-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
               NV+ +K+CF     +   ++ + + Y+       I +     +      V+ Y   
Sbjct: 77  GGQDNVMGVKYCF-----RKNDHVVIAMPYLEHESFLDILNSLSFQE------VREYMLN 125
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----------VLVKGEP- 223
           + +AL  IH   G+ HRD+KP N L N    +  L DFG A+            V+ E  
Sbjct: 126 LFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 224 ------NISYIC-SRY-----------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
                 N   IC SR            +RAPE++      T AID+WSAG +   LL G+
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 266 -PLFPGESGVDQLVEIIKV 283
            P +     +  L +I+ +
Sbjct: 245 YPFYKASDDLTALAQIMTI 263

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 24  KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 83  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 136
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 137 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 194
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 20/223 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 113
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 114 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            +  +R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 45/228 (19%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 123 LKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
             +C  S T    LY+     NL L+ + E+ + V   + K+ +    I +     QI  
Sbjct: 74  Y-YC--SETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL---LRQIAS 126
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 226 SYICSRY-----YRAPELIFGAT------EYTAAIDIWSAGCVLAELL 262
               +       +RAPEL+  +         T +IDI+S GCV   +L
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 112
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKL 170
             ++   VVSL + + +   KD L L L L    +     +K H Y M Q   P      
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGD-----LKFHIYHMGQAGFPEARAVF 290
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y  +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +
Sbjct: 291 YAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGT 348
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y APE++     YT + D W+ GC+L E++ GQ  F
Sbjct: 349 VGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 108 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 161 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 217
Query: 245 YTAAIDIWSAGCVLAELLLGQPLF 268
           ++  +D+WS GC++  LL+G+P F
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 64  TISYMAERVVGHGSFGVVFQA-KCLETGEAVAI-----KKVLQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +  K L   E  A+     K   +D +   RE +  RLL H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 70  PNIVRLHD---SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 120
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            A+ + H  +GV HR++KP+NLL+        +KL DFG A + V+GE      +  +  
Sbjct: 121 EAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPG 178
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E 
Sbjct: 179 YLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 106 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 159 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 215
Query: 245 YTAAIDIWSAGCVLAELLLGQPLF 268
           ++  +D+WS GC++  LL+G+P F
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLG 264
           PE I     +  +  +WS G +L +++ G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 112
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKL 170
             ++   VVSL + + +   KD L L L L    +     +K H Y M Q   P      
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGD-----LKFHIYHMGQAGFPEARAVF 290
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y  +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +
Sbjct: 291 YAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGT 348
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y APE++     YT + D W+ GC+L E++ GQ  F
Sbjct: 349 VGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 73  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 178
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 179 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 74  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 179
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 180 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQDKRYKN------RELQTMRLLDHP 118
           Y+   ++G GS+G V +    ET    AV I K  + +R  N      +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NV+ L    ++  EK ++Y+  V+EY    +  ++       +R P+     YF Q+   
Sbjct: 67  NVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 235
           L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 236 PELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGES 272
           PE+  G   ++   +DIWSAG  L  +  G   F G++
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           PE I     +  +  +WS G +L +++ G   F
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +      E  L +++E+      + V   ++     SQ      +++   Q   AL Y+H
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAVMLELERPLTESQ------IQVVCKQTLDALNYLH 152
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
           +   + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   
Sbjct: 153 DN-KIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 243 TE----YTAAIDIWSAGCVLAELLLGQP 266
           T     Y    D+WS G  L E+   +P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           PE I     +  +  +WS G +L +++ G   F
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 408 HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I    
Sbjct: 461 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 517
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +      E  L +++E+      + V   ++     SQ      +++   Q   AL Y+H
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAVMLELERPLTESQ------IQVVCKQTLDALNYLH 152
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
           +   + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   
Sbjct: 153 DN-KIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 243 TE----YTAAIDIWSAGCVLAELLLGQP 266
           T     Y    D+WS G  L E+   +P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 67
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 68  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 123 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           PE I     +  +  +WS G +L +++ G   F
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K  + + M       R L H +VV   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 82  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 135 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 191
Query: 245 YTAAIDIWSAGCVLAELLLGQPLF 268
           ++  +D+WS GC++  LL+G+P F
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 62  KQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           ++ + +M  +  VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +
Sbjct: 54  REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRI 112
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L         ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L
Sbjct: 113 VPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGL 163
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------Y 233
            Y+H T  + H D+K  N+L++    +  LCDFG A  L       S +   Y      +
Sbjct: 164 EYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            APE++ G     A +DIWS+ C++  +L G
Sbjct: 223 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 252

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 113/247 (45%), Gaps = 35/247 (14%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +++  R +G G+FG V   + ++  +  A+K V   K+Y         +L       + +
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 126 CFFSTTEKDELYLN---LVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
                     +Y +   L+ E +  +++ +I +++Y       +  +KLY  +I +AL Y
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNY 152
Query: 182 IHNTIGVCHRDIKPQNLLVN-PHTHQ-----------------------LKLCDFGSAKV 217
           +   + + H D+KP+N+L++ P+  +                       +KL DFG A  
Sbjct: 153 LRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
             K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF     ++ L
Sbjct: 212 --KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 278 VEIIKVI 284
             +  +I
Sbjct: 269 AMMESII 275

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQT-MRLLDHPNVVSLKH 125
           +GHGS+G VF+ +  E G   A+K+ +      +D+  K  E+ +  ++  HP  V L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    E   LYL   L         + +H       +P   V  Y      ALA++H+ 
Sbjct: 125 AW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNISYICSRYYRAPE 237
            G+ H D+KP N+ + P   + KL DFG         A  + +G+P         Y APE
Sbjct: 177 -GLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPE 226
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           L+ G+  Y  A D++S G  + E+     L  G  G  QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 62  KQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           ++ + +M  +  VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +
Sbjct: 70  REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRI 128
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L         ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L
Sbjct: 129 VPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGL 179
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------Y 233
            Y+H T  + H D+K  N+L++    +  LCDFG A  L       S +   Y      +
Sbjct: 180 EYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            APE++ G     A +DIWS+ C++  +L G
Sbjct: 239 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 268

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKV-LQDKRYKNRELQTMRLL 115
           T  Y     +G G+F VV   +C++         + +  KK+  +D +   RE +  RLL
Sbjct: 30  TDDYQLFEELGKGAFSVV--RRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQ 174
            HPN+V L     S +E+   YL   L    E    ++ + +Y  +     I+      Q
Sbjct: 88  KHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH------Q 138
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICS 230
           I  ++ +IH    + HRD+KP+NLL+        +KL DFG A + V+GE      +  +
Sbjct: 139 ILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGT 196
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             Y +PE +     Y   +DIW+ G +L  LL+G P F  E 
Sbjct: 197 PGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDED 237

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 73  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 122
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 123 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 222

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 17/220 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDEDFAKEFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            + YY +PE +     Y    DIWS GC+L EL    P F
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 217

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 176 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 234
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 235 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 275

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 217

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 229 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 70
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 71  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 120
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 121 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 179 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 220

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 125 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 183
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 184 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 224

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI 217

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 131 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 189
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 190 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 230

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 130 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 188
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 189 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 229

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMR------LLDHPNVVSL 123
           +G G FGVVF+AK        AIK++    R  NREL   + MR       L+HP +V  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 124 KHCFF--STTEK-----DELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
            + +   +TTEK      ++YL + ++    E +   +     + +R   + + + F QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI-FLQI 127
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISY- 227
             A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 228 -----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
                + ++ Y +PE I G + Y+  +DI+S G +L ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 132 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 190
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 191 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 231

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 182
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 62  KQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           ++ + +M  +  +G GSFG V + K  +TG   A+KKV + + ++  EL     L  P +
Sbjct: 68  REEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRI 126
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L         ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L
Sbjct: 127 VPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGL 177
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------Y 233
            Y+H T  + H D+K  N+L++    +  LCDFG A  L       S +   Y      +
Sbjct: 178 EYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
            APE++ G     A +DIWS+ C++  +L G
Sbjct: 237 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 266

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 140 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 199 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 239

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
              VV LK                E+ + ++ L+LE +   + +   I     + + +  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILERMEPVQDLFDFITERGALQEEL-- 115
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 116 --ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            +  +R Y  PE I     +  +  +WS G +L +++ G   F
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM 112
            G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  +
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 113 RL-------LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRM 163
            L       ++H N++ +   F     +++ +  LV+E       +   I  H ++ +  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-- 129
Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
           PL      F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+ 
Sbjct: 130 PL--ASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKL 185
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             ++  +  Y APE++ G       +++WS G  L  L+  +  F
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+     L +++EY+       +     + +      +     +I + L Y+H+   
Sbjct: 95  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQ----IATILREILKGLDYLHSEKK 145
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK             + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY 182
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D+WS G ++  LL G P F    G+
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 245 --YTAAIDIWSAGCVLAELLLGQP 266
             Y    D+WS G  L E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD---------- 116
           Y    ++G G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 117 ---------HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
                    HP V+ L   F    E  E ++ LVLE  P     +  +   ++++ PL  
Sbjct: 88  LWKVGAGGGHPGVIRLLDWF----ETQEGFM-LVLER-PLPAQDLFDY---ITEKGPLGE 138
Query: 168 --VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS   L+  EP  
Sbjct: 139 GPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL 285
            +  +R Y  PE I     +     +WS G +L +++ G    P E   DQ  EI++  L
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD--IPFER--DQ--EILEAEL 250
Query: 286 H 286
           H
Sbjct: 251 H 251

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+     L +++EY+       +     + +      +     +I + L Y+H+   
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQ----IATILREILKGLDYLHSEKK 125
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 182
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 22/225 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 123
           +V+G G+FG V   K     +  A+K + + +  K  E    R         D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +D+  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 140 HYAF-----QDDNNLYLVMDYY--VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI-- 239
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 193 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 240 --FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              G   Y    D WS G  + E+L G+  F  ES V+   +I+ 
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTM-RLLDHPNVVS 122
           +   ++G G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F     +D+    LV E +   ++   I+     ++R     V+     +  AL +
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVR----DVAAALDF 126
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNISYIC-SR 231
           +H T G+ HRD+KP+N+L         +K+CDF  GS   L         P ++  C S 
Sbjct: 127 LH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 232 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
            Y APE++      AT Y    D+WS G VL  +L G P F G  G D
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGAD 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 127
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 128 FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 146
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 240
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 147 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 203
Query: 241 ----GATEYTAAIDIWSAGCVLAELLLGQP 266
                AT Y    D+WS G    E+  G P
Sbjct: 204 DENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+     L +++EY+       +     + +      +     +I + L Y+H+   
Sbjct: 90  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQ----IATILREILKGLDYLHSEKK 140
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 141 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 197
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 198 SKADIWSLGITAIELARGEP 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+     L +++EY+       +     + +      +     +I + L Y+H+   
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQ----IATILREILKGLDYLHSEKK 125
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 182
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 20/228 (8%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 131 T----EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 154 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 210
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 240
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE 288
           G  +Y    D WS G  + E+L G+  F  ES    LVE    I++ E
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHE 313

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 32/212 (15%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G+F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHH---YKMSQRMPLIYVKLYFYQICR 177
           L   + S        L +V E++   +    ++K     +  S+ +   Y++    QI  
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QILE 141
Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRY 232
           AL Y H+   + HRD+KP+N+L+    ++  +KL DFG A  L  GE  +     + + +
Sbjct: 142 ALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPH 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
           + APE++     Y   +D+W  G +L  LL G
Sbjct: 199 FMAPEVV-KREPYGKPVDVWGCGVILFILLSG 229

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 131 T----EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 138 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 194
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 240
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           +E+  ++ LDHPNVV L        E D LY+  V E V +     +     +S+     
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNE-DHLYM--VFELVNQGPVMEVPTLKPLSEDQ--- 138
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
             + YF  + + + Y+H    + HRDIKP NLLV    H +K+ DFG +      +  +S
Sbjct: 139 -ARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDALLS 195
Query: 227 -YICSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGE 271
             + +  + APE +    +  +  A+D+W+ G  L   + GQ  F  E
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 209
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++       LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +D+WS+ C++  +L G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y APE + G  +Y  + D WS G +   LL G P F    G+
Sbjct: 229 YVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL 269

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 70/139 (50%), Gaps = 22/139 (15%)
Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---------------- 207
           P+  V+   +Q+C+A+ ++H+   + H D+KP+N+L     ++L                
Sbjct: 135 PIHQVRHMAFQLCQAVKFLHDN-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKST 193
Query: 208 --KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
             ++ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  +G 
Sbjct: 194 AVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGF 250
Query: 266 PLFPGESGVDQLVEIIKVI 284
            LF      + L  + +++
Sbjct: 251 TLFQTHDNREHLAMMERIL 269

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 62/116 (53%), Gaps = 17/116 (14%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 224
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 225 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 28/225 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 178 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 234
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +S   +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 235 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGE 271
            P++   A        +Y A +D+WS G        G  P  P E
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
           R Y  PE I     +  +  +WS G +L +++ G
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 109/250 (43%), Gaps = 44/250 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L +  EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HR++KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEX-----IYPFSTGXER-VNIL 238
Query: 282 KVILHTEISL 291
           K +    I  
Sbjct: 239 KKLRSVSIEF 248

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVS-ATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 143
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 144 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 203 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 247

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 122
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 123 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 182 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 129
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 190
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++       LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +D+WS+ C++  +L G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 79  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 131 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 185
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 186 SI-NFRRFTSASDVWMFGVCMWEILM 210

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 104 L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 156 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 210
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 211 SI-NFRRFTSASDVWMFGVCMWEILM 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 65  ISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDKRYKNRELQTMR-LLDHPNVVS 122
           +S +  R V H + G  F  K +E T E ++ +++ + +    RE   +R +  HP++++
Sbjct: 106 VSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + S++     ++ LV + + +  +   +     +S++      +     +  A+++
Sbjct: 165 LIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEK----ETRSIMRSLLEAVSF 215
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y APE++  
Sbjct: 216 LHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 242 ATE-----YTAAIDIWSAGCVLAELLLGQPLF 268
           + +     Y   +D+W+ G +L  LL G P F
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 81  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 132
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 133 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 188 SI-NFRRFTSASDVWMFGVCMWEILM 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 184
            F         L++V EY+   +++R++ H     +++         Y + + + Y+HN 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPEL 238
              + HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + APE+
Sbjct: 157 NPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEV 210
Query: 239 IFGATEYTAAIDIWSAGCVLAEL-LLGQP 266
           +        + D++S G +L EL  L QP
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 78  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 130 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 184
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 185 SI-NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 73  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 125 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 179
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 180 SI-NFRRFTSASDVWMFGVCMWEILM 204

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG V++     T E VAIK +       +     +E+  +   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
             +T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 87  LKSTK-----LWIIMEYLGGG------SALDLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 136 RKI-HRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 192
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y    DIWS G    EL  G+P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 178 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 234
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +    +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYL 182
Query: 235 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGE 271
            P++   A        +Y A +D+WS G        G  P  P E
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/315 (26%), Positives = 125/315 (39%), Gaps = 78/315 (24%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGK-NGQPKQTISYMAERVVGHGSF 78
           PE+  ++   DD E E    D N    G   +  IG   NG+      Y   R +G G F
Sbjct: 1   PEQEEEILGSDDDEQE----DPNDYCKGGYHLVKIGDLFNGR------YHVIRKLGWGHF 50
Query: 79  GVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHPN---VVSLKHCF 127
             V+ +  ++  + VA+K V   + Y    L  +RLL        + PN   VV L   F
Sbjct: 51  STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110
Query: 128 FSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
              +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q+ + L Y+H   
Sbjct: 111 -KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKC 166
Query: 187 GVCHRDIKPQNL------------------------------------------LVNP-- 202
            + H DIKP+N+                                          LVNP  
Sbjct: 167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226
Query: 203 ----HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
                  ++K+ D G+A  + K       I +R YR+ E++ G+  Y    DIWS  C+ 
Sbjct: 227 PKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMA 283
Query: 259 AELLLGQPLFPGESG 273
            EL  G  LF   SG
Sbjct: 284 FELATGDYLFEPHSG 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 184
            F         L++V EY+   +++R++ H     +++         Y + + + Y+HN 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPEL 238
              + HR++K  NLLV+   + +K+CDFG +++        +++ S+       + APE+
Sbjct: 157 NPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWMAPEV 210
Query: 239 IFGATEYTAAIDIWSAGCVLAEL-LLGQP 266
           +        + D++S G +L EL  L QP
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ ++  +++E       R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL 263
            I     +T+A D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 113/228 (49%), Gaps = 32/228 (14%)
Query: 59  GQPKQTIS---YMAERVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE---- 108
           G P+  I+    +  R++G G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 109 -LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLI 166
               M+ LDHP++V L        E++  ++  ++E  P   +  + H+ + ++  + ++
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWI--IMELYP---YGELGHYLERNKNSLKVL 125
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNI 225
            + LY  QIC+A+AY+  +I   HRDI  +N+LV +P    +KL DFG ++  ++ E   
Sbjct: 126 TLVLYSLQICKAMAYLE-SINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYY 181
Query: 226 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LG-QPLF 268
               +R    + +PE I     +T A D+W     + E+L  G QP F
Sbjct: 182 KASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 72/134 (53%), Gaps = 10/134 (7%)
Query: 131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQR----MPLIYVKLYFYQICRALAYIHNT 185
           T  DE+Y+  + EY+  +++ +  ++ + + +     +P+  +K     +  + +YIHN 
Sbjct: 113 TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             +CHRD+KP N+L++ +  ++KL DFG ++ +V  +   S   +  +  PE     + Y
Sbjct: 171 KNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSY 228
Query: 246 TAA-IDIWSAGCVL 258
             A +DIWS G  L
Sbjct: 229 NGAKVDIWSLGICL 242

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 71  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 122
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        E++  ++ + L    E  H + ++       + ++ + LY  QIC+A+AY+
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL 129
Query: 183 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
             +I   HRDI  +N+LV +P    +KL DFG ++  ++ E       +R    + +PE 
Sbjct: 130 E-SINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 185
Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LG-QPLF 268
           I     +T A D+W     + E+L  G QP F
Sbjct: 186 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 29/213 (13%)
Query: 71  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 122
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAY 181
           L        E++  ++  ++E  P   +  + H+ + ++  + ++ + LY  QIC+A+AY
Sbjct: 74  L----IGIIEEEPTWI--IMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 182 IHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 237
           +  +I   HRDI  +N+LV +P    +KL DFG ++  ++ E       +R    + +PE
Sbjct: 125 LE-SINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPE 180
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLF 268
            I     +T A D+W     + E+L  G QP F
Sbjct: 181 SI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKV-----LQDKRYKNRELQTM 112
           P + +   ++RV+G G FGVV+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R L+HPNV++L            + L       P   H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ R + Y+     V HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 232 YYRAPELIFGATE------YTAAIDIWSAGCVLAELL 262
           + R P + + A E      +T   D+WS G +L ELL
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 61/116 (52%), Gaps = 17/116 (14%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 224
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 225 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DFG+++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ ++  +++E       R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--------VKGEPNISYICSRYYR 234
            +   V HRDI  +N+LV+ +   +KL DFG ++ +         KG+  I ++      
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM------ 179
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL 263
           APE I     +T+A D+W  G  + E+L+
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 51/233 (21%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V         +S
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKV--------TLS 122
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           ++     ++     IC AL    + + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 123 EKETRKIMRALLEVIC-AL----HKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLF 268
           GE   S   +  Y APE+I  +       Y   +D+WS G ++  LL G P F
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ERV+G G FG V   +    G+   AVAIK +      K R     E   M   DHPNVV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     T  K  +   +V+E++    +   ++ H     +  +I +      I   + 
Sbjct: 108 HLEGVV--TRGKPVM---IVIEFMENGALDAFLRKH---DGQFTVIQLVGMLRGIAAGMR 159
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + A
Sbjct: 160 YLAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTA 216
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 217 PEAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 65/267 (24%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 118
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 174
           N   VV L    F  +  + +++ +V E +   + + +IK +Y   Q +P+  VK    Q
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLGHHLLKWIIKSNY---QGLPVRCVKSIIRQ 148
Query: 175 ICRALAYIHNTIGVCHRDIKPQN------------------------------------- 197
           + + L Y+H+   + H DIKP+N                                     
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 198 ---LLVNP------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA 248
              LLVNP         ++K+ D G+A  + K       I +R YR+ E++ GA  Y+  
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YSTP 265
Query: 249 IDIWSAGCVLAELLLGQPLFPGESGVD 275
            DIWS  C+  EL  G  LF   SG D
Sbjct: 266 ADIWSTACMAFELATGDYLFEPHSGED 292

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   +K   K   +  +I +      I   + 
Sbjct: 87  HLEGVVTKSKP-----VMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMK 138
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 139 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 195
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 196 PEAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 98  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 149
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 150 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 206
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 207 PEAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 132
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 133 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 190 PEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 231
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 137 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 193
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A K  ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAK-FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 231
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 118 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 174
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G
Sbjct: 175 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 215

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 26/169 (15%)
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           HP++V + +    T    +    +V+EYV  +++ R         Q++P+     Y  +I
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQKLPVAEAIAYLLEI 191
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICS 230
             AL+Y+H +IG+ + D+KP+N+++     QLKL D G+   +     + G P       
Sbjct: 192 LPALSYLH-SIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG------ 242
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
             ++APE++   T  T A DI++ G  LA L L  P   G   VD L E
Sbjct: 243 --FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPE 286

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A K  ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAK-FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 108 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 159
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 160 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 216
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 217 PEAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DFG ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 107/267 (40%), Gaps = 67/267 (25%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 118
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 174
           N   VV L   F   +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQ 138
Query: 175 ICRALAYIHNTIGVCHRDIKPQNL------------------------------------ 198
           + + L Y+H    + H DIKP+N+                                    
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 199 ------LVNP------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
                 LVNP         ++K+ D G+A  + K       I +R YR+ E++ G+  Y 
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 255
Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESG 273
              DIWS  C+  EL  G  LF   SG
Sbjct: 256 TPADIWSTACMAFELATGDYLFEPHSG 282

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 51/233 (21%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V         +S
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKV--------TLS 122
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           ++     ++     IC AL    + + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 123 EKETRKIMRALLEVIC-AL----HKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLF 268
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 51/233 (21%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ 
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIM 117
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           + +  +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 118 RALLEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 163
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLF 268
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+             + ++ EY+   ++   ++   K   R  +I +      I   + 
Sbjct: 94  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMK 145
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ +   V HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 146 YLSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTA 202
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 203 PEAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 133
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKN--------RELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D   V      +
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              ++     L +++EY+       +       +      +     +I + L Y+H+   
Sbjct: 91  LKGSK-----LWIIMEYLGGGSALDLLRAGPFDE----FQIATMLKEILKGLDYLHSEKK 141
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 142 I-HRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 198
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 199 SKADIWSLGITAIELAKGEP 218

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+             + ++ EY+   ++   ++   K   R  +I +      I   + 
Sbjct: 73  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMK 124
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 125 YLSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 182 PEAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+             + ++ EY+   ++   ++   K   R  +I +      I   + 
Sbjct: 79  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMK 130
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 131 YLSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 188 PEAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 146
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 237 ELI-FGATEYTAAIDIWSAGCVLAELL 262
           E I FG  +YT   D+WS G  + EL+
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 128
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 237 ELI-FGATEYTAAIDIWSAGCVLAELL 262
           E I FG  +YT   D+WS G  + EL+
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DF  ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKL----YFYQIC 176
           L      T   D + L +V E++   +    ++K           +Y +     Y  QI 
Sbjct: 93  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHYMRQIL 142
Query: 177 RALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSR 231
            AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + 
Sbjct: 143 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 199
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
           ++ APE++     Y   +D+W  G +L  LL G
Sbjct: 200 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSG 231

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I   T +++A D+WS G V+ E+L
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 21/227 (9%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 120
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++L   + +T+E     + L+LEY    E     +    +M     +I +     QI   
Sbjct: 92  INLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQILEG 143
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           + Y+H    + H D+KPQN+L++       +K+ DFG ++ +         + +  Y AP
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           E I      T A D+W+ G +   LL     F GE   +  + I +V
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+ E V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           ++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHH---YKMSQRMPLIYVKLYFYQICR 177
           L      T   D + L +V E++   +    ++K     +  S+ +   Y++    QI  
Sbjct: 91  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QILE 141
Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRY 232
           AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + +
Sbjct: 142 ALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPH 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLG 264
           + APE++     Y   +D+W  G +L  LL G
Sbjct: 199 FMAPEVV-KREPYGKPVDVWGCGVILFILLSG 229

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            L     S T      + LV + +P     E VH   +H   +  ++ L +      QI 
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVH---EHKDNIGSQLLLNWC----VQIA 150
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---Y 233
           + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    +
Sbjct: 151 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 208
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 266
            A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 209 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            L     S T      + LV + +P     E VH   +H   +  ++ L +      QI 
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVH---EHKDNIGSQLLLNWC----VQIA 127
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---Y 233
           + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    +
Sbjct: 128 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 266
            A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 186 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKN--------RELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKN--------RELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKN--------RELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 72  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 127 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 106/234 (45%), Gaps = 49/234 (20%)
Query: 71  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRY-KNRELQT-MRLLDH------ 117
           + +G G+FG V +A         T   VA+K + +   + ++R L + +++L H      
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 118 -------------PNVVSLKHCFFSTTEKDELYL----NLVLEYVPETVHRVIKHHYKMS 160
                        P +V ++ C F        YL    N  + Y PE +++         
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYKDF------- 144
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
             + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 --LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 221 GEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
               +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKN--------RELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    Y+   D+WS G +L E+  LG   +PG
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 125
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPN+V    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 184
            + ST  K +  + LV E       +     +K+ +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTV-KGKKCIVLVTELXTSGTLKTYLKRFKVXK---IKVLRSWCRQILKGLQFLHTR 148
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
           T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 245 YTAAIDIWSAG-CVL 258
           Y  ++D+++ G C L
Sbjct: 206 YDESVDVYAFGXCXL 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 84  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGXLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 123
           +G G FG V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F+  TE    Y NL L+Y+ E   + +         + L+Y+     QI  A+ Y+ 
Sbjct: 79  EPPFYIITEF-MTYGNL-LDYLRECNRQEV-------SAVVLLYMAT---QISSAMEYLE 126
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 240
                 HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 127 KK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL- 182
Query: 241 GATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 270
              +++   D+W+ G +L E+   G   +PG
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 84  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 87  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 135
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 136 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 194 LESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 106 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 154
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 155 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 213 LESILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 91  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 139
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 140 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 198 LESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTA 222
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I   T +++A D+WS G V+ E+L
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
             +ST  +    L +V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 124 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 182 LESILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 41/243 (16%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIK-KVLQDKRYKNR------ELQ 110
           P++ + +   +V+G G+FG V  A      +TG ++ +  K+L++K   +       EL+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 111 TM-RLLDHPNVVSLKHCFFSTTEKDELYLNL-------VLEYVPETVHRVIKHH--YKMS 160
            M +L  H N+V+L     + T    +YL         +L Y+     +  +    Y+  
Sbjct: 101 MMTQLGSHENIVNL---LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 161 QRMP-------LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 211
           +R+        L +  L  + YQ+ + + ++     V HRD+  +N+LV  H   +K+CD
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVKICD 215
Query: 212 FGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPL 267
           FG A+ ++     +    +R    + APE +F    YT   D+WS G +L E+  LG   
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP 274
Query: 268 FPG 270
           +PG
Sbjct: 275 YPG 277

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 119
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQI--C 176
           ++ L+    + TE+      LV  Y+   +V   ++   +   + PL + K     +   
Sbjct: 89  LLRLRGFCMTPTER-----LLVYPYMANGSVASCLRE--RPESQPPLDWPKRQRIALGSA 141
Query: 177 RALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-- 232
           R LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIG 200
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           + APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 201 HIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 149
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 150 YLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 115 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 163
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 164 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 222 LESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI   
Sbjct: 78  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAEG 126
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 127 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 185 LESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 205 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 263 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 305

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 103/264 (39%), Gaps = 81/264 (30%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMR------LLDHPNVVSL 123
           +G G FGVVF+AK        AIK++    R  NREL   + MR       L+HP +V  
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 124 KHCFFSTT------EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV--------- 168
            + +  T       E DE++L       P +    +       +RM              
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 169 ---KLYFY---QICR-------------------------------ALAYIHNTIGVCHR 191
              K+Y Y   Q+CR                               A+ ++H+  G+ HR
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLMHR 188
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISY------ICSRYYRAPEL 238
           D+KP N+        +K+ DFG    + + E       P  +Y      + ++ Y +PE 
Sbjct: 189 DLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 239 IFGATEYTAAIDIWSAGCVLAELL 262
           I G   Y+  +DI+S G +L ELL
Sbjct: 248 IHG-NNYSHKVDIFSLGLILFELL 270

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 153 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHP 118
           ++ I+ + E  +G G FGVV   K  +    VA+K + +    ++   +E QTM  L HP
Sbjct: 7   REEITLLKE--LGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            +V     F+    K E  + +V EY+    +   ++ H K  +   L+ +    Y +C 
Sbjct: 64  KLVK----FYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM---CYDVCE 115
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YR 234
            +A++ +   + HRD+  +N LV+     +K+ DFG  + ++  +  +S + +++   + 
Sbjct: 116 GMAFLESHQFI-HRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWS 172
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE +F   +Y++  D+W+ G ++ E+ 
Sbjct: 173 APE-VFHYFKYSSKSDVWAFGILMWEVF 199

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 153 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 203 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 261 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 303

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 196 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 254 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 296

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 90  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 144 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 202 RG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 149 YSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 153 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 198 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 256 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 298

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 119
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI--CR 177
           ++ L+    + TE+  +Y  +    V   +        +   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSAR 150
Query: 178 ALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY--Y 233
            LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTM 112
           QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLY 171
             +    +VSL + F + T+     L LV+  +     R   H Y + +  P     +  
Sbjct: 240 AKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAI 292
Query: 172 FY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           FY  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTM 112
           QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLY 171
             +    +VSL + F + T+     L LV+  +     R   H Y + +  P     +  
Sbjct: 240 AKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAI 292
Query: 172 FY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           FY  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTM 112
           QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VK 169
             +    +VSL + F + T+     L LV+  +     R   H Y + +  P        
Sbjct: 240 AKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAI 292
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
            Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 190 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 248 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 290

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 155 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 213 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 255

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 153 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +  K +       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVK 169
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P     +
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 170 LYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
             FY  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 65  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 115
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 73  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 124
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               + APE I    ++T+A D WS G V+ E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 122
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 123 --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
             L  C  ST +       LV + +P     ++ H  +   R+    +  +  QI + ++
Sbjct: 83  RLLGICLTSTVQ-------LVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 237
           Y+ + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 134 YLED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            I     +T   D+WS G  + EL+
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 119
           ++V+G G FG V++   L+T        VAIK +      K R     E   M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L+             + ++ EY+      + K   +      ++ +      I   +
Sbjct: 108 IIRLEGVISKYKP-----MMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYR 234
            Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 161 KYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 218 APEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 88  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 63  QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-ELQTMRLLDHPNVV 121
           Q++      V   G FG V++A+ L    AV I  +   + ++N  E+ ++  + H N++
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----- 176
                 F   EK    +++ L  +          H K S    L    + + ++C     
Sbjct: 82  Q-----FIGAEKRGTSVDVDLWLI-------TAFHEKGSLSDFLKANVVSWNELCHIAET 129
Query: 177 --RALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP 223
             R LAY+H  I          + HRDIK +N+L+    + L  C  DFG A     G+ 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKS 186
Query: 224 ---NISYICSRYYRAPELIFGATEYTA----AIDIWSAGCVLAEL 261
                  + +R Y APE++ GA  +       ID+++ G VL EL
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 60/244 (24%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYK-----NRELQ 110
           P+  I Y+  R +G G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 111 TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
            M   D+PN+V L          C    + +  + +E   ++    V    H  +    +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 159 MSQRMP--------LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 210
           +S   P        L   +    Q+   +AY+     V HRD+  +N LV      +K+ 
Sbjct: 163 VSSPGPPPLSCAEQLCIAR----QVAAGMAYLSERKFV-HRDLATRNCLVG-ENMVVKIA 216
Query: 211 DFGSAKVLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVL 258
           DFG ++ +   +         YY+A            PE IF    YT   D+W+ G VL
Sbjct: 217 DFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVL 266
Query: 259 AELL 262
            E+ 
Sbjct: 267 WEIF 270

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 46/102 (45%), Gaps = 25/102 (24%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK    GE          
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE---------- 173
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
                      +Y  + D+WS G ++  LL G P F    G+
Sbjct: 174 -----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVVS 122
           M    +G GSFG V++ K      AV I KV+     Q + ++N E+  +R   H N++ 
Sbjct: 39  MLSTRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL- 95
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               F     KD L   +V ++   +   + KH +    +  +  +     Q  + + Y+
Sbjct: 96  ---LFMGYMTKDNL--AIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELI 239
           H    + HRD+K  N+ ++     +K+ DFG A V  +  G   +     S  + APE+I
Sbjct: 149 HAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 240 F--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
                  ++   D++S G VL EL+ G+  +   +  DQ++ ++
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 123
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+ + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 124 YLAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
           +V+L              ++C +         LN +    P  +       +   +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 166 RDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 223
Query: 226 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+ DFG A+ + K    +    +
Sbjct: 149 YSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKH 125
           G G FGVV++     T   VA+KK+         + K+  ++E++      H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             FS+   D   L LV  Y P     ++     +    PL +     +  C+      N 
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG--SLLDRLSCLDGTPPLSW-----HXRCKIAQGAANG 136
Query: 186 IGVCH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 236
           I   H      RDIK  N+L++      K+ DFG A+   K    +     + +  Y AP
Sbjct: 137 INFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           E + G  E T   DI+S G VL E++ G P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 247 AAIDIWSAGCVLAELLLGQPLFPGE 271
              DI++  CVL E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 65  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 115
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 75  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 126
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               + APE I    ++T+A D WS G V+ E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 126 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 144 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQ 110
           P+  + +   + +G G+FG V +A     G+  A+ KV            +K     EL+
Sbjct: 36  PRNNLQF--GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 111 TMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMP 164
            M  L  H N+V+L     + T    + +  + EY     +   + R  +         P
Sbjct: 94  IMSHLGQHENIVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 165 LIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L    L  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++   
Sbjct: 149 LELRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDS 206
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
             I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 42/239 (17%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQ 110
           P+  + +   + +G G+FG V +A     G+  A+ KV            +K     EL+
Sbjct: 44  PRNNLQF--GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 111 TMRLL-DHPNVVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKH 155
            M  L  H N+V+L              ++C +     D L        V ET       
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG----DLLNFLRRKSRVLETDPAFAIA 157
Query: 156 HYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA 215
           +  +S R  L +      Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A
Sbjct: 158 NSTLSTRDLLHFSS----QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLA 211
Query: 216 KVLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           + ++     I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQ 110
           P+  + +   + +G G+FG V +A     G+  A+ KV            +K     EL+
Sbjct: 44  PRNNLQF--GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 111 TMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMP 164
            M  L  H N+V+L     + T    + +  + EY     +   + R  +         P
Sbjct: 102 IMSHLGQHENIVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 165 LIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L    L  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++   
Sbjct: 157 LELRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDS 214
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
             I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 215 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             +ST  +    L +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 240
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 44/240 (18%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQ 110
           P+  + +   + +G G+FG V +A     G+  A+ KV            +K     EL+
Sbjct: 44  PRNNLQF--GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 111 TMRLL-DHPNVVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKH 155
            M  L  H N+V+L              ++C +          + VLE  P         
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA-------- 153
Query: 156 HYKMSQRMPLIYVKLYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS 214
            + ++         L+F  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG 
Sbjct: 154 -FAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGL 210
Query: 215 AKVLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           A+ ++     I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 211 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           + Y+ +   + HRD+  +NLL+   T  L K+ DFG  + L + + +  Y+   + + P 
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVP- 181
Query: 238 LIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             + A E      ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
           VG G +G V++   L  GE+VA+K      +   ++  E+    LL H N++        
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM- 72
Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--- 186
           T+      L L+  Y     H  +    +     P + ++L     C  LA++H  I   
Sbjct: 73  TSRNSSTQLWLITHY---HEHGSLYDFLQRQTLEPHLALRLAVSAAC-GLAHLHVEIFGT 128
Query: 187 ----GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPE 237
                + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 238 LI--------FGATEYTAAIDIWSAGCVLAEL 261
           ++        F + ++T   DIW+ G VL E+
Sbjct: 188 VLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           + Y+ +   + HRD+  +NLL+   T  L K+ DFG  + L + + +  Y+   + + P 
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVP- 187
Query: 238 LIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             + A E      ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 232
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 166 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 223
Query: 233 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           + Y+ +   + HRD+  +NLL+   T  L K+ DFG  + L + + +  Y+   + + P 
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVP- 177
Query: 238 LIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             + A E      ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           + Y+ +   + HRD+  +NLL+   T  L K+ DFG  + L + + +  Y+   + + P 
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVP- 181
Query: 238 LIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             + A E      ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           + Y+ +   + HRD+  +NLL+   T  L K+ DFG  + L + + +  Y+   + + P 
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVP- 177
Query: 238 LIFGATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
             + A E      ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL----QTMRLL 115
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
                  + +  +   E D  Y  LV++ +  ++  +       S+++ L  V +   Q+
Sbjct: 60  Q--GGTGIPNVRWFGVEGD--YNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
Query: 176 CRALAYIHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAK 216
              + ++H+     HRDIKP N L  +    +Q+ + DFG AK
Sbjct: 113 INRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 188 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LIFG 241
            C  HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 242 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 272
              Y++  D+WS G +L E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 188 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 244
            C  HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 245 -----YTAAIDIWSAGCVLAELL-LGQPLFPGES 272
                Y++  D+WS G +L E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQL-KLCDFGSAKVLVKGEPNISYICSR----YY 233
           + Y+ +   + HRD+  +NLL+   T  L K+ DFG  + L + + +      R     +
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
            APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 191 CAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQL-KLCDFGSAKVLVKGEPNISYICSR----YY 233
           + Y+ +   + HRD+  +NLL+   T  L K+ DFG  + L + + +      R     +
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
            APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 181 CAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSL-KHC 126
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 182
                E++E+ L  + +Y+       +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYMENGN---LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 231
           H T  + HRD+K  N+L++      K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELGQTHLXXVVKG--TLGYIDPE 211
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           Y+    L       T   D++S G VL E+L
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSL-KHC 126
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 182
                E++E+ L  + +Y+       +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYMENGN---LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 231
           H T  + HRD+K  N+L++      K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLXXVVKG--TLGYIDPE 211
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           Y+    L       T   D++S G VL E+L
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVL 235

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 13/107 (12%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +   SY+  
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILVA-EGRKMKISDFGLSRDVYEED---SYVKR 209
Query: 231 RYYRAP------ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
              R P      E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 210 SQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 90  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 145 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 200
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL--LLGQP 266
             +  R+     L +    YT   D+WS G +L E+  L G P
Sbjct: 201 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 80  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 135 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 190
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL--LLGQP 266
             +  R+     L +    YT   D+WS G +L E+  L G P
Sbjct: 191 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKN 106
           G    + + T  +     +G G FG VF  KC++   G   AIK+  +      D++   
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 58
Query: 107 RELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMP 164
           RE+    +L  H +VV     +FS   +D+ ++ +  EY    ++   I  +Y++     
Sbjct: 59  REVYAHAVLGQHSHVVR----YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFK 113
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVL 218
              +K    Q+ R L YIH ++ + H DIKP N+ +      N  + +    D+ S KV+
Sbjct: 114 EAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 219 VK 220
            K
Sbjct: 173 FK 174

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 16/113 (14%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDXXXVVKD 186
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLF 268
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 123
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 17  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              +FS   +D+  L +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 74  ---YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 183 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	296
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-162
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-159
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-155
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-145
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-74
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-74
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-73
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-72
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-71
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-71
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-71
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-70
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-70
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-69
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-69
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-69
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-68
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-68
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-68
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-68
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-68
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-67
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-67
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-65
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-65
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-64
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-64
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-62
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-62
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-61
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-61
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-55
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-54
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-51
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-51
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-51
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-51
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-50
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-49
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-49
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-48
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-48
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-48
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-47
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-47
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-47
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-47
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-46
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-46
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-46
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-46
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-46
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-46
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-46
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-46
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-45
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-45
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-45
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-45
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-44
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-44
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-44
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-44
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-44
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-43
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-43
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-43
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-43
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-43
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-43
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-43
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-42
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-42
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-41
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-41
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-41
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-41
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-40
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-40
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-40
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-40
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-40
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-39
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-39
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-39
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-39
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-38
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-38
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-38
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-38
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-38
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-38
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-38
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-38
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-38
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-38
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-38
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-37
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-37
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-37
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-36
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-36
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-36
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-35
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-35
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-35
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-35
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-34
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-34
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-34
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-33
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-33
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-32
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-32
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-32
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-31
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-31
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-31
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-31
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-31
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-31
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-31
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-31
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-30
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-29
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-29
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-28
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  456 bits (1176), Expect = e-162
 Identities = 168/277 (60%), Positives = 214/277 (77%), Gaps = 13/277 (4%)

Query: 9   ASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYM 68
           +   +    + P     MK+  DK         +G++   ++ T   G+     Q +SY 
Sbjct: 9   SFAESCKPVQQPSAFGSMKVSRDK---------DGSKVTTVVATP--GQGPDRPQEVSYT 57

Query: 69  AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
             +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117

Query: 129 STTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFG 176

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
           +CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT+
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 236

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  448 bits (1155), Expect = e-159
 Identities = 159/255 (62%), Positives = 200/255 (78%), Gaps = 4/255 (1%)

Query: 31  DKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG 90
           +  +    ++        I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 91  EAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETV 149
           E VAIKKVLQDKR+KNRELQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV
Sbjct: 66  E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124

Query: 150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
           +R  +H+ K+ Q MP++ +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKL 183

Query: 210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
            DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 270 GESGVDQLVEIIKVI 284
           GESG+DQLVEIIKV+
Sbjct: 244 GESGIDQLVEIIKVL 258

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  435 bits (1122), Expect = e-155
 Identities = 115/246 (46%), Positives = 166/246 (67%), Gaps = 8/246 (3%)

Query: 47  GHIIVTTIGGKNGQP--KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY 104
           G ++         +   K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 105 KNRELQTMRLL---DHPNVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKM 159
           +NRELQ M+ L    HPN+V L+  F++  E+   ++YLN+V+EYVP+T+HR  +++Y+ 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 160 SQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               P I +K++ +Q+ R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
              EPN++YICSRYYRAPELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 279 EIIKVI 284
           EI++V+
Sbjct: 243 EIVRVL 248

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  413 bits (1063), Expect = e-145
 Identities = 117/259 (45%), Positives = 169/259 (65%), Gaps = 34/259 (13%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G    +  Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 119 NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYV 145
           N++ L   F++T ++                                    YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 146 PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH 205
           P+T+H+V+K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDN 179

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
            LKLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 266 PLFPGESGVDQLVEIIKVI 284
           PLF GE+ +DQLV II+++
Sbjct: 240 PLFSGETSIDQLVRIIQIM 258

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  229 bits (587), Expect = 2e-74
 Identities = 84/219 (38%), Positives = 128/219 (58%), Gaps = 17/219 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F     K  L+L  V EY   TV   +    +  + +P   VK   +Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 245
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              +D+W+ GCV AELL G PL+PG+S VDQL  I K +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  228 bits (584), Expect = 8e-74
 Identities = 79/218 (36%), Positives = 125/218 (57%), Gaps = 17/218 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           VG GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                +K   YL  V E+V  T+   ++        +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 245
            + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  227 bits (580), Expect = 2e-73
 Identities = 78/239 (32%), Positives = 125/239 (52%), Gaps = 31/239 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 120
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 121 VSLKHCF-----------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           V +                S TE + +Y+  V EY+   +  V++        +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 226
           L+ YQ+ R L YIH +  V HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 227 -YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
             + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+  I++ I
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  224 bits (573), Expect = 3e-72
 Identities = 67/223 (30%), Positives = 116/223 (52%), Gaps = 17/223 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 123
           Y   R +G G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 124 KHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                    +       V E+V  T   ++        Q +    ++ Y Y+I +AL Y 
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 146

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+   
Sbjct: 147 H-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205

Query: 243 TEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVI 284
             Y  ++D+WS GC+LA ++   +P F G    DQLV I KV+
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  223 bits (571), Expect = 1e-71
 Identities = 80/223 (35%), Positives = 120/223 (53%), Gaps = 24/223 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F     K  + L  V +++   +  +IK     S  +   ++K Y     + L Y+H
Sbjct: 78  LDAF---GHKSNISL--VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 240
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + 
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  222 bits (569), Expect = 2e-71
 Identities = 76/238 (31%), Positives = 132/238 (55%), Gaps = 31/238 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 119
           +  + ++G G++GVV  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 120 VVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++++ +     + ++  E+Y+  + E +   +HRVI      +Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 226
           A+  +H    V HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLH-GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++ +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  +I
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  222 bits (569), Expect = 4e-71
 Identities = 70/237 (29%), Positives = 113/237 (47%), Gaps = 29/237 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------------RELQT 111
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 112 MRLLDHPNVVSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IY 167
           +    HPN++ L+  F  F      +LYL  V E +   + +VI       QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  220 bits (563), Expect = 3e-70
 Identities = 76/231 (32%), Positives = 128/231 (55%), Gaps = 24/231 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQD----KR-YKNRELQTMRLLDHPN 119
           Y     +G G++G+V  A        VAIKK+   +     +R    RE++ +    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 120 VVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ +     + T +   ++Y+  V + +   +++++K     +Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILR 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYY 233
            L YIH +  V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  217 bits (556), Expect = 3e-69
 Identities = 77/228 (33%), Positives = 123/228 (53%), Gaps = 22/228 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 121 VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L   F    +  +  + YL  V+ ++   + +++K      +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 236
            L YIH   G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIH-AAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           E+I     YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  215 bits (551), Expect = 6e-69
 Identities = 73/230 (31%), Positives = 123/230 (53%), Gaps = 28/230 (12%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLD 116
           +Y+    +G G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           H N+V+L         +  L L  V EY+ + + + +         + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLL 110

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYY 233
           R LAY H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           R P+++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  215 bits (550), Expect = 9e-69
 Identities = 71/224 (31%), Positives = 120/224 (53%), Gaps = 25/224 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                    L+L  + EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151

Query: 187 GVCHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +V
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  214 bits (548), Expect = 2e-68
 Identities = 73/225 (32%), Positives = 123/225 (54%), Gaps = 27/225 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G+G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH--YKMSQRMPLIYVKLYFYQICRALAY 181
                    +++L L  V E++   + + +         + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 238
            H    + HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + G+  Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  215 bits (550), Expect = 2e-68
 Identities = 80/230 (34%), Positives = 124/230 (53%), Gaps = 27/230 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQD----KR-YKNRELQTMRLLDHP 118
           Y++   VG G++G V  A    +GE VAIKK+    Q     KR Y  REL  ++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 119 NVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           NV+ L   F   +      + YL  V+ ++   + +++        +     ++   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQM 135

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYR 234
            + L YIH+  GV HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YR
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYR 190

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APE+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  215 bits (550), Expect = 5e-68
 Identities = 80/249 (32%), Positives = 139/249 (55%), Gaps = 43/249 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---QD----KR-YKNRELQTMRLL-DH 117
           Y   + +G G++G+V+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V+L +   +  ++D +YL  V +Y+   +H VI+     +  +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 226
            + Y+H + G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLH-SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 227 -----------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 276 QLVEIIKVI 284
           QL  II VI
Sbjct: 239 QLERIIGVI 247

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  212 bits (542), Expect = 6e-68
 Identities = 76/220 (34%), Positives = 122/220 (55%), Gaps = 22/220 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 K  L L  V E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  212 bits (542), Expect = 6e-68
 Identities = 78/221 (35%), Positives = 120/221 (54%), Gaps = 22/221 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                   +L L  V E+  + + +        +  +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 283
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  211 bits (540), Expect = 2e-67
 Identities = 79/220 (35%), Positives = 126/220 (57%), Gaps = 22/220 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +  L L  V E++ + + +V+         +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  213 bits (544), Expect = 3e-67
 Identities = 80/230 (34%), Positives = 125/230 (54%), Gaps = 26/230 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 119 NVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           NV+ L   F      +   ++YL  V   +   ++ ++K      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYR 234
            R L YIH+   + HRD+KP NL VN    +LK+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           APE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  205 bits (523), Expect = 7e-65
 Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 23/227 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 120
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLD 134

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           ++H    + HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  +I
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  206 bits (526), Expect = 8e-65
 Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 19/225 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK-- 124
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 125 -HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                S   + +  + LV ++     H +      +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPEL 238
               + HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  206 bits (526), Expect = 1e-64
 Identities = 75/231 (32%), Positives = 120/231 (51%), Gaps = 28/231 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQD----KR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A        VAIKK+    Q+    KR Y  REL  M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 119 NVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFY 173
           N++ L + F    S  E  ++Y+  V+E +   + +VI        +M L    +    Y
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVI--------QMELDHERMSYLLY 134

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           Q+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYY
Sbjct: 135 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ +
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  208 bits (531), Expect = 2e-64
 Identities = 73/229 (31%), Positives = 120/229 (52%), Gaps = 24/229 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQD----KR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A        VAIKK+    Q+    KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 119 NVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N++SL + F    +  E  ++YL  V+E +   + +VI+        +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           PE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  199 bits (509), Expect = 2e-62
 Identities = 74/226 (32%), Positives = 119/226 (52%), Gaps = 23/226 (10%)

Query: 73  VGHGSFGVVFQAK-CLETGEAVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 121
           +G G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L      +    E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDF 135

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 238
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           +  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ VI
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  201 bits (512), Expect = 6e-62
 Identities = 80/279 (28%), Positives = 117/279 (41%), Gaps = 71/279 (25%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQD-KR-YKNRELQTMRLLDHP 118
           Y+ + ++G GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 119 NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            ++ L             ELY+  VLE     + ++ K    +++     ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTE----EHIKTILYNLL 139

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 226
               +IH   G+ HRD+KP N L+N     +K+CDFG A+ +   +              
Sbjct: 140 LGENFIH-ESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 227 -------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-------- 265
                        ++ +R+YRAPELI     YT +IDIWS GC+ AELL           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 266 ---PLFPGESG-----------------VDQLVEIIKVI 284
              PLFPG S                   DQL  I  +I
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNII 296

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  201 bits (512), Expect = 1e-61
 Identities = 81/287 (28%), Positives = 119/287 (41%), Gaps = 79/287 (27%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 119 NVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +VV +         +  DELY  +VLE       ++ +        +  +++K   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLL 166

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 226
             + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVH-SAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 227 ------------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL----- 263
                             ++ +R+YRAPELI     YT AID+WS GC+ AELL      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 264 ------GQPLFPGES--------------------GVDQLVEIIKVI 284
                   PLFPG S                      DQL  I  ++
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  198 bits (504), Expect = 5e-61
 Identities = 78/238 (32%), Positives = 118/238 (49%), Gaps = 33/238 (13%)

Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALAYIH 183
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 184 NTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 234
               V HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------GVDQLVEIIKV 283
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  180 bits (459), Expect = 2e-55
 Identities = 63/249 (25%), Positives = 95/249 (38%), Gaps = 30/249 (12%)

Query: 51  VTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKN 106
           +  I  K+        Y+  + +G G F  V   + L  G   A+K++L    QD+    
Sbjct: 23  MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 107 RELQTMRLLDHPNVVSLKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMP 164
           RE    RL +HPN++ L          K E +  L+L +    T+   I+        + 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--- 221
              +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS          
Sbjct: 133 EDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEG 190

Query: 222 -------EPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
                  +   +  C+  YRAPEL             D+WS GCVL  ++ G+  +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 273 GVDQLVEII 281
                V + 
Sbjct: 251 QKGDSVALA 259

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  178 bits (454), Expect = 1e-54
 Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 19/223 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHP 118
           S+     +GHGS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             V L+  +    E   LY  L  E    ++ +  +        +P   V  Y      A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTLLA 169

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           LA++H+  G+ H D+KP N+ + P     KL DFG    L              Y APEL
Sbjct: 170 LAHLHSQ-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           +     Y  A D++S G  + E+     L  G  G  QL +  
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  176 bits (449), Expect = 1e-52
 Identities = 76/231 (32%), Positives = 118/231 (51%), Gaps = 27/231 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 117
           Y   +V+G GSFG V +A   +  + VA+K V  +KR+      E++ +  L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 118 PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            NV+ +   F         + N   +  E +   ++ +IK +    Q   L  V+ + + 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHS 208

Query: 175 ICRALAYIHNTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           I + L  +H    + H D+KP+N LL       +K+ DFGS+      +   +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           RAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I+++
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  170 bits (434), Expect = 1e-51
 Identities = 75/234 (32%), Positives = 111/234 (47%), Gaps = 34/234 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 119
           +  E+ +G G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+     F    E +EL   +VLE      + R+IKH  K  + +P   V  YF Q+C A
Sbjct: 94  VIKYYASFI---EDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYIC 229
           L ++H+   V HRDIKP N+ +   T  +KL D G  +           + G P      
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIK 282
             YY +PE I     Y    DIWS GC+L E+   Q  F G+   +  L + I+
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 251

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  169 bits (431), Expect = 1e-51
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 18/228 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V          ++    L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 180 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
              H        V HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +PE +     Y    DIWS GC+L EL    P F   S   +L   I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR 229

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  169 bits (431), Expect = 4e-51
 Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 23/247 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      TT        L++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKV--LIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 180 AYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 237 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           ++   A        +Y A +D+WS G        G   F    G  +  E++  I+  + 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 290 SLSIKAA 296
           S +I   
Sbjct: 245 SGAISGV 251

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  171 bits (435), Expect = 5e-51
 Identities = 74/232 (31%), Positives = 122/232 (52%), Gaps = 27/232 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 117
           Y  + ++G GSFG V +A      E VAIK +   K + N    E++ + L+        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 118 PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +V LK  F         + N   LV E +   ++ ++++     + + L   + +  Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165

Query: 175 ICRALAYIH-NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +C AL ++    + + H D+KP+N LL NP    +K+ DFGS+     G+    YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++V+
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  169 bits (430), Expect = 4e-50
 Identities = 55/244 (22%), Positives = 102/244 (41%), Gaps = 23/244 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      TT        L++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKV--LIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 180 AYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 237 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           ++   A        +Y A +D+WS G        G   F    G  +  E++  I+  + 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 290 SLSI 293
           S +I
Sbjct: 245 SGAI 248

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  166 bits (422), Expect = 5e-50
 Identities = 57/240 (23%), Positives = 102/240 (42%), Gaps = 19/240 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +    ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 127 FFSTTEKDEL-----------YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +       E             L + +E+  + T+ + I+   +  +++  +     F Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQ 130

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y 
Sbjct: 131 ITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIK 294
           +PE I    +Y   +D+++ G +LAELL                ++   I+        K
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRDGIISDIFDKKEK 245

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  166 bits (422), Expect = 2e-49
 Identities = 67/244 (27%), Positives = 104/244 (42%), Gaps = 20/244 (8%)

Query: 48  HIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQ 100
           H       G      Q++  Y+  + +G GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 101 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKM 159
           ++    RE+  +  + HPN+V  +  F    E   LY  +V++Y     + + I      
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINAQKG- 119

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 219
                   +  +F QIC AL ++H+   + HRDIK QN+ +      ++L DFG A+VL 
Sbjct: 120 -VLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176

Query: 220 KGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
                      + YY +PE+      Y    DIW+ GCVL EL   +  F   S +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 279 EIIK 282
             I 
Sbjct: 235 LKII 238

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  164 bits (417), Expect = 4e-49
 Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 35/238 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 236 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIK 282
           PE I             ++ +   D+WS GC+L  +  G+  F      + +L  II 
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  165 bits (420), Expect = 1e-48
 Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 35/238 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 236 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIK 282
           PE I             ++ +   D+WS GC+L  +  G+  F      + +L  II 
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  166 bits (421), Expect = 1e-48
 Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 25/235 (10%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 122
           IS+  + V+GHG+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
                   TEKD  +  + +E    T+   + +  +      P+  ++    Q    LA+
Sbjct: 83  YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 182 IHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNISY---IC-SRYY 233
           +H+ + + HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 234 RAPELIFGATE--YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVIL 285
            APE++    +   T  +DI+SAGCV   ++  G   F         + +    L
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  163 bits (414), Expect = 3e-48
 Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 35/238 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 236 PELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIK 282
           PE I             ++ +   D+WS GC+L  +  G+  F      + +L  II 
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  160 bits (406), Expect = 1e-47
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
            V+G G++G+V+  + L     +AIK++  +D RY      E+   + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHN 184
            +  +  +  ++ + +E VP  ++  +++  +  +      I    Y  QI   L Y+H+
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 243
              + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I    
Sbjct: 141 N-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 244 E-YTAAIDIWSAGCVLAELLLGQP 266
             Y  A DIWS GC + E+  G+P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  161 bits (409), Expect = 1e-47
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 28/231 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 121
               RV+  G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 122 SLKHCFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
                     E        +L L+ E     +   +K   +    +    V   FYQ CR
Sbjct: 90  QFCSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCR 147

Query: 178 ALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EP 223
           A+ ++H     + HRD+K +NLL++     +KLCDFGSA  +                E 
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 224 NISYICSRYYRAPELI--FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F   +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  162 bits (411), Expect = 1e-47
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 29/242 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 118
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 119 NVVSLKHC-----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           + +   H       F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 138

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNISYI 228
           Q+   L Y+H   G+ H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 282
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 283 VI 284
           ++
Sbjct: 256 LL 257

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  160 bits (406), Expect = 3e-47
 Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 22/231 (9%)

Query: 45  EAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK 102
             G ++   +   + + ++ +     +  VG GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 103 RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ 161
            ++  EL     L  P +V L         ++  ++N+ +E +   ++ ++IK    + +
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149

Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 221
                    Y  Q    L Y+H    + H D+K  N+L++    +  LCDFG A  L   
Sbjct: 150 D----RALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 222 EPNISYICSR------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
               S +          + APE++ G     A +DIWS+ C++  +L G  
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCH 254

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  159 bits (403), Expect = 4e-47
 Identities = 62/252 (24%), Positives = 102/252 (40%), Gaps = 38/252 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
           +    V+G G+FG V +A+        AIKK+   +   +    E+  +  L+H  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 124 KHCF--------FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
              +          T  K +  L + +EY    T++ +I       QR         F Q
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I  AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK + +    +         
Sbjct: 125 ILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 232 ------------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                        Y A E++ G   Y   ID++S G +  E++   P   G       V 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236

Query: 280 IIKVILHTEISL 291
           I+K +    I  
Sbjct: 237 ILKKLRSVSIEF 248

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  157 bits (400), Expect = 1e-46
 Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 33/242 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 121
           +   + +G G FGVVF+AK        AIK++        +    RE++ +  L+HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 122 SLKHCFF-------STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              + +              ++YL + ++    E +   +       +          F 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 232 -----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
                       Y +PE I G   Y+  +DI+S G +L ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 281 IK 282
           ++
Sbjct: 240 VR 241

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  165 bits (418), Expect = 1e-46
 Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 17/253 (6%)

Query: 55  GGKNGQPKQTIS---YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----- 106
           GG       T +   +  +  +G G FG V +    +TGE VAIK+  Q+   KN     
Sbjct: 1   GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60

Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN-LVLEYVP--ETVHRVIKHHYKMSQRM 163
            E+Q M+ L+HPNVVS +       +     L  L +EY    +    + +        +
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGL 118

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKG 221
               ++     I  AL Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +G
Sbjct: 119 KEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           E    ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    +
Sbjct: 178 ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

Query: 282 KVILHTEISLSIK 294
           +   +  I +   
Sbjct: 237 REKSNEHIVVYDD 249

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  161 bits (409), Expect = 3e-46
 Identities = 69/238 (28%), Positives = 110/238 (46%), Gaps = 30/238 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQIC 176
           ++ L   F     +D+ Y  LV E     E    +I    +  S+            Q+ 
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRF--SEV----DAARIIRQVL 136

Query: 177 RALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYR 234
             + Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY 
Sbjct: 137 SGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           APE++ G   Y    D+WS G +L  LL G P F G +  +   +I+K +   + +  
Sbjct: 196 APEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DILKKVEKGKYTFE 247

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  157 bits (400), Expect = 4e-46
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 49/253 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 118
           ++  R +G G+FG V   + ++  +  A+K V   K+Y      E   ++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 119 NVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N+V     F        +Y +   L+ E +  +++ +I  +        +  +KLY  +I
Sbjct: 97  NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146

Query: 176 CRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-----------------------QLKLCD 211
            +AL Y+   + + H D+KP+N LL +P+                          +KL D
Sbjct: 147 LKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           FG A    K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF   
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 272 SGVDQLVEIIKVI 284
             ++ L  +  +I
Sbjct: 263 EHMEHLAMMESII 275

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  155 bits (395), Expect = 5e-46
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 37/229 (16%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 113
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
            L H +VV     F      D ++  +VLE     ++  + K      + +     + Y 
Sbjct: 71  SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRR----KALTEPEARYYL 121

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 223
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 122 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           N        Y APE++     ++  +D+WS GC++  LL+G+P F    
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  155 bits (393), Expect = 8e-46
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 37/232 (15%)

Query: 59  GQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQ 110
               + I  +    ++G GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 169
               L HP+++ L + F      + +Y  LVLE      ++R +K+  K          +
Sbjct: 64  IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVK---PFSENEAR 115

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE------ 222
            + +QI   + Y+H+  G+ HRD+   NLL+  +   +K+ DFG + ++ +  E      
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173

Query: 223 --PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             PN        Y +PE+    + +    D+WS GC+   LL+G+P F  ++
Sbjct: 174 GTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  156 bits (397), Expect = 8e-46
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 37/229 (16%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 113
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
            L H +VV     F      D ++  +VLE     ++  + K      + +     + Y 
Sbjct: 97  SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRR----KALTEPEARYYL 147

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 223
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 148 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           N        Y APE++     ++  +D+WS GC++  LL+G+P F    
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  159 bits (405), Expect = 9e-46
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 29/237 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y    ++G GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEH----DAARIIKQVFS 132

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           PE++ G   Y    D+WSAG +L  LL G P F G++  +   +I+K +   + +  
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DILKRVETGKYAFD 242

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  160 bits (406), Expect = 9e-46
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 29/237 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L   F     +D+    LV+E     E    +I    +  ++        +   Q+  
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKF--NEV----DAAVIIKQVLS 147

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY A
Sbjct: 148 GVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           PE++    +Y    D+WS G +L  LL G P F G++  DQ  EI++ +   + +  
Sbjct: 207 PEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILRKVEKGKYTFD 257

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (392), Expect = 1e-45
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 30/225 (13%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 125
            +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH- 183
            + ST +  +  + LV E +   T+   +K      + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 236
            T  + HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           E+     +Y  ++D+++ G  + E+   +  +       Q+   +
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  154 bits (390), Expect = 2e-45
 Identities = 44/233 (18%), Positives = 79/233 (33%), Gaps = 45/233 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHPN 119
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           VV     +    E D + +    EY    ++   I  +Y++        +K    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPH------------------THQLKLCDFGSAKVL-- 218
           L YIH+   + H DIKP N+ ++                        K+ D G    +  
Sbjct: 128 LRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 219 ---VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               +G+          + A E++     +    DI++    +      +PL 
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  154 bits (392), Expect = 4e-45
 Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 51/252 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 116
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q +  L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 117 HPNVVSLKHCF------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 170
               V +   F          E   L L+          +  IK +        L +++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFEL--LGLST---------YDFIKENGF--LPFRLDHIRK 122

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDF 212
             YQIC+++ ++H+   + H D+KP+N+L                         +K+ DF
Sbjct: 123 MAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           GSA      E + + + +R+YRAPE+I     ++   D+WS GC+L E  LG  +FP   
Sbjct: 182 GSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 273 GVDQLVEIIKVI 284
             + L  + +++
Sbjct: 239 SKEHLAMMERIL 250

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  157 bits (398), Expect = 4e-45
 Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 38/245 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 124
            ++E+++G+GS G V   +    G  VA+K++L D       E++ +    DHPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQICRALAY 181
                 +E  + +L + LE     +  +++      + + L           QI   +A+
Sbjct: 76  C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGE----PNI 225
           +H+ + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N+
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 226 SYIC-SRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           +    +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F  +    + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 278 VEIIK 282
             II+
Sbjct: 248 SNIIR 252

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  151 bits (385), Expect = 1e-44
 Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 29/244 (11%)

Query: 59  GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM 112
           G  K  I+  Y  E  +G GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 169
           + LDHPN++ L   F     +D   + LV+E     E   RV+    +   +        
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVF--RES----DAA 109

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 227
                +  A+AY H  + V HRD+KP+N L    +    LKL DFG A     G+   + 
Sbjct: 110 RIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT 287
           + + YY +P+++ G   Y    D WSAG ++  LL G P F   +  D   E++  I   
Sbjct: 169 VGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPT--DS--EVMLKIREG 222

Query: 288 EISL 291
             + 
Sbjct: 223 TFTF 226

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  154 bits (390), Expect = 1e-44
 Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 45/249 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 116
           Y     +G G+FG V +      G   VA+K +    +Y+     E+  ++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 117 HPNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
               V +   F         +     +  E + +     +K +    Q  PL +V+   Y
Sbjct: 81  KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHVRHMAY 130

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDFGSA 215
           Q+C AL ++H    + H D+KP+N+L                         +++ DFGSA
Sbjct: 131 QLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
                 E + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 276 QLVEIIKVI 284
            LV + K++
Sbjct: 247 HLVMMEKIL 255

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  157 bits (398), Expect = 1e-44
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 40/248 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------------REL 109
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLI 166
             ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I    +   +     
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKF--DEC---- 146

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPN 224
                  QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K    
Sbjct: 147 DAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205

Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  DQ  +IIK +
Sbjct: 206 RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DIIKKV 259

Query: 285 LHTEISLS 292
              +    
Sbjct: 260 EKGKYYFD 267

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  151 bits (384), Expect = 2e-44
 Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 30/259 (11%)

Query: 48  HIIVTTIGGKNGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQ 100
           H    + G +N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 101 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYK 158
                  E++ ++ LDHPN++ +   F     +D   + +V+E     E + R++    +
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 159 M---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFG 213
               S+     YV     Q+  ALAY H+   V H+D+KP+N+L    +    +K+ DFG
Sbjct: 118 GKALSEG----YVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFG 172

Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
            A++    E + +   +  Y APE+     + T   DIWSAG V+  LL G   F G S 
Sbjct: 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTS- 229

Query: 274 VDQLVEIIKVILHTEISLS 292
              L E+ +   + E + +
Sbjct: 230 ---LEEVQQKATYKEPNYA 245

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  150 bits (381), Expect = 4e-44
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 37/232 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F      D   + L+LEY P       + K       +        Y  ++  AL+Y
Sbjct: 75  YGYF-----HDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSY 124

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 234
            H+   V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 125 CHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YL 174

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH 286
            PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V   
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 225

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  154 bits (390), Expect = 5e-44
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 32/235 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------------RELQTMRL 114
           Y+  + +G G+ G V  A   +T + VAI+ + + K                 E++ ++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 172
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 197 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEAT----CKLYF 245

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 229
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 246 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 230 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I 
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  150 bits (381), Expect = 2e-43
 Identities = 73/277 (26%), Positives = 112/277 (40%), Gaps = 63/277 (22%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---------QDKRYKNRELQTMRLLDH 117
           Y  +  +G GS+GVV  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL----- 170
           PN+  L   +     +DE Y+ LV+E       + ++       + +  +  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 171 ------------------------------YFYQICRALAYIHNTIGVCHRDIKPQN-LL 199
                                            QI  AL Y+HN  G+CHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201

Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTAAIDIWS 253
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 254 AGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS 290
           AG +L  LL+G   FPG +      + I  +L+ ++ 
Sbjct: 262 AGVLLHLLLMGAVPFPGVN----DADTISQVLNKKLC 294

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  152 bits (385), Expect = 2e-43
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 14/232 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
            +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----EASEIMKSIGEAIQYL 177

Query: 183 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE + 
Sbjct: 178 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           G  +Y  + D+WS G ++  LL G P F    G+     +   I   +    
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  151 bits (383), Expect = 2e-43
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG     K        DK     E+  M  L HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L 
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163

Query: 181 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
                     D+W+ G +   LL G   F GE  ++ L  + + 
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  150 bits (381), Expect = 2e-43
 Identities = 47/240 (19%), Positives = 95/240 (39%), Gaps = 38/240 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN----------------REL 109
           R +  G F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMP 164
           Q +  + +   ++      +    DE+Y+  + EY+      +            +  +P
Sbjct: 95  QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +K     +  + +YIHN   +CHRD+KP N+L++ +   +KL DFG ++ +V  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206

Query: 225 ISYIC-SRYYRAPELIFGATEY-TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           I     +  +  PE     + Y  A +DIWS G  L  +      F  +  + +L   I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  150 bits (381), Expect = 3e-43
 Identities = 33/239 (13%), Positives = 65/239 (27%), Gaps = 36/239 (15%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHP 118
                  +  G   VVF  + +E  E  A+K                +        L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 119 NVVSLKHCFFSTTEKDELYLN---------------------LVLEYVP---ETVHRVIK 154
           +    +         D + +                      L++       E +   + 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 155 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS 214
             Y       ++ + +   Q+ R  A + +  G+ H    P NL + P    L L D  +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVSA 240

Query: 215 AKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
              +  G    +      Y   E +      +T A++ W  G  +  +      F   +
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  154 bits (390), Expect = 5e-43
 Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 18/223 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG   A K V      DK    +E+QTM +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L 
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 181 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            G        D+WS G +   LL G   F GE+  + L  +  
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  148 bits (377), Expect = 5e-43
 Identities = 55/231 (23%), Positives = 110/231 (47%), Gaps = 23/231 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 123
           YM    +G G FG+V +     + +      +K    D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +    L ++ E++   +   R+    +++++R  + YV     Q+C AL +
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117

Query: 182 IHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
           +H+   + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +
Sbjct: 118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS 290
                 + A D+WS G ++  LL G   F  E+  +Q  +II+ I++ E +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QIIENIMNAEYT 221

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  147 bits (373), Expect = 7e-43
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 37/232 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +  +Y  L+LE+ P  E    + KH      R        +  ++  AL Y
Sbjct: 80  YNYFHD---RKRIY--LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 234
            H    V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 130 CHER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH 286
            PE+I G   +   +D+W AG +  E L+G P F   S  +    I+ V L 
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  148 bits (376), Expect = 8e-43
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 17/230 (7%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 128
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P++V +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 129 STTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
                 +  L +++E +   E   R+  +     ++R            I  A+ ++H+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHS- 146

Query: 186 IGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
             + HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE + G 
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
            +Y  + D+WS G ++  LL G P F   +G      + + I   +    
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  148 bits (377), Expect = 8e-43
 Identities = 70/257 (27%), Positives = 115/257 (44%), Gaps = 24/257 (9%)

Query: 44  TEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR 103
           T   H IV  +   + Q      Y  +  +G GS+ V  +     T    A+K + + KR
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 104 YKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKM 159
               E++ + R   HPN+++LK  +      D  Y+ +V E +   E + ++++   +  
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFF-- 113

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAK 216
           S+R          + I + + Y+H   GV HRD+KP N+L    + +   +++CDFG AK
Sbjct: 114 SERE----ASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 217 VLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
            L      +   C +  + APE +     Y AA DIWS G +L  +L G   F       
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227

Query: 276 QLVEIIKVILHTEISLS 292
              EI+  I   + SLS
Sbjct: 228 P-EEILARIGSGKFSLS 243

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  148 bits (375), Expect = 1e-42
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 32/235 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN--------RELQTMRL 114
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 172
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 72  LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEA----TCKLYF 120

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 229
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 121 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 178

Query: 230 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  146 bits (372), Expect = 1e-42
 Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 29/235 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y    ++G GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEHD----AARIIKQVFS 132

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS 290
           PE++ G   Y    D+WSAG +L  LL G P F G++  +   +I+K +   + +
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DILKRVETGKYA 240

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  146 bits (370), Expect = 4e-42
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 25/226 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 122
           ++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRAL 179
           L+  +         Y  LV++ V   E   R++ +  Y  +++       L   Q+  A+
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVY--TEKDA----SLVIQQVLSAV 119

Query: 180 AYIHNTIGVCHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 236
            Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y AP
Sbjct: 120 KYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAP 176

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E +     Y+ A+D WS G +   LL G P F  E+      +I +
Sbjct: 177 E-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  147 bits (373), Expect = 5e-42
 Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 18/236 (7%)

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNREL 109
           +  K G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY 167
             M  LDH N++ L   F     + +  + LV+EYV   E   R+I   Y +++   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           +K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              +  + APE +      +   D+WS G +   LL G   F G++  + L  I+ 
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  145 bits (367), Expect = 3e-41
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 23/228 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           Y   + +G G+FGV    +   T E VA+K       + +     RE+   R L HPN+V
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K    +      L   +++EY    E   R+         R      + +F Q+   +
Sbjct: 80  RFKEVILT---PTHLA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +Y H+ + +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 239 IFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL 285
           +    EY     D+WS G  L  +L+G   F          + I+ IL
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  144 bits (365), Expect = 5e-41
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 24/235 (10%)

Query: 58  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMR 113
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 170
            L HPN++ LK  F     +    ++LVLE V   E   R+++  +Y  S+R        
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYY--SERD----AAD 152

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYI 228
              QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K++      +  +
Sbjct: 153 AVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTV 210

Query: 229 C-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           C +  Y APE I     Y   +D+WS G +   LL G   F  E G   +   I 
Sbjct: 211 CGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  143 bits (362), Expect = 5e-41
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 27/222 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN---RELQTMRLLDHP 118
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           NV+ L    ++  ++  +Y  +V+EY      E +  V +       R P+     YF Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SR 231
           +   L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 232 YYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGES 272
            ++ PE+  G   ++   +DIWSAG  L  +  G   F G++
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  143 bits (363), Expect = 6e-41
 Identities = 63/237 (26%), Positives = 116/237 (48%), Gaps = 24/237 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 124
            + ++ +G GSF +  +    ++ +A A+K + +       +E+  ++L + HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
             F      D+L+  LV+E +   E   R+  K H+  S+            ++  A+++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHF--SETE----ASYIMRKLVSAVSH 121

Query: 182 IHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
           +H+ +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE 
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE- 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVILHTEISLS 292
           +     Y  + D+WS G +L  +L GQ  F            VEI+K I   + S  
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  145 bits (367), Expect = 2e-40
 Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 25/228 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G+F VV +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           V L          +E +  L+ + V   E    ++   +Y  S+            QI  
Sbjct: 73  VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYY--SEAD----ASHCIQQILE 121

Query: 178 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           A+ + H  +GV HR++KP+NLL  +      +KL DFG A  +   +        +  Y 
Sbjct: 122 AVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +PE +     Y   +D+W+ G +L  LL+G P F  E       +I  
Sbjct: 181 SPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  141 bits (357), Expect = 2e-40
 Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 35/241 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           HPN+++L   F     +++  + L+LE V   E    +  K     ++         +  
Sbjct: 67  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESL--TEDE----ATQFLK 115

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G      I  
Sbjct: 116 QILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFG 173

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           +  + APE I          D+WS G +   LL G   F GE+   Q  E +  I     
Sbjct: 174 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGET--KQ--ETLTNISAVNY 228

Query: 290 S 290
            
Sbjct: 229 D 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  142 bits (361), Expect = 2e-40
 Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 32/234 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 117
           Y    V+G G F VV +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY----VKLY 171
           P++V L   +       +  L +V E++   +    ++K           +Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 229
             QI  AL Y H+   + HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            + ++ APE +     Y   +D+W  G +L  LL G   F G    ++L E I 
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  142 bits (358), Expect = 6e-40
 Identities = 34/253 (13%), Positives = 85/253 (33%), Gaps = 32/253 (12%)

Query: 66  SYMAERVVGHGSFGVVFQAKC-----LETGEAVAIK----KVLQDKRYKNRELQTMRLLD 116
                 ++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
               +           ++   L  V E       ++ +  +     + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----------LKLCDFGSA---KVLVKG 221
           +   +  +H+   + H DIKP N ++     +          L L D G +   K+  KG
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGESGVDQLVEI 280
               +   +  ++  E++     +   ID +     +  +L G  +    E G  +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 281 IKVILHTEISLSI 293
            + + H ++    
Sbjct: 299 FRRLPHLDMWNEF 311

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  139 bits (354), Expect = 6e-40
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 26/228 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y  +  +G G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 177
           V L         ++E +  LV + V   E    ++ +  Y  S+            QI  
Sbjct: 68  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----ASHCIQQILE 116

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E        +  Y 
Sbjct: 117 SIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYL 174

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I  
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  140 bits (356), Expect = 7e-40
 Identities = 54/233 (23%), Positives = 99/233 (42%), Gaps = 29/233 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F VV + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           HPNV++L   +     +++  + L+LE V   E    + +    +++         +  Q
Sbjct: 73  HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKES-LTEEE----ATEFLKQ 122

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           I   + Y+H+ + + H D+KP+N+++   N    ++K+ DFG A  +  G      I  +
Sbjct: 123 ILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGT 180

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             + APE I          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 181 PEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  141 bits (357), Expect = 9e-40
 Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 24/227 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y  +  +G G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           V L         ++E +  LV + V   E    ++    Y  S+            QI  
Sbjct: 91  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----ASHCIQQILE 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  +  Y +
Sbjct: 140 SIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 198

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE +     Y+  +DIW+ G +L  LL+G P F  E       +I  
Sbjct: 199 PE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  139 bits (352), Expect = 2e-39
 Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 31/234 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           H NV++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  137 bits (348), Expect = 3e-39
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 236
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 237 ELIFGATEYTAA-IDIWSAGCVLAELLLG 264
           EL+    E+ A  +D+WS G VL  +L G
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAG 204

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  138 bits (350), Expect = 8e-39
 Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 31/234 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           HPN+++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  138 bits (350), Expect = 9e-39
 Identities = 39/273 (14%), Positives = 88/273 (32%), Gaps = 51/273 (18%)

Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRL 114
           ++  + +   V+G        +A   ETGE+  +      +R  +        E+  +RL
Sbjct: 70  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129

Query: 115 L-------------------------DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 149
           L                             ++ ++            +L   ++   +T 
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189

Query: 150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             V+  H    + +          Q+ R LA +H+  G+ H  ++P +++++     + L
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VFL 247

Query: 210 CDFGSAKVLVKGEPNISYICSRYYRAPELI----------FGATEYTAAIDIWSAGCVLA 259
             F      V+    +    SR +  PEL              T  T + D W+ G V+ 
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 260 ELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
            +         ++     +   + I  +  ++ 
Sbjct: 305 WIWCADLPITKDA----ALGGSEWIFRSCKNIP 333

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  137 bits (346), Expect = 1e-38
 Identities = 62/253 (24%), Positives = 99/253 (39%), Gaps = 46/253 (18%)

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--- 106
            G +G   Q   Y  +  +G GS+GVV  A         A+K     K+++   +     
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 107 ----------------------RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY 144
                                 +E+  ++ LDHPNVV L         +D LY+  V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119

Query: 145 VP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP 202
           V     V  V        + +     + YF  + + + Y+H    + HRDIKP NLLV  
Sbjct: 120 VNQGP-VMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG- 171

Query: 203 HTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-AAIDIWSAGCVLA 259
               +K+ DFG +      +  +S    +  + APE +      ++  A+D+W+ G  L 
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 260 ELLLGQPLFPGES 272
             + GQ  F  E 
Sbjct: 232 CFVFGQCPFMDER 244

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  137 bits (346), Expect = 2e-38
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 236
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 237 ELIFGATEYTAA-IDIWSAGCVLAELLLG 264
           EL+    E+ A  +D+WS G VL  +L G
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAG 204

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  136 bits (345), Expect = 2e-38
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 41/239 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D+  L   L Y    E     +  + +          + Y  +I  AL Y
Sbjct: 96  YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------YICSRY 232
           +H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             +PEL+        + D+W+ GC++ +L+ G P F   +       I + I+  E   
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKIIKLEYDF 251

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  136 bits (344), Expect = 2e-38
 Identities = 55/239 (23%), Positives = 104/239 (43%), Gaps = 37/239 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK------------KVLQDKRYK-NRELQTMR 113
           Y  + ++G G   VV +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 114 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 169
            +  HPN++ LK  +     +   +  LV + +   E    + +      S++      +
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTL--SEK----ETR 127

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
                +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +C
Sbjct: 128 KIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREVC 184

Query: 230 -SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+ 
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  135 bits (343), Expect = 4e-38
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 31/222 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 116
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 117 H--PNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 171
                V+ L   +F     D   L  +LE      +    + +        +     + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS  +L       +    +
Sbjct: 155 FWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211

Query: 231 RYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGE 271
           R Y  PE I     Y      +WS G +L +++ G   F  +
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  135 bits (341), Expect = 6e-38
 Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 35/232 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
            +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----ASEIMKSIGEAIQYL 133

Query: 183 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK     +                  
Sbjct: 134 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK------------------ 174

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
               Y  + D+WS G ++  LL G P F    G+     +   I   +    
Sbjct: 175 ----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  135 bits (343), Expect = 6e-38
 Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 29/228 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L       TEK    L L++EY    E    ++ H      RM     +  F QI 
Sbjct: 75  NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            A+ Y H    + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181

Query: 236 PELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PEL  G  +Y    +D+WS G +L  L+ G   F G++ + +L E + 
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  136 bits (345), Expect = 6e-38
 Identities = 54/228 (23%), Positives = 104/228 (45%), Gaps = 36/228 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----------KVLQDKRYK-NRELQTMRL 114
           Y  + V+G G   VV +     TG   A+K           + L++ R    RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 115 L-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 170
           +  HP++++L   +     +   ++ LV + +   E    + +      S++      + 
Sbjct: 156 VAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVAL--SEK----ETRS 204

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
               +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +C 
Sbjct: 205 IMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRELCG 261

Query: 230 SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGES 272
           +  Y APE++  + +     Y   +D+W+ G +L  LL G P F    
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  135 bits (342), Expect = 7e-38
 Identities = 64/251 (25%), Positives = 105/251 (41%), Gaps = 36/251 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 124
           E V+G G+   V     L T +  A+K    +    +    RE++ + +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICRALAY 181
             F     ++E    LV E +     +  + K  H+  ++        +    +  AL +
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHF--NEL----EASVVVQDVASALDF 126

Query: 182 IHNTIGVCHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------PNISYIC-SR 231
           +HN  G+ HRD+KP+N+L  +P     +K+CDF     +           P +   C S 
Sbjct: 127 LHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 232 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT 287
            Y APE++      A+ Y    D+WS G +L  LL G P F G  G D   +  +     
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 288 EISL--SIKAA 296
           +  L  SI+  
Sbjct: 246 QNMLFESIQEG 256

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  136 bits (345), Expect = 8e-38
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 24/230 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +DE  + +V++ +   +     +++H + +       VKL+  ++  AL Y
Sbjct: 81  WYSF-----QDEEDMFMVVDLLLGGD-----LRYHLQQNVHFKEETVKLFICELVMALDY 130

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 240
           + N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQN-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
                Y+ A+D WS G    ELL G+  +   S      EI+     T +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVV 237

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  133 bits (338), Expect = 9e-38
 Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 23/228 (10%)

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------R 107
           G K+    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E+Q ++L  HP+++ L     +     + +  +V+EYV   E    + KH      R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVIST---PTDFF--MVMEYVSGGELFDYICKH-----GRVEE 110

Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           +  +  F QI  A+ Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
              C S  Y APE+I G       +DIWS G +L  LL G   F  E 
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  134 bits (340), Expect = 1e-37
 Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 33/224 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 116
           Y    ++G G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 117 ----HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---IKHHYKMSQRMPLIYVK 169
               HP V+ L   +F T  ++   L  VLE  P     +   I     + +       +
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLER-PLPAQDLFDYITEKGPLGEGP----SR 142

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS  +L       +   
Sbjct: 143 CFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD 199

Query: 230 -SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGE 271
            +R Y  PE I    +Y A    +WS G +L +++ G   F  +
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERD 242

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  138 bits (350), Expect = 4e-37
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 28/235 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 119
           R++G G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V + + F +    D+L    +L+ +   +     + +H           ++ Y  +I  
Sbjct: 254 IVCMSYAFHT---PDKLSF--ILDLMNGGD-----LHYHLSQHGVFSEADMRFYAAEIIL 303

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE
Sbjct: 304 GLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           ++     Y ++ D +S GC+L +LL G   F      D+  EI ++ L   + L 
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP 414

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  134 bits (339), Expect = 7e-37
 Identities = 45/291 (15%), Positives = 94/291 (32%), Gaps = 56/291 (19%)

Query: 50  IVTTIGGKNGQPKQTISYMAER--------VVGHGSFGVVFQAKCLETGEAVAIKKVLQD 101
           +V+T     GQP +  S + ER        V+G        +A   ETGE+  +      
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114

Query: 102 KRYKN-------RELQTMRLL-------------------------DHPNVVSLKHCFFS 129
           +R  +        E+  +RLL                             ++ ++     
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
                  +L   ++   +T   V+  H    + +          Q+ R LA +H+  G+ 
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLV 233

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 242
           H  ++P +++++     + L  F        G   +S I   +      A  ++      
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290

Query: 243 -TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
            T  T A D W+ G  +  +         ++     +   + I  +  ++ 
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDA----ALGGSEWIFRSCKNIP 337

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  132 bits (334), Expect = 1e-36
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 25/229 (10%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 120
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 177
           ++L   +     ++   + L+LEY    E     + +    +S+      V     QI  
Sbjct: 92  INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
            + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y 
Sbjct: 143 GVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           APE I      T A D+W+ G +   LL     F GE   +  + I +V
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  130 bits (329), Expect = 2e-36
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 16/221 (7%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKH 125
            +G G++GVV + + + +G+ +A+K++   +  +  K    +L  +MR +D P  V+   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             F   +     + + +E +  ++ +  K      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---A 242
           + V HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK 282
             Y+   DIWS G  + EL + +  +        QL ++++
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  130 bits (330), Expect = 3e-36
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 184
                     + LV+EY    +++ V+ H  +        +   +  Q  + +AY+H   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           Y+   D++S G +L E++  +  F    G    + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  134 bits (339), Expect = 4e-36
 Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 21/235 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           RV+G G FG VF  +   TG+  A K  L  KR K R        E + +  +    +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L + F +   K +L L  V+  +   +  +  I +  + +          Y  QI   L 
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
           ++H    + +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSIK 294
            G  EY  ++D ++ G  L E++  +  F       +  E+ + +L   ++   K
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  130 bits (329), Expect = 8e-36
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 22/215 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 119
           Y+    +G GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++ L     +     ++   +V+EY   E    +++      +RM     + +F QI  A
Sbjct: 71  IIKLYDVITT---PTDIV--MVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           + Y H    + HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S  Y APE
Sbjct: 121 IEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           +I G       +D+WS G VL  +L+G+  F  E 
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  131 bits (332), Expect = 1e-35
 Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 44/246 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +V+G G+F  V   K  +TG+  A+K      +L+         E   +   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +DE YL LV+EY    + +        K  +R+P    + Y  +I  A+  
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 233
           +H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+     
Sbjct: 178 VHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 234 RAPELI------FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT 287
            +PE++       G   Y    D W+ G    E+  GQ  F  +S      E    I+H 
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS----TAETYGKIVHY 285

Query: 288 EISLSI 293
           +  LS+
Sbjct: 286 KEHLSL 291

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  133 bits (337), Expect = 1e-35
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 28/235 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           RV+G G FG V   +   TG+  A K  L+ KR K R        E Q +  ++   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPET-----VHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           L + + +   KD L L  VL  +        ++ + +  +  ++         Y  +IC 
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKFHIYHMGQAGFPEAR------AVFYAAEICC 297

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE
Sbjct: 298 GLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           ++     YT + D W+ GC+L E++ GQ  F       +  E+ +++       S
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  131 bits (332), Expect = 1e-35
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 30/238 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +V+G G+FG V   K     +  A+K     ++L+         E   +   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D+  L LV++Y    + +        K   R+P    + Y  ++  A+  
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 239
           +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 240 ----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSI 293
                G   Y    D WS G  + E+L G+  F  ES    LVE    I++ +     
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKERFQF 302

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  131 bits (332), Expect = 2e-35
 Identities = 69/238 (28%), Positives = 109/238 (45%), Gaps = 25/238 (10%)

Query: 56  GKNGQPKQTI-SYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--R 107
            +    +  I  Y+    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E+Q ++L  HP+++ L     +     +++  +V+EYV   E    + K+      R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVIST---PSDIF--MVMEYVSGGELFDYICKN-----GRLDE 115

Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              +  F QI   + Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              C S  Y APE+I G       +DIWS+G +L  LL G   F  +  V  L + I 
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC 229

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 2e-35
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 19/229 (8%)

Query: 53  TIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--R 107
           T   K G+ K    +     +G G+ GVVF+     +G  +A K +   ++        R
Sbjct: 22  TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLI 166
           ELQ +   + P +V     F+S  E     +++ +E++   ++ +V     K + R+P  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQV----LKKAGRIPEQ 131

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +      + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           ++ +R Y +PE + G   Y+   DIWS G  L E+ +G+   P     +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  127 bits (320), Expect = 1e-34
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 20/222 (9%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 125
            +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +V    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F + T+     + + +E +     ++ K   +M   +P   +      I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FG 241
            GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK 282
             +Y    D+WS G  L EL  GQ  +       + L ++++
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  127 bits (320), Expect = 1e-34
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 31/215 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-------RELQTMRL 114
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 171
           ++H N++ +    F    +      LV+E      +    + +H      R+        
Sbjct: 86  VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH-----PRLDEPLASYI 135

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 231 RYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLG 264
             Y APE++ G   Y    +++WS G  L  L+  
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFE 226

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  125 bits (315), Expect = 2e-34
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 32/225 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L                +V+E+VP   ++  +    + +   + L  +      I 
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM----LDIA 132

Query: 177 RALAYIHN-TIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYICSR 231
             + Y+ N    + HRD++  N+ +           K+ DFG ++           + + 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNF 190

Query: 232 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
            + APE I    E YT   D +S   +L  +L G+  F   S   
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  127 bits (322), Expect = 2e-34
 Identities = 67/243 (27%), Positives = 112/243 (46%), Gaps = 43/243 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +V+G G+FG V   +   T +  A+K     ++++     +   E   M   + P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D+ YL +V+EY+P  + V+ +  +       +P  + + Y  ++  AL  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDA 183

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 233
           IH+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI     
Sbjct: 184 IHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 234 RAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEIS 290
            +PE++    G   Y    D WS G  L E+L+G   F  +S    LV     I++ + S
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYSKIMNHKNS 291

Query: 291 LSI 293
           L+ 
Sbjct: 292 LTF 294

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  124 bits (313), Expect = 1e-33
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 17/222 (7%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 125
            +G G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +V    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHN 184
             F   +       + +E +  +  +  K+ Y +    +P   +        +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
            + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 245 ---YTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK 282
              Y    D+WS G  L EL  G+  +P  + V DQL +++K
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (324), Expect = 1e-33
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD-------KRYKNRELQTMRLLDHP 118
           Y  +  + HG  G ++ A      G  V +K  L               E Q +  + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139

Query: 119 NVVSLKHCFFSTTEKDELYLN-LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           ++V +   F   T++    +  +V+EYV  +++ R         Q++P+     Y  +I 
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSR 231
            AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +     + G P        
Sbjct: 193 PALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTP-------- 241

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            ++APE++      T A DI++ G  LA L L  P   G  
Sbjct: 242 GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  126 bits (318), Expect = 1e-33
 Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 33/279 (11%)

Query: 27  KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAK 85
            ++     E     G+ ++        +     + + T++ +   +++G G+FG V   K
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVK 168

Query: 86  CLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTEKDE 135
              TG   A+K      ++           NR LQ  R   HP + +LK+ F +    D 
Sbjct: 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYSFQT---HDR 222

Query: 136 LYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 193
           L    V+EY    E     +  H    +       + Y  +I  AL Y+H+   V +RD+
Sbjct: 223 LCF--VMEYANGGE-----LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275

Query: 194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIW 252
           K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++    +Y  A+D W
Sbjct: 276 KLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWW 333

Query: 253 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             G V+ E++ G+  F  +   +   ++ ++IL  EI  
Sbjct: 334 GLGVVMYEMMCGRLPFYNQD-HE---KLFELILMEEIRF 368

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (306), Expect = 8e-33
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYK---NRELQTMRLLDHP 118
           Y   R+VG G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +VV +        E D     + +  +    +  +++    ++    +  V+    QI  
Sbjct: 95  HVVPI----HDFGEIDGQLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVR----QIGS 145

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYY 233
           AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            APE    +   T   DI++  CVL E L G P + G+ 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  122 bits (307), Expect = 9e-33
 Identities = 56/286 (19%), Positives = 98/286 (34%), Gaps = 76/286 (26%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G FGVVF+AK        AIK++    R        RE++ +  L+HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------------- 168
              + +  T  +        +    E+    +     M      I               
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 169 -------KLY--------------------------------FYQICRALAYIHNTIGVC 189
                   LY                                F QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGLM 186

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNISYICSRYYRAP 236
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           E I G   Y+  +DI+S G +L ELL     F  +    +++  ++
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR 287

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  122 bits (308), Expect = 2e-32
 Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 67  YMAERVVGHG--SFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHP 118
           Y    V+G G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           N+V  +  F +    +EL+  +V  ++   +   +I  H+     M  + +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLK 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNISYIC 229
           AL YIH+  G  HR +K  ++L++    ++ L    S         +  V  +     + 
Sbjct: 140 ALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 230 SRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQP 266
              + +PE++      Y A  DI+S G    EL  G  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  120 bits (303), Expect = 2e-32
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 27/218 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR--- 177
           S    F     KDEL+  LV++ +   +V  +IKH     +    +  +     I R   
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 178 -ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR---- 231
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
               + APE++     Y    DIWS G    EL  G  
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  119 bits (301), Expect = 2e-32
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 121
           E ++G G FG V++A  +  G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 122 SLK-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQICRA 178
           +L+  C     ++  L L  V+E+     ++RV+          +          QI R 
Sbjct: 70  ALRGVC----LKEPNLCL--VMEFARGGPLNRVLSGKRIPPDILVNWAV------QIARG 117

Query: 179 LAYIH--NTIGVCHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNISYIC 229
           + Y+H    + + HRD+K  N+L+             LK+ DFG A+   +    +S   
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAG 176

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
           +  + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (301), Expect = 5e-32
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNR---ELQTMRLLDHP 118
           Y    ++G G    V  A+ L     VA+K VL     +D  +  R   E Q    L+HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHP 72

Query: 119 NVVSLKHCFFSTTEKDELYLN---LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            +V++    + T E +        +V+EYV   T+  ++     M+ +  +  +      
Sbjct: 73  AIVAV----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA----D 124

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICS 230
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  120 bits (303), Expect = 5e-32
 Identities = 67/238 (28%), Positives = 119/238 (50%), Gaps = 29/238 (12%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNREL--QTM---RLL----DHP 118
           +V+G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V+L + F  T  K  L+L  +L+Y+   E     +  H    +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF-QTETK--LHL--ILDYINGGE-----LFTHLSQRERFTEHEVQIYVGEIV 169

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYR 234
            AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 235 APELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           AP+++ G    +  A+D WS G ++ ELL G   F  +   +   EI + IL +E   
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (299), Expect = 7e-32
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 30/222 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDH 117
           Y     +G G    V+ A+       VAIK  +           KR++ RE+     L H
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFE-REVHNSSQLSH 70

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            N+VS+        E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI 
Sbjct: 71  QNIVSM----IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QIL 121

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRY 232
             + + H+   + HRDIKPQN+L++     LK+ DFG AK L   E +++     + +  
Sbjct: 122 DGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQ 177

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y +PE   G        DI+S G VL E+L+G+P F GE+ V
Sbjct: 178 YFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  119 bits (301), Expect = 8e-32
 Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 33/234 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K      ++           +R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++  L    V+EY    E     +  H    +       + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR--LCF--VMEYANGGE-----LFFHLSRERVFTEERARFYGAEIVSA 117

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           ++    +Y  A+D W  G V+ E++ G+  F  +   +    + ++IL  EI  
Sbjct: 176 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HE---RLFELILMEEIRF 224

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  119 bits (301), Expect = 9e-32
 Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 40/234 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +  F     KD   L +V+EYV   E     +  H +   R    + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 235
           +H+ + + +RD+KP+NLL++   + +++ DFG AK +        G P           A
Sbjct: 157 LHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI 289
           PE+I     Y  A+D W+ G ++ E+  G P F      DQ ++I + I+  ++
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKV 255

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  117 bits (296), Expect = 2e-31
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 124 K-HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                   T+   L   +V EY+   +++R++ H     +++         Y + + + Y
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152

Query: 182 IHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI 239
           +HN    + HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
                     D++S G +L EL   Q  +  
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (295), Expect = 3e-31
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 125
             V+G G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAYIH 183
                 +   L    + EY+   T+  +IK    M  + P    ++ F   I   +AY+H
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWS-QRVSFAKDIASGMAYLH 125

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------------ 231
           + + + HRD+   N LV      + + DFG A+++V  +     + S             
Sbjct: 126 S-MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
              Y+ APE+I G   Y   +D++S G VL E++      P 
Sbjct: 184 GNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  118 bits (297), Expect = 3e-31
 Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 35/237 (14%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQ----DKRYKNRELQTM---RLL---DH 117
           RV+G G +G VFQ + +    TG+  A+K VL+     +  K+    T     +L    H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTA-HTKAERNILEEVKH 80

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           P +V L + F  T  K  LYL  +LEY+   E     +    +            Y  +I
Sbjct: 81  PFIVDLIYAF-QTGGK--LYL--ILEYLSGGE-----LFMQLEREGIFMEDTACFYLAEI 130

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YR 234
             AL ++H   G+ +RD+KP+N+++N   H +KL DFG  K  +         C    Y 
Sbjct: 131 SMALGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           APE++   + +  A+D WS G ++ ++L G P F GE+      + I  IL  +++L
Sbjct: 189 APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RK---KTIDKILKCKLNL 240

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  117 bits (296), Expect = 3e-31
 Identities = 63/233 (27%), Positives = 112/233 (48%), Gaps = 29/233 (12%)

Query: 71  RVVGHGSFGVVFQAK---CLETGEAVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 121
           +V+G GSFG VF  K     +  +  A+K + +        ++T     +L   +HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L + F  T  K  LYL  +L+++   +     +              VK Y  ++  AL
Sbjct: 90  KLHYAF-QTEGK--LYL--ILDFLRGGD-----LFTRLSKEVMFTEEDVKFYLAELALAL 139

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
            ++H+ +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           +     +T + D WS G ++ E+L G   F G+       E + +IL  ++ +
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RK---ETMTMILKAKLGM 245

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (296), Expect = 4e-31
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 22/209 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +  + C+     +   +  LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQP 266
               E  Y   +D+WS G    EL   +P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP 251

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  118 bits (297), Expect = 5e-31
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 30/233 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 121
           +V+G GSFG V  A+        A+ KVLQ     K +E +  M       + + HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L    F T +K  LY   VL+Y+   E     + +H +  +       + Y  +I  AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGE-----LFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            Y+H+ + + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE+
Sbjct: 153 GYLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           +     Y   +D W  G VL E+L G P F   +      E+   IL+  + L
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TA---EMYDNILNKPLQL 258

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  116 bits (294), Expect = 5e-31
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 40/236 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D   + ++++Y+   E     +    + SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGE-----LFSLLRKSQRFPNPVAKFYAAEVCLALEY 121

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 235
           +H+   + +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y A
Sbjct: 122 LHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           PE++     Y  +ID WS G ++ E+L G   F         ++  + IL+ E+  
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRF 222

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  117 bits (296), Expect = 6e-31
 Identities = 71/234 (30%), Positives = 113/234 (48%), Gaps = 32/234 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
           RV+G GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  C F T ++  L+   V+E+V   +     +  H + S+R      + Y  +I  A
Sbjct: 87  TQLFCC-FQTPDR--LF--FVMEFVNGGD-----LMFHIQKSRRFDEARARFYAAEIISA 136

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 237
           L ++H+  G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE
Sbjct: 137 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           ++     Y  A+D W+ G +L E+L G   F  E+  D   ++ + IL+ E+  
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-ED---DLFEAILNDEVVY 243

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  117 bits (295), Expect = 8e-31
 Identities = 68/250 (27%), Positives = 116/250 (46%), Gaps = 41/250 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           RV+G GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 71  FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 120

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 121 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV-----EIIKVILHTEI- 289
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D         + +VIL  +I 
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237

Query: 290 ---SLSIKAA 296
              SLS+KAA
Sbjct: 238 IPRSLSVKAA 247

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  117 bits (295), Expect = 8e-31
 Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 36/236 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           +++G GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +  +   F  T E   L+   V+EY+   +     + +H +   +  L     Y  +I 
Sbjct: 79  FLTHMFCTF-QTKEN--LFF--VMEYLNGGD-----LMYHIQSCHKFDLSRATFYAAEII 128

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 235
             L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y A
Sbjct: 129 LGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           PE++ G  +Y  ++D WS G +L E+L+GQ  F G+   +   E+   I       
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EE---ELFHSIRMDNPFY 237

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 8e-31
 Identities = 44/216 (20%), Positives = 84/216 (38%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
            + +G G +G V+  K    GE VA+K     ++    RE  +    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
               T    +LYL  + +Y    +++  +K         + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A   +     +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 232 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 262
            Y  PE++  +      +     D++S G +L E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  116 bits (294), Expect = 1e-30
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 32/234 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  C F T ++  LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 84  TQLHSC-FQTMDR--LY--FVMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 133

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 237
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE
Sbjct: 134 LFFLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           +I     Y  ++D W+ G +L E+L GQ  F GE   D   E+ + I+   ++ 
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-ED---ELFQSIMEHNVAY 240

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (289), Expect = 2e-30
 Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
              VG G +G V++      GE VA+K    +D++   RE  L    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
              S     +L+L  +  Y    +++  ++         + +         I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRI------VLSIASGLAHLH 122

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 232 YYRAPELI-----FGATEYTAAIDIWSAGCVLAELL 262
            Y APE++         +    +DIW+ G VL E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  116 bits (292), Expect = 4e-30
 Identities = 67/250 (26%), Positives = 116/250 (46%), Gaps = 41/250 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           RV+G GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 163

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 164 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV-----EIIKVILHTEI- 289
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D         + +VIL  +I 
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280

Query: 290 ---SLSIKAA 296
              SLS+KAA
Sbjct: 281 IPRSLSVKAA 290

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (287), Expect = 4e-30
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +     +G GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                +   T+     L +++EY+   +   +++        +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 239
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
             +  Y +  DIWS G    EL  G+P
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  113 bits (285), Expect = 5e-30
 Identities = 28/211 (13%), Positives = 74/211 (35%), Gaps = 22/211 (10%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
              +     G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                        +  L+  ++P  +++ V+  H   +  +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 183 HN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H     +    +  ++++++      ++                  + +  + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEALQK 182

Query: 242 --ATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
                   + D+WS   +L EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (282), Expect = 2e-29
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 21/215 (9%)

Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR 113
            G PK+   Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
              +PN+V+    +      DEL+  +V+EY+   ++  V+         M    +    
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTET-----CMDEGQIAAVC 122

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
            +  +AL ++H+   V HRDIK  N+L+      +KL DFG    +   +    + + + 
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           Y+ APE++     Y   +DIWS G +  E++ G+P
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP 214

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  115 bits (290), Expect = 3e-29
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 32/234 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  CF  T ++  LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 405 TQLHSCF-QTMDR--LYF--VMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 454

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE
Sbjct: 455 LFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           +I     Y  ++D W+ G +L E+L GQ  F GE   D   E+ + I+   ++ 
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-ED---ELFQSIMEHNVAY 561

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  111 bits (279), Expect = 5e-29
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   ++   +     L +++E+ P   V  ++    +    +    +++   Q+  AL +
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNF 132

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H+   + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++ 
Sbjct: 133 LHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 241 GAT----EYTAAIDIWSAGCVLAELLLGQP 266
             T     Y    DIWS G  L E+   +P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (281), Expect = 6e-29
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
           +  +G G FG V++ K    GE VA+K    +++R   RE  +    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
                    +L+L  V +Y    ++   +  +   +   + L             LA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A         I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 232 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 262
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (278), Expect = 9e-29
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 15/204 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           +     +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             +F  T+     L +V+EY    +V  +I+     ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH 142

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
                 HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 FM-RKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 243 TEYTAAIDIWSAGCVLAELLLGQP 266
             Y    DIWS G    E+  G+P
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKP 223

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (277), Expect = 9e-29
 Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 26/224 (11%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   +   +L +  V ++    +++  +        +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H    + HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 H-AKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  112 bits (281), Expect = 1e-28
 Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 71/283 (25%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLL-----DHP 118
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N   VV L   F  +      ++ +V E +   + + I       Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLV----------------------------------- 200
            + L Y+H    + H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 201 -------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVI 284
             DIWS  C+  EL  G  LF   SG       D +  II+++
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  110 bits (276), Expect = 2e-28
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
             +   +G GS G+V  A+   +G  VA+K +     Q +     E+  MR   H NVV 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +   +      +EL+  +++E++    +  ++        R+    +      + +ALAY
Sbjct: 107 MYKSYLV---GEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAY 156

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H   GV HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I 
Sbjct: 157 LHAQ-GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQP 266
             + Y   +DIWS G ++ E++ G+P
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEP 239

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (275), Expect = 3e-28
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 15/211 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 122
           +    +VG+G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 123 LKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               F        +  L LV+E+    +V  +IK+       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLS 143

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 240 ----FGATEYTAAIDIWSAGCVLAELLLGQP 266
                    Y    D+WS G    E+  G P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (272), Expect = 9e-28
 Identities = 41/228 (17%), Positives = 85/228 (37%), Gaps = 47/228 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 124 K-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI---KHHYKMSQRMPLIYVKLYFYQICRA 178
              C         L   ++       T++ V+   K    +++   +        +I + 
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNKTRQIA------QEIVKG 142

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------ 232
           + Y+H   G+ H+D+K +N+  +     + + DFG     + G         +       
Sbjct: 143 MGYLH-AKGILHKDLKSKNVFYDNGK--VVITDFGLFS--ISGVLQAGRREDKLRIQNGW 197

Query: 233 --YRAPELIFGATE--------YTAAIDIWSAGCVLAELLLGQPLFPG 270
             + APE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  104 bits (262), Expect = 2e-26
 Identities = 54/239 (22%), Positives = 96/239 (40%), Gaps = 39/239 (16%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 120
           ++      V   G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 121 VS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICR 177
           +  +      T+   +L+L  +  +  + ++   +K +    ++   +         + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132

Query: 178 ALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
            LAY+H  I          + HRDIK +N+L+  +     + DFG A      E   S  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAG 188

Query: 229 CSRY------YRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
            +        Y APE++ GA     +    ID+++ G VL EL        G      L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  102 bits (256), Expect = 1e-25
 Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 36/231 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 126
             ++G G +G V++         VA+K     +++    E    R+  ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
               T    +   LV+EY P  ++ + +  H         +      + + R LAY+H  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130

Query: 186 I--------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNISYI 228
           +         + HRD+  +N+LV        + DFG +  L               IS +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 229 CSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLLG-QPLFPGES 272
            +  Y APE++ GA            +D+++ G +  E+ +    LFPGES
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 9e-23
 Identities = 29/219 (13%), Positives = 46/219 (21%), Gaps = 48/219 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNR---ELQTMRLLDHPN 119
           Y      G       +QA        VA+  V                    +  +D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +              L +V E++   ++  V             +        +  A
Sbjct: 93  VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
               H   GV      P  + V+     + L                             
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
                      DI   G  L  LL+ +   P       L
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L            +   L+ + +P    +  V +H       +   Y+  +  QI + 
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKG 129

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 44/235 (18%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            R +G G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     +     L LV+EYVP      ++  Y     + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLR-DYLPRHSIGLAQLLLFAQQICEGMA 148

Query: 181 YIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 280
                   APE +     +  A D+WS G  L ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.1 bits (219), Expect = 2e-20
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K             L L++EY+P       + KH  ++     L Y      QIC+ 
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKG 126

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     I   HRD+  +N+LV  + +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAELL 262
                     APE +   ++++ A D+WS G VL EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 4e-20
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 44/217 (20%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 121
            + +G G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K             L L++EY+P       + KH  ++     L Y      QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKGM 158

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL 262
                    APE +   ++++ A D+WS G VL EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 87.4 bits (217), Expect = 5e-20
 Identities = 49/233 (21%), Positives = 88/233 (37%), Gaps = 40/233 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
            R++G G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 121 VSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQIC 176
             L      S  +       ++L ++    +H  +           L    L  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
             + Y+ ++    HRD+  +N ++      + + DFG ++ +  G+         YYR  
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------YYRQG 196

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     A E L      YT   D+W+ G  + E++  GQ  + G    +
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 86.2 bits (214), Expect = 8e-20
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            R +G G FG V   +       TGE VA+K +  +    +     +E++ +R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V  K      TE     + L++E++P  ++   +  +     ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGM 139

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL 262
                    APE +  +  +  A D+WS G  L ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 86.6 bits (215), Expect = 9e-20
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 48/219 (21%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
              +G G+FG V   +       TG  VA+K  LQ           RE+Q ++ L    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +   +    +  L   LV+EY+P       + +H  ++     L+Y      QIC+ 
Sbjct: 87  VKYRGVSYGPGRQS-LR--LVMEYLPSGCLRDFLQRHRARLDASRLLLYS----SQICKG 139

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   +         YY   
Sbjct: 140 MEYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVR 187

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL 262
                     APE L      ++   D+WS G VL EL 
Sbjct: 188 EPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELF 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 33/226 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E +     ++   D+W+ G +L E+   G   +PG       +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 43/234 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
            +++G G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQICR 177
           + L       + +      ++L ++    +H  + +    +    +    L  +   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         YYR 
Sbjct: 159 GMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YYRQ 205

Query: 235 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                      A E L      YT+  D+W+ G  + E+   G   +PG    +
Sbjct: 206 GRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 85.3 bits (211), Expect = 8e-19
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.1 bits (206), Expect = 1e-18
 Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 47/232 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 119
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V +        E +     LV+E         +  + + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + +   ++++  D+WS G ++ E    GQ  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 45/228 (19%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 124
              +G G+FG VF  +       VA+K   +      +     E + ++   HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 125 H--CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 181
              C    T+K  +Y  +V+E V            +       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------- 234
           + +     HRD+  +N LV    + LK+ DFG ++    G          Y         
Sbjct: 229 LES-KCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277

Query: 235 -----APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                APE L +G   Y++  D+WS G +L E   LG   +P  S   
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 48/236 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             L            +   L+ + +P   +   ++ H      +   Y+  +  QI + +
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y    
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                   A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 55/224 (24%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 124
           + ++GHG FG V++   L  G  VA+K+   +      E +T    +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 125 HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMS--QRMPLIYVKLYFYQIC- 176
            C     E++E+ L  + +Y+        ++        MS  QR+          +IC 
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EICI 146

Query: 177 ---RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 232
              R L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +   +++ +   
Sbjct: 147 GAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVK 202

Query: 233 ----YRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQP 266
               Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 203 GTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 45/235 (19%), Positives = 78/235 (33%), Gaps = 50/235 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN----RELQTMRLLDHP 118
              +G G+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 119 NVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQIC 176
           ++V     C       DE    LV E+V       +  + K ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 177 RALAYI--HNTIGVCHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNISY 227
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 228 ICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +       PE I        A D WS G  L E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 47/232 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L        + + L   LV+E      +H+ +       + +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGM 449

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 51/237 (21%), Positives = 92/237 (38%), Gaps = 50/237 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G FG V +   +  GE+    V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L            L   LV +Y+P  ++   ++ H      +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +               
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---------KQLLYS 175

Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 176 EAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 37/215 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 183
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 237
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 238 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            L     +++   D+WS G +L E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 82.3 bits (204), Expect = 2e-18
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 33/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           E L +   +++   D+W+ G +L E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 37/220 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 183
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 237
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 238 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
            L     +++   D+WS G +L E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E+ +G G FG V+ A   +  + VA+K +            E   M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
             +   K+ +Y  ++ E++       +    K  +       KL  +  QI   +A+I  
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 235 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
              APE + FG   +T   D+WS G +L E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.5 bits (202), Expect = 5e-18
 Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 56/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            + +G G+FG V +A        +    VA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPL 165
           N+V+L       T        ++ EY                 +             + L
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               L    YQ+ + +A++  +    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                    Y             APE IF    YT   D+WS G  L EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 271 ESGVDQLVEIIK 282
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.8 bits (200), Expect = 7e-18
 Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 49/238 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L        + + L   LV+E      +H+ +    +      +       +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAE---LLHQVSMGM 123

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 80.4 bits (199), Expect = 1e-17
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 49/242 (20%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTM 112
           P + +   ++RV+G G FGVV+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R L+HPNV++L         +   +  ++L Y+    H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC---HGDLLQFIRSPQRNPTVKDLISF 129

Query: 173 -YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
             Q+ R + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E       
Sbjct: 130 GLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------- 178

Query: 230 SRYYR--------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
             YY               A E L      +T   D+WS G +L ELL  G P +     
Sbjct: 179 --YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

Query: 274 VD 275
            D
Sbjct: 235 FD 236

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.0 bits (198), Expect = 1e-17
 Identities = 56/261 (21%), Positives = 102/261 (39%), Gaps = 63/261 (24%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQT 111
            ++ I     R +G G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMS 160
           +  L H ++V          + D L   +V EY+                 ++       
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 161 QRMPLIYVKLYF--YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
            +  L   ++     QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181

Query: 217 VLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL- 262
            +   +         YYR             PE +++   ++T   D+WS G +L E+  
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230

Query: 263 LG-QPLFPGESGVDQLVEIIK 282
            G QP +   S   +++E I 
Sbjct: 231 YGKQP-WFQLS-NTEVIECIT 249

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.6 bits (197), Expect = 1e-17
 Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 51/229 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C     E+  +   LV E++         R  +  +       L+        +C  +AY
Sbjct: 72  C----LEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAET---LLG---MCLDVCEGMAY 119

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +     I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y       
Sbjct: 120 LEEACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTK 166

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +PE   F    Y++  D+WS G ++ E+   G+  +   S  +
Sbjct: 167 FPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 52/243 (21%), Positives = 95/243 (39%), Gaps = 50/243 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 120
           R +G GSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           V L       ++       +++E +            R    +  +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           +I   +AY+ N     HRD+  +N +V      +K+ DFG  + + + +         YY
Sbjct: 146 EIADGMAYL-NANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194

Query: 234 R------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
           R            +PE L  G   +T   D+WS G VL E+  L +  + G S  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 280 IIK 282
            + 
Sbjct: 252 FVM 254

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.6 bits (197), Expect = 2e-17
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
              +G G FG V+        + VA+K + Q     +    E   M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  ++ EY+    +  +    K    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 235 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
              APE + +G   +T   D+WS G +L E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 53/249 (21%)

Query: 71  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 119
           + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPLI 166
           VV+L      T     L   +++E+               E V   +         + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           ++  Y +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202

Query: 227 YICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
                 Y             APE IF    YT   D+WS G +L E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 274 VDQLVEIIK 282
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 53/235 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FGVV   K     + VA+K + +    ++   +E QTM  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    +++  +Y  +V EY+         R      + SQ   L+      Y +C  +A+
Sbjct: 72  C----SKEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQ---LLE---MCYDVCEGMAF 119

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +  H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y       
Sbjct: 120 LESHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTK 166

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
                 APE   +   +Y++  D+W+ G ++ E+  LG+  +   +   V   V 
Sbjct: 167 FPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 56/239 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L         ++ ++  +++E        +  +V K    ++    LI    Y YQ+  
Sbjct: 455 KL----IGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLAS---LIL---YAYQLST 502

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 503 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 549

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
                     APE + F    +T+A D+W  G  + E+L  G   F G     V   +E
Sbjct: 550 SKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.0 bits (193), Expect = 5e-17
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R++G G FG V++            VA+K   +D    N+     E   M+ LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L        E++  +  +++E  P           K+  K+     L+    Y  QIC+
Sbjct: 77  KL----IGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLT---LVL---YSLQICK 124

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           A+AY+   N +   HRDI  +N+LV      +KL DFG ++ +   +         YY+ 
Sbjct: 125 AMAYLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKA 171

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     +PE + F    +T A D+W     + E+L  G+  F      D
Sbjct: 172 SVTRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 55/236 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 175
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + Y+ +     HRD+  +N +++     +K+ DFG A+ +   E         YY  
Sbjct: 138 AKGMKYLAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186

Query: 235 -------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                        A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 78.1 bits (193), Expect = 6e-17
 Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 54/240 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L    +       +   +V E  P    + R+ KH         L  +  Y  Q+  
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAE 132

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y  
Sbjct: 133 GMGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVM 180

Query: 235 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                      APE L      ++ A D W  G  L E+   GQ  + G +G      ++
Sbjct: 181 QEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.9 bits (195), Expect = 7e-17
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 43/229 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L+       T+   +   +V EY+   ++   ++ H      + L+        I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGM 160

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
            Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL              Y      
Sbjct: 161 KYL-SDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +PE + +   ++T+A D+WS G VL E++  G+  +   S  D
Sbjct: 212 IPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 77.7 bits (192), Expect = 9e-17
 Identities = 64/239 (26%), Positives = 99/239 (41%), Gaps = 56/239 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L         ++ ++  +++E        +  +V K+   ++    LI    Y YQ+  
Sbjct: 80  KL----IGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLAS---LIL---YAYQLST 127

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 128 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 174

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                     APE + F    +T+A D+W  G  + E+L  G   F G    D    +E
Sbjct: 175 SKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 78.1 bits (193), Expect = 9e-17
 Identities = 55/249 (22%), Positives = 96/249 (38%), Gaps = 56/249 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQTMRLLDHPNV 120
           +  +G G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP----------ETVHRVIKHHYKMSQRMPLIYVKL 170
           V         TE   L   +V EY+                 +    +     PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 171 YF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
                Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +   +      
Sbjct: 161 LAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212

Query: 229 CSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGESG 273
              YYR             PE +++   ++T   D+WS G VL E+   G QP +   S 
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265

Query: 274 VDQLVEIIK 282
             + ++ I 
Sbjct: 266 NTEAIDCIT 274

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 51/238 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L+       T        +V EY+   ++   ++ H      M L+        +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGM 164

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    APE + F    +++A D+WS G V+ E+L  G+  +   +  D    VE
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FGVV   K     + VAIK + +    ++    E + M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    T++  ++  ++ EY+         R ++H ++  Q   L+        +C A+ Y
Sbjct: 88  C----TKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQ---LLE---MCKDVCEAMEY 135

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +     +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y       
Sbjct: 136 LESKQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSK 182

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                  PE L++   ++++  DIW+ G ++ E+  LG+  +   +  +
Sbjct: 183 FPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 47/223 (21%), Positives = 87/223 (39%), Gaps = 43/223 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 123
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +       ++ L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH
Sbjct: 72  YYFG-----QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 184 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 234
               + +RDIKP N L+    + + + + + DFG  K          Y          YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173

Query: 235 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
             + + G   Y  +I            D+ + G V    L G 
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 77.1 bits (190), Expect = 3e-16
 Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 175
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + ++  +    HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 202 AKGMKFL-ASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 173
           +V        + +    +  ++LE +      +  R  +   + SQ   L  + L     
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 188

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 231
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 189 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 232 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 278 VEIIK 282
           +E + 
Sbjct: 296 LEFVT 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 173
           +V        + +    +  +++E +      +  R  +   + SQ   L  + L     
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 147

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 231
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 148 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 232 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 278 VEIIK 282
           +E + 
Sbjct: 255 LEFVT 259

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 68/268 (25%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 110
           P+  I Y+  R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-------------------ETVHR 151
            M   D+PN+V L            + L  + EY+                         
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 152 VIKHHYKMSQRMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             +         PL   +      Q+   +AY+ +     HRD+  +N LV  +   +K+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKI 215

Query: 210 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGC 256
            DFG ++ +   +         YY+             PE + +    YT   D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 257 VLAELL-LG-QPLFPGESGVDQLVEIIK 282
           VL E+   G QP + G +  ++++  ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 76.2 bits (188), Expect = 5e-16
 Identities = 50/238 (21%), Positives = 93/238 (39%), Gaps = 50/238 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           ++V+G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 121 VSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 178
           + L+       ++   +   ++ EY+    +  +    +       +   +     I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL              Y   
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTS 208

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
                    APE + +    +T+A D+WS G V+ E++  G+  +   S   V + + 
Sbjct: 209 GGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.9 bits (187), Expect = 5e-16
 Identities = 45/223 (20%), Positives = 81/223 (36%), Gaps = 43/223 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 123
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +           Y  +VLE +  ++  +        +   L  V +   Q+   + Y+H
Sbjct: 71  YYFG-----PCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 184 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 234
           +   + +RD+KP+N L+    N     + + DF  AK          YI         YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172

Query: 235 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
             + + G   Y  +I            D+ + G +    L G 
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.7 bits (187), Expect = 6e-16
 Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 64/258 (24%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            + +G G FG V +A             VA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVK--- 169
           V+ L       ++   L   L++EY             R +   Y  S            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 170 ----------LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
                     + F +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG- 264
            + +          Y             A E +F    YT   D+WS G +L E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 265 QPLFPGESGVDQLVEIIK 282
            P +PG    ++L  ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 75.7 bits (187), Expect = 7e-16
 Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 50/222 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 124
           + ++G G FG V++ + L  G  VA+K++ +++          E++ + +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 125 -HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKM--SQRMPLIYVKLYFYQIC 176
             C        E  L  V  Y+        +    +    +   +R           +I 
Sbjct: 94  GFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIA 137

Query: 177 ----RALAYIHNTIGVC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
               R LAY+H+       HRD+K  N+L++    +  + DFG AK++   +   +++ +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTT 193

Query: 231 RY-----YRAPE-LIFG-ATEYTAAIDIWSAGCVLAELLLGQ 265
                  + APE L  G ++E T   D++  G +L EL+ GQ
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 123
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +         +  Y  LV++ +  ++  +       S+++ L  V +   Q+   + ++H
Sbjct: 69  RWFG-----VEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 184 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 236
           +     HRDIKP N L+      +Q+ + DFG AK          Y  +       YR  
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170

Query: 237 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
           + + G   Y A++            D+ S G VL   L G 
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 74.7 bits (184), Expect = 1e-15
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 41/221 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 123
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C       +  Y  +V+E +  ++  +       S++  L  V L   Q+   + YIH
Sbjct: 71  RWCG-----AEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 184 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           +     HRD+KP N L+      + + + DFG AK          Y  +R      YR  
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172

Query: 237 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
           + + G   Y A+I            D+ S G VL    LG 
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 59/251 (23%), Positives = 96/251 (38%), Gaps = 58/251 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP---------ETVHRVIKHHYKMSQRMPLIYVK 169
           N+V+L       T    +   ++ EY                +                 
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 170 L-YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           L +F  Q+ + +A++   N I   HRD+  +N+L+    H  K+ DFG A+ ++      
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS--- 218

Query: 226 SYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGE 271
                  Y             APE IF    YT   D+WS G +L E+  LG  P +PG 
Sbjct: 219 ------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGI 270

Query: 272 SGVDQLVEIIK 282
               +  +++K
Sbjct: 271 LVNSKFYKLVK 281

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 63/258 (24%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            +V+G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-----------------ETVHRVIKHHYKMSQ 161
           N+V+L       T    +YL  + EY                   + +    +   +  +
Sbjct: 110 NIVNLLGA---CTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 162 RMPLIYVK--LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            + ++  +  L F YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLG 264
           +             Y             APE +F    YT   D+WS G +L E+  L  
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 265 QPLFPGESGVDQLVEIIK 282
            P +PG        ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 57/251 (22%), Positives = 93/251 (37%), Gaps = 58/251 (23%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
              +G   FG V++         E  +AVAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYV 168
           VV L       T+   L   ++  Y                  V       + +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 169 KLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
                  QI   + Y+ ++  V H+D+  +N+LV      +K+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182

Query: 227 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGE 271
                YY+            APE +++G  +++   DIWS G VL E+   G QP + G 
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGY 234

Query: 272 SGVDQLVEIIK 282
           S    +VE+I+
Sbjct: 235 S-NQDVVEMIR 244

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 58/252 (23%), Positives = 103/252 (40%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPL 165
           H N+++L       T+   LY  +++EY                     ++   +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               L    YQ+ R + Y+  +    HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRM 163
           H N+++L       T+   LY  +++EY              P  +      +    ++M
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               +    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.4 bits (179), Expect = 5e-15
 Identities = 41/241 (17%), Positives = 68/241 (28%), Gaps = 58/241 (24%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----------RELQTMRLL----- 115
           +G G FG VFQ         VAIK + ++     N            E+   + L     
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 116 ----DHPNVVSLKHCFFSTTEKDELYLNLVLEY---------------------VPETVH 150
                    + L            L L     Y                     V E   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 151 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 210
             I      ++   L   K   +Q+  +LA    ++   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
              + K                     L     +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 271 E 271
           +
Sbjct: 252 D 252

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 56/252 (22%), Positives = 105/252 (41%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G+FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-----------TVHRVIKHHYKMSQRMPL 165
           H N+++L       T+   LY  +++EY  +                  +         +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            +  L    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 263 IP-VEELFKLLK 273

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.5 bits (178), Expect = 9e-15
 Identities = 40/250 (16%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK 105
            G ++    G +         ++  + +G G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 106 N---RELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVPET 148
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 149 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQL 207
           + ++   +    +      V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKISGQNGTFKKST----VLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWSAG 255
            L D+G +        +  Y         +   G  E+  ++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 256 CVLAELLLGQ 265
             +   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 69.1 bits (170), Expect = 1e-13
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 46/218 (21%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 123
            +G G FGVV++   +     VA+KK+            ++       M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 124 K-HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----R 177
                   ++ D+L L  V  Y+P  ++         +    PL +      +I      
Sbjct: 96  LGFS----SDGDDLCL--VYVYMPNGSLLD---RLSCLDGTPPLSWHMRC--KIAQGAAN 144

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
            + ++H      HRDIK  N+L+           K+ DFG A+   K     + + SR  
Sbjct: 145 GINFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIV 196

Query: 232 --Y-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
               Y APE + G  E T   DI+S G VL E++ G P
Sbjct: 197 GTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 60/238 (25%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA--VAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYVKL 170
           +L         +  LYL   +EY P             +          S    L   +L
Sbjct: 90  NLLGA---CEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 171 -YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +F   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 227 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                 Y             A E L +    YT   D+WS G +L E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.5 bits (160), Expect = 2e-12
 Identities = 38/252 (15%), Positives = 80/252 (31%), Gaps = 50/252 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG--------EAVAIKK 97
            G ++    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 98  VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTEKDELYLNLVLEYVP 146
             +D R  N +    R      V   K            C      +D+    LVL  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 205
            ++   +    K    +    V     ++  AL ++H      H ++  +N+ V+P    
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 253
           Q+ L  +G A        +++Y             G  E+  ++            D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253

Query: 254 AGCVLAELLLGQ 265
            G  + + L G 
Sbjct: 254 LGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 43/252 (17%), Positives = 77/252 (30%), Gaps = 50/252 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQA-----KCLETGEAVAIKKVLQ 100
            G II                +     +G G FG ++ A     + + +     +K    
Sbjct: 25  VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75

Query: 101 DKRYKNRELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVP 146
           D      EL+  +    P  +                        +  + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 205
             + ++ + + K   R     V     +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 253
           Q+ L D+G A        + +Y             G  E+  +I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 254 AGCVLAELLLGQ 265
            G  + + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 25/123 (20%)

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K            
Sbjct: 200 FQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP---------D 248

Query: 233 YR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
           Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++   
Sbjct: 249 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

Query: 280 IIK 282
            +K
Sbjct: 308 RLK 310

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.6 bits (100), Expect = 8e-05
 Identities = 27/147 (18%), Positives = 52/147 (35%), Gaps = 23/147 (15%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HP 118
            + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NVV+L      T     L   +++E+        +  +   S+R   +  K    +  + 
Sbjct: 87  NVVNLLGA--CTKPGGPLM--VIVEFCK---FGNLSTYL-RSKRNEFVPYKTKGARFRQG 138

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTH 205
             Y+         D+K +   +     
Sbjct: 139 KDYVGA----IPVDLKRRLDSITSSQS 161

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 2e-04
 Identities = 29/177 (16%), Positives = 52/177 (29%), Gaps = 47/177 (26%)

Query: 80  VVFQAKCLETGEAVAIK-KVLQ----DKRYKN-----RELQTMRLLD---HPNVVSLKHC 126
            VF         +  I   +L     D    +      +L    L++     + +S+   
Sbjct: 379 SVFP-------PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-----MPLIYVKLYFYQICRALAY 181
           +     K E    L         HR I  HY + +      +   Y+  YFY     + +
Sbjct: 432 YLELKVKLENEYAL---------HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH---IGH 479

Query: 182 IH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--------SYIC 229
            H   I    R    + + ++    + K+    +A        N          YIC
Sbjct: 480 -HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC 535

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	296
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.75
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.69
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.35
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.18
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.87
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.63
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.6
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.58
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.55
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.4
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.37
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.29
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.24
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.06
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.51
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.98
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.54
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.27

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-56  Score=377.94  Aligned_cols=214  Identities=30%  Similarity=0.466  Sum_probs=171.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++...       .....+|+++++.++|||||+++++|     .+..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence            35799999999999999999999999999999998532       22356899999999999999999998     3444


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+|+|||||+|+|.+.+..    ..++++..++.+++||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            5899999999999988876    47899999999999999999999999 999999999999999887 89999999998


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .........+..||+.|||||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.....+
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p  232 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP  232 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            776655566778999999999998777567899999999999999999999999887776677766544433

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.5e-56  Score=380.73  Aligned_cols=217  Identities=30%  Similarity=0.506  Sum_probs=186.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .++|++.+.||+|+||+||+|++..+++.||+|++...       .....+|+++|+.++|||||+++++|     .+..
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            35799999999999999999999999999999998532       23356899999999999999999998     4455


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+|+|||||+| +|.+.+...    +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g-~vKl~DFGla  179 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTA  179 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCC-CEEEEEcCCc
Confidence            68999999985 888888753    6899999999999999999999999 999999999999999887 7999999999


Q ss_pred             eeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          216 KVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       216 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      +.+....   ...+.+||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+.++.+.-...+...|
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s  258 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFF  258 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCC
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Confidence            8764332   234568999999999997655 899999999999999999999999998887777888775544443343

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-54  Score=376.31  Aligned_cols=207  Identities=29%  Similarity=0.434  Sum_probs=180.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..|++.++||+|+||+||+|+++.+|+.||||++...    .....+|+++|+.++|||||+++++|..     ...+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3345689999999999999999999844     344899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |||||+| +|.+++..     .++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999995 66666653     5799999999999999999999999 999999999999999888 89999999998765


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ... ...+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.+..
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~  286 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL  286 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred             CCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            443 345678999999999986554 8999999999999999999999999988877777776643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-54  Score=378.64  Aligned_cols=210  Identities=30%  Similarity=0.475  Sum_probs=175.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++|++++.||+|+||+||+|++..+|+.||||++...      ...+.+|+++|+.++|||||+++++|.     +...+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence            5799999999999999999999999999999998543      233458999999999999999999984     34458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |||||||+ |+|.+++....  ...+++..++.|+.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        99 yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~~  174 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARV  174 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTC-CEEECSTTEESC
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-CEEEccccccee
Confidence            99999998 58888886532  35679999999999999999999998 999999999999999887 899999999986


Q ss_pred             eccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          218 LVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       218 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ...... ....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.++.+.-
T Consensus       175 ~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~  241 (350)
T 4b9d_A          175 LNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS  241 (350)
T ss_dssp             CCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             ecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            543221 23457999999999997654 8999999999999999999999999998888777777653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4e-54  Score=369.78  Aligned_cols=216  Identities=28%  Similarity=0.437  Sum_probs=177.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|++.+.||+|+||+||+|++.   .+++.||+|++...      .....+|+++|+.++|||||+++++|.     +.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence            57999999999999999999984   46789999988432      234567999999999999999999984     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..+|+|||||+ |+|.+.+..    .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence            45899999998 588888876    36899999999999999999999999 999999999999999888 799999999


Q ss_pred             eeeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       215 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      |+..... ....+..||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.+.-...+...|
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s  250 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS  250 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred             ceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCC
Confidence            9865433 3345678999999999997655 899999999999999999999999999888888888775544443333

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-53  Score=378.86  Aligned_cols=207  Identities=29%  Similarity=0.434  Sum_probs=180.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|..     ...+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3345689999999999999999999954     334899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |||||+| +|.+++..     .++++..++.+++||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+.+.
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999995 66666643     5799999999999999999999999 999999999999999888 89999999998765


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ... ...+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~  363 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL  363 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             CCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            443 345678999999999996554 8999999999999999999999999988877777776643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.1e-54  Score=372.55  Aligned_cols=208  Identities=26%  Similarity=0.386  Sum_probs=176.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEe
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  143 (296)
                      ...|++.++||+|+||.||+|+++.+|+.||||++... ....+|+.+++.++|||||+++++|.     +...+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~-~~~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFRVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH-HhHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEe
Confidence            34699999999999999999999999999999998643 33457999999999999999999984     3445899999


Q ss_pred             ccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC
Q 022520          144 YVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (296)
Q Consensus       144 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~  222 (296)
                      ||+ |+|.+++...    +++++..++.++.||+.||+|||++ +|+||||||+|||++.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            998 5888888653    6799999999999999999999998 999999999999999887579999999998764432


Q ss_pred             C------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          223 P------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       223 ~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .      ....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.+.
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~  271 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE  271 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS
T ss_pred             cccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC
Confidence            1      12346999999999997655 899999999999999999999999987766666666553

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.9e-53  Score=360.74  Aligned_cols=207  Identities=23%  Similarity=0.361  Sum_probs=173.8

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |++.++||+|+||+||+|.+..++..||+|++....      ..+.+|+++|+.++|||||+++++|.... .+..++++
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            478889999999999999999999999999985321      23568999999999999999999885433 34556899


Q ss_pred             EEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |||||+ |+|.+++..    ..++++..++.++.||+.||+|||++ +  |+||||||+|||++...+.+||+|||+|+.
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            999998 578887765    36799999999999999999999998 8  999999999999985333899999999975


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      . ......+..||+.|||||++.+  .|+.++|||||||++|||+||++||.+.+....+...+.
T Consensus       182 ~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~  243 (290)
T 3fpq_A          182 K-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  243 (290)
T ss_dssp             C-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             C-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence            3 3334456789999999999853  489999999999999999999999988766555544443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=374.29  Aligned_cols=219  Identities=37%  Similarity=0.636  Sum_probs=189.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      ++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+++|+.++|||||++++++..... .+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47999999999999999999999999999999985322      234479999999999999999998754321 23355


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +|+|||||+|+|.+.+..    .+++++..++.+++||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCC-CEEEeecceeee
Confidence            899999999998887765    47899999999999999999999998 999999999999999887 899999999976


Q ss_pred             eccC-----CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          218 LVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       218 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      +...     ....+.+||+.|||||++.+...++.++||||+||++|||++|++||.+.+..+.+..|.+..+.++.
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            5332     22345689999999999887777899999999999999999999999999999999999998877654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-51  Score=353.85  Aligned_cols=213  Identities=23%  Similarity=0.351  Sum_probs=174.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ...+|.+.+.||+|+||+||+|++.     .++..||||++....    +.+.+|+++|++++|||||++++++...   
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~---   87 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG---   87 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---
Confidence            3457999999999999999999875     357899999986432    3456899999999999999999998433   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHY---------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~  203 (296)
                        ..+++|||||+ |+|.+++....         .....+++..+..++.|+++||.|||++ +|+||||||+|||++.+
T Consensus        88 --~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 --DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             --SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGG
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCC
Confidence              33889999998 68888887542         1235799999999999999999999998 99999999999999988


Q ss_pred             CCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 022520          204 THQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (296)
Q Consensus       204 ~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~  279 (296)
                      + .+||+|||+++........   ....||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..
T Consensus       165 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  242 (299)
T 4asz_A          165 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  242 (299)
T ss_dssp             G-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             C-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            7 8999999999765433221   2346899999999997655 8999999999999999998 8999999887776666


Q ss_pred             HHHh
Q 022520          280 IIKV  283 (296)
Q Consensus       280 ~~~~  283 (296)
                      +.+.
T Consensus       243 i~~~  246 (299)
T 4asz_A          243 ITQG  246 (299)
T ss_dssp             HHHT
T ss_pred             HHcC
Confidence            6653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=350.75  Aligned_cols=213  Identities=23%  Similarity=0.345  Sum_probs=170.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ...++.+.++||+|+||+||+|++.     .+++.||||++....    +.+.+|+++|++++|||||++++++..    
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----  114 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----  114 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence            4457999999999999999999874     368899999986432    345689999999999999999999843    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~  201 (296)
                       ...+++|||||+ |+|.+++.....           ...++++.++..++.|++.||.|||++ +|+||||||+|||++
T Consensus       115 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          115 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVG  192 (329)
T ss_dssp             -SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEEC
Confidence             334889999999 578888765421           235699999999999999999999998 999999999999999


Q ss_pred             CCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022520          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (296)
Q Consensus       202 ~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  277 (296)
                      .++ .+||+|||+++.......   .....||+.|||||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+
T Consensus       193 ~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          193 QGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             TTT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             CCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 899999999986543322   23456899999999996654 8999999999999999998 89999998877777


Q ss_pred             HHHHHh
Q 022520          278 VEIIKV  283 (296)
Q Consensus       278 ~~~~~~  283 (296)
                      ..+.+.
T Consensus       271 ~~i~~g  276 (329)
T 4aoj_A          271 DCITQG  276 (329)
T ss_dssp             HHHHHT
T ss_pred             HHHHcC
Confidence            666553

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-50  Score=347.99  Aligned_cols=200  Identities=26%  Similarity=0.482  Sum_probs=156.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccC-------
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-------  132 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  132 (296)
                      .+|++.+.||+|+||+||+|+++.+++.||||++....     ....+|+++|+.++|||||+++++|...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999999999999999986432     234589999999999999999999876543       


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                      ....++|+|||||++ +|.+.+..... ....+...++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCC-cEEEcc
Confidence            234467899999985 77777765321 23355667889999999999999999 999999999999999887 899999


Q ss_pred             ecceeeeccCCC-------------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          212 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       212 fg~~~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ||+|+.......             ..+.+||+.|||||++.+.. |+.++|||||||++|||++   ||.+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            999987644322             12357999999999997654 8999999999999999996   88654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-50  Score=355.14  Aligned_cols=213  Identities=27%  Similarity=0.459  Sum_probs=176.2

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeecc--hhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      |...++|++.+.||+|+||+||+|++.   .+++.||+|.+....  ....+|+++|+.+ +||||++++++|.     +
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----K   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----E
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----E
Confidence            334567999999999999999999875   467899999885433  3345899999988 6999999999984     3


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..++++|||||++ +|.+.+       ..+++.+++.+++||+.||+|||++ ||+||||||+|||++.+.+.+||+|||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            4458999999985 666655       3589999999999999999999998 999999999999999875589999999


Q ss_pred             ceeeeccCCC-----------------------------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhC
Q 022520          214 SAKVLVKGEP-----------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  264 (296)
Q Consensus       214 ~~~~~~~~~~-----------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g  264 (296)
                      +|+...+...                             ..+.+||+.|||||++.+...|+.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            9976533221                             12346899999999998777799999999999999999999


Q ss_pred             CCCCC-CCChHHHHHHHHHhhcC
Q 022520          265 QPLFP-GESGVDQLVEIIKVILH  286 (296)
Q Consensus       265 ~~pf~-~~~~~~~~~~~~~~~~~  286 (296)
                      ++||. +.++.+++..|.+.++.
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~  266 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGS  266 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCC
Confidence            99985 55667778888776654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=349.01  Aligned_cols=209  Identities=22%  Similarity=0.331  Sum_probs=168.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ....++.+.+.||+|+||+||+|++.   ..||||+++..      .+.+.+|++++++++|||||++++++..    + 
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~-  104 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D-  104 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S-
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C-
Confidence            34457899999999999999999853   35899988532      2345689999999999999999997621    1 


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                       .+++|||||+ |+|.+.+...   ..++++..+..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+
T Consensus       105 -~~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~-~~Ki~DFGl  178 (307)
T 3omv_A          105 -NLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGL  178 (307)
T ss_dssp             -SCEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTE-EEEECCCSS
T ss_pred             -eEEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCC-cEEEeeccC
Confidence             2679999999 5777777543   36799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCC---CcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          215 AKVLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       215 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      |+......   ......||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+..+.+..++...
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~  253 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG  253 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence            97653322   23345799999999998643  348999999999999999999999999887777766665544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.7e-50  Score=347.80  Aligned_cols=211  Identities=24%  Similarity=0.330  Sum_probs=174.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ..++++.++||+|+||+||+|++.     .+++.||||++...     .+.+.+|+.++++++|||||++++++...   
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD---  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence            356899999999999999999863     46789999998532     23466899999999999999999998433   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli  200 (296)
                        ..+++|||||+ |+|.+++....            .....+++..+..++.||++||.|||++ +||||||||+|||+
T Consensus       102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLV  178 (308)
T ss_dssp             --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEE
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEE
Confidence              33789999998 58888886532            1235689999999999999999999998 99999999999999


Q ss_pred             cCCCCcEEEeeecceeeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022520          201 NPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  276 (296)
Q Consensus       201 ~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  276 (296)
                      +.++ .+||+|||+++......   ......||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 89999999998654332   233457899999999997655 8999999999999999998 8999999887666


Q ss_pred             HHHHHH
Q 022520          277 LVEIIK  282 (296)
Q Consensus       277 ~~~~~~  282 (296)
                      +..+.+
T Consensus       257 ~~~i~~  262 (308)
T 4gt4_A          257 VEMIRN  262 (308)
T ss_dssp             HHHHHT
T ss_pred             HHHHHc
Confidence            665554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.1e-49  Score=366.54  Aligned_cols=200  Identities=25%  Similarity=0.411  Sum_probs=170.4

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHH---HHHHHHhcCCCCceecceeeeec
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFST  130 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~---E~~~l~~l~h~niv~~~~~~~~~  130 (296)
                      +.-.++|++.++||+|+||.||+|+++.+|+.||+|++....       ....+   ++.+++.++|||||+++++|   
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f---  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF---  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence            344568999999999999999999999999999999985321       11223   35566677999999999999   


Q ss_pred             cCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEE
Q 022520          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                        .+...+|+|||||+ |+|...+..    .+.+++..++.++.||+.||+|||++ |||||||||+||||+.++ .+||
T Consensus       262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G-~vKL  333 (689)
T 3v5w_A          262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRI  333 (689)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTS-CEEE
T ss_pred             --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCC-CEEe
Confidence              44556899999998 477777765    37899999999999999999999998 999999999999999988 7999


Q ss_pred             eeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       210 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      +|||+|+...... ..+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+
T Consensus       334 ~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          334 SDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             CCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             cccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999998765443 4567899999999999655568999999999999999999999998654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-49  Score=346.68  Aligned_cols=220  Identities=23%  Similarity=0.374  Sum_probs=177.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEEeecc-----hhhHHHHHHHHhcCC-CCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLDH-PNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  131 (296)
                      ..++|++.+.||+|+||+||+|++...     ++.||+|.+....     ..+.+|+++|+.++| ||||++++++....
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            346899999999999999999998653     3689999885432     235579999999976 89999999875432


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCce
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NI  198 (296)
                          ..+++|||||+ |+|.+++......            ...+++..+..++.||++||.|||++ +||||||||+||
T Consensus       142 ----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NI  216 (353)
T 4ase_A          142 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNI  216 (353)
T ss_dssp             ----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGE
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccce
Confidence                23789999999 5888888764321            34588999999999999999999999 999999999999


Q ss_pred             EEcCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 022520          199 LVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  274 (296)
Q Consensus       199 li~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~  274 (296)
                      |++.++ .+||+|||+|+........   ....||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..
T Consensus       217 Ll~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          217 LLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             EECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             eeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999887 8999999999866443322   2356799999999997654 8999999999999999998 99999987765


Q ss_pred             HHHHHHHHhhcCCCc
Q 022520          275 DQLVEIIKVILHTEI  289 (296)
Q Consensus       275 ~~~~~~~~~~~~~~~  289 (296)
                      +.+...+....+++.
T Consensus       295 ~~~~~~i~~g~~~~~  309 (353)
T 4ase_A          295 EEFCRRLKEGTRMRA  309 (353)
T ss_dssp             HHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHcCCCCCC
Confidence            666666655555444

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.1e-48  Score=361.50  Aligned_cols=212  Identities=27%  Similarity=0.439  Sum_probs=184.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++....    ....+|+.+|+.++|||||+++++|     .+...+++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence            57999999999999999999999999999999885432    3345899999999999999999998     44556899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC-CCcEEEeeecceeee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~-~~~ikl~Dfg~~~~~  218 (296)
                      |||||+| +|.+.+...   ...+++..++.+++||+.||.|||++ +|+||||||+|||++.+ .+.+||+|||+++.+
T Consensus       232 v~E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          232 IYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEeecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            9999985 777766532   36799999999999999999999999 99999999999999864 237999999999987


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ..........||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+.+....
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~  374 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN  374 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             cCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC
Confidence            6666566778999999999997655 899999999999999999999999999888888887765443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.8e-47  Score=343.06  Aligned_cols=226  Identities=71%  Similarity=1.177  Sum_probs=199.7

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccC-CCceEEE
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLN  139 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  139 (296)
                      .....+|++.+.||+|+||.||+|++..+++.||||++........+|+++++.++|+||++++++|+.... .+..+++
T Consensus        50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            344568999999999999999999999999999999997776667789999999999999999998866543 4456778


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+++++.+.+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++..+||+|||+++...
T Consensus       130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            9999999998888877666678899999999999999999999998 999999999999999776578999999998776


Q ss_pred             cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       220 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      .........||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+.+.++.+.++.+
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  276 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            66666677899999999998776668999999999999999999999999999989999998876654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5e-48  Score=333.84  Aligned_cols=196  Identities=21%  Similarity=0.270  Sum_probs=157.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-hh--HHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YK--NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~--~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|.+.++||+|+||+||+|++  +|+.||||++..... ..  +.|+..+..++|||||++++++..... ....+++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEE
Confidence            4699999999999999999998  689999999854332 22  235555667899999999999865432 23457899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcc-------CCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------IGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ||||+ |+|.+.+..     .++++..+..++.|++.||+|||++       .+|+||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            99998 578887764     5689999999999999999999964       2899999999999999887 89999999


Q ss_pred             ceeeeccCCCc-----ccccccccccCCccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          214 SAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       214 ~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      +++........     ....||+.|||||++.+..     .++.++|||||||++|||+||.+||.
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            99876554322     2357999999999986532     36779999999999999999987653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-46  Score=335.74  Aligned_cols=224  Identities=52%  Similarity=1.000  Sum_probs=197.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccC-----------
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-----------  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----------  132 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++..+.....+|+++++.++||||++++++|.....           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            457999999999999999999999999999999998777777799999999999999999999865433           


Q ss_pred             ----------------------CCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCcee
Q 022520          133 ----------------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (296)
Q Consensus       133 ----------------------~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH  190 (296)
                                            .+..+.++||||++++|.+.+.........+++..++.++.||+.||.|||++ ||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-cCcc
Confidence                                  34456889999999999988887776678899999999999999999999998 9999


Q ss_pred             ccCCCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       191 ~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      |||||+|||++...+.+||+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|++||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998544489999999998876666666778899999999987766789999999999999999999999999


Q ss_pred             CChHHHHHHHHHhhcCCC
Q 022520          271 ESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~  288 (296)
                      .+..+.+..+.+.++.+.
T Consensus       245 ~~~~~~~~~i~~~~g~p~  262 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPT  262 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCC
T ss_pred             CChHHHHHHHHHHhCCCC
Confidence            999999999988777653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.8e-46  Score=333.23  Aligned_cols=224  Identities=68%  Similarity=1.150  Sum_probs=197.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccC-CCceEEEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLV  141 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~iv  141 (296)
                      ...+|++.+.||+|+||.||+|++..+++ +|+|++........+|+++++.++||||++++++|..... .+..++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            34589999999999999999999877765 8999887777667789999999999999999999876654 556678899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      |||+++++...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++...+.+||+|||+++.....
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            99999998888777666678899999999999999999999998 99999999999999943448999999999887666


Q ss_pred             CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       222 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++.+.++.+.
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            6667788999999999997766799999999999999999999999999999999999988776553

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.8e-45  Score=320.42  Aligned_cols=217  Identities=29%  Similarity=0.452  Sum_probs=183.7

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....++|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+++++.++||||+++++++.     .
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~   85 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----T   85 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----E
Confidence            334568999999999999999999999999999999985432      23457999999999999999999883     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||++ +++.+.+...    +++++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG  159 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADM-NIKIADFG  159 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCC-CEEEeecc
Confidence            445889999997 5787777653    6799999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ++.............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p  234 (328)
T 3fe3_A          160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP  234 (328)
T ss_dssp             CCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             CceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            997665555555678899999999997776556899999999999999999999999887666666665443333

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-44  Score=330.29  Aligned_cols=216  Identities=31%  Similarity=0.541  Sum_probs=181.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++||||+++++++..... .+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35799999999999999999999999999999998643      2234579999999999999999999854432 2335


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++||||+++++.+.+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            578999999998777663      3589999999999999999999998 999999999999999887 89999999998


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+.
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            776555556678999999999997654 89999999999999999999999999999999999998887664

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=321.47  Aligned_cols=214  Identities=29%  Similarity=0.469  Sum_probs=175.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|..+++.+ +||||+++++++     .+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~   95 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT   95 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence            3457999999999999999999999999999999986431       2334788899987 799999999988     34


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...+++||||+++ +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g-~ikL~DFG  169 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFG  169 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCC-CEEEcccc
Confidence            4458999999985 777777653    6799999999999999999999998 999999999999999887 79999999


Q ss_pred             ceeeec-cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          214 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       214 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      +++... .........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.....+
T Consensus       170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p  244 (353)
T 3txo_A          170 MCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP  244 (353)
T ss_dssp             TCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            987532 223344567899999999986544 89999999999999999999999999888777777766544433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.4e-44  Score=315.53  Aligned_cols=208  Identities=25%  Similarity=0.384  Sum_probs=176.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|..+++.++||||+++++++.     ...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence            35799999999999999999999999999999998542       123457999999999999999999883     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            58999999985 77766665    36799999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeecc-CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          216 KVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       216 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      +.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  220 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME  220 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             hhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            76322 33345667899999999986544 899999999999999999999999988766666655543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=312.65  Aligned_cols=220  Identities=32%  Similarity=0.559  Sum_probs=188.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------hhhHHHHHHHHhc---CCCCceecceeeeecc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLL---DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~  131 (296)
                      ..+|++.+.||+|+||+||+|++..+++.||+|++....         ....+|+++++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            458999999999999999999999999999999885322         2345788777766   4999999999987766


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          132 EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                      .......++||||++++|.+++....  ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEEee
Confidence            55566789999999999998887643  23499999999999999999999998 999999999999999887 899999


Q ss_pred             ecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.+..++
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998765555556678899999999986655 89999999999999999999999999998888888888776553

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-44  Score=322.05  Aligned_cols=215  Identities=35%  Similarity=0.684  Sum_probs=175.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcC-CCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.+. ||||+++++++...   +..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence            35799999999999999999999999999999988432      223347999999997 99999999988542   223


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++|||||+++|...+..     ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAEC-HVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence            4789999999998888765     5789999999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccC----------------------CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022520          217 VLVKG----------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (296)
Q Consensus       217 ~~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  274 (296)
                      .....                      .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                      11233578999999999977666899999999999999999999999999999


Q ss_pred             HHHHHHHHhhcCCC
Q 022520          275 DQLVEIIKVILHTE  288 (296)
Q Consensus       275 ~~~~~~~~~~~~~~  288 (296)
                      +.+..+...++.+.
T Consensus       238 ~~~~~i~~~~~~p~  251 (388)
T 3oz6_A          238 NQLERIIGVIDFPS  251 (388)
T ss_dssp             HHHHHHHHHHCCCC
T ss_pred             HHHHHHHHhcCCCC
Confidence            99999988777664

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.7e-44  Score=310.54  Aligned_cols=215  Identities=36%  Similarity=0.668  Sum_probs=182.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..++|++.+.||+|+||+||+|++. +++.||+|++....      ....+|+++++.++||||+++++++.     +..
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCC
Confidence            3458999999999999999999985 58899999885322      23458999999999999999999883     444


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++||||+++++.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        93 ~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~  167 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLAR  167 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCC-CEEEccCcCce
Confidence            58899999999988887753   35699999999999999999999998 999999999999999887 89999999998


Q ss_pred             eeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       217 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN  240 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence            754332 233457799999999987766689999999999999999999999999888888888888776553

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-44  Score=322.43  Aligned_cols=210  Identities=29%  Similarity=0.474  Sum_probs=179.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|..+++.++||||++++++|     .+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            346899999999999999999999999999999998532       23355899999999999999999988     344


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..+++|||||+ ++|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCC-CEEEeccce
Confidence            55899999997 477776653     5689999999999999999999998 999999999999999888 799999999


Q ss_pred             eeeeccCCC--cccccccccccCCccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          215 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       215 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      +........  .....||+.|+|||++.+..   .++.++|||||||++|+|++|++||.+.+..+.+..+.+..
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  289 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  289 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence            987644331  23567899999999986543   26789999999999999999999999988888888777643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.9e-44  Score=311.22  Aligned_cols=216  Identities=34%  Similarity=0.600  Sum_probs=172.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+++++.++||||+++++++.     .....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeEE
Confidence            47999999999999999999999999999999885432     34558999999999999999999883     344588


Q ss_pred             EEEecccccHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          140 LVLEYVPETVHRVIKHHYKM--SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +||||++++|.+++......  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            99999999999888765422  24589999999999999999999998 999999999999999887 899999999986


Q ss_pred             eccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       218 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ..... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP  228 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            54322 23445789999999999766668999999999999999999999999999888888888776654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.7e-44  Score=315.07  Aligned_cols=211  Identities=24%  Similarity=0.397  Sum_probs=181.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----------hhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      ..+.|.+.+.||+|+||.||+|++..+|+.||+|.+....          ....+|+.+++.++||||++++++|     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            4457999999999999999999999999999999986432          2356899999999999999999988     


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC---cEE
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---~ik  208 (296)
                      .+...+++||||++ ++|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.   .+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEE
Confidence            34445899999997 577777654    46799999999999999999999998 9999999999999987653   699


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      |+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+..
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~  234 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS  234 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence            99999998876655556678999999999986544 8999999999999999999999999988777666665543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.7e-45  Score=320.46  Aligned_cols=198  Identities=31%  Similarity=0.503  Sum_probs=173.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++.     ..
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~   81 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TP   81 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence            446899999999999999999999999999999988532       224568999999999999999999884     33


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ...++||||+++++.+.+...    .++++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~DFG~s  155 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNL-NVKIADFGLS  155 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTC-CEEECCSSCT
T ss_pred             CEEEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCC-CEEEEEeccc
Confidence            448899999999998888763    6799999999999999999999999 999999999999999887 8999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      .............||+.|+|||++.+....++++|||||||++|+|++|+.||.+.
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            87655555566789999999999977664578999999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.2e-44  Score=323.19  Aligned_cols=211  Identities=26%  Similarity=0.415  Sum_probs=180.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+|++.++||+|+||+||+|++..+++.||+|++...       .....+|..++..++||||++++++|     .+..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence            45799999999999999999999999999999998532       12356899999999999999999988     3445


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+++|||||+ |+|..++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            5899999997 5777777653   36799999999999999999999998 999999999999999888 8999999999


Q ss_pred             eeeccCCCc--ccccccccccCCcccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          216 KVLVKGEPN--ISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       216 ~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      +........  ....||+.|+|||++.    +...++.++|||||||++|||++|++||.+.+..+.+..+.+..
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  297 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  297 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence            766443322  2357899999999986    23458999999999999999999999999988888887776543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-43  Score=305.27  Aligned_cols=214  Identities=35%  Similarity=0.595  Sum_probs=181.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|++.+.||+|+||+||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            47999999999999999999999999999999985332      234579999999999999999999843     3448


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+++++...+...   ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            899999999888877653   46799999999999999999999999 999999999999999887 8999999999866


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhcCCC
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .... ......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+....+.
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            4332 234457899999999997766689999999999999999987755 667777777788887766553

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=315.72  Aligned_cols=199  Identities=29%  Similarity=0.444  Sum_probs=172.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...++|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||++++++|.     +
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            34568999999999999999999999999999999885332       23457999999999999999999883     3


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  160 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHG-HVHITDFN  160 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCC-CEEEeccc
Confidence            4458899999975 66666654    46799999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ++.............||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||...
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence            99887666666677899999999998542  34789999999999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-44  Score=309.63  Aligned_cols=209  Identities=27%  Similarity=0.501  Sum_probs=178.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|..+++.++||||+++++++     .+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            35799999999999999999999999999999998542       12345799999999999999999988     3444


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCC-CEEEeecCcc
Confidence            58999999985 77777765    36799999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      .....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+....
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  221 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR  221 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC
T ss_pred             eecCC--ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            86533  234567899999999986544 899999999999999999999999988877777776664433

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8e-44  Score=318.09  Aligned_cols=198  Identities=27%  Similarity=0.493  Sum_probs=169.0

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (296)
                      .....+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|..+++.+ +||||++++++|     
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----  122 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----  122 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----
Confidence            334568999999999999999999999999999999986432       2345788888876 899999999988     


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                      .....+++||||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~D  196 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTD  196 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECC
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCC-CEEEee
Confidence            344458999999985 77666665    36799999999999999999999998 999999999999999888 799999


Q ss_pred             ecceeee-ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          212 FGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       212 fg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ||+++.. ..........||+.|+|||++.+.. ++.++|||||||++|+|++|++||..
T Consensus       197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            9999763 3334455678999999999996654 89999999999999999999999964

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.9e-44  Score=312.52  Aligned_cols=209  Identities=27%  Similarity=0.479  Sum_probs=176.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|.+.+.||+|+||.||+|++..+++.||+|++....       .....|..+++.+ +||||+++++++.     +
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----T   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----C
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----e
Confidence            3457999999999999999999999999999999986431       2334688888876 9999999999883     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||++ ++|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCC-CEEEeECh
Confidence            445899999997 4777777653    6799999999999999999999998 999999999999999887 79999999


Q ss_pred             ceeeecc-CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       214 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      +++.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  233 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD  233 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence            9975432 22344567899999999996654 899999999999999999999999988876666666554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-44  Score=326.46  Aligned_cols=219  Identities=34%  Similarity=0.561  Sum_probs=170.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .++|++.+.||+|+||.||+|++..+++.||||++...      .....+|+++|+.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            35799999999999999999999999999999988542      233458999999999999999999986655444556


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++||||++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCC-CEeecccccchh
Confidence            899999999998888765    46799999999999999999999998 999999999999999887 899999999986


Q ss_pred             eccCC----------------------------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh------
Q 022520          218 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL------  263 (296)
Q Consensus       218 ~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~------  263 (296)
                      .....                            ......||++|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            53221                            12345679999999987666669999999999999999998      


Q ss_pred             -----CCCCCCCCC--------------------hHHHHHHHHHhhcCCC
Q 022520          264 -----GQPLFPGES--------------------GVDQLVEIIKVILHTE  288 (296)
Q Consensus       264 -----g~~pf~~~~--------------------~~~~~~~~~~~~~~~~  288 (296)
                           |++||.+.+                    ..+.+..+.+.++.++
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~  335 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS  335 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC
Confidence                 778887654                    2466677777666554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.6e-44  Score=306.19  Aligned_cols=212  Identities=34%  Similarity=0.648  Sum_probs=178.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+|++.+.||+|+||.||+|++ .+++.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            4799999999999999999998 678999999885332      334589999999999999999998843     3348


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+++++.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            899999999988887653   36789999999999999999999998 999999999999999887 8999999998754


Q ss_pred             ccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.+..+
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP  220 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC
Confidence            322 222345679999999999766668999999999999999999999999998888888888766544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=317.98  Aligned_cols=211  Identities=27%  Similarity=0.448  Sum_probs=179.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|..++..++||||++++++|     .+.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            346899999999999999999999999999999998532       22345799999999999999999988     444


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..+++||||++ ++|..++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g-~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCG-HIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCC-CEEEeechh
Confidence            55899999996 5787777653   35799999999999999999999998 999999999999999887 799999999


Q ss_pred             eeeeccCCC--cccccccccccCCccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          215 AKVLVKGEP--NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       215 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      +........  .....||+.|+|||++..      ...++.++|||||||++|||++|+.||.+.+..+.+..+.+.
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            987644432  224578999999999862      234899999999999999999999999998887777777653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.7e-44  Score=313.83  Aligned_cols=213  Identities=27%  Similarity=0.415  Sum_probs=178.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|..++..+ +||||+++++++     ..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence            3457999999999999999999999999999999986431       2334688888877 899999999988     34


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||+++ +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  166 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  166 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence            4458999999985 777777653    6799999999999999999999998 999999999999999887 79999999


Q ss_pred             ceeeecc-CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       214 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.....
T Consensus       167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~  240 (353)
T 2i0e_A          167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY  240 (353)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            9976422 23345567899999999986554 8999999999999999999999999988777777766644333

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-43  Score=311.05  Aligned_cols=209  Identities=27%  Similarity=0.432  Sum_probs=179.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     +
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~  112 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----D  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----c
Confidence            34468999999999999999999999999999999985332       23457999999999999999999883     4


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...+++||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DFg  186 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFG  186 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCC-CEEEcccc
Confidence            445899999997 5787777653    6799999999999999999999998 999999999999999887 79999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ++......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.-
T Consensus       187 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  254 (350)
T 1rdq_E          187 FAKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK  254 (350)
T ss_dssp             TCEECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cceeccCC--cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            99865332  34567899999999986554 8999999999999999999999999888777666666543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=309.39  Aligned_cols=214  Identities=33%  Similarity=0.628  Sum_probs=179.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....     ...+|+.+++.++||||+++++++..     ....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            479999999999999999999999999999998853321     23369999999999999999998843     33478


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+++++.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999998888764   35689999999999999999999998 999999999999999887 89999999997653


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.++
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  221 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT  221 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            322 223456799999999987766689999999999999999999999999998888888888777654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-43  Score=311.65  Aligned_cols=225  Identities=48%  Similarity=0.908  Sum_probs=183.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch---hhHHHHHHHHhcCCCCceecceeeeeccC--CCceE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTE--KDELY  137 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~~  137 (296)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+++..++.++||||+++++++.....  ....+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            44579999999999999999999999999999998865433   23456677788899999999999866543  34556


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--ccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .++||||+++++...+.........+++..+..++.|++.||.|||  ++ ||+||||||+|||++...+.+||+|||++
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            8899999999988888776666788999999999999999999999  88 99999999999999973348999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.++
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            8776666666678899999999987766689999999999999999999999999998888888888766553

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.8e-43  Score=311.82  Aligned_cols=212  Identities=29%  Similarity=0.429  Sum_probs=179.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++.     +..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence            3457999999999999999999999999999999985432      23457999999999999999999883     444


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeec
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg  213 (296)
                      ..++||||+.+ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++  ..+||+|||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            58899999985 77666654    36789999999999999999999998 999999999999998653  269999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ++.............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus       177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~  247 (362)
T 2bdw_A          177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  247 (362)
T ss_dssp             TCBCCTTCCSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             cceEecCCcccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            998766555455678899999999986544 89999999999999999999999998887666666665443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-43  Score=309.39  Aligned_cols=197  Identities=27%  Similarity=0.497  Sum_probs=168.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (296)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|..+++.+ +||||+++++++.     
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----
Confidence            34568999999999999999999999999999999986432       2245788999887 8999999999883     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      .....++||||+++ +|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DF  154 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDY  154 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEEec
Confidence            34458999999985 777777653    6799999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeec-cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          213 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       213 g~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      |+++... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus       155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            9997532 233345567899999999996644 89999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5e-43  Score=310.53  Aligned_cols=217  Identities=34%  Similarity=0.600  Sum_probs=187.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....     ....+|+++++.++||||+++++++...........+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            47999999999999999999999999999999985322     2345899999999999999999998655444445688


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||++++|.+.+..     ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++....
T Consensus       107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  179 (364)
T ss_dssp             EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCC-CEEEEeCcceEecC
Confidence            9999999998888764     5699999999999999999999998 999999999999999887 79999999998664


Q ss_pred             cCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          220 KGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       220 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ....    .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.++
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  252 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  252 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            3322    23457899999999986666689999999999999999999999999998899988888776654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.4e-43  Score=317.63  Aligned_cols=219  Identities=34%  Similarity=0.545  Sum_probs=180.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .++|++.+.||+|+||.||+|++..+++.||||++...      .....+|+++|+.++|+||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            35799999999999999999999999999999998542      133458999999999999999999886544333355


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~-~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence            889999999999888865    46799999999999999999999998 999999999999999887 899999999987


Q ss_pred             eccCCC-----------------------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-----------
Q 022520          218 LVKGEP-----------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-----------  263 (296)
Q Consensus       218 ~~~~~~-----------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-----------  263 (296)
                      ......                       .....||++|+|||++.....++.++|||||||++|||++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            643321                       2456789999999997666669999999999999999997           


Q ss_pred             CCCCCCCCC-----------------hHHHHHHHHHhhcCCC
Q 022520          264 GQPLFPGES-----------------GVDQLVEIIKVILHTE  288 (296)
Q Consensus       264 g~~pf~~~~-----------------~~~~~~~~~~~~~~~~  288 (296)
                      |.++|.+.+                 ..+++..+.+.++.++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~  300 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT  300 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCC
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCC
Confidence            455565543                 3566777777777665

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=307.10  Aligned_cols=212  Identities=24%  Similarity=0.405  Sum_probs=179.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+....   ....+|+.+++.++||||+++++++..     ....++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence            357999999999999999999999999999999885432   234589999999999999999998843     334889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC-CCcEEEeeecceeee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~-~~~ikl~Dfg~~~~~  218 (296)
                      ||||+++ +|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.+ ...+||+|||++...
T Consensus        79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9999985 777766432   35799999999999999999999998 99999999999999862 338999999999877


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ..........+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  220 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY  220 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred             CCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC
Confidence            6555555667899999999986544 79999999999999999999999999887776666665443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-43  Score=302.40  Aligned_cols=206  Identities=27%  Similarity=0.451  Sum_probs=175.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++...     ...+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            45799999999999999999999999999999988532    23345899999999999999999988543     3478


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||++ ++|.+.+..     ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence            9999997 577777654     4689999999999999999999998 999999999999999887 8999999998766


Q ss_pred             ccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  230 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT  230 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            44332 34557899999999986654 89999999999999999999999998876665555443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=311.40  Aligned_cols=215  Identities=36%  Similarity=0.630  Sum_probs=179.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+++++.++||||+++++++..... .+...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            47999999999999999999999999999999884321      234589999999999999999999854322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++||||++++|.+++..     ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            689999998888887764     5789999999999999999999998 999999999999999887 899999999987


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            533  234567899999999987756689999999999999999999999999999899999988877664

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=305.02  Aligned_cols=211  Identities=24%  Similarity=0.391  Sum_probs=179.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----------chhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+...          .....+|+.+++.++||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---   84 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE---   84 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE---
Confidence            3446799999999999999999999999999999988543          233568999999999999999999883   


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC---cE
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QL  207 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---~i  207 (296)
                        .....++||||++ ++|.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.   .+
T Consensus        85 --~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~  157 (326)
T 2y0a_A           85 --NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRI  157 (326)
T ss_dssp             --CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCE
T ss_pred             --eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCE
Confidence              3445889999997 577777654    46799999999999999999999998 9999999999999987652   69


Q ss_pred             EEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       208 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ||+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus       158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  232 (326)
T 2y0a_A          158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV  232 (326)
T ss_dssp             EECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred             EEEECCCCeECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence            999999998775555555677899999999986544 899999999999999999999999988776666555543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-43  Score=313.14  Aligned_cols=211  Identities=25%  Similarity=0.432  Sum_probs=172.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-------hhHHHHHH-HHhcCCCCceecceeeeeccCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++.....       ...+|..+ ++.++||||++++++|.     
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----
Confidence            344689999999999999999999999999999999854321       12234444 46689999999999883     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      +....++||||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~ikL~DF  183 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDF  183 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEeeC
Confidence            34458999999985 77777765    36789999999999999999999998 999999999999999887 7999999


Q ss_pred             cceeeecc-CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          213 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       213 g~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      |+++.... ........||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+.+.-
T Consensus       184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  255 (373)
T 2r5t_A          184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP  255 (373)
T ss_dssp             CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC
T ss_pred             ccccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc
Confidence            99875332 23345668899999999986544 8999999999999999999999999988777777766643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-42  Score=306.91  Aligned_cols=222  Identities=30%  Similarity=0.528  Sum_probs=186.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC---C
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---K  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~  133 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+++++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4568999999999999999999999999999999884332      234589999999999999999998855332   1


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      .....++||||+++++...+...   ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-CEEEccch
Confidence            13457899999999988887654   36799999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccC-----CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          214 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       214 ~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ++......     .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+..+
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99765422     1223456799999999987766689999999999999999999999999998888888887766554


Q ss_pred             c
Q 022520          289 I  289 (296)
Q Consensus       289 ~  289 (296)
                      .
T Consensus       250 ~  250 (351)
T 3mi9_A          250 P  250 (351)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.4e-43  Score=307.32  Aligned_cols=202  Identities=28%  Similarity=0.400  Sum_probs=172.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...         .....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            445799999999999999999999999999999988532         2345689999999999999999998843    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEe
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLC  210 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~  210 (296)
                       ...+++|||||+ ++|.+.+.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++  ..+||+
T Consensus        98 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 -DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             -TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             -CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEe
Confidence             344889999998 577777776655556799999999999999999999998 999999999999998654  249999


Q ss_pred             eecceeeeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          211 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       211 Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            9999987644332 33457899999999986554 899999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=315.88  Aligned_cols=214  Identities=27%  Similarity=0.377  Sum_probs=178.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++....      ....+|+.+++.++||||+++++++     .+..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence            4468999999999999999999999999999999885432      2345899999999999999999988     3445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--CCcEEEeeec
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~~~ikl~Dfg  213 (296)
                      ..++|||||.+ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.+  +..+||+|||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            58899999985 77777765    36799999999999999999999998 99999999999999842  3379999999


Q ss_pred             ceeeeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          214 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       214 ~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  232 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF  232 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC
Confidence            9976644332 24567899999999986544 8999999999999999999999999988777777776654433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3e-43  Score=311.59  Aligned_cols=205  Identities=28%  Similarity=0.449  Sum_probs=160.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++||||+++++++.     .....+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            3458999999999999999999999999999999986432   34568999999999999999999984     334488


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC-cEEEeeecceee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~-~ikl~Dfg~~~~  217 (296)
                      +||||++ ++|.+.+..    ..++++..++.++.|++.||.|||++ ||+||||||+|||++.++. .+||+|||+++.
T Consensus        93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999997 577777765    36799999999999999999999998 9999999999999986542 499999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  277 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  277 (296)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.....
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  227 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY  227 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence            544444556679999999999977664445599999999999999999999876543333

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-42  Score=307.28  Aligned_cols=220  Identities=31%  Similarity=0.576  Sum_probs=180.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------------hhhHHHHHHHHhcCCCCceecceeee
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFF  128 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~~~  128 (296)
                      ..+|++.+.||+|+||.||+|.+.. +..||+|++....               ....+|+++++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            3579999999999999999999754 8999999884321               33468999999999999999999997


Q ss_pred             eccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                      .........+++||||+++++.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .++
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNN-DIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEE
T ss_pred             eccCCCcceEEEEEccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCC-CEE
Confidence            7665666678999999999988888753   35799999999999999999999998 999999999999999877 799


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      |+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999997655555555667899999999987656689999999999999999999999999998888888888776654


Q ss_pred             c
Q 022520          289 I  289 (296)
Q Consensus       289 ~  289 (296)
                      .
T Consensus       255 ~  255 (362)
T 3pg1_A          255 I  255 (362)
T ss_dssp             H
T ss_pred             h
Confidence            3

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.6e-43  Score=304.37  Aligned_cols=211  Identities=28%  Similarity=0.478  Sum_probs=170.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeec--------chhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ...+|++.+.||+|+||.||+|++.   .+++.||+|++...        .....+|+.+++.++||||+++++++..  
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   92 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--   92 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence            4468999999999999999999985   68899999988542        1234579999999999999999998843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                         ....++||||++ ++|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus        93 ---~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           93 ---GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             ---SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCC-cEEEE
Confidence               334889999998 577777765    36789999999999999999999998 999999999999999887 89999


Q ss_pred             eecceeeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          211 DFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       211 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      |||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+...
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  238 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL  238 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            99998754322 2234457899999999986544 89999999999999999999999998887776666665433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-43  Score=306.96  Aligned_cols=217  Identities=31%  Similarity=0.595  Sum_probs=178.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            34468999999999999999999999999999999885332      234589999999999999999998843     3


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC----CcEEEee
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCD  211 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~----~~ikl~D  211 (296)
                      ..+++||||++++|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++    ..+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECc
Confidence            44889999999999888876    35799999999999999999999998 999999999999995332    2599999


Q ss_pred             ecceeeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          212 FGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       212 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...+..++
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            9998765322 2234456799999999997766689999999999999999999999999998888888888766554

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-42  Score=299.75  Aligned_cols=203  Identities=30%  Similarity=0.439  Sum_probs=167.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+....       ..+.+|+.+++.++||||+++++++     ...
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~   83 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED   83 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence            3457999999999999999999999999999999884321       2345799999999999999999987     344


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||+++ +|.+++...    .++++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~  157 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNK-TLKIFDFGI  157 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCSS
T ss_pred             CeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEEeCCC
Confidence            558899999985 787777653    6799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022520          215 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  277 (296)
Q Consensus       215 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  277 (296)
                      +.......  ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA  221 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred             ccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            87653332  223456899999999987655 799999999999999999999999987755443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-43  Score=319.53  Aligned_cols=213  Identities=31%  Similarity=0.456  Sum_probs=182.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..++|.+.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++.     ..
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TP   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence            4468999999999999999999999999999999985431       23568999999999999999999883     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||++ ++|.+++..    ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~-~vkL~DFG~  162 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFGL  162 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCC-CeEEEeccc
Confidence            45889999997 577776653    46799999999999999999999998 999999999999999887 799999999


Q ss_pred             eeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       215 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      +.............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  234 (476)
T 2y94_A          163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY  234 (476)
T ss_dssp             CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC
T ss_pred             hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC
Confidence            987766555566789999999999977665678999999999999999999999988776666666655433

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2e-42  Score=305.95  Aligned_cols=215  Identities=28%  Similarity=0.478  Sum_probs=182.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcC-----CCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~  134 (296)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   .....|+.+++.+.     ||||+++++++...    
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~----  108 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY----  108 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET----
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC----
Confidence            3457999999999999999999999999999999986432   33457999999986     99999999988543    


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC------------
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP------------  202 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~------------  202 (296)
                       ...++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.            
T Consensus       109 -~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          109 -DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             -TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             -CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhc
Confidence             3488999999889998887643  34699999999999999999999998 9999999999999975            


Q ss_pred             ------------CCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          203 ------------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       203 ------------~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                                  ....+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        133799999999976433  334567899999999997655 89999999999999999999999999


Q ss_pred             CChHHHHHHHHHhhcCCC
Q 022520          271 ESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~  288 (296)
                      .+..+.+..+.......+
T Consensus       262 ~~~~~~~~~~~~~~~~~p  279 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIP  279 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCC
T ss_pred             CcHHHHHHHHHHhcCCCC
Confidence            988888888877665544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.6e-43  Score=321.73  Aligned_cols=203  Identities=25%  Similarity=0.382  Sum_probs=173.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....+|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|..+++.++||||++++++|     ..
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  256 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET  256 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence            34568999999999999999999999999999999985332       2345799999999999999999988     33


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||++ ++|...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g-~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDG-NVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCC-CEEEeecc
Confidence            445899999998 477777765443346799999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCc-ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          214 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       214 ~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ++......... ....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            99876544432 345899999999999664 48999999999999999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-42  Score=307.81  Aligned_cols=214  Identities=31%  Similarity=0.556  Sum_probs=172.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... .+...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            47999999999999999999999999999999986432      234579999999999999999998854331 22346


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++||||+++++.+.+.      ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  176 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLART  176 (371)
T ss_dssp             EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred             eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence            88999999999887764      4588999999999999999999998 999999999999999887 899999999987


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ...........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             -------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             cccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            65444445567899999999997654 8999999999999999999999999998888888887765543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.6e-43  Score=300.59  Aligned_cols=213  Identities=28%  Similarity=0.406  Sum_probs=170.6

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------------------------hhhHHHH
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------------------RYKNREL  109 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------~~~~~E~  109 (296)
                      ......+|++.+.||+|+||.||+|++..+++.||+|++....                              ....+|+
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A            8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred             CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            3345568999999999999999999999999999999885332                              3356899


Q ss_pred             HHHHhcCCCCceecceeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCc
Q 022520          110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV  188 (296)
Q Consensus       110 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i  188 (296)
                      ++++.++||||+++++++...   .....++||||+++ ++.+.+     ...++++..+..++.|++.||.|||++ ||
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i  158 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ-KI  158 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT-TE
T ss_pred             HHHHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-Ce
Confidence            999999999999999988532   23457899999985 443321     246799999999999999999999998 99


Q ss_pred             eeccCCCCceEEcCCCCcEEEeeecceeeeccCCC-cccccccccccCCccccCCCC--CCCchhHHHHHHHHHHHHhCC
Q 022520          189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQ  265 (296)
Q Consensus       189 iH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~l~~g~  265 (296)
                      +||||||+|||++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|+
T Consensus       159 vH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             ECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             eccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            9999999999999887 899999999987644322 234578999999999865442  477899999999999999999


Q ss_pred             CCCCCCChHHHHHHHHH
Q 022520          266 PLFPGESGVDQLVEIIK  282 (296)
Q Consensus       266 ~pf~~~~~~~~~~~~~~  282 (296)
                      .||...+.......+..
T Consensus       238 ~pf~~~~~~~~~~~~~~  254 (298)
T 2zv2_A          238 CPFMDERIMCLHSKIKS  254 (298)
T ss_dssp             CSSCCSSHHHHHHHHHH
T ss_pred             CCCCCccHHHHHHHHhc
Confidence            99988765544444443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-42  Score=300.61  Aligned_cols=218  Identities=23%  Similarity=0.349  Sum_probs=167.5

Q ss_pred             CCCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      .......+|++.+.||+|+||.||+|++  ++..||+|++....      ..+.+|+++++.++||||+++++++.    
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----  104 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----  104 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence            3444556899999999999999999987  68899999885432      23457999999999999999999883    


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEE
Q 022520          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                       .....++||||+++ +|.+.+.... ....+++..+..++.|++.||+|||++ |  |+||||||+|||++.++ .+||
T Consensus       105 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~-~~kL  180 (309)
T 3p86_A          105 -QPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY-TVKV  180 (309)
T ss_dssp             -STTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTC-CEEE
T ss_pred             -ECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCC-cEEE
Confidence             33337899999985 7777776432 112489999999999999999999998 9  99999999999999887 8999


Q ss_pred             eeecceeeeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          210 CDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       210 ~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      +|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus       181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  258 (309)
T 3p86_A          181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL  258 (309)
T ss_dssp             CCCC-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             CCCCCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            9999987543332 233467899999999986554 8999999999999999999999999887766655554433333

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=297.83  Aligned_cols=212  Identities=40%  Similarity=0.697  Sum_probs=174.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            47999999999999999999999999999999885432      233479999999999999999999843     3347


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||++++++..+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            899999998655544432   46799999999999999999999998 999999999999999887 8999999999875


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      .... ......+|+.|+|||++.+...++.++||||||+++|+|++|++||.+.+..+.+..+.+.+..
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD  221 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcc
Confidence            4332 2345578999999999977666899999999999999999999999999888888777765543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.9e-43  Score=310.30  Aligned_cols=215  Identities=35%  Similarity=0.615  Sum_probs=167.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999988542      1234479999999999999999998854321 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|+++++++|.+.+..     .++++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            789999998888877754     5799999999999999999999998 999999999999999887 899999999976


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.++
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  250 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            433  234567899999999987756689999999999999999999999999999899999888777654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=302.99  Aligned_cols=203  Identities=24%  Similarity=0.392  Sum_probs=170.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....     ....+|+++++.++||||+++++++...   .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            357999999999999999999999999999999985322     3345899999999999999999987533   22347


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE----cCCCCcEEEeeec
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFG  213 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli----~~~~~~ikl~Dfg  213 (296)
                      ++||||++ ++|.+++.... ....+++..+..++.|++.||.|||++ ||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999998 57777776543 234499999999999999999999998 99999999999998    5544 79999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ++.............||+.|+|||++..       ...++.++|||||||++|+|++|+.||...+
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9988766665566778999999999752       3458999999999999999999999997644

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-42  Score=321.81  Aligned_cols=202  Identities=28%  Similarity=0.440  Sum_probs=173.3

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      +....+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+|+.++||||+++++++.     
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----  254 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----  254 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----
Confidence            34456899999999999999999999999999999998532       123457999999999999999999883     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      +....++||||++ ++|...+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g-~vKL~DF  330 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHG-HIRISDL  330 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCC-CeEEEec
Confidence            3445899999997 57776665432  24599999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       213 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      |++.............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+
T Consensus       331 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             TTCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             ccceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            9998776555555678999999999996644 8999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-42  Score=303.55  Aligned_cols=198  Identities=21%  Similarity=0.271  Sum_probs=170.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|.+...  .....+|+.+++.+ +||||+++++++..     ....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEE
Confidence            35799999999999999999999999999999988533  34567899999999 99999999998743     345789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc-----EEEeeecce
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSA  215 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~-----ikl~Dfg~~  215 (296)
                      ||||++++|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .     ++|+|||++
T Consensus        83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           83 VLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGG-GTCTTSEEECCCTTC
T ss_pred             EEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCC-CCCCceEEEEEcccc
Confidence            9999988888888764   36899999999999999999999998 999999999999998766 4     999999999


Q ss_pred             eeeccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          216 KVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       216 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ........        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            87644332        23567899999999986644 8999999999999999999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.8e-42  Score=311.18  Aligned_cols=215  Identities=34%  Similarity=0.558  Sum_probs=183.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhc------CCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL------DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....   ....+|+.+++.+      +|+||+++++++..     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence            357999999999999999999999999999999986543   2345688888877      57799999998843     


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC-cEEEeeec
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~-~ikl~Dfg  213 (296)
                      ...+++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++. .+||+|||
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            34488999999999998887643  34589999999999999999999999 9999999999999998762 29999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      ++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.++.
T Consensus       248 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          248 SSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ  320 (429)
T ss_dssp             TCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            9976432  334567899999999997655 899999999999999999999999999999999999888776654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3e-42  Score=307.52  Aligned_cols=210  Identities=27%  Similarity=0.413  Sum_probs=178.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++||||+++++++.     +....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            45799999999999999999999999999999988643    234568999999999999999999883     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC-CCcEEEeeecceee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~-~~~ikl~Dfg~~~~  217 (296)
                      +||||+.+ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.+ ...+||+|||++..
T Consensus       125 lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999985 776665432   35789999999999999999999998 99999999999999753 33799999999987


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ...........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~  265 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC  265 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred             cCCCcceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            76555555667899999999986544 899999999999999999999999998877766666554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.1e-43  Score=317.19  Aligned_cols=212  Identities=25%  Similarity=0.381  Sum_probs=170.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----H  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----T
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----C
Confidence            4468999999999999999999999999999999885321       233468888999999999999998843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++ .+||+|||
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~-~~kl~DFG  294 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDFG  294 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSS-CEEECCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCC-CEEEccCC
Confidence            348899999985 67666655    3679999999999999999999998 7 999999999999999887 89999999


Q ss_pred             ceeeecc-CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       214 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  367 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR  367 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9875322 22334567899999999986654 899999999999999999999999988776666665554433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=306.43  Aligned_cols=214  Identities=36%  Similarity=0.643  Sum_probs=179.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|.+...         .....+|+++++.++||||+++++++.     .
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----H   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----e
Confidence            35799999999999999999999999999999988532         123458999999999999999999884     3


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ....++||||+++++...+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            3347899999999888777653   35688889999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          215 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       215 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      +....... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~  232 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP  232 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            97653322 23445789999999998766668999999999999999999999999999888888888876654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-42  Score=294.12  Aligned_cols=209  Identities=29%  Similarity=0.425  Sum_probs=171.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ...++|.+.+.||+|+||.||+|.+..++..+|+|.+....     ....+|+++++.++||||+++++++.     +..
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   93 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYH   93 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCC
Confidence            34468999999999999999999999999999999885433     34568999999999999999999883     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--CCcEEEeeec
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~~~ikl~Dfg  213 (296)
                      ..++||||+++ +|.+.+.........+++..+..++.|++.||.|||++ ||+||||||+||+++.+  ...++|+|||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            58899999985 88888877665568899999999999999999999998 99999999999999532  2379999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      ++.............+|+.|+|||++.  ..++.++||||||+++|+|++|+.||.+.+..+...
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~  235 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ  235 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence            998765555555677899999999984  347899999999999999999999998876544433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-41  Score=291.40  Aligned_cols=211  Identities=29%  Similarity=0.443  Sum_probs=178.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++     .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence            457999999999999999999999999999999885432      2345799999999999999999988     34445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeecc
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  214 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg~  214 (296)
                      .++||||+++ ++.+.+...    ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++  ..++|+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7899999985 776766653    6799999999999999999999998 999999999999998654  2499999999


Q ss_pred             eeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       215 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      +.............+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  224 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  224 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc
Confidence            98766555555677899999999986554 89999999999999999999999998877666666655443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-41  Score=296.41  Aligned_cols=224  Identities=35%  Similarity=0.593  Sum_probs=187.2

Q ss_pred             CCCccccceEEeeeeeecCceEEEEEEEc-CCCcEEEEEEEeecc------hhhHHHHHHHHhc---CCCCceecceeee
Q 022520           59 GQPKQTISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFF  128 (296)
Q Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~  128 (296)
                      +......+|++.+.||+|+||.||+|++. .+++.||+|++....      ....+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            34455678999999999999999999995 678999999885322      2345788877766   8999999999886


Q ss_pred             eccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                      ..........++||||++++|.+++....  ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~-~~k  160 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIK  160 (326)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEE
T ss_pred             ecccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCC-CEE
Confidence            44444566789999999999988887643  34589999999999999999999998 999999999999999887 899


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      |+|||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+
T Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (326)
T 1blx_A          161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  238 (326)
T ss_dssp             ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EecCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999997654433344567899999999986554 8999999999999999999999999999888888888766543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.8e-42  Score=300.90  Aligned_cols=218  Identities=33%  Similarity=0.628  Sum_probs=183.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357999999999999999999999999999999985332     233479999999999999999988754433334568


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||++++|.+.+..     ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++...
T Consensus        90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence            89999999998888765     5799999999999999999999998 999999999999999887 8999999999865


Q ss_pred             ccCCC-----------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          219 VKGEP-----------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      .....           .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            43221           1234679999999998665668999999999999999999999999998888888777766654


Q ss_pred             C
Q 022520          288 E  288 (296)
Q Consensus       288 ~  288 (296)
                      .
T Consensus       243 ~  243 (353)
T 2b9h_A          243 H  243 (353)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.7e-42  Score=306.28  Aligned_cols=212  Identities=23%  Similarity=0.375  Sum_probs=175.8

Q ss_pred             CccccceEEeeeeeec--CceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           61 PKQTISYMAERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      ....++|++.+.||+|  +||.||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---   97 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---   97 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence            3445689999999999  99999999999999999999986432      334579999999999999999999853   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                        ....++||||++ ++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~d  171 (389)
T 3gni_B           98 --DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSG  171 (389)
T ss_dssp             --TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECC
T ss_pred             --CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEcc
Confidence              334889999998 57777776542  35699999999999999999999998 999999999999999887 899999


Q ss_pred             ecceeeeccCC--------CcccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          212 FGSAKVLVKGE--------PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       212 fg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      ||.+.......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  250 (389)
T 3gni_B          172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL  250 (389)
T ss_dssp             GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred             cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            99876543221        12234678999999998663 458999999999999999999999999877666655443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.8e-42  Score=301.03  Aligned_cols=206  Identities=29%  Similarity=0.502  Sum_probs=176.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ..|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+++++.++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            46999999999999999999999999999999985321       2345799999999999999999988543     34


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++||||+.|++.+.+...   ..++++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            8899999999988887654   36799999999999999999999998 999999999999999877 899999999876


Q ss_pred             eccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          218 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  268 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  268 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence            432   234578999999999853  345889999999999999999999999988776666655553

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-42  Score=303.50  Aligned_cols=198  Identities=28%  Similarity=0.466  Sum_probs=169.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++........+|++++.++ +||||+++++++     .+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence            44679999999999999999999999999999999977666677899999887 799999999988     344568999


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC---cEEEeeecceee
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKLCDFGSAKV  217 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---~ikl~Dfg~~~~  217 (296)
                      ||||++ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||+..+.+   .+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999985 77777765    36799999999999999999999998 9999999999999854322   499999999987


Q ss_pred             eccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       218 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence            64433 234567899999999986544 789999999999999999999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=301.85  Aligned_cols=197  Identities=25%  Similarity=0.447  Sum_probs=171.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhcCCCCceecceeeeec
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFST  130 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~  130 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+....            ....+|+.+++.++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            4468999999999999999999999999999999886432            2345799999999999999999988   


Q ss_pred             cCCCceEEEEEEeccc-c-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          131 TEKDELYLNLVLEYVP-E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                        .+...+++||||+. + ++...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+|
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  170 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDF-TIK  170 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEE
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCC-cEE
Confidence              34445889999986 4 67777664    46799999999999999999999998 999999999999999887 899


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      |+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||..
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            99999998876666566678999999999997766558899999999999999999999965

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=301.27  Aligned_cols=203  Identities=30%  Similarity=0.435  Sum_probs=158.3

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++...  .....+|+++++.++||||+++++++.     .....
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~  123 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI  123 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence            34456799999999999999999999999999999998643  334567999999999999999999884     33458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC---CCCcEEEeeecc
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGS  214 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~---~~~~ikl~Dfg~  214 (296)
                      ++||||++ ++|.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.   ++ .+||+|||+
T Consensus       124 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~  197 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDA-PLKIADFGL  197 (349)
T ss_dssp             EEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTC-CEEECCCC-
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCC-CEEEccCcc
Confidence            89999998 477776654    46789999999999999999999998 9999999999999975   44 899999999


Q ss_pred             eeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       215 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      +.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+
T Consensus       198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~  257 (349)
T 2w4o_A          198 SKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQ  257 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred             ccccCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence            98765544445567899999999986554 8999999999999999999999998766544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-41  Score=296.87  Aligned_cols=210  Identities=24%  Similarity=0.383  Sum_probs=179.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----------chhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      ..++|++.+.||+|+||.||+|++..+++.||+|.+...          .....+|+.+++.++||||+++++++.    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   85 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----   85 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence            345799999999999999999999999999999988543          223568999999999999999999883    


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC---cEE
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---~ik  208 (296)
                       +....++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.   .++
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           86 -NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             -cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEE
Confidence             3445889999997 578777764    46789999999999999999999998 9999999999999987653   699


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  233 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV  233 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence            99999998776655555667899999999986544 899999999999999999999999988776666555543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6e-42  Score=314.69  Aligned_cols=213  Identities=28%  Similarity=0.450  Sum_probs=178.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ....+|++.+.||+|+||+||+|++..+++.||+|++...      .....+|+++++.++||||+++++++     .+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence            3456899999999999999999999999999999998432      23456899999999999999999988     344


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--CCcEEEeee
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDF  212 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~~~ikl~Df  212 (296)
                      ..+++|||||.+ +|.+.+...    .++++..+..++.||+.||.|||++ ||+||||||+|||++..  ...+||+||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            458999999985 777776653    6799999999999999999999998 99999999999999643  227999999


Q ss_pred             cceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       213 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      |++.............||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus       169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  240 (486)
T 3mwu_A          169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA  240 (486)
T ss_dssp             SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99976655555556789999999999864  3899999999999999999999999998877777776665443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-42  Score=327.29  Aligned_cols=218  Identities=27%  Similarity=0.419  Sum_probs=181.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....       .....|..++..+ +||+|++++++|     .+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            4457999999999999999999999999999999986421       2334688888877 799999999888     44


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...+++||||+++ +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCC-cEEEeecc
Confidence            4558999999985 777777653    6799999999999999999999998 999999999999999888 89999999


Q ss_pred             ceeeec-cCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          214 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       214 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      +++... .........||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..|.+.....+..+|
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  566 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS  566 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSC
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCC
Confidence            998643 233445668999999999996554 899999999999999999999999998887777777765444443333

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.9e-42  Score=300.03  Aligned_cols=199  Identities=30%  Similarity=0.429  Sum_probs=168.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++     .+....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence            35799999999999999999999999999999988532     23456899999999999999999988     344458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  154 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (323)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCC-CEEEEEeeccce
Confidence            899999985 66555543    45799999999999999999999998 999999999999999887 899999999976


Q ss_pred             eccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       218 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .....   ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+.
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  213 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence            53322   223457899999999997766568899999999999999999999987554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.6e-41  Score=289.55  Aligned_cols=207  Identities=30%  Similarity=0.461  Sum_probs=177.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++...    .....+|+++++.++||||+++++++.     +....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            45799999999999999999999999999999988543    344568999999999999999999883     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE---cCCCCcEEEeeecce
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA  215 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli---~~~~~~ikl~Dfg~~  215 (296)
                      +||||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||+||++   +.++ .++|+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999975 77777665    36789999999999999999999998 99999999999999   5555 8999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .............+|+.|+|||++.+  .++.++||||||+++|+|++|+.||...+..+....+.+.
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG  222 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            87766655666788999999999854  3799999999999999999999999988776666555544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-42  Score=299.38  Aligned_cols=212  Identities=28%  Similarity=0.449  Sum_probs=170.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++..... ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CC
Confidence            3457999999999999999999999999999999985432       134578889999999999999998755432 33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||++ ++|.+++..    ..++++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  162 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  162 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTS-CEEECCCSC
T ss_pred             cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCC-CEEEeeccC
Confidence            45689999997 577777765    36799999999999999999999998 999999999999999887 799999999


Q ss_pred             eeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      +........    .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+...++..
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~  233 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR  233 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc
Confidence            976543321    22346899999999997654 89999999999999999999999998876665554444

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.1e-42  Score=292.99  Aligned_cols=203  Identities=26%  Similarity=0.389  Sum_probs=159.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh------hHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++......      ..++...++.++||||+++++++...     .
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----G   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----C
Confidence            446899999999999999999999999999999988543211      12344457778999999999988533     3


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++||||+++++.+.+.........+++..+..++.|++.||.|||++.||+||||||+||+++.++ .++|+|||++.
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISG  158 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            37899999999998888876666788999999999999999999999854999999999999999877 89999999998


Q ss_pred             eeccCCCcccccccccccCCccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ............+|+.|+|||++   .....++.++|||||||++|+|++|+.||...
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW  216 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence            76555555556789999999997   23445889999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-41  Score=303.71  Aligned_cols=204  Identities=27%  Similarity=0.384  Sum_probs=161.9

Q ss_pred             cccceEEe-eeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHH-HhcCCCCceecceeeeeccCCCceEEEE
Q 022520           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        63 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..++|.+. +.||+|+||+||+|.+..+++.||+|++.. .....+|++++ +..+||||++++++|.... .+..++++
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            34568876 789999999999999999999999998853 44556788887 4568999999999874322 33566899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--CCcEEEeeecceee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKV  217 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~~~ikl~Dfg~~~~  217 (296)
                      |||||++ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+  ...+||+|||+++.
T Consensus       137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            9999985 7877776532  34699999999999999999999998 99999999999999872  23799999999987


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             CC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             cCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            6554445567789999999998554 48999999999999999999999998654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.3e-42  Score=315.50  Aligned_cols=215  Identities=32%  Similarity=0.513  Sum_probs=181.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++     .+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   97 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED   97 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            3456899999999999999999999999999999998432       23456899999999999999999988     34


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC--CCCcEEEee
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCD  211 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~--~~~~ikl~D  211 (296)
                      ...+++||||+. ++|.+.+..    ..++++..+..++.||+.||.|||++ ||+||||||+|||++.  ....+||+|
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            455899999998 477776654    46799999999999999999999998 9999999999999952  233799999


Q ss_pred             ecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ||++.............||+.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+.+..+.+.....+
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  247 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE  247 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999987655555566789999999999865  489999999999999999999999999888777777766544433

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=303.90  Aligned_cols=218  Identities=17%  Similarity=0.192  Sum_probs=173.1

Q ss_pred             cccceEEeeeeeecCceEEEEE-----EEcCCCcEEEEEEEeec-chhhHHHHHHHHhcC---CCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQA-----KCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~  133 (296)
                      ...+|.+.+.||+|+||.||+|     .+..+++.||+|++... .....+|..+++.++   |+||+++++++....  
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~--  140 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN--  140 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS--
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC--
Confidence            3457999999999999999999     46778999999998644 334567888888887   899999999885433  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC---------
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---------  202 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~---------  202 (296)
                         ..++||||++ ++|.+++..... ....+++..+..++.||+.||+|||++ ||+||||||+|||++.         
T Consensus       141 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          141 ---GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             ---CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC----
T ss_pred             ---CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCccccc
Confidence               3789999998 688888876443 246799999999999999999999998 9999999999999987         


Q ss_pred             --CCCcEEEeeecceeeeccC---CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------
Q 022520          203 --HTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE------  271 (296)
Q Consensus       203 --~~~~ikl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~------  271 (296)
                        ++ .+||+|||++......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...      
T Consensus       217 ~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          217 DLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             --CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence              55 8999999999765322   2234456899999999997655 899999999999999999999998532      


Q ss_pred             --------ChHHHHHHHHHhhcCCC
Q 022520          272 --------SGVDQLVEIIKVILHTE  288 (296)
Q Consensus       272 --------~~~~~~~~~~~~~~~~~  288 (296)
                              ...+.+..++..+...+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~l~~~  319 (365)
T 3e7e_A          295 PEGLFRRLPHLDMWNEFFHVMLNIP  319 (365)
T ss_dssp             ECSCCTTCSSHHHHHHHHHHHHCCC
T ss_pred             echhccccCcHHHHHHHHHHHcCCC
Confidence                    12455666665555443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-41  Score=297.55  Aligned_cols=214  Identities=35%  Similarity=0.666  Sum_probs=176.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++.     +..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~   97 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKK   97 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCC
Confidence            4468999999999999999999999999999999885432      22347999999999999999999884     334


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      ..++||||++++++..+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++.
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  172 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFAR  172 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred             EEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCC-cEEEEeCCCce
Confidence            48899999998766655432   46799999999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       217 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ...... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.
T Consensus       173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  243 (331)
T 4aaa_A          173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN  243 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            654322 2334568999999999977656899999999999999999999999999888888777765543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-41  Score=312.02  Aligned_cols=210  Identities=29%  Similarity=0.492  Sum_probs=177.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----------------hhhHHHHHHHHhcCCCCceecce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------------RYKNRELQTMRLLDHPNVVSLKH  125 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~E~~~l~~l~h~niv~~~~  125 (296)
                      ...+|.+.+.||+|+||+||+|++..+++.||+|++....                 ....+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3457999999999999999999999999999999885321                 23457999999999999999999


Q ss_pred             eeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC
Q 022520          126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (296)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~  204 (296)
                      ++     .+...+++|||||++ +|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus       114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          114 VF-----EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EE-----ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTT
T ss_pred             EE-----EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCC
Confidence            98     344558999999985 777777653    6799999999999999999999998 999999999999998765


Q ss_pred             C--cEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          205 H--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       205 ~--~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .  .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            3  599999999987766555566789999999999853  489999999999999999999999999887766666665


Q ss_pred             hh
Q 022520          283 VI  284 (296)
Q Consensus       283 ~~  284 (296)
                      ..
T Consensus       262 ~~  263 (504)
T 3q5i_A          262 GK  263 (504)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-42  Score=295.90  Aligned_cols=194  Identities=29%  Similarity=0.406  Sum_probs=160.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHH-hcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMR-LLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+|++.++||+|+||+||+|++..+++.||||++.....      ....|+..+. ..+|+||+++++++.     +...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            579999999999999999999999999999998754321      1123444444 449999999999884     3444


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++||||+++++.+.+...   ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8899999999998887765   46799999999999999999999998 999999999999999887 899999999987


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            655555555678999999999865  489999999999999999999766654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.2e-42  Score=303.25  Aligned_cols=209  Identities=27%  Similarity=0.406  Sum_probs=170.5

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      +...+.||+|+||.||+|.+..+++.||+|++...    .....+|+++++.++||||+++++++.     .....++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEE
Confidence            33467899999999999999999999999998643    234568999999999999999999883     334588999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC-CCCcEEEeeecceeeecc
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~-~~~~ikl~Dfg~~~~~~~  220 (296)
                      ||++ ++|.+.+...   ...+++..+..++.||+.||.|||++ +|+||||||+|||+.. +...+||+|||++.....
T Consensus       166 E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          166 EYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             ECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            9998 4777777643   35689999999999999999999998 9999999999999942 233899999999987765


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  305 (373)
T 2x4f_A          242 REKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW  305 (373)
T ss_dssp             TCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred             ccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence            5555556789999999998554 489999999999999999999999999888777777776543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-41  Score=303.34  Aligned_cols=219  Identities=27%  Similarity=0.407  Sum_probs=181.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcC--------CCCceecceeeeeccC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTE  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~~  132 (296)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++        |+||+++++++.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            457999999999999999999999999999999986543   33457999999885        788999999885332 


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--------
Q 022520          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--------  204 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--------  204 (296)
                      .....+++||||+++++.+.+....  ...+++..++.++.||+.||.|||++.||+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            2455689999999999888877642  357999999999999999999999854899999999999998664        


Q ss_pred             ----------------------------------------CcEEEeeecceeeeccCCCcccccccccccCCccccCCCC
Q 022520          205 ----------------------------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE  244 (296)
Q Consensus       205 ----------------------------------------~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  244 (296)
                                                              ..++|+|||++......  .....||+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence                                                    26999999999865432  34557899999999997655 


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhhcCCC
Q 022520          245 YTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVEIIKVILHTE  288 (296)
Q Consensus       245 ~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~  288 (296)
                      ++.++|||||||++|+|++|+.||...+      ..+.+..+.+.++.++
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p  319 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP  319 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCC
Confidence            8999999999999999999999998755      4455666766666544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.6e-42  Score=303.30  Aligned_cols=200  Identities=19%  Similarity=0.229  Sum_probs=164.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEEeecchhhHHHHH---------------HHHhcCCCCceecc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKRYKNRELQ---------------TMRLLDHPNVVSLK  124 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~E~~---------------~l~~l~h~niv~~~  124 (296)
                      .+|++.+.||+|+||.||+|.+..+     ++.||+|.+........+|++               .++.++|+||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4799999999999999999998764     588999998665544444444               44456799999999


Q ss_pred             eeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc--C
Q 022520          125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN--P  202 (296)
Q Consensus       125 ~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~--~  202 (296)
                      +++.... .+..+.++||||++++|.+++...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCC
Confidence            9886543 345668999999977888887763   36799999999999999999999998 999999999999998  5


Q ss_pred             CCCcEEEeeecceeeeccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          203 HTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       203 ~~~~ikl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ++ .+||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            55 899999999976543321        12345899999999986655 899999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.8e-41  Score=312.14  Aligned_cols=212  Identities=28%  Similarity=0.462  Sum_probs=177.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ...+|++.+.||+|+||+||+|++..++..||+|++...      .....+|+.+++.++||||+++++++.     +..
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~  109 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKR  109 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence            345799999999999999999999999999999988532      234568999999999999999999983     444


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeec
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg  213 (296)
                      .+++|||||.+ +|.+.+...    .++++..+..++.||+.||.|||++ ||+||||||+|||++..+  ..+||+|||
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            58899999985 777777653    6799999999999999999999998 999999999999997643  259999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+....
T Consensus       185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  255 (494)
T 3lij_A          185 LSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT  255 (494)
T ss_dssp             TCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9987766555566789999999999843  4899999999999999999999999998877777776665443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2e-41  Score=301.05  Aligned_cols=214  Identities=35%  Similarity=0.622  Sum_probs=178.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCC-CceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  137 (296)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            47999999999999999999999999999999986431      2345799999999999999999998544321 1123


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++||||+++++...+      ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            4899999999877665      24599999999999999999999998 999999999999999887 799999999976


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            533  234567899999999987756689999999999999999999999999998888888887766553

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=306.14  Aligned_cols=220  Identities=34%  Similarity=0.566  Sum_probs=168.5

Q ss_pred             cceEE-eeeeeecCceEEEEEEEc--CCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMA-ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      +.|.+ .++||+|+||.||+|++.  .+++.||+|++...  .....+|+.+|+.++||||+++++++....   ...++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEE
Confidence            45776 568999999999999976  56889999988543  234568999999999999999999986432   33478


Q ss_pred             EEEecccccHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE----cCCCCcEEEe
Q 022520          140 LVLEYVPETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLC  210 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli----~~~~~~ikl~  210 (296)
                      +||||+++++...+......     ...+++..++.++.||+.||.|||++ ||+||||||+|||+    +.++ .+||+
T Consensus        97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kl~  174 (405)
T 3rgf_A           97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIA  174 (405)
T ss_dssp             EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTT-CEEEC
T ss_pred             EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCC-cEEEE
Confidence            99999999998888754422     23589999999999999999999998 99999999999999    4444 89999


Q ss_pred             eecceeeeccCC----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHH
Q 022520          211 DFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQL  277 (296)
Q Consensus       211 Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------~~~~  277 (296)
                      |||+++......    ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.         .+.+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            999997654321    223457899999999997766689999999999999999999999986554         4677


Q ss_pred             HHHHHhhcCCCc
Q 022520          278 VEIIKVILHTEI  289 (296)
Q Consensus       278 ~~~~~~~~~~~~  289 (296)
                      ..+.+.++.++.
T Consensus       255 ~~i~~~~g~p~~  266 (405)
T 3rgf_A          255 DRIFNVMGFPAD  266 (405)
T ss_dssp             HHHHHHHCCCCT
T ss_pred             HHHHHhhCCCCh
Confidence            888887776643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.3e-41  Score=294.62  Aligned_cols=211  Identities=31%  Similarity=0.559  Sum_probs=177.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-chhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++ ||||+++++++...   .....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEE
Confidence            35799999999999999999999999999999998643 445678999999997 99999999988532   23447899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+++ ++...+       ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++..++|+|||++.....
T Consensus       112 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999986 444443       2488999999999999999999998 9999999999999997766899999999987766


Q ss_pred             CCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhhc
Q 022520          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP-GESGVDQLVEIIKVIL  285 (296)
Q Consensus       221 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~  285 (296)
                      ........+|+.|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+.+..+.+.+.
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~  249 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  249 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence            6555667889999999998775668999999999999999999999985 4455566666655544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=293.58  Aligned_cols=196  Identities=29%  Similarity=0.532  Sum_probs=166.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|.+...    ...+.+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            45799999999999999999999999999999988432    2334589999999999999999999853     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ +|.+++...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999985 777777653   46799999999999999999999998 999999999999999887 7999999999865


Q ss_pred             ccCCCc---------------ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          219 VKGEPN---------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       219 ~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ......               ....||+.|+|||++.+. .++.++||||||+++|+|++|..||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            333221               145689999999998654 489999999999999999999999865

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-41  Score=295.19  Aligned_cols=197  Identities=28%  Similarity=0.506  Sum_probs=149.4

Q ss_pred             cceEEe---eeeeecCceEEEEEEEcCCCcEEEEEEEeecc-hhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAE---RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|.+.   +.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. ||||+++++++     .+....+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence            467775   78999999999999999999999999986543 44568999999997 99999999998     3444588


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC--cEEEeeeccee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAK  216 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~--~ikl~Dfg~~~  216 (296)
                      +||||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.  .++|+|||++.
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 77777765    46799999999999999999999998 9999999999999976542  69999999998


Q ss_pred             eeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       217 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             ECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            654332 234456799999999986544 8999999999999999999999998643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.5e-41  Score=286.42  Aligned_cols=210  Identities=31%  Similarity=0.471  Sum_probs=168.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++.     .
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   82 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----T   82 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----c
Confidence            34468999999999999999999999899999999885432       23458999999999999999999883     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||++ ++|.+.+...    ..+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg  156 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFG  156 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCC-CEEEeecc
Confidence            345889999997 5888887653    5789999999999999999999999 999999999999999887 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++.............+|+.|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  225 (276)
T 2h6d_A          157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG  225 (276)
T ss_dssp             GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence            997765544445567899999999987655457899999999999999999999988766555554444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.1e-41  Score=289.11  Aligned_cols=199  Identities=22%  Similarity=0.304  Sum_probs=169.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...  .....+|+.+++.+ +|+|++++++++.     .....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEE
Confidence            34799999999999999999999999999999988543  34567899999999 7999999988873     3345789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC----cEEEeeeccee
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH----QLKLCDFGSAK  216 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~----~ikl~Dfg~~~  216 (296)
                      ||||++++|.+++...   ..++++..+..++.|++.||.|||++ ||+||||||+|||++.++.    .++|+|||++.
T Consensus        84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999988998888764   35699999999999999999999998 9999999999999986652    39999999998


Q ss_pred             eeccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          217 VLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       217 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            7654322        23456899999999986544 8999999999999999999999998743

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.5e-41  Score=286.08  Aligned_cols=210  Identities=30%  Similarity=0.477  Sum_probs=173.4

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      .....+|++.+.||+|+||.||+|.+..++..||+|++...       .....+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----
Confidence            34556899999999999999999999999999999988532       223457999999999999999999883     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      +....++||||+++ ++.+.+...    .++++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+||
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~l~Df  153 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADF  153 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTS-CEEECSC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCC-CEEEEec
Confidence            34458899999984 777777653    6789999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       213 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |++...... ......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+...
T Consensus       154 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  222 (279)
T 3fdn_A          154 GWSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV  222 (279)
T ss_dssp             CEESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred             cccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC
Confidence            988654332 23456789999999998654 4789999999999999999999999988766666555543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.1e-41  Score=285.89  Aligned_cols=208  Identities=25%  Similarity=0.420  Sum_probs=172.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      .++|++.+.||+|+||.||+|++..+++.||+|.+...          .....+|+.+++.++||||+++++++.     
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----
Confidence            35799999999999999999999999999999988543          234568999999999999999999884     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC---cEEE
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKL  209 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---~ikl  209 (296)
                      +....++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++.   .++|
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             CCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEE
Confidence            3345889999997 588887765    36789999999999999999999998 9999999999999987542   6999


Q ss_pred             eeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       210 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      +|||++.............+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+..
T Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  225 (283)
T 3bhy_A          154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA  225 (283)
T ss_dssp             CCCTTCEECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             EecccceeccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence            9999998765554445567899999999986544 89999999999999999999999998876665555443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-41  Score=292.24  Aligned_cols=214  Identities=33%  Similarity=0.588  Sum_probs=173.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeecc---------
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT---------  131 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------  131 (296)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+++++.++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47999999999999999999999999999999885432    33457999999999999999998873321         


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          132 EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                      ..+....++||||++++|.+.+..     .++++..++.++.|++.||+|||++ ||+||||||+|||++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            123356889999999988887753     6789999999999999999999998 9999999999999986555899999


Q ss_pred             ecceeeeccCC----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          212 FGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       212 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ||++.......    ......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99997653221    22344568999999998765668999999999999999999999999988877777776654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-41  Score=296.16  Aligned_cols=202  Identities=26%  Similarity=0.449  Sum_probs=164.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccC------
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE------  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  132 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....     ....+|+++++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457999999999999999999999999999999986322     334589999999999999999998865432      


Q ss_pred             ----------------------------------------------CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCH
Q 022520          133 ----------------------------------------------KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPL  165 (296)
Q Consensus       133 ----------------------------------------------~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~  165 (296)
                                                                    ....+.++|||||++ +|.+++.... .....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                          122357899999986 7777766533 2344566


Q ss_pred             HHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC-------------Cccccccccc
Q 022520          166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNISYICSRY  232 (296)
Q Consensus       166 ~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~-------------~~~~~~~t~~  232 (296)
                      ..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++.......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            77889999999999999998 999999999999999887 89999999998764432             1233568999


Q ss_pred             ccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       233 y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      |+|||++.+.. ++.++|||||||++|+|++|..|+.
T Consensus       242 y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          242 YMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             GSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             ccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChh
Confidence            99999986654 8999999999999999999987763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.7e-41  Score=292.91  Aligned_cols=205  Identities=28%  Similarity=0.441  Sum_probs=172.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..|...+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++...     ...++
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  119 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV  119 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            45888999999999999999999899999999885332    3355899999999999999999988543     34889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+++ +|.+.+.     ..++++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus       120 v~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          120 LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQIS  192 (321)
T ss_dssp             EECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-cEEEeeeeeeeecc
Confidence            9999985 5655543     25799999999999999999999998 999999999999999887 89999999987764


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+.+..+..
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~  255 (321)
T 2c30_A          193 KDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD  255 (321)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             cCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            432 23456789999999998654 489999999999999999999999998776655555443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=294.41  Aligned_cols=211  Identities=24%  Similarity=0.386  Sum_probs=171.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCc---EEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ....+|++.+.||+|+||.||+|.+..++.   .||+|.+...     ...+.+|+.+++.++||||+++++++.     
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            445689999999999999999999975554   5999998643     223457999999999999999999883     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      +....++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Df  195 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNL-VCKVSDF  195 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCC
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCC-CEEECCC
Confidence            34447899999975 777777543   36799999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          213 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       213 g~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |++.........    ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  270 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG  270 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence            999876443221    2233477899999986544 8999999999999999998 99999988776666555543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-41  Score=298.19  Aligned_cols=217  Identities=31%  Similarity=0.490  Sum_probs=173.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...         .....+|+++++.++||||+++++++.     +
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence            45799999999999999999999999999999988532         134557999999999999999999983     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhc------------------------------------CCCCCHHHHHHHHHHHHH
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKM------------------------------------SQRMPLIYVKLYFYQICR  177 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~~i~~  177 (296)
                      ....++||||++ ++|.+.+......                                    ...+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            445889999997 5776666321100                                    112357778889999999


Q ss_pred             HHHHHHccCCceeccCCCCceEEcCCCC-cEEEeeecceeeeccCCC-----cccccccccccCCccccCC-CCCCCchh
Q 022520          178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGA-TEYTAAID  250 (296)
Q Consensus       178 ~l~~LH~~~~iiH~Dlkp~NIli~~~~~-~ikl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~D  250 (296)
                      ||.|||++ +|+||||||+|||++.++. .+||+|||++........     .....||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999998 9999999999999986542 699999999986543221     2355789999999998642 45889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          251 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       251 iwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ||||||++|+|++|+.||.+.+..+.+.++.+....
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC  294 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc
Confidence            999999999999999999998877777776665443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-40  Score=291.49  Aligned_cols=209  Identities=28%  Similarity=0.431  Sum_probs=175.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|.+.+.||+|+||.||++++..+++.||+|++...       .....+|+.+++.++|+||+++++++.     +.
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence            446899999999999999999999999999999988543       233457999999999999999999883     34


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  187 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  187 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCC-CEEEeeccC
Confidence            45889999998 477776655    36799999999999999999999998 999999999999999887 799999999


Q ss_pred             eeeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       215 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      +...... .......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||......+.+..+.+.
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  256 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN  256 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred             ceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC
Confidence            9876432 2234456899999999986544 789999999999999999999999987766555555443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-40  Score=285.48  Aligned_cols=208  Identities=28%  Similarity=0.428  Sum_probs=174.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+++++++.     +.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cC
Confidence            4468999999999999999999999999999999885431       23457999999999999999999883     34


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||++ +++.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~  161 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  161 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCC-CEEEEeccC
Confidence            45889999998 577776654    36799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      +...... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||......+....+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  229 (294)
T 2rku_A          162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK  229 (294)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             ceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Confidence            9875432 2234456899999999986544 78999999999999999999999998776555544443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.9e-41  Score=297.01  Aligned_cols=212  Identities=23%  Similarity=0.395  Sum_probs=171.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEc-------CCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeee
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  128 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~  128 (296)
                      ...++|++.+.||+|+||.||+|++.       .++..||+|.+....     ....+|+.+++.+ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            34568999999999999999999975       345679999885432     2345899999999 8999999999883


Q ss_pred             eccCCCceEEEEEEecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCC
Q 022520          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp  195 (296)
                      .     ...+++||||+++ +|.+++.....            ....+++..+..++.||+.||.|||++ ||+||||||
T Consensus       158 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp  231 (370)
T 2psq_A          158 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAA  231 (370)
T ss_dssp             S-----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCG
T ss_pred             c-----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ceeccccch
Confidence            3     3347899999985 88888876431            124588999999999999999999998 999999999


Q ss_pred             CceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 022520          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGE  271 (296)
Q Consensus       196 ~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~  271 (296)
                      +|||++.++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.
T Consensus       232 ~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          232 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             GGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999887 899999999986544322   23345678999999986654 8999999999999999999 99999987


Q ss_pred             ChHHHHHHHH
Q 022520          272 SGVDQLVEII  281 (296)
Q Consensus       272 ~~~~~~~~~~  281 (296)
                      +..+....+.
T Consensus       310 ~~~~~~~~~~  319 (370)
T 2psq_A          310 PVEELFKLLK  319 (370)
T ss_dssp             CGGGHHHHHH
T ss_pred             CHHHHHHHHh
Confidence            7655444433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.5e-41  Score=296.00  Aligned_cols=208  Identities=25%  Similarity=0.427  Sum_probs=176.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            47999999999999999999998899999999885432            2345799999998 8999999999873   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                        .....++||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+|+||||+|||++.++ .++|+
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEE
Confidence              34458899999985 77777765    36799999999999999999999998 999999999999999887 89999


Q ss_pred             eecceeeeccCCCcccccccccccCCccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       211 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|+.||...+....+..+...
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~  320 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG  320 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            9999987766555566788999999999853     234788999999999999999999999887766655555443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-40  Score=283.83  Aligned_cols=208  Identities=28%  Similarity=0.469  Sum_probs=176.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...++|.+.+.||+|+||.||+|++..+++.||+|.+...       .....+|+++++.++||||+++++++.     +
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   85 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----D   85 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----c
Confidence            3456899999999999999999999999999999988532       234568999999999999999999884     3


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||+++ +|.+.+...    ..+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg  159 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKG-ELKIADFG  159 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCC-CEEEeccc
Confidence            4458899999985 887777653    5789999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++...... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+..
T Consensus       160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  226 (284)
T 2vgo_A          160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN  226 (284)
T ss_dssp             TCEECSSS-CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             ccccCccc-ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc
Confidence            98765332 234567899999999986544 78999999999999999999999998776665555544

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-41  Score=298.20  Aligned_cols=201  Identities=28%  Similarity=0.482  Sum_probs=166.0

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeec--------chhhHHHHHHHHhc-CCCCceecceeee
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFF  128 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l-~h~niv~~~~~~~  128 (296)
                      .....+|++.+.||+|+||.||+|++.   .+++.||+|++...        .....+|+.+++.+ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            344568999999999999999999985   57899999988432        23345799999999 6999999999884


Q ss_pred             eccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcE
Q 022520          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~i  207 (296)
                      .     ....++||||+++ +|.+.+...    ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+
T Consensus       130 ~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~  198 (355)
T 1vzo_A          130 T-----ETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HV  198 (355)
T ss_dssp             E-----TTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CE
T ss_pred             e-----CceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-cE
Confidence            3     3348899999985 787777653    5799999999999999999999998 999999999999999887 89


Q ss_pred             EEeeecceeeeccCC--CcccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          208 KLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       208 kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ||+|||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+
T Consensus       199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence            999999998653322  12345789999999998653 347899999999999999999999997543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.1e-41  Score=305.44  Aligned_cols=199  Identities=30%  Similarity=0.510  Sum_probs=159.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....            ....+|+.+|+.++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            457999999999999999999999999999999885421            13468999999999999999999862   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEE
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLK  208 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ik  208 (296)
                        ... .++||||+++ +|.+.+..    ..++++..+..++.|++.||.|||++ +|+||||||+|||++.++  ..+|
T Consensus       211 --~~~-~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SSE-EEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cCc-eEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEE
Confidence              222 6799999985 66554433    46799999999999999999999998 999999999999997543  2599


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      |+|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|++||.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  349 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  349 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence            999999987655544556778999999999853  34578899999999999999999999986543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=287.68  Aligned_cols=198  Identities=28%  Similarity=0.510  Sum_probs=150.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++.     +..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence            357999999999999999999999999999999985432       34568999999999999999999883     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+.+...   ..++++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~  159 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGLA  159 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence            58899999975 777766643   36789999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          216 KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       216 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ....... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence            7654322 233456899999999986544 7899999999999999999999998654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.5e-41  Score=284.22  Aligned_cols=210  Identities=21%  Similarity=0.381  Sum_probs=173.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ....+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++.     +....
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPI   80 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCce
Confidence            34468999999999999999999986 5677999998643   344568999999999999999999883     33347


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~  155 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRF  155 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGG-CEEECCTTGGGG
T ss_pred             EEEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCC-CEEecccccccc
Confidence            899999985 677777543   35689999999999999999999998 999999999999998877 899999999875


Q ss_pred             eccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          218 LVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       218 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .....  ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~  223 (269)
T 4hcu_A          156 VLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG  223 (269)
T ss_dssp             BCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             ccccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Confidence            43221  223345678899999986544 8999999999999999999 99999988776666655543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.4e-41  Score=286.41  Aligned_cols=202  Identities=26%  Similarity=0.425  Sum_probs=175.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccC----------
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE----------  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----------  132 (296)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+........+|+++++.++||||+++++++.....          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            3457999999999999999999999899999999998777788899999999999999999998743211          


Q ss_pred             -CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          133 -KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       133 -~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                       ......++||||+++ +|.+++....  ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~  164 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTK-QVKIG  164 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEEC
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCC-CEEEC
Confidence             224558899999995 8888887543  46799999999999999999999998 999999999999999877 89999


Q ss_pred             eecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       211 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      |||++.............+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             cchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcch
Confidence            999998776555555667899999999986544 8999999999999999999998874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-40  Score=296.73  Aligned_cols=215  Identities=33%  Similarity=0.569  Sum_probs=179.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcC-CC-----CceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-HP-----NVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~  133 (296)
                      ...+|++.+.||+|+||+||+|++..+++.||+|++....   ....+|+.+++.++ |+     +|+++++++..    
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~----  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF----  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence            3468999999999999999999999999999999986543   23346888888875 54     48888887743    


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc--cCCceeccCCCCceEEcC-CCCcEEEe
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--TIGVCHRDIKPQNLLVNP-HTHQLKLC  210 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~--~~~iiH~Dlkp~NIli~~-~~~~ikl~  210 (296)
                       ....++||||++++|.+.+....  ...+++..++.++.|++.||.|||+  . ||+||||||+|||++. ....+||+
T Consensus       128 -~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 -RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTT-CEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             -CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCC-CEEcCCCCcccEEEecCCCCcEEEE
Confidence             33488999999999999887643  2568999999999999999999994  5 8999999999999954 23379999


Q ss_pred             eecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       211 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      |||++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.++
T Consensus       204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             eccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999987533  234567899999999997655 89999999999999999999999999998888988888776654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=306.23  Aligned_cols=202  Identities=25%  Similarity=0.399  Sum_probs=167.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....     ....+|+++++.++||||+++++++....   ....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence            357999999999999999999999999999999985322     33458999999999999999999875332   2347


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE----cCCCCcEEEeeec
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFG  213 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli----~~~~~~ikl~Dfg  213 (296)
                      ++||||+++ +|.+++.... ....+++..+..++.|++.||.|||++ ||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            899999985 7777665432 233499999999999999999999998 99999999999998    5444 69999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      ++.............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||...
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~  226 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99876555444566789999999998531       34688999999999999999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.1e-41  Score=298.59  Aligned_cols=195  Identities=25%  Similarity=0.377  Sum_probs=160.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcC--CCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~  136 (296)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+++.++  |+||+++++++..     ..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            469999999999999999999764 8899999885432      33458999999997  5999999998743     33


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++|||+.+++|.+++..    ...+++..+..++.||+.||.|||++ +|+||||||+|||++. + .+||+|||++.
T Consensus       130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~-~-~~kl~DFG~a~  202 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIAN  202 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEESS-S-CEEECCCSSSC
T ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEEC-C-eEEEEecCccc
Confidence            4889999777888888876    35788999999999999999999998 9999999999999964 4 79999999998


Q ss_pred             eeccCCC---cccccccccccCCccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          217 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       217 ~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||....
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            6643322   2345789999999998541          348899999999999999999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.7e-40  Score=283.86  Aligned_cols=211  Identities=24%  Similarity=0.387  Sum_probs=178.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------------hhhHHHHHHHHhcC-CCCceecceeee
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFF  128 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~  128 (296)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+....             ....+|+++++.+. ||||+++++++ 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            3458999999999999999999999999999999985331             23347999999995 99999999988 


Q ss_pred             eccCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcE
Q 022520          129 STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~i  207 (296)
                          ......++||||++ ++|.+++...    ..+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .+
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~  163 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NI  163 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CE
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCC-cE
Confidence                33455889999998 5888877653    5789999999999999999999998 999999999999999887 79


Q ss_pred             EEeeecceeeeccCCCcccccccccccCCcccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       208 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      +|+|||++.............+|+.|+|||++.     ....++.++||||||+++|+|++|+.||...+..+....+..
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            999999998776555555667899999999974     234478999999999999999999999988776665555555


Q ss_pred             hh
Q 022520          283 VI  284 (296)
Q Consensus       283 ~~  284 (296)
                      ..
T Consensus       244 ~~  245 (298)
T 1phk_A          244 GN  245 (298)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=298.17  Aligned_cols=214  Identities=20%  Similarity=0.287  Sum_probs=171.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ....+|++.+.||+|+||.||+|++     ..++..||+|++...     .....+|+.+++.++||||+++++++..  
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence            3446899999999999999999994     456789999988532     1234579999999999999999998843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--C
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--H  205 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~  205 (296)
                         ....++||||++ ++|.+++.....   ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++  .
T Consensus       146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          146 ---SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCc
Confidence               333689999997 588888876542   224589999999999999999999998 999999999999998543  2


Q ss_pred             cEEEeeecceeeeccC---CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          206 QLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       206 ~ikl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .+||+|||+++.....   .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+.+..+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            5999999998754222   2233456789999999986554 8999999999999999998 999999887665555444


Q ss_pred             H
Q 022520          282 K  282 (296)
Q Consensus       282 ~  282 (296)
                      .
T Consensus       301 ~  301 (367)
T 3l9p_A          301 S  301 (367)
T ss_dssp             T
T ss_pred             c
Confidence            4

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.5e-40  Score=285.98  Aligned_cols=208  Identities=27%  Similarity=0.424  Sum_probs=174.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|.+...    .....+|+.+++.++||||+++++++.     +....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            45799999999999999999999999999999998643    234568999999999999999999883     344588


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE---cCCCCcEEEeeecce
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA  215 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli---~~~~~~ikl~Dfg~~  215 (296)
                      +||||++ ++|.+.+...    ..+++..+..++.|++.||.|||++ ||+|+||||+||++   +.++ .++|+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            9999997 4787777653    5789999999999999999999998 99999999999999   4455 8999999998


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.+..
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  223 (304)
T 2jam_A          157 KMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY  223 (304)
T ss_dssp             CCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC
T ss_pred             eecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            754322 23445689999999998654 48999999999999999999999999887666666665543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=290.33  Aligned_cols=206  Identities=29%  Similarity=0.464  Sum_probs=156.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcC-CCCceecceeeeeccC---CCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTE---KDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~---~~~~  136 (296)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999999999999999885443    23457899999996 9999999998854322   4456


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .+++||||++++|.+++..... ..++++..+..++.||+.||.|||++ +  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            6889999999999988876432 45799999999999999999999998 9  99999999999999887 899999999


Q ss_pred             eeeeccCCCc-------------ccccccccccCCcccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          215 AKVLVKGEPN-------------ISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       215 ~~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      +.........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|+.||.....
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            9765432211             1345899999999983  234478899999999999999999999976543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-40  Score=283.40  Aligned_cols=214  Identities=28%  Similarity=0.426  Sum_probs=176.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.++||||+++++++....   ..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cc
Confidence            4568999999999999999999999999999999985432      23457999999999999999999875432   33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC-----ceeccCCCCceEEcCCCCcEEEe
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-----iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                      ..++||||+++ +|.+++.........+++..+..++.|++.||.|||++ +     |+|+||||+||+++.++ .++|+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~-~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSS-CEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence            47899999985 88888887665556799999999999999999999998 8     99999999999999877 89999


Q ss_pred             eecceeeeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          211 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       211 Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      |||++........ .....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+..
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~  230 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE  230 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh
Confidence            9999876533221 12346799999999986654 89999999999999999999999998876555444444

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=295.15  Aligned_cols=213  Identities=35%  Similarity=0.626  Sum_probs=176.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCC-CceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  137 (296)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            47999999999999999999999999999999985432      2345799999999999999999988543221 1123


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++||||+++++...+.      ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            58999999987765542      4589999999999999999999998 999999999999999887 899999999876


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  243 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  243 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            432  23345789999999998765668999999999999999999999999998888888887766544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.7e-40  Score=283.30  Aligned_cols=199  Identities=24%  Similarity=0.322  Sum_probs=166.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee--cchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..  ......+|+++++.++|++++..+..+..    .....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence            3579999999999999999999999999999997643  23456789999999999988887766543    23347899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE---cCCCCcEEEeeecceeee
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli---~~~~~~ikl~Dfg~~~~~  218 (296)
                      |||++++|.+++...   ..++++..+..++.|++.||.|||++ ||+||||||+|||+   +.++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence            999988988887753   36799999999999999999999998 99999999999999   5555 7999999999876


Q ss_pred             ccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          219 VKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       219 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .....        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            44432        23457899999999986654 8999999999999999999999998643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.7e-40  Score=289.24  Aligned_cols=214  Identities=27%  Similarity=0.467  Sum_probs=177.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEE-cCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCC------CceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKC-LETGEAVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~  133 (296)
                      ..+|++.+.||+|+||.||+|.+ ..+++.||+|++....   ....+|+.+++.++|+      +++++++++.     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----
Confidence            35899999999999999999998 5688999999986433   3445799999888665      4899888873     


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC----------
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----------  203 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~----------  203 (296)
                      .....++||||+++++.+.+....  ..++++..+..++.|++.||+|||++ ||+||||||+|||++..          
T Consensus        88 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           88 HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcc
Confidence            333588999999989998887642  24689999999999999999999998 99999999999999863          


Q ss_pred             --------CCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          204 --------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       204 --------~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                              ...++|+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    22699999999976432  334567899999999986554 8999999999999999999999999998888


Q ss_pred             HHHHHHHhhcCCC
Q 022520          276 QLVEIIKVILHTE  288 (296)
Q Consensus       276 ~~~~~~~~~~~~~  288 (296)
                      .+..+.+.....+
T Consensus       242 ~~~~~~~~~~~~p  254 (339)
T 1z57_A          242 HLAMMERILGPLP  254 (339)
T ss_dssp             HHHHHHHHHCSCC
T ss_pred             HHHHHHHHhCCCC
Confidence            7777777665544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.6e-41  Score=298.28  Aligned_cols=210  Identities=21%  Similarity=0.311  Sum_probs=172.5

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ......+|.+.+.||+|+||.||+|++..+++.||+|.+....     ..+.+|+++++.++||||+++++++..     
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----  183 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----  183 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----
Confidence            3345568999999999999999999999899999999885432     244589999999999999999998833     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||++ ++|.+++...   ...++...+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~-~~kl~DfG  258 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKN-VLKISDFG  258 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGG
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCC-cEEECcCC
Confidence            333789999997 5888887654   35689999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       214 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      +++........   ....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~  328 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV  328 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99764332111   1223477899999986544 8999999999999999998 99999988765544433

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.8e-40  Score=282.22  Aligned_cols=205  Identities=23%  Similarity=0.351  Sum_probs=170.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+....      ....+|+.+++.++||||+++++++.... .+..++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            46999999999999999999999999999999885432      23457999999999999999999875443 345668


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ++||||+++ +|.+++...    ..+++..+..++.|++.||.|||++ +  |+|+||||+|||++.+.+.++|+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            899999975 888777653    6789999999999999999999998 8  9999999999999843348999999998


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      ..... .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||........+.
T Consensus       180 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  239 (290)
T 1t4h_A          180 TLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY  239 (290)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred             ccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH
Confidence            64322 23345678999999998853  38999999999999999999999998865544443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.9e-41  Score=287.82  Aligned_cols=199  Identities=30%  Similarity=0.494  Sum_probs=162.5

Q ss_pred             cccceEEeeeeeecCceEEEEEE----EcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+++++.++||||+++++++.....  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH--
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--
Confidence            44689999999999999999998    55688999999986433    234589999999999999999998754322  


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                       ..+++||||++ ++|.+++...   ..++++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||
T Consensus        86 -~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           86 -RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             -TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             -CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCC-eEEEccCc
Confidence             23679999997 5888887664   24589999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       214 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ++........    .....++..|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCC
Confidence            9976543321    22334677899999986554 89999999999999999999998865

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.6e-41  Score=298.07  Aligned_cols=201  Identities=15%  Similarity=0.139  Sum_probs=149.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhc--CCCCceecceeee------
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVVSLKHCFF------  128 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l--~h~niv~~~~~~~------  128 (296)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.+  +||||++++..++      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999986532       1234665444444  6999888654332      


Q ss_pred             -eccCC------------CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHHccCCce
Q 022520          129 -STTEK------------DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------KLYFYQICRALAYIHNTIGVC  189 (296)
Q Consensus       129 -~~~~~------------~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~ii  189 (296)
                       .....            ....+++||||++++|.+++.....   .++....      ..++.||+.||+|||++ ||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK-GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCc
Confidence             11110            0145789999999999999887532   2333344      56669999999999998 999


Q ss_pred             eccCCCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCccccC-CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 022520          190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLF  268 (296)
Q Consensus       190 H~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf  268 (296)
                      ||||||+|||++.++ .+||+|||+++....  ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999887 899999999986522  2225667899999999964 135899999999999999999999999


Q ss_pred             CCC
Q 022520          269 PGE  271 (296)
Q Consensus       269 ~~~  271 (296)
                      .+.
T Consensus       294 ~~~  296 (371)
T 3q60_A          294 GLV  296 (371)
T ss_dssp             TBC
T ss_pred             CCc
Confidence            776

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-40  Score=290.29  Aligned_cols=212  Identities=25%  Similarity=0.391  Sum_probs=171.1

Q ss_pred             ccceEEe-eeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcC-CCCceecceeeeeccCCCc
Q 022520           64 TISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|.+. +.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.+. ||||+++++++     .+.
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~  101 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENT  101 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeC
Confidence            3468887 8999999999999999999999999988532      234457999999985 69999999988     344


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC---CCCcEEEee
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCD  211 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~---~~~~ikl~D  211 (296)
                      ...++||||+.+ +|.+.+...  ....+++..+..++.|++.||+|||++ ||+||||||+|||++.   ++ .++|+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~-~~kL~D  177 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLG-DIKIVD  177 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBC-CEEECC
T ss_pred             CeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCC-cEEEee
Confidence            458899999986 666555332  236799999999999999999999998 9999999999999987   44 899999


Q ss_pred             ecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       212 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  250 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV  250 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             CccccccCCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc
Confidence            99998775555555667899999999986554 89999999999999999999999999887777666665443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-40  Score=279.76  Aligned_cols=208  Identities=22%  Similarity=0.378  Sum_probs=171.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+++++.++||||+++++++     .+....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence            4468999999999999999999875 5677999998643   33456899999999999999999988     3334478


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            9999997 5687777654   35689999999999999999999998 999999999999999887 8999999999865


Q ss_pred             ccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      .....  .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+..
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  220 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ  220 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc
Confidence            44322  12334567899999986544 7899999999999999998 9999998776665555443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.4e-41  Score=295.66  Aligned_cols=216  Identities=24%  Similarity=0.376  Sum_probs=172.1

Q ss_pred             cccceEEeeeeeecCceEEEEEE-----EcCCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ..++|++.+.||+|+||.||+|+     +..+++.||+|++....     ....+|+++++.+ +||||+++++++....
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            44689999999999999999999     44567899999986432     2355899999999 7899999999885322


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhc---------------------------------------------------
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM---------------------------------------------------  159 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~---------------------------------------------------  159 (296)
                          ...++||||+++ +|.+++......                                                   
T Consensus       100 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A          100 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             ----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence                236799999985 888887654321                                                   


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC---cc
Q 022520          160 -----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NI  225 (296)
Q Consensus       160 -----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~  225 (296)
                                 ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++........   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence                       12288999999999999999999999 999999999999999877 899999999976533322   22


Q ss_pred             cccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhc
Q 022520          226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       226 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ...+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+........
T Consensus       254 ~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  313 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT  313 (359)
T ss_dssp             -CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred             ccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC
Confidence            346788999999986544 8999999999999999998 9999998765555544444433

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-41  Score=301.75  Aligned_cols=204  Identities=16%  Similarity=0.193  Sum_probs=157.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHH---HHHhcCCCCceecceeee-----
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQ---TMRLLDHPNVVSLKHCFF-----  128 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~---~l~~l~h~niv~~~~~~~-----  128 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...       ...+.+|++   +++.++||||+++++.+.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999889999999998532       133457884   455558999999984432     


Q ss_pred             --ecc---------CCCce---EEEEEEecccccHHHHHHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHHccCCceec
Q 022520          129 --STT---------EKDEL---YLNLVLEYVPETVHRVIKHHYKMSQ---RMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (296)
Q Consensus       129 --~~~---------~~~~~---~~~iv~e~~~~~l~~~l~~~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~  191 (296)
                        ...         ..+..   ..++||||++|+|.+++........   .+++..+..++.||+.||+|||++ ||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence              111         01111   2679999999999998887532211   233477888999999999999998 99999


Q ss_pred             cCCCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCccccCC----------CCCCCchhHHHHHHHHHHH
Q 022520          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAEL  261 (296)
Q Consensus       192 Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~l  261 (296)
                      ||||+|||++.++ .+||+|||+++...  .......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999887 89999999998532  22334556 999999998665          2489999999999999999


Q ss_pred             HhCCCCCCCCC
Q 022520          262 LLGQPLFPGES  272 (296)
Q Consensus       262 ~~g~~pf~~~~  272 (296)
                      ++|+.||.+.+
T Consensus       307 ltg~~Pf~~~~  317 (377)
T 3byv_A          307 WCADLPITKDA  317 (377)
T ss_dssp             HHSSCCC----
T ss_pred             HHCCCCCcccc
Confidence            99999997643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.5e-40  Score=281.93  Aligned_cols=198  Identities=24%  Similarity=0.323  Sum_probs=167.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...  .....+|+.+++.++|+++++.+..+..    .....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence            35799999999999999999999999999999988543  3456789999999999988877665533    23347899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc---CCCCcEEEeeecceeee
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~---~~~~~ikl~Dfg~~~~~  218 (296)
                      |||++++|.+++...   ..++++..+..++.|++.||.|||++ ||+||||||+|||++   .++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence            999988988888743   36799999999999999999999998 999999999999994   454 8999999999876


Q ss_pred             ccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          219 VKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       219 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      .....        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            54432        23457899999999986655 899999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=286.37  Aligned_cols=212  Identities=28%  Similarity=0.425  Sum_probs=174.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...        .....+|+.+++.++||||+++++++...   +.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence            35799999999999999999999999999999998533        23446899999999999999999987532   23


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ...++||||+++++.+.+....  ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~-~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGG-TLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCC-cEEeeccccc
Confidence            3478999999998877776543  46799999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeeccCC---CcccccccccccCCccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      .......   ......+|+.|+|||++.+.. .++.++||||||+++|+|++|+.||.+.+..+....+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~  227 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK  227 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc
Confidence            8654322   123456899999999986533 247799999999999999999999998776555555444

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=291.69  Aligned_cols=196  Identities=26%  Similarity=0.383  Sum_probs=160.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCC--CCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||.||+|.+ .+++.||+|++....      ....+|+.+++.++|  +||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            35799999999999999999987 468899999885332      334579999999987  99999999884     34


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ...++|||+.+++|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++. + .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~~-~-~~kl~DFG~a  154 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIA  154 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred             CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEEC-C-cEEEeecccc
Confidence            45889999888899888876    46799999999999999999999998 9999999999999974 4 7999999999


Q ss_pred             eeeccCCC---cccccccccccCCccccC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          216 KVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       216 ~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ........   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence            76543332   234578999999999853          2458899999999999999999999998643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.8e-41  Score=291.63  Aligned_cols=199  Identities=25%  Similarity=0.356  Sum_probs=164.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch---hhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..+|++.+.||+|+||.||+|++  .++.||+|++.....   ...+|+.+++.++||||+++++++..... ....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence            35799999999999999999988  478999999854332   23458888999999999999999865432 2345789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC---------CceeccCCCCceEEcCCCCcEEEe
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                      ||||+++ +|.+++..     ..+++..+..++.|++.||.|||+..         +|+||||||+|||++.++ .+||+
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEEC
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEc
Confidence            9999985 88888764     56999999999999999999999742         899999999999999887 89999


Q ss_pred             eecceeeeccCCC---cccccccccccCCccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          211 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       211 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |||++........   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+.
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            9999987644332   2335789999999998653    23567889999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.1e-40  Score=283.52  Aligned_cols=201  Identities=21%  Similarity=0.296  Sum_probs=168.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+..+..+ +||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----   82 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----   82 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence            3456899999999999999999999999999999988643      12334688888888 99999999998843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC---------
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---------  204 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~---------  204 (296)
                      ....++||||+++ +|.+.+.........+++..+..++.||+.||.|||++ ||+||||||+|||++.++         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCccccccc
Confidence            3348899999975 89988887765567899999999999999999999998 999999999999998432         


Q ss_pred             ---------CcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          205 ---------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       205 ---------~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                               ..++|+|||++......   ....+|+.|+|||++.+...++.++|||||||++|+|++|.+|+...
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                     26999999999865432   23458999999999976655778999999999999999999877543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.3e-40  Score=290.62  Aligned_cols=213  Identities=26%  Similarity=0.462  Sum_probs=177.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCC-cEEEEEEEeecc---hhhHHHHHHHHhcCCCC------ceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~  133 (296)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++....   ....+|+.+++.++|++      ++.+++++.     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----
Confidence            358999999999999999999998776 789999986432   33457899999987665      788777763     


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE-------------
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-------------  200 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli-------------  200 (296)
                      .....++||||+++++.+.+....  ..++++..+..++.||+.||.|||++ ||+||||||+|||+             
T Consensus        93 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           93 FHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccc
Confidence            233588999999999888877642  35799999999999999999999998 99999999999999             


Q ss_pred             ------cCCCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022520          201 ------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (296)
Q Consensus       201 ------~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  274 (296)
                            +.++ .+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..
T Consensus       170 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  3444 799999999976432  334567899999999996554 899999999999999999999999999888


Q ss_pred             HHHHHHHHhhcCCC
Q 022520          275 DQLVEIIKVILHTE  288 (296)
Q Consensus       275 ~~~~~~~~~~~~~~  288 (296)
                      +.+..+.+..+..+
T Consensus       246 ~~~~~~~~~~~~~p  259 (355)
T 2eu9_A          246 EHLVMMEKILGPIP  259 (355)
T ss_dssp             HHHHHHHHHHCCCC
T ss_pred             HHHHHHHHHcCCCc
Confidence            88887777766544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.6e-40  Score=284.21  Aligned_cols=198  Identities=23%  Similarity=0.349  Sum_probs=163.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-hhhHHHHHHHHh--cCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..++|++.+.||+|+||.||+|++  +++.||+|++.... ....+|.+++..  ++||||+++++++.... ......+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence            346899999999999999999988  78999999985443 333467777776  79999999999875543 3345688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------ccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                      +||||+++ +|.+++.     ...+++..+..++.|++.||.|||        ++ +|+||||||+|||++.++ .+||+
T Consensus        83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~-~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNG-QCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEEC
T ss_pred             EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCC-CEEEe
Confidence            99999985 7777774     357999999999999999999999        88 999999999999999887 89999


Q ss_pred             eecceeeeccCCCc-----ccccccccccCCccccCCC-----CCCCchhHHHHHHHHHHHHhC----------CCCCCC
Q 022520          211 DFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLG----------QPLFPG  270 (296)
Q Consensus       211 Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g----------~~pf~~  270 (296)
                      |||++.........     ....||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999766444322     2347899999999986543     244789999999999999999          889865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9e-41  Score=293.24  Aligned_cols=213  Identities=24%  Similarity=0.346  Sum_probs=172.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ....+|++.+.||+|+||.||+|++.     .+++.||+|.+....     ..+.+|+.+++.++||||+++++++..  
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV--  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence            34568999999999999999999986     345899999885432     334589999999999999999998843  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHccCCcee
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM--------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH  190 (296)
                         ....++||||+++ +|.+++......                    ...+++..+..++.||+.||.|||++ ||+|
T Consensus       122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH  197 (343)
T 1luf_A          122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVH  197 (343)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence               3347899999985 888888764211                    25789999999999999999999998 9999


Q ss_pred             ccCCCCceEEcCCCCcEEEeeecceeeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 022520          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  266 (296)
Q Consensus       191 ~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~  266 (296)
                      |||||+|||++.++ .+||+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..
T Consensus       198 ~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          198 RDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             SCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCC
Confidence            99999999999877 89999999987653321   223456788999999986554 8999999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHH
Q 022520          267 LFPGESGVDQLVEIIK  282 (296)
Q Consensus       267 pf~~~~~~~~~~~~~~  282 (296)
                      ||.+.+..+....+.+
T Consensus       276 p~~~~~~~~~~~~~~~  291 (343)
T 1luf_A          276 PYYGMAHEEVIYYVRD  291 (343)
T ss_dssp             TTTTSCHHHHHHHHHT
T ss_pred             cCCCCChHHHHHHHhC
Confidence            9998776555554443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-40  Score=290.25  Aligned_cols=199  Identities=31%  Similarity=0.527  Sum_probs=165.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      .++|++.+.||+|+||.||+|++..+++.||+|.+....            ....+|+++++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            357999999999999999999999999999999884321            235689999999999999999988732  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC--cEE
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLK  208 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~--~ik  208 (296)
                         .. .++||||+++ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.  .++
T Consensus        87 ---~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 ---ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEE
Confidence               11 6899999985 77766654    46799999999999999999999998 9999999999999987542  499


Q ss_pred             EeeecceeeeccCCCcccccccccccCCcccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      |+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||.....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            99999998764433334456899999999973  344588999999999999999999999986543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-40  Score=292.24  Aligned_cols=213  Identities=23%  Similarity=0.383  Sum_probs=172.8

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCC-------CcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceee
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCF  127 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~  127 (296)
                      ....++|.+.+.||+|+||.||+|++...       +..||+|++....     ....+|+++++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            44556899999999999999999997543       3579999886432     2345899999999 999999999988


Q ss_pred             eeccCCCceEEEEEEecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCC
Q 022520          128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (296)
Q Consensus       128 ~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlk  194 (296)
                      ..     ....++||||+++ +|.+++.....            ....+++..+..++.|++.||.|||++ ||+|||||
T Consensus       145 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlk  218 (382)
T 3tt0_A          145 TQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLA  218 (382)
T ss_dssp             CS-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCC
T ss_pred             cc-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCC
Confidence            43     3337899999985 88888876531            124589999999999999999999998 99999999


Q ss_pred             CCceEEcCCCCcEEEeeecceeeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 022520          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (296)
Q Consensus       195 p~NIli~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  270 (296)
                      |+|||++.++ .+||+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+
T Consensus       219 p~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          219 ARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             GGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999887 89999999997654332   223345688999999986644 8999999999999999999 9999998


Q ss_pred             CChHHHHHHHH
Q 022520          271 ESGVDQLVEII  281 (296)
Q Consensus       271 ~~~~~~~~~~~  281 (296)
                      .+..+....+.
T Consensus       297 ~~~~~~~~~~~  307 (382)
T 3tt0_A          297 VPVEELFKLLK  307 (382)
T ss_dssp             CCHHHHHHHHH
T ss_pred             CCHHHHHHHHH
Confidence            77654444443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.8e-40  Score=291.83  Aligned_cols=223  Identities=30%  Similarity=0.504  Sum_probs=179.5

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcC-----------CCCceecce
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKH  125 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~  125 (296)
                      .+....+|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+++++.++           |+||+++++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            4445568999999999999999999999999999999986432   33457899988876           899999999


Q ss_pred             eeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--
Q 022520          126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--  203 (296)
Q Consensus       126 ~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--  203 (296)
                      ++.... .+..++++|||+++++|.+++....  ...+++..+..++.||+.||.|||++.||+||||||+|||++.+  
T Consensus        94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HhhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            886543 3445688999999889998887643  35699999999999999999999984489999999999999532  


Q ss_pred             ---CCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hH
Q 022520          204 ---THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GV  274 (296)
Q Consensus       204 ---~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~  274 (296)
                         ...+||+|||++......  .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+      ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence               226999999999765432  33457899999999997655 8999999999999999999999998754      44


Q ss_pred             HHHHHHHHhhcCCC
Q 022520          275 DQLVEIIKVILHTE  288 (296)
Q Consensus       275 ~~~~~~~~~~~~~~  288 (296)
                      +.+.++...++..+
T Consensus       248 ~~~~~~~~~~~~~p  261 (373)
T 1q8y_A          248 DHIAQIIELLGELP  261 (373)
T ss_dssp             HHHHHHHHHHCSCC
T ss_pred             HHHHHHHHhcCCCC
Confidence            56667776666544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-40  Score=281.31  Aligned_cols=199  Identities=24%  Similarity=0.384  Sum_probs=165.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----------hhhHHHHHHHHhcCCCCceecceeeeec
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFST  130 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~  130 (296)
                      ....+|++.+.||+|+||.||+|++..+++.||+|.+....           ....+|+.+++.++||||+++++++.  
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--   93 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--   93 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET--
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec--
Confidence            34468999999999999999999999999999999884321           34568999999999999999999872  


Q ss_pred             cCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCC--
Q 022520          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTH--  205 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~--  205 (296)
                         +..  ++||||++ ++|.+.+...   ..++++..+..++.|++.||.|||++ +  |+||||||+|||++.++.  
T Consensus        94 ---~~~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           94 ---NPP--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             ---TTT--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTC
T ss_pred             ---CCC--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCC
Confidence               222  58999998 6777776653   46799999999999999999999998 9  999999999999987662  


Q ss_pred             --cEEEeeecceeeeccCCCcccccccccccCCccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          206 --QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       206 --~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                        .++|+|||++.....  ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+.
T Consensus       165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence              299999999875322  3345678999999999842 33478899999999999999999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.9e-40  Score=279.93  Aligned_cols=205  Identities=30%  Similarity=0.518  Sum_probs=159.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||.||+|.+  .+..||+|++...        .....+|+++++.++||||+++++++.     ..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence            35799999999999999999998  5889999987432        133457999999999999999999883     34


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC---ceeccCCCCceEEcCC-------C
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG---VCHRDIKPQNLLVNPH-------T  204 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~---iiH~Dlkp~NIli~~~-------~  204 (296)
                      ...++||||+++ ++.+.+.     ..++++..+..++.|++.||.|||++ +   |+||||||+||+++.+       .
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccC
Confidence            447899999985 5555543     46799999999999999999999998 8   9999999999999862       3


Q ss_pred             CcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          205 HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       205 ~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ..++|+|||++....... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus       153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             CCEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             cceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            379999999997654332 33567899999999986544 899999999999999999999999987765555444433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.2e-40  Score=281.56  Aligned_cols=212  Identities=21%  Similarity=0.327  Sum_probs=171.7

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ......+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++.     +..
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~   92 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQR   92 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCC
Confidence            3445568999999999999999999875 6678999998643   344568999999999999999999883     334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~~  167 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLS  167 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTS-CEEECSTTGG
T ss_pred             CeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCC-CEEEcccccc
Confidence            4789999997 5777777653   35699999999999999999999998 999999999999999887 8999999998


Q ss_pred             eeeccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          216 KVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       216 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .......  ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+.+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~  237 (283)
T 3gen_A          168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG  237 (283)
T ss_dssp             GGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             ccccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence            7543221  122345578899999986554 8999999999999999998 99999988776666666554

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-40  Score=289.43  Aligned_cols=217  Identities=24%  Similarity=0.376  Sum_probs=173.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeec-----chhhHHHHHHHHhc-CCCCceecceeeeec
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  130 (296)
                      ....+|.+.+.||+|+||.||+|++.     .++..||+|.+...     .....+|+.+++.+ +||||+++++++.. 
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence            34468999999999999999999973     45678999988532     23456899999999 89999999998843 


Q ss_pred             cCCCceEEEEEEeccc-ccHHHHHHHhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHccCCcee
Q 022520          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH  190 (296)
                          ....++||||++ ++|.+++......                   ...+++..+..++.||+.||.|||++ ||+|
T Consensus       121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH  195 (344)
T 1rjb_A          121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVH  195 (344)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEE
T ss_pred             ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence                333789999997 4888888754311                   13478999999999999999999998 9999


Q ss_pred             ccCCCCceEEcCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 022520          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  266 (296)
Q Consensus       191 ~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~  266 (296)
                      |||||+|||++.++ .++|+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..
T Consensus       196 ~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          196 RDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             TTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             CCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCC
Confidence            99999999999887 8999999999766444322   2345678899999986544 8999999999999999998 999


Q ss_pred             CCCCCChHHHHHHHHHhhcC
Q 022520          267 LFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       267 pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ||.+.+..+.+..+......
T Consensus       274 p~~~~~~~~~~~~~~~~~~~  293 (344)
T 1rjb_A          274 PYPGIPVDANFYKLIQNGFK  293 (344)
T ss_dssp             SSTTCCCSHHHHHHHHTTCC
T ss_pred             CcccCCcHHHHHHHHhcCCC
Confidence            99987755555555544333

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.9e-40  Score=280.25  Aligned_cols=209  Identities=29%  Similarity=0.455  Sum_probs=175.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+++++.++||||+++++++.     ...
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   94 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS   94 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCC
Confidence            345799999999999999999999999999999988532      234458999999999999999999883     334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeec
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg  213 (296)
                      ..++||||++ +++.+.+...    ..+++..+..++.|++.||.|||++ ||+|+||||+||+++.++  ..++|+|||
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             eEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccC
Confidence            5889999997 5777776653    5789999999999999999999998 999999999999997643  269999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ++.............+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+.+..+.+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (287)
T 2wei_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG  237 (287)
T ss_dssp             GGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            9876655444455678999999999854  3789999999999999999999999988776666655554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.8e-40  Score=282.57  Aligned_cols=200  Identities=19%  Similarity=0.242  Sum_probs=164.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCC-------cEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ...+|.+.+.||+|+||.||+|++..++       ..||+|.+....    ....+|+.+++.++||||+++++++..  
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence            3458999999999999999999988766       479999885432    334579999999999999999998843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc----
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----  206 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~----  206 (296)
                         ....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++..    
T Consensus        84 ---~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           84 ---GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             ---TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             ---CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccc
Confidence               233679999998 5888887764   24489999999999999999999998 99999999999999877621    


Q ss_pred             ---EEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChH
Q 022520          207 ---LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGV  274 (296)
Q Consensus       207 ---ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~  274 (296)
                         ++|+|||++...   .......+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+..
T Consensus       157 ~~~~kl~Dfg~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  225 (289)
T 4fvq_A          157 PPFIKLSDPGISITV---LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ  225 (289)
T ss_dssp             CCEEEECCCCSCTTT---SCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             cceeeeccCcccccc---cCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence               999999998643   22234567899999999976566899999999999999999955 666555543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.5e-40  Score=283.55  Aligned_cols=212  Identities=20%  Similarity=0.332  Sum_probs=175.7

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ......+|++.+.||+|+||.||+|.+..++..||+|.+....   ....+|+++++.++||||+++++++.     +..
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~   82 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REP   82 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence            4455678999999999999999999999999999999986543   33458999999999999999999883     334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||++ ++|.+++....  ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~  158 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLS  158 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGG-CEEECCCCGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCC-CEEEccCccc
Confidence            4789999998 58888876532  35689999999999999999999999 999999999999999877 8999999998


Q ss_pred             eeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          216 KVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       216 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ........  .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~  226 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE  226 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             eeccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            76543322  12345578899999986554 8999999999999999999 999998876554444433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=282.69  Aligned_cols=217  Identities=26%  Similarity=0.418  Sum_probs=171.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhc-CCCCceecceeeeeccCC-Cce
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK-DEL  136 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~~  136 (296)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...   .....+|+.+++.+ +||||+++++++...... ...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            3456899999999999999999999999999999988543   34456899999998 899999999998654321 134


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+++....  ...+++..+..++.||+.||.|||++ ||+|+||||+|||++.++ .++|+|||++
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~  176 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVS  176 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCCTTT
T ss_pred             eEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCC-CEEEeeCcCc
Confidence            58899999985 8888777542  35789999999999999999999998 999999999999999877 8999999998


Q ss_pred             eeeccCC-CcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  282 (296)
                      ....... ......+|+.|+|||++..    ...++.++|||||||++|+|++|..||...+..+.+..+..
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  248 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  248 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence            7653322 2334568999999999852    34478999999999999999999999988776655554443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=293.56  Aligned_cols=199  Identities=17%  Similarity=0.202  Sum_probs=159.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcC---CCcEEEEEEEeecchh---------------hHHHHHHHHhcCCCCceeccee
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKHC  126 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~---------------~~~E~~~l~~l~h~niv~~~~~  126 (296)
                      .+|.+.+.||+|+||.||+|.+..   ++..+|+|.+......               ..+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   7889999988654322               2256677788899999999998


Q ss_pred             eeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC-C
Q 022520          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT-H  205 (296)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~-~  205 (296)
                      +.... .+....++||||++++|.+++...    ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCC
Confidence            86533 335668999999977888776653    4799999999999999999999998 999999999999998654 2


Q ss_pred             cEEEeeecceeeeccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          206 QLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       206 ~ikl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      .+||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence            799999999976533211        13456899999999987654 89999999999999999999999965

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.5e-40  Score=284.62  Aligned_cols=200  Identities=28%  Similarity=0.362  Sum_probs=159.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++..     
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----  105 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----  105 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence            34468999999999999999999999999999999885431       334579999999999999999998843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||+++ +|.+++...    .++++..+..++.|++.||.|||++ ||+|+||||+|||++.++ .++|+|||
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~-~~kl~Dfg  179 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADD-FAYLVDFG  179 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSCC
T ss_pred             CCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCC-CEEEecCc
Confidence            3347899999985 788777653    6799999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          214 SAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       214 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ++.......  ......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (309)
T 2h34_A          180 IASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL  240 (309)
T ss_dssp             C----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred             cCccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence            987654332  12345689999999998654 489999999999999999999999987654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.5e-40  Score=285.20  Aligned_cols=212  Identities=22%  Similarity=0.378  Sum_probs=171.4

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeee
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFS  129 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~  129 (296)
                      ......+|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ....+|+++++.++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3344568999999999999999999983     455899999885432     234579999999999999999998833


Q ss_pred             ccCCCceEEEEEEeccc-ccHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCc
Q 022520          130 TTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGV  188 (296)
Q Consensus       130 ~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~i  188 (296)
                           ....++||||++ ++|.+++.....                    ....+++..+..++.|++.||.|||++ ||
T Consensus        98 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i  171 (314)
T 2ivs_A           98 -----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KL  171 (314)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TE
T ss_pred             -----CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CC
Confidence                 334789999998 688888876432                    123488999999999999999999998 99


Q ss_pred             eeccCCCCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-C
Q 022520          189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-G  264 (296)
Q Consensus       189 iH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g  264 (296)
                      +||||||+|||++.++ .++|+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |
T Consensus       172 vH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          172 VHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             ECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred             cccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999877 899999999986644322   22345678899999986544 8999999999999999999 9


Q ss_pred             CCCCCCCChHHHHHH
Q 022520          265 QPLFPGESGVDQLVE  279 (296)
Q Consensus       265 ~~pf~~~~~~~~~~~  279 (296)
                      ..||.+.+..+....
T Consensus       250 ~~p~~~~~~~~~~~~  264 (314)
T 2ivs_A          250 GNPYPGIPPERLFNL  264 (314)
T ss_dssp             CCSSTTCCGGGHHHH
T ss_pred             CCCCCCCCHHHHHHH
Confidence            999988765444433

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.3e-40  Score=279.69  Aligned_cols=199  Identities=30%  Similarity=0.420  Sum_probs=167.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence            357999999999999999999999999999999885432     344689999999999999999998843     3447


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCC-CEEEeeCCCccc
Confidence            899999985 66665533    35789999999999999999999998 999999999999999877 799999999876


Q ss_pred             eccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       218 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .....   ......+|+.|+|||++.+...++.++||||||+++|+|++|+.||...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence            53322   223456899999999987655457899999999999999999999987653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.4e-40  Score=287.92  Aligned_cols=207  Identities=24%  Similarity=0.368  Sum_probs=166.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcE----EEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ...+|++.+.||+|+||.||+|.+..+++.    ||+|.+...     .....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            345799999999999999999999888776    677766322     233458999999999999999999772     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      + ...++||||+. ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        86 ~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Df  159 (325)
T 3kex_A           86 G-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVADF  159 (325)
T ss_dssp             B-SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred             C-CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCC-eEEECCC
Confidence            1 12678999998 5787777653   25688889999999999999999998 999999999999999877 7999999


Q ss_pred             cceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          213 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       213 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      |+++.......   .....+|..|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+.
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  231 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE  231 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence            99986543322   23345677999999986554 8999999999999999999 999999877555444443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6e-40  Score=284.30  Aligned_cols=214  Identities=24%  Similarity=0.362  Sum_probs=173.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ...+|++.+.||+|+||.||+|++     ..+++.||+|.+....     ....+|+.+++.+ +||||+++++++..  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence            445899999999999999999985     3567899999986432     3345899999999 99999999998843  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCC
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~  196 (296)
                         ....++||||+++ +|.+++.....              ...++++..+..++.|++.||.|||++ ||+||||||+
T Consensus        99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~  174 (313)
T 1t46_A           99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAAR  174 (313)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccc
Confidence               3337899999985 88888876431              123589999999999999999999998 9999999999


Q ss_pred             ceEEcCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022520          197 NLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (296)
Q Consensus       197 NIli~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~  272 (296)
                      ||+++.++ .++|+|||++.........   ....+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+..
T Consensus       175 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999877 8999999999765443321   2345678899999986544 8999999999999999998 999998876


Q ss_pred             hHHHHHHHHHhh
Q 022520          273 GVDQLVEIIKVI  284 (296)
Q Consensus       273 ~~~~~~~~~~~~  284 (296)
                      ....+.......
T Consensus       253 ~~~~~~~~~~~~  264 (313)
T 1t46_A          253 VDSKFYKMIKEG  264 (313)
T ss_dssp             SSHHHHHHHHHT
T ss_pred             chhHHHHHhccC
Confidence            555555444443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.7e-40  Score=286.50  Aligned_cols=217  Identities=21%  Similarity=0.345  Sum_probs=159.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCc---EEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ...+|++.+.||+|+||.||+|++..++.   .||+|.+...      .....+|+++++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            44579999999999999999999876664   8999988532      23445899999999999999999998654332


Q ss_pred             C-ceEEEEEEecccc-cHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEE
Q 022520          134 D-ELYLNLVLEYVPE-TVHRVIKHHYKM--SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       134 ~-~~~~~iv~e~~~~-~l~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                      + ....++||||+.+ +|.+++......  ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~-~~kl  178 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDM-TVCV  178 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCC-CEEE
Confidence            1 1224899999985 777777654321  22689999999999999999999998 999999999999999887 8999


Q ss_pred             eeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          210 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       210 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      +|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            99999976544322   22344578899999986554 8999999999999999999 9999998776665555544

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-39  Score=295.73  Aligned_cols=209  Identities=23%  Similarity=0.334  Sum_probs=171.1

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .....+|++.+.||+|+||.||+|.+  .++.||||.+....  ..+.+|+.+++.++||||+++++++....    ...
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  262 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL  262 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cce
Confidence            34556899999999999999999998  47799999986543  34568999999999999999999875432    237


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||++ ++|.+++....  ...++...+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~  338 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKE  338 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCC-CEEEeeCCCccc
Confidence            89999998 58888887642  23478999999999999999999998 999999999999999887 899999999975


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ....  .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+.+
T Consensus       339 ~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~  401 (450)
T 1k9a_A          339 ASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK  401 (450)
T ss_dssp             CC--------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT
T ss_pred             cccc--ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            4322  22335688999999996554 8999999999999999998 9999998776555555443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.9e-39  Score=280.24  Aligned_cols=203  Identities=27%  Similarity=0.442  Sum_probs=171.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            46999999999999999999999999999999885332     345689999999999999999998854     23478


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||+++ +|.+++.     ..++++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999986 6666654     36799999999999999999999998 999999999999999887 8999999999776


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  280 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  280 (296)
                      .... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  231 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI  231 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh
Confidence            4433 233457899999999986544 789999999999999999999999887665544443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=282.80  Aligned_cols=203  Identities=28%  Similarity=0.434  Sum_probs=168.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+++++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            47999999999999999999999999999999885432    33458999999999999999999886432 23456789


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      ||||+.+ +|.+.+.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999985 88888887665567899999999999999999999998 999999999999999887 89999999987542


Q ss_pred             cCCCc----------ccccccccccCCccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          220 KGEPN----------ISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       220 ~~~~~----------~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      .....          ....||+.|+|||++.+..  .++.++||||||+++|+|++|+.||..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            21111          1234689999999985433  268899999999999999999999953

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-39  Score=282.56  Aligned_cols=219  Identities=20%  Similarity=0.332  Sum_probs=165.6

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcC---CCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      .....+|.+.+.||+|+||.||+|.+..   ++..||+|.+....      ....+|+.+++.++||||+++++++....
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3445689999999999999999998765   45689999885332      23457999999999999999999986655


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                      ..+....++||||+++ +|..++....  .....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~k  187 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDM-TVC  187 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTS-CEE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEE
Confidence            4434456899999985 7777775433  2246799999999999999999999998 999999999999999887 899


Q ss_pred             EeeecceeeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          209 LCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       209 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      |+|||++.......   ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  264 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH  264 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence            99999987654332   122345678899999986544 8999999999999999999 8899988776655554444

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.5e-40  Score=287.09  Aligned_cols=207  Identities=25%  Similarity=0.391  Sum_probs=151.0

Q ss_pred             CccccceEEee-eeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           61 PKQTISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        61 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ....++|.+.+ .||+|+||.||+|.+..+++.||+|++........+....++.++||||+++++++.... .+..+.+
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~  102 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLL  102 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEE
Confidence            33456899965 699999999999999999999999998765555445555677889999999999885433 3355688


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeeccee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAK  216 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg~~~  216 (296)
                      +||||+++ +|.+.+....  ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++  ..++|+|||++.
T Consensus       103 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            99999986 8888777532  35799999999999999999999998 999999999999998643  259999999997


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      ..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus       180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (336)
T 3fhr_A          180 ETTQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTG  234 (336)
T ss_dssp             EC-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             ecccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence            65432 234567799999999985444 78999999999999999999999976543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=280.69  Aligned_cols=205  Identities=29%  Similarity=0.442  Sum_probs=168.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+|+.+++.++||||+++++++...     ...++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEE
Confidence            34799999999999999999999999999999988643  34456899999999999999999988542     347899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence            999986 777777643   46799999999999999999999998 999999999999999887 899999999976544


Q ss_pred             CC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 022520          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (296)
Q Consensus       221 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  279 (296)
                      .. ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+.+..
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  236 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM  236 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             hccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            32 233456899999999986544 89999999999999999999999988765544433

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.4e-40  Score=279.92  Aligned_cols=211  Identities=28%  Similarity=0.388  Sum_probs=161.6

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ......+|++.+.||+|+||.||+|.+..+   +..||+|.+...     .....+|+.+++.++||||+++++++..  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   87 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--   87 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--
Confidence            445567899999999999999999998653   457999987532     2234579999999999999999988721  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                         . ..++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+
T Consensus        88 ---~-~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~  158 (281)
T 1mp8_A           88 ---N-PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLG  158 (281)
T ss_dssp             ---S-SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEEC
T ss_pred             ---C-ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCC-CEEEC
Confidence               1 26799999985 777777653   35689999999999999999999998 999999999999999877 89999


Q ss_pred             eecceeeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          211 DFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       211 Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      |||++........  .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+.+
T Consensus       159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~  232 (281)
T 1mp8_A          159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN  232 (281)
T ss_dssp             C-------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             ccccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc
Confidence            9999976544322  22334578899999986544 8999999999999999997 9999998776665555544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.1e-40  Score=286.57  Aligned_cols=214  Identities=23%  Similarity=0.345  Sum_probs=173.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCc-----EEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ...+|.+.+.||+|+||.||+|.+..++.     .||+|.+....     ....+|+.+++.+ +||||+++++++..  
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence            34579999999999999999999876654     79999885432     3345899999999 89999999998843  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEE
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli  200 (296)
                         ....++||||+++ +|.+++......          ...+++..+..++.|++.||.|||++ ||+||||||+|||+
T Consensus       122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLL  197 (333)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEE
T ss_pred             ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEE
Confidence               3337899999985 888888765421          35689999999999999999999998 99999999999999


Q ss_pred             cCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022520          201 NPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  276 (296)
Q Consensus       201 ~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  276 (296)
                      +.++ .++|+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......
T Consensus       198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            9877 8999999999765443321   2345678899999986544 8999999999999999998 9999988765555


Q ss_pred             HHHHHHhh
Q 022520          277 LVEIIKVI  284 (296)
Q Consensus       277 ~~~~~~~~  284 (296)
                      +..+....
T Consensus       276 ~~~~~~~~  283 (333)
T 2i1m_A          276 FYKLVKDG  283 (333)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHhcC
Confidence            55555443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.9e-40  Score=284.16  Aligned_cols=200  Identities=27%  Similarity=0.412  Sum_probs=161.7

Q ss_pred             cccceEEe-eeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhc-CCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+.|.+. +.||+|+||.||+|++..+++.||+|++....    ....+|+++++++ +||||+++++++..     ..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~   84 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED   84 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence            34579985 78999999999999999999999999985432    3455899999884 79999999999843     33


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC--cEEEeeec
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~--~ikl~Dfg  213 (296)
                      .+++||||++ ++|.+.+...    ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.  .+||+|||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            4889999998 5888877663    5789999999999999999999998 9999999999999987652  39999999


Q ss_pred             ceeeeccCC--------CcccccccccccCCccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          214 SAKVLVKGE--------PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       214 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ++.......        ......||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            987543211        11234589999999998531    337889999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.8e-40  Score=293.73  Aligned_cols=212  Identities=25%  Similarity=0.389  Sum_probs=161.7

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      .....+|.+.+.||+|+||.||+|++.   .++..||+|.+...     ...+.+|+.+++.++||||+++++++..   
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  117 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK---  117 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee---
Confidence            334468999999999999999999876   45778999988543     2234579999999999999999998843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                        ....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|
T Consensus       118 --~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~D  190 (373)
T 2qol_A          118 --SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNL-VCKVSD  190 (373)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECC
T ss_pred             --CCceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCC-CEEECc
Confidence              334789999997 5888877653   35799999999999999999999998 999999999999999887 899999


Q ss_pred             ecceeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          212 FGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       212 fg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ||+++........    ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||...+..+....+...
T Consensus       191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~  266 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG  266 (373)
T ss_dssp             C----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT
T ss_pred             CccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999765433211    1223467899999986544 8999999999999999997 99999988766555554443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.3e-40  Score=286.94  Aligned_cols=206  Identities=25%  Similarity=0.434  Sum_probs=162.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEE----EEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ...+|++.+.||+|+||.||+|++..+++.+    |+|.+...     ...+.+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence            3457999999999999999999998777654    77765322     23456899999999999999999988532   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                        . .++|++|+. ++|.+.+...   ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus        90 --~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Df  161 (327)
T 3poz_A           90 --T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             --S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             --C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCC-CEEEccC
Confidence              1 567888887 5787777654   36799999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          213 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       213 g~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      |+++........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  232 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL  232 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH
Confidence            999765443322   2334578999999987654 8999999999999999999 99999987665444333

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=290.92  Aligned_cols=207  Identities=14%  Similarity=0.170  Sum_probs=167.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcC--------CCcEEEEEEEeecchhhHHHHHHHHhcCCCCceec-------------
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLE--------TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------------  123 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~-------------  123 (296)
                      .+|++.+.||+|+||.||+|++..        .++.||+|.+... ....+|+++++.++||||+++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            479999999999999999999987        4889999988643 567789999999999999984             


Q ss_pred             --ceeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc
Q 022520          124 --KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (296)
Q Consensus       124 --~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~  201 (296)
                        ++++..    +....++||||++++|.+++....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEc
Confidence              333322    234578999999879998887642  36799999999999999999999999 999999999999999


Q ss_pred             CCCC-cEEEeeecceeeeccCCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          202 PHTH-QLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       202 ~~~~-~ikl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .++. .++|+|||++........        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            7642 699999999976533221        13347899999999986544 8999999999999999999999998764


Q ss_pred             -hHHHHHHH
Q 022520          273 -GVDQLVEI  280 (296)
Q Consensus       273 -~~~~~~~~  280 (296)
                       ..+.+...
T Consensus       273 ~~~~~~~~~  281 (352)
T 2jii_A          273 PNTEDIMKQ  281 (352)
T ss_dssp             TCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence             33333333

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.7e-40  Score=287.78  Aligned_cols=209  Identities=23%  Similarity=0.356  Sum_probs=169.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEE--EEEEEeec-----chhhHHHHHHHHhc-CCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--avK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+++++.+ +||||+++++++..     .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----C
Confidence            368999999999999999999998888765  89987532     23456899999999 89999999998843     3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~  202 (296)
                      ...++||||++ ++|.+++....            .....+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  177 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcC
Confidence            44889999997 48888876542            2235799999999999999999999998 9999999999999998


Q ss_pred             CCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       203 ~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      ++ .++|+|||++.............+++.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+
T Consensus       178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CC-eEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            77 89999999987543333334455688999999986544 7899999999999999998 99999887765544443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-40  Score=289.38  Aligned_cols=203  Identities=24%  Similarity=0.332  Sum_probs=166.8

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .....+|.+.+.||+|+||.||+|++ .+++.||+|++....    ....+|+.+++.++||||+++++++.     ...
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  108 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERN  108 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTT
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCC
Confidence            34556899999999999999999995 468899999875332    34568999999999999999999873     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+.+.........+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~  186 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENF-VPKITDFGIS  186 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCC-CEEEeecccc
Confidence            47899999984 77666654333334689999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          216 KVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       216 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             cccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccC
Confidence            7643222   123345899999999986554 8999999999999999999999997643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-39  Score=297.65  Aligned_cols=200  Identities=24%  Similarity=0.319  Sum_probs=167.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+++++.++|.+.+..+..+..    ...+.++
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~l   80 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVL   80 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEE
Confidence            345799999999999999999999999999999987533  3456789999999998666655554432    2334789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc---CCCCcEEEeeecceee
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKV  217 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~---~~~~~ikl~Dfg~~~~  217 (296)
                      ||||++++|.+++...   ...+++..++.++.||+.||.|||++ +|+||||||+|||++   .++ .+||+|||+++.
T Consensus        81 vme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~  155 (483)
T 3sv0_A           81 VMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK  155 (483)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred             EEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCC-eEEEEeCCccee
Confidence            9999988998888753   36799999999999999999999998 999999999999994   455 899999999987


Q ss_pred             eccCCCc--------ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEPN--------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .......        ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            6544321        2567899999999986654 8999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.8e-40  Score=290.24  Aligned_cols=201  Identities=28%  Similarity=0.492  Sum_probs=169.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....     ....+|+.+++.++||||+++++++..     ...
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  105 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE  105 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCE
Confidence            3458999999999999999999999999999999886432     234589999999999999999998853     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++||||+++ +|.+++...    ..+++..+..++.|++.||.|||+..||+||||||+|||++.++ .++|+|||++.
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  180 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG  180 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred             EEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence            8899999985 888877653    57899999999999999999999832899999999999999887 79999999986


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+
T Consensus       181 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  237 (360)
T 3eqc_A          181 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE  237 (360)
T ss_dssp             HHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred             ccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            54332 23345789999999998654 48999999999999999999999999876544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.6e-40  Score=301.53  Aligned_cols=211  Identities=20%  Similarity=0.331  Sum_probs=174.5

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .....+|.+.+.||+|+||.||+|.+..++..||+|.+...   ...+.+|+.+++.++||||+++++++..     ...
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~  290 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP  290 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCc
Confidence            34556899999999999999999999988999999998643   2345689999999999999999998843     333


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++||||++ ++|.+++....  ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  366 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENH-LVKVADFGLSR  366 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEE
T ss_pred             EEEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCC-cEEEeecccce
Confidence            789999998 68888887532  35689999999999999999999998 999999999999999877 89999999998


Q ss_pred             eeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          217 VLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       217 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .......  .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~  433 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE  433 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            6543321  12334577899999986544 8999999999999999999 999999877655444433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-39  Score=279.25  Aligned_cols=201  Identities=35%  Similarity=0.569  Sum_probs=159.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++...     
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----
Confidence            345799999999999999999999999999999988531       12345799999999999999999988543     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||+++ +|.+++.........+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~-~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence            347899999985 88888877655567899999999999999999999998 999999999999999877 899999999


Q ss_pred             eeeeccCCC-cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          215 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       215 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      +........ .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            876543322 23456899999999986544 899999999999999999999999764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.2e-39  Score=282.71  Aligned_cols=215  Identities=22%  Similarity=0.388  Sum_probs=171.1

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEc-------CCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceeccee
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHC  126 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~  126 (296)
                      ......+|++.+.||+|+||.||+|++.       .++..||+|++....     ....+|+++++.+ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            4445578999999999999999999985       356789999885432     2345799999999 89999999998


Q ss_pred             eeeccCCCceEEEEEEecccc-cHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccC
Q 022520          127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI  193 (296)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dl  193 (296)
                      +..     ....++||||+++ +|.+++.....            ....+++..+..++.||+.||.|||++ ||+||||
T Consensus       110 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dl  183 (334)
T 2pvf_A          110 CTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDL  183 (334)
T ss_dssp             ECS-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             Ecc-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCC
Confidence            833     3347899999985 88888875431            123588999999999999999999998 9999999


Q ss_pred             CCCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 022520          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  269 (296)
Q Consensus       194 kp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  269 (296)
                      ||+|||++.++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.
T Consensus       184 kp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          184 AARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             SGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            99999999887 899999999986644322   22345578899999986544 8999999999999999999 999999


Q ss_pred             CCChHHHHHHHHH
Q 022520          270 GESGVDQLVEIIK  282 (296)
Q Consensus       270 ~~~~~~~~~~~~~  282 (296)
                      +.+..+....+..
T Consensus       262 ~~~~~~~~~~~~~  274 (334)
T 2pvf_A          262 GIPVEELFKLLKE  274 (334)
T ss_dssp             TCCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHhc
Confidence            8776554444433

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.9e-40  Score=286.77  Aligned_cols=199  Identities=22%  Similarity=0.373  Sum_probs=166.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ...+|++.+.||+|+||.||+|++ .+++.||+|++....     ....+|+++++.++||||+++++++..     ...
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~  101 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE  101 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSC
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCc
Confidence            345799999999999999999984 468899999885332     245689999999999999999999843     333


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC--CceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--GVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      .++||||+++ +|.+.+........++++..+..++.|++.||.|||++.  ||+||||||+|||++.++ .++|+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  180 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGL  180 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSS
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCcc
Confidence            6799999985 888888776555567999999999999999999999853  899999999999999887 899999999


Q ss_pred             eeeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          215 AKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       215 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      +........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCccc
Confidence            987643332  22345899999999986554 8999999999999999999999995

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.5e-39  Score=274.54  Aligned_cols=214  Identities=15%  Similarity=0.233  Sum_probs=172.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ...+|++.+.||+|+||.||+|++  ++..||+|++....      ....+|+.+++.++||||+++++++...   +..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence            446899999999999999999998  58899999886432      2345799999999999999999988433   123


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeec
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ..++||||+++ +|.+++....  ...+++..+..++.|++.||.|||++ +  |+||||||+||+++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCc-ceeEEecc
Confidence            47899999984 8888886532  23689999999999999999999998 9  99999999999999877 79999988


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      ++...    ......+|+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+..+....+......++.
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (271)
T 3kmu_A          159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI  232 (271)
T ss_dssp             SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred             ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence            86532    2234577999999999865432  334799999999999999999999988877666666555444433

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-39  Score=280.04  Aligned_cols=211  Identities=27%  Similarity=0.431  Sum_probs=169.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++||||+++++++...     ...
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeE
Confidence            345799999999999999999999999999999988533    23445799999999999999999988532     347


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+++ ++..++...   ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++..
T Consensus        92 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  166 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAK  166 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTS-CEEECCCHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCC-CEEEEECCCCcc
Confidence            899999986 566655543   46799999999999999999999998 999999999999999887 799999998753


Q ss_pred             eccC-CCcccccccccccCCcccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          218 LVKG-EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       218 ~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      .... .......+|+.|+|||++.    ....++.++||||||+++|+|++|..||...+..+.+..+.+.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  237 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS  237 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc
Confidence            2111 1223456899999999974    3445789999999999999999999999988766665555443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.1e-39  Score=282.36  Aligned_cols=198  Identities=27%  Similarity=0.414  Sum_probs=167.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----------hhhHHHHHHHHhcC--CCCceecceeeeec
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFST  130 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~  130 (296)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+....          ....+|+.+++.++  |+||+++++++.  
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--  118 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--  118 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe--
Confidence            4457999999999999999999999999999999985432          33457999999996  599999999884  


Q ss_pred             cCCCceEEEEEEeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEE
Q 022520          131 TEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ik  208 (296)
                         .....++|||++.  ++|.+++...    ..+++..+..++.|++.||.|||++ ||+||||||+|||++.+.+.+|
T Consensus       119 ---~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          119 ---RPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             ---CSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEE
T ss_pred             ---cCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEE
Confidence               3344889999987  6788877763    6789999999999999999999998 9999999999999995444899


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...
T Consensus       191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            9999999866433 3345578999999999876665578899999999999999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-39  Score=283.13  Aligned_cols=201  Identities=27%  Similarity=0.424  Sum_probs=168.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEE----EcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ....+|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+++++.++|+||+++++++..   .
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence            344689999999999999999999    46788999999985432    235689999999999999999998753   2


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      +....++||||++ ++|.+++....   ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~-~~kl~Df  171 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA-HVKIADF  171 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCC-CEEEccc
Confidence            3445789999996 57888776642   4689999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          213 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       213 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |++........    .....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            99987644332    22345688899999986544 789999999999999999999998653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=282.97  Aligned_cols=206  Identities=25%  Similarity=0.428  Sum_probs=161.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEE----EEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|++.+.||+|+||.||+|++..+++.+    |+|.+...     .....+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            357999999999999999999998887765    55655321     23456899999999999999999988532    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                       . .++|++++. +++.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||
T Consensus        90 -~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kL~DfG  162 (327)
T 3lzb_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence             1 567888887 5787777654   36799999999999999999999998 999999999999999877 89999999


Q ss_pred             ceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       214 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      ++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  233 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  233 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            99765433222   2334577899999986554 8999999999999999999 999999877655444433

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-39  Score=273.65  Aligned_cols=209  Identities=22%  Similarity=0.375  Sum_probs=171.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+++++.++||||+++++++..     ....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   79 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeE
Confidence            3458999999999999999999986 6678999998643   2345689999999999999999998843     33378


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~  154 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  154 (267)
T ss_dssp             EEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCC-CEEEccccccccc
Confidence            9999997 5787777653   35689999999999999999999998 999999999999999877 7999999998754


Q ss_pred             ccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       219 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ....  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~  221 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG  221 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             ccccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Confidence            2211  122345678899999986544 8999999999999999999 89999987766655555443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-39  Score=295.88  Aligned_cols=211  Identities=25%  Similarity=0.373  Sum_probs=172.3

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .....+|.+.+.||+|+||.||+|.+. ++..||||.+...   ...+.+|+.+++.++||||+++++++.     + ..
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-----~-~~  256 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EP  256 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SS
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-----C-Cc
Confidence            344568999999999999999999985 4678999998643   344568999999999999999998873     1 12


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++||||+. ++|.+++....  ...++...+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DFG~a~  332 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLAR  332 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTC-CEEECSTTGGG
T ss_pred             cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCC-cEEEeeCCCce
Confidence            679999997 58888887543  24678889999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          217 VLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       217 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ......  ......+|..|+|||++.... ++.++|||||||++|||++ |+.||.+.+..+.+..+.+.
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~  401 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG  401 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            643221  112334577899999986544 8999999999999999999 99999998876666655543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-39  Score=278.86  Aligned_cols=209  Identities=22%  Similarity=0.335  Sum_probs=157.8

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....++|++.+.||+|+||.||+|++.   ..||+|++....      ..+.+|+.+++.++||||++++++..      
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------   90 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------   90 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------
Confidence            344568999999999999999999853   359999885332      23458999999999999999988541      


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg  165 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDN-TVKIGDFG  165 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTT-EEEECCCC
T ss_pred             CCccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCC-CEEEccce
Confidence            112679999998 4666666432   46789999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCC---CcccccccccccCCcccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          214 SAKVLVKGE---PNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       214 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ++.......   ......||+.|+|||++.  ....++.++||||||+++|+|++|+.||.+.+..+.+..+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  240 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR  240 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence            987543221   223456899999999985  2334788999999999999999999999987766666555443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-39  Score=282.99  Aligned_cols=203  Identities=26%  Similarity=0.399  Sum_probs=149.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-----hhHHHHH-HHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++.....     ....|+. +++.++||||+++++++..     ..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~   94 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG   94 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence            34579999999999999999999999999999999864321     1223444 6677899999999998843     33


Q ss_pred             EEEEEEecccccHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++++.+++..... ....+++..+..++.|++.||.|||++.||+||||||+|||++.++ .+||+|||++
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  173 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGIS  173 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence            4789999999998888775433 2567899999999999999999999844899999999999999887 8999999999


Q ss_pred             eeeccCCCcccccccccccCCcccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      .............||+.|+|||++.   ....++.++|||||||++|+|++|+.||...
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            7765544444557899999999983   2334889999999999999999999999764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.4e-39  Score=274.47  Aligned_cols=211  Identities=26%  Similarity=0.374  Sum_probs=167.8

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcC---CCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ......+|.+.+.||+|+||.||+|.+..   ++..||+|.+...     .....+|+.+++.++||||+++++++..  
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--
Confidence            44456789999999999999999998754   3456999988543     2344579999999999999999998731  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                         .. .++||||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+
T Consensus        85 ---~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~  155 (281)
T 3cc6_A           85 ---EP-TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPE-CVKLG  155 (281)
T ss_dssp             ---SS-CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETT-EEEEC
T ss_pred             ---CC-CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCC-cEEeC
Confidence               11 478999998 5787777654   35689999999999999999999998 999999999999999877 89999


Q ss_pred             eecceeeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          211 DFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       211 Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      |||++........  .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+..
T Consensus       156 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~  229 (281)
T 3cc6_A          156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK  229 (281)
T ss_dssp             CCCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH
T ss_pred             ccCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc
Confidence            9999876543321  22345578899999986544 8999999999999999998 9999987666555444433

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-39  Score=280.50  Aligned_cols=209  Identities=23%  Similarity=0.350  Sum_probs=164.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCC----cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----
Confidence            4457999999999999999999986543    469999886432     23457999999999999999999883     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      .....++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Df  191 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDF  191 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCC-cEEECCC
Confidence            33448899999986 777777653   36799999999999999999999998 999999999999999877 8999999


Q ss_pred             cceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          213 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       213 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      |++........    .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  265 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND  265 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC
Confidence            99976543321    12234577899999986544 8999999999999999998 9999988776555555444

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=278.63  Aligned_cols=211  Identities=25%  Similarity=0.392  Sum_probs=154.3

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch------hhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      .....+|++.+.||+|+||.||+|++..+++.||+|++.....      ...++..+++.++||||+++++++..     
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----   95 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----   95 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----
Confidence            3445689999999999999999999999999999999864321      12234456788899999999998843     


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||+++.+..+....   ...+++..+..++.|++.||.|||+ + ||+|+||||+||+++.++ .++|+|||
T Consensus        96 ~~~~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg  170 (318)
T 2dyl_A           96 NTDVFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERG-QIKLCDFG  170 (318)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCcEEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC-CEEeCCCCHHHEEECCCC-CEEEEECC
Confidence            3458899999966655554432   4679999999999999999999998 6 999999999999999887 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCcccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHH
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEII  281 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~  281 (296)
                      ++.............+|+.|+|||++.    ....++.++|||||||++|+|++|+.||.... ..+.+..+.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            997765554455567899999999984    23447899999999999999999999998743 333344443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.8e-39  Score=281.40  Aligned_cols=215  Identities=21%  Similarity=0.270  Sum_probs=172.7

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeee
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFS  129 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~  129 (296)
                      ......+|++.+.||+|+||.||+|.+.     .+++.||+|.+....     ....+|+.+++.++||||+++++++..
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3445568999999999999999999876     357889999885432     234579999999999999999998833


Q ss_pred             ccCCCceEEEEEEeccc-ccHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC
Q 022520          130 TTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (296)
Q Consensus       130 ~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~  202 (296)
                           ....++||||++ ++|.+++......      ..++++..+..++.|++.||.|||++ ||+||||||+||+++.
T Consensus       100 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~  173 (322)
T 1p4o_A          100 -----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAE  173 (322)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECT
T ss_pred             -----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcC
Confidence                 334789999998 4888887754321      24678999999999999999999998 9999999999999998


Q ss_pred             CCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 022520          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (296)
Q Consensus       203 ~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  278 (296)
                      ++ .++|+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+...
T Consensus       174 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          174 DF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             TC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             CC-eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            87 899999999876533321   12335588899999986544 8999999999999999999 899998877655544


Q ss_pred             HHHH
Q 022520          279 EIIK  282 (296)
Q Consensus       279 ~~~~  282 (296)
                      .+.+
T Consensus       252 ~~~~  255 (322)
T 1p4o_A          252 FVME  255 (322)
T ss_dssp             HHHT
T ss_pred             HHHc
Confidence            4433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=282.75  Aligned_cols=199  Identities=22%  Similarity=0.347  Sum_probs=159.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-hhHHHHHH--HHhcCCCCceecceeeeeccCCCceEE
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRELQT--MRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ...++|++.+.||+|+||.||+|++  +++.||+|++..... ....|.++  +..++|+||+++++.+......+...+
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            3446899999999999999999987  789999999864332 22334444  445899999999987765555666678


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC--------CceeccCCCCceEEcCCCCcEEE
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                      ++||||++ ++|.+++..     ...++..+..++.|++.||.|||++.        ||+||||||+|||++.++ .+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEE
T ss_pred             EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEE
Confidence            89999997 588888764     45588889999999999999999742        899999999999999887 8999


Q ss_pred             eeecceeeeccCC---------CcccccccccccCCccccCC------CCCCCchhHHHHHHHHHHHHhCCCCC
Q 022520          210 CDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLLGQPLF  268 (296)
Q Consensus       210 ~Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlG~il~~l~~g~~pf  268 (296)
                      +|||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            9999998654321         12244689999999998652      23567899999999999999997554

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.6e-39  Score=276.52  Aligned_cols=197  Identities=26%  Similarity=0.415  Sum_probs=163.7

Q ss_pred             ccceEEeeeeeecCceEEEEEE----EcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+.+++.++||||+++++++...   +
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            3469999999999999999999    46789999999885332     3456899999999999999999988543   2


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...+++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCC-CEEECccc
Confidence            2347899999975 888887654   36799999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       214 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      ++........    .....+|..|+|||++.+.. ++.++||||||+++|+|++|..|+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCc
Confidence            9987644432    23345688899999986554 7899999999999999999998763

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.1e-39  Score=281.22  Aligned_cols=214  Identities=24%  Similarity=0.391  Sum_probs=170.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ...+|++.+.||+|+||.||+|.+     ..+++.||+|.+....     ....+|+.+++.+ +||||+++++++... 
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence            346899999999999999999985     3567899999986432     2345799999999 789999999987432 


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCce
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NI  198 (296)
                         ...+++||||+++ +|.+++......            ...+++..+..++.|++.||.|||++ ||+||||||+||
T Consensus       104 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Ni  179 (316)
T 2xir_A          104 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNI  179 (316)
T ss_dssp             ---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGE
T ss_pred             ---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceE
Confidence               2236899999985 888887754321            12278999999999999999999998 999999999999


Q ss_pred             EEcCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 022520          199 LVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGV  274 (296)
Q Consensus       199 li~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~  274 (296)
                      +++.++ .++|+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....
T Consensus       180 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          180 LLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999877 7999999999765433221   2345688999999986544 8999999999999999998 99999887654


Q ss_pred             HHHHHHHHh
Q 022520          275 DQLVEIIKV  283 (296)
Q Consensus       275 ~~~~~~~~~  283 (296)
                      +.+......
T Consensus       258 ~~~~~~~~~  266 (316)
T 2xir_A          258 EEFCRRLKE  266 (316)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHhcc
Confidence            444444433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.1e-40  Score=283.96  Aligned_cols=210  Identities=28%  Similarity=0.429  Sum_probs=156.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.++||||+++++++....     
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----
Confidence            3446899999999999999999999889999999987432     233457889999999999999999884332     


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYK----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                      ..++||||++ ++|.+++.....    ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~d  164 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDG-SVQIAD  164 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCC-CEEEEe
Confidence            3789999997 578777765322    235689999999999999999999998 999999999999999887 899999


Q ss_pred             ecceeeeccCC------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          212 FGSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       212 fg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      ||++.......      ......+|+.|+|||++.+...++.++||||||+++|+|++|+.||...+..+.+.
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  237 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM  237 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH
Confidence            99986543221      12345689999999998654458999999999999999999999998866554443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-39  Score=286.05  Aligned_cols=206  Identities=21%  Similarity=0.387  Sum_probs=170.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------------------hhhHHHHHHHHhcCCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNVV  121 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~E~~~l~~l~h~niv  121 (296)
                      ...+|++.+.||+|+||.||+|.+  +++.||+|.+....                     ....+|+.+++.++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            345899999999999999999998  89999999885321                     5567899999999999999


Q ss_pred             ecceeeeeccCCCceEEEEEEecccc-cHHHH------HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccC
Q 022520          122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV------IKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDI  193 (296)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~------l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dl  193 (296)
                      ++++++..     ....++||||+++ +|.++      +...  ....+++..+..++.|++.||.|||+ + ||+|+||
T Consensus       107 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl  178 (348)
T 2pml_X          107 TCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDV  178 (348)
T ss_dssp             CCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCC
T ss_pred             eEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCC
Confidence            99999843     3458899999986 66655      3221  14679999999999999999999998 8 9999999


Q ss_pred             CCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       194 kp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ||+||+++.++ .++|+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|+.||...+
T Consensus       179 ~p~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          179 KPSNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             CGGGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ChHhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999887 8999999999865433 3345678999999999976534555 9999999999999999999999876


Q ss_pred             h-HHHHHHH
Q 022520          273 G-VDQLVEI  280 (296)
Q Consensus       273 ~-~~~~~~~  280 (296)
                      . .+....+
T Consensus       257 ~~~~~~~~i  265 (348)
T 2pml_X          257 SLVELFNNI  265 (348)
T ss_dssp             CSHHHHHHH
T ss_pred             cHHHHHHHH
Confidence            6 3434443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.4e-39  Score=275.28  Aligned_cols=208  Identities=23%  Similarity=0.336  Sum_probs=164.6

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ......+|++.+.||+|+||.||+|.+  +++.||+|.+....  ....+|+.+++.++||||+++++++...    ...
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~   89 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG   89 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence            444557899999999999999999987  58899999886432  3456899999999999999999986432    223


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++||||+++ +|.+.+....  ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~  165 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTK  165 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC--
T ss_pred             eEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCC-cEEEeeccccc
Confidence            7899999985 8888887643  23478899999999999999999998 999999999999999877 89999999987


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      .....  .....+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  227 (278)
T 1byg_A          166 EASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  227 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred             ccccc--ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            54332  22345688999999986544 8999999999999999998 99999887655444433

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.5e-39  Score=275.01  Aligned_cols=204  Identities=23%  Similarity=0.326  Sum_probs=165.6

Q ss_pred             ccceEEee-eeeecCceEEEEEEE--cCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           64 TISYMAER-VVGHGSFGVVFQAKC--LETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        64 ~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||+|++...      .....+|+.+++.++||||+++++++ ..    
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~----   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA----   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES----
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC----
Confidence            45799998 999999999999955  456789999988543      23455899999999999999999987 21    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                       ...++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        90 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           90 -ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             -CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCC-cEEEccCC
Confidence             12679999998 577777765    36799999999999999999999998 999999999999999877 89999999


Q ss_pred             ceeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       214 ~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      ++.........    ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  233 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML  233 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99876443321    1233568899999986544 7899999999999999999 99999987764444333

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=277.32  Aligned_cols=195  Identities=30%  Similarity=0.448  Sum_probs=156.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc--hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      ..+|++.+.||+|+||.||+|++  .++.||+|.+....  ..+.+|+.+++.++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            45799999999999999999998  57889999885432  34568999999999999999988763     22  5789


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc---cCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~---~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |||+++ +|.+.+.... ....++...+..++.|++.||.|||+   + ||+||||||+|||++.++..+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999985 7777776432 12347888999999999999999999   7 9999999999999998774589999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ....  .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~  207 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIG  207 (307)
T ss_dssp             -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred             cccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence            4322  2345689999999998654 48999999999999999999999998653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-38  Score=274.90  Aligned_cols=208  Identities=24%  Similarity=0.373  Sum_probs=164.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||.||+|.+..+   ...+|+|.+....     ....+|+.+++.++||||+++++++...    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            35799999999999999999997543   3468999875322     2345799999999999999999986432    2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCC-CEEECcccc
Confidence            336799999986 887777643   46689999999999999999999998 999999999999999877 899999999


Q ss_pred             eeeeccCC-----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          215 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       215 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      +.......     ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |.+||...+..+....+.
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~  246 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL  246 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence            97653321     123345678899999986544 8999999999999999999 667887766544444433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.9e-39  Score=293.32  Aligned_cols=209  Identities=26%  Similarity=0.353  Sum_probs=167.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ....+|++.+.||+|+||.||+|.+.. +..||+|.+...   ...+.+|+.+++.++||||+++++++..      ...
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            445679999999999999999999864 467999988643   2345689999999999999999988732      126


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||++ ++|.+++....  ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~  329 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARL  329 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred             EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCC-CEEECCCcccee
Confidence            79999998 58888876532  35689999999999999999999998 999999999999999877 899999999976


Q ss_pred             eccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ......  .....+|..|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+.+
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~  396 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER  396 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             cCCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            543221  22344578899999986544 8999999999999999999 9999998887666655544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=273.36  Aligned_cols=209  Identities=23%  Similarity=0.370  Sum_probs=165.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCc---EEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      .....|.+.+.||+|+||.||+|.+..++.   .||+|.+....     ....+|+.+++.++||||+++++++....  
T Consensus        18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   95 (298)
T 3pls_A           18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--   95 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS--
T ss_pred             ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC--
Confidence            344568899999999999999999765544   79999885322     23458999999999999999999885332  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                        ...++||+|+. ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+||
T Consensus        96 --~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~-~~kl~Df  168 (298)
T 3pls_A           96 --GLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESF-TVKVADF  168 (298)
T ss_dssp             --SCCEEEECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECCT
T ss_pred             --CCcEEEEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEeCcC
Confidence              22478999986 6777777653   46789999999999999999999998 999999999999999887 8999999


Q ss_pred             cceeeeccC-----CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q 022520          213 GSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEI  280 (296)
Q Consensus       213 g~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~~  280 (296)
                      |++......     .......+|+.|+|||.+.+.. ++.++||||||+++|+|++|. +||...+..+....+
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~  241 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL  241 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence            998754222     1223456688999999986544 899999999999999999955 656655544433333

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.6e-39  Score=272.84  Aligned_cols=211  Identities=24%  Similarity=0.343  Sum_probs=170.8

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ......+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+++++.++||||+++++++..     . 
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-   80 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-   80 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-
Confidence            3344568999999999999999999974 5678999988643   3445689999999999999999987631     1 


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||++ ++|.+++....  ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~  156 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLA  156 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             CcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCC-CEEECCCccc
Confidence            1679999997 57777775432  23689999999999999999999998 999999999999999877 8999999999


Q ss_pred             eeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ........  .....+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+.+..+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  225 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER  225 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             ccccCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc
Confidence            87643321  12334577899999986544 7899999999999999999 9999998776555554443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-38  Score=274.57  Aligned_cols=195  Identities=28%  Similarity=0.432  Sum_probs=159.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccC--------
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTE--------  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--------  132 (296)
                      ..+|++.+.||+|+||.||+|++..+++.||+|.+....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            357999999999999999999999999999999986543   234579999999999999999998865321        


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                      ......++||||+++ +|.+.+...   ...+++..+..++.|++.||.|||++ ||+|+||||+|||++.++ .++|+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCC-CEEEee
Confidence            235668899999975 888887653   34678889999999999999999998 999999999999999887 899999


Q ss_pred             ecceeeeccC---------------CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh
Q 022520          212 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  263 (296)
Q Consensus       212 fg~~~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~  263 (296)
                      ||++......               .......+|+.|+|||++.+...++.++|||||||++|+|++
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            9998754321               112345679999999998766568999999999999999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=272.77  Aligned_cols=208  Identities=26%  Similarity=0.356  Sum_probs=168.1

Q ss_pred             cccceEEee-eeeecCceEEEEEEEc--CCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           63 QTISYMAER-VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...+|.+.+ .||+|+||.||+|.+.  .++..||+|.+....     ....+|+++++.++||||+++++++. ..   
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~---   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE---   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS---
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC---
Confidence            345788777 9999999999999864  467889999986532     23458999999999999999999872 11   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                        ..++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        83 --~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg  155 (287)
T 1u59_A           83 --ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFG  155 (287)
T ss_dssp             --SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCT
T ss_pred             --CcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCC-CEEECccc
Confidence              17899999986 777766532   46699999999999999999999998 999999999999999877 89999999


Q ss_pred             ceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       214 ~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++........    .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~  228 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  228 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence            9987643322    12234578999999986544 7899999999999999998 9999998776555544443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=273.99  Aligned_cols=200  Identities=29%  Similarity=0.509  Sum_probs=162.3

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      |.....||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++++..     ....++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence            444458999999999999999999999999885432    345689999999999999999998843     33478999


Q ss_pred             eccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      ||++ ++|.+++.... ....+++..+..++.|++.||.|||++ ||+|+||||+||+++...+.++|+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9997 57777776532 234567888999999999999999998 99999999999999974448999999999765432


Q ss_pred             CC-cccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          222 EP-NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       222 ~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .. .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||...+.
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE  230 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence            22 2345689999999998543 2378999999999999999999999976543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.7e-39  Score=278.84  Aligned_cols=196  Identities=27%  Similarity=0.352  Sum_probs=162.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .|...+.||+|+||.||+|.+  +++.||+|++...        .....+|+.+++.++||||+++++++..     ...
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCc
Confidence            355668999999999999986  6889999988532        1234589999999999999999998843     333


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++||||++ ++|.+.+.... ...++++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~  181 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAF-TAKISDFGLAR  181 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCC-cEEEeeccccc
Confidence            789999997 57777776432 246799999999999999999999998 999999999999999877 89999999987


Q ss_pred             eeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          217 VLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       217 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .......   .....||+.|+|||++.+  .++.++||||||+++|+|++|.+||.....
T Consensus       182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            6543322   223468999999999854  378999999999999999999999987543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.8e-39  Score=278.80  Aligned_cols=213  Identities=20%  Similarity=0.282  Sum_probs=165.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEE-----EcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ....+|++.+.||+|+||.||+|+     +..++..||+|.+...     .....+|+.+++.++||||+++++++..  
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence            344689999999999999999999     5567889999988532     2234579999999999999999998843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--C
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--H  205 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~  205 (296)
                         ....++||||++ ++|.+++......   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++  .
T Consensus       105 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          105 ---SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcc
Confidence               333689999996 5888888764321   14588999999999999999999998 999999999999998432  2


Q ss_pred             cEEEeeecceeeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 022520          206 QLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (296)
Q Consensus       206 ~ikl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  281 (296)
                      .++|+|||++.......   ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            69999999986543322   223456788999999986544 8999999999999999998 999999877655444443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=286.35  Aligned_cols=208  Identities=23%  Similarity=0.354  Sum_probs=157.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ....|.+.+.||+|+||.||+|++..+   +..||+|.+....     ..+.+|+.+++.++||||+++++++....   
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---  163 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---  163 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS---
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC---
Confidence            345699999999999999999997543   2468999875322     33457999999999999999999864322   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                       ...++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       164 -~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DFG  237 (373)
T 3c1x_A          164 -GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFG  237 (373)
T ss_dssp             -SCCEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             -CCeEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCC-CEEEeecc
Confidence             236799999985 888877643   35688899999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCC-----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 022520          214 SAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (296)
Q Consensus       214 ~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~  280 (296)
                      +++.......     .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~  309 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL  309 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH
Confidence            9976533221     12345678899999986544 8999999999999999999 67889876654444433

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=290.34  Aligned_cols=198  Identities=27%  Similarity=0.423  Sum_probs=155.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-chhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      .+|.+.+.||+|+||+||. ....+++.||||++... .....+|+.+|+.+ +||||+++++++     .+....++||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence            3699999999999999764 34568899999988543 33456899999999 799999999887     3344589999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC----CcEEEeeecceeee
Q 022520          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCDFGSAKVL  218 (296)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~----~~ikl~Dfg~~~~~  218 (296)
                      |||+++|.+.+....   ..+....+..++.||+.||.|||++ ||+||||||+|||++.++    ..++|+|||++...
T Consensus        98 E~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999999998887542   3444555678999999999999998 999999999999995322    25889999999876


Q ss_pred             ccCC----CcccccccccccCCccccC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022520          219 VKGE----PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (296)
Q Consensus       219 ~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~  272 (296)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||....
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~  234 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL  234 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence            4432    2234568999999999864  3447889999999999999999 899996543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=275.79  Aligned_cols=197  Identities=28%  Similarity=0.427  Sum_probs=161.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----------hhhHHHHHHHHhc----CCCCceecceeee
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFF  128 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l----~h~niv~~~~~~~  128 (296)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+....          ....+|+.+++.+    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3457999999999999999999999999999999885332          2334799999998    8999999999883


Q ss_pred             eccCCCceEEEEEEec-cc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCc
Q 022520          129 STTEKDELYLNLVLEY-VP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~-~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~  206 (296)
                      .     ....++|||+ +. ++|.+++...    ..+++..+..++.|++.||.|||++ ||+||||||+||+++.+.+.
T Consensus       109 ~-----~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          109 T-----QEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTE
T ss_pred             c-----CCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCe
Confidence            3     3347889998 55 6888887763    5799999999999999999999999 99999999999999943348


Q ss_pred             EEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       207 ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ++|+|||++...... ......+|+.|+|||++.+....+.++||||||+++|+|++|+.||..
T Consensus       179 ~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             EEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            999999999866443 334566899999999986655456689999999999999999999965

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.4e-39  Score=278.60  Aligned_cols=194  Identities=30%  Similarity=0.444  Sum_probs=160.5

Q ss_pred             eEEeeeeeecCceEEEEEEE----cCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           67 YMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      |++.+.||+|+||.||++.+    ..+++.||+|++....     ....+|+++++.++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            49999999999999988764    3578999999986432     2346899999999999999999988543   2345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++||||+++ +|.+.+..     ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDR-LVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCC-CEEECCccccc
Confidence            7899999985 77776653     4589999999999999999999998 999999999999999887 89999999998


Q ss_pred             eeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       217 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      .......    .....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            7644432    22345688899999986544 789999999999999999999998753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-38  Score=287.41  Aligned_cols=201  Identities=28%  Similarity=0.393  Sum_probs=153.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-hhhHHHHHHHHhc-CCCCceecceeeeeccCCCceEEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ..|.+.+.||+|+||+||.+. ..+|+.||||++.... ....+|+++++.+ +||||+++++++     .+....++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence            357788999999999998754 5679999999886543 3446899999876 899999998887     3445589999


Q ss_pred             ecccccHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC------------CCcE
Q 022520          143 EYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH------------THQL  207 (296)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~------------~~~i  207 (296)
                      |||+++|.+++.........   .++..+..++.||+.||.|||++ ||+||||||+|||++.+            ...+
T Consensus        89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            99999999888764322111   12334567999999999999998 99999999999999753            2379


Q ss_pred             EEeeecceeeeccCCC-----cccccccccccCCccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022520          208 KLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (296)
Q Consensus       208 kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~  272 (296)
                      ||+|||++........     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |+.||....
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            9999999987644322     123578999999999864      2458999999999999999998 999997654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.1e-39  Score=296.52  Aligned_cols=209  Identities=26%  Similarity=0.362  Sum_probs=171.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ....+|++.+.||+|+||.||+|.+.. +..||||++....   ..+.+|+++|+.++|+||+++++++..      ...
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  336 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  336 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence            445679999999999999999999864 4679999986432   346689999999999999999988732      126


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++||||+.+ +|.+++....  ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  412 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARL  412 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCTTSTTT
T ss_pred             eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCC-cEEEccccccee
Confidence            799999985 8888876532  35689999999999999999999998 999999999999999877 899999999975


Q ss_pred             eccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          218 LVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      .....  ......++..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+.+
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~  479 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER  479 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT
T ss_pred             cCCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            43211  112334578899999986544 8999999999999999999 9999998877666555544

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-38  Score=273.13  Aligned_cols=197  Identities=21%  Similarity=0.322  Sum_probs=157.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecch-hhHHHHHHHHhc--CCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNRELQTMRLL--DHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .++|++.+.||+|+||.||+|++  .++.||+|++..... ...+|.+++..+  +||||+++++++..... .....++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~l  112 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYL  112 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEE
Confidence            35799999999999999999998  489999998854432 234566666554  89999999998865432 2245889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC-------CceeccCCCCceEEcCCCCcEEEeee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      ||||+++ +|.+++..     ..+++..+..++.|++.||.|||++.       ||+||||||+|||++.++ .+||+||
T Consensus       113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            9999985 88888754     56999999999999999999999742       899999999999999887 8999999


Q ss_pred             cceeeeccCCCc-----ccccccccccCCccccCCCCCCC------chhHHHHHHHHHHHHhC----------CCCCCC
Q 022520          213 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTA------AIDIWSAGCVLAELLLG----------QPLFPG  270 (296)
Q Consensus       213 g~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DiwSlG~il~~l~~g----------~~pf~~  270 (296)
                      |++.........     ....||+.|+|||++.+.. ++.      ++|||||||++|+|++|          ..||..
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999765433222     2457899999999986544 344      39999999999999999          777765

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.4e-38  Score=274.53  Aligned_cols=197  Identities=22%  Similarity=0.287  Sum_probs=163.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-hhhHHHHHHHHh--cCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|.+.+.||+|+||.||+|++  +++.||+|.+.... ....+|.++++.  ++||||+++++++..... .....++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEE
Confidence            5799999999999999999998  68999999985432 344578888887  799999999998854431 12357899


Q ss_pred             Eecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------ccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      |||+++ +|.+++..     .++++..+..++.|++.||.|||        +. +|+||||||+|||++.++ .++|+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999985 88888764     46899999999999999999999        87 999999999999999887 8999999


Q ss_pred             cceeeeccCCC-----cccccccccccCCccccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCC
Q 022520          213 GSAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLG----------QPLFPGE  271 (296)
Q Consensus       213 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~l~~g----------~~pf~~~  271 (296)
                      |++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||...
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99987655432     234568999999999865432     23689999999999999999          7888764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-38  Score=272.20  Aligned_cols=208  Identities=27%  Similarity=0.396  Sum_probs=161.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcC-CC--cEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLE-TG--EAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~--~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ..+|++.+.||+|+||.||+|++.. ++  ..||+|++...       .....+|+.+++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3579999999999999999998643 33  36899987532       12345899999999999999999988432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                        . .++||||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+||
T Consensus        94 --~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           94 --P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             --S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             --C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCC-CEEEccc
Confidence              1 578999998 5888877764   25689999999999999999999998 999999999999999877 8999999


Q ss_pred             cceeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          213 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       213 g~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |++.........    ....+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+.+..+.+.
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  240 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE  240 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence            999876443321    2345677899999986544 7899999999999999999 99999988776666655544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.6e-38  Score=271.48  Aligned_cols=196  Identities=25%  Similarity=0.369  Sum_probs=158.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcC--CCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++....      ....+|+.+++.++  |+||+++++++.     ..
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CS
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cC
Confidence            357999999999999999999975 58899999885332      33457999999997  599999999874     33


Q ss_pred             eEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       136 ~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ...++|||+.+++|.+.+..    ...+++..+..++.|++.||.|||++ +|+||||||+|||++. + .+||+|||++
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred             CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-C-eEEEeecccc
Confidence            45889999877899888876    36789999999999999999999998 9999999999999974 4 7999999999


Q ss_pred             eeeccCCC---cccccccccccCCccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          216 KVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       216 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ........   .....||+.|+|||++.+.          ..++.++||||||+++|+|++|+.||....
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            76543322   2245689999999998541          347889999999999999999999998654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.6e-38  Score=297.53  Aligned_cols=203  Identities=23%  Similarity=0.337  Sum_probs=161.9

Q ss_pred             eEE-eeeeeecCceEEEEEEEc--CCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           67 YMA-ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        67 y~~-~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      +.+ .+.||+|+||.||+|.+.  .+++.||||+++...      ..+.+|+++++.++||||+++++++.     +.. 
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~-  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AES-  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SSS-
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCC-
Confidence            444 348999999999999653  567899999886432      34568999999999999999999772     111 


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .++||||+++ +|.+++..    ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            6799999984 77777754    46799999999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       217 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      .......    .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+.+
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~  587 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK  587 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            6543321    12234578899999996544 8999999999999999998 9999999877655554443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=297.89  Aligned_cols=206  Identities=26%  Similarity=0.357  Sum_probs=163.9

Q ss_pred             cceEEee-eeeecCceEEEEEEEc--CCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAER-VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .++.+.+ .||+|+||.||+|.+.  .++..||||++...     ...+.+|+++++.++||||+++++++..     . 
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~-  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E-  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----S-
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----C-
Confidence            3456665 8999999999999875  35667999988643     2345689999999999999999998732     1 


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+++...   ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~-~vkL~DFGla  483 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRH-YAKISDFGLS  483 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred             CeEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence            27899999985 677766542   46799999999999999999999998 999999999999999877 8999999999


Q ss_pred             eeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       216 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      +........    ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+.+
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~  554 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  554 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence            765332211    1223467899999986544 8999999999999999998 9999999887666555544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=275.14  Aligned_cols=200  Identities=30%  Similarity=0.486  Sum_probs=164.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEE----cCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ....+|++.+.||+|+||.||+|++    ..+++.||+|++....    ....+|+++++.++||||+++++++....  
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence            3445799999999999999999984    5689999999985432    23568999999999999999999874332  


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                       ....++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+||
T Consensus       116 -~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          116 -RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCC-cEEEecC
Confidence             2246899999985 888887653   35689999999999999999999998 999999999999999877 8999999


Q ss_pred             cceeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          213 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       213 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      |++........    .....++..|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            99987644332    12234577899999986544 78999999999999999999998864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-37  Score=293.40  Aligned_cols=210  Identities=29%  Similarity=0.393  Sum_probs=168.9

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           61 PKQTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        61 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      .....+|++.+.||+|+||.||+|.+..+   +..||+|.+....     ..+.+|+.+++.++||||+++++++..   
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence            34556899999999999999999998643   4679999875432     334579999999999999999998721   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEee
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~D  211 (296)
                       +  ..++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|
T Consensus       463 -~--~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~-~vkL~D  534 (656)
T 2j0j_A          463 -N--PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGD  534 (656)
T ss_dssp             -S--SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC
T ss_pred             -C--ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCC-CEEEEe
Confidence             1  2679999998 5787777653   35689999999999999999999998 999999999999999877 899999


Q ss_pred             ecceeeeccCCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          212 FGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       212 fg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ||++.........  ....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+.+
T Consensus       535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~  607 (656)
T 2j0j_A          535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN  607 (656)
T ss_dssp             CCCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred             cCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence            9999765433221  223457899999998654 48999999999999999997 9999998877666655554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=273.41  Aligned_cols=210  Identities=19%  Similarity=0.247  Sum_probs=165.2

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      ......+|++.+.||+|+||.||+|.+..   .+|+|.+...      ...+.+|+.+++.++|+||+++++++...   
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---  101 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP---  101 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS---
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC---
Confidence            34445689999999999999999999743   4899987532      23345799999999999999999988533   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                        ...++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++ ++ .++|+||
T Consensus       102 --~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~-~~~l~Df  173 (319)
T 2y4i_B          102 --PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NG-KVVITDF  173 (319)
T ss_dssp             --SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC----CCEECCC
T ss_pred             --CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CC-CEEEeec
Confidence              33889999998 4776666542   34689999999999999999999998 999999999999998 44 7999999


Q ss_pred             cceeeeccC------CCcccccccccccCCccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 022520          213 GSAKVLVKG------EPNISYICSRYYRAPELIFG--------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (296)
Q Consensus       213 g~~~~~~~~------~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  278 (296)
                      |++......      .......||+.|+|||++.+        ...++.++|||||||++|+|++|+.||...+..+...
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  253 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW  253 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            997654211      12233458999999999854        2347889999999999999999999999887665555


Q ss_pred             HHHHh
Q 022520          279 EIIKV  283 (296)
Q Consensus       279 ~~~~~  283 (296)
                      .+...
T Consensus       254 ~~~~~  258 (319)
T 2y4i_B          254 QMGTG  258 (319)
T ss_dssp             HHHTT
T ss_pred             HhccC
Confidence            55443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-38  Score=296.86  Aligned_cols=206  Identities=29%  Similarity=0.425  Sum_probs=168.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccC-CCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  138 (296)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...     .....+|+++++.++||||+++++++..... ......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5799999999999999999999999999999987543     2234579999999999999999887633111 123446


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC--cEEEeeecce
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSA  215 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~--~ikl~Dfg~~  215 (296)
                      ++||||++ ++|.+++.... ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++.  .++|+|||++
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            89999997 57777776532 234688899999999999999999998 9999999999999987653  3899999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      .............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~  228 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQ  228 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred             cccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence            8776655556678899999999986544 89999999999999999999999987543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-38  Score=298.84  Aligned_cols=194  Identities=27%  Similarity=0.414  Sum_probs=162.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcC-CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..++|++.+.||+|+||.||+|.+.. +++.||+|++....     ....+|+.+++.++||||+++++++......+..
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            34689999999999999999999976 78999999885322     2345799999999999999999998766555555


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+++ +|.+.+.      .++++..+..++.||+.||.|||++ ||+||||||+|||++.+  .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~--~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS--CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC--cEEEEecccc
Confidence            67899999986 5544332      3799999999999999999999998 99999999999999874  7999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  270 (296)
                      ......   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+
T Consensus       229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            865332   445789999999998543  48899999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-37  Score=279.68  Aligned_cols=203  Identities=17%  Similarity=0.151  Sum_probs=154.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCC-CCceec---------ceee
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDH-PNVVSL---------KHCF  127 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h-~niv~~---------~~~~  127 (296)
                      .+|...+.||+|+||.||+|++..+|+.||||++...       ...+.+|+.+++.++| +|....         .+..
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4699999999999999999999999999999988622       2334589999998877 322111         1111


Q ss_pred             e------------eccCCCceEEEEEEecccccHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceecc
Q 022520          128 F------------STTEKDELYLNLVLEYVPETVHRVIKHHY---KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  192 (296)
Q Consensus       128 ~------------~~~~~~~~~~~iv~e~~~~~l~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~D  192 (296)
                      .            .........++++|+++.++|.+++....   .....+++..+..++.|++.||+|||++ ||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence            0            00000122367889998888888875432   2234567778888999999999999998 999999


Q ss_pred             CCCCceEEcCCCCcEEEeeecceeeeccCCCcccccccccccCCcccc---------CCCCCCCchhHHHHHHHHHHHHh
Q 022520          193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTAAIDIWSAGCVLAELLL  263 (296)
Q Consensus       193 lkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwSlG~il~~l~~  263 (296)
                      |||+|||++.++ .+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999988 7999999998764332  334566 9999999983         33347889999999999999999


Q ss_pred             CCCCCCCCC
Q 022520          264 GQPLFPGES  272 (296)
Q Consensus       264 g~~pf~~~~  272 (296)
                      |+.||...+
T Consensus       313 g~~Pf~~~~  321 (413)
T 3dzo_A          313 ADLPNTDDA  321 (413)
T ss_dssp             SSCCCCTTG
T ss_pred             CCCCCCCcc
Confidence            999998753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.6e-39  Score=281.93  Aligned_cols=193  Identities=19%  Similarity=0.173  Sum_probs=153.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhcC---------CCCcee
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVS  122 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~---------h~niv~  122 (296)
                      ..+|++.+.||+|+||+||+|++  +++.||+|++....            ....+|+.+++.++         |+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35799999999999999999998  78999999986542            44568999998886         666666


Q ss_pred             cceeeeecc-------------------------CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 022520          123 LKHCFFSTT-------------------------EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQIC  176 (296)
Q Consensus       123 ~~~~~~~~~-------------------------~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~  176 (296)
                      +.+++....                         ..+....++|||||++ ++++.+.     ...+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence            555432110                         0013458899999975 4555543     25689999999999999


Q ss_pred             HHHHHHH-ccCCceeccCCCCceEEcCCC-------------------CcEEEeeecceeeeccCCCcccccccccccCC
Q 022520          177 RALAYIH-NTIGVCHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAP  236 (296)
Q Consensus       177 ~~l~~LH-~~~~iiH~Dlkp~NIli~~~~-------------------~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aP  236 (296)
                      .||.||| ++ ||+||||||+|||++.++                   ..+||+|||+++.....    ...||+.|+||
T Consensus       172 ~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          172 ASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            9999999 88 999999999999998764                   27999999999876432    45789999999


Q ss_pred             ccccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCC
Q 022520          237 ELIFGATEYTAAIDIWSAGCV-LAELLLGQPLFPG  270 (296)
Q Consensus       237 E~~~~~~~~~~~~DiwSlG~i-l~~l~~g~~pf~~  270 (296)
                      |++.+..  +.++|||||+++ .++++.|..||.+
T Consensus       247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             hhhcCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence            9996544  889999998777 7778889999954

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.9e-36  Score=261.13  Aligned_cols=183  Identities=28%  Similarity=0.395  Sum_probs=151.4

Q ss_pred             cccceEEe-eeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHH-HhcCCCCceecceeeeeccCCCceEEEE
Q 022520           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        63 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ..++|.+. +.||+|+||.||+|.+..+++.||+|.+.. .....+|+.++ +.++||||+++++++.... .+..+.++
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l   92 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   92 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence            44578887 789999999999999999999999998854 44556788887 6679999999999885422 23556899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--CCcEEEeeecceee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKV  217 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~~~ikl~Dfg~~~~  217 (296)
                      ||||+++ +|.+.+....  ...+++..+..++.|++.||.|||++ ||+||||||+|||++.+  ...++|+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            9999985 8888887632  34799999999999999999999998 99999999999999873  23799999999864


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ..                      ...++.++|||||||++|+|++|+.||.+.+
T Consensus       170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~  202 (299)
T 3m2w_A          170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  202 (299)
T ss_dssp             CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred             cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            31                      1236789999999999999999999996543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.1e-36  Score=258.32  Aligned_cols=171  Identities=16%  Similarity=0.074  Sum_probs=143.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....       ..+.+|+.+++.++||||+++++++..     
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----  102 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----  102 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----
Confidence            44468999999999999999999999999999999885432       345689999999999999999998843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ....++||||+++ +|.+++..     + .....+..++.|++.||.|||++ ||+||||||+|||++.++ .++|++++
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g-~~kl~~~~  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDG-DVVLAYPA  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTS-CEEECSCC
T ss_pred             CCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCC-CEEEEecc
Confidence            3348899999985 77776632     2 35557888999999999999998 999999999999999887 78887443


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                                         |++|        ++.++|||||||++|+|++|+.||.+.+
T Consensus       175 -------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 -------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             -------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             -------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                               3332        6889999999999999999999998754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.6e-33  Score=262.29  Aligned_cols=178  Identities=17%  Similarity=0.093  Sum_probs=123.2

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEEeec--------------chhhHHHHHHHHhc-CCCCceecceeeeeccCCCce
Q 022520           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        72 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ..+.|++|.+..++....|+.+++|.+...              ...+.+|+++|+++ .|+||+++++++     ++..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            467788888877777778999999998533              12345799999999 799999999988     5555


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..||||||++| +|.+.+..    .++++..   .|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||++
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCC-CEEEeecccC
Confidence            68999999996 77777765    3667654   5788999999999999 999999999999999887 8999999999


Q ss_pred             eeeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 022520          216 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  265 (296)
Q Consensus       216 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~  265 (296)
                      +..... ....+.+||+.|||||++.+.  +..++|+||+|++++++.++.
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            866443 234566899999999998653  577899999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=5e-29  Score=230.85  Aligned_cols=179  Identities=17%  Similarity=0.238  Sum_probs=132.3

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------------hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        68 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ...+.||+|+||.||+|..  .+..+++|+.....            +...+|+++++.++||||+++..++.....   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            4467899999999999954  67789999763221            124689999999999999955444432222   


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                        .++||||++ ++|.+++..            +..++.|++.||.|||++ +|+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC---eEEEEECcc
Confidence              479999998 577666543            447899999999999998 9999999999999997   699999999


Q ss_pred             eeeeccCCC--------cccccccccccCCccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          215 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       215 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      ++.......        .....||+.|||||++... ..|+...|+||..+-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            987643221        1255789999999998541 236778899999988888888777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.2e-25  Score=191.86  Aligned_cols=137  Identities=16%  Similarity=0.203  Sum_probs=108.3

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----------------------chhhHHHHHHHHhcCCCCceecc
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------------------KRYKNRELQTMRLLDHPNVVSLK  124 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------------------~~~~~~E~~~l~~l~h~niv~~~  124 (296)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|.+...                      .....+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55669999999999999999 88999999988532                      123458999999999  5 6776


Q ss_pred             eeeeeccCCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC
Q 022520          125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (296)
Q Consensus       125 ~~~~~~~~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~  203 (296)
                      +++- .     ...++||||++| +|.+ +.          ......++.|++.||.|||++ ||+||||||+|||++ +
T Consensus       168 ~~~~-~-----~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYA-W-----EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEE-E-----ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-T
T ss_pred             eEEe-c-----cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-C
Confidence            6552 1     225799999986 6554 21          123456899999999999998 999999999999999 6


Q ss_pred             CCcEEEeeecceeeeccCCCcccccccccccCCccc
Q 022520          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI  239 (296)
Q Consensus       204 ~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~  239 (296)
                      + .++|+|||++..            +..++|||.+
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l  251 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREIL  251 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHH
Confidence            5 899999999864            3446788876

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=1.9e-22  Score=169.96  Aligned_cols=135  Identities=17%  Similarity=0.247  Sum_probs=102.2

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcE--EEEEEEeecc----------------------------hhhHHHHHHHHhc
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDK----------------------------RYKNRELQTMRLL  115 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~----------------------------~~~~~E~~~l~~l  115 (296)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+|+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999998778888  9999864321                            1345799999999


Q ss_pred             CCCCceecceeeeeccCCCceEEEEEEecccc------cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-ccCCc
Q 022520          116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGV  188 (296)
Q Consensus       116 ~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~------~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~i  188 (296)
                      .|+++... ..+. ..     ..++||||+++      .+.+....       .++..+..++.|++.+|.+|| +. ||
T Consensus       128 ~~~~i~~p-~~~~-~~-----~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~-gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYT-YM-----KNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA-EL  192 (258)
T ss_dssp             HHTTCCCC-CEEE-EE-----TTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS-CE
T ss_pred             HhCCCCCC-eEEE-cC-----CCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC-CE
Confidence            88865221 1111 11     15799999953      44443221       123456788999999999999 88 99


Q ss_pred             eeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       189 iH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||||+|||++.   .++|+|||++...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999987   6999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=1e-19  Score=159.91  Aligned_cols=134  Identities=13%  Similarity=0.161  Sum_probs=90.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh------------------h--------HHHHHHHHhcCCCC
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY------------------K--------NRELQTMRLLDHPN  119 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~--------~~E~~~l~~l~h~n  119 (296)
                      -|++...||.|+||.||+|.+ .+|+.||||+++.....                  .        .+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            399999999999999999987 46899999987421100                  0        12444444443332


Q ss_pred             ceecceeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceE
Q 022520          120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (296)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIl  199 (296)
                      +. ....+. .. .    .++||||++|..+..+       .  .......++.|++.+|.+||+. |||||||||.|||
T Consensus       175 v~-vp~p~~-~~-~----~~LVME~i~G~~L~~l-------~--~~~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FP-VPEPIA-QS-R----HTIVMSLVDALPMRQV-------S--SVPDPASLYADLIALILRLAKH-GLIHGDFNEFNIL  237 (397)
T ss_dssp             CS-CCCEEE-EE-T----TEEEEECCSCEEGGGC-------C--CCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEE
T ss_pred             CC-CCeeee-cc-C----ceEEEEecCCccHhhh-------c--ccHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEE
Confidence            21 111110 01 1    3689999997422111       1  1123456789999999999998 9999999999999


Q ss_pred             EcCCCC---------cEEEeeecceee
Q 022520          200 VNPHTH---------QLKLCDFGSAKV  217 (296)
Q Consensus       200 i~~~~~---------~ikl~Dfg~~~~  217 (296)
                      ++.++.         .+.|+||+.+..
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EeCCCCcccccccccceEEEEeCCccc
Confidence            987652         289999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=1.8e-12  Score=108.80  Aligned_cols=135  Identities=16%  Similarity=0.115  Sum_probs=98.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEee----cchhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .|++...++.|+.+.||++..  .+..+++|....    ......+|+++++.+. +..+.++++.+.     +....++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence            588899999999999999974  467899998753    2345678999999985 555666666552     2334789


Q ss_pred             EEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------
Q 022520          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN------------------------------------  184 (296)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------  184 (296)
                      |||+++|......   .  .   +......++.++..+|..||+                                    
T Consensus        88 v~e~i~G~~l~~~---~--~---~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEE---Y--E---DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHH---C--C---TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhc---c--C---CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999998433221   0  0   111234677889999999998                                    


Q ss_pred             -----------------------cCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          185 -----------------------TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       185 -----------------------~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                                             . .++|+|++|.||+++.+. .+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~-~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEEL-VFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCE-EEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCc-eEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence                                   3 589999999999998643 456999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=2.5e-11  Score=101.41  Aligned_cols=134  Identities=17%  Similarity=0.081  Sum_probs=88.8

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-chhhHHHHHHHHhcCCCCc-e-ecceeeeeccCCCceEEEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLDHPNV-V-SLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h~ni-v-~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      .|.+....+.|..+.||++.. .+|..+++|..... .....+|+++++.+.+.++ + +++.....     ....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence            456554444566699999963 56778999987543 2345689999999865554 3 35554421     22368999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccC------------------------------------
Q 022520          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI------------------------------------  186 (296)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  186 (296)
                      ||++|.... .       ....   ...++.+++..|..||+..                                    
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999974222 1       1111   1245566777777777630                                    


Q ss_pred             ---------------------CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 ---------------------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ---------------------~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                                           .++|+|++|.||+++.+. .+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence                                 299999999999998653 456999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=5.7e-11  Score=104.33  Aligned_cols=140  Identities=16%  Similarity=0.195  Sum_probs=97.1

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEe--ec-----chhhHHHHHHHHhcCCC--CceecceeeeeccCCCceEEE
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVL--QD-----KRYKNRELQTMRLLDHP--NVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~--~~-----~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ..+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.+...  .+.+++..+....  .....+
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence            356789999999999875  34678888765  22     23556899999999743  3555555442221  112356


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcc----------------------------------
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT----------------------------------  185 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------  185 (296)
                      +||||++|.....     .....++......++.++...|..||..                                  
T Consensus       118 ~vme~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            8999999742210     0123466777888899999999999961                                  


Q ss_pred             -----------------------CCceeccCCCCceEEcCCCCc-EEEeeecceee
Q 022520          186 -----------------------IGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKV  217 (296)
Q Consensus       186 -----------------------~~iiH~Dlkp~NIli~~~~~~-ikl~Dfg~~~~  217 (296)
                                             ..++|+|++|.||+++.++.. +.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                   269999999999999976533 58999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=4.1e-11  Score=102.82  Aligned_cols=186  Identities=12%  Similarity=0.152  Sum_probs=109.7

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeec-cCCCceEEEEEEeccc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFST-TEKDELYLNLVLEYVP  146 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~~~iv~e~~~  146 (296)
                      .+.++.|....||++.     ..+++|.....  .....+|.++|+.+.+..-++.-..+... ........|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            3458999999999763     45888976433  24456899999888432212222222111 1111123468999999


Q ss_pred             cc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcc----------------------------------------
Q 022520          147 ET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT----------------------------------------  185 (296)
Q Consensus       147 ~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------  185 (296)
                      |. +.....      ..++..+...++.+++..|..||+.                                        
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            73 322211      2345555666666777777766640                                        


Q ss_pred             -----------------CCceeccCCCCceEEcCC-CCcEEEeeecceeeeccCCCcccccccccc---cCCccc----c
Q 022520          186 -----------------IGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYY---RAPELI----F  240 (296)
Q Consensus       186 -----------------~~iiH~Dlkp~NIli~~~-~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y---~aPE~~----~  240 (296)
                                       ..++|+|++|.||+++.+ +..+.|+||+.+.......   .......+   ..|+..    .
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHH
Confidence                             147999999999999974 3357899999987532210   00000000   112111    0


Q ss_pred             CCCC---------CCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          241 GATE---------YTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       241 ~~~~---------~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      ....         .....+.|+++.++|.+.+|..+|.
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0000         1123689999999999999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.69  E-value=3.5e-07  Score=78.34  Aligned_cols=73  Identities=12%  Similarity=0.053  Sum_probs=44.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEEecccc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE  147 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~  147 (296)
                      .+.++.|....||+.     +..+++|+....  .....+|.++|+.+.+..-+++-....... ......++||++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEeccCC
Confidence            455788888899987     456888875322  234568999999997532122212211111 112235689999997


Q ss_pred             c
Q 022520          148 T  148 (296)
Q Consensus       148 ~  148 (296)
                      .
T Consensus        98 ~   98 (306)
T 3tdw_A           98 Q   98 (306)
T ss_dssp             E
T ss_pred             e
Confidence            3

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.38  E-value=2.1e-06  Score=74.25  Aligned_cols=30  Identities=23%  Similarity=0.488  Sum_probs=26.5

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|+|+++.||+++.++ .+.|+||+.+..
T Consensus       223 ~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~  252 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENE-QIWVIDLDTVSF  252 (346)
T ss_dssp             CEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred             ceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence            899999999999997655 699999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.35  E-value=3.6e-06  Score=74.62  Aligned_cols=71  Identities=20%  Similarity=0.206  Sum_probs=44.4

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----------chhhHHHHHHHHhcCC--CCcee-cceeeeeccCCCc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLDH--PNVVS-LKHCFFSTTEKDE  135 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~E~~~l~~l~h--~niv~-~~~~~~~~~~~~~  135 (296)
                      .+.||.|..+.||++....++..+++|.....           ......|.++++.+..  +..++ ++. + ..   +.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~-d~---~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-DT---EM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ET---TT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E-cC---Cc
Confidence            56789999999999976556788999975321           1223578889888743  34443 322 1 11   11


Q ss_pred             eEEEEEEecccc
Q 022520          136 LYLNLVLEYVPE  147 (296)
Q Consensus       136 ~~~~iv~e~~~~  147 (296)
                        .++|||++++
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              3689999976

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=6.9e-06  Score=68.63  Aligned_cols=131  Identities=15%  Similarity=0.128  Sum_probs=79.1

Q ss_pred             eeecCce-EEEEEEEcCCCcEEEEEEEeec-chhhHHHHHHHHhcCCC-CceecceeeeeccCCCceEEEEEEeccccc-
Q 022520           73 VGHGSFG-VVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELYLNLVLEYVPET-  148 (296)
Q Consensus        73 lG~G~~g-~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~iv~e~~~~~-  148 (296)
                      +..|..+ .||+......+..+++|.-... .....+|...|+.+... -+.+++....     +....++||++++|. 
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEeeCCcc
Confidence            3445544 6898887667778999976433 23456799999888531 1223333331     122367899999974 


Q ss_pred             HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcc-------------------------------------------
Q 022520          149 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------------------------------------------  185 (296)
Q Consensus       149 l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  185 (296)
                      +.+.....        ......+..++...|.-||..                                           
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            33322211        011123334444444444431                                           


Q ss_pred             --------------CCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          186 --------------IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       186 --------------~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                                    ..++|+|+.|.||+++.++ .+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence                          0279999999999998654 556999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.18  E-value=9.3e-06  Score=70.75  Aligned_cols=78  Identities=10%  Similarity=0.072  Sum_probs=47.3

Q ss_pred             EEeeee-eecCceEEEEEEEc--C----CCcEEEEEEEeecc-------hhhHHHHHHHHhcCC---CCceecceeeeec
Q 022520           68 MAERVV-GHGSFGVVFQAKCL--E----TGEAVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFST  130 (296)
Q Consensus        68 ~~~~~l-G~G~~g~V~~~~~~--~----~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h---~niv~~~~~~~~~  130 (296)
                      ...+.| +.|....+|++...  .    ++..+++|......       ....+|..+++.+..   -.+.+++......
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345677 77888999988753  1    15678888764332       345689999988743   2344444433111


Q ss_pred             cCCCceEEEEEEecccc
Q 022520          131 TEKDELYLNLVLEYVPE  147 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~~  147 (296)
                        .-....++|||+++|
T Consensus       103 --~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 --DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             --TTTSSCEEEEECCCC
T ss_pred             --CccCCceEEEEecCC
Confidence              101224679999986

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.87  E-value=8.8e-05  Score=62.99  Aligned_cols=65  Identities=15%  Similarity=0.112  Sum_probs=40.8

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeecch---hhHHHHHHHHhcCCCCce-ecceeeeeccCCCceEEEEEEecc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      .+.|+.|....+|++      ..+++|+......   ...+|..+++.+...++. +++...     .+.  -+++++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            678888999999998      4588887753321   235788888887544443 332221     111  24689999


Q ss_pred             -cc
Q 022520          146 -PE  147 (296)
Q Consensus       146 -~~  147 (296)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             65

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=0.00099  Score=56.83  Aligned_cols=143  Identities=13%  Similarity=0.065  Sum_probs=74.4

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEee--cchhhHHHHHHHHhcCCCCc--eecceeeeeccC----CCceEEEE
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDHPNV--VSLKHCFFSTTE----KDELYLNL  140 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~----~~~~~~~i  140 (296)
                      -.+.|+.|....+|++... ++ .+++|....  .......|..+++.+...++  .+++..   ...    ......++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence            3566778888999999753 33 688998764  33455678888887743232  222211   000    00123578


Q ss_pred             EEecccccH------------HHHHHHhhh----cCCC----CCHHHHHHHH---------------HHHHHHHHHHHc-
Q 022520          141 VLEYVPETV------------HRVIKHHYK----MSQR----MPLIYVKLYF---------------YQICRALAYIHN-  184 (296)
Q Consensus       141 v~e~~~~~l------------~~~l~~~~~----~~~~----~~~~~~~~i~---------------~~i~~~l~~LH~-  184 (296)
                      +++|++|..            -..+.....    ...+    .........+               ..+...++.+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999998631            011111100    0011    1111111100               013334444442 


Q ss_pred             -----cCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          185 -----TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       185 -----~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                           ..+++|+|+++.||+++.+. .+.|+||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                 12699999999999998653 347999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.63  E-value=0.00057  Score=57.50  Aligned_cols=74  Identities=16%  Similarity=0.138  Sum_probs=49.2

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ..-++.+|.|..+.||+++. .+|+.|.+|+....    ...+..|.+.|+.|....-++.-.++...  .    -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEE
Confidence            45578899999999999984 67889999976432    23457899999988543223222222211  1    25789


Q ss_pred             ecccc
Q 022520          143 EYVPE  147 (296)
Q Consensus       143 e~~~~  147 (296)
                      ||+.+
T Consensus        90 e~l~~   94 (288)
T 3f7w_A           90 EWVDE   94 (288)
T ss_dssp             ECCCC
T ss_pred             Eeecc
Confidence            99873

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.60  E-value=0.0013  Score=59.23  Aligned_cols=70  Identities=13%  Similarity=0.204  Sum_probs=45.2

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh---hHHHHHHHHhcCCCCce-ecceeeeeccCCCceEEEEEEec
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY---KNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYLNLVLEY  144 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~iv~e~  144 (296)
                      -.+.|+.|....+|++.....+..+++|+.......   ..+|..+++.+...++. ++++.+     .+    ..|++|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            355778888899999987443478889977432221   25899999999766664 344433     22    248999


Q ss_pred             ccc
Q 022520          145 VPE  147 (296)
Q Consensus       145 ~~~  147 (296)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            886

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.58  E-value=0.00073  Score=60.41  Aligned_cols=70  Identities=17%  Similarity=0.223  Sum_probs=46.4

Q ss_pred             EeeeeeecCceEEEEEEEcC-------CCcEEEEEEEee-cc-hhhHHHHHHHHhcCCCCce-ecceeeeeccCCCceEE
Q 022520           69 AERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQ-DK-RYKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYL  138 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~-~~-~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~  138 (296)
                      -.+.|+.|....+|++....       ++..+++|+... .. ....+|..+++.+...++. ++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            35577888889999998642       257889998743 22 3445799999888644553 444433     22    


Q ss_pred             EEEEecccc
Q 022520          139 NLVLEYVPE  147 (296)
Q Consensus       139 ~iv~e~~~~  147 (296)
                      .+|++|++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            268999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.55  E-value=0.00037  Score=62.09  Aligned_cols=79  Identities=11%  Similarity=-0.048  Sum_probs=45.2

Q ss_pred             HccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCcccccc--cccccCCccccCCC--CCCCchhHHHHHHHH
Q 022520          183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGAT--EYTAAIDIWSAGCVL  258 (296)
Q Consensus       183 H~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DiwSlG~il  258 (296)
                      +.. .++|+|++|.||+++.++  +.++||+.+........-.....  ...|.+|+......  ......++.++...+
T Consensus       230 ~~~-~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          230 RAQ-ALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             BCC-EEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCC-eEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            344 799999999999998654  99999999875321111011111  23456655442111  011234455666667


Q ss_pred             HHHHhC
Q 022520          259 AELLLG  264 (296)
Q Consensus       259 ~~l~~g  264 (296)
                      |+.+.+
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            766654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.40  E-value=0.00058  Score=59.64  Aligned_cols=69  Identities=12%  Similarity=0.132  Sum_probs=40.7

Q ss_pred             eeeeeecCceEEEEEEEcC--------CCcEEEEEEEeecchh---hHHHHHHHHhcCCCCce-ecceeeeeccCCCceE
Q 022520           70 ERVVGHGSFGVVFQAKCLE--------TGEAVAIKKVLQDKRY---KNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELY  137 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~---~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~  137 (296)
                      .+.|+.|....+|++....        .+..+++|+.......   ...|.++++.+...+++ ++++.+     .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence            4567778888999998642        1267888876443222   35788888888544443 443322     21   


Q ss_pred             EEEEEecccc
Q 022520          138 LNLVLEYVPE  147 (296)
Q Consensus       138 ~~iv~e~~~~  147 (296)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             468999886

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.37  E-value=0.0013  Score=56.17  Aligned_cols=71  Identities=15%  Similarity=0.065  Sum_probs=48.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeec-chhhHHHHHHHHhcCC---CCceecceeeeeccCCCceEEEEEEecc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLDH---PNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~iv~e~~  145 (296)
                      .+.|+.|....+|+...  ++..+++|..... ......|.+.|+.|..   ..+.+++....     .....++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEec
Confidence            56789999999999874  5678889976543 2345689888888742   33444444331     123478999999


Q ss_pred             cc
Q 022520          146 PE  147 (296)
Q Consensus       146 ~~  147 (296)
                      +|
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            86

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.0015  Score=56.11  Aligned_cols=32  Identities=38%  Similarity=0.480  Sum_probs=26.9

Q ss_pred             CceeccCCCCceEEcCC---CCcEEEeeecceeee
Q 022520          187 GVCHRDIKPQNLLVNPH---THQLKLCDFGSAKVL  218 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~---~~~ikl~Dfg~~~~~  218 (296)
                      .++|+|+.+.||+++.+   ...+.|+||+.+...
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            79999999999999864   137899999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.29  E-value=0.0028  Score=54.18  Aligned_cols=73  Identities=14%  Similarity=0.004  Sum_probs=42.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCC--ceecceeeeeccC--CCceEEEEEEe
Q 022520           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE--KDELYLNLVLE  143 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~iv~e  143 (296)
                      ..++ |....||++.. .+|+.+++|.....   ......|..+++.+....  +.+++..  ....  ......+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence            3456 77889998763 35667999988532   334557888888774323  2333221  0000  01123567999


Q ss_pred             cccc
Q 022520          144 YVPE  147 (296)
Q Consensus       144 ~~~~  147 (296)
                      +++|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9986

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.24  E-value=0.0021  Score=56.37  Aligned_cols=139  Identities=17%  Similarity=0.237  Sum_probs=76.7

Q ss_pred             eeeeeecCceEEEEEEEcC-------CCcEEEEEEEee---cchhhHHHHHHHHhcCCCCce-ecceeeeeccCCCceEE
Q 022520           70 ERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQ---DKRYKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYL  138 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~---~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~  138 (296)
                      .+.|..|....+|++....       ++..+++|+.-.   ......+|..+++.+...++. ++++.+     .+    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            3456667788899887532       346888897632   223345799999888544443 333333     22    


Q ss_pred             EEEEecccccHH---------------HHHHHhhhc----CCCCC--HHHHHHHHHHHHH-------------------H
Q 022520          139 NLVLEYVPETVH---------------RVIKHHYKM----SQRMP--LIYVKLYFYQICR-------------------A  178 (296)
Q Consensus       139 ~iv~e~~~~~l~---------------~~l~~~~~~----~~~~~--~~~~~~i~~~i~~-------------------~  178 (296)
                      .+||+|++|...               +.+...-..    .....  ...+.+++.++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            278999986211               111111111    11111  3455555544422                   1


Q ss_pred             HHHHHc-------cCCceeccCCCCceEEcCC---CCcEEEeeecceee
Q 022520          179 LAYIHN-------TIGVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  217 (296)
Q Consensus       179 l~~LH~-------~~~iiH~Dlkp~NIli~~~---~~~ikl~Dfg~~~~  217 (296)
                      +..|..       ...++|+|+.+.||+++.+   .+.+.++||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            233321       1259999999999999876   23799999999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.06  E-value=0.0014  Score=56.52  Aligned_cols=30  Identities=27%  Similarity=0.546  Sum_probs=26.4

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            699999999999998655 699999998765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.51  E-value=0.027  Score=45.00  Aligned_cols=103  Identities=16%  Similarity=0.074  Sum_probs=64.1

Q ss_pred             cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCCcccc
Q 022520          148 TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY  227 (296)
Q Consensus       148 ~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~~~~  227 (296)
                      +|.+.|...   +.++++++++.++.|.+.+|.-+-.+..-..+=+.|..|++..+| .|.+.+ ..+           .
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s-----------~   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AAD-----------D   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-ccc-----------c
Confidence            677777765   699999999999999999987662110111223456888888887 565543 111           0


Q ss_pred             cccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 022520          228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  268 (296)
Q Consensus       228 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf  268 (296)
                      .....+.|||...  ...+.+.=|||||+++|..+- |-++=
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~  137 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKEN  137 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence            1133466888762  235678889999999999995 54543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.03  E-value=0.06  Score=47.80  Aligned_cols=69  Identities=13%  Similarity=0.159  Sum_probs=43.8

Q ss_pred             eeeeeecCceEEEEEEEcCC-------CcEEEEEEEeecch---hhHHHHHHHHhcCCCCcee-cceeeeeccCCCceEE
Q 022520           70 ERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS-LKHCFFSTTEKDELYL  138 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~---~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~  138 (296)
                      ++.+..|....+|++.....       +..+++|+......   ...+|..+++.+...++++ +++.+     .    -
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----E  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence            45566678889999986421       57789997643322   2357999998886444443 33222     2    1


Q ss_pred             EEEEecccc
Q 022520          139 NLVLEYVPE  147 (296)
Q Consensus       139 ~iv~e~~~~  147 (296)
                      +.|++|++|
T Consensus       146 ~~I~efI~G  154 (424)
T 3mes_A          146 GRIEEFIDG  154 (424)
T ss_dssp             EEEEECCCS
T ss_pred             CEEEEEeCC
Confidence            468999986

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.54  E-value=0.36  Score=42.35  Aligned_cols=32  Identities=28%  Similarity=0.437  Sum_probs=25.7

Q ss_pred             CceeccCCCCceEEcC-----CCCcEEEeeecceeee
Q 022520          187 GVCHRDIKPQNLLVNP-----HTHQLKLCDFGSAKVL  218 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~-----~~~~ikl~Dfg~~~~~  218 (296)
                      .++|+|+.+.||++.+     +...+.++||..|..-
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            3689999999999943     3347999999998753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.27  E-value=0.11  Score=46.65  Aligned_cols=55  Identities=13%  Similarity=0.031  Sum_probs=16.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEE------EEEeecc------hhhHHHHHHHHhcCCCCceecceee
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAI------KKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCF  127 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vav------K~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~  127 (296)
                      .+.||   ||.||++.......+||+      |......      ..+.+|..+++.++|+|+++.+.+-
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            34565   999999998765668888      6554321      1234677788888999999987654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	296
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-81
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-57
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-53
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-52
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-51
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-50
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-47
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-46
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-45
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-44
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-41
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-39
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-37
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-37
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-36
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-33
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-31
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (629), Expect = 7e-81
 Identities = 164/236 (69%), Positives = 202/236 (85%), Gaps = 3/236 (1%)

Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 110 QTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ E KDE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKV+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-57
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 16/226 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +     +G G+ GVVF+     +G  +A K +  + +        RELQ +   + P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                F       E+ +   +E++       +    K + R+P   +      + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT 287
            T Y+   DIWS G  L E+ +G+   P     +  +     +   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (461), Expect = 8e-56
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 14/225 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F     +D+  + ++ E++      + +       +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF-----EDDNEMVMIYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 183 HNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH 286
                   D+WS G +   LL G   F GE+  + L  +     +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-54
 Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 17/228 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V         T      L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 180 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYR 234
              H        V HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +PE +     Y    DIWS GC+L EL    P F   S  +   +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-53
 Identities = 50/220 (22%), Positives = 100/220 (45%), Gaps = 14/220 (6%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
           +  +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +  + +T K +  + LV E +       +K + K  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 184 -NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
             T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            +Y  ++D+++ G  + E+   +  +       Q+   + 
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-53
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 10/226 (4%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 128
            +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 129 STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +     +  L +V+E +    +   I+   +  Q             I  A+ Y+H+ I 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131

Query: 188 VCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
           + HRD+KP+NLL         LKL DFG AK         +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
             + D+WS G ++  LL G P F    G+     +   I   +   
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-53
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 18/224 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                             L LEY             +    MP    + +F+Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 238
           +H  IG+ HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +     +   +D+WS G VL  +L G+  +   S   Q     K
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (443), Expect = 4e-53
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 18/223 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG     K +      DK     E+  M  L HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + L+LE++   E   R+    YKMS+      V  Y  Q C  L 
Sbjct: 91  LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----VINYMRQACEGLK 141

Query: 181 YIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE++
Sbjct: 142 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
                     D+W+ G +   LL G   F GE  ++ L  + +
Sbjct: 201 DR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (439), Expect = 6e-53
 Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 22/225 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +  + C+       E    LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
               E  Y   +D+WS G    EL   +P     + +  L  I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-53
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 18/225 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F       E  L +++E+             ++ + +    +++   Q   AL Y+
Sbjct: 74  LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 241
           H+   + HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 242 AT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            T     Y    D+WS G  L E+   +P     + +  L++I K
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-52
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 19/224 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L   F      D   + L+LEY P      +    +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF-----HDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +Y H+   V HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
            G   +   +D+WS G +  E L+G+P F   +  +    I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 3e-51
 Identities = 76/227 (33%), Positives = 124/227 (54%), Gaps = 16/227 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++ +    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + LV   +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 237
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-51
 Identities = 74/224 (33%), Positives = 115/224 (51%), Gaps = 20/224 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 121
             +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L   F     K  + L  V +++   +          S  +   ++K Y     + L Y
Sbjct: 64  GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H    + HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-50
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 17/221 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               +      DEL++  V+EY+                 M    +     +  +AL ++
Sbjct: 82  YLDSY---LVGDELWV--VMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+   V HRDIK  N+L+      +KL DFG    +   +   S +  + Y+ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              Y   +DIWS G +  E++ G+P +  E+ +  L  I  
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 3e-50
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 23/235 (9%)

Query: 60  QPKQTI--SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQ 110
           QP++     +   +++G GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 170
            M  LDHP  V L   F    + ++LY    L Y     +  +  + +          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRF 112

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SY 227
           Y  +I  AL Y+H    + HRD+KP+N+L+N   H +++ DFG+AKVL          S+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           + +  Y +PEL+        + D+W+ GC++ +L+ G P F   +      +IIK
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 6e-50
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 19/232 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 121 VSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           V+L     +      + +  + LV ++     H +      +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-----SYICSRY 232
            L YIH    + HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ 
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 8e-50
 Identities = 50/221 (22%), Positives = 96/221 (43%), Gaps = 15/221 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 123
           YM    +G G FG+V +     + +    K V     D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F     +    L ++ E++    +   I      +  +    +  Y +Q+C AL ++
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFL 118

Query: 183 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+   
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
               + A D+WS G ++  LL G   F  E+    +  I+ 
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  163 bits (413), Expect = 6e-49
 Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 13/221 (5%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 124
           Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                  +       LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
            +G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVI 284
           Y  ++D+WS GC+LA ++  + P F G    DQLV I KV+
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  161 bits (407), Expect = 2e-48
 Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 31/236 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------------LQDKRYKNRELQTMR 113
           Y  + ++G G   VV +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 114 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLY 171
            +  HPN++ LK  +     +   +  LV + +    +   +     +S++      +  
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE----TRKI 115

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
              +   +  +H    + HRD+KP+N+L++   + +KL DFG +  L  GE       + 
Sbjct: 116 MRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 232 YYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+ 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 2e-48
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 19/224 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK + +            E+  +  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   +        LYL  +++ V    +   I      ++R          +Q+  A+ 
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVSGGELFDRIVEKGFYTERD----ASRLIFQVLDAVK 121

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           Y+H+   + HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE+
Sbjct: 122 YLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +     Y+ A+D WS G +   LL G P F  E+      +I+K
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-48
 Identities = 79/225 (35%), Positives = 125/225 (55%), Gaps = 16/225 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           +     +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           E  L LV E++ + + + +         +PLI  K Y +Q+ + LA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+   V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-47
 Identities = 78/228 (34%), Positives = 122/228 (53%), Gaps = 15/228 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDKRYKN------RELQTMRLL---D 116
           Y     +G G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           HPNVV L      +    E  L LV E+V + +   +    +    +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLL 126

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
           E++   + Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ VI
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  158 bits (401), Expect = 3e-47
 Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 119
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ +   F     +D   + ++++Y+       +    + SQR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y+H+   + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
                Y  +ID WS G ++ E+L G   F   + +    +I+ 
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 8e-47
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 20/225 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--------MRLLDHP 118
           ++  +++G GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +  +   F     + +  L  V+EY+       + +H +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L ++H+  G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           ++ G  +Y  ++D WS G +L E+L+GQ  F G+   +    I  
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  158 bits (401), Expect = 9e-47
 Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 24/236 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 116
           +   R++G G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
            P +V + + F      D+L    +L+ +    +H  +  H   S+      ++ Y  +I
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEI 116

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y A
Sbjct: 117 ILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMA 173

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           PE++     Y ++ D +S GC+L +LL G   F      D+  EI ++ L   + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVEL 228

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 1e-46
 Identities = 78/225 (34%), Positives = 120/225 (53%), Gaps = 16/225 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 121 VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L   F    T  D     LV+ ++   + +++KH     +++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            YIH   G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
                YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-46
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 14/224 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L   F      +E     ++ ++         ++    Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           YIH+   + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
               Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  155 bits (392), Expect = 2e-46
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 18/227 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V++ +              +V+EYV       ++        M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRA 235
            + H   G+ HRD+KP N++++   + +K+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           PE   G     A  D++S GCVL E+L G+P F G+S V    + ++
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  152 bits (385), Expect = 3e-45
 Identities = 73/225 (32%), Positives = 122/225 (54%), Gaps = 18/225 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           +  L LV E++ + + +++         +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIA 114

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           Y H+   V HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I +++
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 5e-45
 Identities = 75/226 (33%), Positives = 119/226 (52%), Gaps = 18/226 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           +  L LV E+       + K+    +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+   V HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVI 284
           FGA  Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I +++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-44
 Identities = 51/237 (21%), Positives = 101/237 (42%), Gaps = 25/237 (10%)

Query: 62  KQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------REL 109
           ++ +   Y     +G G F VV + +   TG   A K + + +   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ + HPNV++L   +     +++  + L+LE V       +       + +      
Sbjct: 65  SILKEIQHPNVITLHEVY-----ENKTDVILILELVA---GGELFDFLAEKESLTEEEAT 116

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +  QI   + Y+H+   + H D+KP+N+++   N    ++K+ DFG A  +  G    +
Sbjct: 117 EFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
              +  + APE++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-44
 Identities = 47/225 (20%), Positives = 94/225 (41%), Gaps = 26/225 (11%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                         L +V ++    +++  +     +  +  +I +     Q  + + Y+
Sbjct: 70  MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I
Sbjct: 121 HAK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 240 FG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 7e-44
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 21/222 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD 116
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 117 --HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
                V+ L   F            L+LE       + +         +     + +F+Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           +  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 276
            PE I     +  +  +WS G +L +++ G   F  +  + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-42
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 17/219 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +++G G+FG V   +   TG   A+K + ++             E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K+ F      D L        +       +  H    +       + Y  +I  AL Y+H
Sbjct: 71  KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   V +RDIK +NL+++   H +K+ DFG  K  +     +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +Y  A+D W  G V+ E++ G+  F  +        I+ 
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (364), Expect = 5e-42
 Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 21/228 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     +   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               +    +  Y  +V+E +  ++          S++  L  V L   Q+   + YIH+
Sbjct: 69  RWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNI--------SYICSRYYR 234
                HRD+KP N L+        +   DFG AK       +         +   +  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           +     G  E +   D+ S G VL    LG   + G     +  +  +
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (363), Expect = 7e-42
 Identities = 46/231 (19%), Positives = 87/231 (37%), Gaps = 23/231 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     +   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           + F      + L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH 
Sbjct: 67  YYFGQ----EGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 185 TIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNI--------SYICSRY 232
              + +RDIKP N L+      + + + + DFG  K                 +   +  
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           Y +     G  E +   D+ + G V    L G   + G        +  ++
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-41
 Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 16/225 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 121 VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F    T ++   + LV+E +   + +VI+      +      +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLCGI 132

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI 284
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ +
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-41
 Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 17/216 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
           + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
               +++  L +V EY+ + ++   ++   +    +    +  +   +C A+ Y+     
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-N 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
             HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++ 
Sbjct: 124 FVHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179

Query: 248 AIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
             D+WS G +L E+   G+  +P     D +  + K
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  141 bits (356), Expect = 3e-40
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 29/242 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 124 KH----------CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
                         F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISK 132

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNISYI 228
           Q+   L Y+H   G+ H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 282
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 283 VI 284
           ++
Sbjct: 250 LL 251

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (349), Expect = 3e-39
 Identities = 52/229 (22%), Positives = 97/229 (42%), Gaps = 20/229 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F   +    +                +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSFKDNSNLYMVM--------EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           + + + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I    
Sbjct: 159 S-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
            Y  A+D W+ G ++ E+  G P F  +  +    +I+   +      S
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 8e-39
 Identities = 48/222 (21%), Positives = 88/222 (39%), Gaps = 17/222 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    ++ +Y  ++ EY+                ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIY--IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 241
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 242 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
              +T   D+WS G +L E++  G+  +PG +  + +  + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-37
 Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 24/226 (10%)

Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 120
             +G GSFGVV + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L     +        + +V E  P     ++    K      L  +  Y  Q+   + 
Sbjct: 74  IRLYGVVLTP------PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 237
           Y+ +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +     
Sbjct: 126 YLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
                  ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (329), Expect = 8e-37
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 25/232 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVL-----QDKRYKNRELQTMRLLDH 117
               E+V+G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PNV+ L+      T+   +   ++ E++            +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------ 231
            + Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
            + APE I    ++T+A D+WS G V+ E++  G+  +   +  D +  I +
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 9e-37
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 17/219 (7%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 ++ +Y+  V EY+ +          +  + + L  +     QI   +AY+   +
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 244
              HRD++  N+LV  +    K+ DFG A+++   E            + APE       
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 245 YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
           +T   D+WS G +L EL   G+  +PG    + L ++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 9e-37
 Identities = 48/218 (22%), Positives = 95/218 (43%), Gaps = 17/218 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T++  ++  ++ EY+         +  +M  R     +      +C A+ Y+ +   
Sbjct: 69  ---TKQRPIF--IITEYMANGCLL--NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-Q 120

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 245
             HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 246 TAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
           ++  DIW+ G ++ E+  LG+  +   +  +    I +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 9e-37
 Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 25/240 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKV--------LQDKRYKNRELQTMRLL 115
           +   +V+G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 116 DH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
              P +V+L + F     + E  L+L+L+Y+       +  H    +R     V++Y  +
Sbjct: 86  RQSPFLVTLHYAF-----QTETKLHLILDYIN---GGELFTHLSQRERFTEHEVQIYVGE 137

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SR 231
           I  AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y       
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISL 291
           Y     +  G + +  A+D WS G ++ ELL G   F  +   +   EI + IL +E   
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 3e-36
 Identities = 45/229 (19%), Positives = 90/229 (39%), Gaps = 14/229 (6%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               T +   Y+    E++               Q +  + +     QI  A+ Y+    
Sbjct: 82  C---TREPPFYII--TEFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 244
              HRD+  +N LV  + H +K+ DFG ++++                + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLSI 293
           ++   D+W+ G +L E+            + Q+ E+++     E     
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 241

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-36
 Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 43/248 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKN-----RELQTM-RLLDHP 118
            +V+G G+FG V  A      +      VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------------- 158
           N+V+L       T    +Y  L+ EY     +   ++   +                   
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214

Query: 219 VKGEPNISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
           +     +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 275 DQLVEIIK 282
               ++I+
Sbjct: 274 ANFYKLIQ 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 6e-36
 Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 25/225 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L     ++T      + L+ + +P     ++ +  +    +   Y+  +  QI + + Y
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 238
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
           I     YT   D+WS G  + EL+  G   + G     ++  I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILE 227

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 7e-36
 Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 16/217 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           + +G G FG+V         + VAIK + +    +     E + M  L HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
               E+  + L  V E++         +            +      +C  +AY+     
Sbjct: 70  ---LEQAPICL--VFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 245
           V HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           ++  D+WS G ++ E+     +        ++VE I 
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 8e-35
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 23/225 (10%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVS 122
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +V 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        + + L   LV+E          K      + +P+  V    +Q+   + Y+
Sbjct: 74  LIGVC----QAEALM--LVMEMAGGGPLH--KFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 238
                  HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE 
Sbjct: 126 EEK-NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
           I    ++++  D+WS G  + E L  GQ  +    G + +  I +
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 9e-35
 Identities = 47/226 (20%), Positives = 92/226 (40%), Gaps = 25/226 (11%)

Query: 70  ERVVGHGSFGVVFQAKC--LETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
           ++ +G G+FG V +      +  + VA+K +  +            E   M+ LD+P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +        E +     LV+E         +  + + ++ +    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 237
           +  +    HRD+  +N+L+    H  K+ DFG +K L   E              + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
            I    ++++  D+WS G ++ E    GQ  + G  G +    + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-34
 Identities = 48/227 (21%), Positives = 93/227 (40%), Gaps = 23/227 (10%)

Query: 70  ERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K + +            E   M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           SL         + E    +VL Y+     R        +    +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 236
           + +     HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
           E +    ++T   D+WS G +L EL+  G P +P  +  D  V +++
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-34
 Identities = 44/228 (19%), Positives = 84/228 (36%), Gaps = 30/228 (13%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 122
           + + +  +G G FG V++ K    GE VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                 +        L LV +Y    ++   +  +      + +  +          LA+
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115

Query: 182 IHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YIC 229
           +H  I        + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 230 SRYYRAPELIFGA-----TEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           ++ Y APE++  +      E     DI++ G V  E+     +     
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-33
 Identities = 48/241 (19%), Positives = 88/241 (36%), Gaps = 23/241 (9%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLD 116
               ++V+G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           H N++ L+             + ++ EY+        K   +      ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC----SRY 232
             + Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS 292
           + APE I      +A+ D+WS G V+ E++        E    ++++ I         + 
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 293 I 293
            
Sbjct: 238 C 238

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (301), Expect = 8e-33
 Identities = 50/247 (20%), Positives = 87/247 (35%), Gaps = 43/247 (17%)

Query: 71  RVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           R +G G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP---------------------ETVHRVIKHHYKM 159
           V              + L  + EY+                        +    +     
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 219
              +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191

Query: 220 KGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
             +      +      +  PE IF    YT   D+W+ G VL E+   G   + G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 276 QLVEIIK 282
            +  +  
Sbjct: 251 VIYYVRD 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 9e-33
 Identities = 55/243 (22%), Positives = 96/243 (39%), Gaps = 38/243 (15%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKN-----RELQTM-RLLDHP 118
            + +G G+FG V +A        +    VA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM--------------SQRM 163
           N+V+L       T        ++ EY     +   ++                      +
Sbjct: 88  NIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            L  +  + YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200

Query: 224 NISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
            +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 280 IIK 282
           +IK
Sbjct: 260 MIK 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 9e-33
 Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 29/234 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE--AVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYV 168
           +L             YL L +EY P   +   ++    +            +  +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
               + A E +   + YT   D+WS G +L E++             +L E + 
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-32
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 22/227 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHP 118
               R +G G FG V Q   +       AVAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++V L           E  + +++E       R           + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 236
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
           E I     +T+A D+W  G  + E+L+ G   F G    D +  I  
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-31
 Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 39/246 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN-----RELQTM-R 113
            +  + +G G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS------------ 160
           +  H N+++L       T+   LY+  ++EY  +  +   ++                  
Sbjct: 75  IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 221 GEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQ 276
            +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 277 LVEIIK 282
           L +++K
Sbjct: 246 LFKLLK 251

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 6e-29
 Identities = 48/244 (19%), Positives = 93/244 (38%), Gaps = 35/244 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD------KRYKNRELQTMRLL 115
               + +G G+FG V +A         T   VA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-------------SQR 162
            H NVV+L              L +++E+             +                 
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 223 PNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLV 278
             +          + APE IF    YT   D+WS G +L E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 279 EIIK 282
             +K
Sbjct: 248 RRLK 251

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 8e-28
 Identities = 45/234 (19%), Positives = 92/234 (39%), Gaps = 29/234 (12%)

Query: 70  ERVVGHGSFGVVFQAKC-----LETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +G GSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLI------YVKLYF 172
           VV         ++       +++E +    +   ++         P++       +    
Sbjct: 85  VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--- 229
            +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
              + +PE +     +T   D+WS G VL E+  L +  + G S    L  +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 3e-19
 Identities = 30/204 (14%), Positives = 56/204 (27%), Gaps = 32/204 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------------LQDKRYKNRELQTMRLLD 116
           +++G G    VF     E      +K                     + +         +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
              +  L+               +++E              K   R+ +         I 
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             +A  ++   + H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 237 ELIFGATEYTAAIDIWSAGCVLAE 260
              F    Y    DI SA   + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	296
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.26
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.07
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.31
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.12
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.38

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-53  Score=354.36  Aligned_cols=210  Identities=30%  Similarity=0.488  Sum_probs=180.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .++|++.+.||+|+||+||+|++..+++.||+|++...       .....+|+++++.++||||+++++++.     +..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence            35799999999999999999999999999999988532       223458999999999999999999984     444


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+++|||||+ |+|.+.+..    ..++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCC-CEeeccccee
Confidence            5899999998 577777765    36799999999999999999999998 999999999999999887 7999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ...... ......||+.|||||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.-..
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~  222 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT  222 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            765433 344567999999999997654 899999999999999999999999998877777776654433

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=354.91  Aligned_cols=201  Identities=30%  Similarity=0.403  Sum_probs=171.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++...     .....+|+++++.++||||+++++++..     ...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            35799999999999999999999999999999988532     2345689999999999999999999843     3458


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++|||||++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCC-CEEEccchhhee
Confidence            899999985 77666543    46799999999999999999999998 999999999999999887 799999999987


Q ss_pred             eccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022520          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (296)
Q Consensus       218 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  275 (296)
                      .....   ......||+.|||||++.+...++.++|||||||++|+|++|++||...+...
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~  213 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC  213 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence            64332   23456799999999999776656788999999999999999999998765433

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=360.32  Aligned_cols=222  Identities=72%  Similarity=1.197  Sum_probs=198.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHHhcCCCCceecceeeeeccC-CCceEEEEEEe
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLE  143 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~iv~e  143 (296)
                      .+|+..++||+|+||+||+|++..+|+.||||++........+|+++|+.++|+||++++++|..... .+..++++|||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            47999999999999999999999999999999998777777799999999999999999999876543 45567899999


Q ss_pred             cccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCCC
Q 022520          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (296)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~  223 (296)
                      ||++++...+.........+++..++.+++||+.||+|||++ ||+||||||+|||++.++..+||+|||++........
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            999988888777666677899999999999999999999998 9999999999999998766899999999988766666


Q ss_pred             cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       224 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      .....||+.|+|||.+.+...++.++|||||||++|||++|++||...+..+.+..+.+.++.+
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~  242 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  242 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            6778899999999998777779999999999999999999999999999989999888876654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-52  Score=354.41  Aligned_cols=210  Identities=31%  Similarity=0.534  Sum_probs=177.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ++|++.+.||+|+||+||+|++..+++.||||++...       .....+|++++++++||||++++++|     .+...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            5799999999999999999999999999999998532       12356899999999999999999998     34455


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++|||||++ +|.+++..    .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCc-eEEecccccce
Confidence            8999999985 77776665    36899999999999999999999998 999999999999999887 79999999998


Q ss_pred             eeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       217 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      ......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+.++.+.-..
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~  228 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD  228 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred             ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC
Confidence            764332   223457999999999997655 899999999999999999999999998877777777665433

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=353.60  Aligned_cols=206  Identities=27%  Similarity=0.446  Sum_probs=177.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .+|++.+.||+|+||+||+|++..+|+.||+|++...    .+...+|+++++.++||||++++++|..     ...+++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            3799999999999999999999999999999998532    2345689999999999999999999844     334889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |||||++ +|.+++..     .++++..++.+++||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus        95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCC-cEeeccchhheeec
Confidence            9999985 66555433     5799999999999999999999998 999999999999999887 89999999998765


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~  231 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN  231 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred             cccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence            443 345567999999999997654 899999999999999999999999998877777666654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-52  Score=351.32  Aligned_cols=213  Identities=28%  Similarity=0.413  Sum_probs=171.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|.+....      ..+.+|+++++.++|||||++++++.+..   ...+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence            57999999999999999999999999999999985432      23457999999999999999999885422   2337


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC-----ceeccCCCCceEEcCCCCcEEEeee
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-----iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      ++|||||+ |+|.+++.........+++..++.++.||+.||.|||++ +     |+||||||+|||++.++ .+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTS-CEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence            89999998 588888877766678899999999999999999999987 6     99999999999999887 8999999


Q ss_pred             cceeeeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          213 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       213 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      |+++...... ......||+.|||||++.+.. ++.++|||||||++|||++|++||.+.+..+....+.+.
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~  229 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG  229 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            9998764433 234567899999999996544 899999999999999999999999998876666666553

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=356.46  Aligned_cols=216  Identities=25%  Similarity=0.372  Sum_probs=183.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ++|++++.||+|+||.||+|+++.+++.||+|++...       .....+|+.+|+.++||||++++++|     .+...
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence            4799999999999999999999999999999998532       12345799999999999999999999     44556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++|||||++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g-~vkl~DFG~a~  153 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCC-CEEEeeccccc
Confidence            8999999995 66666655    37899999999999999999999999 999999999999999887 89999999998


Q ss_pred             eeccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          217 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       217 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      ..... .......||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+....+...-...+...|
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s  229 (337)
T d1o6la_         154 EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS  229 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCC
Confidence            65443 3345578999999999997655 899999999999999999999999998877766666665444443343

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-51  Score=353.25  Aligned_cols=213  Identities=27%  Similarity=0.418  Sum_probs=167.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      .+.|++.+.||+|+||+||+|++..+++.||||++...     .....+|+++|+.++||||+++++++     .+...+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            35699999999999999999999999999999998532     22345899999999999999999998     344558


Q ss_pred             EEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC--CCCcEEEeeecce
Q 022520          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSA  215 (296)
Q Consensus       139 ~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~--~~~~ikl~Dfg~~  215 (296)
                      ++|||||+ ++|.+.+..    ..++++..+..++.||+.||.|||++ ||+||||||+|||+..  +.+.+||+|||++
T Consensus        83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEecccee
Confidence            99999998 588887765    46899999999999999999999998 9999999999999953  2337999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      +............||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+....+.+.-...
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~  228 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF  228 (307)
T ss_dssp             ---------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC
Confidence            8776665556678999999999996654 8999999999999999999999999988777777777654443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-51  Score=352.70  Aligned_cols=214  Identities=26%  Similarity=0.475  Sum_probs=181.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+.+++.++||||+++++++.     +...
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4799999999999999999999999999999998532       223458999999999999999999984     4455


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++|||||+| ++...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCC-CEEEecCccce
Confidence            8999999996 44444444    46789999999999999999999998 999999999999999887 89999999998


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      .....  .....||+.|||||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+.+.-...+..+|
T Consensus       153 ~~~~~--~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  225 (316)
T d1fota_         153 YVPDV--TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN  225 (316)
T ss_dssp             ECSSC--BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred             Eeccc--cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCC
Confidence            76433  34568999999999996654 899999999999999999999999998887777777765444443333

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-51  Score=349.17  Aligned_cols=209  Identities=27%  Similarity=0.401  Sum_probs=177.6

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      +.|++.+.||+|+||+||+|++..+++.||+|++...    .+...+|+++|+.++|||||++++++..     ...+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            4699999999999999999999999999999998543    2345689999999999999999999843     334889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      |||||++ +|..++...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999985 666655543   46799999999999999999999998 999999999999999887 89999999997653


Q ss_pred             cCC-CcccccccccccCCccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          220 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ... ......||+.|+|||++..    ...|+.++|||||||++|+|++|++||.+.+..+.+.++.+.
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~  230 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS  230 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            322 1234678999999999842    344789999999999999999999999998888887777764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-51  Score=342.87  Aligned_cols=206  Identities=23%  Similarity=0.369  Sum_probs=172.1

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      |++.++||+|+||+||+|++..+++.||+|.+....      ..+.+|+++|+.++|||||+++++|.... .+...+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            578889999999999999999999999999885432      23458999999999999999999885543 34566889


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCC--ceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |||||++ +|.+++...    ..+++..++.++.||+.||+|||++ +  |+||||||+|||++.+.+.+||+|||+++.
T Consensus        90 vmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999985 777777653    6799999999999999999999998 8  999999999999975433899999999975


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  281 (296)
                      . .........||+.|||||++.+  .++.++|||||||++|+|++|+.||.+..+...+.+..
T Consensus       165 ~-~~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i  225 (270)
T d1t4ha_         165 K-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV  225 (270)
T ss_dssp             C-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred             c-cCCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH
Confidence            3 2333456789999999999854  38999999999999999999999998776655554433

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-50  Score=349.01  Aligned_cols=208  Identities=29%  Similarity=0.495  Sum_probs=177.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ..|++.+.||+|+||+||+|++..+++.||||++....       ....+|+++|+.++|||||++++++..     ...
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            35999999999999999999999999999999985432       234579999999999999999999844     334


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +++|||||.++++..+...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        90 ~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCC-CEEEeecccccc
Confidence            8899999997766544433   47899999999999999999999998 999999999999999887 899999999976


Q ss_pred             eccCCCcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ...   .....||+.|||||++.+.  ..|+.++|||||||++|||++|+.||.+.+..+.+..+.+...
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~  231 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  231 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            433   3456799999999998642  3488999999999999999999999999887777777766543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=344.05  Aligned_cols=212  Identities=24%  Similarity=0.392  Sum_probs=183.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----------chhhHHHHHHHHhcCCCCceecceeeeeccC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (296)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++...          ...+.+|+++|+.++|||||+++++|     
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----   82 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----   82 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            345799999999999999999999999999999998532          12356899999999999999999998     


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC---cEE
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~---~ik  208 (296)
                      .+...+++|||||+ |+|.+++...    .++++..++.++.|++.||.|||++ +|+||||||+|||++.++.   .+|
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceE
Confidence            44455899999998 5777777653    6799999999999999999999998 9999999999999987653   599


Q ss_pred             EeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       209 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      |+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.-.
T Consensus       158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~  233 (293)
T d1jksa_         158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY  233 (293)
T ss_dssp             ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred             ecchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence            9999999887666666677889999999999654 489999999999999999999999999887777777666443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-50  Score=354.45  Aligned_cols=214  Identities=26%  Similarity=0.387  Sum_probs=183.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++....    ....+|+.+|+.++|||||+++++|.     +...++
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            357999999999999999999999999999999985432    23457999999999999999999983     445589


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcC-CCCcEEEeeecceee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  217 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~-~~~~ikl~Dfg~~~~  217 (296)
                      +|||||++ +|.+.+...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++. +.+.+||+|||++..
T Consensus       103 ivmE~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeeccccee
Confidence            99999995 665554432   45799999999999999999999998 9999999999999973 234899999999998


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ...........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.....
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  247 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF  247 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            87766666778999999999996654 8999999999999999999999999998888888877755443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.7e-51  Score=354.87  Aligned_cols=213  Identities=26%  Similarity=0.421  Sum_probs=183.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....    ....+|+.+|+.++|||||+++++|..     ...+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            47999999999999999999999999999999985432    234589999999999999999999843     344899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC-CCcEEEeeecceeee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~-~~~ikl~Dfg~~~~~  218 (296)
                      |||||++ +|.+.+...   ..++++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+++..
T Consensus       101 vmE~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999985 777766432   36799999999999999999999998 99999999999999643 337999999999987


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ..........||+.|||||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.....
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  244 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM  244 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS
T ss_pred             ccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            7666666788999999999997655 8999999999999999999999999988888888877665443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-50  Score=351.09  Aligned_cols=215  Identities=27%  Similarity=0.429  Sum_probs=183.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .++|++++.||+|+||.||+|+++.+|+.||||++....       ....+|+.+|+.++||||++++++|     .+..
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence            468999999999999999999999999999999985321       2345899999999999999999998     3444


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..++||||+.+ ++...+...    ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g-~ikL~DFG~a  188 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCC-CEEeeeceee
Confidence            58899999985 666666553    6799999999999999999999998 999999999999999887 8999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCcccc
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEISLS  292 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  292 (296)
                      +.....  .....||+.|||||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.....+...|
T Consensus       189 ~~~~~~--~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  262 (350)
T d1rdqe_         189 KRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             EECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCC
T ss_pred             eecccc--cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCC
Confidence            876433  34568999999999997655 899999999999999999999999998887777777776555444443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-51  Score=353.05  Aligned_cols=198  Identities=28%  Similarity=0.497  Sum_probs=170.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++....     ....+|+.+|+.++|||||+++++|.     +...
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence            3468999999999999999999999999999999985432     23458999999999999999999994     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-cCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       138 ~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      +++|||||++ +|.+++...    ..+++..++.++.|++.||.|||+ + ||+||||||+|||++.++ .+||+|||+|
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla  152 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRG-EIKLCDFGVS  152 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH-CCCCSCCSGGGEEECTTC-CEEECCCCCC
T ss_pred             EEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC-CEEccccCHHHeeECCCC-CEEEeeCCCc
Confidence            8999999995 777777653    679999999999999999999996 6 899999999999999887 8999999999


Q ss_pred             eeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022520          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (296)
Q Consensus       216 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  273 (296)
                      +..... ...+..||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+.
T Consensus       153 ~~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         153 GQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             HHHHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             cccCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            866443 234568999999999997755 89999999999999999999999987654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=340.75  Aligned_cols=214  Identities=36%  Similarity=0.673  Sum_probs=185.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++|++++.||+|+||+||+|++..+|+.||+|++...      .....+|+++|+.++|||||+++++|..     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            4799999999999999999999999999999998432      2344589999999999999999999943     3448


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      ++||||+.+++...+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 ~iv~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccC-cceeccCCcceec
Confidence            9999999998777765543  46799999999999999999999998 999999999999999887 8999999999765


Q ss_pred             ccC-CCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ... .......||+.|+|||.+.....++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~  222 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP  222 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            433 233455789999999998777767899999999999999999999999999888888888776654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=338.99  Aligned_cols=219  Identities=36%  Similarity=0.602  Sum_probs=187.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCC-CcEEEEEEEeec------chhhHHHHHHHHhc---CCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~------~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~  133 (296)
                      ..+|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999755 678999988532      22344788887766   799999999998766656


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       134 ~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      .....+++|||+++++........  ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCC-Ceeecchh
Confidence            677889999999988766554432  56799999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ++.............||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.+.++.+
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            988765555556778999999999997655 8999999999999999999999999999999999988877654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=343.34  Aligned_cols=210  Identities=36%  Similarity=0.643  Sum_probs=179.0

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        69 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+++||+|+||+||+|++..+|+.||||++....         ....+|+.+++.++|||||++++++.     ....++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence            4689999999999999999999999999884321         23458999999999999999999984     334488


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +||||+.+++...+..   ....+++..++.+++||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        77 ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCC-ccccccCccccccC
Confidence            9999999876665543   246799999999999999999999998 999999999999999887 89999999997654


Q ss_pred             cCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       220 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ... ......||+.|+|||++.....|+.++|||||||++|||++|.+||.+.+..+.+..+.+.++.+.
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~  221 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT  221 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC
Confidence            433 334567899999999987766789999999999999999999999999999999999998876654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.6e-49  Score=332.13  Aligned_cols=211  Identities=24%  Similarity=0.391  Sum_probs=182.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------------hhhHHHHHHHHhcC-CCCceecceeeeec
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFFST  130 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~~~  130 (296)
                      ++|++.+.||+|+||+||+|++..+++.||||++....             ....+|+.++++++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            57999999999999999999999999999999985321             12447999999997 99999999998   


Q ss_pred             cCCCceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEE
Q 022520          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (296)
Q Consensus       131 ~~~~~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl  209 (296)
                        .+...+++|||||+ ++|.+++..    ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCC-CeEE
Confidence              34455899999998 588888865    36799999999999999999999998 999999999999999887 8999


Q ss_pred             eeecceeeeccCCCcccccccccccCCccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       210 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      +|||+++............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999998766666667789999999999852     3347889999999999999999999999988877777777654


Q ss_pred             cC
Q 022520          285 LH  286 (296)
Q Consensus       285 ~~  286 (296)
                      ..
T Consensus       232 ~~  233 (277)
T d1phka_         232 YQ  233 (277)
T ss_dssp             CC
T ss_pred             CC
Confidence            33

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=340.60  Aligned_cols=207  Identities=28%  Similarity=0.492  Sum_probs=174.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHH-hcCCCCceecceeeeeccCCCce
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMR-LLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      ++|++.+.||+|+||+||+|++..+++.||||++..+.       .....|..++. .++||||+++++++.     +..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence            47999999999999999999999999999999985321       12235666554 689999999999983     444


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      .+|+|||||++ +|..++..    ..++++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCC-ceeccccchh
Confidence            58999999985 77777765    36799999999999999999999999 999999999999999887 8999999999


Q ss_pred             eeeccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 022520          216 KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       216 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  283 (296)
                      +...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~  218 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD  218 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            8654333 334467899999999997655 899999999999999999999999998877766666543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.5e-49  Score=332.89  Aligned_cols=215  Identities=28%  Similarity=0.430  Sum_probs=173.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHHHHHHHHhcCCCCceecceeeeeccCCCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (296)
                      .++|++.+.||+|+||+||+|++..+++.||||++....       ..+.+|+++++.++||||+++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            457999999999999999999999999999999985321       23458999999999999999999886544 3345


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecce
Q 022520          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (296)
Q Consensus       137 ~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~  215 (296)
                      ..|+|||||+| +|...+..    .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~-~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccc-cceeehhhhh
Confidence            67899999995 56655554    36899999999999999999999998 999999999999999887 7999999998


Q ss_pred             eeeccCC----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC
Q 022520          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILH  286 (296)
Q Consensus       216 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  286 (296)
                      .......    ......||+.|+|||++.+.. ++.++|||||||++|+|+||++||.+.+..+.+.++.+.-..
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC
Confidence            6543322    234457899999999986554 899999999999999999999999998877777766665433

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-49  Score=339.55  Aligned_cols=217  Identities=20%  Similarity=0.299  Sum_probs=177.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ...+|++.+.||+|+||+||+|++..+++.||||++..+   .+.+.+|+++|+.++|||||++++++..     ...++
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeE
Confidence            445899999999999999999999999999999998543   3345689999999999999999999843     33378


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|||||+ |++...+....  ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus        90 iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCC-cEEEccccceeec
Confidence            9999998 57777776532  46789999999999999999999998 999999999999999887 8999999999865


Q ss_pred             ccCCCc--ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCc
Q 022520          219 VKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       219 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      ......  ....||+.|+|||++.+.. ++.++|||||||++|||++|..||....+...+.+++.....++.
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~  237 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER  237 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            443322  2345788999999986655 899999999999999999977665554455555555554444444

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=343.96  Aligned_cols=215  Identities=27%  Similarity=0.359  Sum_probs=174.5

Q ss_pred             ccceEEee-eeeecCceEEEEEEEcCCCcEEEEEEEeecchhhHHHHHHHH-hcCCCCceecceeeeeccCCCceEEEEE
Q 022520           64 TISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-LLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        64 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .++|.+.. .||+|+||+||+|++..+++.||||++.. .....+|++++. .++|||||+++++|.... ....++|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence            45798875 69999999999999999999999998854 455678998865 458999999999885432 235668999


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC--CcEEEeeecceeee
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  218 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~--~~ikl~Dfg~~~~~  218 (296)
                      ||||+ |+|.+++...  ...++++.+++.++.||+.||+|||++ ||+||||||+|||++.+.  ..+||+|||+++..
T Consensus        88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeec
Confidence            99998 5888887653  135799999999999999999999998 999999999999998632  36999999999887


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      ..........||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+....+...+
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i  229 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  229 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred             cCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence            7766667788999999999986544 8999999999999999999999998766544444444433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=341.19  Aligned_cols=214  Identities=23%  Similarity=0.395  Sum_probs=182.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .++|++.+.||+|+||+||+|++..+++.||+|.+....   ....+|+++|+.++|||||+++++|.     +...+|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            457999999999999999999999999999999986443   23458999999999999999999984     3345899


Q ss_pred             EEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC-CCcEEEeeecceeee
Q 022520          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (296)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~-~~~ikl~Dfg~~~~~  218 (296)
                      |||||+| +|.+.+...   ..++++.+++.++.||+.||.|||++ ||+||||||+|||++.+ ...++|+|||++...
T Consensus        79 vmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999995 777776542   34799999999999999999999998 99999999999999753 337999999999877


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ..........+|+.|+|||.+.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+.-...
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~  222 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF  222 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred             ccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            5555556677899999999986554 8999999999999999999999999998877777777654433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.7e-49  Score=346.05  Aligned_cols=198  Identities=25%  Similarity=0.423  Sum_probs=168.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-------hhhHH---HHHHHHhcCCCCceecceeeeeccCCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....       ....+   |+.+++.++|||||+++++|.     +
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence            47999999999999999999999999999999985321       11223   456667778999999999983     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      ...+++|||||+ ++|...+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g-~iKl~DFG  152 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLG  152 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCC-cEEEeeec
Confidence            445889999998 5777777653    6789999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 022520          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (296)
Q Consensus       214 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  274 (296)
                      +|+..... ......||+.|+|||++.....|+.++|||||||++|+|++|+.||.+.+..
T Consensus       153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~  212 (364)
T d1omwa3         153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  212 (364)
T ss_dssp             TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred             eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence            99876443 3445679999999999976666899999999999999999999999876543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-49  Score=332.67  Aligned_cols=208  Identities=23%  Similarity=0.318  Sum_probs=167.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceE
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (296)
                      .++|++.+.||+|+||+||+|++.   ..||||++...      ...+.+|++++++++|||||++++++..      ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            457999999999999999999752   35999988532      1344589999999999999999887521      12


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       138 ~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      +++|||||+ |+|.+++...   ..++++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            679999999 5777777543   36799999999999999999999998 999999999999999887 89999999997


Q ss_pred             eeccCC---CcccccccccccCCccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022520          217 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVIL  285 (296)
Q Consensus       217 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  285 (296)
                      ......   ......||+.|||||++.+.  ..++.++|||||||++|||+||+.||.+.+..+.+........
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~  226 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY  226 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence            654322   22345789999999998643  2478999999999999999999999999887777665555443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-48  Score=333.83  Aligned_cols=209  Identities=25%  Similarity=0.394  Sum_probs=161.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCc---EEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..+|++.+.||+|+||+||+|++..+++   .||+|.+...     .+.+.+|+++|++++|||||++++++...     
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            3579999999999999999999876654   5888887432     22456899999999999999999998433     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ..+++|||||++ +|.+++...   ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  174 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNL-VCKVSDFGL  174 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CEEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCC-cEEECCccc
Confidence            337899999995 566655543   35799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCCCc------ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          215 AKVLVKGEPN------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       215 ~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ++........      ....+|+.|||||.+.+.. ++.++|||||||++|||+| |++||.+.+..+.+..+.+.
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~  249 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD  249 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9876443221      2235689999999986554 8999999999999999998 89999998876666665543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=336.87  Aligned_cols=220  Identities=23%  Similarity=0.379  Sum_probs=177.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCc-----EEEEEEEeec-----chhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ..++|++.+.||+|+||+||+|++...++     .||+|.+...     ...+.+|+.++.++ +|||||++++++..  
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence            34589999999999999999999865543     6999987432     22345799999888 89999999999843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceec
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK-------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~  191 (296)
                         ....++|||||+ |+|.+++.....                   ....+++..++.++.|++.||.|||++ +|+||
T Consensus       113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHR  188 (325)
T d1rjba_         113 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHR  188 (325)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred             ---CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-Ceeec
Confidence               334789999998 588888765431                   124588999999999999999999998 99999


Q ss_pred             cCCCCceEEcCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 022520          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  267 (296)
Q Consensus       192 Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~p  267 (296)
                      ||||+|||++.++ .+||+|||+|+........   ....||+.|||||++.+.. ++.++|||||||++|||+| |++|
T Consensus       189 DlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         189 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCC
Confidence            9999999999887 8999999999876554432   2345799999999986554 8999999999999999997 8999


Q ss_pred             CCCCChHHHHHHHHHhhcCCCcc
Q 022520          268 FPGESGVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~  290 (296)
                      |.+.+..+.+.++++...+++.+
T Consensus       267 f~~~~~~~~~~~~~~~~~~~~~p  289 (325)
T d1rjba_         267 YPGIPVDANFYKLIQNGFKMDQP  289 (325)
T ss_dssp             STTCCCSHHHHHHHHTTCCCCCC
T ss_pred             CCCCCHHHHHHHHHhcCCCCCCC
Confidence            99887777777777766555543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-48  Score=325.81  Aligned_cols=206  Identities=22%  Similarity=0.381  Sum_probs=161.7

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.+.||+|+||+||+|++. ++..||||++...   .+.+.+|+++++.++|||||++++++...     ...++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEE
Confidence            46999999999999999999975 5678999998643   34456899999999999999999998433     237899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      ||||+ |+|.+++...   ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus        79 ~E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred             EEecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCC-CeEecccchheeccC
Confidence            99998 5677766543   36788999999999999999999998 999999999999999887 899999999986644


Q ss_pred             CCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          221 GEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       221 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...  .....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+.+..+.+
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~  217 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST  217 (263)
T ss_dssp             -----------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH
T ss_pred             CCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh
Confidence            332  23356799999999996655 8999999999999999999 5677777666555555544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=328.03  Aligned_cols=196  Identities=27%  Similarity=0.417  Sum_probs=167.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----------hhhHHHHHHHHhcC--CCCceecceeeeeccC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTE  132 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  132 (296)
                      ++|++.+.||+|+||+||+|++..+++.||||++....          ....+|+.++++++  ||||++++++|.    
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~----   79 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE----   79 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence            47999999999999999999999999999999885321          22458999999986  899999999983    


Q ss_pred             CCceEEEEEEecccc--cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          133 KDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       133 ~~~~~~~iv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                       +....++||||+.+  ++.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+.+.+||+
T Consensus        80 -~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          80 -RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             -CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             -eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEEC
Confidence             34458899999974  55556554    36799999999999999999999998 999999999999999765589999


Q ss_pred             eecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022520          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  271 (296)
Q Consensus       211 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  271 (296)
                      |||++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.
T Consensus       154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence            9999976533 33456789999999999977665678899999999999999999999763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=325.05  Aligned_cols=208  Identities=23%  Similarity=0.350  Sum_probs=168.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ...+|++.+.||+|+||.||+|++. ++..||||++...   .+.+.+|++++++++|||||++++++..    +  ..+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~--~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----C--CeE
Confidence            4468999999999999999999974 5778999998643   3345689999999999999999997632    1  157


Q ss_pred             EEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +|||||++ +|.+.+....  ..++++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus        84 iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~  159 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeeccc-ceeeccccceEEc
Confidence            89999985 6666554332  34689999999999999999999998 999999999999999887 8999999999876


Q ss_pred             ccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 022520          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       219 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~~~~~~~~  282 (296)
                      ....  ......||+.|||||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+.+
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~  225 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER  225 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             cCCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            4433  223456789999999986554 89999999999999999995 566666665555555544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-47  Score=327.74  Aligned_cols=213  Identities=34%  Similarity=0.629  Sum_probs=180.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++|++.++||+|+||+||+|++. +++.||||++...      .....+|+.+|+.++||||++++++|...     ...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            47999999999999999999985 7799999998543      23455899999999999999999998543     338


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +++|+++.++++..+...   ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||.+...
T Consensus        76 ~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            899999999877777654   47899999999999999999999998 999999999999999887 8999999998765


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      .... ......+++.|+|||.+.+...++.++|||||||++|||++|++||.+.+..+.+.++.+.++.+.
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN  221 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence            4332 234456899999999997777789999999999999999999999999998888888888776653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=333.78  Aligned_cols=216  Identities=36%  Similarity=0.627  Sum_probs=179.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCce
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (296)
                      ..+|++++.||+|+||+||+|++..+|+.||||++....      ....+|+++|+.++|||||+++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357999999999999999999999999999999985321      234579999999999999999999865432 2334


Q ss_pred             EEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeeccee
Q 022520          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (296)
Q Consensus       137 ~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~  216 (296)
                      .+++|||||+.++......     .++++..++.+++||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhccccc-cccccccccee
Confidence            5789999998777766543     6799999999999999999999998 999999999999999888 89999999998


Q ss_pred             eeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       217 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ....  ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.++
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            7533  344567899999999998777789999999999999999999999999998888888887776654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-47  Score=330.38  Aligned_cols=216  Identities=34%  Similarity=0.601  Sum_probs=180.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      .+|++++.||+|+||+||+|++..+|+.||||++....     ....+|+.+|+.++||||+++++++..........++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46999999999999999999999999999999985332     2345799999999999999999998655444445567


Q ss_pred             EEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeec
Q 022520          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (296)
Q Consensus       140 iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~  219 (296)
                      +++++++++|.+++..     .++++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence            7887777899888864     5799999999999999999999998 999999999999999887 89999999998764


Q ss_pred             cCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          220 KGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       220 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ....    .....||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+........+..+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence            4322    2345689999999998666668999999999999999999999999988877777776655444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=326.73  Aligned_cols=220  Identities=30%  Similarity=0.535  Sum_probs=182.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC---CC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  134 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  134 (296)
                      .++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+++|+.++|+||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            468999999999999999999999999999999874321      234589999999999999999998854322   12


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       135 ~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...+++||||+++++.......   ...+++..++.+++|++.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCC-cEEeeecce
Confidence            3457899999998876655443   47899999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCC-----CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          215 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       215 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      +.......     ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.++.+.+..+.+.++.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            97653222     223456899999999998776789999999999999999999999999998888888888776654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=319.18  Aligned_cols=207  Identities=21%  Similarity=0.333  Sum_probs=173.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.++||+|+||+||+|++. ++..||||.+...   ...+.+|++++++++||||+++++++...     ..+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEE
Confidence            47999999999999999999984 7788999998643   34456899999999999999999988432     338899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeecc
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~  220 (296)
                      |||++ |++..++...   ...+++..+..++.|+++||.|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99998 5666665543   36788999999999999999999998 999999999999999887 899999999976544


Q ss_pred             CCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          221 GEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       221 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      ...  .....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+.
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~  217 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG  217 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             CCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC
Confidence            332  22356799999999986554 8999999999999999998 89999999877766666653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-47  Score=322.00  Aligned_cols=214  Identities=22%  Similarity=0.320  Sum_probs=161.0

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCC----cEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      ..|++.+.||+|+||.||+|.+..++    ..||||++....     ..+.+|+++++.++|||||++++++...     
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence            36999999999999999999987554    479999885322     2345899999999999999999988433     


Q ss_pred             eEEEEEEeccccc-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      ...++|||||.++ +...+...   ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  156 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFGL  156 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC
T ss_pred             CceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCC-eEEEcccch
Confidence            3378999999864 44444433   46799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhcCCCc
Q 022520          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       215 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~  289 (296)
                      ++.......    .....||+.|||||++.+. .++.++|||||||++|||++|. +||...+..+ +...+....+++.
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~~~~  234 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGFRLPT  234 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCC
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhccCCCCC
Confidence            987644322    2234578999999998655 4899999999999999999965 5555555444 4444443444444


Q ss_pred             c
Q 022520          290 S  290 (296)
Q Consensus       290 ~  290 (296)
                      +
T Consensus       235 ~  235 (283)
T d1mqba_         235 P  235 (283)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-47  Score=322.31  Aligned_cols=207  Identities=26%  Similarity=0.363  Sum_probs=169.1

Q ss_pred             ccceEEeee-eeecCceEEEEEEEcC--CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           64 TISYMAERV-VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        64 ~~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .++|.+.+. ||+|+||+||+|.+..  ++..||||++....     ..+.+|+++|+.++|||||++++++..    + 
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~-   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----E-   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----S-
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----C-
Confidence            357888885 9999999999998753  45689999985432     234589999999999999999998731    1 


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                       .+++|||||++ +|.+++...   ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGl  155 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGL  155 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -eEEEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCC-ceeeccchh
Confidence             16899999995 666665432   36799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCCC----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++.......    .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+..+.+
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~  227 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  227 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             hhcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            987644332    22345789999999986554 8999999999999999998 9999999887666555544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.5e-47  Score=328.86  Aligned_cols=210  Identities=31%  Similarity=0.551  Sum_probs=177.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec-chhhHHHHHHHHhcC-CCCceecceeeeeccCCCceEEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ++|+++++||+|+||+||+|++..+++.||||++... .....+|+++|+.++ ||||++++++|...   ....+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence            5799999999999999999999999999999998643 345568999999995 99999999988532   233478999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccCC
Q 022520          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (296)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~~  222 (296)
                      |||+++.+..      ..+.+++..++.+++||+.||+|||++ ||+||||||+|||++.++..++|+|||++.......
T Consensus       112 e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999653321      136799999999999999999999998 999999999999999777579999999998876666


Q ss_pred             CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhh
Q 022520          223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVI  284 (296)
Q Consensus       223 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~  284 (296)
                      ......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.... ..+....+.+.+
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~  247 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  247 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence            66777889999999998777778999999999999999999999997654 444555555544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=319.26  Aligned_cols=199  Identities=24%  Similarity=0.347  Sum_probs=162.3

Q ss_pred             eeeeecCceEEEEEEEc--CCCcEEEEEEEeec------chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           71 RVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        71 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ++||+|+||+||+|.+.  .+++.||||++...      .+.+.+|+++|++++|||||++++++..     .. .++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~-~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES-WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SS-EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CC-EEEEE
Confidence            47999999999999864  35678999988532      1235689999999999999999998721     11 57999


Q ss_pred             ecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeeeccC
Q 022520          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (296)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~~~~  221 (296)
                      |||++ +|.+++..    ..++++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus        87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  160 (277)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence            99985 67776654    46799999999999999999999998 999999999999999887 8999999999876443


Q ss_pred             CCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          222 EPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       222 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ...    ....||+.|||||++.+.. ++.++|||||||++|||++ |++||.+.+..+....+.+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~  225 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK  225 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             ccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc
Confidence            322    2346789999999986554 8999999999999999997 8999999887655555544

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=318.03  Aligned_cols=209  Identities=26%  Similarity=0.362  Sum_probs=163.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ...++|++.+.||+|+||+||+|++..+ ..||||++...   .+.+.+|+.++++++|||||++++++..     .. +
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~-~   86 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EP-I   86 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS-C
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CC-e
Confidence            3456899999999999999999998654 57999998543   3456689999999999999999998731     11 5


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++|||||++ ++...+....  ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~-~~kl~DfGla~~  162 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARL  162 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred             EEEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCC-cEEEcccchhhh
Confidence            789999995 5665554432  35799999999999999999999998 999999999999999887 899999999976


Q ss_pred             eccCC--CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 022520          218 LVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIK  282 (296)
Q Consensus       218 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~~~~  282 (296)
                      .....  ......||+.|+|||.+.... ++.++|||||||++|||++|. +||.+....+.+..+.+
T Consensus       163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~  229 (285)
T d1fmka3         163 IEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER  229 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             ccCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            54332  223456799999999996544 899999999999999999965 55566655555555544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=322.95  Aligned_cols=206  Identities=26%  Similarity=0.434  Sum_probs=164.2

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCc----EEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCc
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (296)
                      .+|++++.||+|+||+||+|.+..+|+    .||+|.+...     .+.+.+|++++++++|||||++++++...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            469999999999999999999987775    5888877432     23456899999999999999999988532     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecc
Q 022520          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (296)
Q Consensus       136 ~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~  214 (296)
                      . .+++++++. +++.+.+...   ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             C-eeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCC-CeEeecccc
Confidence            1 456677766 6777766654   46799999999999999999999998 999999999999999887 899999999


Q ss_pred             eeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022520          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (296)
Q Consensus       215 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  282 (296)
                      ++........   ....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.+
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~  228 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK  228 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH
T ss_pred             ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence            9876443322   2345799999999987654 8999999999999999998 7899998776554444433

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=325.27  Aligned_cols=214  Identities=31%  Similarity=0.547  Sum_probs=173.4

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      .+|+++++||+|+||+||+|++..+|+.||||++....      ....+|+.+|+.++||||++++++|..... +....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            47999999999999999999999999999999986432      234589999999999999999999854432 34567


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      +|+|||||.+++...+      ...+++..++.+++|++.||.|||++ ||+||||||+|||++.++ .++++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCcccccccccc-ceeeechhhhhc
Confidence            8999999999877655      25689999999999999999999998 999999999999999887 799999999887


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  287 (296)
                      ...........+|+.|+|||++.+. .+++++||||+||++|+|++|++||.+.+....+..+...+..+
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~  237 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_dssp             ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence            7666666677889999999999765 48999999999999999999999999998888888887766554

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=316.42  Aligned_cols=209  Identities=29%  Similarity=0.387  Sum_probs=161.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      ..++|++.+.||+|+||.||+|++..+   +..||+|.+...     ...+.+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----   79 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----   79 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            346899999999999999999998654   356888877432     2234589999999999999999998731     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                       ..+++||||+++ ++..++...   ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~-~~Kl~DfG  153 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFG  153 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC--
T ss_pred             -CeEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCC-cEEEccch
Confidence             126899999985 555555443   46789999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCC--cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 022520          214 SAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (296)
Q Consensus       214 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  283 (296)
                      +++.......  .....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+.+.
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~  225 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG  225 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             hheeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9986543322  23446789999999996554 8999999999999999998 89999998877777666553

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-45  Score=315.28  Aligned_cols=198  Identities=22%  Similarity=0.308  Sum_probs=167.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCC-CCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++| +|++.+++++.     .....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEE
Confidence            4799999999999999999999999999999987543  3446789999999976 89999888773     34457899


Q ss_pred             EecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC----CCcEEEeeecceee
Q 022520          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKV  217 (296)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~----~~~ikl~Dfg~~~~  217 (296)
                      |||++++|...+...   ...++...+..++.|++.||.|||++ ||+||||||+|||++.+    .+.++|+|||+++.
T Consensus        80 me~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999988877653   46799999999999999999999998 99999999999999742    33799999999987


Q ss_pred             eccCC--------CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      .....        ......||+.|||||++.+.. ++.++|||||||++|||++|+.||.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence            64332        123457899999999997654 8999999999999999999999998654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-45  Score=314.72  Aligned_cols=203  Identities=24%  Similarity=0.317  Sum_probs=166.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  142 (296)
                      ++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+++++.++|+|++..+..+..    .....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEEE
Confidence            3699999999999999999999999999999987543  3456789999999998877766554432    233478999


Q ss_pred             ecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCC--CCcEEEeeecceeeecc
Q 022520          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVK  220 (296)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~--~~~ikl~Dfg~~~~~~~  220 (296)
                      ||+++++...+...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++..  ...++|+|||+++....
T Consensus        83 e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999887766553   46899999999999999999999998 99999999999998642  33699999999987654


Q ss_pred             CCC--------cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 022520          221 GEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ  276 (296)
Q Consensus       221 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  276 (296)
                      ...        .....||+.|||||++.+.. ++.++|||||||++|||++|+.||......+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~  221 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  221 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence            332        23457899999999986655 89999999999999999999999987654433

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-46  Score=311.84  Aligned_cols=215  Identities=22%  Similarity=0.321  Sum_probs=169.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec--chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEEE
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (296)
                      ....+|++.+.||+|+||.||+|++  .|+.||||+++.+  .+.+.+|++++++++||||+++++++.+..    ..++
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~   77 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   77 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEE
Confidence            3456899999999999999999998  5789999998644  345668999999999999999999875432    2268


Q ss_pred             EEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       140 iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +||||++ |+|.+++....  ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus        78 lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~  153 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  153 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC----
T ss_pred             EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCC-CEeecccccceec
Confidence            9999998 57888876543  24589999999999999999999998 999999999999999888 7999999999865


Q ss_pred             ccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCcc
Q 022520          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       219 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  290 (296)
                      ...  .....+|+.|+|||++.+.. +++++|||||||++|||+| |++||...+..+.+..+.+ ..+++.+
T Consensus       154 ~~~--~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~  222 (262)
T d1byga_         154 SST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAP  222 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCC
T ss_pred             CCC--CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence            332  23456788999999997654 8999999999999999998 7899988876665555543 3444443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=315.17  Aligned_cols=219  Identities=23%  Similarity=0.370  Sum_probs=164.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeeccC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (296)
                      .++|++.+.||+|+||.||+|++..     +++.||+|++....     ....+|..++.++ +|+||+.+++++...  
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence            4579999999999999999999754     44789999885432     2233566666665 689999998876433  


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceE
Q 022520          133 KDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (296)
Q Consensus       133 ~~~~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIl  199 (296)
                        ...+++|||||+ |+|.+++.....            ....+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus        90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  166 (299)
T ss_dssp             --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEE
T ss_pred             --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCcccee
Confidence              233789999998 578888765432            124588999999999999999999998 9999999999999


Q ss_pred             EcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHH
Q 022520          200 VNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVD  275 (296)
Q Consensus       200 i~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~  275 (296)
                      ++.++ .+||+|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+.+..+
T Consensus       167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99887 899999999976543322   23457899999999997654 89999999999999999986 57898877666


Q ss_pred             HHHHHHHhhcCCCc
Q 022520          276 QLVEIIKVILHTEI  289 (296)
Q Consensus       276 ~~~~~~~~~~~~~~  289 (296)
                      .+...++....++.
T Consensus       245 ~~~~~~~~~~~~~~  258 (299)
T d1ywna1         245 EFCRRLKEGTRMRA  258 (299)
T ss_dssp             HHHHHHHHTCCCCC
T ss_pred             HHHHHHhcCCCCCC
Confidence            66666665555544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=314.44  Aligned_cols=213  Identities=26%  Similarity=0.353  Sum_probs=167.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCC---CcEEEEEEEeec-------chhhHHHHHHHHhcCCCCceecceeeeeccCCC
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (296)
                      .+|++.+.||+|+||.||+|++..+   ...||||++...       .+.+.+|+++|+.++||||+++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            4799999999999999999987533   247899987432       1244689999999999999999998832     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeec
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg  213 (296)
                      . ..++|||||+ +++.+.+...   ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhcccccc-ceeeccch
Confidence            1 2578999998 5666665554   35699999999999999999999998 999999999999999887 89999999


Q ss_pred             ceeeeccCCCc----ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       214 ~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      +++........    ....+|..|+|||++.+.. ++.++|||||||++|||+| |++||.+.+..+.+..+.+...+++
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  235 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            99876444322    2335678999999997654 8999999999999999998 8999999988888888777655554


Q ss_pred             c
Q 022520          289 I  289 (296)
Q Consensus       289 ~  289 (296)
                      .
T Consensus       236 ~  236 (273)
T d1u46a_         236 R  236 (273)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=309.80  Aligned_cols=213  Identities=34%  Similarity=0.588  Sum_probs=177.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      ++|++++.||+|+||+||+|++..+++.||||+++...      ....+|+.+|+.++||||+++++++.     +....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            47999999999999999999999999999999985332      23458999999999999999999884     44458


Q ss_pred             EEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceeee
Q 022520          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (296)
Q Consensus       139 ~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~~  218 (296)
                      +++++++.++.+..+...   .+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||.+...
T Consensus        77 ~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            899999998766555443   47889999999999999999999998 999999999999999877 8999999999876


Q ss_pred             ccCC-CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhhcCC
Q 022520          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGESGVDQLVEIIKVILHT  287 (296)
Q Consensus       219 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~  287 (296)
                      .... ......+++.|+|||++.....++.++|||||||++|||++|+.|| .+.+..+.+..+......+
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC
Confidence            4433 3334456888999999877766899999999999999999999775 5555666666666655543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=320.56  Aligned_cols=215  Identities=35%  Similarity=0.612  Sum_probs=176.8

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc------hhhHHHHHHHHhcCCCCceecceeeeeccC-CCceE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (296)
                      ++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+.+|+.++|||++++++++..... .+...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999985432      234589999999999999999999854433 22333


Q ss_pred             EEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       138 ~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      .++++++++++|.+++.     .+++++..++.+++||+.||+|||++ ||+||||||+|||++.++ .++++|||++..
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccc-cccccccchhcc
Confidence            45555555567777664     36799999999999999999999998 999999999999999887 899999999875


Q ss_pred             eccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC
Q 022520          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVILHTE  288 (296)
Q Consensus       218 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  288 (296)
                      ..  .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+....++
T Consensus       171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  239 (348)
T ss_dssp             CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            42  2344567899999999987777789999999999999999999999999998888888887766553

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=316.27  Aligned_cols=210  Identities=28%  Similarity=0.477  Sum_probs=172.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc---CCCcEEEEEEEeec--------chhhHHHHHHHHhcCC-CCceecceeeeecc
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDH-PNVVSLKHCFFSTT  131 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  131 (296)
                      .++|++.+.||+|+||+||+|++.   .+|+.||+|.+...        .....+|++++++++| |||+++++++.   
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec---
Confidence            367999999999999999999984   46899999987422        2234589999999977 89999998883   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEe
Q 022520          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~  210 (296)
                        +....+++|||+.+ +|...+...    ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .++|+
T Consensus       100 --~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~vkL~  171 (322)
T d1vzoa_         100 --TETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLT  171 (322)
T ss_dssp             --ETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEES
T ss_pred             --cCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCC-CEEEe
Confidence              33458899999984 777776653    6788999999999999999999998 999999999999999887 89999


Q ss_pred             eecceeeeccCC--CcccccccccccCCccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 022520          211 DFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVI  284 (296)
Q Consensus       211 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  284 (296)
                      |||+++......  ......|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+..
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~  248 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  248 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999998754332  234567899999999986543 46889999999999999999999998876555555555544

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-45  Score=313.53  Aligned_cols=218  Identities=22%  Similarity=0.316  Sum_probs=174.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCc--EEEEEEEeec-----chhhHHHHHHHHhc-CCCCceecceeeeeccCCC
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (296)
                      ..++|++.++||+|+||+||+|++..++.  .||||++...     ...+.+|+++|+++ +|||||++++++...    
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----   83 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----   83 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC----
Confidence            34589999999999999999999988776  4677876422     23456899999998 799999999998543    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEc
Q 022520          135 ELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (296)
Q Consensus       135 ~~~~~iv~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~  201 (296)
                       ...++||||++ |+|.+++....            .....+++..+..++.||+.||.|||++ +|+||||||+|||++
T Consensus        84 -~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          84 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVG  161 (309)
T ss_dssp             -TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC
T ss_pred             -CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEc
Confidence             34889999999 57888775431            2346799999999999999999999998 999999999999999


Q ss_pred             CCCCcEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q 022520          202 PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEI  280 (296)
Q Consensus       202 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~~  280 (296)
                      .++ .+||+|||+++............||..|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+.+..+
T Consensus       162 ~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         162 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            887 89999999998665554555567899999999996654 899999999999999999965 678877765555554


Q ss_pred             HHhhcCCCc
Q 022520          281 IKVILHTEI  289 (296)
Q Consensus       281 ~~~~~~~~~  289 (296)
                      .+ ..+++.
T Consensus       240 ~~-~~~~~~  247 (309)
T d1fvra_         240 PQ-GYRLEK  247 (309)
T ss_dssp             GG-TCCCCC
T ss_pred             Hh-cCCCCC
Confidence            44 334443

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-45  Score=312.24  Aligned_cols=211  Identities=24%  Similarity=0.339  Sum_probs=170.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCC
Q 022520           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (296)
Q Consensus        64 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (296)
                      .++|++.+.||+|+||+||+|++.     .+++.||||++...     ...+.+|+++|+.++||||+++++++...   
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~---   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG---   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence            457999999999999999999975     35678999988533     23456899999999999999999988433   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHccCCceecc
Q 022520          134 DELYLNLVLEYVP-ETVHRVIKHHY--------------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  192 (296)
Q Consensus       134 ~~~~~~iv~e~~~-~~l~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~D  192 (296)
                        ...+++|||++ ++|.+++....                    .....+++..+..++.|++.||+|||++ +|+|||
T Consensus        89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrD  165 (301)
T d1lufa_          89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRD  165 (301)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSC
T ss_pred             --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeE
Confidence              33789999998 57777775421                    1234588999999999999999999998 999999


Q ss_pred             CCCCceEEcCCCCcEEEeeecceeeeccCC---CcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 022520          193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLF  268 (296)
Q Consensus       193 lkp~NIli~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf  268 (296)
                      |||+|||++.++ .+||+|||+++......   ......+|+.|+|||.+.+.. ++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCC
Confidence            999999999887 79999999997653332   223456789999999997654 899999999999999999985 788


Q ss_pred             CCCChHHHHHHHHH
Q 022520          269 PGESGVDQLVEIIK  282 (296)
Q Consensus       269 ~~~~~~~~~~~~~~  282 (296)
                      .+.+..+.+..+.+
T Consensus       244 ~~~~~~e~~~~v~~  257 (301)
T d1lufa_         244 YGMAHEEVIYYVRD  257 (301)
T ss_dssp             TTSCHHHHHHHHHT
T ss_pred             CCCCHHHHHHHHHc
Confidence            88877666665544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=309.01  Aligned_cols=221  Identities=22%  Similarity=0.368  Sum_probs=169.2

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEEcCCC-------cEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceeccee
Q 022520           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHC  126 (296)
Q Consensus        60 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~  126 (296)
                      +....++|++.+.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            3344568999999999999999999976543       479999885433     2234677778777 89999999999


Q ss_pred             eeeccCCCceEEEEEEeccc-ccHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccC
Q 022520          127 FFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI  193 (296)
Q Consensus       127 ~~~~~~~~~~~~~iv~e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dl  193 (296)
                      +..     ...+++|||||. |++.+++.....            ....+++.++..++.||+.||.|||++ +|+||||
T Consensus        88 ~~~-----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDi  161 (299)
T d1fgka_          88 CTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDL  161 (299)
T ss_dssp             ECS-----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCC
T ss_pred             ccc-----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeee
Confidence            843     334789999998 577777764421            235689999999999999999999999 9999999


Q ss_pred             CCCceEEcCCCCcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 022520          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  269 (296)
Q Consensus       194 kp~NIli~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  269 (296)
                      ||+|||++.++ .+||+|||+++.......   .....+|+.|+|||.+.+.. |+.++|||||||++|||++ |.+||.
T Consensus       162 Kp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         162 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             SGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCC
Confidence            99999999987 899999999987655432   23356799999999996654 8999999999999999998 789998


Q ss_pred             CCChHHHHHHHHHhhcCCCc
Q 022520          270 GESGVDQLVEIIKVILHTEI  289 (296)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~  289 (296)
                      +.+..+... .+.....++.
T Consensus       240 ~~~~~~~~~-~i~~~~~~~~  258 (299)
T d1fgka_         240 GVPVEELFK-LLKEGHRMDK  258 (299)
T ss_dssp             TCCHHHHHH-HHHTTCCCCC
T ss_pred             CCCHHHHHH-HHHcCCCCCC
Confidence            877654444 4443444444

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-44  Score=307.37  Aligned_cols=220  Identities=24%  Similarity=0.352  Sum_probs=177.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEEeecc-----hhhHHHHHHHHhc-CCCCceecceeeeecc
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (296)
                      ...+|++.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++.+ +|||||++++++..  
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence            3468999999999999999999863     466799999985432     2345799999998 69999999999843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCC
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~  196 (296)
                         ....++|||||+ +++..++.....              ....+++..+..++.||+.||.|||++ +|+||||||+
T Consensus        99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~  174 (311)
T d1t46a_          99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAAR  174 (311)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecccccc
Confidence               333789999998 477777765431              234688999999999999999999999 9999999999


Q ss_pred             ceEEcCCCCcEEEeeecceeeeccCCCc---ccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022520          197 NLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (296)
Q Consensus       197 NIli~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~  272 (296)
                      ||+++.++ .++++|||+++........   ....||+.|+|||.+.+. .++.++|||||||++|||+| |.+||.+.+
T Consensus       175 NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            99999887 8999999999876443322   234679999999998654 48999999999999999998 677788877


Q ss_pred             hHHHHHHHHHhhcCCCcc
Q 022520          273 GVDQLVEIIKVILHTEIS  290 (296)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~  290 (296)
                      ..+.+.++++.-.+++.+
T Consensus       253 ~~~~~~~~i~~~~~~~~~  270 (311)
T d1t46a_         253 VDSKFYKMIKEGFRMLSP  270 (311)
T ss_dssp             SSHHHHHHHHHTCCCCCC
T ss_pred             HHHHHHHHHhcCCCCCCc
Confidence            777777777665555543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=308.35  Aligned_cols=195  Identities=22%  Similarity=0.276  Sum_probs=158.3

Q ss_pred             cceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecchh-hHHH--HHHHHhcCCCCceecceeeeeccCCCceEEEEE
Q 022520           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-KNRE--LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (296)
Q Consensus        65 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~E--~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  141 (296)
                      .+|.+.+.||+|+||.||+|++  +|+.||||++...... ..+|  +..+..++||||+++++++.... .....+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            4799999999999999999987  7889999998544322 2234  44445689999999999987654 344568899


Q ss_pred             Eeccc-ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc--------cCCceeccCCCCceEEcCCCCcEEEeee
Q 022520          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--------TIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (296)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~--------~~~iiH~Dlkp~NIli~~~~~~ikl~Df  212 (296)
                      ||||+ |+|...+..     .++++..+..++.|++.||+|||+        + ||+||||||+|||++.++ .+||+||
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~-~IvHrDlKp~NILl~~~~-~~Kl~DF  152 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIADL  152 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC-CeeccccCccceEEcCCC-CeEEEec
Confidence            99998 578788764     468999999999999999999996        4 899999999999999887 8999999


Q ss_pred             cceeeeccCCC-----cccccccccccCCccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCC
Q 022520          213 GSAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFP  269 (296)
Q Consensus       213 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g~~pf~  269 (296)
                      |+++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||..||.
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            99987755432     23457899999999985432     25678999999999999999988764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=304.97  Aligned_cols=196  Identities=22%  Similarity=0.311  Sum_probs=156.5

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCC---cEEEEEEEeec-----chhhHHHHHHHHhcCCCCceecceeeeeccCCCceEE
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (296)
                      +.+.++||+|+||+||+|++..++   ..||||++...     ...+.+|+++|++++||||+++++++...    ....
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence            344688999999999999986543   46899988532     23356899999999999999999987543    2347


Q ss_pred             EEEEecccc-cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       139 ~iv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      ++|||||++ ++.+++...   ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCC-CEEEecccchhh
Confidence            899999995 555555432   45677888999999999999999998 999999999999999877 899999999987


Q ss_pred             eccCCC-----cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 022520          218 LVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (296)
Q Consensus       218 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  272 (296)
                      ......     .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~  238 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDV  238 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred             ccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence            644322     22346799999999986554 8999999999999999999877766543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=303.82  Aligned_cols=214  Identities=21%  Similarity=0.260  Sum_probs=173.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEEeecc-----hhhHHHHHHHHhcCCCCceecceeeeecc
Q 022520           62 KQTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (296)
Q Consensus        62 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (296)
                      ...++|.+.+.||+|+||+||+|.+..     ++..||||++....     ..+.+|++++++++||||+++++++... 
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-   95 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-   95 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-
Confidence            344689999999999999999998752     35789999885332     2245899999999999999999988432 


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC
Q 022520          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (296)
Q Consensus       132 ~~~~~~~~iv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~  204 (296)
                          ...++|||||+ |++..++.....      ....++...+..++.|+++||.|||++ +|+||||||+|||++.++
T Consensus        96 ----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          96 ----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC
T ss_pred             ----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCc
Confidence                23789999998 577777654431      224578889999999999999999998 999999999999999887


Q ss_pred             CcEEEeeecceeeeccCCC---cccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 022520          205 HQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEI  280 (296)
Q Consensus       205 ~~ikl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~~~~~~  280 (296)
                       .+||+|||+++.......   .....+|+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+.+..+
T Consensus       171 -~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i  248 (308)
T d1p4oa_         171 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  248 (308)
T ss_dssp             -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             -eEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             899999999976544332   22346799999999986554 88999999999999999998 5889888877777666


Q ss_pred             HHh
Q 022520          281 IKV  283 (296)
Q Consensus       281 ~~~  283 (296)
                      .+.
T Consensus       249 ~~~  251 (308)
T d1p4oa_         249 MEG  251 (308)
T ss_dssp             HTT
T ss_pred             HhC
Confidence            553

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.7e-39  Score=282.09  Aligned_cols=217  Identities=30%  Similarity=0.502  Sum_probs=165.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc---hhhHHHHHHHHhcC-----------CCCceecceeee
Q 022520           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFF  128 (296)
Q Consensus        63 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~~~~  128 (296)
                      ..++|+++++||+|+||+||+|++..+|+.||||++..+.   ....+|+.+++.++           |+||+++++++.
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            3357999999999999999999999999999999996543   33457898888875           578999998874


Q ss_pred             eccCCCceEEEEEEeccc--ccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCCC-
Q 022520          129 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-  205 (296)
Q Consensus       129 ~~~~~~~~~~~iv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~~-  205 (296)
                      ...   ....++++.++.  ++.......  .....+++..++.++.|++.||+|||+..||+||||||+|||++.++. 
T Consensus        91 ~~~---~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          91 HKG---PNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEE---TTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             ecc---ccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            432   222344555443  444443333  335788999999999999999999998339999999999999976542 


Q ss_pred             ----cEEEeeecceeeeccCCCcccccccccccCCccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHH
Q 022520          206 ----QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVD  275 (296)
Q Consensus       206 ----~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~  275 (296)
                          .++++|||.+.....  ......||+.|+|||++.... ++.++||||+||++++|++|+.||...+      ..+
T Consensus       166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cccceeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                489999999876533  335567899999999987654 8999999999999999999999997543      234


Q ss_pred             HHHHHHHhhcCC
Q 022520          276 QLVEIIKVILHT  287 (296)
Q Consensus       276 ~~~~~~~~~~~~  287 (296)
                      .+......++.+
T Consensus       243 ~~~~~~~~lg~~  254 (362)
T d1q8ya_         243 HIAQIIELLGEL  254 (362)
T ss_dssp             HHHHHHHHHCSC
T ss_pred             HHHHHHHHhCCC
Confidence            556666655543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.6e-27  Score=188.93  Aligned_cols=159  Identities=18%  Similarity=0.147  Sum_probs=114.9

Q ss_pred             eEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeecc----------------------hhhHHHHHHHHhcCCCCceecc
Q 022520           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK  124 (296)
Q Consensus        67 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~E~~~l~~l~h~niv~~~  124 (296)
                      |.+.++||+|+||+||+|++ .+|+.||||++....                      ....+|...+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            56889999999999999997 478899999764211                      1112578888999999988875


Q ss_pred             eeeeeccCCCceEEEEEEecccccHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHccCCceeccCCCCceEEcCCC
Q 022520          125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (296)
Q Consensus       125 ~~~~~~~~~~~~~~~iv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~iiH~Dlkp~NIli~~~~  204 (296)
                      +..     .    .+++|||+++...          ..++...+..++.|++.+|.|||++ ||+||||||+|||++++ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-
Confidence            543     2    2689999997421          1234445678899999999999998 99999999999999965 


Q ss_pred             CcEEEeeecceeeeccCCCcccccccccccC------CccccCCCCCCCchhHHHHHHH
Q 022520          205 HQLKLCDFGSAKVLVKGEPNISYICSRYYRA------PELIFGATEYTAAIDIWSAGCV  257 (296)
Q Consensus       205 ~~ikl~Dfg~~~~~~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~~DiwSlG~i  257 (296)
                       .++|+|||+|........       ..|..      .+.+  ...|+.++|+||+.--
T Consensus       140 -~~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGW-------REILERDVRNIITYF--SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             -EEEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHH--HHHHCCCCCHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHH--cCCCCCcccHHHHHHH
Confidence             499999999875422211       01111      1112  2347889999996543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.26  E-value=2.5e-06  Score=68.90  Aligned_cols=76  Identities=17%  Similarity=0.112  Sum_probs=46.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEcCCCcEEEEEEEeec----chhhHHHHHHHHhcCCCC-ceecceeeeeccCCCceEEEE
Q 022520           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPN-VVSLKHCFFSTTEKDELYLNL  140 (296)
Q Consensus        66 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~i  140 (296)
                      .|+..+..+.++.+.||+..  .++..+++|+....    .....+|...+..+.-.. +.+++...     .+....++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            56777665555567899886  35666788877433    223467888888774221 23333332     12234678


Q ss_pred             EEeccccc
Q 022520          141 VLEYVPET  148 (296)
Q Consensus       141 v~e~~~~~  148 (296)
                      ||++++|.
T Consensus        88 v~~~l~G~   95 (263)
T d1j7la_          88 LMSEADGV   95 (263)
T ss_dssp             EEECCSSE
T ss_pred             EEEecccc
Confidence            99999874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.07  E-value=1.8e-05  Score=67.92  Aligned_cols=71  Identities=21%  Similarity=0.232  Sum_probs=42.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEEeec-----------chhhHHHHHHHHhcC-C-CCcee-cceeeeeccCCCc
Q 022520           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLD-H-PNVVS-LKHCFFSTTEKDE  135 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~E~~~l~~l~-h-~niv~-~~~~~~~~~~~~~  135 (296)
                      .+.||.|....||++.+..+++.+++|.....           ......|.+.|+.+. + |..++ ++.  ++.   +.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~---~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDT---EM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EET---TT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcC---CC
Confidence            45689999999999987777888999965321           122345888888763 2 33333 322  121   11


Q ss_pred             eEEEEEEecccc
Q 022520          136 LYLNLVLEYVPE  147 (296)
Q Consensus       136 ~~~~iv~e~~~~  147 (296)
                        ..+|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3579999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=5.1e-05  Score=60.60  Aligned_cols=68  Identities=18%  Similarity=0.142  Sum_probs=41.9

Q ss_pred             eecC-ceEEEEEEEcCCCcEEEEEEEeecc-hhhHHHHHHHHhcCCCCc--eecceeeeeccCCCceEEEEEEecccc
Q 022520           74 GHGS-FGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYVPE  147 (296)
Q Consensus        74 G~G~-~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~iv~e~~~~  147 (296)
                      ..|. -+.||+... ..+..+++|...... .....|...++.+....+  .+++.+..     +....++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            4444 367898874 456668889765433 345679999888754443  23333321     22236789999986

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.31  E-value=0.00078  Score=57.37  Aligned_cols=69  Identities=17%  Similarity=0.218  Sum_probs=43.7

Q ss_pred             eeeeeecCceEEEEEEEcC-------CCcEEEEEEEeec--chhhHHHHHHHHhcCCCCce-ecceeeeeccCCCceEEE
Q 022520           70 ERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYLN  139 (296)
Q Consensus        70 ~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~  139 (296)
                      ++.|+.|-.-.+|++....       ....|.+++.-..  .....+|..+++.+.-.++. ++++++     .+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence            3567778888999998643       2356777766322  12234788898888644555 444444     22    4


Q ss_pred             EEEecccc
Q 022520          140 LVLEYVPE  147 (296)
Q Consensus       140 iv~e~~~~  147 (296)
                      +|++|++|
T Consensus       118 ~I~efi~g  125 (395)
T d1nw1a_         118 RLEEYIPS  125 (395)
T ss_dssp             EEECCCCE
T ss_pred             eEEEEecc
Confidence            68898875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.12  E-value=0.00022  Score=59.19  Aligned_cols=38  Identities=18%  Similarity=-0.013  Sum_probs=27.8

Q ss_pred             ceEEEEEEEcCCCcEEEEEEEeec---chhhHHHHHHHHhcC
Q 022520           78 FGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLD  116 (296)
Q Consensus        78 ~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~  116 (296)
                      --.||+++. .+|..+++|+....   ......|.+.+..|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence            468999974 67888999987543   344567888888774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.38  E-value=0.013  Score=47.60  Aligned_cols=30  Identities=30%  Similarity=0.257  Sum_probs=26.0

Q ss_pred             CceeccCCCCceEEcCCCCcEEEeeecceee
Q 022520          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (296)
Q Consensus       187 ~iiH~Dlkp~NIli~~~~~~ikl~Dfg~~~~  217 (296)
                      |+||+|+.+.||+++.+. ..-++||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDE-LSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccccCCcchhhhhccccc-ceeEeccccccc
Confidence            799999999999999765 457999998864